CA2383592A1 - 2384891 acids including open reading frames encoding polypeptides; orfx - Google Patents

2384891 acids including open reading frames encoding polypeptides; orfx Download PDF

Info

Publication number
CA2383592A1
CA2383592A1 CA002383592A CA2383592A CA2383592A1 CA 2383592 A1 CA2383592 A1 CA 2383592A1 CA 002383592 A CA002383592 A CA 002383592A CA 2383592 A CA2383592 A CA 2383592A CA 2383592 A1 CA2383592 A1 CA 2383592A1
Authority
CA
Canada
Prior art keywords
orfx
protein
nucleic acid
polypeptide
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002383592A
Other languages
French (fr)
Inventor
Richard A. Shimkets
Martin Leach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2383592A1 publication Critical patent/CA2383592A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/14Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)

Abstract

The present invention provides open reading frames encoding isolated polypeptides, as well as polynucleotides encoding ORFX and antibodies that immunospecifically bind to ORFX or any derivative, variant, mutant, or fragment of the ORFX polypeptides, polynucleotides or antibodies. The invention additionally provides methods in which the ORFX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as to other uses.

Description

DEMANDE OU BREVET VOLUMINEUX
LA PRESENTE PARTIE DE CETTE DEMANDE OU CE BREVET COMPREND
PLUS D'UN TOME.

NOTE : Pour les tomes additionels, veuillez contacter 1e Bureau canadien des brevets JUMBO APPLICATIONS/PATENTS
THIS SECTION OF THE APPLICATION/PATENT CONTAINS MORE THAN ONE
VOLUME

NOTE: For additional volumes, please contact the Canadian Patent Office NOM DU FICHIER / FILE NAME
US2000008621.TIF
NOTE POUR LE TOME / VOLUME NOTE:
CD 2000/192 available in Client Service Centre and images available via AppFiles (5502 Pages) NOVEL POLYNUCLEOTIDES AND POLYPEPTIDES ENCODED THEREBY
BACKGROUND OF THE INVENTION
The invention relates generally to nucleic acids and polypeptides encoded thereby, and methods of using these nucleic acids and polypeptides.
SUMMARY OF THE INVENTION
The invention is based in part on the discovery of nucleic acids that include open reading frames encoding novel polypeptides, and on the polypeptides encoded thereby.
The nucleic acids and polypeptides are collectively referred to herein as "ORFX".
Accordingly, in one aspect, the invention provides an isolated nucleic acid molecule (SEQ ID N0:2n-1, wherein n is an integer between 1-3161), that encodes novel polypeptide, or a fragment, homolog, analog or derivative thereof. The nucleic acid can include, e.g., a nucleic acid sequence encoding a polypeptide at least 85% identical to a polypeptide comprising the amino acid sequences of SEQ ID N0:2n, wherein n is an integer between 1-3161.
The nucleic acid can be, e.g., a genomic DNA fragment, or a cDNA molecule.
Also included in the invention is a vector containing one or more of the nucleic acids described herein, and a cell containing the vectors or nucleic acids described herein.
The invention is also directed to host cells transformed with a recombinant expression vector comprising any of the nucleic acid molecules described above.
In another aspect, the invention includes a pharmaceutical composition that includes an ORFX nucleic acid and a pharmaceutically acceptable carrier or diluent.

In a further aspect, the invention includes a substantially purified ORF
polypeptide, e.g., any of the ORFX polypeptides encoded by an ORFX nucleic acid, and fragments, homologs, analogs, and derivatives thereof. The invention also includes a pharmaceutical composition that includes a ORFX polypeptide and a pharmaceutically acceptable carrier or diluent.
S In a still a further aspect, the invention provides an antibody that binds specifically to an ORFX polypeptide. The antibody can be, e.g., a monoclonal or polyclonal antibody, and fragments, homologs, analogs, and derivatives thereof. The invention also includes a pharmaceutical composition including ORFX antibody and a pharmaceutically acceptable carrier or diluent. The invention is also directed to isolated antibodies that bind to an epitope on a polypeptide encoded by any of the nucleic acid molecules described above.
The invention also includes kits comprising any of the pharmaceutical compositions described above.
The invention fiu~ther provides a method for producing an ORFX polypeptide by providing a cell containing a ORFX nucleic acid, e.g., a vector that includes a ORFX nucleic 1 S acid, and culturing the cell under conditions sufficient to express the ORFX polypeptide encoded by the nucleic acid. The expressed ORFX polypeptide is then recovered from the cell.
Preferably, the cell produces little or no endogenous ORFX polypeptide. The cell can be, e.g., a prokaryotic cell or eukaryotic cell.
The invention is also directed to methods of identifying an ORFX polypeptide or nucleic acids in a sample by contacting the sample with a compound that specifically binds to the polypeptide or nucleic acid, and detecting complex formation, if present.
The invention further provides methods of identifying a compound that modulates the activity of a ORFX polypeptide by contacting ORFX polypeptide with a compound and determining whether the ORFX polypeptide activity is modified.
The invention is also directed to compounds that modulate ORFX polypeptide activity identified by contacting a ORFX polypeptide with the compound and determining whether the compound modifies activity of the ORFX polypeptide, binds to the ORFX
polypeptide, or binds to a nucleic acid molecule encoding a ORFX polypeptide.
In a another aspect, the invention provides a method of determining the presence of or predisposition of an ORFX-associated disorder in a subject. The method includes providing a sample from the subject and measuring the amount of ORFX polypeptide in the subject sample.
The amount of ORFX polypeptide in the subject sample is then compared to the amount of ORFX polypeptide in a control sample. An alteration in the amount of ORFX
polypeptide in the subject protein sample relative to the amount of ORFX polypeptide in the control protein sample indicates the subject has a tissue proliferation-associated condition. A
control sample is preferably taken from a matched individual, i.e., an individual of similar age, sex, or other general condition but who is not suspected of having a tissue proliferation-associated condition.
Alternatively, the control sample may be taken from the subject at a time when the subject is not suspected of having a tissue proliferation-associated disorder. In some embodiments, the ORFX
is detected using a ORFX antibody.
In a further aspect, the invention provides a method of determining the presence of or predisposition of an ORFX-associated disorder in a subject. The method includes providing a nucleic acid sample, e.g., RNA or DNA, or both, from the subject and measuring the amount of the ORFX nucleic acid in the subject nucleic acid sample. The amount of ORFX
nucleic acid sample in the subject nucleic acid is then compared to the amount of an ORFX
nucleic acid in a control sample. An alteration in the amount of ORFX nucleic acid in the sample relative to the amount of ORFX in the control sample indicates the subject has a tissue proliferation-associated disorder.
In a still further aspect, the invention provides method of treating or preventing or delaying a ORFX-associated disorder. The method includes administering to a subject in which such treatment or prevention or delay is desired a ORFX nucleic acid, a ORFX
polypeptide, or an ORFX antibody in an amount sufficient to treat, prevent, or delay a tissue proliferation-associated disorder in the subject.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, suitable methods and materials are described below. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety. In the case of conflict, the present specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.

Other features and advantages of the invention will be apparent from the following detailed description and claims.
DETAILED DESCRIPTION OF THE INVENTION
The invention provides novel polypeptides and nucleotides encoded thereby. The polynucleotides and their encoded polypeptides can be grouped according to the functions played by their gene products. Such functions include, structural proteins, proteins from which associated with metabolic pathways fatty acid metabolism, glycolysis, intermediary metabolism, calcium metabolism, proteases, and amino acid metabolism, etc.
Included in the invention are 3161 novel nucleic acid sequences and their encoded polypeptides. The sequences are collectively referred to as "ORFX nucleic acids" or ORFX
polynucleotides" and the corresponding encoded polypeptide is referred to as a "ORFX
polypeptide" or ORFX protein". For example, an ORFX nucleic acid according to the invention is a nucleic acid including an ORF 1 nucleic acid, and an ORF polypeptide according to the invention is a polypeptide that includes the amino acid sequence of an ORF1 polypeptide.
Unless indicated otherwise, "ORFX" is meant to refer to any of the ORF1-3161 sequences disclosed herein.
Table 1 provides a summary of the ORFX nucleic acids and their encoded polypeptides are summarized in Table 1. Nucleic acid sequences and polypeptide sequences for ORFX
nucleic acids according to the invention is provided in the section of the specification entitled "Disclosed Sequences of ORFX Nucleic Acid and Polypeptide Sequences."
Column 1 of Table 1, entitled "ORF #", denotes an ORF number assigned to a nucleic acid containing an open reading frame according to the invention.
Column 2 of Table 1, entitled "Internal Identification number (Nucleic Acid Sequence Identification Number, Polypeptide Sequence Identification Number), provides an internal identification number for the indicated ORF, along with sequence identification numbers (SEQ
ID NOs.) corresponding to the indicated ORF. In general, for an ORFn according to the invention (wherein n is any integer from 1 to 3161 ), a nucleic acid corresponding to the ORF is SEQ ID N0:2n-1, and an amino acid sequence encoded by the ORF is SEQ ID N0:2n.
For example, a nucleic acid sequence corresponding to an ORF1 nucleic acid is SEQ
ID NO:1, and a polypeptide sequence corresponding to an ORF 1 polypeptide is SEQ ID N0:2.
Similarly, a nucleic acid sequence corresponding to an ORF4 nucleic acid is SEQ ID N0:7, and a polypeptide sequence corresponding to an ORF4 polypeptide is SEQ ID N0:8; a nucleic acid sequence corresponding to an ORF198 nucleic acid sequence is SEQ ID N0:395, and a polypeptide sequence corresponding to an ORF198 polypeptide is SEQ ID N0:396.
Nucleic acid sequences and polypeptide sequences for ORFX nucleic acids according to the invention are provided in the section of the specification entitled "Disclosed Sequences of ORFX Nucleic Acid and Polypeptide Sequences."
Column 2 of Table 1, entitled "Protein Similarity", lists previously described proteins that are related to polypeptides encoded by the ORFs. Genbank identifiers for the previously described proteins are provided. These can be retrieved from http://www.ncbi.nlm.nih.gov/.
To determine similarity to previously described proteins, polypeptides encoded by ORFX
DNA sequences were tested using the Framesearch Algorithm against a nonredundant version of the GenPept Database from NCBI/Genbank. DNA sequences that had a score of'90' or above (Framesearch algorithm score, Edelman et. al. GCG Genetics) to a known protein were selected.
Open reading frames were extended beyond the region of the protein matched using standard DNA translation and codon tables. Novel proteins that lacked a protein match were translated against the standard genetic codons and proteins with an ORF at least 80 amino acids and containing a Methionine start are included in the Table.
Column 3 of Table 3, entitled "Protein Domains", lists previously described protein domains, designated by pfam entries, that are present in polypeptides encoded by the ORFs, Also included in column 3 are proteins in which these domains are present. The pfam entries can be retrieved from http://pfam.wustl.edu/. DNA sequences were translated in all six frames and tested using the Hmmer Algorithm against the Pfam Database (References to the algorithm and Pfam database can be found at http://pfam.wustl.edu). Translated DNA sequences that matched a protein domain entry in the Pfam database AND had a score of 7.5' were selected.
Column 4 of Table 3, entitled "Protein Classification", lists the type of classification assigned for the protein, based on its homology. Examples of proteins in the classification include the following proteins:

Amylases Amylase is responsible for endohydrolysis of 1,4-alpha-glucosidic linkages in oligosaccharides and polysaccharides. Variations in amylase gene may be indicative of delayed maturation and of various amylase producing neoplasms and carcinomas.
Amyloid The serum amyloid A (SAA) proteins comprise a family of vertebrate proteins that associate predominantly with high density lipoproteins (HDL). The synthesis of certain members of the family is greatly increased in inflammation. Prolonged elevation of plasma SAA levels, as in chronic inflammation, 15 results in a pathological condition, called amyloidosis, which affects the liver, kidney and spleen and which is characterized by the highly insoluble accumulation of SAA in these tissues. Amyloid selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle, while not affecting adipocyte glucose metabolism. Deposition of fibrillar amyloid proteins intraneuronally, as neurofibrillary tangles, extracellularly, as plaques and in blood vessels, is characteristic of both Alzheimer's disease and aged Down's syndrome.
Amyloid deposition is also associated with type II diabetes mellitus.
Angiopoeitin Members of the angiopoeitin/fibrinogen family have been shown to stimulate the generation of new blood vessels, inhibit the generation of new blood vessels, and perform several roles in blood clotting. This generation of new blood vessels, called angiogenesis, is also an essential step in tumor growth in order for the tumor to get the blood supply it needs to expand.
Variation in these genes may be predictive of any form of heart disease, numerous blood clotting disorders, stroke, hypertension and predisposition to tumor formation and metastasis. In particular, these variants may be predictive of the response to various antihypertensive drugs and chemotherapeutic and anti-tumor agents.
Apoptosis-related proteins Active cell suicide (apoptosis) is induced by events such as growth factor withdrawal and toxins. It is controlled by regulators, which have either an inhibitory effect on programmed cell death (anti-apoptotic) or block the protective effect of inhibitors (pro-apoptotic). Many viruses have found a way of countering defensive apoptosis by encoding their own anti-apoptosis genes preventing their target-cells from dying too soon. Variants of apoptosis related genes may be useful in formulation of anti-aging drugs.
Cadherin, Cyclin, Polymerase, Oncogenes, Histones, Kinases Members of the cell division/cell cycle pathways such as cyclins, many transcription factors and kinases, DNA polymerases, histones, helicases and other oncogenes play a critical role in carcinogenesis where the uncontrolled proliferation of cells leads to tumor formation and eventually metastasis. Variation in these genes may be predictive of predisposition to any form of cancer, from increased risk of tumor formation to increased rate of metastasis. In particular, these variants may be predictive of the response to various chemotherapeutic and anti-tumor agents.
Colony-stimulating factor-related proteins Granulocyte/macrophage colony-stimulating factors are cytokines that act in 1 S hematopoiesis by controlling the production, differentiation, and function of 2 related white cell populations of the blood, the granulocytes and the monocytes-macrophages.
Complement-related proteins Complement proteins are immune associated cytotoxic agents, acting in a chain reaction to exterminate target cells to that were opsonized (primed) with antibodies, by forming a membrane attack complex (MAC). The mechanism of killing is by opening pores in the target cell membrane. Variations in 20 complement genes or their inhibitors are associated with many autoimmune disorders. Modified serum levels of complement products cause edemas of various tissues, lupus (SLE), vasculitis, glomerulonephritis, renal failure, hemolytic anemia, thrombocytopenia, and arthritis. They interfere with mechanisms of ADCC
(antibody dependent cell cytotoxicity), severely impair immune competence and reduce phagocytic ability. Variants of complement genes may also be indicative of type I diabetes mellitus, meningitis neurological disorders such as nemaline myopathy, neonatal hypotonia, muscular disorders such as congenital myopathy and other diseases.

Cytochrome The respiratory chain is a key biochemical pathway which is essential to all aerobic cells.
There are five different cytochromes involved in the chain. These are heme bound proteins which serve as electron carriers. Modifications in these genes may be predictive of ataxia areflexia, dementia and myopathic and neuropathic changes in muscles. Also, association with various types of solid tumors.
Kinesins Kinesins are tubulin molecular motors that function to transport organelles within cells and to move chromosomes along microtubules during cell division. Modifications of these genes may be indicative of neurological disorders such as Pick disease of the brain, tuberous sclerosis.
Cytokines, Interferon, Interleukin Members of the cytokine families are known for their potent ability to stimulate cell growth and division even at low concentrations. Cytokines such as erythropoietin are cell-specific in their growth stimulation; erythropoietin is useful for the stimulation of the proliferation of erythroblasts. Variants in cytokines may be predictive for a wide variety of diseases, including cancer predisposition.
G-protein coupled receptors G-protein coupled receptors (also called R7G) are an extensive group of hormones, neurotransmitters, odorants and light receptors which transduce extracellular signals by interaction with guanine nucleotide-binding (G) proteins. Alterations in genes coding for G-coupled proteins may be involved in and indicative of a vast number of physiological conditions. These include blood pressure regulation, renal dysfunctions, male infertility, dopamine associated cognitive, emotional, and endocrine functions, hypercalcemia, chondrodysplasia and osteoporosis, pseudohypoparathyroidism, -growth retardation and dwarfism.

Thioesterases Eukaryotic thiol proteases are a family of proteolytic enzymes which contain an active site cysteine. Catalysis proceeds through a thioester intermediate and is facilitated by a nearby histidine side chain; an asparagine completes the essential catalytic triad.
Variants of thioester associated genes may be predictive of neuronal disorders and mental illnesses such as Ceroid Lipoffiscinosis, Neuronal 1, Infantile, Santavuori disease and more.
The key to the molecule type is as follows:
Abbrev: Title:

amylase amylase protein amylaseinhib amylase inhibitor amyloid amyloid protein apoptosis apoptosis associated protein apoptosisinhib apoptosis inhibitors apoptosisrecep apoptosis receptors ATPase_associated ATPase associated protein biotindep biotin dependent enzyme/protein cadherin cadherin protein calcium_channel calcium channel protein carboxylase carboxylase protein cathepsin cathepsin/carboxypeptidases cathepsininhib cathepsin/carboxypeptidase inhibitor chloride_channel chloride channel protein collagen collagen complement complement protein complementrecept complement receptor protein complementinhib complement inhibitor csf colony stimulating factor csfrecept colony stimulating factor receptor cyclin cyclin protein cyto450 cytochrome p450 protein cytochrome cytochrome related protein deaminase deaminase dehydrogenase dehydrogenase desaturase desaturase dna_rna_bind DNA/RNA binding protein/factor dna_rna_inhib DNA/RNA binding protein/factor inhibitor dynein dynein elastase elastase elastaseinhib elastase inhibitor eph EPH family of tyrosine kinases esterase esterase esteraseinhib esterase inhibitor fgf fibroblast growth factor fgfreceptor fibroblast growth factor receptor gaba GABA receptor glucoamylase glucoamylase glucoronidase glucoronidase glycoprotein glycoprotein Guanylyl guanylylate cyclase helicase helicase histone histone HOM homologous homeobox homeobox protein hydrolase hydrolase hydroxysteroid hydroxysteroid associated protein hypoxanthine hypoxanthine associated protein immunoglob immunoglobulin immunoglobrecept immunoglobulin receptor interferon interferon interleukin interleukin interleukinrecept interleukin receptor isomerase isomerase isomeraseinhibitor isomerase inhibitor isomerasereceptor isomerase receptor kinase kinase kinaseinhibitor kinase inhibitor kinasereceptor kinase receptor kinesin kinesin laminin laminin associated protein lipase lipase metallothionein metallothionein MHC major histocompatability complex misc_channel miscellaneous channel ngf nerve growth factor nuci_recpt nuclear receptor nuclease nuclease oncogene oncogene associated protein oxidase oxidase oxygenase oxygenase peptidase peptidase peroxidase peroxidase phosphatase phosphatase phosphataseinhib phosphatase inhibitor phosphorylase phosphorylase PIR PIR DATABASE (release 56, 29-OCT-1998) polymerase polymerase potassium_channel potassium channel protein prostaglandin prostaglandin protease protease proteaseinhib protease inhibitor reductase reductase ribosomalprot ribosomal associated protein RTR EMBLDATABASE translated entries not to be incorporated into SWISS-PROT (20-JUL-1998) SIM similar 1 S SPTR EMBL DATABASE translated entries to be incorporated into SWISS-PROT (20-JLJL-1998) struct structural associated protein sulfotransferase sulfotransferase SWP SWISS-PROT DATABASE (release 18-OCT-1998) SWPN SWISS-PROT Update (release 11-NOV-98) synthase synthase tgf transforming growth factor tgfreceptor transforming growth factor receptor thioesterase thioesterase thiolase thiolase tm7 seven transmembrane domain G-protein coupled receptor tnf necrosis factor receptor traffic tumor necrosis factor tnfreceptor tumor trafficking associated protein TRN EMBL DATABASE translated entries update (20-JLJL-1998) transcriptfactor transcription factor transferase transferase transport transport protein tubulin tubulin ubiquitin ubiquitin unclassified Protein not categorized into one of the aforementioned protein families water channel water channel protein Column S of Table 1, entitled, "Cells or Tissues in Which Gene is Expressed", denotes tissues, represented by five digit numbers, in which RNA homologous to the ORF nucleic acid sequences is present. Tissues or cells corresponding to the numbers are provided in Table 2.
ORFX nucleic acids, and their encoded polypeptides, according to the invention are useful in a variety of applications and contexts. For example, various ORFX
nucleic acids and polypeptides according to the invention are useful, inter alia, as novel members of the protein families indicated in Table 1, and/or according to the presence of domains and sequence relatedness to previously described proteins as summarized in Table 1.
ORFX nucleic acids and polypeptides according to the invention can also be used to identify cell types listed in Table 1 for an indicated ORFX according to the invention.
Additional utilities for ORFX nucleic acids and polypeptides according to the invention are disclosed herein.
ORFX Nucleic Acids The novel nucleic acids of the invention include those that encode an ORFX or ORFX-like protein, or biologically active portions thereof. The nucleic acids include nucleic acids encoding polypeptides that include the amino acid sequence of one or more of SEQ ID N0:2n, wherein n = 1 to 3161. The encoded polypeptides can thus include, e.g., the amino acid sequences of SEQ ID NO: 2, 4, 6, 8, 10, . . ., 6310, 6312, 6314, 6316, 6318, 6320, and/or 6322.
In some embodiments, a nucleic acid encoding a polypeptide having the amino acid sequence of one or more of SEQ ID N0:2n (wherein n = 1 to 3161 ) includes the nucleic acid sequence of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161 ), or a fragment thereof.
Additionally, the invention includes mutant or variant nucleic acids of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161 ), or a fragment thereof, any of whose bases may be changed from the disclosed sequence while still encoding a protein that maintains its ORFX -like activities and physiological functions. The invention further includes the complement of the nucleic acid sequence of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161 ), including fragments, derivatives, analogs and homolog thereof. The invention additionally includes nucleic acids or nucleic acid fragments, or complements thereto, whose structures include chemical modifications.
Also included are nucleic acid fragments sufficient for use as hybridization probes to identify ORFX-encoding nucleic acids (e.g., ORFX mRNA) and fragments for use as polymerase chain reaction (PCR) primers for the amplification or mutation of ORFX nucleic acid molecules. As used herein, the term "nucleic acid molecule" is intended to include DNA
molecules (e.g., cDNA or genomic DNA), RNA molecules (e.g., mRNA), analogs of the DNA or RNA generated using nucleotide analogs, and derivatives, fragments and homologs thereof. The nucleic acid molecule can be single-stranded or double-stranded, but preferably is double-stranded DNA.
"Probes" refer to nucleic acid sequences of variable length, preferably between at least about 10 nucleotides (nt), 100 nt, or as many as about, e.g., 6,000 nt, depending on use. Probes are used in the detection of identical, similar, or complementary nucleic acid sequences. Longer length probes are usually obtained from a natural or recombinant source, are highly specific and much slower to hybridize than oligomers. Probes may be single- or double-stranded and designed to have specificity in PCR, membrane-based hybridization technologies, or ELISA-like technologies.
An "isolated" nucleic acid molecule is one that is separated from other nucleic acid molecules that are present in the natural source of the nucleic acid. Examples of isolated nucleic acid molecules include, but are not limited to, recombinant DNA molecules contained in a vector, recombinant DNA molecules maintained in a heterologous host cell, partially or substantially purified nucleic acid molecules, and synthetic DNA or RNA
molecules. Preferably, an "isolated" nucleic acid is free of sequences which naturally flank the nucleic acid (i.e., sequences located at the 5' and 3' ends of the nucleic acid) in the genomic DNA of the organism from which the nucleic acid is derived. For example, in various embodiments, the isolated ORFX nucleic acid molecule can contain less than about 50 kb, 25 kb, 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5 kb or 0.1 kb of nucleotide sequences which naturally flank the nucleic acid molecule in genomic DNA of the cell from which the nucleic acid is derived: Moreover, an "isolated"
nucleic acid molecule, such as a cDNA molecule, can be substantially free of other cellular material or culture medium when produced by recombinant techniques, or of chemical precursors or other chemicals when chemically synthesized.

A nucleic acid molecule of the present invention, e.g., a nucleic acid molecule having the nucleotide sequence of SEQ ID N0:2n-1 (wherein n = 1 to 3161), or a complement of any of this nucleotide sequence, can be isolated using standard molecular biology techniques and the sequence information provided herein. Using all or a portion of the nucleic acid sequence of any S of SEQ ID N0:2n-1 (wherein n=1 to 3161) as a hybridization probe, ORFX
nucleic acid sequences can be isolated using standard hybridization and cloning techniques (e.g., as described in Sambrook et al., eds., MOLECULAR CLONING: A LABORATORY MANUAL 2°d Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989; and Ausubel, et al., eds., CURRENT
PROTOCOLS IN MOLECULAR BIOLOGY, John Wiley & Sons, New York, NY, 1993.) A nucleic acid of the invention can be amplified using cDNA, mRNA or alternatively, genomic DNA, as a template and appropriate oligonucleotide primers according to standard PCR
amplification techniques. The nucleic acid so amplified can be cloned into an appropriate vector and characterized by DNA sequence analysis. Furthermore, oligonucleotides corresponding to ORFX nucleotide sequences can be prepared by standard synthetic techniques, e.g., using an automated DNA synthesizer.
As used herein, the term "oligonucleotide" refers to a series of linked nucleotide residues, which oligonucleotide has a sufficient number of nucleotide bases to be used in a PCR reaction.
A short oligonucleotide sequence may be based on, or designed from, a genomic or cDNA
sequence and is used to amplify, confirm, or reveal the presence of an identical, similar or complementary DNA or RNA in a particular cell or tissue. Oligonucleotides comprise portions of a nucleic acid sequence having about 10 nt, 50 nt, or 100 nt in length, preferably about 15 nt to 30 nt in length. In one embodiment, an oligonucleotide comprising a nucleic acid molecule less than 100 nt in length would further comprise at lease 6 contiguous nucleotides of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161), or a complement thereof.
Oligonucleotides may be chemically synthesized and may be used as probes.
In another embodiment, an isolated nucleic acid molecule of the invention comprises a nucleic acid molecule that is a complement of the nucleotide sequence shown in any of SEQ ID
N0:2n-1 (wherein n = 1 to 3161). In another embodiment, an isolated nucleic acid molecule of the invention comprises a nucleic acid molecule that is a complement of the nucleotide sequence shown in any of SEQ ID N0:2n-1 (wherein n = 1 to 3161), or a portion of this nucleotide sequence. A nucleic acid molecule that is complementary to the nucleotide sequence shown in is one that is sufficiently complementary to the nucleotide sequence shown in of any of SEQ ID
N0:2n-1 (wherein n = 1 to 3161) that it can hydrogen bond with little or no mismatches to the nucleotide sequence shown in of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161)"
thereby forming a stable duplex.
As used herein, the term "complementary" refers to Watson-Crick or Hoogsteen base pairing between nucleotides units of a nucleic acid molecule, and the term "binding" means the physical or chemical interaction between two polypeptides or compounds or associated polypeptides or compounds or combinations thereof. Binding includes ionic, non-ionic, Von der Waals, hydrophobic interactions, etc. A physical interaction can be either direct or indirect.
Indirect interactions may be through or due to the effects of another polypeptide or compound.
Direct binding refers to interactions that do not take place through, or due to, the effect of another polypeptide or compound, but instead are without other substantial chemical intermediates.
Moreover, the nucleic acid molecule of the invention can comprise only a portion of the nucleic acid sequence of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161), e.g., a fragment that can be used as a probe or primer, or a fragment encoding a biologically active portion of ORFX.
Fragments provided herein are defined as sequences of at least 6 (contiguous) nucleic acids or at least 4 (contiguous) amino acids, a length sufficient to allow for specific hybridization in the case of nucleic acids or for specific recognition of an epitope in the case of amino acids, respectively, and are at most some portion less than a full length sequence. Fragments may be derived from any contiguous portion of a nucleic acid or amino acid sequence of choice.
Derivatives are nucleic acid sequences or amino acid sequences formed from the native compounds either directly or by modification or partial substitution. Analogs are nucleic acid sequences or amino acid sequences that have a structure similar to, but not identical to, the native compound but differs from it in respect to certain components or side chains. Analogs may be synthetic or from a different evolutionary origin and may have a similar or opposite metabolic activity compared to wild type.
Derivatives and analogs may be full length or other than full length, if the derivative or analog contains a modified nucleic acid or amino acid, as described below.
Derivatives or analogs of the nucleic acids or proteins of the invention include, but are not limited to, molecules comprising regions that are substantially homologous to the nucleic acids or proteins of the invention, in various embodiments, by at least about 70%, 80%, 85%, 90%, 95%, 98%, or even 99% identity (with a preferred identity of 80-99%) over a nucleic acid or amino acid sequence of identical size or when compared to an aligned sequence in which the alignment is done by a computer homology program known in the art, or whose encoding nucleic acid is capable of hybridizing to the complement of a sequence encoding the aforementioned proteins under stringent, moderately stringent, or low stringent conditions. See e.g.
Ausubel, et al., CURRENT
PROTOCOLS IN MOLECULAR BIOLOGY, John Wiley & Sons, New York, NY, 1993, and below.
An exemplary program is the Gap program (Wisconsin Sequence Analysis Package, Version 8 for UNIX, Genetics Computer Group, University Research Park, Madison, WI) using the default settings, which uses the algorithm of Smith and Waterman (Adv. Appl. Math., 1981, 2: 482-489, which is incorporated herein by reference in its entirety).
A "homologous nucleic acid sequence" or "homologous amino acid sequence," or variations thereof, refer to sequences characterized by a homology at the nucleotide level or amino acid level as discussed above. Homologous nucleotide sequences encode those sequences coding for isoforms of ORFX polypeptide. Isoforms can be expressed in different tissues of the same organism as a result of, for example, alternative splicing of RNA.
Alternatively, isoforms can be encoded by different genes. In the present invention, homologous nucleotide sequences include nucleotide sequences encoding for a ORFX polypeptide of species other than humans;
including, but not limited to, mammals, and thus can include, e.g., mouse, rat, rabbit, dog, cat cow, horse, and other organisms. Homologous nucleotide sequences also include, but are not limited to, naturally occurring allelic variations and mutations of the nucleotide sequences set forth herein. A homologous nucleotide sequence does not, however, include the nucleotide sequence encoding human ORFX protein. Homologous nucleic acid sequences include those nucleic acid sequences that encode conservative amino acid substitutions (see below) in any of SEQ ID N0:2n (wherein n = 1 to 3161 ) as well as a polypeptide having ORFX
activity.
Biological activities of the ORFX proteins are described below. A homologous amino acid sequence does not encode the amino acid sequence of a human ORFX polypeptide.
The nucleotide sequence determined from the cloning of the human ORFX gene allows for the generation of probes and primers designed for use in identifying the cell types disclosed and/or cloning ORFX homologues in other cell types, e.g., from other tissues, as well as ORFX
homologues from other mammals. The probe/primer typically comprises a substantially purified oligonucleotide. The oligonucleotide typically comprises a region of nucleotide sequence that hybridizes under stringent conditions to at least about 12, 25, 50, 100, 150, 200, 250, 300, 350 or 400 or more consecutive sense strand nucleotide sequence of SEQ ID N0:2n-1 (wherein n = 1 to 3161 ); or an anti-sense strand nucleotide sequence of SEQ ID N0:2n-1 (wherein n = 1 to 3161 );
or of a naturally occurring mutant of SEQ ID N0:2n-1 (wherein n = 1 to 3161).
Probes based on the human ORFX nucleotide sequence can be used to detect transcripts or genomic sequences encoding the same or homologous proteins. In various embodiments, the probe further comprises a label group attached thereto, e.g., the label group can be a radioisotope, a fluorescent compound, an enzyme, or an enzyme co-factor. Such probes can be used as a part of a diagnostic test kit for identifying cells or tissue which misexpress a ORFX
protein, such as by measuring a level of a ORFX-encoding nucleic acid in a sample of cells from a subject e.g., detecting ORFX mRNA levels or determining whether a genomic ORFX gene has been mutated or deleted.
"A polypeptide having a biologically active portion of ORFX" refers to polypeptides exhibiting activity similar, but not necessarily identical to, an activity of a polypeptide of the present invention, including mature forms, as measured in a particular biological assay, with or without dose dependency. A nucleic acid fragment encoding a "biologically active portion of ORFX" can be prepared by isolating a portion of SEQ ID N0:2n-1 (wherein n = 1 to 3161), that encodes a polypeptide having a ORFX biological activity (biological activities of the ORFX
proteins are summarized in Table 1), expressing the encoded portion of ORFX
protein (e.g., by recombinant expression in vitro) and assessing the activity of the encoded portion of ORFX. For example, a nucleic acid fragment encoding a biologically active portion of ORFX can optionally include a domain as shown in Table 1, column 4.
ORFX variants The invention further encompasses nucleic acid molecules that differ from the disclosed ORFX nucleotide sequences due to degeneracy of the genetic code. These nucleic acids thus encode the same ORFX protein as that encoded by the nucleotide sequence shown in SEQ ID
N0:2n-1 (wherein n = 1 to 3161). In another embodiment, an isolated nucleic acid molecule of the invention has a nucleotide sequence encoding a protein having an amino acid sequence shown in any of SEQ ID N0:2n (wherein n = 1 to 3161 ).

In addition to the human ORFX nucleotide sequence shown in any of SEQ ID N0:2n-(wherein n = 1 to 3161), it will be appreciated by those skilled in the art that DNA sequence polymorphisms that lead to changes in the amino acid sequences of ORFX may exist within a population (e.g., the human population). Such genetic polymorphism in the ORFX
gene may S exist among individuals within a population due to natural allelic variation. As used herein, the terms "gene" and "recombinant gene" refer to nucleic acid molecules comprising an open reading frame encoding a ORFX protein, preferably a mammalian ORFX protein. Such natural allelic variations can typically result in 1-5% variance in the nucleotide sequence of the ORFX gene.
Any and all such nucleotide variations and resulting amino acid polymorphisms in ORFX that are the result of natural allelic variation and that do not alter the functional activity of ORFX are intended to be within the scope of the invention.
Moreover, nucleic acid molecules encoding ORFX proteins from other species, and thus that have a nucleotide sequence that differs from the human sequence of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161), are intended to be within the scope of the invention. Nucleic acid molecules corresponding to natural allelic variants and homologues of the ORFX
cDNAs of the invention can be isolated based on their homology to the human ORFX nucleic acids disclosed herein using the human cDNAs, or a portion thereof, as a hybridization probe according to standard hybridization techniques under stringent hybridization conditions.
In another embodiment, an isolated nucleic acid molecule of the invention is at least 6 nucleotides in length and hybridizes under stringent conditions to the nucleic acid molecule comprising the nucleotide sequence of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161). In another embodiment, the nucleic acid is at least 10, 25, 50, 100, 250, 500 or 750 nucleotides in length. In another embodiment, an isolated nucleic acid molecule of the invention hybridizes to the coding region. As used herein, the term "hybridizes under stringent conditions" is intended to describe conditions for hybridization and washing under which nucleotide sequences at least 60% homologous to each other typically remain hybridized to each other.
Homologs (i. e., nucleic acids encoding ORFX proteins derived from species other than human) or other related sequences (e.g., paralogs) can be obtained by low, moderate or high stringency hybridization with all or a portion of the particular human sequence as a probe using methods well known in the art for nucleic acid hybridization and cloning.

As used herein, the phrase "stringent hybridization conditions" refers to conditions under which a probe, primer or oligonucleotide will hybridize to its target sequence, but to no other sequences. Stringent conditions are sequence-dependent and will be different in different circumstances. Longer sequences hybridize specifically at higher temperatures than shorter sequences. Generally, stringent conditions are selected to be about 5°C
lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. The Tm is the temperature (under defined ionic strength, pH and nucleic acid concentration) at which 50% of the probes complementary to the target sequence hybridize to the target sequence at equilibrium.
Since the target sequences are generally present at excess, at Tm, 50% of the probes are occupied at equilibrium. Typically, stringent conditions will be those in which the salt concentration is less than about 1.0 M sodium ion, typically about 0.01 to 1.0 M sodium ion (or other salts) at pH
7.0 to 8.3 and the temperature is at least about 30°C for short probes, primers or oligonucleotides (e.g., 10 nt to SO nt) and at least about 60°C for longer probes, primers and oligonucleotides.
Stringent conditions may also be achieved with the addition of destabilizing agents, such as formamide.
Stringent conditions are known to those skilled in the art and can be found in CURRENT
PROTOCOLS IN MOLECULAR BIOLOGY, John Wiley & Sons, N.Y. (1989), 6.3.1-6.3.6.
Preferably, the conditions are such that sequences at least about 65%, 70%, 75%, 85%, 90%, 95%, 98%, or 99% homologous to each other typically remain hybridized to each other. A non-limiting example of stringent hybridization conditions is hybridization in a high salt buffer comprising 6X SSC, 50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 0.02% PVP, 0.02% Ficoll, 0.02%
BSA, and 500 mg/ml denatured salmon sperm DNA at 65°C. This hybridization is followed by one or more washes in 0.2X SSC, 0.01% BSA at 50°C. An isolated nucleic acid molecule of the invention that hybridizes under stringent conditions to the sequence of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161 ) corresponds to a naturally occurnng nucleic acid molecule. As used herein, a "naturally-occurring" nucleic acid molecule refers to an RNA or DNA
molecule having a nucleotide sequence that occurs in nature (e.g., encodes a natural protein).
In a second embodiment, a nucleic acid sequence that is hybridizable to the nucleic acid molecule comprising the nucleotide sequence of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161), or fragments, analogs or derivatives thereof, under conditions of moderate stringency is provided. A non-limiting example of moderate stringency hybridization conditions are hybridization in 6X SSC, SX Denhardt's solution, 0.5% SDS and 100 mg/ml denatured salmon sperm DNA at 55°C, followed by one or more washes in 1X SSC, 0.1% SDS
at 37°C. Other conditions of moderate stringency that may be used are well known in the art.
See, e.g., Ausubel et al. (eds.), 1993, CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, John Wiley &
Sons, NY, and Kriegler, 1990, GENE TRANSFER AND EXPRESSION, A LABORATORY MANUAL, Stockton Press, NY.
In a third embodiment, a nucleic acid that is hybridizable to the nucleic acid molecule comprising the nucleotide sequence of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161), or fragments, analogs or derivatives thereof, under conditions of low stringency, is provided. A
non-limiting example of low stringency hybridization conditions are hybridization in 35%
formamide, SX SSC, 50 mM Tris-HCl (pH 7.5), 5 mM EDTA, 0.02% PVP, 0.02%
Ficoll, 0.2%
BSA, 100 mg/ml denatured salmon sperm DNA, 10% (wt/vol) dextran sulfate at 40°C, followed by one or more washes in 2X SSC, 25 mM Tris-HCl (pH 7.4), 5 mM EDTA, and 0.1%
SDS at 50°C. Other conditions of low stringency that may be used are well known in the art (e.g., as employed for cross-species hybridizations). See, e.g., Ausubel et al. (eds.), 1993, CURRENT
PROTOCOLS IN MOLECULAR BIOLOGY, John Wiley & Sons, NY, and Kriegler, 1990, GENE
TRANSFER AND EXPRESSION, A LABORATORY MANUAL, Stockton Press, NY; Shilo and Weinberg, 1981, Proc Natl Acad Sci USA 78: 6789-6792.
Conservative mutations In addition to naturally-occurring allelic variants of the ORFX sequence that may exist in the population, the skilled artisan will further appreciate that changes can be introduced by mutation into the nucleotide sequence of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161), thereby leading to changes in the amino acid sequence of the encoded ORFX
protein, without altering the functional ability of the ORFX protein. For example, nucleotide substitutions leading to amino acid substitutions at "non-essential" amino acid residues can be made in the sequence of any of SEQ ID N0:2n-1 (wherein n = 1 to 3161). A "non-essential"
amino acid residue is a residue that can be altered from the wild-type sequence of ORFX
without altering the biological activity, whereas an "essential" amino acid residue is required for biological activity.
For example, amino acid residues that are conserved among the ORFX proteins of the present invention, are predicted to be particularly unamenable to alteration.

Amino acid residues that are conserved among members of an ORFX family members are predicted to be less amenable to alteration. For example, an ORFX protein according to the present invention can contain at least one domain (e.g., as shown in Table 1 ) that is a typically conserved region in an ORFX family member. As such, these conserved domains are not likely to be amenable to mutation. Other amino acid residues, however, (e.g., those that are not conserved or only semi-conserved among members of the ORFX family) may not be as essential for activity and thus are more likely to be amenable to alteration.
Another aspect of the invention pertains to nucleic acid molecules encoding ORFX
proteins that contain changes in amino acid residues that are not essential for activity. Such ORFX proteins differ in amino acid sequence from any of any of SEQ ID N0:2n (wherein n = 1 to 3161 ), yet retain biological activity. In one embodiment, the isolated nucleic acid molecule comprises a nucleotide sequence encoding a protein, wherein the protein comprises an amino acid sequence at least about 75% homologous to the amino acid sequence of any of SEQ ID
N0:2n (wherein n = 1 to 3161 ). Preferably, the protein encoded by the nucleic acid is at least about 80% homologous to any of SEQ ID N0:2n (wherein n = 1 to 3161 ), more preferably at least about 90%, 95%, 98%, and most preferably at least about 99% homologous to SEQ ID
N0:2.
An isolated nucleic acid molecule encoding a ORFX protein homologous to the protein of any of SEQ ID N0:2n (wherein n = 1 to 3161) can be created by introducing one or more nucleotide substitutions, additions or deletions into the corresponding nucleotide sequence, i. e.
SEQ ID N0:2n-1 for the corresponding n, such that one or more amino acid substitutions, additions or deletions are introduced into the encoded protein.
Mutations can be introduced into SEQ ID N0:2n-1 (wherein n = 1 to 3161) by standard techniques, such as site-directed mutagenesis and PCR-mediated mutagenesis.
Preferably, conservative amino acid substitutions are made at one or more predicted non-essential amino acid residues. A "conservative amino acid substitution" is one in which the amino acid residue is replaced with an amino acid residue having a similar side chain. Families of amino acid residues having similar side chains have been defined in the art. These families include amino acids with basic side chains (e.g., lysine, arginine, histidine), acidic side chains (e.g., aspartic acid, glutamic acid), uncharged polar side chains (e.g., glycine, asparagine, glutamine, serine, threonine, tyrosine, cysteine), nonpolar side chains (e.g., alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine, tryptophan), beta-branched side chains (e.g., threonine, valine, isoleucine) and aromatic side chains (e.g., tyrosine, phenylalanine, tryptophan, histidine). Thus, a predicted nonessential amino acid residue in ORFX is replaced with another amino acid residue from the same side chain family. Alternatively, in another embodiment, mutations can be introduced randomly along all or part of a ORFX coding sequence, such as by saturation mutagenesis, and the resultant mutants can be screened for ORFX biological activity to identify mutants that retain activity. Following mutagenesis of SEQ ID N0:2n-1 (wherein n = 1 to 3161 ), the encoded protein can be expressed by any recombinant technology known in the art and the activity of the protein can be determined.
In one embodiment, a mutant ORFX protein can be assayed for ( 1 ) the ability to form protein:protein interactions with other ORFX proteins, other cell-surface proteins, or biologically active portions thereof, (2) complex formation between a mutant ORFX protein and a ORFX
receptor; (3) the ability of a mutant ORFX protein to bind to an intracellular target protein or biologically active portion thereof; (e.g., avidin proteins); (4) the ability to bind BRA protein; or (5) the ability to specifically bind an anti-ORFX protein antibody.
Antisense Another aspect of the invention pertains to isolated antisense nucleic acid molecules that are hybridizable to or complementary to the nucleic acid molecule comprising the nucleotide sequence of SEQ ID N0:2n-1 (wherein n = 1 to 3161), or fragments, analogs or derivatives thereof. An "antisense" nucleic acid comprises a nucleotide sequence that is complementary to a "sense" nucleic acid encoding a protein, e.g., complementary to the coding strand of a double-stranded cDNA molecule or complementary to an mRNA sequence. In specific aspects, antisense nucleic acid molecules are provided that comprise a sequence complementary to at least about 10, 25, 50, 100, 250 or 500 nucleotides or an entire ORFX coding strand, or to only a portion thereof. Nucleic acid molecules encoding fragments, homologs, derivatives and analogs of a ORFX protein of any of SEQ ID N0:2n (wherein n = 1 to 3161) or antisense nucleic acids complementary to a ORFX nucleic acid sequence of SEQ ID N0:2n-1 (wherein n = 1 to 3161 ) are additionally provided.
In one embodiment, an antisense nucleic acid molecule is antisense to a "coding region"
of the coding strand of a nucleotide sequence encoding ORFX. The term "coding region" refers to the region of the nucleotide sequence comprising codons which are translated into amino acid residues (e.g., the protein coding region of a human ORFX that corresponds to any of SEQ ID
N0:2n (wherein n = 1 to 3161 )). In another embodiment, the antisense nucleic acid molecule is antisense to a "noncoding region" of the coding strand of a nucleotide sequence encoding ORFX.
The term "noncoding region" refers to 5' and 3' sequences which flank the coding region that are not translated into amino acids (i.e., also referred to as 5' and 3' untranslated regions).
Given the coding strand sequences encoding ORFX disclosed herein (e.g., SEQ ID
N0:2n-1 (wherein n = 1 to 3161 ) ), antisense nucleic acids of the invention can be designed according to the rules of Watson and Crick or Hoogsteen base pairing. The antisense nucleic acid molecule can be complementary to the entire coding region of ORFX mRNA, but more preferably is an oligonucleotide that is antisense to only a portion of the coding or noncoding region of ORFX mRNA. For example, the antisense oligonucleotide can be complementary to the region surrounding the translation start site of ORFX mRNA. An antisense oligonucleotide can be, for example, about 5, 10, 15, 20, 25, 30, 35, 40, 45 or 50 nucleotides in length. An antisense nucleic acid of the invention can be constructed using chemical synthesis or enzymatic ligation reactions using procedures known in the art. For example, an antisense nucleic acid (e.g., an antisense oligonucleotide) can be chemically synthesized using naturally occurring nucleotides or variously modified nucleotides designed to increase the biological stability of the molecules or to increase the physical stability of the duplex formed between the antisense and sense nucleic acids, e.g., phosphorothioate derivatives and acridine substituted nucleotides can be used.
Examples of modified nucleotides that can be used to generate the antisense nucleic acid include: 5-fluorouracil, 5-bromouracil, 5-chlorouracil, 5-iodouracil, hypoxanthine, xanthine, 4-acetylcytosine, 5-(carboxyhydroxylmethyl) uracil, 5-carboxymethylaminomethyl-2-thiouridine, 5-carboxymethylaminomethyluracil, dihydrouracil, beta-D-galactosylqueosine, inosine, N6-isopentenyladenine, 1-methylguanine, 1-methylinosine, 2,2-dimethylguanine, 2-methyladenine, 2-methylguanine, 3-methylcytosine, 5-methylcytosine, N6-adenine, 7-methylguanine, 5-methylaminomethyluracil, 5-methoxyaminomethyl-2-thiouracil, beta-D-mannosylqueosine, 5'-methoxycarboxymethyluracil, S-methoxyuracil, 2-methylthio-N6-isopentenyladenine, uracil-5-oxyacetic acid (v), wybutoxosine, pseudouracil, queosine, 2-thiocytosine, S-methyl-2-thiouracil, 2-thiouracil, 4-thiouracil, 5-methyluracil, uracil-5-oxyacetic acid methylester, uracil-5-oxyacetic acid (v), S-methyl-2-thiouracil, 3-(3-amino-3-N-2-carboxypropyl) uracil, (acp3)w, and 2,6-diaminopurine.
Alternatively, the antisense nucleic acid can be produced biologically using an expression vector into which a nucleic acid has been subcloned in an antisense orientation (i.e., RNA
transcribed from the inserted nucleic acid will be of an antisense orientation to a target nucleic acid of interest, described further in the following subsection).
The antisense nucleic acid molecules of the invention are typically administered to a subject or generated in situ such that they hybridize with or bind to cellular mRNA and/or genomic DNA encoding a ORFX protein to thereby inhibit expression of the protein, e.g., by inhibiting transcription and/or translation. The hybridization can be by conventional nucleotide complementarity to form a stable duplex, or, for example, in the case of an antisense nucleic acid molecule that binds to DNA duplexes, through specific interactions in the major groove of the double helix. An example of a route of administration of antisense nucleic acid molecules of the invention includes direct injection at a tissue site. Alternatively, antisense nucleic acid molecules can be modified to target selected cells and then administered systemically. For example, for systemic administration, antisense molecules can be modified such that they specifically bind to receptors or antigens expressed on a selected cell surface, e.g., by linking the antisense nucleic acid molecules to peptides or antibodies that bind to cell surface receptors or antigens. The antisense nucleic acid molecules can also be delivered to cells using the vectors described herein. To achieve sufficient intracellular concentrations of antisense molecules, vector constructs in which the antisense nucleic acid molecule is placed under the control of a strong pol II or pol III promoter are preferred.
In yet another embodiment, the antisense nucleic acid molecule of the invention is an oc-anomeric nucleic acid molecule. An a-anomeric nucleic acid molecule forms specific double-stranded hybrids with complementary RNA in which, contrary to the usual (3-units, the strands run parallel to each other (Gaultier et al. (1987) Nucleic Acids Res 15: 6625-6641). The antisense nucleic acid molecule can also comprise a 2'-o-methylribonucleotide (moue et al.
(1987) Nucleic Acids Res 1 S: 6131-6148) or a chimeric RNA -DNA analogue (moue et al. (1987) FEBS Lett 215: 327-330).
Ribozymes and PNA moieties Such modifications include, by way of nonlimiting example, modified bases, and nucleic acids whose sugar phosphate backbones are modified or derivatized. These modifications are carried out at least in part to enhance the chemical stability of the modified nucleic acid, such that they may be used, for example, as antisense binding nucleic acids in therapeutic applications in a subject.
In still another embodiment, an antisense nucleic acid of the invention is a ribozyme.
Ribozymes are catalytic RNA molecules with ribonuclease activity that are capable of cleaving a single-stranded nucleic acid, such as an mRNA, to which they have a complementary region.
Thus, ribozymes (e.g., hammerhead ribozymes (described in Haselhoff and Gerlach (1988) Nature 334:585-591)) can be used to catalytically cleave ORFX mRNA transcripts to thereby inhibit translation of ORFX mRNA. A ribozyme having specificity for a ORFX-encoding nucleic acid can be designed based upon the nucleotide sequence of a ORFX DNA
disclosed herein (i.e., SEQ ID N0:2n-1 (wherein n = 1 to 3161)). For example, a derivative of a Tetrahymena L-19 IVS RNA can be constructed in which the nucleotide sequence of the active site is complementary to the nucleotide sequence to be cleaved in a ORFX-encoding mRNA.
See, e.g., Cech et al. U.S. Pat. No. 4,987,071; and Cech et al. U.S. Pat. No.
5,116,742.
Alternatively, ORFX mRNA can be used to select a catalytic RNA having a specific ribonuclease activity from a pool of RNA molecules. See, e.g., Bartel et al., (1993) Science 261:1411-1418.
Alternatively, ORFX gene expression can be inhibited by targeting nucleotide sequences complementary to the regulatory region of the ORFX (e.g., the ORFX promoter and/or enhancers) to form triple helical structures that prevent transcription of the ORFX gene in target cells. See generally, Helene. (1991) Anticancer Drug Des. 6: 569-84; Helene.
et al. (1992) Ann.
N. Y. Acad. Sci. 660:27-36; and Maher (1992) Bioassays 14: 807-15.
In various embodiments, the nucleic acids of ORFX can be modified at the base moiety, sugar moiety or phosphate backbone to improve, e.g., the stability, hybridization, or solubility of the molecule. For example, the deoxyribose phosphate backbone of the nucleic acids can be modified to generate peptide nucleic acids (see Hyrup et al. (1996) Bioorg Med Chem 4: S-23).
As used herein, the terms "peptide nucleic acids" or "PNAs" refer to nucleic acid mimics, e.g., DNA mimics, in which the deoxyribose phosphate backbone is replaced by a pseudopeptide backbone and only the four natural nucleobases are retained. The neutral backbone of PNAs has been shown to allow for specific hybridization to DNA and RNA under conditions of low ionic strength. The synthesis of PNA oligomers can be performed using standard solid phase peptide synthesis protocols as described in Hyrup et al. (1996) above; Perry-O'Keefe et al. (1996) PNAS
93: 14670-675.
PNAs of ORFX can be used in therapeutic and diagnostic applications. For example, PNAs can be used as antisense or antigene agents for sequence-specific modulation of gene expression by, e.g., inducing transcription or translation arrest or inhibiting replication. PNAs of ORFX can also be used, e.g., in the analysis of single base pair mutations in a gene by, e.g., PNA
directed PCR clamping; as artificial restriction enzymes when used in combination with other enzymes, e.g., S1 nucleases (Hyrup B. (1996) above); or as probes or primers for DNA sequence and hybridization (Hyrup et al. (1996), above; Perry-O'Keefe (1996), above).
In another embodiment, PNAs of ORFX can be modified, e.g., to enhance their stability or cellular uptake, by attaching lipophilic or other helper groups to PNA, by the formation of PNA-DNA chimeras, or by the use of liposomes or other techniques of drug delivery known in the art. For example, PNA-DNA chimeras of ORFX can be generated that may combine the advantageous properties of PNA and DNA. Such chimeras allow DNA recognition enzymes, e.g., RNase H and DNA polymerases, to interact with the DNA portion while the PNA portion would provide high binding affinity and specificity. PNA-DNA chimeras can be linked using linkers of appropriate lengths selected in terms of base stacking, number of bonds between the nucleobases, and orientation (Hyrup (1996) above). The synthesis of PNA-DNA
chimeras can be performed as described in Hyrup (1996) above and Finn et al. (1996) Nucl Acids Res 24:
3357-63. For example, a DNA chain can be synthesized on a solid support using standard phosphoramidite coupling chemistry, and modified nucleoside analogs, e.g., 5'-(4-methoxytrityl)amino-5'-deoxy-thymidine phosphoramidite, can be used between the PNA
and the 5' end of DNA (Mag et al. (1989) Nucl Acid Res 17: 5973-88). PNA
monomers are then coupled in a stepwise manner to produce a chimeric molecule with a 5' PNA
segment and a 3' DNA segment (Finn et al. ( 1996) above). Alternatively, chimeric molecules can be synthesized with a S' DNA segment and a 3' PNA segment. See, Petersen et al. (1975) Bioorg Med Chem Lett 5: 1119-11124.
In other embodiments, the oligonucleotide may include other appended groups such as peptides (e.g., for targeting host cell receptors in vivo), or agents facilitating transport across the cell membrane (see, e.g., Letsinger et al., 1989, Proc. Natl. Acad. Sci.
U.S.A. 86:6553-6556;
Lemaitre et al., 1987, Proc. Natl. Acad. Sci. 84:648-652; PCT Publication No.
W088/09810) or the blood-brain barrier (see, e.g., PCT Publication No. W089/10134). In addition, oligonucleotides can be modified with hybridization triggered cleavage agents (See, e.g., Krol et al., 1988, BioTechniques 6:958-976) or intercalating agents. (See, e.g., Zon, 1988, Pharm. Res.
S: 539-549). To this end, the oligonucleotide may be conjugated to another molecule, e.g., a peptide, a hybridization triggered cross-linking agent, a transport agent, a hybridization-triggered cleavage agent, etc.
ORFX polypeptides The novel protein of the invention includes the ORFX-like protein whose sequence is provided in any of SEQ ID N0:2n (wherein n = 1 to 3161 ). The invention also includes a mutant or variant protein any of whose residues may be changed from the corresponding residue shown in FIG. 1 while still encoding a protein that maintains its ORFX-like activities and physiological functions, or a functional fragment thereof. For example, the invention includes the polypeptides encoded by the variant ORFX nucleic acids described above. In the mutant or variant protein, up to 20% or more of the residues may be so changed.
In general, an ORFX -like variant that preserves ORFX-like function includes any variant in which residues at a particular position in the sequence have been substituted by other amino acids, and further include the possibility of inserting an additional residue or residues between two residues of the parent protein as well as the possibility of deleting one or more residues from the parent sequence. Any amino acid substitution, insertion, or deletion is encompassed by the invention. In favorable circumstances, the substitution is a conservative substitution as defined above. Furthermore, without limiting the scope of the invention, positions of any of SEQ ID
N0:2n (wherein n = 1 to 3161 ) may be substitute such that a mutant or variant protein may include one or more substitutions The invention also includes isolated ORFX proteins, and biologically active portions thereof, or derivatives, fragments, analogs or homologs thereof. Also provided are polypeptide fragments suitable for use as immunogens to raise anti-ORFX antibodies. In one embodiment, native ORFX proteins can be isolated from cells or tissue sources by an appropriate purification scheme using standard protein purification techniques. In another embodiment, ORFX proteins are produced by recombinant DNA techniques. Alternative to recombinant expression, a ORFX

protein or polypeptide can be synthesized chemically using standard peptide synthesis techniques.
An "isolated" or "purified" protein or biologically active portion thereof is substantially free of cellular material or other contaminating proteins from the cell or tissue source from which the ORFX protein is derived, or substantially free from chemical precursors or other chemicals when chemically synthesized. The language "substantially free of cellular material" includes preparations of ORFX protein in which the protein is separated from cellular components of the cells from which it is isolated or recombinantly produced. In one embodiment, the language "substantially free of cellular material" includes preparations of ORFX
protein having less than about 30% (by dry weight) of non-ORFX protein (also referred to herein as a "contaminating protein"), more preferably less than about 20% of non-ORFX protein, still more preferably less than about 10% of non-ORFX protein, and most preferably less than about 5% non-ORFX
protein. When the ORFX protein or biologically active portion thereof is recombinantly produced, it is also preferably substantially free of culture medium, i.e., culture medium 1 S represents less than about 20%, more preferably less than about 10%, and most preferably less than about 5% of the volume of the protein preparation.
The language "substantially free of chemical precursors or other chemicals"
includes preparations of ORFX protein in which the protein is separated from chemical precursors or other chemicals that are involved in the synthesis of the protein. In one embodiment, the language "substantially free of chemical precursors or other chemicals"
includes preparations of ORFX protein having less than about 30% (by dry weight) of chemical precursors or non-ORFX
chemicals, more preferably less than about 20% chemical precursors or non-ORFX
chemicals, still more preferably less than about 10% chemical precursors or non-ORFX
chemicals, and most preferably less than about 5% chemical precursors or non-ORFX chemicals.
Biologically active portions of a ORFX protein include peptides comprising amino acid sequences sufficiently homologous to or derived from the amino acid sequence of the ORFX
protein, e.g., the amino acid sequence shown in SEQ ID N0:2 that include fewer amino acids than the full length ORFX proteins, and exhibit at least one activity of a ORFX protein.
Typically, biologically active portions comprise a domain or motif with at least one activity of the ORFX protein. A biologically active portion of a ORFX protein can be a polypeptide which is, for example, 10, 25, 50, 100 or more amino acids in length.

A biologically active portion of a ORFX protein of the present invention may contain at least one of the above-identified domains conserved between the FGF family of proteins.
Moreover, other biologically active portions, in which other regions of the protein are deleted, can be prepared by recombinant techniques and evaluated for one or more of the functional activities of a native ORFX protein.
In an embodiment, the ORFX protein has an amino acid sequence shown in any of SEQ
ID N0:2n (wherein n = 1 to 3161 ). In other embodiments, the ORFX protein is substantially homologous to any of SEQ ID N0:2n (wherein n = 1 to 3161) and retains the functional activity of the protein of any of SEQ ID N0:2n (wherein n = 1 to 3161), yet differs in amino acid sequence due to natural allelic variation or mutagenesis, as described in detail below.
Accordingly, in another embodiment, the ORFX protein is a protein that comprises an amino acid sequence at least about 45% homologous, and more preferably about 55, 65, 70, 75, 80, 85, 90, 95, 98 or even 99% homologous to the amino acid sequence of any of SEQ ID
N0:2n (wherein n = 1 to 3161 ) and retains the functional activity of the ORFX
proteins of the 1 S corresponding polypeptide having the sequence of SEQ ID N0:2n (wherein n =
1 to 3161 ).
Determining homology between two or more sequences To determine the percent homology of two amino acid sequences or of two nucleic acids, the sequences are aligned for optimal comparison purposes (e.g., gaps can be introduced in either of the sequences being compared for optimal alignment between the sequences).
The amino acid residues or nucleotides at corresponding amino acid positions or nucleotide positions are then compared. When a position in the first sequence is occupied by the same amino acid residue or nucleotide as the corresponding position in the second sequence, then the molecules are homologous at that position (i.e., as used herein amino acid or nucleic acid "homology" is equivalent to amino acid or nucleic acid "identity").
The nucleic acid sequence homology may be determined as the degree of identity between two sequences. The homology may be determined using computer programs known in the art, such as GAP software provided in the GCG program package. See, Needleman and Wunsch 1970 JMol Biol 48: 443-453. Using GCG GAP software with the following settings for nucleic acid sequence comparison: GAP creation penalty of 5.0 and GAP
extension penalty of 0.3, the coding region of the analogous nucleic acid sequences referred to above exhibits a degree of identity preferably of at least 70%, 75%, 80%, 85%, 90%, 95%, 98%, or 99%, with the CDS (encoding) part of the DNA sequence shown in SEQ ID N0:2n-1 (wherein n = 1 to 3161).
The term "sequence identity" refers to the degree to which two polynucleotide or polypeptide sequences are identical on a residue-by-residue basis over a particular region of comparison. The term "percentage of sequence identity" is calculated by comparing two optimally aligned sequences over that region of comparison, determining the number of positions at which the identical nucleic acid base (e.g., A, T, C, G, U, or I, in the case of nucleic acids) occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the region of comparison (i.e., the window size), and multiplying the result by 100 to yield the percentage of sequence identity. The term "substantial identity" as used herein denotes a characteristic of a polynucleotide sequence, wherein the polynucleotide comprises a sequence that has at least 80 percent sequence identity, preferably at least 85 percent identity and often 90 to 95 percent sequence identity, more usually at least 99 percent sequence identity as compared to a reference sequence over a comparison region. The term "percentage of positive residues" is calculated by comparing two optimally aligned sequences over that region of comparison, determining the number of positions at which the identical and conservative amino acid substitutions, as defined above, occur in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the region of comparison (i. e., the window size), and multiplying the result by 100 to yield the percentage of positive residues.
Chimeric and fusion proteins The invention also provides ORFX chimeric or fusion proteins. As used herein, a ORFX
"chimeric protein" or "fusion protein" includes a ORFX polypeptide operatively linked to a non-ORFX polypeptide. A "ORFX polypeptide" refers to a polypeptide having an amino acid sequence corresponding to ORFX, whereas a "non-ORFX polypeptide" refers to a polypeptide having an amino acid sequence corresponding to a protein that is not substantially homologous to the ORFX protein, e.g., a protein that is different from the ORFX protein and that is derived from the same or a different organism. Within a ORFX fusion protein the ORFX
polypeptide can correspond to all or a portion of a ORFX protein. In one embodiment, a ORFX fusion protein comprises at least one biologically active portion of a ORFX protein.
In another embodiment, a ORFX fusion protein comprises at least two biologically active portions of a ORFX protein. Within the fusion protein, the term "operatively linked" is intended to indicate that the ORFX polypeptide and the non-ORFX polypeptide are fused in-frame to each other.
The non-ORFX polypeptide can be fused to the N-terminus or C-terminus of the ORFX
polypeptide.
For example, in one embodiment a ORFX fusion protein comprises a ORFX
polypeptide operably linked to the extracellular domain of a second protein. Such fusion proteins can be further utilized in screening assays for compounds that modulate ORFX activity (such assays are described in detail below).
In another embodiment, the fusion protein is a GST-ORFX fusion protein in which the ORFX sequences are fused to the C-terminus of the GST (i.e., glutathione S-transferase) sequences. Such fusion proteins can facilitate the purification of recombinant ORFX.
In yet another embodiment, the fusion protein is a ORFX protein containing a heterologous signal sequence at its N-terminus. For example, the native ORFX
signal sequence can be removed and replaced with a signal sequence from another protein. In certain host cells (e.g., mammalian host cells), expression and/or secretion of ORFX can be increased through use of a heterologous signal sequence.
In another embodiment, the fusion protein is a ORFX-immunoglobulin fusion protein in which the ORFX sequences comprising one or more domains are fused to sequences derived from a member of the immunoglobulin protein family. The ORFX-immunoglobulin fusion proteins of the invention can be incorporated into pharmaceutical compositions and administered to a subject to inhibit an interaction between a ORFX ligand and a ORFX
protein on the surface of a cell, to thereby suppress ORFX-mediated signal transduction in vivo. In one nonlimiting example, a contemplated ORFX ligand of the invention is an ORFX receptor. The ORFX-immunoglobulin fusion proteins can be used to modulate the bioavailability of a ORFX
cognate ligand. Inhibition of the ORFX ligand/ORFX interaction may be useful therapeutically for both the treatment of proliferative and differentiative disorders, as well as modulating (e.g., promoting or inhibiting) cell survival. Moreover, the ORFX-immunoglobulin fusion proteins of the invention can be used as immunogens to produce anti-ORFX antibodies in a subject, to purify ORFX ligands, and in screening assays to identify molecules that inhibit the interaction of ORFX with a ORFX ligand.

A ORFX chimeric or fusion protein of the invention can be produced by standard recombinant DNA techniques. For example, DNA fragments coding for the different polypeptide sequences are ligated together in-frame in accordance with conventional techniques, e.g., by employing blunt-ended or stagger-ended termini for ligation, restriction enzyme digestion to provide for appropriate termini, filling-in of cohesive ends as appropriate, alkaline phosphatase treatment to avoid undesirable joining, and enzymatic ligation. In another embodiment, the fusion gene can be synthesized by conventional techniques including automated DNA synthesizers. Alternatively, PCR amplification of gene fragments can be carried out using anchor primers that give rise to complementary overhangs between two consecutive gene fragments that can subsequently be annealed and reamplified to generate a chimeric gene sequence (see, for example, Ausubel et al. (eds.) CURRENT PROTOCOLS IN
MOLECULAR BIOLOGY, John Wiley & Sons, 1992). Moreover, many expression vectors are commercially available that already encode a fusion moiety (e.g., a GST polypeptide). A ORFX-encoding nucleic acid can be cloned into such an expression vector such that the fusion moiety is linked in-frame to the ORFX protein.
ORFX agonists and antagonists The present invention also pertains to variants of the ORFX proteins that function as either ORFX agonists (mimetics) or as ORFX antagonists. Variants of the ORFX
protein can be generated by mutagenesis, e.g., discrete point mutation or truncation of the ORFX protein. An agonist of the ORFX protein can retain substantially the same, or a subset of, the biological activities of the naturally occurring form of the ORFX protein. An antagonist of the ORFX
protein can inhibit one or more of the activities of the naturally occurnng form of the ORFX
protein by, for example, competitively binding to a downstream or upstream member of a cellular signaling cascade which includes the ORFX protein. Thus, specific biological effects can be elicited by treatment with a variant of limited function. In one embodiment, treatment of a subject with a variant having a subset of the biological activities of the naturally occurring form of the protein has fewer side effects in a subject relative to treatment with the naturally occurring form of the ORFX proteins.
Variants of the ORFX protein that function as either ORFX agonists (mimetics) or as ORFX antagonists can be identified by screening combinatorial libraries of mutants, e.g., truncation mutants, of the ORFX protein for ORFX protein agonist or antagonist activity. In one embodiment, a variegated library of ORFX variants is generated by combinatorial mutagenesis at the nucleic acid level and is encoded by a variegated gene library. A
variegated library of ORFX
variants can be produced by, for example, enzymatically ligating a mixture of synthetic oligonucleotides into gene sequences such that a degenerate set of potential ORFX sequences is expressible as individual polypeptides, or alternatively, as a set of larger fusion proteins (e.g., for phage display) containing the set of ORFX sequences therein. There are a variety of methods which can be used to produce libraries of potential ORFX variants from a degenerate oligonucleotide sequence. Chemical synthesis of a degenerate gene sequence can be performed in an automatic DNA synthesizer, and the synthetic gene then ligated into an appropriate expression vector. Use of a degenerate set of genes allows for the provision, in one mixture, of all of the sequences encoding the desired set of potential ORFX sequences.
Methods for synthesizing degenerate oligonucleotides are known in the art (see, e.g., Narang (1983) Tetrahedron 39:3; Itakura et al. (1984) Annu Rev Biochem 53:323; Itakura et al. (1984) Science 198:1056; Ike et al. (1983) Nucl Acid Res 11:477.
Polypeptide libraries In addition, libraries of fragments of the ORFX protein coding sequence can be used to' generate a variegated population of ORFX fragments for screening and subsequent selection of variants of a ORFX protein. In one embodiment, a library of coding sequence fragments can be generated by treating a double stranded PCR fragment of a ORFX coding sequence with a nuclease under conditions wherein nicking occurs only about once per molecule, denaturing the double stranded DNA, renaturing the DNA to form double stranded DNA that can include sense/antisense pairs from different nicked products, removing single stranded portions from reformed duplexes by treatment with S 1 nuclease, and ligating the resulting fragment library into an expression vector. By this method, an expression library can be derived which encodes N-terminal and internal fragments of various sizes of the ORFX protein.
Several techniques are known in the art for screening gene products of combinatorial libraries made by point mutations or truncation, and for screening cDNA
libraries for gene products having a selected property. Such techniques are adaptable for rapid screening of the gene libraries generated by the combinatorial mutagenesis of ORFX proteins.
The most widely used techniques, which are amenable to high throughput analysis, for screening large gene libraries typically include cloning the gene library into replicable expression vectors, transforming appropriate cells with the resulting library of vectors, and expressing the combinatorial genes under conditions in which detection of a desired activity facilitates isolation of the vector encoding the gene whose product was detected. Recrusive ensemble mutagenesis (REM), a new technique that enhances the frequency of functional mutants in the libraries, can be used in combination with the screening assays to identify ORFX variants (Arkin and Yourvan (1992) PNAS 89:7811-7815; Delgrave et al. (1993) Protein Engineering 6:327-331).
Anti-ORFX Antibodies The invention further encompasses antibodies and antibody fragments, such as Fab or (Fab)2, that bind immunospecifically to any of the proteins of the invention.
An isolated ORFX protein, or a portion or fragment thereof, can be used as an immunogen to generate antibodies that bind ORFX using standard techniques for polyclonal and monoclonal antibody preparation. Full-length ORFX protein can be used.
Alternatively, the invention provides antigenic peptide fragments of ORFX for use as immunogens.
The antigenic peptide of ORFX comprises at least 4 amino acid residues of the amino acid sequence shown in any of SEQ ID N0:2n (wherein n = 1 to 3161). The antigenic peptide encompasses an epitope of ORFX such that an antibody raised against the peptide forms a specific immune complex with ORFX. The antigenic peptide may comprise at least 6 as residues, at least 8 as residues, at least 10 as residues, at least 15 as residues, at least 20 as residues, or at least 30 as residues. In one embodiment of the invention, the antigenic peptide comprises a polypeptide comprising at least 6 contiguous amino acids of any of SEQ ID N0:2n (wherein n = 1 to 3161 ).
In an embodiment of the invention, epitopes encompassed by the antigenic peptide are regions of ORFX that are located on the surface of the protein, e.g., hydrophilic regions. As a means for targeting antibody production, hydropathy plots showing regions of hydrophilicity and hydrophobicity may be generated by any method well known in the art, including, for example, the Kyte Doolittle or the Hopp Woods methods, either with or without Fourier transformation.
See, e.g., Hopp and Woods, 1981, Proc. Nat. Acad. Sci. USA 78: 3824-3828; Kyte and Doolittle 1982, J. Mol. Biol. 157: 105-142, each incorporated herein by reference in their entirety.
As disclosed herein, an ORFX protein sequence of any of SEQ ID N0:2n (wherein n = 1 to 3161 ) , or derivatives, fragments, analogs or homologs thereof, may be utilized as immunogens in the generation of antibodies that immunospecifically-bind these protein components. The term "antibody" as used herein refers to immunoglobulin molecules and immunologically active portions of immunoglobulin molecules, i.e., molecules that contain an antigen binding site that specifically binds (immunoreacts with) an antigen, such as ORFX. Such antibodies include, but are not limited to, polyclonal, monoclonal, chimeric, single chain, Fab and F(ab')2 fragments, and an Fab expression library. In a specific embodiment, antibodies to human ORFX proteins are disclosed. Various procedures known within the art may be used for the production of polyclonal or monoclonal antibodies to a ORFX protein sequence of any of SEQ
ID N0:2n (wherein n = 1 to 3161 ) or derivative, fragment, analog or homolog thereof. Some of these proteins are discussed below.
For the production of polyclonal antibodies, various suitable host animals (e.g., rabbit, r goat, mouse or other mammal) may be immunized by injection with the native protein, or a synthetic variant thereof, or a derivative of the foregoing. An appropriate immunogenic preparation can contain, for example, recombinantly expressed ORFX protein or a chemically synthesized ORFX polypeptide. The preparation can further include an adjuvant.
Various adjuvants used to increase the immunological response include, but are not limited to, Freund's (complete and incomplete), mineral gels (e.g., aluminum hydroxide), surface active substances (e.g., lysolecithin, pluronic polyols, polyanions, peptides, oil emulsions, dinitrophenol, etc.), human adjuvants such as Bacille Calmette-Guerin and Corynebacterium parvum, or similar immunostimulatory agents. If desired, the antibody molecules directed against ORFX can be isolated from the mammal (e.g., from the blood) and further purified by well known techniques, such as protein A chromatography to obtain the IgG fraction.
The term "monoclonal antibody" or "monoclonal antibody composition", as used herein, refers to a population of antibody molecules that contain only one species of an antigen binding site capable of immunoreacting with a particular epitope of ORFX. A monoclonal antibody composition thus typically displays a single binding affinity for a particular ORFX protein with which it immunoreacts. For preparation of monoclonal antibodies directed towards a particular ORFX protein, or derivatives, fragments, analogs or homologs thereof, any technique that provides for the production of antibody molecules by continuous cell line culture may be utilized. Such techniques include, but are not limited to, the hybridoma technique (see Kohler &
Milstein, 1975 Nature 256: 495-497); the trioma technique; the human B-cell hybridoma technique (see Kozbor, et al., 1983 Immunol Today 4: 72) and the EBV hybridoma technique to produce human monoclonal antibodies (see Cole, et al., 1985 In: MONOCLONAL
ANTIBODIES AND

CANCER THERAPY, Alan R. Liss, Inc., pp. 77-96). Human monoclonal antibodies may be utilized in the practice of the present invention and may be produced by using human hybridomas (see Cote, et al., 1983. Proc Natl Acad Sci USA 80: 2026-2030) or by transforming human B-cells with Epstein Barr Virus in vitro (see Cole, et al., 1985 In: MONOCLONAL
ANTIBODIES AND
S CANCER THERAPY, Alan R. Liss, Inc., pp. 77-96). Each of the above citations are incorporated herein by reference in their entirety According to the invention, techniques can be adapted for the production of single-chain antibodies specific to a ORFX protein (see e.g., U.S. Patent No. 4,946,778).
In addition, methods can be adapted for the construction of Fab expression libraries (see e.g., Huse, et al., 1989 Science 246: 1275-1281 ) to allow rapid and effective identification of monoclonal Fab fragments with the desired specificity for a ORFX protein or derivatives, fragments, analogs or homologs thereof. Non-human antibodies can be "humanized" by techniques well known in the art. See e.g., U.S. Patent No. 5,225,539. Each of the above citations are incorporated herein by reference. Antibody fragments that contain the idiotypes to a ORFX protein may be produced by techniques known in the art including, but not limited to: (i) an F~ab~~2 fragment produced by pepsin digestion of an antibody molecule; (ii) an Fab fragment generated by reducing the disulfide bridges of an F~ab')2 fragment; (iii) an Fab fragment generated by the treatment of the antibody molecule with papain and a reducing agent and (iv) F,, fragments.
Additionally, recombinant anti-ORFX antibodies, such as chimeric and humanized monoclonal antibodies, comprising both human and non-human portions, which can be made using standard recombinant DNA techniques, are within the scope of the invention. Such chimeric and humanized monoclonal antibodies can be produced by recombinant DNA
techniques known in the art, for example using methods described in PCT
International Application No. PCT/US86/02269; European Patent Application No. 184,187;
European Patent Application No. 171,496; European Patent Application No. 173,494; PCT
International Publication No. WO 86/01533; U.S. Pat. No. 4,816,567; European Patent Application No.
125,023; Better et a1.(1988) Science 240:1041-1043; Liu et al. (1987) PNAS
84:3439-3443; Liu et al. (1987) Jlmmunol. 139:3521-3526; Sun et al. (1987) PNAS 84:214-218;
Nishimura et al.
(1987) Cancer Res 47:999-1005; Wood et al. (1985) Nature 314:446-449; Shaw et al. (1988), J.
Natl Cancer Inst 80:1553-1559); Morrison(1985) Science 229:1202-1207; Oi et al. (1986) BioTechniques 4:214; U.S. Pat. No. 5,225,539; Jones et al. (1986) Nature 321:552-525;

Verhoeyan et al. (1988) Science 239:1534; and Beidler et al. (1988) Jlmmunol 141:4053-4060.
Each of the above citations are incorporated herein by reference.
In one embodiment, methods for the screening of antibodies that possess the desired specificity include, but are not limited to, enzyme-linked immunosorbent assay (ELISA) and other immunologically-mediated techniques known within the art. In a specific.embodiment, selection of antibodies that are specific to a particular domain of a ORFX
protein is facilitated by generation of hybridomas that bind to the fragment of a ORFX protein possessing such a domain.
Antibodies that are specific for one or more domains within a ORFX protein, e.g., the domain spanning the first fifty amino-terminal residues specific to ORFX when compared to FGF-9, or derivatives, fragments, analogs or homologs thereof, are also provided herein.
Anti-ORFX antibodies may be used in methods known within the art relating to the localization and/or quantitation of a ORFX protein (e.g., for use in measuring levels of the ORFX protein within appropriate physiological samples, for use in diagnostic methods, for use in imaging the protein, and the like). In a given embodiment, antibodies for ORFX proteins, or 1 S derivatives, fragments, analogs or homologs thereof, that contain the antibody derived binding domain, are utilized as pharmacologically-active compounds [hereinafter "Therapeutics"J.
An anti-ORFX antibody (e.g., monoclonal antibody) can be used to isolate ORFX
by standard techniques, such as affinity chromatography or immunoprecipitation.
An anti-ORFX
antibody can facilitate the purification of natural ORFX from cells and of recombinantly produced ORFX expressed in host cells. Moreover, an anti-ORFX antibody can be used to detect ORFX protein (e.g., in a cellular lysate or cell supernatant) in order to evaluate the abundance and pattern of expression of the ORFX protein. Anti-ORFX antibodies can be used diagnostically to monitor protein levels in tissue as part of a clinical testing procedure, e.g., to, for example, determine the efficacy of a given treatment regimen. Detection can be facilitated by coupling (i.e., physically linking) the antibody to a detectable substance.
Examples of detectable substances include various enzymes, prosthetic groups, fluorescent materials, luminescent materials, bioluminescent materials, and radioactive materials.
Examples of suitable enzymes include horseradish peroxidase, alkaline phosphatase, ~i-galactosidase, or acetylcholinesterase; examples of suitable prosthetic group complexes include streptavidin/biotin and avidin/biotin; examples of suitable fluorescent materials include umbelliferone, fluorescein, fluorescein isothiocyanate, rhodamine, dichlorotriazinylamine fluorescein, dansyl chloride or phycoerythrin; an example of a luminescent material includes luminol; examples of bioluminescent materials include luciferase, luciferin, and aequorin, and examples of suitable radioactive material include l2sh ~3~I, 3sS or 3H.
ORFX Recombinant Vectors and Host Cells Another aspect of the invention pertains to vectors, preferably expression vectors, containing a nucleic acid encoding ORFX protein, or derivatives, fragments, analogs or homologs thereof. As used herein, the term "vector" refers to a nucleic acid molecule capable of transporting another nucleic acid to which it has been linked. One type of vector is a "plasmid", which refers to a circular double stranded DNA loop into which additional DNA
segments can be ligated. Another type of vector is a viral vector, wherein additional DNA
segments can be ligated into the viral genome. Certain vectors are capable of autonomous replication in a host cell into which they are introduced (e.g., bacterial vectors having a bacterial origin of replication and episomal mammalian vectors). Other vectors (e.g., non-episomal mammalian vectors) are integrated into the genome of a host cell upon introduction into the host cell, and thereby are 1 S replicated along with the host genome. Moreover, certain vectors are capable of directing the expression of genes to which they are operatively linked. Such vectors are referred to herein as "expression vectors". In general, expression vectors of utility in recombinant DNA techniques are often in the form of plasmids. In the present specification, "plasmid" and "vector" can be used interchangeably as the plasmid is the most commonly used form of vector.
However, the invention is intended to include such other forms of expression vectors, such as viral vectors (e.g., replication defective retroviruses, adenoviruses and adeno-associated viruses), which serve equivalent functions.
The recombinant expression vectors of the invention comprise a nucleic acid of the invention in a form suitable for expression of the nucleic acid in a host cell, which means that the recombinant expression vectors include one or more regulatory sequences, selected on the basis of the host cells to be used for expression, that is operatively linked to the nucleic acid sequence to be expressed. Within a recombinant expression vector, "operably linked" is intended to mean that the nucleotide sequence of interest is linked to the regulatory sequences) in a manner that allows for expression of the nucleotide sequence (e.g., in an in vitro transcription/translation system or in a host cell when the vector is introduced into the host cell).
The term "regulatory sequence" is intended to includes promoters, enhancers and other expression control elements (e.g., polyadenylation signals). Such regulatory sequences are described, for example, in Goeddel; GENE EXPRESSION TECHNOLOGY: METHODS IN ENZYMOLOGY 185, Academic Press, San Diego, Calif. (1990). Regulatory sequences include those that direct constitutive expression of a nucleotide sequence in many types of host cell and those that direct expression of the nucleotide sequence only in certain host cells (e.g., tissue-specific regulatory sequences). It will be appreciated by those skilled in the art that the design of the expression vector can depend on such factors as the choice of the host cell to be transformed, the level of expression of protein desired, etc. The expression vectors of the invention can be introduced into host cells to thereby produce proteins or peptides, including fusion proteins or peptides, encoded by nucleic acids as described herein (e.g., ORFX proteins, mutant forms of ORFX, fusion proteins, etc.).
The recombinant expression vectors of the invention can be designed for expression of ORFX in prokaryotic or eukaryotic cells. For example, ORFX can be expressed in bacterial cells such as E. coli, insect cells (using baculovirus expression vectors) yeast cells or mammalian cells. Suitable host cells are discussed further in Goeddel, GENE EXPRESSION
TECHNOLOGY:
METHODS IN ENZYMOLOGY 185, Academic Press, San Diego, Calif. (1990).
Alternatively, the recombinant expression vector can be transcribed and translated in vitro, for example using T7 promoter regulatory sequences and T7 polymerase.
Expression of proteins in prokaryotes is most often carried out in E. coli with vectors containing constitutive or inducible promoters directing the expression of either fusion or non-fusion proteins. Fusion vectors add a number of amino acids to a protein encoded therein, usually to the amino terminus of the recombinant protein. Such fusion vectors typically serve three purposes: (1) to increase expression of recombinant protein; (2) to increase the solubility of the recombinant protein; and (3) to aid in the purification of the recombinant protein by acting as a ligand in affinity purification. Often, in fusion expression vectors, a proteolytic cleavage site is introduced at the junction of the fusion moiety and the recombinant protein to enable separation of the recombinant protein from the fusion moiety subsequent to purification of the fusion protein. Such enzymes, and their cognate recognition sequences, include Factor Xa, thrombin and enterokinase. Typical fusion expression vectors include pGEX (Pharmacia Biotech Inc;
Smith and Johnson (1988) Gene 67:31-40), pMAL (New England Biolabs, Beverly, Mass.) and pRITS (Pharmacia, Piscataway, N.J.) that fuse glutathione S-transferase (GST), maltose E
binding protein, or protein A, respectively, to the target recombinant protein.

Examples of suitable inducible non-fusion E. coli expression vectors include pTrc (Amrann et al., (1988) Gene 69:301-315) and pET 1 1d (Studier et al., GENE
EXPRESSION
TECHNOLOGY: METHODS IN ENZYMOLOGY 185, Academic Press, San Diego, Calif.
(1990) 60-89).
One strategy to maximize recombinant protein expression in E. coli is to express the protein in a host bacteria with an impaired capacity to proteolytically cleave the recombinant protein. See, Gottesman, GENE EXPRESSION TECHNOLOGY: METHODS IN ENZYMOLOGY
185, Academic Press, San Diego, Calif. (1990) 119-128. Another strategy is to alter the nucleic acid sequence of the nucleic acid to be inserted into an expression vector so that the individual codons for each amino acid are those preferentially utilized in E. coli (Wada et al., (1992) Nucleic Acids Res. 20:2111-2118). Such alteration of nucleic acid sequences of the invention can be carried out by standard DNA synthesis techniques.
In another embodiment, the ORFX expression vector is a yeast expression vector.
Examples of vectors for expression in yeast S. cerivisae include pYepSecl (Baldari, et al., (1987) EMBOJ6:229-234), pMFa (Kurjan and Herskowitz, (1982) Cell 30:933-943), pJRY88 (Schultz et al., (1987) Gene 54:113-123), pYES2 (Invitrogen Corporation, San Diego, Calif.), and picZ (InVitrogen Corp, San Diego, Calif.).
Alternatively, ORFX can be expressed in insect cells using baculovirus expression vectors. Baculovirus vectors available for expression of proteins in cultured insect cells (e.g., SF9 cells) include the pAc series (Smith et al. (1983) Mol Cell Biol 3:2156-2165) and the pVL
series (Lucklow and Summers (1989) Virology 170:31-39).
In yet another embodiment, a nucleic acid of the invention is expressed in mammalian cells using a mammalian expression vector. Examples of mammalian expression vectors include pCDM8 (Seed (1987) Nature 329:840) and pMT2PC (Kaufinan et al. (1987) EMBO J
6: 187-195). When used in mammalian cells, the expression vector's control functions are often provided by viral regulatory elements. For example, commonly used promoters are derived from polyoma, Adenovirus 2, cytomegalovirus and Simian Virus 40. For other suitable expression systems for both prokaryotic and eukaryotic cells. See, e.g., Chapters 16 and 17 of Sambrook et al., MOLECULAR CLONING: A LABORATORY MANUAL. 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1989.

In another embodiment, the recombinant mammalian expression vector is capable of directing expression of the nucleic acid preferentially in a particular cell type (e.g., tissue-specific regulatory elements are used to express the nucleic acid).
Tissue-specific regulatory elements are known in the art. Non-limiting examples of suitable tissue-specific S promoters include the albumin promoter (liver-specific; Pinkert et al.
(1987) Genes Dev 1:268-277), lymphoid-specific promoters (Calame and Eaton (1988) Adv Immunol 43:235-275), in particular promoters of T cell receptors (Winoto and Baltimore (1989) EMBO
J 8:729-733) and immunoglobulins (Banerji et al. (1983) Cell 33:729-740; Queen and Baltimore (1983) Cell 33:741-748), neuron-specific promoters (e.g., the neurofilament promoter;
Byrne and Ruddle (1989) PNAS 86:5473-5477), pancreas-specific promoters (Edlund et al. (1985) Science 230:912-916), and mammary gland-specific promoters (e.g., milk whey promoter;
U.S. Pat. No.
4,873,316 and European Application Publication No. 264,166). Developmentally-regulated promoters are also encompassed, e.g., the marine hox promoters (Kessel and Grass (1990) Science 249:374-379) and the a-fetoprotein promoter (Campes and Tilghman (1989) Genes Dev 3:537-546).
The invention further provides a recombinant expression vector comprising a DNA
molecule of the invention cloned into the expression vector in an antisense orientation. That is, the DNA molecule is operatively linked to a regulatory sequence in a manner that allows for expression (by transcription of the DNA molecule) of an RNA molecule that is antisense to ORFX mRNA. Regulatory sequences operatively linked to a nucleic acid cloned in the antisense orientation can be chosen that direct the continuous expression of the antisense RNA molecule in a variety of cell types, for instance viral promoters and/or enhancers, or regulatory sequences can be chosen that direct constitutive, tissue specific or cell type specific expression of antisense RNA. The antisense expression vector can be in the form of a recombinant plasmid, phagemid or attenuated virus in which antisense nucleic acids are produced under the control of a high efficiency regulatory region, the activity of which can be determined by the cell type into which the vector is introduced. For a discussion of the regulation of gene expression using antisense genes see Weintraub et al., "Antisense RNA as a molecular tool for genetic analysis,"
Reviews--Trends in Genetics, V o1. 1 ( 1 ) 1986.
Another aspect of the invention pertains to host cells into which a recombinant expression vector of the invention has been introduced. The terms "host cell"
and "recombinant host cell" are used interchangeably herein. It is understood that such terms refer not only to the particular subject cell but to the progeny or potential progeny of such a cell. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the parent cell, but are still included within the scope of the term as used herein.
A host cell can be any prokaryotic or eukaryotic cell. For example, ORFX
protein can be expressed in bacterial cells such as E. coli, insect cells, yeast or mammalian cells (such as Chinese hamster ovary cells (CHO) or COS cells). Other suitable host cells are known to those skilled in the art.
Vector DNA can be introduced into prokaryotic or eukaryotic cells via conventional transformation or transfection techniques. As used herein, the terms "transformation" and "transfection" are intended to refer to a variety of art-recognized techniques for introducing foreign nucleic acid (e.g., DNA) into a host cell, including calcium phosphate or calcium chloride co-precipitation, DEAE-dextran-mediated transfection, lipofection, or electroporation.
Suitable methods for transforming or transfecting host cells can be found in Sambrook, et al.
(MOLECULAR CLONING: A LABORATORY MANUAL. Zrid ed., COId Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1989), and other laboratory manuals.
For stable transfection of mammalian cells, it is known that, depending upon the expression vector and transfection technique used, only a small fraction of cells may integrate the foreign DNA into their genome. In order to identify and select these integrants, a gene that encodes a selectable marker (e.g., resistance to antibiotics) is generally introduced into the host cells along with the gene of interest. Various selectable markers include those that confer resistance to drugs, such as 6418, hygromycin and methotrexate. Nucleic acid encoding a selectable marker can be introduced into a host cell on the same vector as that encoding ORFX
or can be introduced on a separate vector. Cells stably transfected with the introduced nucleic acid can be identified by drug selection (e.g., cells that have incorporated the selectable marker gene will survive, while the other cells die).
A host cell of the invention, such as a prokaryotic or eukaryotic host cell in culture, can be used to produce (i.e., express) ORFX protein. Accordingly, the invention further provides methods for producing ORFX protein using the host cells of the invention. In one embodiment, the method comprises culturing the host cell of invention (into which a recombinant expression vector encoding ORFX has been introduced) in a suitable medium such that ORFX
protein is produced. In another embodiment, the method further comprises isolating ORFX
from the medium or the host cell.
Transgenic animals The host cells of the invention can also be used to produce nonhuman transgenic animals.
For example, in one embodiment, a host cell of the invention is a fertilized oocyte or an embryonic stem cell into which ORFX-coding sequences have been introduced.
Such host cells can then be used to create non-human transgenic animals in which exogenous ORFX sequences have been introduced into their genome or homologous recombinant animals in which endogenous ORFX sequences have been altered. Such animals are useful for studying the function and/or activity of ORFX and for identifying and/or evaluating modulators of ORFX
activity. As used herein, a "transgenic animal" is a non-human animal, preferably a mammal, more preferably a rodent such as a rat or mouse, in which one or more of the cells of the animal 1 S includes a transgene. Other examples of transgenic animals include non-human primates, sheep, dogs, cows, goats, chickens, amphibians, etc. A transgene is exogenous DNA
that is integrated into the genome of a cell from which a transgenic animal develops and that remains in the genome of the mature animal, thereby directing the expression of an encoded gene product in one or more cell types or tissues of the transgenic animal. As used herein, a "homologous recombinant animal" is a non-human animal, preferably a mammal, more preferably a mouse, in which an endogenous ORFX gene has been altered by homologous recombination between the endogenous gene and an exogenous DNA molecule introduced into a cell of the animal, e.g., an embryonic cell of the animal, prior to development of the animal.
A transgenic animal of the invention can be created by introducing ORFX-encoding nucleic acid into the male pronuclei of a fertilized oocyte, e.g., by microinjection, retroviral infection, and allowing the oocyte to develop in a pseudopregnant female foster animal. The human ORFX DNA sequence of SEQ ID N0:2n-1 (wherein n = 1 to 3161) can be introduced as a transgene into the genome of a non-human animal. Alternatively, a nonhuman homologue of the human ORFX gene, such as a mouse ORFX gene, can be isolated based on hybridization to the human ORFX cDNA (described further above) and used as a transgene.
Intronic sequences and polyadenylation signals can also be included in the transgene to increase the efficiency of expression of the transgene. A tissue-specific regulatory sequences) can be operably linked to the ORFX transgene to direct expression of ORFX protein to particular cells.
Methods for generating transgenic animals via embryo manipulation and microinjection, particularly animals such as mice, have become conventional in the art and are described, for example, in U.S. Pat.
Nos. 4,736,866; 4,870,009; and 4,873,191; and Hogan 1986, In: MANIPULATING THE
MousE
EMBRYO, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. Similar methods are used for production of other transgenic animals. A transgenic founder animal can be identified based upon the presence of the ORFX transgene in its genome and/or expression of ORFX
mRNA in tissues or cells of the animals. A transgenic founder animal can then be used to breed additional animals carrying the transgene. Moreover, transgenic animals carrying a transgene encoding ORFX can further be bred to other transgenic animals carrying other transgenes.
To create a homologous recombinant animal, a vector is prepared which contains at least a portion of a ORFX gene into which a deletion, addition or substitution has been introduced to thereby alter, e.g., functionally disrupt, the ORFX gene. The ORFX gene can be a human gene (e.g., SEQ ID N0:2n-1 (wherein n = 1 to 3161)), but more preferably, is a non-human homologue of a human ORFX gene. For example, a mouse homologue of human ORFX
gene of SEQ ID N0:2n-1 (wherein n = 1 to 3161) can be used to construct a homologous recombination vector suitable for altering an endogenous ORFX gene in the mouse genome. In one embodiment, the vector is designed such that, upon homologous recombination, the endogenous ORFX gene is functionally disrupted (i.e., no longer encodes a functional protein; also referred to as a "knock out" vector).
Alternatively, the vector can be designed such that, upon homologous recombination, the endogenous ORFX gene is mutated or otherwise altered but still encodes functional protein (e.g., the upstream regulatory region can be altered to thereby alter the expression of the endogenous ORFX protein). In the homologous recombination vector, the altered portion of the ORFX gene is flanked at its 5' and 3' ends by additional nucleic acid of the ORFX gene to allow for homologous recombination to occur between the exogenous ORFX gene carried by the vector and an endogenous ORFX gene in an embryonic stem cell. The. additional flanking ORFX
nucleic acid is of sufficient length for successful homologous recombination with the endogenous gene. Typically, several kilobases of flanking DNA (both at the 5' and 3' ends) are included in the vector. See e.g., Thomas et al. (1987) Cell 51:503 for a description of homologous recombination vectors. The vector is introduced into an embryonic stem cell line (e.g., by electroporation) and cells in which the introduced ORFX gene has homologously recombined with the endogenous ORFX gene are selected (see e.g., Li et al.
(1992) Cell 69:915).
The selected cells are then injected into a blastocyst of an animal (e.g., a mouse) to form aggregation chimeras. See e. g., Bradley 1987, In: TERATOCARCINOMAS AND
EMBRYONIC STEM
CELLS: A PRACTICAL APPROACH, Robertson, ed. IRL, Oxford, pp. 113-152. A
chimeric embryo can then be implanted into a suitable pseudopregnant female foster animal and the embryo brought to term. Progeny harboring the homologously recombined DNA in their germ cells can be used to breed animals in which all cells of the animal contain the homologously recombined DNA by germline transmission of the transgene. Methods for constructing homologous recombination vectors and homologous recombinant animals are described further in Bradley (1991) Curr Opin Biotechnol 2:823-829; PCT International Publication Nos.: WO
90/11354;
WO 91/01140; WO 92/0968; and WO 93/04169.
In another embodiment, transgenic non-humans animals can be produced that contain selected systems that allow for regulated expression of the transgene. One example of such a system is the cre/loxP recombinase system of bacteriophage P 1. For a description of the cre/loxP
recombinase system, see, e.g., Lakso et al. (1992) PNAS 89:6232-6236. Another example of a recombinase system is the FLP recombinase system of Saccharomyces cerevisiae (O'Gorman et al. (1991) Science 251:1351-1355. If a cre/loxP recombinase system is used to regulate expression of the transgene, animals containing transgenes encoding both the Cre recombinase and a selected protein are required. Such animals can be provided through the construction of "double" transgenic animals, e.g., by mating two transgenic animals, one containing a transgene encoding a selected protein and the other containing a transgene encoding a recombinase.
Clones of the non-human transgenic animals described herein can also be produced according to the methods described in Wilmut et al. (1997) Nature 385:810-813.
In brief, a cell, e.g., a somatic cell, from the transgenic animal can be isolated and induced to exit the growth cycle and enter Go phase. The quiescent cell can then be fused, e.g., through the use of electrical pulses, to an enucleated oocyte from an animal of the same species from which the quiescent cell is isolated. The reconstructed oocyte is then cultured such that it develops to morula or blastocyte and then transferred to pseudopregnant female foster animal. The offspring borne of this female foster animal will be a clone of the animal from which the cell, e.g., the somatic cell, is isolated.
Pharmaceutical Compositions The ORFX nucleic acid molecules, ORFX proteins, and anti-ORFX antibodies (also S referred to herein as "active compounds") of the invention, and derivatives, fragments, analogs and homologs thereof, can be incorporated into pharmaceutical compositions suitable for administration. Such compositions typically comprise the nucleic acid molecule, protein, or antibody and a pharmaceutically acceptable carrier. As used herein, "pharmaceutically acceptable carrier" is intended to include any and all solvents, dispersion media, coatings, antibacterial and antifungal agents, isotonic and absorption delaying agents, and the like, compatible with pharmaceutical administration. Suitable carriers are described in the most recent edition of Remington's Pharmaceutical Sciences, a standard reference text in the field, which is incorporated herein by reference. Preferred examples of such carriers or diluents include, but are not limited to, water, saline, finger's solutions, dextrose solution, and 5% human serum albumin. Liposomes and non-aqueous vehicles such as fixed oils may also be used. The use of such media and agents for pharmaceutically active substances is well known in the art.
Except insofar as any conventional media or agent is incompatible with the active compound, use thereof in the compositions is contemplated. Supplementary active compounds can also be incorporated into the compositions.
A pharmaceutical composition of the invention is formulated to be compatible with its intended route of administration. Examples of routes of administration include parenteral, e.g., intravenous, intradermal, subcutaneous, oral (e.g., inhalation), transdermal (topical), transmucosal, and rectal administration. Solutions or suspensions used for parenteral, intradermal, or subcutaneous application can include the following components:
a sterile diluent such as water for injection, saline solution, fixed oils, polyethylene glycols, glycerine, propylene glycol or other synthetic solvents; antibacterial agents such as benzyl alcohol or methyl parabens; antioxidants such as ascorbic acid or sodium bisulfate; chelating agents such as ethylenediam'inetetraacetic acid; buffers such as acetates, citrates or phosphates, and agents for the adjustment of tonicity such as sodium chloride or dextrose. The pH can be adjusted with acids or bases, such as hydrochloric acid or sodium hydroxide. The parenteral preparation can be enclosed in ampoules, disposable syringes or multiple dose vials made of glass or plastic.

Pharmaceutical compositions suitable for injectable use include sterile aqueous solutions (where water soluble) or dispersions and sterile powders for the extemporaneous preparation of sterile injectable solutions or dispersion. For intravenous administration, suitable carriers include physiological saline, bacteriostatic water, Cremophor ELTM (BASF, Parsippany, N.J.) or phosphate buffered saline (PBS). In all cases, the composition must be sterile and should be fluid to the extent that easy syringeability exists. It must be stable under the conditions of manufacture and storage and must be preserved against the contaminating action of microorganisms such as bacteria and fungi. The Garner can be a solvent or dispersion medium containing, for example, water, ethanol, polyol (for example, glycerol, propylene glycol, and liquid polyethylene glycol, and the like), and suitable mixtures thereof. The proper fluidity can be maintained, for example, by the use of a coating such as lecithin, by the maintenance of the required particle size in the case of dispersion and by the use of surfactants. Prevention of the action of microorganisms can be achieved by various antibacterial and antifungal agents, for example, parabens, chlorobutanol, phenol, ascorbic acid, thimerosal, and the like. In many cases, it will be preferable to include isotonic agents, for example, sugars, polyalcohols such as manitol, sorbitol, sodium chloride in the composition. Prolonged absorption of the injectable compositions can be brought about by including in the composition an agent which delays absorption, for example, aluminum monostearate and gelatin.
Sterile injectable solutions can be prepared by incorporating the active compound (e.g., a ORFX protein or anti-ORFX antibody) in the required amount in an appropriate solvent with one or a combination of ingredients enumerated above, as required, followed by filtered sterilization.
Generally, dispersions are prepared by incorporating the active compound into a sterile vehicle that contains a basic dispersion medium and the required other ingredients from those enumerated above. In the case of sterile powders for the preparation of sterile injectable solutions, methods of preparation are vacuum drying and freeze-drying that yields a powder of the active ingredient plus any additional desired ingredient from a previously sterile-filtered solution thereof.
Oral compositions generally include an inert diluent or an edible carrier.
They can be enclosed in gelatin capsules or compressed into tablets. _For the purpose of oral therapeutic administration, the active compound can be incorporated with excipients and used in the form of tablets, troches, or capsules. Oral compositions can also be prepared using a fluid Garner for use as a mouthwash, wherein the compound in the fluid Garner is applied orally and swished and expectorated or swallowed. Pharmaceutically compatible binding agents, and/or adjuvant materials can be included as part of the composition. The tablets, pills, capsules, troches and the like can contain any of the following ingredients, or compounds of a similar nature: a binder such as microcrystalline cellulose, gum tragacanth or gelatin; an excipient such as starch or lactose, a disintegrating agent such as alginic acid, Primogel, or corn starch; a lubricant such as magnesium stearate or Sterotes; a glidant such as colloidal silicon dioxide; a sweetening agent such as sucrose or saccharin; or a flavoring agent such as peppermint, methyl salicylate, or orange flavoring.
For administration by inhalation, the compounds are delivered in the form of an aerosol spray from pressured container or dispenser which contains a suitable propellant, e.g., a gas such as carbon dioxide, or a nebulizer.
Systemic administration can also be by transmucosal or transdermal means. For transmucosal or transdermal administration, penetrants appropriate to the barner to be permeated are used in the formulation. Such penetrants are generally known in the art, and include, for example, for transmucosal administration, detergents, bile salts, and fusidic acid derivatives.
Transmucosal administration can be accomplished through the use of nasal sprays or suppositories. For transdermal administration, the active compounds are formulated into ointments, salves, gels, or creams as generally known in the art.
The compounds can also be prepared in the form of suppositories (e.g., with conventional suppository bases such as cocoa butter and other glycerides) or retention enemas for rectal delivery.
In one embodiment, the active compounds are prepared with carriers that will protect the compound against rapid elimination from the body, such as a controlled release formulation, including implants and microencapsulated delivery systems. Biodegradable, biocompatible polymers can be used, such as ethylene vinyl acetate, polyanhydrides, polyglycolic acid, collagen, polyorthoesters, and polylactic acid. Methods for preparation of such formulations will be apparent to those skilled in the art. The materials can also be obtained commercially from Alza Corporation and Nova Pharmaceuticals, Inc. Liposomal suspensions (including liposomes targeted to infected cells with monoclonal antibodies to viral antigens) can also be used as pharmaceutically acceptable carriers. These can be prepared according to methods known to those skilled in the art, for example, as described in U.S. Pat. No.
4,522,811.

It is especially advantageous to formulate oral or parenteral compositions in dosage unit form for ease of administration and uniformity of dosage. Dosage unit form as used herein refers to physically discrete units suited as unitary dosages for the subject to be treated; each unit containing a predetermined quantity of active compound calculated to produce the desired therapeutic effect in association with the required pharmaceutical Garner. The specification for the dosage unit forms of the invention are dictated by and directly dependent on the unique characteristics of the active compound and the particular therapeutic effect to be achieved.
The nucleic acid molecules of the invention can be inserted into vectors and used as gene therapy vectors. Gene therapy vectors can be delivered to a subject by any of a number of routes, e.g., as described in U.S. Patent Nos. 5,703,055. Delivery can thus also include, e.g., intravenous injection, local administration (see U.S. Pat. No. 5,328,470) or stereotactic injection (see e.g., Chen et al. (1994) PNAS 91:3054-3057). The pharmaceutical preparation of the gene therapy vector can include the gene therapy vector in an acceptable diluent, or can comprise a slow release matrix in which the gene delivery vehicle is imbedded.
Alternatively, where the complete gene delivery vector can be produced intact from recombinant cells, e.g., retroviral vectors, the pharmaceutical preparation can include one or more cells that produce the gene delivery system.
The pharmaceutical compositions can be included in a container, pack, or dispenser together with instructions for administration.
Additional Uses and Methods of the Invention The nucleic acid molecules, proteins, protein homologues, and antibodies described herein can be used in one or more of the following methods: (a) screening assays; (b) detection assays (e.g., chromosomal mapping, cell and tissue typing, forensic biology), (c) predictive medicine (e.g., diagnostic assays, prognostic assays, monitoring clinical trials, and pharmacogenomics); and (d) methods of treatment (e.g., therapeutic and prophylactic).
The isolated nucleic acid molecules of the invention can be used to express ORFX
protein (e.g., via a recombinant expression vector in a host cell in gene therapy applications), to detect ORFX mRNA (e.g., in a biological sample) or a genetic lesion in a ORFX
gene, and to modulate ORFX activity, as described further below. In addition, the ORFX
proteins can be used to screen drugs or compounds that modulate the ORFX activity or expression as well as to treat disorders characterized by insufficient or excessive production of ORFX
protein, for example proliferative or differentiative disorders, or production of ORFX
protein forms that have decreased or aberrant activity compared to ORFX wild type protein. In addition, the anti-ORFX
antibodies of the invention can be used to detect and isolate ORFX proteins and modulate ORFX
activity.
This invention further pertains to novel agents identified by the above described screening assays and uses thereof for treatments as described herein.
Screening Assays The invention provides a method (also referred to herein as a "screening assay") for identifying modulators, i.e., candidate or test compounds or agents (e.g., peptides, peptidomimetics, small molecules or other drugs) that bind to ORFX proteins or have a stimulatory or inhibitory effect on, for example, ORFX expression or ORFX
activity.
In one embodiment, the invention provides assays for screening candidate or test compounds which bind to or modulate the activity of a ORFX protein or polypeptide or biologically active portion thereof. The test compounds of the present invention can be obtained using any of the numerous approaches in combinatorial library methods known in the art, including: biological libraries; spatially addressable parallel solid phase or solution phase libraries; synthetic library methods requiring deconvolution; the "one-bead one-compound"
library method; and synthetic library methods using affinity chromatography selection. The biological library approach is limited to peptide libraries, while the other four approaches are applicable to peptide, non-peptide oligomer or small molecule libraries of compounds (Lam (1997) Anticancer Drug Des 12:145).
Examples of methods for the synthesis of molecular libraries can be found in the art, for example in: DeWitt et al. (1993) Proc Natl Acad Sci U.S.A. 90:6909; Erb et al.
(1994) Proc Natl Acad Sci U.S.A. 91:11422; Zuckermann et al. (1994) JMed Chem 37:2678; Cho et al. (1993) Science 261:1303; Carrell et al. (1994) Angew Chem Int Ed Engl 33:2059; Carell et al. (1994) Angew Chem Int Ed Engl 33:2061; and Gallop et al. (1994) JMed Chem 37:1233.
Libraries of compounds may be presented in solution (e.g., Houghten (1992) Biotechniques 13:412-421), or on beads (Lam (1991) Nature 354:82-84), on chips (Fodor (1993) Nature 364:555-556), bacteria (Ladner U.S. Pat. No. 5,223,409), spores (Ladner USP'409), plasmids (Cull et al. (1992) ProcNatl Acad Sci USA 89:1865-1869) or on phage (Scott and Smith ( 1990) Science 249:3 86-390; Devlin ( 1990) Science 249:404-406; Cwirla et al. ( 1990) Proc Natl Acad Sci U.S.A. 87:6378-6382; Felici (1991) .l Mol Biol 222:301-310;
Ladner above.).
In one embodiment, an assay is a cell-based assay in which a cell which expresses a membrane-bound form of ORFX protein, or a biologically active portion thereof, on the cell surface is contacted with a test compound and the ability of the test compound to bind to a ORFX protein determined. The cell, for example, can of mammalian origin or a yeast cell.
Determining the ability of the test compound to bind to the ORFX protein can be accomplished, for example, by coupling the test compound with a radioisotope or enzymatic label such that binding of the test compound to the ORFX protein or biologically active portion thereof can be determined by detecting the labeled compound in a complex. For example, test compounds can be labeled with 1251, 355, laC, or 3H, either directly or indirectly, and the radioisotope detected by direct counting of radioemission or by scintillation counting. Alternatively, test compounds can be enzymatically labeled with, for example, horseradish peroxidase, alkaline phosphatase, or luciferase, and the enzymatic label detected by determination of conversion of an appropriate substrate to product. In one embodiment, the assay comprises contacting a cell which expresses a membrane-bound form of ORFX protein, or a biologically active portion thereof, on the cell surface with a known compound which binds ORFX to form an assay mixture, contacting the assay mixture with a test compound, and determining the ability of the test compound to interact with a ORFX protein, wherein determining the ability of the test compound to interact with a ORFX protein comprises determining the ability of the test compound to preferentially bind to ORFX or a biologically active portion thereof as compared to the known compound.
In another embodiment, an assay is a cell-based assay comprising contacting a cell expressing a membrane-bound form of ORFX protein, or a biologically active portion thereof, on the cell surface with a test compound and determining the ability of the test compound to modulate (e.g., stimulate or inhibit) the activity of the ORFX protein or biologically active portion thereof. Determining the ability of the test compound to modulate the activity of ORFX
or a biologically active portion thereof can be accomplished, for example, by determining the ability of the ORFX protein to bind to or interact with a ORFX target molecule. As used herein, a "target molecule" is a molecule with which a ORFX protein binds or interacts in nature, for example, a molecule on the surface of a cell which expresses a ORFX
interacting protein, a molecule on the surface of a second cell, a molecule in the extracellular milieu, a molecule associated with the internal surface of a cell membrane or a cytoplasmic molecule. A ORFX
target molecule can be a non-ORFX molecule or a ORFX protein or polypeptide of the present invention. In one embodiment, a ORFX target molecule is a component of a signal transduction pathway that facilitates transduction of an extracellular signal (e.g., a signal generated by binding of a compound to a membrane-bound ORFX molecule) through the cell membrane and into the cell. The target, for example, can be a second intercellular protein that has catalytic activity or a protein that facilitates the association of downstream signaling molecules with ORFX.
Determining the ability of the ORFX protein to bind to or interact with a ORFX
target molecule can be accomplished by one of the methods described above for determining direct binding. In one embodiment, determining the ability of the ORFX protein to bind to or interact with a ORFX target molecule can be accomplished by determining the activity of the target molecule. For example, the activity of the target molecule can be determined by detecting induction of a cellular second messenger of the target (i. e. intracellular Ca2+, diacylglycerol, IP3, etc.), detecting catalytic/enzymatic activity of the target an appropriate substrate, detecting the induction of a reporter gene (comprising a ORFX-responsive regulatory element operatively linked to a nucleic acid encoding a detectable marker, e.g., luciferase), or detecting a cellular response, for example, cell survival, cellular differentiation, or cell proliferation.
In yet another embodiment, an assay of the present invention is a cell-free assay comprising contacting a ORFX protein or biologically active portion thereof with a test compound and determining the ability of the test compound to bind to the ORFX
protein or biologically active portion thereof. Binding of the test compound to the ORFX
protein can be determined either directly or indirectly as described above. In one embodiment, the assay comprises contacting the ORFX protein or biologically active portion thereof with a known compound which binds ORFX to form an assay mixture, contacting the assay mixture with a test compound, and determining the ability of the test compound to interact with a ORFX protein, wherein determining the ability of the test compound to interact with a ORFX
protein comprises determining the ability of the test compound to preferentially bind to ORFX or biologically active portion thereof as compared to the known compound.
In another embodiment, an assay is a cell-free assay comprising contacting ORFX protein or biologically active portion thereof with a test compound and determining the ability of the test compound to modulate (e.g., stimulate or inhibit) the activity of the ORFX
protein or biologically active portion thereof. Determining the ability of the test compound to modulate the activity of ORFX can be accomplished, for example, by determining the ability of the ORFX
protein to bind to a ORFX target molecule by one of the methods described above for determining direct binding. In an alternative embodiment, determining the ability of the test compound to modulate the activity of ORFX can be accomplished by determining the ability of the ORFX protein further modulate a ORFX target molecule. For example, the catalytic/enzymatic activity of the target molecule on an appropriate substrate can be determined as previously described.
In yet another embodiment, the cell-free assay comprises contacting the ORFX
protein or biologically active portion thereof with a known compound which binds ORFX to form an assay mixture, contacting the assay mixture with a test compound, and determining the ability of the test compound to interact with a ORFX protein, wherein determining the ability of the test compound to interact with a ORFX protein comprises determining the ability of the ORFX
protein to preferentially bind to or modulate the activity of a ORFX target molecule.
The cell-free assays of the present invention are amenable to use of both the soluble form or the membrane-bound form of ORFX. In the case of cell-free assays comprising the membrane-bound form of ORFX, it may be desirable to utilize a solubilizing agent such that the membrane-bound form of ORFX is maintained in solution. Examples of such solubilizing agents include non-ionic detergents such as n-octylglucoside, n-dodecylglucoside, n-dodecylmaltoside, octanoyl-N-methylglucamide, decanoyl-N-methylglucamide, Triton X-100, Triton X-114, Thesit~, Isotridecypoly(ethylene glycol ether)", N-dodecyl--N,N-dimethyl-3-ammonio-1-propane sulfonate, 3-(3-cholamidopropyl)dimethylamminiol-1-propane sulfonate (CHAPS), or 3-(3-cholamidopropyl)dimethylamminiol-2-hydroxy-1-propane sulfonate (CHAPSO).
In more than one embodiment of the above assay methods of the present invention, it may be desirable to immobilize either ORFX or its target molecule to facilitate separation of complexed from uncomplexed forms of one or both of the proteins, as well as to accommodate automation of the assay. Binding of a test compound to ORFX, or interaction of ORFX with a target molecule in the presence and absence of a candidate compound, can be accomplished in any vessel suitable for containing the reactants. Examples of such vessels include microtiter plates, test tubes, and micro-centrifuge tubes. In one embodiment, a fusion protein can be provided that adds a domain that allows one or both of the proteins to be bound to a matrix. For example, GST-ORFX fusion proteins or GST-target fusion proteins can be adsorbed onto glutathione sepharose beads (Sigma Chemical, St. Louis, MO) or glutathione derivatized microtiter plates, that are then combined with the test compound or the test compound and either the non-adsorbed target protein or ORFX protein, and the mixture is incubated under conditions S conducive to complex formation (e.g., at physiological conditions for salt and pH). Following incubation, the beads or microtiter plate wells are washed to remove any unbound components, the matrix immobilized in the case of beads, complex determined either directly or indirectly, for example, as described above. Alternatively, the complexes can be dissociated from the matrix, and the level of ORFX binding or activity determined using standard techniques.
Other techniques for immobilizing proteins on matrices can also be used in the screening assays of the invention. For example, either ORFX or its target molecule can be immobilized utilizing conjugation of biotin and streptavidin. Biotinylated ORFX or target molecules can be prepared from biotin-NHS (N-hydroxy-succinimide) using techniques well known in the art (e.g., biotinylation kit, Pierce Chemicals, Rockford, Ill.), and immobilized in the wells of 1 S streptavidin-coated 96 well plates (Pierce Chemical). Alternatively, antibodies reactive with ORFX or target molecules, but which do not interfere with binding of the ORFX
protein to its target molecule, can be derivatized to the wells of the plate, and unbound target or ORFX
trapped in the wells by antibody conjugation. Methods for detecting such complexes, in addition to those described above for the GST-immobilized complexes, include immunodetection of complexes using antibodies reactive with the ORFX or target molecule, as well as enzyme-linked assays that rely on detecting an enzymatic activity associated with the ORFX
or target molecule.
In another embodiment, modulators of ORFX expression are identified in a method wherein a cell is contacted with a candidate compound and the expression of ORFX mRNA or protein in the cell is determined. The level of expression of ORFX mRNA or protein in the presence of the candidate compound is compared to the level of expression of ORFX mRNA or protein in the absence of the candidate compound. The candidate compound can then be identified as a modulator of ORFX expression based on this comparison. For example, when expression of ORFX mRNA or protein is greater (statistically significantly greater) in the presence of the candidate compound than in its absence, the candidate compound is identified as a stimulator of ORFX mRNA or protein expression. Alternatively, when expression of ORFX
mRNA or protein is less (statistically significantly less) in the presence of the candidate compound than in its absence, the candidate compound is identified as an inhibitor of ORFX
mRNA or protein expression. The level of ORFX mRNA or protein expression in the cells can be determined by methods described herein for detecting ORFX mRNA or protein.
In yet another aspect of the invention, the ORFX proteins can be used as "bait proteins"
in a two-hybrid assay or three hybrid assay (see, e.g., U.S. Pat. No.
5,283,317; Zervos et al.
(1993) Cell 72:223-232; Madura et al. (1993) J Biol Chem 268:12046-12054;
Bartel et al. (1993) Biotechniques 14:920-924; Iwabuchi et al. (1993) Oncogene 8:1693-1696; and Brent W094/10300), to identify other proteins that bind to or interact with ORFX
("ORFX-binding proteins" or "ORFX-by") and modulate ORFX activity. Such ORFX-binding proteins are also likely to be involved in the propagation of signals by the ORFX proteins as, for example, upstream or downstream elements of the ORFX pathway.
The two-hybrid system is based on the modular nature of most transcription factors, which consist of separable DNA-binding and activation domains. Briefly, the assay utilizes two different DNA constructs. In one construct, the gene that codes for ORFX is fused to a gene encoding the DNA binding domain of a known transcription factor (e.g., GAL-4).
In the other construct, a DNA sequence, from a library of DNA sequences, that encodes an unidentified protein ("prey" or "sample") is fused to a gene that codes for the activation domain of the known transcription factor. If the "bait" and the "prey" proteins are able to interact, in vivo, forming a ORFX-dependent complex, the DNA-binding and activation domains of the transcription factor are brought into close proximity. This proximity allows transcription of a reporter gene (e.g., LacZ) that is operably linked to a transcriptional regulatory site responsive to the transcription factor. Expression of the reporter gene can be detected and cell colonies containing the functional transcription factor can be isolated and used to obtain the cloned gene that encodes the protein which interacts with ORFX.
This invention further pertains to novel agents identified by the above-described screening assays and uses thereof for treatments as described herein.
Detection Assays Portions or fragments of the cDNA sequences identified herein (and the corresponding complete gene sequences) can be used in numerous ways as polynucleotide reagents. For example, these sequences can be used to: (i) map their respective genes on a chromosome; and, thus, locate gene regions associated with genetic disease; (ii) identify an individual from a SS

minute biological sample (tissue typing); and (iii) aid in forensic identification of a biological sample.
The ORFX sequences of the present invention can also be used to identify individuals from minute biological samples. In this technique, an individual's genomic DNA
is digested with one or more restriction enzymes, and probed on a Southern blot to yield unique bands for identification. The sequences of the present invention are useful as additional DNA markers for RFLP ("restriction fragment length polymorphisms," described in U.S. Pat. No.
5,272,057).
Furthermore, the sequences of the present invention can be used to provide an alternative technique that determines the actual base-by-base DNA sequence of selected portions of an individual's genome. Thus, the ORFX sequences described herein can be used to prepare two PCR primers from the 5' and 3' ends of the sequences. These primers can then be used to amplify an individual's DNA and subsequently sequence it.
Panels of corresponding DNA sequences from individuals, prepared in this manner, can provide unique individual identifications, as each individual will have a unique set of such DNA
sequences due to allelic differences. The sequences of the present invention can be used to obtain such identification sequences from individuals and from tissue. The ORFX sequences of the invention uniquely represent portions of the human genome. Allelic variation occurs to some degree in the coding regions of these sequences, and to a greater degree in the noncoding regions. It is estimated that allelic variation between individual humans occurs with a frequency of about once per each 500 bases. Much of the allelic variation is due to single nucleotide polymorphisms (SNPs), which include restriction fragment length polymorphisms (RFLPs).
Each of the sequences described herein can, to some degree, be used as a standard against which DNA from an individual can be compared for identification purposes.
Because greater numbers of polymorphisms occur in the noncoding regions, fewer sequences are necessary to differentiate individuals. The noncoding sequences of SEQ ID N0:2n-1 (wherein n = 1 to 3161), as described above, can comfortably provide positive individual identification with a panel of perhaps 10 to 1,000 primers that each yield a noncoding amplified sequence of 100 bases. If predicted coding sequences are used, a more appropriate number of primers for positive individual identification would be 500-2,000.

Predictive Medicine The present invention also pertains to the field of predictive medicine in which diagnostic assays, prognostic assays, pharmacogenomics, and monitoring clinical trials are used for prognostic (predictive) purposes to thereby treat an individual prophylactically. Accordingly, one aspect of the present invention relates to diagnostic assays for determining ORFX protein and/or nucleic acid expression as well as ORFX activity, in the context of a biological sample (e.g., blood, serum, cells, tissue) to thereby determine whether an individual is afflicted with a disease or disorder, or is at risk of developing a disorder, associated with aberrant ORFX
expression or activity. The invention also provides for prognostic (or predictive) assays for determining whether an individual is at risk of developing a disorder associated with ORFX
protein, nucleic acid expression or activity. For example, mutations in a ORFX
gene can be assayed in a biological sample. Such assays can be used for prognostic or predictive purpose to thereby prophylactically treat an individual prior to the onset of a disorder characterized by or associated with ORFX protein, nucleic acid expression or activity.
Another aspect of the invention provides methods for determining ORFX protein, nucleic acid expression or ORFX activity in an individual to thereby select appropriate therapeutic or prophylactic agents for that individual (referred to herein as "pharmacogenomics") Pharmacogenomics allows for the selection of agents (e.g., drugs) for therapeutic or prophylactic treatment of an individual based on the genotype of the individual (e.g., the genotype of the individual examined to determine the ability of the individual to respond to a particular agent.) Yet another aspect of the invention pertains to monitoring the influence of agents (e.g., drugs, compounds) on the expression or activity of ORFX in clinical trials.
Use of Partial ORFX Sequences in Forensic Biology DNA-based identification techniques can also be used in forensic biology.
Forensic biology is a scientific field employing genetic typing of biological evidence found at a crime scene as a means for positively identifying, for example, a perpetrator of a crime. To make such an identification, PCR technology can be used to amplify DNA sequences taken from very small biological samples such as tissues, e.g., hair or skin, or body fluids, e.g., blood, saliva, or semen found at a crime scene. The amplified sequence can then be compared to a standard, thereby allowing identification of the origin of the biological sample.
The sequences of the present invention can be used to provide polynucleotide reagents, e.g., PCR primers, targeted to specific loci in the human genome, that can enhance the reliability of DNA-based forensic identifications by, for example, providing another "identification marker"
(i.e. another DNA sequence that is unique to a particular individual). As mentioned above, actual base sequence information can be used for identification as an accurate alternative to patterns formed by restriction enzyme generated fragments. Sequences targeted to noncoding regions of SEQ ID NOs:- are particularly appropriate for this use as greater numbers of polymorphisms occur in the noncoding regions, making it easier to differentiate individuals using this technique.
Examples of polynucleotide reagents include the ORFX sequences or portions thereof, e.g., fragments derived from the noncoding regions of one or more of SEQ ID N0:2n-1 (where n = 1 to 3161), having a length of at least 20 bases, preferably at least 30 bases.
The ORFX sequences described herein can further be used to provide polynucleotide reagents, e.g., labeled or label-able probes that can be used, for example, in an in situ hybridization technique, to identify a specific tissue, e.g., brain tissue, etc. This can be very useful in cases where a forensic pathologist is presented with a tissue of unknown origin. Panels of such ORFX probes can be used to identify tissue by species and/or by organ type.
In a similar fashion, these reagents, e.g., ORFX primers or probes can be used to screen tissue culture for contamination (i. e. screen for the presence of a mixture of different types of cells in a culture).
Predictive Medicine The present invention also pertains to the field of predictive medicine in which diagnostic assays, prognostic assays, pharmacogenomics, and monitoring clinical trials are used for prognostic (predictive) purposes to thereby treat an individual prophylactically. Accordingly, one aspect of the present invention relates to diagnostic assays for determining ORFX protein and/or nucleic acid expression as well as ORFX activity, in the context of a biological sample (e.g., blood, serum, cells, tissue) to thereby determine whether an individual is afflicted with a disease or disorder, or is at risk of developing a disorder, associated with aberrant ORFX expression or activity. The invention also provides for prognostic (or predictive) assays for determining whether an individual is at risk of developing a disorder associated with ORFX
protein, nucleic acid expression or activity. For example, mutations in a ORFX gene can be assayed in a biological sample. Such assays can be used for prognostic or predictive purpose to thereby prophylactically treat an individual prior to the onset of a disorder characterized by or associated with ORFX protein, nucleic acid expression or activity.
Another aspect of the invention provides methods for determining ORFX protein, nucleic acid expression or ORFX activity in an individual to thereby select appropriate therapeutic or prophylactic agents for that individual (referred to herein as "pharmacogenomics").
Pharmacogenomics allows for the selection of agents (e.g., drugs) for therapeutic or prophylactic treatment of an individual based on the genotype of the individual (e.g., the genotype of the individual examined to determine the ability of the individual to respond to a particular agent.) Yet another aspect of the invention pertains to monitoring the influence of agents (e.g., drugs, compounds) on the expression or activity of ORFX in clinical trials.
These and other agents are described in further detail in the following sections.
Diagnostic Assays Other conditions in which proliferation of cells plays a role include tumors, restenosis, psoriasis, Dupuytren's contracture, diabetic complications, Kaposi's sarcoma and rheumatoid arthritis.
An ORFX polypeptide may be used to identify an interacting polypeptide a sample or tissue. The method comprises contacting the sample or tissue with ORFX, allowing formation of a complex between the ORFX polypeptide and the interacting polypeptide, and detecting the complex, if present.
The proteins of the invention may be used to stimulate production of antibodies specifically binding the proteins. Such antibodies may be used in immunodiagnostic procedures to detect the occurrence of the protein in a sample. The proteins of the invention may be used to stimulate cell growth and cell proliferation in conditions in which such growth would be favorable. An example would be to counteract toxic side effects of chemotherapeutic agents on, for example, hematopoiesis and platelet formation, linings of the gastrointestinal tract, and hair follicles. They may also be used to stimulate new cell growth in neurological disorders including, for example, Alzheimer's disease. Alternatively, antagonistic treatments may be administered in which an antibody specifically binding the ORFX -like proteins of the invention would abrogate the specific growth-inducing effects of the proteins. Such antibodies may be useful, for example, in the treatment of proliferative disorders including various tumors and benign hyperplasias.
Polynucleotides or oligonucleotides corresponding to any one portion of the ORFX
nucleic acids of SEQ ID N0:2n-1 (wherein n = 1 to 3161) may be used to detect DNA
containing a corresponding ORF gene, or detect the expression of a corresponding ORFX gene, or ORFX-like gene. For example, an ORFX nucleic acid expressed in a particular cell or tissue, as noted in Table 2, can be used to identify the presence of that particular cell type.
An exemplary method for detecting the presence or absence of ORFX in a biological sample involves obtaining a biological sample from a test subject and contacting the biological sample with a compound or an agent capable of detecting ORFX protein or nucleic acid (e.g., mRNA, genomic DNA) that encodes ORFX protein such that the presence of ORFX is detected in the biological sample. An agent for detecting ORFX mRNA or genomic DNA is a labeled nucleic acid probe capable of hybridizing to ORFX mRNA or genomic DNA. The nucleic acid probe can be, for example, a full-length ORFX nucleic acid, such as the nucleic acid of SEQ ID
N0:2n-1 (wherein n = 1 to 3161), or a portion thereof, such as an oligonucleotide of at least 15, 30, 50, 100, 250 or 500 nucleotides in length and sufficient to specifically hybridize under stringent conditions to ORFX mRNA or genomic DNA, as described above. Other suitable probes for use in the diagnostic assays of the invention are described herein.
An agent for detecting ORFX protein is an antibody capable of binding to ORFX
protein, preferably an antibody with a detectable label. Antibodies can be polyclonal, or more preferably, monoclonal. An intact antibody, or a fragment thereof (e.g., Fab or F(ab')z) can be used. The term "labeled", with regard to the probe or antibody, is intended to encompass direct labeling of the probe or antibody by coupling (i.e., physically linking) a detectable substance to the probe or antibody, as well as indirect labeling of the probe or antibody by reactivity with another reagent that is directly labeled. Examples of indirect labeling include detection of a primary antibody using a fluorescently labeled secondary antibody and end-labeling of a DNA
probe with biotin such that it can be detected with fluorescently labeled streptavidin. The term "biological sample"
is intended to include tissues, cells and biological fluids isolated from a subject, as well as tissues, cells and fluids present within a subject. That is, the detection method of the invention can be used to detect ORFX mRNA, protein, or genomic DNA in a biological sample in vitro as well as in vivo. For example, in vitro techniques for detection of ORFX mRNA
include Northern hybridizations and in situ hybridizations. In vitro techniques for detection of ORFX protein include enzyme linked immunosorbent assays (ELISAs), Western blots, immunoprecipitations and immunofluorescence. In vitro techniques for detection of ORFX genomic DNA
include Southern hybridizations. Furthermore, in vivo techniques for detection of ORFX
protein include introducing into a subject a labeled anti-ORFX antibody. For example, the antibody can be labeled with a radioactive marker whose presence and location in a subject can be detected by standard imaging techniques.
In one embodiment, the biological sample contains protein molecules from the test subject. Alternatively, the biological sample can contain mRNA molecules from the test subject or genomic DNA molecules from the test subject. A preferred biological sample is a peripheral blood leukocyte sample isolated by conventional means from a subject.
In another embodiment, the methods further involve obtaining a control biological sample from a control subject, contacting the control sample with a compound or agent capable of detecting ORFX protein, mRNA, or genomic DNA, such that the presence of ORFX protein, mRNA or genomic DNA is detected in the biological sample, and comparing the presence of ORFX protein, mRNA or genomic DNA in the control sample with the presence of ORFX
protein, mItNA or genomic DNA in the test sample.
The invention also encompasses kits for detecting the presence of ORFX in a biological sample. For example, the kit can comprise: a labeled compound or agent capable of detecting ORFX protein or mIZNA in a biological sample; means for determining the amount of ORFX in the sample; and means for comparing the amount of ORFX in the sample with a standard. The compound or agent can be packaged in a suitable container. The kit can further comprise instructions for using the kit to detect ORFX protein or nucleic acid.
Prognostic Assays The diagnostic methods described herein can furthermore be utilized to identify subjects having or at risk of developing a disease or disorder associated with aberrant ORFX expression or activity. For example, the assays described herein, such as the preceding diagnostic assays or the following assays, can be utilized to identify a subject having or at risk of developing a disorder associated with ORFX protein, nucleic acid expression or activity in, e.g., proliferative or differentiative disorders such as hyperplasias, tumors, restenosis, psoriasis, Dupuytren's contracture, diabetic complications, or rheumatoid arthritis, etc.; and glia-associated disorders such as cerebral lesions, diabetic neuropathies, cerebral edema, senile dementia, Alzheimer's disease, etc. Alternatively, the prognostic assays can be utilized to identify a subject having or at risk for developing a disease or disorder. Thus, the present invention provides a method for identifying a disease or disorder associated with aberrant ORFX expression or activity in which a test sample is obtained from a subject and ORFX protein or nucleic acid (e.g., mRNA, genomic DNA) is detected, wherein the presence of ORFX protein or nucleic acid is diagnostic for a subject having or at risk of developing a disease or disorder associated with aberrant ORFX
expression or activity. As used herein, a "test sample" refers to a biological sample obtained from a subject of interest. For example, a test sample can be a biological fluid (e.g., serum), cell sample, or tissue.
Furthermore, the prognostic assays described herein can be used to determine whether a subject can be administered an agent (e.g., an agonist, antagonist, peptidomimetic, protein, peptide, nucleic acid, small molecule, or other drug candidate) to treat a disease or disorder associated with aberrant ORFX expression or activity. For example, such methods can be used to determine whether a subject can be effectively treated with an agent for a disorder, such as a proliferative disorder, differentiative disorder, glia-associated disorders, etc. Thus, the present invention provides methods for determining whether a subject can be effectively treated with an agent for a disorder associated with aberrant ORFX expression or activity in which a test sample is obtained and ORFX protein or nucleic acid is detected (e.g., wherein the presence of ORFX
protein or nucleic acid is diagnostic for a subject that can be administered the agent to treat a disorder associated with aberrant ORFX expression or activity.) The methods of the invention can also be used to detect genetic lesions in a ORFX gene, thereby determining if a subject with the lesioned gene is at risk for, or suffers from, a proliferative disorder, differentiative disorder, glia-associated disorder, etc. In various embodiments, the methods include detecting, in a sample of cells from the subject, the presence or absence of a genetic lesion characterized by at least one of an alteration affecting the integrity of a gene encoding a ORFX-protein, or the mis-expression of the ORFX gene. For example, such genetic lesions can be detected by ascertaining the existence of at least one of (1) a deletion of one or more nucleotides from a ORFX gene; (2) an addition of one or more nucleotides to a ORFX gene; (3) a substitution of one or more nucleotides of a ORFX gene, (4) a chromosomal rearrangement of a ORFX gene; (5) an alteration in the level of a messenger RNA transcript of a ORFX gene, (6) aberrant modification of a ORFX gene, such as of the methylation pattern of the genomic DNA, (7) the presence of a non-wild type splicing pattern of a messenger RNA
transcript of a ORFX gene, (8) a non-wild type level of a ORFX-Protein, (9) allelic loss of a ORFX gene, and (10) inappropriate post-translational modification of a ORFX-protein. As described herein, there are a large number of assay techniques known in the art which can be used for detecting lesions in a ORFX gene. A preferred biological sample is a peripheral blood leukocyte sample isolated by conventional means from a subject. However, any biological sample containing nucleated cells may be used, including, for example, buccal mucosal cells.
In certain embodiments, detection of the lesion involves the use of a probe/primer in a polymerase chain reaction (PCR) (see, e.g., U.S. Pat. Nos. 4,683,195 and 4,683,202), such as anchor PCR or RACE PCR, or, alternatively, in a ligation chain reaction (LCR) (see, e.g., Landegran et al. (1988) Science 241:1077-1080; and Nakazawa et al. (1994) PNAS
91:360-364), the latter of which can be particularly useful for detecting point mutations in the ORFX-gene (see Abravaya et al. (1995) Nucl Acids Res 23:675-682). This method can include the steps of collecting a sample of cells from a patient, isolating nucleic acid (e.g., genomic, mRNA or both) from the cells of the sample, contacting the nucleic acid sample with one or more primers that specifically hybridize to a ORFX gene under conditions such that hybridization and amplification of the ORFX gene (if present) occurs, and detecting the presence or absence of an amplification product, or detecting the size of the amplification product and comparing the length to a control sample. It is anticipated that PCR and/or LCR may be desirable to use as a preliminary amplification step in conjunction with any of the techniques used for detecting mutations described herein.
Alternative amplification methods include: self sustained sequence replication (Guatelli et al., 1990, Proc Natl Acad Sci USA 87:1874-1878), transcriptional amplification system (Kwoh, et al., 1989, Proc Natl Acad Sci USA 86:1173-1177), Q-Bees Replicase (Lizardi et al, 1988, BioTechnolo~ 6:1197), or any other nucleic acid amplification method, followed by the detection of the amplified molecules using techniques well known to those of skill in the art.
These detection schemes are especially useful for the detection of nucleic acid molecules if such molecules are present in very low numbers.

In an alternative embodiment, mutations in a ORFX gene from a sample cell can be identified by alterations in restriction enzyme cleavage patterns. For example, sample and control DNA is isolated, amplified (optionally), digested with one or more restriction endonucleases, and fragment length sizes are determined by gel electrophoresis and compared.
Differences in fragment length sizes between sample and control DNA indicates mutations in the sample DNA. Moreover, the use of sequence specific ribozymes (see, for example, U.S. Pat. No.
5,493,531) can be used to score for the presence of specific mutations by development or loss of a ribozyme cleavage site.
In other embodiments, genetic mutations in ORFX can be identified by hybridizing a sample and control nucleic acids, e.g., DNA or RNA, to high density arrays containing hundreds or thousands of oligonucleotides probes (Cronin et al. (1996) Human Mutation 7: 244-255;
Kozal et al. (1996) Nature Medicine 2: 753-759). For example, genetic mutations in ORFX can be identified in two dimensional arrays containing light-generated DNA probes as described in Cronin et al. above. Briefly, a first hybridization array of probes can be used to scan through long stretches of DNA in a sample and control to identify base changes between the sequences by making linear arrays of sequential overlapping probes. This step allows the identification of point mutations. This step is followed by a second hybridization array that allows the characterization of specific mutations by using smaller, specialized probe arrays complementary to all variants or mutations detected. Each mutation array is composed of parallel probe sets, one complementary to the wild-type gene and the other complementary to the mutant gene.
In yet another embodiment, any of a variety of sequencing reactions known in the art can be used to directly sequence the ORFX gene and detect mutations by comparing the sequence of the sample ORFX with the corresponding wild-type (control) sequence. Examples of sequencing reactions include those based on techniques developed by Maxim and Gilbert (1977) PNAS
74:560 or Sanger (1977) PNAS 74:5463. It is also contemplated that any of a variety of automated sequencing procedures can be utilized when performing the diagnostic assays (Naeve et al., (1995) Biotechniques 19:448), including sequencing by mass spectrometry (see, e.g., PCT
International Publ. No. WO 94/16101; Cohen et al. (1996) Adv Chromatogr 36:127-162; and Griffin et al. (1993) Appl Biochem Biotechnol 38:147-159).
Other methods for detecting mutations in the ORFX gene include methods in which protection from cleavage agents is used to detect mismatched bases in RNA/RNA
or RNA/DNA

heteroduplexes (Myers et al. (1985) Science 230:1242). In general, the art technique of "mismatch cleavage" starts by providing heteroduplexes of formed by hybridizing (labeled) RNA
or DNA containing the wild-type ORFX sequence with potentially mutant RNA or DNA
obtained from a tissue sample. The double-stranded duplexes are treated with an agent that cleaves single-stranded regions of the duplex such as which will exist due to basepair mismatches between the control and sample strands. For instance, RNA/DNA
duplexes can be treated with RNase and DNA/DNA hybrids treated with S 1 nuclease to enzymatically digesting the mismatched regions. In other embodiments, either DNA/DNA or RNA/DNA
duplexes can be treated with hydroxylamine or osmium tetroxide and with piperidine in order to digest mismatched regions. After digestion of the mismatched regions, the resulting material is then separated by size on denaturing polyacrylamide gels to determine the site of mutation. See, for example, Cotton et al (1988) Proc Natl Acad Sci USA 85:4397; Saleeba et al (1992) Methods Enrymol 217:286-295. In an embodiment, the control DNA or RNA can be labeled for detection.
1 S In still another embodiment, the mismatch cleavage reaction employs one or more proteins that recognize mismatched base pairs in double-stranded DNA (so called "DNA
mismatch repair" enzymes) in defined systems for detecting and mapping point mutations in ORFX cDNAs obtained from samples of cells. For example, the mutt enzyme of E.
coli cleaves A at G/A mismatches and the thymidine DNA glycosylase from HeLa cells cleaves T at G/T
mismatches (Hsu et al. (1994) Carcinogenesis 15:1657-1662). According to an exemplary embodiment, a probe based on a ORFX sequence, e.g., a wild-type ORFX sequence, is hybridized to a cDNA or other DNA product from a test cell(s). The duplex is treated with a DNA mismatch repair enzyme, and the cleavage products, if any, can be detected from electrophoresis protocols or the like. See, for example, U.S. Pat. No.
5,459,039.
In other embodiments, alterations in electrophoretic mobility will be used to identify mutations in ORFX genes. For example, single strand conformation polymorphism (SSCP) may be used to detect differences in electrophoretic mobility between mutant and wild type nucleic acids (Orita et al. (1989) Proc Natl Acad Sci USA: 86:2766, see also Cotton (1993) Mutat Res 285:125-144; Hayashi (1992) Genet Anal Tech Appl 9:73-79). Single-stranded DNA
fragments of sample and control ORFX nucleic acids will be denatured and allowed to renature. The secondary structure of single-stranded nucleic acids varies according to sequence, the resulting alteration in electrophoretic mobility enables the detection of even a single base change. The DNA fragments may be labeled or detected with labeled probes. The sensitivity of the assay may be enhanced by using RNA, rather than DNA, in which the secondary structure is more sensitive to a change in sequence. In one embodiment, the subject method utilizes heteroduplex analysis to separate double stranded heteroduplex molecules on the basis of changes in electrophoretic mobility. See, e.g., Keen et al. (1991) Trends Genet 7:5.
In yet another embodiment the movement of mutant or wild-type fragments in polyacrylamide gels containing a gradient of denaturant is assayed using denaturing gradient gel electrophoresis (DGGE). See, e.g., Myers et al (1985) Nature 313:495. When DGGE is used as the method of analysis, DNA will be modified to insure that it does not completely denature, for example by adding a GC clamp of approximately 40 by of high-melting GC-rich DNA by PCR.
In a further embodiment, a temperature gradient is used in place of a denaturing gradient to identify differences in the mobility of control and sample DNA. See, e.g., Rosenbaum and Reissner ( 1987) Biophys Chem 265:12753.
Examples of other techniques for detecting point mutations include, but are not limited to, selective oligonucleotide hybridization, selective amplification, or selective primer extension.
For example, oligonucleotide primers may be prepared in which the known mutation is placed centrally and then hybridized to target DNA under conditions that permit hybridization only if a perfect match is found. See, e.g., Saiki et al. (1986) Nature 324:163); Saiki et al. (1989) Proc Natl Acad. Sci USA 86:6230. Such allele specific oligonucleotides are hybridized to PCR
amplified target DNA or a number of different mutations when the oligonucleotides are attached to the hybridizing membrane and hybridized with labeled target DNA.
Alternatively, allele specific amplification technology that depends on selective PCR
amplification may be used in conjunction with the instant invention.
Oligonucleotides used as primers for specific amplification may carry the mutation of interest in the center of the molecule (so that amplification depends on differential hybridization) (Gibbs et al.
(1989) Nucleic Acids Res 17:2437-2448) or at the extreme 3' end of one primer where, under appropriate conditions, mismatch can prevent, or reduce polymerase extension (Prossner (1993) Tibtech 11:238). In addition it may be desirable to introduce a novel restriction site in the region of the mutation to create cleavage-based detection. See, e.g., Gasparini et al (1992) Mol Cell Probes 6:1. It is anticipated that in certain embodiments amplification may also be performed using Taq ligase for amplification. See, e.g., Barany (1991) Proc Natl Acad Sci USA 88:189. In such cases, ligation will occur only if there is a perfect match at the 3' end of the 5' sequence, making it possible to detect the presence of a known mutation at a specific site by looking for the presence or absence of amplification.
The methods described herein may be performed, for example, by utilizing pre-packaged diagnostic kits comprising at least one probe nucleic acid or antibody reagent described herein, which may be conveniently used, e.g., in clinical settings to diagnose patients exhibiting symptoms or family history of a disease or illness involving a ORFX gene.
Furthermore, any cell type or tissue, preferably peripheral blood leukocytes, in which ORFX is expressed may be utilized in the prognostic assays described herein.
However, any biological sample containing nucleated cells may be used, including, for example, buccal mucosal cells.
Pharmacogenomics Agents, or modulators that have a stimulatory or inhibitory effect on ORFX
activity (e.g., ORFX gene expression), as identified by a screening assay described herein can be administered to individuals to treat (prophylactically or therapeutically) disorders (e.g., neurological, cancer-related or gestational disorders) associated with aberrant ORFX activity. In conjunction with such treatment, the pharmacogenomics (i.e., the study of the relationship between an individual's genotype and that individual's response to a foreign compound or drug) of the individual may be considered. Differences in metabolism of therapeutics can lead to severe toxicity or therapeutic failure by altering the relation between dose and blood concentration of the pharmacologically active drug. Thus, the pharmacogenomics of the individual permits the selection of effective agents (e.g., drugs) for prophylactic or therapeutic treatments based on a consideration of the individual's genotype. Such pharmacogenomics can further be used to determine appropriate dosages and therapeutic regimens. Accordingly, the activity of ORFX protein, expression of ORFX nucleic acid, or mutation content of ORFX genes in an individual can be determined to thereby select appropriate agents) for therapeutic or prophylactic treatment of the individual.
Pharmacogenomics deals with clinically significant hereditary variations in the response to drugs due to altered drug disposition and abnormal action in affected persons. See e.g., Eichelbaum, 1996, Clin Exp Pharmacol Physiol, 23:983-985 and Linder, 1997, Clin Chem, 43:254-266. In general, two types of pharmacogenetic conditions can be differentiated. Genetic conditions transmitted as a single factor altering the way drugs act on the body (altered drug action) or genetic conditions transmitted as single factors altering the way the body acts on drugs (altered drug metabolism). These pharmacogenetic conditions can occur either as rare defects or as polymorphisms. For example, glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common inherited enzymopathy in which the main clinical complication is haemolysis after ingestion of oxidant drugs (anti-malarials, sulfonamides, analgesics, nitrofurans) and consumption of fava beans.
As an illustrative embodiment, the activity of drug metabolizing enzymes is a major determinant of both the intensity and duration of drug action. The discovery of genetic polymorphisms of drug metabolizing enzymes (e.g., N-acetyltransferase 2 (NAT
2) and cytochrome P450 enzymes CYP2D6 and CYP2C 19) has provided an explanation as to why some patients do not obtain the expected drug effects or show exaggerated drug response and serious toxicity after taking the standard and safe dose of a drug. These polymorphisms are expressed in two phenotypes in the population, the extensive metabolizes (EM) and poor metabolizes (PM). The prevalence of PM is different among different populations. For example, the gene coding for CYP2D6 is highly polymorphic and several mutations have been identified in PM, which all lead to the absence of functional CYP2D6. Poor metabolizers of CYP2D6 and CYP2C 19 quite frequently experience exaggerated drug response and side effects when they receive standard doses. If a metabolite is the active therapeutic moiety, PM
show no therapeutic response, as demonstrated for the analgesic effect of codeine mediated by its CYP2D6-formed metabolite morphine. The other extreme are the so called ultra-rapid metabolizers who do not respond to standard doses. Recently, the molecular basis of ultra-rapid metabolism has been identified to be due to CYP2D6 gene amplification.
Thus, the activity of ORFX protein, expression of ORFX nucleic acid, or mutation content of ORFX genes in an individual can be determined to thereby select appropriate agents) for therapeutic or prophylactic treatment of the individual. In addition, pharmacogenetic studies can be used to apply genotyping of polymorphic alleles encoding drug-metabolizing enzymes to the identification of an individual's drug responsiveness phenotype. This knowledge, when applied to dosing or drug selection, can avoid adverse reactions or therapeutic failure and thus enhance therapeutic or prophylactic efficiency when treating a subject with a ORFX modulator, such as a modulator identified by one of the exemplary screening assays described herein.

Monitoring Clinical Efficacy Monitoring the influence of agents (e.g., drugs, compounds) on the expression or activity of ORFX (e.g., the ability to modulate aberrant cell proliferation and/or differentiation) can be applied in basic drug screening and in clinical trials. For example, the effectiveness of an agent determined by a screening assay as described herein to increase ORFX gene expression, protein levels, or upregulate ORFX activity, can be monitored in clinical trials of subjects exhibiting decreased ORFX gene expression, protein levels, or downregulated ORFX
activity.
Alternatively, the effectiveness of an agent determined by a screening assay to decrease ORFX
gene expression, protein levels, or downregulate ORFX activity, can be monitored in clinical trials of subjects exhibiting increased ORFX gene expression, protein levels, or upregulated ORFX activity. In such clinical trials, the expression or activity of ORFX
and, preferably, other genes that have been implicated in, for example, a proliferative or neurological disorder, can be used as a "read out" or marker of the responsiveness of a particular cell.
For example, genes, including ORFX, that are modulated in cells by treatment with an agent (e.g., compound, drug or small molecule) that modulates ORFX activity (e.g., identified in a screening assay as described herein) can be identified. Thus, to study the effect of agents on cellular proliferation disorders, for example, in a clinical trial, cells can be isolated and RNA
prepared and analyzed for the levels of expression of ORFX and other genes implicated in the disorder. The levels of gene expression (i.e., a gene expression pattern) can be quantified by Northern blot analysis or RT-PCR, as described herein, or alternatively by measuring the amount of protein produced, by one of the methods as described herein, or by measuring the levels of activity of ORFX or other genes. In this way, the gene expression pattern can serve as a marker, indicative of the physiological response of the cells to the agent.
Accordingly, this response state may be determined before, and at various points during, treatment of the individual with the agent.
In one embodiment, the invention provides a method for monitoring the effectiveness of treatment of a subject with an agent (e.g., an agonist, antagonist, protein, peptide, nucleic acid, peptidomimetic, small molecule, or other drug candidate identified by the screening assays described herein) comprising the steps of (i) obtaining a pre-administration sample from a subject prior to administration of the agent; (ii) detecting the level of expression of a ORFX
protein, mRNA, or genomic DNA in the preadministration sample; (iii) obtaining one or more post-administration samples from the subject; (iv) detecting the level of expression or activity of the ORFX protein, mRNA, or genomic DNA in the post-administration samples; (v) comparing the level of expression or activity of the ORFX protein, mRNA, or genomic DNA
in the pre-administration sample with the ORFX protein, mRNA, or genomic DNA in the post administration sample or samples; and (vi) altering the administration of the agent to the subject accordingly. For example, increased administration of the agent may be desirable to increase the expression or activity of ORFX to higher levels than detected, i.e., to increase the effectiveness of the agent. Alternatively, decreased administration of the agent may be desirable to decrease expression or activity of ORFX to lower levels than detected, i.e., to decrease the effectiveness of the agent.
Methods of Treatment The present invention provides for both prophylactic and therapeutic methods of treating a subject at risk of (or susceptible to) a disorder or having a disorder associated with aberrant ORFX expression or activity.
Diseases and disorders that are characterized by increased (relative to a subject not suffering from the disease or disorder) levels or biological activity may be treated with Therapeutics that antagonize (i.e., reduce or inhibit) activity. Therapeutics that antagonize activity may be administered in a therapeutic or prophylactic manner.
Therapeutics that may be utilized include, but are not limited to, (i) a ORFX polypeptide, or analogs, derivatives, fragments or homologs thereof; (ii) antibodies to a ORFX peptide; (iii) nucleic acids encoding a ORFX peptide; (iv) administration of antisense nucleic acid and nucleic acids that are "dysfunctional" (i. e., due to a heterologous insertion within the coding sequences of coding sequences to a ORFX peptide) that are utilized to "knockout" endogenous function of a ORFX
peptide by homologous recombination (see, e.g., Capecchi, 1989, Science 244:
1288-1292); or (v) modulators (i.e., inhibitors, agonists and antagonists, including additional peptide mimetic of the invention or antibodies specific to a peptide of the invention) that alter the interaction between a ORFX peptide and its binding partner.
Diseases and disorders that are characterized by decreased (relative to a subject not suffering from the disease or disorder) levels or biological activity may be treated with Therapeutics that increase (i.e., are agonists to) activity. Therapeutics that upregulate activity may be administered in a therapeutic or prophylactic manner. Therapeutics that may be utilized include, but are not limited to, a ORFX peptide, or analogs, derivatives, fragments or homologs thereof; or an agonist that increases bioavailability.
Increased or decreased levels can be readily detected by quantifying peptide and/or RNA, by obtaining a patient tissue sample (e.g., from biopsy tissue) and assaying it in vitro for RNA or peptide levels, structure and/or activity of the expressed peptides (or mRNAs of a ORFX
peptide). Methods that are well-known within the art include, but are not limited to, immunoassays (e.g., by Western blot analysis, immunoprecipitation followed by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis, immunocytochemistry, etc.) and/or hybridization assays to detect expression of mRNAs (e.g., Northern assays, dot blots, in situ hybridization, etc.).
In one aspect, the invention provides a method for preventing, in a subject, a disease or condition associated with an aberrant ORFX expression or activity, by administering to the subject an agent that modulates ORFX expression or at least one ORFX activity.
Subjects at risk for a disease that is caused or contributed to by aberrant ORFX expression or activity can be identified by, for example, any or a combination of diagnostic or prognostic assays as described herein. Administration of a prophylactic agent can occur prior to the manifestation of symptoms characteristic of the ORFX aberrancy, such that a disease or disorder is prevented or, alternatively, delayed in its progression. Depending on the type of ORFX
aberrancy, for example, a ORFX agonist or ORFX antagonist agent can be used for treating the subject. The appropriate agent can be determined based on screening assays described herein.
Another aspect of the invention pertains to methods of modulating ORFX
expression or activity for therapeutic purposes. The modulatory method of the invention involves contacting a cell with an agent that modulates one or more of the activities of ORFX
protein activity associated with the cell. An agent that modulates ORFX protein activity can be an agent as described herein, such as a nucleic acid or a protein, a naturally-occurring cognate ligand of a ORFX protein, a peptide, a ORFX peptidomimetic, or other small molecule. In one embodiment, the agent stimulates one or more ORFX protein activity. Examples of such stimulatory agents include active ORFX protein and a nucleic acid molecule encoding ORFX
that has been introduced into the cell. In another embodiment, the agent inhibits one or more ORFX protein activity. Examples of such inhibitory agents include antisense ORFX nucleic acid molecules and anti-ORFX antibodies. These modulatory methods can be performed in vitro (e.g., by culturing the cell with the agent) or, alternatively, in vivo (e.g., by administering the agent to a subject). As such, the present invention provides methods of treating an individual afflicted with a disease or disorder characterized by aberrant expression or activity of a ORFX
protein or nucleic acid molecule. In one embodiment, the method involves administering an agent (e.g., an agent identified by a screening assay described herein), or combination of agents that modulates (e.g., upregulates or downregulates) ORFX expression or activity. In another embodiment, the method involves administering a ORFX protein or nucleic acid molecule as therapy to compensate for reduced or aberrant ORFX expression or activity.
Determination of the Biological Effect of a Therapeutic In various embodiments of the present invention, suitable in vitro or in vivo assays are utilized to determine the effect of a specific Therapeutic and whether its administration is indicated for treatment of the affected tissue.
In various specific embodiments, in vitro assays may be performed with representative cells of the types) involved in the patient's disorder, to determine if a given Therapeutic exerts the desired effect upon the cell type(s). Compounds for use in therapy may be tested in suitable animal model systems including, but not limited to rats, mice, chicken, cows, monkeys, rabbits, and the like, prior to testing in human subjects. Similarly, for in vivo testing, any of the animal model system known in the art may be used prior to administration to human subjects.
Malignancies Some ORFX polypeptides are expressed in cancerous cells (see, e.g., Tables 1 and 2).
Accordingly, the corresponding ORF protein is involved in the regulation of cell proliferation.
Accordingly, Therapeutics of the present invention may be useful in the therapeutic or prophylactic treatment of diseases or disorders that are associated with cell hyperproliferation and/or loss of control of cell proliferation (e.g., cancers, malignancies and tumors). For a review of such hyperproliferation disorders, see e.g., Fishman, et al., 1985.
MEDICINE, 2nd ed., J.B.
Lippincott Co., Philadelphia, PA.
Therapeutics of the present invention may be assayed by any method known within the art for efficacy in treating or preventing malignancies and related disorders.
Such assays include, but are not limited to, in vitro assays utilizing transformed cells or cells derived from the patient's tumor, as well as in vivo assays using animal models of cancer or malignancies.
Potentially effective Therapeutics are those that, for example, inhibit the proliferation of tumor-derived or transformed cells in culture or cause a regression of tumors in animal models, in comparison to the controls.
In the practice of the present invention, once a malignancy or cancer 'has been shown to be amenable to treatment by modulating (i.e., inhibiting, antagonizing or agonizing) activity, that cancer or malignancy may subsequently be treated or prevented by the administration of a Therapeutic that serves to modulate protein function.
Premalignant conditions The Therapeutics of the present invention that are effective in the therapeutic or prophylactic treatment of cancer or malignancies may also be administered for the treatment of pre-malignant conditions and/or to prevent the progression of a pre-malignancy to a neoplastic or malignant state. Such prophylactic or therapeutic use is indicated in conditions known or suspected of preceding progression to neoplasia or cancer, in particular, where non-neoplastic cell growth consisting of hyperplasia, metaplasia or, most particularly, dysplasia has occurred.
For a review of such abnormal cell growth see e.g., Robbins & Angell, 1976.
Basic PATHOLOGY, 2nd ed., W.B. Saunders Co., Philadelphia, PA.
Hyperplasia is a form of controlled cell proliferation involving an increase in cell number in a tissue or organ, without significant alteration in its structure or function. For example, it has been demonstrated that endometrial hyperplasia often precedes endometrial cancer. Metaplasia is a form of controlled cell growth in which one type of mature or fully differentiated cell substitutes for another type of mature cell. Metaplasia may occur in epithelial or connective tissue cells. Dysplasia is generally considered a precursor of cancer, and is found mainly in the epithelia. Dysplasia is the most disorderly form of non-neoplastic cell growth, and involves a loss in individual cell uniformity and in the architectural orientation of cells. Dysplasia characteristically occurs where there exists chronic irntation or inflammation, and is often found in the cervix, respiratory passages, oral cavity, and gall bladder.

Alternatively, or in addition to the presence of abnormal cell growth characterized as hyperplasia, metaplasia, or dysplasia, the presence of one or more characteristics of a transformed or malignant phenotype displayed either in vivo or in vitro within a cell sample derived from a patient, is indicative of the desirability of prophylactic/therapeutic administration of a Therapeutic that possesses the ability to modulate activity of An aforementioned protein.
Characteristics of a transformed phenotype include, but are not limited to:
(i) morphological changes; (ii) looser substratum attachment; (iii) loss of cell-to-cell contact inhibition; (iv) loss of anchorage dependence; (v) protease release; (vi) increased sugar transport;
(vii) decreased serum requirement; (viii) expression of fetal antigens, (ix) disappearance of the 250 kDal cell-surface protein, and the like. See e.g., Richards, et al., 1986. MOLECULAR PATHOLOGY, W.B. Saunders Co., Philadelphia, PA.
In a specific embodiment of the present invention, a patient that exhibits one or more of the following predisposing factors for malignancy is treated by administration of an effective amount of a Therapeutic: (i) a chromosomal translocation associated with a malignancy (e.g., the Philadelphia chromosome (bcrlabl) for chronic myelogenous leukemia and t(14;18) for follicular lymphoma, etc.); (ii) familial polyposis or Gardner's syndrome (possible forerunners of colon cancer); (iii) monoclonal gammopathy of undetermined significance (a possible precursor of multiple myeloma) and (iv) a first degree kinship with persons having a cancer or pre-cancerous disease showing a Mendelian (genetic) inheritance pattern (e.g., familial polyposis of the colon, Gardner's syndrome, hereditary exostosis, polyendocrine adenomatosis, Peutz-Jeghers syndrome, neurofibromatosis of Von Recklinghausen, medullary thyroid carcinoma with amyloid production and pheochromocytoma, retinoblastoma, carotid body tumor, cutaneous melanocarcinoma, intraocular melanocarcinoma, xeroderma pigmentosum, ataxia telangiectasia, Chediak-Higashi syndrome, albinism, Fanconi's aplastic anemia and Bloom's syndrome).
In another embodiment, a Therapeutic of the present invention is administered to a human patient to prevent the progression to breast, colon, lung, pancreatic, or uterine cancer, or melanoma or sarcoma.

Hyperproliferative and dysproliferative disorders In one embodiment of the present invention, a Therapeutic is administered in the therapeutic or prophylactic treatment of hyperproliferative or benign dysproliferative disorders.
The efficacy in treating or preventing hyperproliferative diseases or disorders of a Therapeutic of the present invention may be assayed by any method known within the art. Such assays include in vitro cell proliferation assays, in vitro or in vivo assays using animal models of hyperproliferative diseases or disorders, or the like. Potentially effective Therapeutics may, for example, promote cell proliferation in culture or cause growth or cell proliferation in animal models in comparison to controls.
Specific embodiments of the present invention are directed to the treatment or prevention of cirrhosis of the liver (a condition in which scarring has overtaken normal liver regeneration processes); treatment of keloid (hypertrophic scar) formation causing disfiguring of the skin in which the scarring process interferes with normal renewal; psoriasis (a common skin condition characterized by excessive proliferation of the skin and delay in proper cell fate determination);
benign tumors; fibrocystic conditions and tissue hypertrophy (e.g., benign prostatic hypertrophy).
Neurodegenerative disorders Some ORFX proteins are found in cell types have been implicated in the deregulation of cellular maturation and apoptosis, which are both characteristic of neurodegenerative disease.
Accordingly, Therapeutics of the invention, particularly but not limited to those that modulate (or supply) activity of an aforementioned protein, may be effective in treating or preventing neurodegenerative disease. Therapeutics of the present invention that modulate the activity of an aforementioned protein involved in neurodegenerative disorders can be assayed by any method known in the art for efficacy in treating or preventing such neurodegenerative diseases and disorders. Such assays include in vitro assays for regulated cell maturation or inhibition of apoptosis or in vivo assays using animal models of neurodegenerative diseases or disorders, or any of the assays described below. Potentially effective Therapeutics, for example but not by way of limitation, promote regulated cell maturation and prevent cell apoptosis in culture, or reduce neurodegeneration in animal models in comparison to controls.

Once a neurodegenerative disease or disorder has been shown to be amenable to treatment by modulation activity, that neurodegenerative disease or disorder can be treated or prevented by administration of a Therapeutic that modulates activity. Such diseases include all degenerative disorders involved with aging, especially osteoarthritis and neurodegenerative S disorders.
Disorders related to organ transplantation Some ORFX can be associated with disorders related to organ transplantation, in particular but not limited to organ rejection. Therapeutics of the invention, particularly those that modulate (or supply) activity, may be effective in treating or preventing diseases or disorders related to organ transplantation. Therapeutics of the invention (particularly Therapeutics that modulate the levels or activity of an aforementioned protein) can be assayed by any method known in the art for efficacy in treating or preventing such diseases and disorders related to organ transplantation. Such assays include in vitro assays for using cell culture models as described below, or in vivo assays using animal models of diseases and disorders related to organ transplantation, see e.g., below. Potentially effective Therapeutics, for example but not by way of limitation, reduce immune rejection responses in animal models in comparison to controls.
Accordingly, once diseases and disorders related to organ transplantation are shown to be amenable to treatment by modulation of activity, such diseases or disorders can be treated or prevented by administration of a Therapeutic that modulates activity.
Cardiovascular Disease GENX has been implicated in cardiovascular disorders, including in atherosclerotic plaque formation. Diseases such as cardiovascular disease, including cerebral thrombosis or hemorrhage, ischemic heart or renal disease, peripheral vascular disease, or thrombosis of other major vessel, and other diseases, including diabetes mellitus, hypertension, hypothyroidism, cholesterol ester storage disease, systemic lupus erythematosus, homocysteinemia, and familial protein or lipid processing diseases, and the like, are either directly or indirectly associated with atherosclerosis. Accordingly, Therapeutics of the invention, particularly those that modulate (or supply) activity or formation may be effective in treating or preventing atherosclerosis-associated diseases or disorders. Therapeutics of the invention (particularly Therapeutics that modulate the levels or activity) can be assayed by any method known in the art, including those described below, for efficacy in treating or preventing such diseases and disorders.
A vast array of animal and cell culture models exist for processes involved in atherosclerosis. A limited and non-exclusive list of animal models includes knockout mice for premature atherosclerosis (Kurabayashi and Yazaki, 1996, Int. Angiol. 15: 187-194), transgenic mouse models of atherosclerosis (Kappel et al., 1994, FASEB J. 8: 583-592), antisense oligonucleotide treatment of animal models (Callow, 1995, Curr. Opin. Cardiol.
10: 569-576), transgenic rabbit models for atherosclerosis (Taylor, 1997, Ann. N.Y. Acad.
Sci 811: 146-152), hypercholesterolemic animal models (Rosenfeld, 1996, Diabetes Res. Clin.
Pract. 30 Suppl.:
1-11), hyperlipidemic mice (Paigen et al., 1994, Curr. Opin. Lipidol. 5: 258-264), and inhibition of lipoxygenase in animals (Sigal et al., 1994, Ann. N.Y. Acad. Sci. 714: 211-224). In addition, in vitro cell models include but are not limited to monocytes exposed to low density lipoprotein (Frostegard et al., 1996, Atherosclerosis 121: 93-103), cloned vascular smooth muscle cells (Suttles et al., 1995, Exp. Cell Res. 218: 331-338), endothelial cell-derived chemoattractant exposed T cells (Katz et al., 1994, J. Leukoc. Biol. 55: 567-573), cultured human aortic endothelial cells (Farber et al., 1992, Am. J. Physiol. 262: H1088-1085), and foam cell cultures (Libby et al., 1996, Curr Opin Lipidol 7: 330-335). Potentially effective Therapeutics, for example but not by way of limitation, reduce foam cell formation in cell culture models, or reduce atherosclerotic plaque formation in hypercholesterolemic mouse models of atherosclerosis in comparison to controls.
Accordingly, once an atherosclerosis-associated disease or disorder has been shown to be amenable to treatment by modulation of activity or formation, that disease or disorder can be treated or prevented by administration of a Therapeutic that modulates activity.
Cytokine and Cell Proliferation/Differentiation Activity A GENX protein of the present invention may exhibit cytokine, cell proliferation (either inducing or inhibiting) or cell differentiation (either inducing or inhibiting) activity or may induce production of other cytokines in certain cell populations. Many protein factors discovered to date, including all known cytokines, have exhibited activity in one or more factor dependent cell proliferation assays, and hence the assays serve as a convenient confirmation of cytokine activity. The activity of a protein of the present invention is evidenced by any one of a number of routine factor dependent cell proliferation assays for cell lines including, without limitation, 32D, DA2, DA1G, T10, B9, B9/11, BaF3, MC9/G, M+ (preB M+ ), 2E8, RBS, DA1, 123, T1165, HT2, CTLL2, TF-1, Mo7e and CMK.
The activity of a protein of the invention may, among other means, be measured by the following methods: Assays for T-cell or thymocyte proliferation include without limitation those described in: CURRENT PROTOCOLS IN IMMUNOLOGY, Ed by Coligan et al., Greene Publishing Associates and Wiley-Interscience (Chapter 3 and Chapter 7); Takai et al., Jlmmunol 137:3494-3500, 1986; Bertagnoili et al., Jlmmunol 145:1706-1712, 1990;
Bertagnolli et al., Cell Immunol 133:327-341, 1991; Bertagnolli, et al., Jlmmunol 149:3778-3783, 1992;
Bowman et al., Jlmmunol 152:1756-1761, 1994.
Assays for cytokine production and/or proliferation of spleen cells, lymph node cells or thymocytes include, without limitation, those described by Kruisbeek and Shevach, In: CURRENT
PROTOCOLS IN IMMUNOLOGY. Coligan et al., eds. Vol 1, pp. 3.12.1-14, John Wiley and Sons, Toronto 1994; and by Schreiber, In: CURRENT PROTOCOLS IN IMMUNOLOGY. Coligan eds. Vol 1 pp. 6.8.1-8, John Wiley and Sons, Toronto 1994.
Assays for proliferation and differentiation of hematopoietic and lymphopoietic cells include, without limitation, those described by Bottomly et al., In: CURRENT
PROTOCOLS IN
IMMUNOLOGY. Coligan et al., eds. Vol 1 pp. 6.3.1-6.3.12, John Wiley and Sons, Toronto 1991;
deVries et al., JExp Med 173:1205-1211, 1991; Moreau et al., Nature 336:690-692, 1988;
Greenberger et al., Proc Natl Acad Sci U.S.A. 80:2931-2938, 1983; Nordan, In:
CURRENT
PROTOCOLS IN IMMUNOLOGY. Coligan et al., eds. Vol 1 pp. 6.6.1-5, John Wiley and Sons, Toronto 1991; Smith et al., Proc Natl Acad Sci U.S.A. 83:1857-1861, 1986;
Measurement of human Interleukin 11-Bennett, et al. Iri: CURRENT PROTOCOLS IN IMMUNOLOGY.
Coligan et al., eds. Vol 1 pp. 6.15.1 John Wiley and Sons, Toronto 1991; Ciarletta, et al., In: CURRENT
PROTOCOLS IN IMMUNOLOGY. Coligan et al., eds. Vol 1 pp. 6.13.1, John Wiley and Sons, Toronto 1991.
Assays for T-cell clone responses to antigens (which will identify, among others, proteins that affect APC-T cell interactions as well as direct T-cell effects by measuring proliferation and cytokine production) include, without limitation, those described In: CURRENT
PROTOCOLS IN
IMMUNOLOGY. Coligan et al., eds., Greene Publishing Associates and Wiley-Interscience (Chapter 3Chapter 6, Chapter 7); Weinberger et al., Proc Natl Acad Sci USA
77:6091-6095, 1980; Weinberger et al., Eur Jlmmun 11:405-411, 1981; Takai et al., Jlmmunol 137:3494-3500, 1986; Takai et al., Jlmmunol 140:508-512, 1988.
Immune Stimulating or Suppressing Activity A GENX protein of the present invention may also exhibit immune stimulating or immune suppressing activity, including without limitation the activities for which assays are described herein. A protein may be useful in the treatment of various immune deficiencies and disorders (including severe combined immunodeficiency (SCID)), e.g., in regulating (up or down) growth and proliferation of T and/or B lymphocytes, as well as effecting the cytolytic activity of NK cells and other cell populations. These immune deficiencies may be genetic or be caused by vital (e.g., HIV) as well as bacterial or fungal infections, or may result from autoimmune disorders. More specifically, infectious diseases causes by vital, bacterial, fungal or . other infection may be treatable using a protein of the present invention, including infections by HIV, hepatitis viruses, herpesviruses, mycobacteria, Leishmania species., malaria species. and various fungal infections such as candidiasis. Of course, in this regard, a protein of the present invention may also be useful where a boost to the immune system generally may be desirable, i.e., in the treatment of cancer.
Autoimmune disorders which may be treated using a protein of the present invention include, for example, connective tissue disease, multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes mellitus, myasthenia gravis, graft-versus-host disease and autoimmune inflammatory eye disease. Such a protein of the present invention may also to be useful in the treatment of allergic reactions and conditions, such as asthma (particularly allergic asthma) or other respiratory problems. Other conditions, in which immune suppression is desired (including, for example, organ transplantation), may also be treatable using a protein of the present invention.
Using the proteins of the invention it may also be possible to immune responses, in a number of ways. Down regulation may be in the form of inhibiting or blocking an immune response already in progress or may involve preventing the induction of an immune response.

The functions of activated T cells may be inhibited by suppressing T cell responses or by inducing specific tolerance in T cells, or both. Immunosuppression of T cell responses is generally an active, non-antigen-specific, process which requires continuous exposure of the T
cells to the suppressive agent. Tolerance, which involves inducing non-responsiveness or energy in T cells, is distinguishable from immunosuppression in that it is generally antigen-specific and persists after exposure to the tolerizing agent has ceased. Operationally, tolerance can be demonstrated by the lack of a T cell response upon re-exposure to specific antigen in the absence of the tolerizing agent.
Down regulating or preventing one or more antigen functions (including without limitation B lymphocyte antigen functions (such as, for example, B7), e.g., preventing high level lymphokine synthesis by activated T cells, will be useful in situations of tissue, skin and organ transplantation and in graft-versus-host disease (GVHD). For example, blockage of T cell function should result in reduced tissue destruction in tissue transplantation. Typically, in tissue transplants, rejection of the transplant is initiated through its recognition as foreign by T cells, followed by an immune reaction that destroys the transplant. The administration of a molecule which inhibits or blocks interaction of a B7 lymphocyte antigen with its natural ligand(s) on immune cells (such as a soluble, monomeric form of a peptide having B7-2 activity alone or in conjunction with a monomeric form of a peptide having an activity of another B
lymphocyte antigen (e.g., B7-1, B7-3)~or blocking antibody), prior to transplantation can lead to the binding of the molecule to the natural ligand(s) on the immune cells without transmitting the corresponding costimulatory signal. Blocking B lymphocyte antigen function in this matter prevents cytokine synthesis by immune cells, such as T cells, and thus acts as an immunosuppressant. Moreover, the lack of costimulation may also be sufficient to energize the T
cells, thereby inducing tolerance in a subject. Induction of long-term tolerance by B lymphocyte antigen-blocking reagents may avoid the necessity of repeated administration of these blocking reagents. To achieve sufficient immunosuppression or tolerance in a subject, it may also be necessary to block the function of B lymphocyte antigens.
The efficacy of particular blocking reagents in preventing organ transplant rejection or GVHD can be assessed using animal models that are predictive of efficacy in humans. Examples of appropriate systems which can be used include allogeneic cardiac grafts in rats and xenogeneic pancreatic islet cell grafts in mice, both of which have been used to examine the immunosuppressive effects of CTLA4Ig fusion proteins in vivo as described in Lenschow et al., Science 257:789-792 (1992) and Turka et al., Proc Natl Acad Sci USA, 89:11102-11105 (1992).
In addition, marine models of GVHD (see Paul ed., FUNDAMENTAL IMMUNOLOGY, Raven Press, New York, 1989, pp. 846-847) can be used to determine the effect of blocking B
lymphocyte antigen function in vivo on the development of that disease.
Blocking antigen function may also be therapeutically useful for treating autoimmune diseases. Many autoimmune disorders are the result of inappropriate activation of T cells that are reactive against self tissue and which promote the production of cytokines and auto-antibodies involved in the pathology of the diseases. Preventing the activation of autoreactive T cells may reduce or eliminate disease symptoms. Administration of reagents which block costimulation of T cells by disrupting receptor:ligand interactions of B lymphocyte antigens can be used to inhibit T cell activation and prevent production of auto-antibodies or T cell-derived cytokines which may be involved in the disease process. Additionally, blocking reagents may induce antigen-specific tolerance of autoreactive T cells which could lead to long-term relief from the 1 S disease. The efficacy of blocking reagents in preventing or alleviating autoimmune disorders can be determined using a number of well-characterized animal models of human autoimmune diseases. Examples include marine experimental autoimmune encephalitis, systemic lupus erythematosis in MRL/lpr/lpr mice or NZB hybrid mice, marine autoimmune collagen arthritis, diabetes mellitus in NOD mice and BB rats, and marine experimental myasthenia gravis (see Paul ed., FUNDAMENTAL IMMUNOLOGY, Raven Press, New York, 1989, pp. 840-856).
Upregulation of an antigen function (preferably a B lymphocyte antigen function), as a means of up regulating immune responses, may also be useful in therapy.
Upregulation of immune responses may be in the form of enhancing an existing immune response or eliciting an initial immune response. For example, enhancing an immune response through stimulating B
lymphocyte antigen function may be useful in cases of viral infection. In addition, systemic vital diseases such as influenza, the common cold, and encephalitis might be alleviated by the administration of stimulatory forms of B lymphocyte antigens systemically.
Alternatively, anti-viral immune responses may be enhanced in an infected patient by removing T cells from the patient, costimulating the T cells in vitro with viral antigen-pulsed APCs either expressing a peptide of the present invention or together with a stimulatory form of a soluble peptide of the present invention and reintroducing the in vitro activated T cells into the patient. Another method of enhancing anti-vital immune responses would be to isolate infected cells from a patient, transfect them with a nucleic acid encoding a protein of the present invention as described herein such that the cells express all or a portion of the protein on their surface, and reintroduce the transfected cells into the patient. The infected cells would now be capable of delivering a costimulatory signal to, and thereby activate, T cells in vivo.
In another application, up regulation or enhancement of antigen function (preferably B
lymphocyte antigen function) may be useful in the induction of tumor immunity.
Tumor cells (e.g., sarcoma, melanoma, lymphoma, leukemia, neuroblastoma, carcinoma) transfected with a nucleic acid encoding at least one peptide of the present invention can be administered to a subject to overcome tumor-specific tolerance in the subject. If desired, the tumor cell can be transfected to express a combination of peptides. For example, tumor cells obtained from a patient can be transfected ex vivo with an expression vector directing the expression of a peptide having B7-2-like activity alone, or in conjunction with a peptide having B7-1-like activity and/or B7-3-like activity. The transfected tumor cells are returned to the patient to result in expression of the peptides on the surface of the transfected cell. Alternatively, gene therapy techniques can be used to target a tumor cell for transfection in vivo.
The presence of the peptide of the present invention having the activity of a B
lymphocyte antigens) on the surface of the tumor cell provides the necessary costimulation signal to T cells to induce a T cell mediated immune response against the transfected tumor cells.
In addition, tumor cells which lack MHC class I or MHC class II molecules, or which fail to reexpress sufficient amounts of MHC class I or MHC class II molecules, can be transfected with nucleic acid encoding all or a portion of (e.g., a cytoplasmic-domain truncated portion) of an MHC class I a chain protein and (32 microglobulin protein or an MHC class II a chain protein and an MHC class II ~i chain protein to thereby express MHC class I or MHC
class II proteins on the cell surface. Expression of the appropriate class I or class II MHC in conjunction with a peptide having the activity of a B lymphocyte antigen (e.g., B7-1, B7-2, B7-3) induces a T cell mediated immune response against the transfected tumor cell. Optionally, a gene encoding an antisense construct which blocks expression of an MHC class II associated protein, such as the invariant chain, can also be cotransfected with a DNA encoding a peptide having the activity of a B lymphocyte antigen to promote presentation of tumor associated antigens and induce tumor specific immunity. Thus, the induction of a T cell mediated immune response in a human subject may be sufficient to overcome tumor-specific tolerance in the subject.
The activity of a protein of the invention may, among other means, be measured by the following methods: Suitable assays for thymocyte or splenocyte cytotoxicity include, without limitation, those described In: CURRENT PROTOCOLS iN IMMUNOLOGY. Coligan et al., eds. Greene Publishing Associates and Wiley-Interscience (Chapter 3, Chapter 7); Herrmann et al., Proc Natl Acad Sci USA 78:2488-2492, 1981; Hernnann et al., Jlmmunol 128:1968-1974, 1982; Handa et al., Jlmmunol 135:1564-1572, 1985; Takai et al., Jlmmunol 137:3494-3500, 1986;
Takai et al., Jlmmunol 140:508-512, 1988; Hemnann et al., Proc Natl Acad Sci USA 78:2488-2492, 1981;
Herrmann et al., Jlmmunol 128:1968-1974, 1982; Handa et al., Jlmmunol 135:1564-1572, 1985; Takai et al., Jlmmunol 137:3494-3500, 1986; Bowman et al., J Virology 61:1992-1998;
Takai et al., Jlmmunol 140:508-512, 1988; Bertagnolli et al., Cell Immunol 133:327-341, 1991;
Brown et al., Jlmmunol 153:3079-3092, 1994.
Assays for T-cell-dependent immunoglobulin responses and isotype switching (which will identify, among others, proteins that modulate T-cell dependent antibody responses and that affect Thl/Th2 profiles) include, without limitation, those described in:
Maliszewski, Jlmmunol 144:3028-3033, 1990; and Mond and Brunswick In: CURRENT PROTOCOLS IN
IMMUNOLOGY.
Coligan et al., (eds:) Vol 1 pp. 3.8.1-3.8.16, John Wiley and Sons, Toronto 1994.
Mixed lymphocyte reaction (MLR) assays (which will identify, among others, proteins that generate predominantly Thl and CTL responses) include, without limitation, those described In: CURRENT PROTOCOLS IN IMMUNOLOGY. Coligan et al., eds. Greene Publishing Associates and Wiley-Interscience (Chapter 3, Chapter 7); Takai et al., Jlmmunol 137:3494-3500, 1986; Takai et al., Jlmmunol 140:508-512, 1988; Bertagnolli et al., Jlmmunol 149:3778-3783, 1992.
Dendritic cell-dependent assays (which will identify, among others, proteins expressed by dendritic cells that activate naive T-cells) include, without limitation, those described in: Guery et al., Jlmmunol 134:536-544, 1995; Inaba et al., JExp Med 173:549-559, 1991;
Macatonia et al., Jlmmunol 154:5071-5079, 1995; Porgador et al., JExp Med 182:255-260, 1995; Nair et al., J Yirol 67:4062-4069, 1993; Huang et al., Science 264:961-965, .1994;
Macatonia et al., JExp Med 169:1255-1264, 1989; Bhardwaj et al., J Clin Investig 94:797-807, 1994;
and Inaba et al., J
Exp Med 172:631-640, 1990.

Assays for lymphocyte survival/apoptosis (which will identify, among others, proteins that prevent apoptosis after superantigen induction and proteins that regulate lymphocyte homeostasis) include, without limitation, those described in: Darzynkiewicz et al., Cytometry 13:795-808, 1992; Gorczyca et al., Leukemia 7:659-670, 1993; Gorczyca et al., Cancer Res 53:1945-1951, 1993; Itoh et al., Cell 66:233-243, 1991; Zacharchuk, Jlmmunol 145:4037-4045, 1990; Zamai et al., Cytometry 14:891-897, 1993; Gorczyca et al., InternatJOncol 1:639-648, 1992.
Assays for proteins that influence early steps of T-cell commitment and development include, without limitation, those described in: Antica et al., Blood 84:111-117, 1994; Fine et al., Cell Immunol 155: 111-122, 1994; Galy et al., Blood 85:2770-2778, 1995; Toki et al., Proc Nat Acad Sci USA 88:7548-7551, 1991.
Hematopoiesis Regulating Activity A GENX protein of the present invention may be useful in regulation of hematopoiesis and, consequently, in the treatment of myeloid or lymphoid cell deficiencies.
Even marginal 1 S biological activity in support of colony forming cells or of factor-dependent cell lines indicates involvement in regulating hematopoiesis, e.g. in supporting the growth and proliferation of erythroid progenitor cells alone or in combination with other cytokines, thereby indicating utility, for example, in treating various anemias or for use in conjunction with irradiation/chemotherapy to stimulate the production of erythroid precursors and/or erythroid cells; in supporting the growth and proliferation of myeloid cells such as granulocytes and monocytes/macrophages (i. e., traditional CSF activity) useful, for example, in conjunction with chemotherapy to prevent or treat consequent myelo-suppression; in supporting the growth and proliferation of megakaryocytes and consequently of platelets thereby allowing prevention or treatment of various platelet disorders such as thrombocytopenia, and generally for use in place of or complimentary to platelet transfusions; and/or in supporting the growth and proliferation of hematopoietic stem cells which are capable of maturing to any and all of the above-mentioned hematopoietic cells and therefore find therapeutic utility in various stem cell disorders (such as those usually treated with transplantation, including, without limitation, aplastic anemia and paroxysmal nocturnal hemoglobinuria), as well as in repopulating the stem cell compartment post irradiation/chemotherapy, either in-vivo or ex-vivo (i.e., in conjunction with bone marrow transplantation or with peripheral progenitor cell transplantation (homologous or heterologous)) as normal cells or genetically manipulated for gene therapy.
The activity of a protein of the invention may, among other means, be measured by the following methods:
Suitable assays for proliferation and differentiation of various hematopoietic lines are cited above.
Assays for embryonic stem cell differentiation (which will identify, among others, proteins that influence embryonic differentiation hematopoiesis) include, without limitation, those described in: Johansson et al. Cellular Biology 15:141-151, 1995; Kelley et al., Mol. Cell.
Biol. 13:473-486, 1993; McClanahan et al., Blood 81:2903-2915, 1993.
Assays for stem cell survival and differentiation (which will identify, among others, proteins that regulate lympho-hematopoiesis) include, without limitation, those described in:
Methylcellulose colony forming assays, Freshney, In: CULTURE OF HEMATOP01ETIC
CELLS.
Freshney, et al. (eds.) Vol pp. 265-268, Wiley-Liss, Inc., New York, N.Y 1994;
Hirayama et al., Proc Natl Acad Sci USA 89:5907-5911, 1992; McNiece and Briddeli, In: CULTURE
OF
HEMATOPOIETIC CELLS. Freshney, et al. (eds.) Vol pp. 23-39, Wiley-Liss, Inc., New York, N.Y.
1994; Neben et al., Exp Hematol 22:353-359, 1994; Ploemacher, In: CULTURE OF
HEMATOPOIETIC CELLS. Freshney, et al. eds. Vol pp. 1-21, Wiley-Liss, Inc., New York, N.Y.
1994; Spoonceret al., In: CULTURE OF HEMATOPOIETIC CELLS. Freshhey, et al., (eds.) Vol pp.
163-179, Wiley-Liss, Inc., New York, N.Y. 1994; Sutherland, In: CULTURE OF
HEMATOPOIETIC
CELLS. Freshney, et al., (eds.) Vol pp. 139-162, Wiley-Liss, Inc., New York, N.Y. 1994.
Tissue Growth Activity A GENX protein of the present invention also may have utility in compositions used for bone, cartilage, tendon, ligament and/or nerve tissue growth or regeneration, as well as for wound healing and tissue repair and replacement, and in the treatment of burns, incisions and ulcers.
A protein of the present invention, which induces cartilage and/or bone growth in circumstances where bone is not normally formed, has application in the healing of bone fractures and cartilage damage or defects in humans and other animals. Such a preparation employing a protein of the invention may have prophylactic use in closed as well as open fracture reduction and also in the improved fixation of artificial joints. De novo bone formation induced by an osteogenic agent contributes to the repair of congenital, trauma induced, or oncologic resection induced craniofacial defects, and also is useful in cosmetic plastic surgery.
A protein of this invention may also be used in the treatment of periodontal disease, and in other tooth repair processes. Such agents may provide an environment to attract bone-forming cells, stimulate growth of bone-forming cells or induce differentiation of progenitors of bone-forming cells. A protein of the invention may also be useful in the treatment of osteoporosis or osteoarthritis, such as through stimulation of bone and/or cartilage repair or by blocking inflammation or processes of tissue destruction (collagenase activity, osteoclast activity, etc.) mediated by inflammatory processes.
Another category of tissue regeneration activity that may be attributable to the protein of the present invention is tendon/ligament formation. A protein of the present invention, which induces tendon/ligament-like tissue or other tissue formation in circumstances where such tissue is not normally formed, has application in the healing of tendon or ligament tears, deformities and other tendon or ligament defects in humans and other animals. Such a preparation employing a tendon/ligament-like tissue inducing protein may have prophylactic use in preventing damage to tendon or ligament tissue, as well as use in the improved fixation of tendon or ligament_to bone or other tissues, and in repairing defects to tendon or ligament tissue.
De novo tendon/ligament-like tissue formation induced by a composition of the present invention contributes to the repair of congenital, trauma induced, or other tendon or ligament defects of other origin, and is also useful in cosmetic plastic surgery for attachment or repair of tendons or ligaments. The compositions of the present invention may provide an environment to attract tendon- or ligament-forming cells, stimulate growth of tendon- or ligament-forming cells, induce differentiation of progenitors of tendon- or ligament-forming cells, or induce growth of tendon/ligament cells or progenitors ex vivo for return in vivo to effect tissue repair. The compositions of the invention may also be useful in the treatment of tendonitis, carpal tunnel syndrome and other tendon or ligament defects. The compositions may also include an appropriate matrix and/or sequestering agent as a career as is well known in the art.
The protein of the present invention may also be useful for proliferation of neural cells and for regeneration of nerve and brain tissue, i. e. for the treatment of central and peripheral nervous system diseases and neuropathies, as well as mechanical and traumatic disorders, which involve degeneration, death or trauma to neural cells or nerve tissue. More specifically, a protein may be used in the treatment of diseases of the peripheral nervous system, such as peripheral nerve injuries, peripheral neuropathy and localized neuropathies, and central nervous system diseases, such as Alzheimer's, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and Shy-Drager syndrome. Further conditions which may be treated in accordance with the present invention include mechanical and traumatic disorders, such as spinal cord disorders, head trauma and cerebrovascular diseases such as stroke. Peripheral neuropathies resulting from chemotherapy or other medical therapies may also be treatable using a protein of the invention.
Proteins of the invention may also be useful to promote better or faster closure of non-healing wounds, including without limitation pressure ulcers, ulcers associated with vascular insufficiency, surgical and traumatic wounds, and the like.
It is expected that a protein of the present invention may also exhibit activity for generation or regeneration of other tissues, such as organs (including, for example, pancreas, liver, intestine, kidney, skin, endothelium), muscle (smooth, skeletal or cardiac) and vascular (including vascular endothelium) tissue, or for promoting the growth of cells comprising such 1 S tissues. Part of the desired effects may be by inhibition or modulation of fibrotic scarnng to allow normal tissue to regenerate. A protein of the invention may also exhibit angiogenic activity.
A protein of the present invention may also be useful for gut protection or regeneration and treatment of lung or liver fibrosis, reperfusion injury in various tissues, and conditions resulting from systemic cytokine damage.
A protein of the present invention may also be useful for promoting or inhibiting differentiation of tissues described above from precursor tissues or cells; or for inhibiting the growth of tissues described above.
The activity of a protein of the invention may, among other means, be measured by the following methods:
Assays for tissue generation activity include, without limitation, those described in:
International Patent Publication No. W095/16035 (bone, cartilage, tendon);
International Patent Publication No. W095/05846 (nerve, neuronal); International Patent Publication No.
W091/07491 (skin, endothelium).
Assays for wound healing activity include, without limitation, those described in: Winter, EPIDERMAL WOUND HEALING, pp. 71-112 (Maibach and Rovee, eds.), Year Book Medical Publishers, Inc., Chicago, as modified by Eaglstein and Menz, J. Invest.
Dermatol 71:382-84 (1978).
Activin/Inhibin Activity A GENX protein of the present invention may also exhibit activin- or inhibin-related activities. Inhibins are characterized by their ability to inhibit the release of follicle stimulating hormone (FSH), while activins and are characterized by their ability to stimulate the release of follicle stimulating hormone (FSH). Thus, a protein of the present invention, alone or in heterodimers with a member of the inhibin a family, may be useful as a contraceptive based on the ability of inhibins to decrease fertility in female mammals and decrease spermatogenesis in male mammals. Administration of sufficient amounts of other inhibins can induce infertility in these mammals. Alternatively, the protein of the invention, as a homodimer or as a heterodimer with other protein subunits of the inhibin-b group, may be useful as a fertility inducing therapeutic, based upon the ability of activin molecules in stimulating FSH
release from cells of the anterior pituitary. See, for example, U.S. Pat. No. 4,798,885. A protein of the invention may also be useful for advancement of the onset of fertility in sexually immature mammals, so as to increase the lifetime reproductive performance of domestic animals such as cows, sheep and pigs.
The activity of a protein of the invention may, among other means, be measured by the following methods:
Assays for activin/inhibin activity include, without limitation, those described in: Vale et al., Endocrinology 91:562-572, 1972; Ling et al., Nature 321:779-782, 1986;
Vale et al., Nature 321:776-779, 1986; Mason et al., Nature 318:659-663, 1985; Forage et al., Proc Natl Acad Sci USA 83:3091-3095, 1986.
Chemotactic/Chemolcinetic Activity A protein of the present invention may have chemotactic or chemokinetic activity (e.g., act as a chemokine) for mammalian cells, including, for example, monocytes, fibroblasts, neutrophils, T-cells, mast cells, eosinophils, epithelial and/or endothelial cells. Chemotactic and chemokinetic proteins can be used to mobilize or attract a desired cell population to a desired site of action. Chemotactic or chemokinetic proteins provide particular advantages in treatment of wounds and other trauma to tissues, as well as in treatment of localized infections. For example, attraction of lymphocytes, monocytes or neutrophils to tumors or sites of infection may result in improved immune responses against the tumor or infecting agent.
A protein or peptide has chemotactic activity for a particular cell population if it can stimulate, directly or indirectly, the directed orientation or movement of such cell population.
S Preferably, the protein or peptide has the ability to directly stimulate directed movement of cells.
Whether a particular protein has chemotactic activity for a population of cells can be readily determined by employing such protein or peptide in any known assay for cell chemotaxis.
The activity of a protein of the invention may, among other means, be measured by following methods:
Assays for chemotactic activity (which will identify proteins that induce or prevent chemotaxis) consist of assays that measure the ability of a protein to induce the migration of cells across a membrane as well as the ability of a protein to induce the adhesion of one cell population to another cell population. Suitable assays for movement and adhesion include, without limitation, those described in: CURRENT PROTOCOLS tN IMMUNOLOGY, Coligan et al., eds. (Chapter 6.12, MEASUREMENT OF ALPHA AND BETA CHEMOKINES 6.12.1-6.12.28);
Taub et al. J Clin Invest 95:1370-1376, 1995; Lind et al. APMIS 103:140-146, 1995;
Muller et al., Eur J
Immunol 25: 1744-1748; Gruberet al. Jlmmunol 152:5860-5867, 1994; Johnston et al., J
Immunol 153: 1762-1768, 1994.
Hemostatic and Thrombolytic Activity ?0 A protein of the invention may also exhibit hemostatic or thrombolytic activity. As a result, such a protein is expected to be useful in treatment of various coagulation disorders (including hereditary disorders, such as hemophilias) or to enhance coagulation and other hemostatic events in treating wounds resulting from trauma, surgery or other causes. A protein of the invention may also be useful for dissolving or inhibiting formation of thromboses and for ZS treatment and prevention of conditions resulting therefrom (such as, for example, infarction of cardiac and central nervous system vessels (e.g., stroke).
The activity of a protein of the invention may, among other means, be measured by the following methods:
Assay for hemostatic and thrombolytic activity include, without limitation, those 30 described in: Linet et al., J. Clin. Pharmacol. 26:131-140, 1986; Burdick et al., Thrombosis Res.

45:413-419, 1987; Humphrey et al., Fibrinolysis 5:71-79 (1991); Schaub, Prostaglandins 35:467-474, 1988.
Receptor/Ligand Activity A protein of the present invention may also demonstrate activity as receptors, receptor ligands or inhibitors or agonists of receptor/ligand interactions. Examples of such receptors and ligands include, without limitation, cytokine receptors and their ligands, receptor kinases and their ligands, receptor phosphatases and their ligands, receptors involved in cell~ell interactions and their ligands (including without limitation, cellular adhesion molecules (such as selectins, integrins and their ligands) and receptor/ligand pairs involved in antigen presentation, antigen recognition and development of cellular and humoral immune responses).
Receptors and ligands are also useful for screening of potential peptide or small molecule inhibitors of the relevant receptor/ligand interaction. A protein of the present invention (including, without limitation, fragments of receptors and ligands) may themselves be useful as inhibitors of receptor/ligand interactions.
1 S The activity of a protein of the invention may, among other means, be measured by the following methods:
Suitable assays for receptor-ligand activity include without limitation those described in:
CURRENT PROTOCOLS IN IMMUNOLOGY, Ed by Coligan, et al., Greene Publishing Associates and Wiley-Interscience (Chapter 7.28, Measurement of Cellular Adhesion under static conditions 7.28.1-7.28.22), Takai et al., Proc Natl Acad Sci USA 84:6864-6868, 1987;
Bierer et al., J. Exp.
Med. 168:1145-1156, 1988; Rosenstein et al., J. Exp. Med. 169:149-160 1989;
Stoltenborg et al., Jlmmunol Methods 175:59-68, 1994; Stitt et al., Cell 80:661-670, 1995.
Anti-Inflammatory Activity Proteins of the present invention may also exhibit anti-inflammatory activity.
The anti-inflammatory activity may be achieved by providing a stimulus to cells involved in the inflammatory response, by inhibiting or promoting cell~ell interactions (such as, for example, cell adhesion), by inhibiting or promoting chemotaxis of cells involved in the inflammatory process, inhibiting or promoting cell extravasation, or by stimulating or suppressing production of other factors which more directly inhibit or promote an inflammatory response. Proteins exhibiting such activities can be used to treat inflammatory conditions including chronic or acute conditions), including without limitation inflammation associated with infection (such as septic shock, sepsis or systemic inflammatory response syndrome (SIRS)), ischemia-reperfusion injury, endotoxin lethality, arthritis, complement-mediated hyperacute rejection, nephritis, cytokine or chemokine-induced lung injury, inflammatory bowel disease, Crohn's disease or resulting from over production of cytokines such as TNF or IL-1. Proteins of the invention may also be useful to treat anaphylaxis and hypersensitivity to an antigenic substance or material.
Tumor Inhibition Activity In addition to the activities described above for immunological treatment or prevention of tumors, a protein of the invention may exhibit other anti-tumor activities. A
protein may inhibit tumor growth directly or indirectly (such as, for example, via ADCC). A
protein may exhibit its tumor inhibitory activity by acting on tumor tissue or tumor precursor tissue, by inhibiting formation of tissues necessary to support tumor growth (such as, for example, by inhibiting angiogenesis), by causing production of other factors, agents or cell types which inhibit tumor growth, or by suppressing, eliminating or inhibiting factors, agents or cell types which promote tumor growth.
Other Activities A protein of the invention may also exhibit one or more of the following additional activities or effects: inhibiting the growth, infection or function of, or killing, infectious agents, including, without limitation, bacteria, viruses, fungi and other parasites;
effecting (suppressing or enhancing) bodily characteristics, including, without limitation, height, weight, hair color, eye color, skin, fat to lean ratio or other tissue pigmentation, or organ or body part size or shape (such as, for example, breast augmentation or diminution, change in bone form or shape);
effecting biorhythms or circadian cycles or rhythms; effecting the fertility of male or female subjects; effecting the metabolism, catabolism, anabolism, processing, utilization, storage or elimination of dietary fat, lipid, protein, carbohydrate, vitamins, minerals, cofactors or other nutritional factors or component(s); effecting behavioral characteristics, including, without limitation, appetite, libido, stress, cognition (including cognitive disorders), depression (including depressive disorders) and violent behaviors; providing analgesic effects or other pain reducing effects; promoting differentiation and growth of embryonic stem cells in lineages other than hematopoietic lineages; hormonal or endocrine activity; in the case of enzymes, correcting deficiencies of the enzyme and treating deficiency-related diseases; treatment of hyperproliferative disorders (such as, for example, psoriasis); immunoglobulin-like activity (such as, for example, the ability to bind antigens or complement); and the ability to act as an antigen in a vaccine composition to raise an immune response against such protein or another material or entity which is cross-reactive with such protein.
Neural disorders in general include Parkinson's disease, Alzheimer's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), peripheral neuropathy, tumors of the nervous system, exposure to neurotoxins, acute brain injury, peripheral nerve trauma or injury, and other neuropathies, epilepsy, and/or tremors.
EQUIVALENTS
From the foregoing detailed description of the specific embodiments of the invention, it should be apparent that particular novel compositions and methods involving nucleic acids, polypeptides, antibodies, detection and treatment have been described.
Although these particular embodiments have been disclosed herein in detail, this has been done by way of example for purposes of illustration only, and is not intended to be limiting with respect to the scope of the appended claims that follow. In particular, it is contemplated by the inventors that various substitutions, alterations, and modifications may be made as a matter of routine for a person of ordinary skill in the art to the invention without departing from the spirit and scope of the invention as defined by the claims. Indeed, various modifications of the invention in addition to those described herein will become apparent to those skilled in the art from the foregoing description and accompanying figures. Such modifications are intended to fall within the scope of the appended claims.

THIS PAGE INTENTIONALLY LEFT BLANK

THIS PAGE INTENTIONALLY LEFT BLANK

THIS PAGE INTENTIONALLY LEFT BLANK

THIS PAGE INTENTIONALLY LEFT BLANK

THIS PAGE INTENTIONALLY LEFT BLANK

THIS PAGE INTENTIONALLY LEFT BLANK

THIS PAGE INTENTIONALLY LEFT BLANK

THIS PAGE INTENTIONALLY LEFT BLANK

O fD tA Q! O
g ~ ~

_ 1~ f0 tD . . f0 O1 O fD h m _ 07 O N M ~ ~ N N
~ ~ ~ ~
N

,O
N
~ N

~

N 47 CO ~ 1s In W
Qf ~ 00 Of !h l0 f1 t H n ~ fN0 N 00f O ~ n ~ ~ ~ N tMD

O ~
~ ~
~ ~

~ ~ O
~ N
N
~ N

0 M ~ ~~IW~
~ O OO~~~tMO~

c Ot~~ t cMD M ~IN
0 t IN~~~~NN1~~N
D
G
~

C N f Nt' N N N N h 0~,a0 N a0 NO

N O ~

00 ~0 0~ cp O O 1fONM
N
~0~~0M0 ~OO~

f0 f0 G~ f O O N
fMO O 7 D ~
IA O O In f~
Of ~ 117 tp O

~ e~ e~N M~~~~~NM~CO f~0 f00 ~f~0~
~ ~~ ~ O
~

~N t N NN ~ tN N N N~
0 N N N N M O ~ N
N N ~ 00 N

N ~ a0Oa0 O IA r 1A O f~ f~<OInO ~N ~ 1A
07 O OOO O IA N 01 fD O O Of D Q1 O Of 0 a0 1~
M M a0 M O _ f ~ ~N M~ O
N (O 0 O) Wf~O ~ 07 O O
Of f0 O ~ ~
fD 00 Of H N) 1~
fD N ~ f0 f0 f0 (O M in ~ ~ ~ ~N~ ~ ~ ~ ~
~ ~

U N N N N N N N
M tn m C
C

W W W WWW W WW Wt V. lL l1 lL!LlL lL lLlL LL

~ 3 5 g ~3~ g ~ ~ UU ~ U

~ U U U UUU U v m H
m ~ Z Z Z ZZZ Z ~ ZZ '~ Zo a a > > > >>> > m >> E ~n -c U

o~ i~ ~ c~

N o CM7 a a a a c c c c "~ --~

E E E E
'a m ~a 0 0 o o o ~
c c v v v C ~c C c C C
n ~
N N

C
. _ p O O O ~
N ~ d 0 n n n n p C ~
C

c c' c c ' o a E

C .m ~ ~ N
m O

O

d U U U U
U U Q
~

m O 'C
' U

T
u' ~ ~ ,~ ~ ~
E

a Z m c ~ ' m N

v _ o m n m U N ~ ~ ~ Q
N

Q V ~ H
N m C $ ~H U U O
J . m m 7 _ r z E n E N a H Z E E
d a n ' d = of o m d m a ~ w V a Z '~ d ~ d c c Q

d r ~ t oo ~ x ,n ~O a m N ~
m d V Q w ~
!n ' Y "
m d U r c i - N m - z E E ~
' ' o~ V o~ ?i m o> oi o H Q g ? ~ m N

Y Y Y p Y Y Y Y
m > C ~- ~ H C H
C x C C H C
1 C = N Q' y~

0 ~ m n m m m cc m m Z ~ ~ N
U c m m m m m m m ! ~ ~ a, o o ~
Q a m ~ o ~ ~ ~ ~

'p ~ 'o o a o_ E H E Y m d E ~
~ E E E m E
~ o ' Q
m Z

C ~N ~Ip N C N ~N N N
~ a U1 l0 3 a ~ ~
~

N C C C O C C C C
~ n N d E C N
(n 111 ~ O
-41 m m N m d m Y
Q N Z
N a O O , ~ N O
N O N
~ ~ H

c d ~ n. cc a a d d ~ a ~ o ~n o o c, U ~ V
x d m m N O 07 m N m p ~ ~ ~ N ~
_V ~ N O

O O O U O p J N ~ h ~ ~ 111 f0 d Z Z Z Q Z Z Z Z
Q of 'oi N a 'or c~ u7 m V a ~

c t0 aDO N~ tDa0 O N
O N NN NN M M

4--...N ? tD QO _ M IA IO M ~f7h 07 ~

G _ M v hOfr _'-'vv NN v M

c0 ~ f~t(7N tO a0 t~07f~O v~ 1~ fd - c0 Of N MMf0 f~ P OO N 47 O N

m M O M o0O~ O N ~~fON ~ M M

(D c0 In a0ON ~ ~ ~~DV OO 00 O
r N O O

_m O N ~ OO~ ~ E Mt~~~ ~ N
E f O 01OfO OM ~ O
O

Z M O O NQi07 N f0 1~IvN~ Nm N N
~ OD a0 ODh1~ OD In ~ ~N M< 1A t0 F""O N M ~tnfD A 00 O

o M n ~

u a W M o n a aDO O N N ~ N N V N O
t0~7 c'N~

M O ~ ~ ~ O O
O

~Of0 O aD O ~DtD W t~ cD 1~ O
O ~O ~O

sr~ In O N N (O (O fD ? M
GO tD <

~n co <c n o r- co N N oo r ~ O ~o N N
N

~ . ~ M fD O O
~

h O 4O N O t0 N N N N N
N N O
(O

N O~ O t0 Q) tDtD fD h N t0 OD
tD N D

V V M f0 O N N f0 00 tD V ~f7 V 00 ~

cc ~c o~ n cc r ~o u~
n ~ ~o ~c N N N ~ ~ ~ N ~ ~ ~ N
N ~ N

N N N ~ N N N 0 N
N ~

~

~f7Of O ~ Iwff a_007 N W ~ fD h M fD t0 t0 O I~
V O O
~D O
~D

~O(O t0 01 (DN h O t0 tD tD
O Y

N N n! ~ M c~0 f0 ~D N ~D
~ ~ N
ap t~0 r (p 1n N (OO N N N O N
N N f0 1~
f- N

m M r N
~

O ~ OfN W N ~ a0 OM tD aDV u71~ O (D M
fD M O~
t0 O a0O a0 a0aD OWa0a0 MO O M O a0 N O t0 O
c0 M 1~t0 O (OO tDu71~O ~O~D f0~f10Dt0 aD t0~ tD
Q~ M Of 07 M
oD V O ~O O
I~ ~O
<O t0 cD
<

M N ~f N V ~ ~ ~fVN ?C ~ ~ ~ ~ O
V ~ 00 f0O O ~ aD
~ ~

(D O N tD N fD ~DfD (Of0N '- N( N N N N (O N N N
N N N N (O N tp NNN N N N r-f0 i0 N N N
N N
N N

~ ~

W W N W W lLW W W N

LL LL C _ O _ lLlLlLlL LL LL O
lL lL

fn !n N !Aa (O N fO(nN (n N d N o g g E g 5 g g g g g U ~ U L U p U~ U U U U U U ~ t Z m Z y Z a Zc Z Z Z Z Z Z

7 r ~ a ~ 'C ~Y > > > > > > N a M M

N M

O
d a a~ a _ _ C C C C
N p .

f0 'E E E
~

E ~ ~

0 0 o o a 0, a a a c o c C C C C_ Y
~ ~N ~
~

y ~ G7 O O
L O

O O O O U
d O.

n as a~ n2 c c c c t o E

. . . .

(0 A N f0 N
N U N

C C C C O
y T a o r o o 0 a U U d U U ~
~ Q

W ~ N

cD
.. (n (0 x ~ ~ Z V - x -07 p U I~ M y ~' . ~ ~c . o n 'o c ccz m Q ~ Z o ~ ~ o o v trn r~
~ E a, N ~ ~ Q Q ~ N ~ Q Z O
H ~ N N d a ~ U _ a~ a~ u- ~o aEO
U"

U uJ E _ ~ O ~ ~ E
m ~ ~ a E y a L
~ o Q ~

_ Q Q O (n d N ~ x ~.O- N , Of , '-' p O u1 X
lL

d 0 N O N CO M
~ J a H

J H M M . O ~ O M ~ _ ~p N. ~pO '-' ~

O m U O ~ o Q ~ N N ~ M
~ U E E H- x E d l0 a I- a x N U u1 ao m ~ d W n ~ v U in O ? o m a ,n _I N 111 I ~ " ~ I Q f'-7N m 7 I N
O d Z .~ l p a ~ d ~~ T -7 ~ a ~ .~ ~~ - ~oi t N 'op C
o a O ~ ~ O .

c c c c ~ c c c Y c c c c ~
j ~ j ~ a fn Z v7 E ~ a m rn O Z ~ o c Q

O f0 _ (C f0 f0 ~O Q (UN f0f0 l0 In fO Q O O m ~ J "7 N LLI T
m ~. A m Y Z m m CDfD (O
N m N f~ M y ~ L M m ~ V O (n a N

O O O ~ O O O M O O
~ O V O y M t0 ~ L1J ~ j V C
O Z ~

E E E E a E E E ~ E E E E E
~ n a ~ ~ ~;~ v ~ a o ~ a Q d U g =
a ~N ~i~1 ~N N Z ~N ~Vl ~N O ~N.N ~N~N N
a ~ N O ' O y ~ Z V

C C C C d C C C d C _C C C G
d ~_ a J ~ d ~ x . ~ a ~ O D N ' Z
.
~

d ..Ø_ ~ ~ ~ O ~ .Ø Ø..Ø_ t N 4: ~ ~ O O ~ ~ p~07 .-O.
' Z M Y t~
~ Ijj N
~

o o o o o o o o o~ o o o o o ~ ~ ~ p ~ ~ x x c . ~,M N
I-- z E ,~
Q

a a d d o d d a N a a a a a c Q cc 2 n rn a ~ 3 t M ~ o Z Z Z o Z a Z

O 0' ~ N O N 0 C O
O

j 7 j 1~ ~ ~ j ~ ~ M ~
a (' j x O
~ ~ J

O O O O =~ O O O ~ O O O O O
=~ O N ~ O x C T ~ x H "

Z Z Z Z ~oi Z Z Z z Z Z Z Z
~Oi !1~ ~Or Q N Q c~ a 7 t a 6~ Q
tn Q Q N a ~

(OaOO N ~ftD a0ON < c0OD O N ~ ~ ~ O

M M M ~ V ~ V ~Nu7u7 ~~ t0(O n M N n W M 47 nOf M Kfn 01 M u'iN m M

.M..~ ~ ~ ~ ~ ~.~.rr~..~ ~~_ ~ f~tv~ (~ (01_~

V ~ ~ aD V m t0 H~~ N N M aD~paD 1~ O N u_7 O u701N ~ I~

Y CON u7 n!7 N h_ OfPM 1~ fD10 M ~ c0 t0 O N
1~ (DW L7 OD f0h ~1~ M

N t0t0Q 1 1l'1Q M1174'f MOD OfCO0)N f~ ~ N O
~ 1 m ~ h N _ O _ Q1~O M OV O)< V oO tD O < <O

N N O I~ ? r ~ NNN N ~V O Y ~ Y O (O M
O O O O O OOO O WN OfW N Of t~ h O O

N a0~DN a0 r oD NaDa~CO 1~a0 ~ f~~ m 1~ a0 O N

I~ W 01O N M V~101~ aD01 O N M ~ ~

M M
N N N N NNN N NN M M ~~M

o M
O O M M
a0 a0 V N fp N M
o r co N o0 ~ ~
~ N

O t0 ~O fD
a0 N ~ N
N N O O
N O N
M N
~

a0 QW
N tD O

O f0 f0 N

(D ~ O
~ f~D
t~D
a0 t0 N O N O
N N N
N M

O
t~ m o0 a 07 t0O

u7 O

O O t0 N M

I~ O N ~ ~ N
tD a0 O N N

u7 1~ N
N N N 1~ N M O . O
N N
aD

_ f0 r O (O O (D M M O
r tD ~ t0 ~ h ~ O O ~ f0 t(1 f (O O
~ ~D D ?
t~0 ? ? V') f0 V ~ N V ~ N
V ? ~t O
N fD
t0 f0 t0 ~ fD ~D ~ N N N
O l0 M N N N
t0 .
N N N
N N

~ N Nu7 Of 01 (D01MMm M ~ N O CD ~ 1 tn O aD M
a0 V
M

O O O ~l7 Ofm OO cD t0 ~OaDa0OO Of M c0M ~ 10 V7 t0 M ' f h ~f0OtD~p M t0 h ~OM
tD ~
u7 fD Of 07 UI4 t0(O . ~ ~~ ~~ ~ p ~ ~ OM ~ f~0 ~ 1' f' ~7 ~~ ~ ~ ~
O ~
~

t O~QO tf tN N 0 tO aD(t N t N N f N N
0 ~~~f 00 0 f Dt r-OO 0 N
N N N N NN N N NN NN N
N N N
~

W CL t W W W_ W W_ L

_ _ C

g 5 gN " g g g g g 5 o Z Z~ j Z mZ Z Z ~ Z Z Z

V > >, ~ ~ C> > > N >
N N

t0 r O
C
.

O N
O
E

aY

c ~ c c ~ :
.

.m c m .~
.

~ E

va ~ E

c ~
' U o v ~a y o ;
._ a ~Z
~

E o C N C C
N N
O

'f0 f0 'O l0 p a o U
~ ~
~

U Q U
U

m u1 _ >

G fn c ~ IL m O ~ N

i E Q N O J j E ' _ = O ~ ~ d -~C

N c~7 ' Z : ' a r U a0 L E ~

E . ' o ' ' o~ N ' c ~n ~ N 'n " N '- a i n ~j co N O ~ ~ p ~ ... d Z N
, U ~ ~ ~ ~
c0 7 Z (O
Q

a u. C7 ~ ~ v U ~ m ~ ~ v a ~

J E Q ' j Q ~ Q ~ a N Q lO l0 of c v ~ = ~ ~' a c y E
H o ~ ~
~ ' ~

o ' is ~ J r I - n a m Z ' 'm o~ o v ~ ~ U n ~ ~ u~ m ~n m ~ E o ~

p N ~ N ~ OD > = ~ E N
~ ~ 67 N L O tn (O D
a> ~n m I ao ~ I c d C

-o . Z m a _ ~ - v ~ ~ ~ Q L a a ~

'D1 'p! !~ ~p1 ~C1 O O O! of O) Of 01 ~ t V 7 O ~,.~
Q N

Y Y d Y Y Y Y C C ~ C
'C d C O 7 ~ N
~ V
'_' , N ~ L ~' N (O N N C ~ l0 U ~ N N ~ d C
J N l0 UJ N ~

N fC c0 O m CD m m 0 CO
' m m V) ~ Q m N m ~

07 CD N ~ N ~ ~ U~ C7 ~ C7 ~ ' ~ 7 Y
H C~

CJ C7 Q U C7 C7 CJ C N ,c a?
N E :: r ~ c ~D N
m O Z

N O ~ A O V C N
C E ~ E E E E E E E
~ '' E c o E ~ ~ = . ~ Q N p H ~N ~
'c H N z N w O ~l0~N
E N ~ N
' ~V1 F~

H N X CO CO - C Ol CnO C' C _ G7 C N C' Cd Nd CO
O Cdlll Cd ~ ~y C d N d N N d N _ r d ~ j N Z o j N ~ d V
7 ~ 2' N
a ~

O O O O O O O O O O O
M E M T ~ a d Of a Y ~
N p d a a ~ o a a o a . a d o ~ d y u o E ,p of '~ ~
o N ~

j j > a > > 7 > > > >
O > J ' t ~ ~ ~
~ ~ h L ~ ~ ~ N O O O ~ O O
O O O O O O Q O N
O ~ C y~

Z C Z Z Z Z Z Z Z Z Z
a Z a~ X c~ 'o~ a ~ 'o~ a S Q
~ E ~ ~ m Q

N ~ co000 O O O O O N

ON ~t0 aD O NV tDaDO ~

r n eoao ao ao rn a~ofrnof ' 0 0 ,~ ,~ pi' riiti n of ofwinai o o 0 C C ncr mor ao ao o~~ o~~~ _ _ _ _ ~

mn soas n ~ aov ma~c rn m o n M co ~ aD

M Na0 (D~O W ON _VO~ (O N 1'O O O
l OW f7 1A O aDt' O M

M f~ fDN ~O N h M0 NDM u7 c0 f0O N ~ M
MM ~I' ~ V MaJ1~O

cO O MN NtD aD o0 OOfOvffO H7 O O1r O N

p fDO h< O M O~D~(OM N N O ~pN O
M

v o0 0o M a~ ~n~ a~ o o a~ coa~o n N W Nt0 NN M Of~ f~NCO aD 1~ M r aD (D

NM V' u7 fDI'OWO N M Y 49 t0 I' ~pW l7 M M <~ <V V V VV Y<O u) n0 O

. r. o .-o . ao < o N 10 w ai u7 t0 O~ i0 ~ O~ . N

~
r W O N a h ~ ~t 0 M O 1~
N

t0 ~ . I~ O
~ 1~ . a0 ~ O 1~ a0 O
O M O) 0 M
~

M ~ O ~ d0 1f7 f0 M a0 OD o~ r ~c M ~ M o . <c ~o . o ~

o~ N ~$ ~ N
r ~ ' ao ~

00 ~ N N N a0 1~
~ ~ N

M O 00 f0 O_ O) ~!7 01 0 0 N ~
M O Qf K
~

f0 10 O O 0 0 f O f0 t0 0 0 0 M ~

N 0 CD 0 i0 f0 f0 O O N f0 a0 ~ N 0 N
M N N N
~ N

N 001 01 N a0 N a0 Off 001 ~ N 0 t0 O
aND M

p a0 0 Y ONO O t0 a0 V
07 c o>oO O) ~ so i o~ o ~o r r-co o so o ~fD~tO(~DO(~ONt~O
so v ~ N
o NN~~~

~NNtNOM~NO 0 NNNNNfONO QIN

~ h NOf ~ M
f~

W f7 O Off0O Q1N M O~ N OfCD0Na0 r V Oa0 M t0 V O N t0M O t0 aD OO OON N aD
N N O
c0 0 a0 Of N Of m ~ 0 0 f~t0O0 ~ 1~ O 07O 070~ ~ t0 N 0t0 I~ u) 0 0 ~O~ ~ 0t~0 0 ~~ ~t~0O t0 0 00 M f0 O I~ Ot~0 40 ~(~O00t~0N

7 f0 ( N N fN 0 N N NN NNN N N t0 NN aD N N
0f00f0 N N N N N N N N
~Lf N
t0 N N
M

y ~ OO O OO O O 0 IL N l1J ll1l l_1JL_1JI_LIl_Ll_LLL

l G __ c LL _LL L Ll L U lL
lL lL L L1. L _ L
l N _O d fn (A(O _ __ _ _ N
(n (~ V7(n fn N
!

w p tON C ~ N cntn cn Ucn N tn fn a> w o_ 3g d a a' U UU U UU U

UU ~ ~ t U U

C (p ~. ZZ C ,y y Z ZZ Z ZZ Z Z Z

;e o~ 7~ ~e a > >> > >> 7 7 a~ c~

c o o o u u . .

a a a a _ _ _ C_ H C_ C

N O f0 N
C
h O Y O O
u f a c a a m c 'u~ c c ' d d ' y o y O d O O

d U d d ~~" Y

C C
O T

' !C ~ N N
O

C Y C C
~

U u~ U U
C7 a N
N C N

U

T n O y , V N
~

Q) 7 F- N W O N ~ aNDM
W ' Q ~ O
V

N ~ ~ M 00 O , C

N ~ p ? j E llJ N ~

UJ

H m r ~ ~ Z ~ ~ a U
'a Z v >- ~ N ~
uJ N

~ a ? a d g H d d E
y = a ~ 'H
N o ' c ~ 'c > ~ Q ~ o a a>
. n Z p c N
a>

p. ~ ~ ~ c ~ o ' _ ~ ' U n O ~ ~ 0 o ~

o ~ ao E- u x. a o ~ 7 7 o E a t rHZ f~ N ~2 m Z _ a00 ? u~7.>
G N ~a O ~

~ = ~ i ~ ~. ~ N ~a ~
~ Q

i= ~ Y ~ ~ G ~ ~
H 'w ~o~ 'c> i ~o~ 'y 'rn 'o~'c~
0 . c a Y d Y Y Y Y .r Y Y Y Y Y
[L N d Y Q .Ø.N
a Y
J

m m c m m m m m n m m ~ ~ ~ Y m p n O ~
Z

ip O e N ~ Q m m m ~ e d G

m tn m (D Cm m m m (D c C7 (9 c9 C7 = C~ p~ c7 C7 - C7 3 m E
C9 7 ~ w ~ o ~
a r C9 Q

~ ~ v E E E ~ ~. Y E ~
~ ~ ~ ~ 7 ~ E
N E ~
o Q

E ~ ~ o E E m y ~ ' 'O ~ ~ ' 'N 'N H
' a ~ ~ Z ~
Z
O

N ~ N N N N N N N C j y~ ~ ~ a G~~N CHI= C~ G~y CNY Cd CQ~ C~ C_7 C_ C

O C N O ~ ~ ~ ~ d d fV ~ N d ~ N - N N u7 N ~_ a d ~
~

~ to O O O O O 0 O O O
N tn 0 N 0 O
C Q.

O O H N M M aD 1~ f0 M
a J d N d ~ a a a. d a a U O ~ d O ,n a O o 0 ~ O . N V o o _ N Q N O r d ~ _ N N N ~ O d N d ~ r E N Q O M O O M
O N U ~
LL . ~ E

O ~ O O p p O ~ p U ~ ~ ~
-Z G ~ ~ J N J J O
U ~ Z d ~ ~

Z o~ Z Z Z Z Z Z Z a Z Z Z
v 'oi = ... of a 'ci a a x ~ Q Y a ~
Q

t0 aD O N ? 00 O N V 0aDON< 0 c0O N ~f a N N N NN M M M MM ??~ ~ V0 ~1 u7 0 _ h U) r W r M 0r Of M 0r OfrM 0 hO M

~ N N NN N M M MM MV~ '? ~V ~O 0 u7 _ _ _ __ _ _ _ ___ __ _ _ 47 v 0 0 0 M0 aD ~ M N G~0A ON M c0 a ~

O 1~ V O 0 0~ O a0 V aD~ N0h V M O a0 f u7 M M 0Dm U1h M M u') M1~MQ01 N VO M t~ Y1 1~ 1~ OD0 ~ <? 0 ~ N 1~ ~I~V u7 I~O V7 ~ N
' ~

N r u7N O rN N Kf 0 _~ hQfM N 1~ O ~ a0 N O O V ~71~ M cO Of c0e0a0apr O MCD 0 ~

_ O N O M O Of 0 c0 OO~Q~0I~ O Om f7 O 1~
W 0~ '-aD ~N 1~ ? f~ hh f~0aO a0 N~ 07 a0 a0 Of O N M ilf 0 1~ a0W O N M ~Y7 0 I~ aD
~

u7 N 0 t00 0 0 0 0 00 PI~f~ h AA h h f~

m N O n a~0 M ~ t0 < Of ~ N O n t0 ~ P ~ fM0 tD ~fJ ? f~ O O O~ O t0 01 ~ t0 cD V tD
O M V <

co co ao cc ~o a> ~n o~ o_ . ~c n r o n O N ~ N ~ cc se co cc N ~
~
~

tp M f f0 t0 tD aD
M 0 f0 N fp f0 N N

OI O O O a0 N N N N N
Q~ N (D V N N N N
N V O N a0 N N (D
N . ~ V . a0 .
. a0 .
M

f0 O N N t0 O u7 M aD Of O u') M f0 of P N M t0 f0 N N V CD of O O O O O t0 O) O N M O V M (O 1~
N (D ~ tO ~O t0 aD V
t0 . 1~ 01 O ~ (O O
Q7 t0 t0 1~
O O c0 h ap o N ~ N t~0 _ N ~
~ O M M ~ ~ ~ ~
~ N
~

tD to tD t M O OD r CD N N N N tD 0 O N (p aD N N N N N
N ~ N

~ r ~
O ~

Of (O (p 01 f~ 1~
G~ a0 O N O) m M c0 t c0 O O) a0 0 Of m N ~ O
N N < O O N O c0 M t0 O~ N M M u7 N
O

~o n so cc o u~ ~n a~ <a cc so n co r ~o co co rn o~

OD 1~ N N ~ N ~ 'C ?
~ M ~ ? ~ N V ~D
Of N O t0 tD <D ~ ~ f0 N ~D tD (O f0 ~D
~ t0 . ~O
~ <O tD u7 CD N N N N N N N
fD h ~ N ~ N N N N
N N M
N

O ~ ~ t0 N
1~ M off O N o0 r O t0 O O O Of tD h tD M 07 f~ f0 aD

N M N ~ O O O O Of O tD
f0 M t0 M CO t0 tD Op 07 M t0 tp N O~ OW D ~D t0 it1 4'f O~ n ~ f0 N ~O u7 O 1~ V
O 1~ t0 h u7 N N I~ V N Y ? V ~ ~
N V M ? V ~ V V ? t t0 t0 t0 c0 V f0 O ~
t0 < t0 00 cD
tD ~D 10 t0 O
fD
f0 p N t0 N ~ ~ N N N N N fD
N N N N N ~ N N N
N N N N
N

N aD f~ Of 01 ~ I~ CO 01 aD ~ O M
QI ~ O 47 ~ ~f7 O t0 V ~O f~ ~ I~ aD
t0 cD O O Q1 N f0 O t0 aD O O O W
M fD O 01 a0 (D M
o M c0 ~
o O
~

a~ o o a n ~n u~ v on uo so a~ o o~ c o < ~ se re o~ cc o c o u~ n ~
mn rn ~f ~l V V
to M ~ V7 e- ~ V' V C
~ V V ~ ~ V Q ?
0 ~
V

~ a~ cc ~o cc so o ~c cc co cc ~o so M ~ o ~n ~o 0 se 0 0 0 o o ~e ~c o M N N N M tn N N N N N N N N N N
N t0 N N N N N N N
N N N
N

O ~ O O

u1 N IL L
L

u- c lL _ LL

d ~

H ~ C A

U ~ L U ~ ~ U

v 7 ~ '~ 7 a c E

v c o. c c E
' m 0 c ~

o I

U d J
_ W
~ E

U ' Z

o ~ , ~ O N
Z O d l1J
- O A Z N n L1J 0 ~ 'N N

N O N W O ~

Z
( O In V Q O U
O j T y O Q n ~ Q
Ill ( 'O N _ Q Q ? '-Q~
O O j ~ N
Z

(n ~ M
f!) ~ r O

it Q = aD t0 ~ ~ O O
= L ~ ~ >
m U ~ o ~ n ~
U ~ Q

Z y ~ a U p I N c IU _ ~a>
' o a ~u , U N ~
n ' , _ _ N Ol _ J Ol C1 r 01 N H Q O
' ' .7C O Y JL Y ~ Y C ~C
O d Q p d ~ Q
Q
~

m O

C~ o_ C ~ C7 C7 Q C~ 7 ~
a ~ m ~
U V C
In C

E ~ E E E ~ E E E
. . w '~' ov m o ~
~

N _ . ~

c c c ~ c c c n 'a a N t -G1 N _ ~ O . ~ ~ ~
N C1 m C u1 ~ p Q.
' Q.
.

o o o ~ ~' ~ m ~o a a a o a a ; ., L Z
T ~, r d M
r ~ Z N N
N Z

O > > ~ > 7 . ~ U O
N

z a Z z Z ~ ~ z z 'o~ E z ~ Q
~ H 'ao H
H

~ ~

c c ~ ~ n_ n i ~ o MO ~ ' ~ n ~ c ~

c _ _ _ c 0 o n o o m o M ao a rn ~ v m m n o v o O V M ~ ~ ~ O
n f V t 0 M V ~t '7 f D
O

Q~l m O ~ O OD M M
N ~

m c a_o ~ O M O h O
N f~ O OD M V I

_ O
1~ Of N N a0 h O O O t0 O ~D
N 01 O O r h V ~ V7 O r Q~ I~ m M
M

ap M O u7 u'f aD f0 N t0 h h O N O
N a0 N

f~ I~ M M M EO M O I~ h f0 N Y t~
01 1n 07 ~ 01 M O_ M
t0 tD t0 f0 c0 N ~ tD

N N O M M O O~ h ~ 1O fD t0 N
O N O Q1 10 N t0 N O 1~ h N O O O
M O 1~ O OD 00 O 1(I
n!1 N
tD N ~ ~ N N ~ ~ N ~ N 01 a0 ~ ~ O
01 M ~ M M O M ~ ~- 10 D N O
CO f0 N f~ f~ N O IA V N N t0 O f0 N 1~ O O Of 00 W f) f _ O
~ N ? ~7 01 OD M
07 m M ~ N W M f0 O O fD M V7 I

_ O
M N N M GO 47 '? V N V CD N N ~ t0 01 t0 M ~Y 1~ N M O N
h ? M a0 aD a0 O

? N
ap tD O) O) ~ O_ ~O N . 1~ O tf t0 ~_ ~
O V
O N h V N h ~D 1~ O V 1~ M O
O O~ O N M N a _ _ O
_ 1p ~ 1~ M ~f M f0 ~ fD O ~O m N t0 f~ N V Q
CO O tD O~ f0 O (O 1~ tD ID M t0 N t0 aO O M N In M M N V O~ I~ f0 ~ M N ~O 10 N N O N O M N N < V O) ~O N t0 M o0 tD ~D ~ QO N O

N . W _ t~ tD V O O N
W O O ~ W O Q 47 t0 a0 V N ? N O
N M ? ~O 1A V t0 N

O a0 I~ t0 < O ~l7 M N (D f0 t0 N
t0 oD h ? a0 O N
t0 P O~ fD a O
- ~

_ l f0 O ~
M O O N N 07 N O f0 M O W 01 N O) t~ N O N
M M O
Q7 10 N f0 i~ f0 ~
M N

_ O
. O
_ f0 '? 0p N N fD <
O O) N O ~ N N f0 1~ N h G~ Im0 aD M h t0 < O M O

_ Of N O ? f0 O <O ~ CD a0 < W N f0 ~ 1~ aD ~ M 1A N
O1 f) M f0 O ~ O M 1~ O 47 M t0 N

N tD N O 10 O M G~ N
M fV ~ O N OD In N
117 t0 M
O

(O O M
N

~ N
~
~
(D
~ fD N
f~ N ID N V fD N N N N ~f1 ED P 0D
N ~O aD N O N M O V aD O

O 1~ O~ N N O O M M . t0 M_ (O N _ N W o0 O O O 10 I~fD
V M - V t0 1~ O N aD ~ aD M M O fD O
D O 47 N 01 h K7 O W ~ a O C

_ O f0O W O O Q) _ 1~O ~O LOO) ~7 _ O
~ N aD O) <D O N O M ~O O tD t0 N 1~
tT fD N (O O tD 01 c0 P O M M O1 Of O M M V O f0 1~ O O tD ? ~O t V V
V N t0 W M 1~ O h V V
V W
N
V' Of u7 ~O < ~ tD
~
~

_ ~ t0t0 (O f0~D ~O
~ <O
~
t0 N ~ M M f0 ~ 1~ ~O ~ ~f O
~
N t0 N ~O O~ Qf u7 ~D f0 ~O O O N
f0 f0 tD N 1~ f0 47 O CD N

N ~O N N N N M N tD N f0 f0 N N N N N N N N N N
N N N ~ N N M t0 f0 ~ N N N

N

N
~

U
O

N
N

N

InN ~ NI

O

z z ~

a a E

a c o c ' a m H
E

c o ~~
v m o U
U

N
y >_Z

U ip a LL

Z n n m O

J N M Z
C~ ~
N

r0 m Q M_ ~

iD O

a O

a w ~ a z a ~

o m V ~ ~ O
a ~

~ , Q
~

m u! ~ ~ m ~ z c a in~

"-' o x~ O 'c> m j ~ ~ ~ O

a ~ n O

c c c c c z ~ p o U m m E p Z

(~ U' U' OL O O~m ~O AW ~

N v ~ ~ ~
m E ,n w E E E E
E ' a ' a ' ' ~N N 'IA f/)(A N N
~ a T O Q
a, Z

C C .a ~ 'd C N N L H
~

A N ~ lO
M O
~

0 oa ornQo' oNova O o . ~ a a cn a w a ~

~ i-~ ,~
$ z ~~w ~~o~.__ ~w~_ M O O O O O
-~ N J ~ =
~ O ' ' z z zQ zuiz o~? o 8 o~~
~a OD O N V fDOD O
m O O O O O

N
n n o M d ~ d a a a a a O o o o m W n N ~n N ~ v ~ ~ o v o ~ ~ v ~ o rn m ~ ~ n oor . ~

m m o~of . n O N . n O

N O) O ~ V P7 f'7 N ~ tD
N O O O f0 r-. O O

a0 10 ~ ~ O Y

V tD ~D . <
_ Qf N CD (D
O~

M t0 N N ~ O fD N
u') t0 (O N
c7 n N
~ N
~
~
N
~

Of fn c~ (D n t0 ( N (D C'1 O ~
O
N W O Q) CD
(O N N ~
N

. O 07 ~O p f0 O O _ _ aD O
.

tOfIt~O~~aD~NN~~ Y~1 aODt~O

N V N N ~ n n N
N O fD f0 N
O

. u9 'C c~ ~D N
tn N N O N O
f0 m CD 07 r7 O Of <O f0 fD
fD n N N O O ~ n O O N P7 f0 N N ~ O
!'~ fD

. a~ o o n rn <n . o . _ so c~ M ~ N so V
07 N ? u7 n ~C1 ~ Qf n fh N a0 of O N tD t0 10 f0 ~ 10 t0 fD tD t0 (D _ ~

Of O N N N N N p N
N n n '- W N
N N
aD f0 . _ O
(O ~ f~ fD

n O n O V N ~ 07~7 O7 F1 a0 O W f0 N
C7 (O

N 10 O O (O O Of O ~ t0 O
O ~O m W O c0 O 10 N u' W W f0 c'7 n ~ ~ ~ O u' f0 t0 p0 N PJ N N ~
~
N M
~0 ~0 ~

f O (O cp f0 f N N N ~ ~ N
i N
h 10 N N N N
N n N Of ~

O1 N _ . t0 N n c0 n . ao o> m c~c u n ~ oo ~ c~ ao n aon o~
a~ co ~c ao o n co n M co o~

~D ~ O O ~ O O O OfN O O Of O _ 4D ~ a0~OO f0 t0 f0 n a0 O
~ O

n c'7 Q) O ~ Of tD (OO fDcD N N ~ M O n (O47OfO n O n O h O V ~ ~O ~ c0 (D (O~ O~ c0 f~0 ~ ~t~0t0~
~ ~ t0 f0 O
N fh V ~ ~ aD
~ O~ t0 ~ fD

N Of f0 tp tD f0 ~ cf aD f0 N N N N N N N N NN N N N N N N f N N NNN N
N N f~ ~- ~
N N
N

_N

CI Q Q Q ~Q Q 0 O Q QQ Q

W L_1JW W ILW I_1J W vp lIJ L_!JltlW

a ~ ~ ~ a a c ~cn d ~ E ~ i r ~ ~c c n n n g g 5 g gg ~ N 5 ' g N a ~ gg g U U U U UU = ~ U a U d ~ U UU U
~

Z Z Z Z ZZ ~,y Z o Z i- ~ Z ZZ Z

7 > > >> tnL ~ U 7 Q >

v n ui n aoN o N O (D O
- O O O
O
~

O O O O
C u.
u.
'E

a a a a ~

c c c c a ~m ' m ~o ~m U ~

o o 0 0 d ~

v v v c c c c c m ~

0 0 o o 0 ~ c 0 d d d d N E l4 H

~ O

C C C C
N ~ O
C

U t U U
2 ~ Q

~ n U

' ' J

' c V ~ o ~' ao ri v ui z ~

(V m O Z d n /- n (O (D
M O M N N N

O C7 O , ~ 111 . ~ W ' d ., " ~'' 'n u, ' ~ o Q ~ x ~n , ~ - S 0 a z O n ~ U
O

v ~" ~ ~ ~ a~ ~ o a ~' m a ~ ~ v " c ' z . ~ E
-cn n a m ~' a r U W a a T c ~ i ~

a m E a N a v~
~

v fn d a ti - ' ~ d m ~ ~
L ~ n Q

N ~ n v7 7 LL ~ rn E O

< y c0lL u ~ n r j e a ~ Z ' m U tn$ n n d m o c c Lll ~ ~ C7 N ~ ~ m x n p Q ~ O C N
m ~ 2 y U
W

O O V m~ H O O _ N M
H T u n d ~ ~ N

V C V C x ? N ~ CO - ~ ' - N
~ ' I ~- ~ x - Q N N
' E Z O Ol .C
' o~ o w o~ U c> o~x of ai~ ~ of rn d a - Y ~ o E

Y ~ Y Y Y Y Y Y Y Y Y Y Y
Y O [L O Q y d (n~ ... H
. ~ C O
C O

Cd C Ca C~ C C C~ CL C CmC~ C C
_ V C N

m m m CD m m m m m Q]
7 C7 C7 O G1 O~ U f O N m 7 w ~ C7 ~ ~ 0 U N ~ d ~ ~ ~ M a '~
~

0~ C~ U C E C U C C
C ~ , o ~

L Eau EE ~'g'Eai ~= EmEaE~c E~ Exo ' 'N ~N N . ~H1 N n N N 'NN N N
Y X p . ~ U N y ~ 'N O
O N Z ~
v .-C C C C C C C C C C C C C
N N N N C d N ~ E N ~ ~
N N ~ _ 0 N A d T N

N N 7 ~ _d d L ~ N ~
N N

On O~ O One O O~O~~ O OL00ON O O~
~ 7 ~

N N et O O W flN O N
a~ du,ao arnO d aMa s a d,oL N aG
' a O an aN o ~ ~

0 ' ~ ~ N n ~ ~ U ~ ~U
N

t O ~N ~ O ~ p ~ ~'? ~ ~
O Q ~ ~ U " ' ~
' ~

Z z z z az z Z z z z z z z Q ~ o~ E o~ X o~or ~ ~
~ x E

N V tD aD ON ~ c0 aD O N V t0 Q O N~tf0a0 !

O Q1 O O~ OO O O O _ N NNN N

NN N N N N N N N N N NNN N

M u' n O M ~ n W e'W l7 n 01 C7~ n O O O C) OfO O O O O ~ NNN N

W . ~ ~ ~ N ~ ~ ~ v~~ N

O O V t'79 OfaD N O aD f0 aD f~a0a0Of c ( N O O N ~O ~ ~p n O O O ~'1 V N ~c'1C~O

N O nff N N cW (7 N O n Q~ _ a~~fOV
N ~ n f0 O~ n (D n ~ N n n N ~t0OfN
f ~

N O N tD ~O D t0 V O N ~ ~'1 c0~D~~1O
t C~ cD ~ ? tDN ~ < N 0 C~O N K710COO 10 v a> o~ o o~0 0 0 t ~ ao0 0 ~ o~rno>n o 0 _ p n n N n0 N N aD n N m O C1 n C~n~ aD
c O N e~ ~ tDn t0 O O ~Nf~V
~ ~ O

~O O O O O O O

N . ~ O
M O

M aD N O N t0 ~O
N O) N 4D ~ ~ M ~
f0 ~ W

N O GD (O n ~ st O r t0 t tD t Of t0 O 0 0 h f0 .
N aD

O~ N ~ N tD N tp ~O
~ O lD N

t0 D ~ ~ 1 O N N M 0 tD
O 47 O t N
(O 1' ~ N
( tp N N N tD
N u7 M
N

N r N O f0 ~ 0 M

~ M f0 O f0 0 p N V
1Y ~ M O O O t' f (D O (D f 7 N
oD
~

O O <D o0 O7 o ~ cW ~n m so O tO V ~ co M M u - ~c M N
~c s ao o ao c m ~ r n ~ ~ OOOaMO~ (SON ~ NNf~O
n ~ ~~ 0~1~0 M ~
O MN~
N ~
~~

Oa f a O N N t D c0 D O D ~ N O
f N N N N O N N
Oa M N M
N M
O N
M M

_ ~ Of O
O tD
e-aD

~ h O t(7 O ~ N M ~
aO f0 <O f0 ~ O O O
O a0 O N 0D O O~
c' M O
M ~
~ O

ap 0 0 O Qf f0 NN
O O O f0 f O t0 00 ~ ~ t f ~ ~ NN 1'~O~Cf ~ ~~~
O ~ O
~
NN

a t (O Of O N ~ ~ N
Df O~Ot CO f0 N N N
O O M a0 N
O t N <
N O ~ M
N N N N N
M ~f M
N

M O O ~
O
O

M f' ~O M M Q O O O O
so tD aO a~ t0 O ~ ~ ~
v 10 O O~ N
c o ~ ~o M
r ao v M ~o oo M

N Of n~ tD O a0 O ~ ~ M N N
r n.p h ~ fD C p V o t0 (O C ~
nl7N1~f7 f' ~ N
~ Q

N O~ i OM t0 t O~~MaDf O ( p N
C f f NN

IO NNNM NN N ~~NfO I N NN A r ~NO ~

~ u7 O V Of~ Of M nI)O ~r aD ~ O' M V ~ M Of f' Q~ aD ~ ~ M 1O O M M N
~ t0 ~f1 O7 ~ O~ ? 4D
aD M O aD
O O
(O

47 O ~O t0 M h a0 O 01O OaD O ~n cco~ a~ cc o t0 N M ~D o~M so ~nm <nO n ~n se r ~c M o t0 a0 ~n ~ o n o M ~
r. o ~n ~ ~ n n seM N ~ ~ V ~_ ~ ~ ~~ 'P 0 ~ _ o so o V V O O t0f V N V
~c ~n ? m i0 < aD
t0 o> < ( 1 0 N
O V ~ V t0 fD
) ~t < fD
~ ~

_ ~ f0f0N N ~O0 ~D00 N N NN N M N '-N fO t0 N N O f N NtD N N
t0 fD f0 f0 N ~ N N
~ f0 (O f0 N
N N N N N ~
N N N N f0 N N
N

W W W
W

_ _ _ C

O (nlC V) m VIV) f0 N ~ NL f n O
(A

d w ~ ga g a ~ N

N N y U UN U C
C N L

N .E Z

Y ' d , , C i _' O ~
. C
O O
O

C

o 0 0 o c a o o ~ o o m E

v a a a a ~ a a ~
o _ _ _ C N C C d C C N C
N d C C U
. . ~ ' .
.

E E E E ~ E E d ~' c ~ ~ a o oa o~ 9 ~oL ~ ~
: 0 E

o c _ c c ~
' c c c c c E
_ .~ ~~ -y -y 'y ._ Z o ~ a c o o '0 o d o o a ~ 0 I
u' o n a aQ a n N = c . ~o d to n .
m m c E

' c .vo .m m m c .m .m ~ D
-' H .
~

a :
o d o W p p o o O7 ~
N ~ m E

Ua U~'v U~ U~ UD Um O N
, Z Z
d M ' C Z d ~ ~ O U
~ T

Q i N
~ ~ ~

l1 L U M m t0 O lL yJ n t/l O O ~ U Q
[

U O. , Q' 7 N Hd F~a'M , E N

' Q_~ =r =U

m ~ m O ~ n L ~ N Z

o a z ~, a - ~
O

M N ' U N a O U' U tO
~ "

a aj r n =

w a, ,~ ' ,~ in , U ' _ m ~ E a d d r- m d M ~ Z _ V

n ~ N N O ~ O Q ~ O (O O
~ ~ Q C N f0 N C
O

N M O ~ ~ O !O W ~ O V
C ~ _ N Q ~ >
a ~

N N ~~ V ~ ~ Z m aD - T
m ~ Z ~ d U ~ ~
~ ~ ~

. 'c, c, c, cn or or m O_ U of rn d ' ~ ~ m ~ a ~ , O ~

Y Y Y Y Y Y Y O Y Y Y
O (A O N f- (' y c VI Z Q

m m m m m m ~ a m m m d ~ c m ~ . ~ m Y
I

m m m m c m m o Z c m t a m o M m .- ~ m m ~

C7 O O U U o O O O ~ U N
a m a O O > U O
m Z E

y E ;, ch ~ ~ c a E ~ " n o Z

E E' E~; E~ E~ ~ Em EN Ed~~x ~U
d ~ ~

~N N N ~M N N N a N N N
C f0 O ~ O ~
N

C C C C C C C C d C ~ C
07 N C p~ N r d ~. N CO
d Q' L r Y ~ 0 _ ~ ~ N ~
10 ~ 00 Z M
0 W O d .

U .. Y .. O O O O O O O
O . O . ~ O ~ O7 O O ~ ~
C a0 41 ~

N 0. d9'n N-N acMnO~- de dNJ d~YdM d O
m c O
O

.

> p p p O O O O ~ O O O
C ~ d ~ N ~ O W N ~
N ~ J ~ O p ~ a Z ~o Z Z Z
~ n ~ X

Z Z Z Z Z Z Z . o~ ...
U cg v N o~ U r ~
eo U C~

aD N C ~ ~ ~ ~ylf ~ (00t0 O ~ ~ O <DV

f' M ~ < N N N NN N N N
y N N

N N N N N ~Y M N ~ ~ 7 M N h Mif Y ~ ~ N t0 N N N

N N N V M ~ ~N ~ .
..

M 01 ~ O v M O n ~ M

a0 t0P a0 N
0 O n O ~ ~ ~ ~ N NV ~ 0 0 O f t O NO O I'a0 O u7 W
0 O ~ t' a0 ~ON M_ ? fDP ~O O ~ ON N
M N t0 N ~

_ O O) N O O O ~ n n ~o ~O O O

p 01 1' a o> a~ u7 N00 O aO

a~ a0 f'a0O a0 a0N m1' o ~n ~n rao o~ o A ~ ~ N N NN N NN N M M

- r ~ N ~

.m N O . O . M
N C_O O aD 00 aD O tp M f0 f0 n f0 . t~p . ~ 01 O f~0 . (O
f~0 fDN N~~ t~0(~O fDNQ~ t~ON
N M r M N M N N N V n N O~
M O M _ 07 _ O V . O
. O M t0 O N t0 O_ fD r N ~
cD O f0 ~ r a0 f0 1f1 u7 t0 IL7 t0 N
~ n ~! ~° ~ ~ ~ ~ ~ N ~° ~ coo N If7 f0 C N ~p N N N ~- N N M
(O O . m . O fD
(O M O 01 N 07 O r- Of 10 M O M
N O M Iff ? O M ~ O O V a0 O O
O tD . t0 tD fD M W t!7 Of tD O_ tD f0 ? If) N N V ~O ~ ~ N ?
(O tD a0 . _ fD N ~ f0 fD . aO t0 N N M c0 n N M N N N N O ~ N N
a0 07 O - O . O _ O O ~7 O Of M O N M n O V Of f0 f0 fD C7 O N7 aD O ~D a0 W u7 O O O t0 M ~f O t0 O
~c cc <c co r so so so so o so In so co a> c~ r o ~o ~t ~ N ~ N 'C ~f1 V ~f N ~t N ? 10 <
t0 fD _ N t0 . 10 ~ fD ~ 10 ~O ~O . t0 tD f0 N N N ~ N N fD N N n N N N N fD N t0 N r N N
n _ . o~ _ _ co o~ . u~ . ao f0 ~ ~ ~ 00 M M M O Cf Of O O~ M aD O N O 0D M Q) O7 n u7 M r M Of V
M O O M O a0 Of aD ~ O a0 ~- t0 a~ O O O O n f0 N a0 a0 O M aD a0 O O
f0 O O t0 ~ (O t0 O O O n O n O O f0 t0 tD 01 In f0 n cD O M t0 O O fD
? ~t W f7 N 10 et Y ~f V < M V ~f N ? ~ ~t ~ ?
(O ~ ~ f0 f0 ~ l0 OD f0 i0 N fD f0 GO f0 t0 f0 f0 t0 tD fG N cD t0 ~ tD aD cD
f0 N N N N N N N ~ N N N N N ~- N N N N N N N N N N (O N ~ N N
y ~ y ~ O
N t_11 N U_J l_1.1 lL
N C u' C lL 11 lL
N N N !n V7 In o N ~ p fn N tn N y C

0 9, = V a, V °' V U v ,a Z Z Z Z
a m ~ a 7 c ~ 7 t a~ r_~ ui m n o °' °° ~°
o ~ 0 0 a_~ a a C N C C
N y N N
f0 a n a N
C N C O C
.G1 L .d Y, .d o n o E o N
a->,~ a°' nm O N
c ~ N c E c o ~C ~ ~ !C C 'IV N
a U U V U U U H

- U O E
' ~ T ' r r ~ ~ ~ ~ i f0 M ~ ? 7 ~ N ~ 'p r O ~ C d ~° Z (p OD _d O O O 'C ~ d f0 . O p a0 O M fD O
r O N y M V f0 O N U O O ~ ~ [1J tD n V
m _ m ~' m ~ ~ E m E m ~d ~ ,n ~ Z ~ ~ ~ p ~ ~ N ~ n o ,~ o _ O o U ~N U ~ U o U a U ~c U ~ U '° ~ U U c ~ ~ a U ° U T
a o a a; a ~, a d n '° ~ '" a ~ ~ a °: a w a ' a ~
E -° E ~ E ~ E ~ E r E ~ E t,° Q E o °.' ~ ~ E y E
cc N ' N G7 'r N ~.. N N G7 _N L GI V O d Z N Qt ap D M O r t0 ~ N ~ y N O O !0 (O H ~ T N ~ n N
M ~ ao o m ao m M o~ n o~ E ~ m In a ~~ m .~ ca E o> >
r m a o N m ~ o c o~ yn O r v ° o U Q r ° cc ~
r E ~0 ~' fD > N c N aD a0 ' N tn N c ~ V N . C
°_~ 3 v D ~ ~ N N '~ ~ i~ N ~ Q a ~I V f'~ a d y 7 H N N N 'd ~or ~ ~w = ~o~ 'a> of m 'w p ~o~ N 'oi Z E U a ~oi d E E m~ W 'w m ~vi ~
Y ~ Y ~ Y O Y N Y L Y N Y O O Y Q m Y n ~ ~0 Y ~ Y a Y n C a C C C E C n C ~ C T C m Z C II C N C O C
m O f0 N d N ~ (4 N N m . N N - N ~ L N ~. O t0 T c0 m ~ m m ~ m .- m o m E m a~ m M u1 m ~' m a m m ~, C7 ~ O ~ O v C~ ~ C~ o O ~ O m ~ C7 c°n~ ~ C7 9 'm o C7 ~ = C7 ~ O
_ E~~ Et E o E~? E~i~ EN o Emu E'S9p' ESN Ep E_'o 'V) MQ '1/l > 'U1 ~ 'tA n nn O 'V1 ~ .N 7 ~ 'H a a 'N G1 ~ N a ~ 'N ~ ~H T
CCl C_n Cn C7. CG CG CEL CH2~NCrNCCn~C7 CL
N .O O ~~ L '~ ~~: ~ ~ pf ~~ N .~ u) U ~Ø. n ~ ~ ~ c~ d N ~ N "o., (O
O ~ O M O O O u7 O M O p N O N O f0 O O r ~ O
a'~ a~ oal°n5ao o a~ ao~, a~n o a~gOaaov °~a°mwa'~° a°o' r y ~ ~1 ~ N ~ ~ O U ~ Y ~ O .~~ ~ M N ~ M ~ 0 ~ M O ~ ~ O ~ ~ N ~ N
O O O O ~O O n a O M O O N O '~ P7 O O V O M W O O O d ~ O ~ J O O O O
Z N Z a U Z N, .o.. Z ~ U Z ~ Z Q Q Z a ~ Z -o~ ~ x z a E d Z ~01 1L Z a Z a .°..
t0 a0 O N ~ tp a0 O N ~t c0 m O N V tO
m cc r r r n n m m ao co co a~ o~ ai o>
N N N N N N N N N N N N N N N N N
M IA r W M u7 r O ~- M 10 n Of M 10 ~c so ~c so n n n r r ao ao 0o ao ~» o> o~ o>
N_ N_ N_ N_ N_ N_ N N N N N N N N N N N_ N M O n M O V
O 00 tD ~ a0 r r ~ ~ m O n O u~'1 f0 fp fD ap c0 O O r Q1 O r O N O !O M a0 r O ~ ~ (O Q_7 u7 aD u7 O ~O N O r h O a0 a0 M M 00 ~ M ~p N O N n O N OD N
aD (D a0 c0 aD t0 f0 tD o0 n O O O O O M N
O ? O) Of Q~ O~ O) f0 O O O ~ h O M ~ O
~ O n r n n ap n N CD ~ Of CD O CO
N M ~ h t0 r OD O O N M ~ 117 fD r OD
M M M M M M M ~ Y Y V V of W t N

u7 M QI p f0 f0 K7 v0 M
t0 M N
t0 O O
V ~
N

f0 t0 tp t0 ~f7 N N
M

N N O N N N
i0 ~

M O
fD

tD ~ ~ u7 O 'p ~D 407 t0 t~0 N ~ ~ (~O ~
M

t N N ~ N N N 0 ~ N

O O N N M ON ~ N aDu7~ N O~u7 p O O f0 t0 O O O Q~ O c0 O~ O O O a0 M OO~O O u'1 o M ~

ao ~a o ~c ~n a~so ~n co o~o <ah sow~ccc o o u~
M

t~0 ~ ~ ~ ~ t~0t~0 ~ f~0 (~O~O~ N ~ ~ ~t~0f~DO ~ ~
r N

( t t N N N N N NN N N N N N N N N NNN N D D
N M N N
' Q W ~ O O Q Q

L N W U W W
_L1 J

L _ N LL L LL O IL1y LL 1L
L LL L

_ y fn GI !/)y _ (n d C (/)In N !n (n fn ~

a 3 ~ g 3 5 g E ' g g 5 g U 'Q U n U ~ U U N ~ U U U U
d 7 7 ,a 7 v 7 7 o 7 7 >
~

2 E t ~ j N (D O N O h h O f0 ~ ~ O N O
Ol ~?M O
C

O
L c ~

L LL LL LL lL 1L
y d d 2~ a d a a a . a ~ h ~

c E c c c c c c 'm a~ ' 1 m 'm - 'm'm a 'm o 'E

t H d M

J
v v~ v~ oda a v U ~ c ~

c c N c c c c c ~ ' ' .~ a 'd =
~ ~ ' ' ' m d d a~ d d d d z o > ~jo M
0 ' 0 T o~ o o oa oU
a ~ a'aa a a m d o Z

c o o W o o c ~
"

' ' ' n S ~ c '~ c m m m 'c ' ~ E : v a .
'~
~

o o ~ 0 0 0 0 o m 0 ~ ~ ~

U U ~ U U U U U
Q iO v ~ ni ' -l , J J Q = J - O
p c0 Q ~ ' V
H

U~ o V Z,.. ~j ~ ~ ao ~ ' m c o H ' ~ o ~ v n v uJ ' ~ "
Z .

H ? = O M a' acoov m m c E H
Z ~ a 'n r ~ O ~H ' Q ~ D U

aN U DL " ~ ~ ~ E N ? H
c~a a~ V V ' , Lu ~ o a~ ~ w _ u1 cn tL ~ o I
I E z j Z ~ _c ~ E E E a ~ ~ O o - ~' N

, a~ a ~ . Q g , a> a~ a -a > E ... i. ~ E v> c ~ ?

, ~ d _d M N Of O ~ v C~ Z J O - H O d ' O
J d Q
w -o~

_ ~ =~N ~L OV O O~ U ODO IO ~V hd D

~ ?N O W Z Z m ' m N ~ o ~ ' h D v) ~ Z E h d ~
Z

~., U m a in in ,~ ~ N ~

~~ ~ ~~ ~ c ~ ~ ~~ ~ N ~ n f' ~ ~ ~N 0 p j y V in J V

~ ~

YO~ Y YO~~ YpN Y~'O Y Y Y Y Y~ Y'C-' Y Y Y
n ~ ~ O V N >' ' C G1 C C
U C C C C C C N C
> ~ O N ~

N t0 N ~ A N d N y O O ~ C) r p 'C t0 (C N f0 IV N f0 f0 t O Q O U ~ C N Vl m m m Q D m m m m m m m Ca m O
,f a -a, ~ O C 'O N Q~ M d ~ 'O
Q L Q = ~ C
~

c~ou~c~ c~~oyc~~a c~o~~ c~ c~ c~ c~ c~ ~Y c~ cs s ~ o ~ ~ o h a oc a ~ c .

E ~ E o E E ~ E E E E E E E E
Q ~ ~ Q E ~o A o a ~ ;~ N ~
~ ~ ' t/1 N O a S . N H H UJ tN 'fIlN N
' f0 N a N - ' N - ~ ~ Cp ' ~ ~ N O

-In Q C a a Q y C C ? Q ~ C C C
a E C C ~ C C O C d r M
C O ~ a ' C 9 C H

_ O Q a N N ~ _ C O N O
H ~ H ~ r ~ _ 4: M
~ V O ~ O 4: ~ H ~
O O Z O J

M O O N p O M ~ v . 4:
Z O -.. O N O O O O O ~ V p O
O ~ . g O ' V E a N O O . V
h .!~ O N N Z CO O O
= ~ O~
= H

d a : ' a _ a a a' a a d O
~ ~ a a > a ' "' ~j _ ~ c a N O > o ~ w d d d , , r. ~ N
~ . > ,, V

> > > ~ > U > > > > > j j ~ ~
~ ~ O rte"O c a~ ~' ~_ o o o U ~ = 0 > d O
~
t ~o Q ~o 'o "o ~i t a ~ 'o a a a N aa = aa a z z z z z z z z z z z z z z ~ > ~ , n ~ a c GO O N ~ 0 aDO N ? 0 a0O N V tpa0ON ~ p a0 f t f p O O O O O N N N N NMM M M M

N M M M M MM M M M M M M M M MMM M M M

h O M ~ hOf r M ~ h Q1 M u7hO7 M ~ h p 07 O O O

OO N N N NNM M M M
M M M M M M

N. v v ~ r v .. v r . . . M M M
. . ~..._.

M m 0 h u 'J t0Of N h D tDp h t0NhM O N
a t h ? O) f 0 f0O p p M h ~ O h O Ot0O p p o~
h ~ a t f M h M C O O pW h D W M O M M pOO ~ M 1(7 Q1 ( O N ( D MO a O W f7 t ~ ~ 0 f _O N ht07 p O Of ? N O p ON a l7 0 p h ~ p hUp p~ M
f 0 t 4'f n N N h O N M~ ~ M h ~DO O (OOaDO M h N
O O O O

O O N N W O ~ N ~ O r-OO0 D O
OD N N O f 0 GON M O h h ~-O ~ COct O p OD
a a0 ~D a W I

O O N M ~~ 0 h D OfO N M If70 h D Of < N ~ ~t 7 7 H7t W a r7O t0(D 0 ~f a u ~ n t ~O t0O 0 D t0 ~t c _ ui n ~ M
o v of o o M

f0 cD a0 N fD

Y N tD O
fD V V V a0 . V Y7 (O f0 O

N aD f0 M u') t0 N t0 N fD

OD N N a0~
M aD - O f0 t0 . . (D
M t0 ~
fD

O O ? fD t0 N
O M o0 V

(O h t0 I~ OD.
O) (D fD
(O V M
NoM0 00f~0~t~G

N N 0 4'f Of~f h O t~ N
N N N

a~ ~ N M M N
. ~

N f0 00 fD c0ap t0 ~D N N N f0 W u7 ~ ~ N
O r t0 N

~ ~ ~
~ ~

N N CJ N O Of ~ N

h N M O M W
V M M O . f07 ~ M M O
- N P O
~

O O 07 Y ~t aD h V t0 O M M 1~

tD O f0 O N O N N c0m t0 tD 47 tD

~ t~ ~ ~ ~ ~ M N N
~ ~ ~ M

N N N N (O f0 M 1~M
P N N M
N

_ N CD f0 tp~7 O W O N ~! t~ . M MO 1~Of O O
aD W M aD

? t0 _ O O~ f0 ~O ~- f0 O (O r- O tDt0 ~DN O
O N f~ 1~ f0 N O a0 O ~D ~f~ O e- (O ~O
N h O f0 N
t0 O
P M O
f tD ~(f h cp (~O ~ ~ f~D f~0f0 _ ~O f~D~ ~ (D
(~O O t0 O t~
tp t0 ~D

N N N N N N N N N N ~- N NN N N N N
N N N N
N

Q Q ~ Q Q Q Q

UJ U l l w l U
J L !J L l O l _ _ _ l _ _ L L l l L l L

N _ _ _ _ _ _ _ VI (n VJ N N fn N

o E o N m N N N m N

d O p. y U U UN U U U U

c o c E ' ~

C ~

N Q 7 N QL > > 7 7 C
~

O aD f~
O
d N O_ OD
C

GD ~ N 47 O O
O C
d 0 o m o 0 E

a a a o a u ~

_ C _ ... 'U
C C C C
d C

_ _ _ _ C
'f0 .N '(0 (C
C
(' O J

v~ adE vc_ c3 ~

C C N E
N ~ E C

_ _ _ C
~N C7 'N ~G1 Y
C C O

'o o a' o o c '~ d a c n" a n a..
c .

c~ c ' co cc n f0 o '(0 f0 N
, E
A C

W y N
'c ~ O c E
c c C N
"~ U U D
U

~ m o ~ U

O m o '~ Q ~ U
~

U gZ S Z U

_ , m Z ~ ~ ' . D
~ ~

I N N E N 7 C ~ Q ~ C
O m ~ V > co ~

U ~ n M ~ o . . , ? M
~

O O ~ M Z Q O O _p ~ ,f7 N f0 d' a O
'V
O

lJJ N I~ W d m d m V m ~ O
~ N E
~

x D ~ ~ O Q OD Q a N J 01 V O
m N N E N
~ ~

O ~ O ~ h-' U O U T ~ ~ O !A
Q' ~~ ~ U
O

Z O

~ 0 v H m c ~ ~ 7 ~ Q ' o ' U ~
~

.7 ~ ~ a ~
( _ o ~ ~ ,n ~ o . ~

w o ~ W ~ N ~ m c w n r oo U ~ M ~ o~ Z ~ ' n ~ N rn N
a E

~ ' E "~ N ~ r- o ,n w ca ~e N
H ~"> ~ a ~

O E N O. ~ o ' c a o ' ~
Z N u) n ~ > ' ao a~
v~ '~
Q
w c r C
m v M ~ Z N v o x~ ~ o ~
Z ~ ~ m N ~ ~ ~ 'a>
~

~ ' p ~d a ' _ ~ ~
~ ' '- ' ~ c~ oo oo or of c> o~ Q o~ or ow ~ N u~ ~ E a~ y Q
v) c ~C ~C JC Y d ~L Y Y O Y Y ~C ~C Y
Ur H W U O. Z N _ d ~
.

m m o ~ ~ ~ m A ~ m m m ~ m r ~ z v Q a H ~
v ~ d c U m c m m m m m _ m m m m C7 C9 a ~ ~ ~ m m ~ C7 7 7 C7 U~ U m ~ ~ 7 ~
Q U
~

~ fn ~ U T y C C C a C
LU ~ o N C L
~

E E c~ E E O E ' E L E E E E E
nm a ~ ~ ' m v L
m a E
v N y ~ 'H ~N ~N _ N 'N 'N ~N ~N 'N
Z N ~2 ~ Q ~N y d d ' U a H

W L N ~, CnZ CQ C~ Cd~'~ C~ _ CE C C~ CE GL
C
VN

tL 4: v ~ O ~ _ CD-.-. ~ N ~~ d d Of O ~ E C d L N N ~ ~ O
~ d I~ 0 N lL
N
~

O O O O O m O O O Q O O O .. O
00 m m ~ n L fD N . O
f- ~ p N O
V

a a ~ a a o a a a ~ ~ a a' a a d o ~ Z ~;,~ o ~ E 'C f0 ~ ? E a N o o O Q a ~ d p a O

7 > O > f- j j j a0 d 7 > > ~ o ~ O > ~ ~ ' O J N o M ~ d ~

poi~ oQ o0 oQOU pv .~ ~ pp p-to p~ ~ Q
oU r ' z z z z ~a Nz za z.r_ z z z z._ z mx.r , o~x O N V ~O o0 O N V ~O 4DO N V t0 aD

V ~ ~ ~ u7 ~ u7 M Ot0 t0t0 f0 (O

M M M M M M MM M M M M

W r M N h O M N r01 M O n M V V ~ ~ ~ ~ u7 V1 M~ O ~O O t0 M M_ M_ M_ _ M_ M_ M_ M_ M_M_ M_M_ M_ M_ ? M 1~ O a0 O t0 N ~O NaD 07O I~ 1~

tDf~ O f0 1~ 1~ Of u7 N ~~O tDW ~O
M O O ~O O N a0 a0 ~ W M a0 O

N M 1~ O M f0 !D V O M(D ~O1~ ~

01 W N O~ ~7 (O aD ~O t000 aph I~
fDN f~ ~O N 1~ O (O ~ NV N u7 (p O7~ 1~ f~ ~ O O t0 W OO W O O

1~O M 47 Of f~ 00 aD I~ NCO I~aD

O N M < ~ (O 1~ O OfO N M

r~ n r r t~ ~ r ~a7 aoao 00 M N . f0 (D
N O ~ N N N
N f~0 N ~t ~ N ~t O N n n 0D M
n O7 M i17 t0 10 n O Mt~Dt'~DO
M N N
N O ~ N r p n O
O M ~ In M n N
~t aD O N
N O ~ ~ p N O a0 M
O a0 N N N h ~ 1~
cD O ~ M Of N (O O n Of M
O V V ~f V' N 100 ~f t0 IN n ~ N N N N (D N N M
V t() O In O Of 1° M a0 n o7 IA c0 O N (O t0 In aN0 t0 n c'N~
O O) fD O t0 In tO f0 O f0 O O M O O M O O OI Ip N
10 u'7 M f0 m OI u7 In IA IA O tD ID fD f0 fD O In M u7 n a0 ~~ i~i~t~0~ cep ~~(~Ot~O ~ t~0 ~f0 tpD ~(~Of~OtO
N N N N M M N N N N N N N N N N N N N N N t(7 W_ W w W_ W
LL LL U. 1y 1y"
V) Lr' fn VI N N (IWII
O
' g 5 O N fp N
7 Y ~ N N ~ ~ Y 7 n n n ~ n , O N u~7 C O ° ID Of O E O r O ~ O O
T T
N d d N d ~U d = a a C_d C_~' CN C C
f0 L N n f0 I~p N N
E a E , E c~ E a~ E o ° N ° T O N O N O
.° O ~ C ~ N .O N ~ A
C Q C ~~ C N C ~ C ~°
O ~d y d ~ ~N O ~N V N
O T O d O ' O U O ~ O
O_ a O. N y d C y d 2 d O N
N N N ~ N N l' fU H O N L Ol C_ C C_ ... l0 C_ L C_ L C d O
N E N d d f0 O d f0 d !O N V
C N N O
L
o r o Y o o ~E L o r o a d U H U ~ !~ U Q a U d U ~ v Z O
m ad U~ o~ c -p O~ m m DUm Z o em.~ H ~ " r " Z O W Q E z Z ~ 1 ~ . m rn ~ z ~ a ~ ~_ ~ ~, m N ~o :E z (0.7 N O o Q O U m Uo d~ Ua~ Qpa om ool Z p U M~ d a m r ~ a H ~ m X N m Z uI o ~ ~ ~ a in ~ ? a o~
d c1 = N d ~' 'a a O " ~ ~ Q ° , O d ~O se p E o Q E >
ao ~ > Z o ~' c~ v w ' ' ~' ' y W n O z a a M ~ N H ~ E
N ~ ap N Q ~m = (n r L ~ O Z ~ ~ N N d N V M O
1u a U o ,~ In m U U o Z ~ Q = O a N v °o ~' m m '~ L ~ m ~ -~ o c m ~ Q Q U = °° ~ ~ L
°' c y w v d cn a n to ao °
f~ ~ a I f 1 O N f0 ~ ~ u1 c~ r W ~a~ W Q p a ~ cu a~ cr x ~c9 ~ m~ ->cn I-~ Q ~ Q u_ _ =E
C)r.. E J O)N O7n 0laQ d~ ~ QO~p a~ 01~ Ol- OC
Y ~ ° Y U a Y O Y d Y = Y m ~ Y ~ Y ~ W ~ Y (p Q W Y d Y Y
~ E ,n m ~' ~ m t m E m ~ ~ m Y a UJ m n c Ico m Z uJ uJ ~ Y Z m c ~ c ~ c m E ~ m o Z m N m ? m m ~ m 1~-n ~ N m Ir~ a m ~ Z tn tn m n Y Z m ~ m ~ m n C~ m C7 ~ C9 C9 y C7 N U ~, Q C9 < > c C9 m O C7 n O C7 o C7 v C7 E~ia o E°~'w E ~ E m Egw Eano~Q E~~ E~~~~ ENU~ E ,~, ~ m E
'N ~ ~ N a ~ ~N T N a 'N ~ a 'N a O. H H fa-- N a IL (n V) N ~ W1I H ~ 'N 'U
'N V:
C d ~ C N ~ C U C ~ C ~ /- C N a ~ ~ ~ Q ,a ~ ~ Z Z .a H ~ O .a C ,Q N ,a C
.. .. .r ~. ~. V m °° N °'~d °~ °~ °'~g °
°z~ °~r °~~Hh- °°0a °°~I
a N o a al p a M a ~ a p a c" u1 m a o o a 1r, O p p d N a m a In a a n c N ~.i c ~ o ~° a m U o N ~ a o ~ ~ o o D ~ ~ o M 2 O o ~ o ° o ~
zaNZ'o~lr~ zaz a zaQZ °laa z'v~_.z'cIQQQ z'olaa z~~ z.?z~
O N ~ t0 aD O N ~ t0 a0 O N
n n r ~ ~ ~ aN0 aD ap a~ O7 O Qf Of Of O O

M M M M M M M M M M M M M M M
tD n n r r n0 pp M In n O M ~ n O
.M.. ~ ~ ~ ~ M v O OD OD a0 Of 01 O O O O
M ~ ~. 'M.. ..M.. ~. ~ ~ .M..
N O ~- N Iff v N O n O 01 01 In IA Ifl 07 ~
N N st N n N ~ a0 ID fD M N
c0 M tD 07 N m O M O M In ID (p n ~ O
O O 10 < aD (O u7 M O of aD u7 a0 M O M IA
10 n a0 t0 M W Of M 10 O ? tD O~
10 O M O O M O In O N aD ~ p1 O O ~ N O tD
N a0 ap N t0 m a0 ~ r N r Cf ' ~ ~ ~ ~ a1°0 aD aO aD a0 c0 ~ ~ N M V In t0 n a0 Of O
Of QJ O °~ O Of W O O O
N N

N fs pp (p a0 aD O
~

V
C7 ~ ~ N
t0 ~
M
f0 O) N N N (O
n CD N

' O O
M

u f0 (~p O~ VN
N

O ~~ NN
ON~ t N N
N

(~7 n O fD

V

01 O tD c0 (O M ~t h fO t0 N O O ~ ~
~ 00 f~ ~O
N O7 a0 10 O O NN
NNN t~00D t~n V
t~O~
~

p N f W M
~ ~ O
~ N
N
N

c'~ 01 n u7 N O th n c0 Of N ~ n O1 O) O O~
M N O
t0 f0 f~

O 01 O fO f0 (O n 47 fD

N ~ ~ N f0 V
Cl V ?
f~1 ~

~f1 N N N cD N
N N N cM'7 O~ N

O ~ O O ~tf0 ~t'fu'7 K) a0a0 ~ ~ O O 00aD V V' OW f7 (O r O
r ~f7 O ap O O Ou7 OO O nO tD O N 'tO O~ O a0 u'7 O Q) O O
fD f'~

~c n o~o~ ~n co~ a~ rnu~ n co ~o ~cv u~ ~n so co ~n o~ o ~e o <o f~0 N f~Of~O~t0 t0~ t0 fD(O N t~O ~ tD~ f~D~~ ~ ~
1O t0 f0 10 (~O tD
~ t~O

f0 f t N N N N N
N N

LIJ WW I_L UJ~ N f7 W

LL lLlL lL - C_ N L lL
t_L

~ t ~~ !n N
"' ' T

g a gg g ~ ~ ~ ~ ~ g Z o ' ~ ZZ Z Q Z ~ , , ui ~ ...>> > N y ~ v E ~n c O O

O
p M T f M O

O
o ~
.E

n. a c, a a :?

c c m c c . c E .E .E .E
.o o n o v o 0 'O C

N N
C T C C
' L =
V ~

O N ~ d G1 E N

o ~ o o ~ U

n o a a y c C N C N N N
N U O
C

(p C
C C
~0 9 _m y ~ ~C
~p C
p V p C
~ a C

O t U Q U U
U U r ~ N

u y -N

~ a N c ~ Z ~
Z ~

o ~
Z N ' . W ' a o N (T) n ~ 7 O ~ H (. (D n n Q N ~ 5 L
~o M~ ~ . o ~. o w J ' N o p ' _ 111 d ~ O m Z ~ ~ n U t00 J O CJ d N 7 Q Q N N
a Q ~ ~

G ~ ~ 7 ~ ~ a ~ ~ 7 m W W N

Z ~ .n a ~ J ~ V (~ ~ E
,~ ~ " ~ o > o o ~ 9 Q Q ~ Q w a ~

Q Q ~ ~ O ' J Q ~ O Z ~ p M
J N v ~ O aO ~ ' O Q J y (n O ~ f~7 H ~ U H m N ~ W O n M
c0 (n - O
N
' L d O u1 t- v M v U J O n ~ H a ~ n p m a Q c~ ~ O m (n ~ ~ M r N ~ ~ O V'~ W O 00 fD
U T Z C Z Vl= O ~
=

- N N ~I d I O U C7I I r N t1 N ~ C ~ C W d O p a E .N
O

~ ~ N I ~

Y ~ ~C Y Y Y 7 [ W Y Y ~. JC Y Y Y
J ~ U Y ~ W O = Y ~ d ~ f0 lL ~L N Z_ M a Z

' m U m ~o m m o m -' _ m ~o m _ ecom m a ~ ~ "' ~ A ~ ~ m ' E
Z - w ~ O ~
w CD f >D m CD m D M m f~m m m m m G7 T , ~ p W V v 't l0 ~ E N
J m W ~ Z F-C H

"Y "~ "~~ =r 'M~g~ "~~
c~ o a'~' E E E Ea I ~>g ~ E E ' E
E Ea E > "' E

_ _ E _o_~da _v0__c _ E Er ~N N ~ l9~N ~ ~: a > ~ c a ~ ~ ~ a d ~ ~
~
~

H N Q N N N Vl N N U1 M t/!H
C . Q ~ ~ ~ a y a ~ d G
~ Z ~
Y a _ . - .C .fn NC_ C H C C C C C C C
E C ~ C N J a ~ N H m 2. N
Q E _ C7 ~ Z Q' ~ ' Lll U

_. .. r ~ ~ r m ~ N G7 ~7 r1 ~ N
W N . O O O) r U7 O ~ 0 O ~
. N a -_ ~ O N ~
f' ' a O J

O N O O O O O O ~ o = O O O O O O
Z ~p ~ E of O a is C m a C ~t n lL ~ O a0 O ~ 0 V1 lL E (n ~

a f~ C~ O N ~ N
n H d d a a a O d a d a a a a N ap ~ o = m d N N 3 ~ ,., ~ ; ~, o ~ m g H
<r ~

O O O >Y> C 0 O

NU~ ~a ~W ~ ~NZ ~N ~t-OOOaW N~ >~O jM j j D o T 0 0 0 ~ I ~ ~ m o o ~ o Z or p N Z :_ 0 (~ ' o o o o o o - F- = Z Z Z Z ' = C f~ -Z tn 'c ~ ' L
~

. .r ... of r a Z Z Z Z Z Z Z
m ~ a ~ rn o~ N o Q
U Q Z

'C 0 W O V f0O O N? 0 a 0 O N V 0 D O N
t a t t a O O O N _ N NN N N MC~ M( '~C ~- y t V ~ V f ~V ~Y ~ ~er V V ~ Y ? V ~~ ~ Y
~

M ~ O n 7 _M u7n O M O n 0 ~ ~ n 0 O O O O ~ NN N N '7M ' ~ c N ~ c f '1 '7 f v.. v.. ~...~.. ~ ~~ ~ ~.Q. ~ p ~ ~ ~ ~ ~ ~ v V _ ~O n D ~ '~'N Of O Of~ M O ~ O n N D
t f N t a V N D 0 MN tD0 O f~n D o 0 c0_ ~ n O n O
a t t f O O ~ nA NO OD Kf~ 7 c 0 N n D V W f7 f I 1( f o aD 7 O O ? O e0 ?N f O f'7n M p D Of n O ~ O ~ aD~ a0n f0 ~'7O f n n n a a M 07 0 a0 O V O O 0 ~

N c 0 0 O 47n NO Of O O _ p N ~ C N
c oN t ' O~ O) ) O nO OO O ON O V O Qi O O h O O f n n n ~ mN N0 0 aDp D a D ~ 0 n 0 N
a aa a c O ~ O OO O O ~N ~ V ~OD n D. ~ O
f f a p O O

N N N N NN NN N NN N N N N N N N N
N

p (O p O p u7 r ~O N f0 ? ? ~f ? ? 47 N N N N

N <

_ f00 tp O n tM0 ~I1 n N
~D

~ ~ ~

M O 1~N N ~ N N

N ~ W

M f) aD M ~O M a0 u7 O
O v V O O O tp ~ 10 O
f0 O O
aD M

N O O ~ O f~ O ap t0 ~f M ~ ~ ~ ~ ~ ~
~ ~

M N N f0 N N N N

Of 1~M t01~O O M O O O h N COf'p~
CD N

V O O O M tD O O O ~OaD
O) ~O01O t0 f0 O h O O t0 f~O_ tp ~ ~ N N ~ cD fD ~ ~O ~ ~ t0 ~
~

(O f ~D t cDa0 N N N ~ f N N N N O 0 N N 0 N
~ N N N N
N

47 f0 N O _ a0fD t0 O 07 f0u'7 O(O O a0 O7 LOO 1~1~
O O ~O~ eDOfOfO MO ~ t0 V
u7t0 M

O f0 OO aDMO N O W OO O M
f0 07~Of0 I~01f~O <O07 fDt0M O (Ot0M N Q1 c0 OftD O)t0 f0 O ~
fD h cp0 ~ ~~ N u0'7f0~ (~Ot0 ~ ~ t~0tD~ t~0t~D~ ~O t ~ ~
f~0 0 t~0 D ( D f0f0 c0t N N NN N M N N NN N N N NN NNf N N N NN N 0 N N N N
N

O ~ O 0 ~ O

l_L 111 U l l1J LL lL lL 1L l11 l11 lU liJN L
J 1J lJ

LL LL _ _ LL lL lL (t.LLy LL lL tL LLC _ tL U. lL

O

fn (n VI N (n In fnN ~ !n- (A C fn VI VIm fn 5 g 3 5 g 5 o g go g a U U U

Z Z Z Z Z Z Z ~ Z Z~ Z c t U

~

J 7 7 7 7 ~ 7 r ~ 7v 7 7 ~ 7v ~

p~> n c v M o ~

v o ~

O O O

N
LL
~
C

a a a ~
~o c c c o . .

E E E
~
o~

O O O
y~
C

9 ~ p C
~

C C C
~X C
C

a 0 o o d E
y a a a t c ui N N N
w C _ C
~ N C Y
(O
U

f0 ~p N ~j C C C
y y w U U U
7 ~ Z
H

U

m N

O n f0 n Q C D n J Z
Q ~

? n0 ID ~ j a p Q O) n > W
~ V U ~ 'o " ~D

o ~ N ~ p 1 L , V a n ~ U

U t Q O - ~ ~ O n0 (O
n D p m N d ~ ~ m = 2 m O
L O C Q H Q C Q
Q J N
Q
O

O CO N O ~ N Q
O '' U

N ? 'r O 0 ~ d O U ~ a'vc ~
p N m a r d N E Q Q ~ = r E .E E Q E
~ ~ w ~ ~
c U - ~ d N O Z N N N N
M a H ~ Gl N
-E p aD _ C ~ O In Q7 ~ O ' N 47I~
(D 1(0 N W O ~p ~ ' O N N
'P n ~ O N y O 00 N ~ N J

p O _ d Y7 (p Z J _ L f0M
~ H M a ~ p ~ M
C

O Ol u7 N O V LL ~ 0 C ~ O O
N ~ d GI Q. N Ø. C
y 1 .L..

N aOD p N ~ V = LLJ C E T
= T p j v ~ _ _ f I Z O N N fJ
I M 7 _ ~ _ W O) C7 07 ~ Ol'OOf O) ' Q Ol CI OrOl N ~. '~ ~ y Ct O N O
~ U
~

Y Y Y Y Y Y Y Y Y O ~ Y Y Y
p ~ a d f0 L N V O J Y U L
C C C Z p ~

- ~ ~ C C C C C C C C C C
~o m m m m m O ~ r ~O f0 .-a a O n m m m m ~
m v E

m m m m ~ m m m m m H U m ~ ~ y m ~ ~ ,~ ~ ~ m m ,~ ~ a ~

c~ U C7 C7 C7C7 C7 c7 C7 7 9 C.7 U ~
a ~ ~ c o 2 ~ Q 0 ~. ' n c m m E E E ~ ~

_ ~ eo E E E E E E E v E E E
t ~N U ~N ~ ~ ~ Q ~ m ~~ v ~
~ ~ ~ ~ ~
~

NJ O~ In Ul N N N N In N N UlN
Q O ~ O ~ [1J ~_ C O

Ca Cn C~ CE cac~ ~ C C Cy~~ C CLG
. . c H~ NH ~

..d. 4: d .0,. O _ _ _ N a _ ~
L M 7 L C d 'd N Q7 J y C d ~ ~ ~
= ~ ~

N . - -. ~ N
0 0 0 0 . . o o o o N o o o 0 0 0 0 z ~n m co u,m 0 'y a a a a a a a a a W a o a a a u ~ g ~ ; ~.~.,uy m '~
,' . u v~ ~

' _ c N c ~.
O a ~ ~ , Z ~

> ~ > > > . > > > Z F- j j j N ~ C O ~ > ~ ~ > O 4:N
d ! ~

z z z z z z z a z z z z z ~ ~ rn ~ E a r z 'o ~ w n ? E 'o ~ a ~ ~ ~ N a a ~ ~0 N V ~ ~ ~~ f 0 ON ?t0aD O N ~ fDm O N

11 ~ t D 0D h!~ rhn 47 0 O N0 O)W
a c V ~V V V Q Y <~ V C fD V~ ~YY ? ~ V Yf ~ V
~

M i0h7 M N P Q) M n ~ O M~I~ Of M ~P m 0 n I

v v vm um m nc cco n cor~ ~r~n n o ao 0oo o rn ~ ~ a ac v vv ~ v v v vv v y c vv vvv v v v vv _ v N O!OV h c01!7t0Oh t0~ A O

O f0N OfOfaOtDOO M a0 IsO O~ 1~ ~ Om ~ N
a0 a0Of~ M N N NN O O O~ t0O Nv 4'f M

_ ~
N M f~p N I~N aDMN InM O MO Nt~O t(1 ~ Op PN7D M N

tD v0WO ~ 1~h M N 4'fp M OV u7t0M M ~ of MV O f0 1 t 1 ( aD O ~OO t~aDM O0 O O N NOf 1~~e< tD
~ t M ~ ~
O

O M O)f O OfO ~O O O ~O Oa0 ~OfN O N Of n coO~ n cor w -N aDp 1~ aDh '-f~c0 N 0 a0 hD ~ 1~
~ a o a1 N M <O 0 h a0OfO N M V u'7t0 haDO O N Mt ~ ~O
~t ~

N N NN N N N N MM M M M MM MMM ~ ~ N N

N N NN N N N N NN N N N NN NNN N N N
N N

a ;

n tDsr _ a0 f0 _ A M ED O
ap 00 M O M N O 07 0D n0 t0 N
M

tD t0at O O~ N7 tD
n N ~ aD u7 O n c0 N
a0 v0 f0p O t0 t0 a~ O ~ ~ p (O ~
N

f0 0D
M N N OaD N t0 tp a ~ N NN NNN D

O O N ~ n n a0 O _ O 10 ~ t0 M O
O tD t0 - t0of OD O tn fD u7 N V N p t0 O
~ M M
r O O

c0 ~ ~f V N

tD
u7 t0 t0 fD

~ N M ~ N f ~ N N N
N N N

1L7 ~ O O N N N fD O In tf7 tfJ

t0 N O M O W O O a0 (D
f M W U7 t0 W O _ f0 fp (O Of 01 O
t0 N ~ ~ ? < ? tD N O
f0 N N f0 U7 ) ~ ~ ~ ~
V ~ Y

VI 10 tDN tD tD (O f0 t0 f0 _ M n N t0 N N N t0 f0 N
M N d0 f0 n0 N N N
N N N N
N

O . O7 _ . O ~ n t0 N t0f0 01~O N p cD
O tD ~ t!7 t0 .
f0 M
n a0 Of Qf ~ ~ M a0 O O aD~ (OO t0 O O
N tD M
it 4'f t0 (O p O O t0 O f0 t0t0 M <n i0 O ~fn V V ~V O n t0 N tptn f0 ~ t0 t0t0 ~ t0 ~O N N Y W ~
t0 p_ ~ <
N ~
V
t0 . tD t0 N (O N CD N N N NN N O t0 N
N f0 t0 N N N N
N N N N

a0 . t0 p . n W ~O ~ c0 M W O ~ ~NO n CD p ~ Of N _ t0 M Of O
tD t0 ~ M
n 4D
N
tD

O t0 O t0 a0 O O W O O O aDQ~O a0 O O 11~
~D t0 aD t0 t0 N
~ M M
(D

01 Q~ 0~p7O V cD t0 47 u7 tD tD fD f~0f~0f0 O o~f Oa~) N
f0 ~ O (~O~ p ~ ~ ~ ~ ~~~ f0 n O
t~0 aD ~ n tD ~
t0 ~ f0 ONIOrt~O ~
~
~
~~
p ~

f t t t c t0c f N M N N ~fl N N Of 0 N 0 0 NN0 N Ot OfO
N N D N N N N O( N
N N Ot N
N N O
N N N
N N N
N

O O O ~~ O O

U_Jl_l.l L_JJL_IJ U_J L_Ll_11W l lLl1 LL LL LL lLlL Li_ l1 N

N (OIn y V) V) N ~ (n cfO(n V)V) N

N r g g ~ g g ~ w ~ ~gg 5 g U U ~? U U n ~ U ,UU U U a' ~

~

Y N > > t > > N 7 U>> > > d f0 o v o n n o E

a a a a >' ~

c c N c c ~E . 'v c . .
.

E E ~ E .m N .

a~ ~ t E
E

O O '~ O O
N - a ~
a a ~ ~ o m c c m c c ~ ' ~ c ' ' ~

a~ d b d y n y ._ o o Q o o n c a ~

$o ad n $o ~

N N E N N
~ O p ~

C C T C C
p '1C ! O
'c9N 'tp .cC
T C
N

c c ~ c c o d H

U U U L U
?
U

d n .
~

o O

_ J (O U O N N

~ . Q oo Q . . ~ E
o m Q ~ M U ' Q ~ N t c U $
Z $ E c . ~ U U .

c" o wC~ M J m m v 'c N o a _ _ VI N ~ O _ m Q ~ O ~ m E N
~ ~ _ Q a~ " N

in a ~ V r ~ 0 ~ u1 U ~ U c ~ ~
d r U U O T ~ E y V

. Q oo o0 J ~ .

E a E = a y a ~ E = E c m a o m Z w in ~ ~ o ~ m C ~

N ' ~ G) ' C = ' N N _ ~
7 WJ N O U 7 O Z d ~ tU N
O ~ ~ (n ~ Z N
d' O ~ O
O

f0 (O O tD a 0 ?
O <V O

O ~ U N u1 U O to C~ ~ ~' N n d F- ~ ~ U p ,~ o M O N M m j lL m V N ~ n ?
= ~ Z O N Q O

~ C lL ~ t . n Q m ~

c ~ I - U ~ ~ a~ cn ry Z ~ ~
a a .u = ~' c~ tn S
~

'oi . o~ c> ~ c~ I O Q o~ 2 o~ O uJ _ . ' ~ a U x . ~ O n c~
. ' Y Y Y Y Y Y Y ~_ Y Y Y 3 V Y
~ v ~ ~ Y U f' ~ O
~ O

C C C C C C C C ~ _ C C ~ %~ C
~ Q a ~. C J O Z C 7 ~ O.
N H Z ~. O ~' J
O H tn N m m W N W t0 N f0 m N y0 CD 11 m TI m . ~ 7 ~ U = .C n LL
~ ~ O Q ~ m m llJ m l L O X r ~

7 7 ~ ' ~ ~ ' 0 - _ a ~ o U n ! O x ~G -~

C C C - U C7 C~ U ~ 7 U C 7 d C7 ~ f C7 N 7 N C~ N t 0 N o o E v E o EMZ d Evm'N~ o w ' o E~ .M Ev ' ~ E . ~ E . E M Q E t . u~ t E
' . A O . . n ~~E- ' . V a ' E
lL ' N N
m N N N N N N LL H fn H fn v1 a 7 ~ f N O ~ Q V1 Y
d ~

N C C C C C C N C C C y C
Z Y d ~ O Q U N L a ~ C ~ Y
N ~ Z J ~ ~
~

' ? ? d ? ~ ; 3 0~ : :? a.' ~ d to v o .p ao v ~' J Z to H m ~ Q n Q F- w w a ' Z

0 o o o o _ o o M o o o a o n n n ao o n ~ o~ t N n = v E ~ t" f- ~ d ~oZ ~
~U ~ ~
O Z
~

am a d dNQ d a a d~ ~ n d d O n , a c c ul > > _ > _ > > > ~ , ~ ~ ~ r? ~
~i ~ > > n ticU Z o N Z o H ' a Q ~
~

d _ E ~
~

Z Z Z Z Z Z Z ~ Z Z Z N a Z
N 'oo a a .ou ~ .ciZ .rn a 'o~ w oW a m U Y t= Q

~ iD aDO N ~ D a0 O N ~ t p aDDN V D aD
c t Q1 Of O~O O O O O NN N N N

Q ? ~ N t0 47 0 n0 p O ~O i 0 ~10t0 ~O0 t ~ t t~ ~ n W M 0 n p r M t t'1nO M 0 n t t O O t7JOf O O O O _ N N N N
O

~. ~.n ~ ~ ~0..yr O O v O _4~ v vOO uy .

N M t0O Of O V t 0 D N NnM n 0 ( f W 1 cp 0 < D W O N N u '7 a0 t7Mt0 ~ N
o a ~

O tDr V n ~ M N V _~t0 M CO
M 0 t W Of n M n D D (r 01 OW1f7 O 0 O
a ~ a a p t n 0 t0tn M ~ N n N tD 1 0 naD aDf n 0 < O

tD ? n 0 M n V O M O N < WMN O M
t o o~ o w c~ ~ 0 0 0 0 o aio0 t o n n p n v n N c0 a 0 N N nNN a0D ap o o e n t0 n D 07O N M ~ 0 D n a 0 OfO N
t V P 0 t0 0 7 t f O t 0 v0t0tD M 0 ~f t t u t lW u' t0 t N N N N N N N N N N ! N NNN N N
N N

O N
~ CD

_ _ 01 N t0 f0 f0 Of f0 a~ m ~ ~ fD O O
N M r tp .p ~ N N
NN~~NN~~~

~m I
N
O N
m N

t0 a0 M
O r <c cc m O f0 N tD
Wri o i o N n M
~o n a o~ ~ a ~
'o ~ ~ n ~ ~ n ~ '~ N ~ ~ ~

N N N ~ N N ~
t0 O ~ ~ M N

a~ N Of N h N N
O a0 N Y t0 M O) O7 O O M Q1 O) r t0 O N O~ < O ~D
~

M ~f V Of ~ aD t0 O f0 N t0 t0 M M 0 M < o~
~0 a~ ~c o ~ ~n o w ~ O N
r M in ~o r ~n ~
N N N
N
N
M M ~

~ N f0 Of I~ N
~ ~ (O N
M N
N N N ~ ~
O
O
N O ~ N

a N ~O
p Of M aD N M ~ f0 ~D N
O
N 10 Q~ N f0 O
a0 O O ~f N aO

t0 ~ ? Of et t0 t0 O1 O N a0 O
a0 W f~ 10 M 1~ ~O M M O ~O (O
M ~ 01 N 10 m f0 l0 f0 t p f~ ~ ~ ~ ? ~ N
O fD (D 10 'Q O aD
f0 N N < N 'C ~O
< N f0 f0 ? ~ t0 N

f0 f0 tD M u7 N N N ~D N
~O ~O N
M M N N OD

M
N ~ N N ~
N N

1 O0Df~NM 07aD ~0 Vh a0 O Oa0 WM O Y7 ~ a0 a0 O N O M M V
f~ a0 ~ ~ u7 a0 (D N ~ O fD ON a0OO O O a0 (OO O O tDO ~la0 u7 ~D O N M ~O aD 7O) O f0 fO N1n O O
Q~ DM O
0 ~f N

~f O ~ Of e- t0 te0~0~0f0t0(O O O t0 uc ~ e~~ ~~
1~ O f0 t0 (pO ~~ ~~~ ~ ~ ~ ~~ ~
M~ tD ~ ~
~
~
~
~
~

l~ ft tOt t0 t tNt u NN OON N N N Df N 0 NN OO N N
'l~t NN NO N N N~
ONf N N
Dt N
O~c O~~
N M (O N ~ N N

W WWUJ W W W UJ W_W

LLLLlLlL lL lL lL O lL LLl1 ~n~nv~cn N N cn cn E ~nN cn~n U UUU U U U U U U

~ o ~

c Z ZZZ Z ~, Z Z a Z~ Z Z

jL 7 >>> 7 N > > >C > >

N
N LL

J

_~ . ~ Q Q
~ Z
E V

' 'r' m O to -. . I
v -~

~ w ~ ~ i '~ p m , E ;
v a o o m c '~ o ~ a 'n c9 . p , ~

a L Q ~ o N a tn m o Z

H '; d a C7 N ~
E ~

v r ~ w ~' H

n Z O Q j ~
N

= a N = N O V
~ U

O ~ ~ m ~
>

O~ cn I !- N
~ ' Z o ~

n or d I r Z
~ d C~ C7 ~ C
~ Y J
~

Y ~ Y Y Y Y Y Z Y ~
CO C Z Y ~ O
7 ~ ~
.n ~ ~ ~ ~ ~ ~ ~
v ~ ~ ~ a p ~n ' LL
m 1n m m fD m CD O
= ~ m n ~ ,~ ~
~ Q ~ ~

C7 rn C7 C7 c9 C7 C~ C7 C7 C7 O M ", ~ ~ a>
- a a O ~

I E~ E E ENOUENa E EQ
' a ~

E EZ a at ~ ~' ~Hl ~ n ~ ~ ~ ~ ~ ~N c ' ~ ~N

H N N N N N C C C
C Y C C C ~ C d ~
~ ~ N O d Z
~ ~C ~

f~ 0 CD D_ ..d..( .0~. ..d. Ø.
0 1~ O Ø.N O
N Q N ~
Z

.. .. O O 4 O O O O
. . M N O O ~ ~ F-O O O ~ ~ O
<O t t tn O M f~ N ~ N N _ N (p a O d U Z a N
d a O a a d a pp O O M
(!J Q O

M 1~ N ~ m C Y
d N

_ > > > > > > ~' >
M O ~ C M N > N
L L V ~ a O

~ ~ =~ O O O O O
C =~ =h ~ ~
p N

O O O N Z Z Z ~
~ , Z Z ~ C~ Z
~ O

Z a Z Z Z .~ y> 07 O. 0l Or Of Cl ?
N ~

p NV tpapO N .-. t0 NO N ~ (Oa0 N ~ 10 In O <O

M MM MM~ ~ ~f V ~Y1 t0 47 t047 fD ~f7O
4747~O~O 47 10 I0 O t0 10 ~ ~

Oj M u7r01 ~ r01 c~ ~r M O

O 0 ~ ~y 0 N u)W 01~O fD(O
O ~ 0 ~ M

r V~y ~ v .. .~ ~. . ~
KfN ~DOV " ~ t0 M . .~O "O ~.e-In 1~ N

1~N t0 ~t O ~D O V~ 1~ M ~ fvO a0 ON 4700~ c1t~ (D N O 1~ t~ ~ t0N

aDN O)10_ N 1~ O ~f~ 01 f0N i0O aD~

O CO~OONtD ~ V ~ NaD t~ 1~ f0O~ M~ Of_ M 4'fM OOM i0A aO u1h t0 O OfN ON ~ tD

N Of~ O)OV O t0 N ON ~D O N~O f0O m O

O 1~~ h(Da0 f~Of MED OD CD ~O K7CO ~ N

t0f~a0OfO N M ~10 t0 1~ c0Of O~ N M

O c0t01010n r r n rr n n rr ~W O ~D

N NN NNN N N N NN N N NN NN N N

? . N

tD O
t0 . r cc M v o ~ v cc o co m N
v m N N a0 O
t0 N W
. N

tD O (O (p (O
N 0 N r _ n N

f0 ( ~ O
m 0 N
~

O f0 W N W N
~O
N
O

~ ~

t 10 r O f c0 O
D~17m ~ ~ O
N O N
~

. t0 ~

~ ~ N t~0 N f0 N Of N c0 N N N
cp a0 N
r r _ ~p t0 O
aD r O 4f 01 M r M N
O
M

M O ~ O O ~t M a0 Of O
o0 Q~ (O c0 t0 f0 07 f0 tD
t0 N ~ ~ N N V
~ t ~O
O
N ~
N

. f0 N 0 N N r N N
. N ~O

N N
N
~

u7 ~ N O
. M O O1r M o0~ t0 Of r ~ c0 W N
t0 O Q~
. ~O
O O
~
Of t0 O t0~O~O 01 t0O O O f0 ? O O O
O ~ M
~
~

O f0 ~ ~ O f0 ~ ~ ~ ~ f0 N ~ f~0tp0 ~ ~ ~ ~

O N M N N N N N N N M h N N N
M N u7 N
~O
N

C

N

(C
. ~ ~

l 111p W l1JW W
L

_ _ l1 lLN <i O LLlL LL lL l1 n ~

y o c E ~

g 5 g g ~ g g g N m " ~ a z z a z z z z ~ z z ~

7 7 Q ~ U > > 7 L O m >

O O O aD

T

o E o o o ' l1 l L LL L L-' yj a a a a c ~

c ~ c c c '~' ' ~

E m o r Z. .

d v v v c is c c c o a o ~ o o o I of E

a~ n~ n~ n~

N O N N N
C C c C

L fO C ' ~
f0 ~ !Q
N N

, p Ud UO Um Ul ~ u M

~ , a w -- '-Z N
O O

O ( A (O W E O W M O

oo o ~

0 G ~

' a o ~O t H ~ M mo ~

n o _, tn c ~ m U ~ U ~ '~ H g ~ ~ U
T o ~ ~ N d o a ~ a ~ o ~ 7 m m a N a ~ V7 ~
m a E H E~ ~U c'-~a ~ a a E~
o E y mm ~ ' ~

~, v a m ~ (1J U ~ ~ I~
d ' m o~ ~ N N d O C r M O J N J 7 N c0 M o d w c O
~ ~

o ,a c o N o O a_o U ~ r a~
d M Z Y r _ o M

n 1 O ~ ~O ~ O ~~ ~ ~
7 C~ > c ~ n N~ _ ~ I N ~I a' ~ ~ ~
O n ~ C7 ' C c E
~

N OZ ~c OllJf0 C! O =N , .-' ~ E ~ ' : ~ 01 N

o~ o~ rn or (~ w ~ I o~ o~ of ~ .~ ~. m ~ Z ~ ~
m Y Y Y Y Y Y Y Y Y Y Y
= d a p O ~ > m U o E
V U U

c c c c c c c c c c c m ~ ~ d m ~. m > ~ ~ m m m m a m . m m m 'c - p m ~ c m m m m U ~ m m m ~ o T 0 m m a E
a m Z J ,~
.-:-.

C7 C7 C7 U~ C7 U~ C9 U~ C~ U~ C9 y O t U ~ E ,N .p o > N
~ ~ O ~

E '~ E E E E E E E _ ~ >'~ " '' v _~ ~ o c ~ ~
. a s ~ . ~ '~ E c~ m ~ u O ~ va l . ~
~ ~

~ N N N N . N N N N N N
~ 0 N ~ a a ~ G1 j N a = N
~

C N c C C C C C C C C C
111 y n N m H ~ j N n ~ Z - ~

L 4: ~ 0. .~ n v d ~:
O L 'C t0 %~ e0 t0 M
N lL N a O

O d O O p O .. O O O O O
c ~ ~ O t0 N N (p ~ ~ C N ~
~ ~

d N a d a a d d N. ~ N 0 O o ~ ' ' o O N d d O
N . ~ ~O ' Q ~f tp N d H M ~ N a0 ~ pi p L

o N ~ ~ O O > > 7 > > >
~ y ~ N O ~ ~ m m ~ ~ O d J W

~' ~ N ' z 'o z'o~ Q a ~ E = a ~

z z zw z z z > z z Z
E ~ o~ > u m N ~ O a0 O N ~ tD 0 O N ~ t0 f a ~c o r r r r coao m ao o o~ a~ a~ o~
m r ~ m n u n u~ ~ a m ~n o N
u~
u u u cii ~ of.- of ~ci n of of Sri <c ai~ n r r r ao ao ao o ao rn a~ a~
r r a uW D W oflW _n of~W W_ n u~ W n W
o ~

0 ~ ~ ~ O

( O N O M ~ O O r O O
0 a ~ N u'1O o0 '-ay 0 ~O M _ O N a0 N O M ~ 0 M O r N N O V r a t r O ~ f ? M tW O cp M < O M _ N ~ O 0 U r O r O O D ~ ~D t0 t O r O ~ O ~ 07 C1 O) r Of 0 m N O aD a0N O O O r r r aD
a e-N c0 a0 r ' ~ O r ~ ~ 0 O ~

a OaD a 0 N 0 Of ~ 0 ~ O) O N N
D a N N 00N 7 N N N N N f N N N N

. ao c ao N N
O
N N

_ O O) W G) m aD aD
~ V O O M O

~ cc ~a r~ r _ ~o o~

h M M N N N u'7 M u'7 tt t~ I~
O M M _ _ (p t0 1n t0 N

O O O 1~ c0 of M N
tt m M O f0 N
N h a0 N N O O aD ~O aD
M ~ N _ N t0 o ~
r _ _ o~ o o n n _ ao a~ ao _ ~n N O O 10 i~ 07 aO
~- fD M 0D ~ a0 (D
~O c0 - f0 N Of a0 ~
0 YI ~ ~ f0 _ v t N O N N N t0 N
N 1~ M V N N

~ N . _ M _ _ t0 f0 _ f0 0D

10 CO M t0 ~ M O N
O N O N ~O N fp N
tp f~ N ~ O ~ ~- t0 W fD h _ ~ f0 O O O O O CD O O ~O
u7 ~ aD ~f7 ~
f~ N
n r ~ ~
p ~
N ~ ~

0 h O a_0 tD tp <O N
t O
f O Of (O N N N a0 N OD V f~ N
n0 c0 ~

aD
_ t0 f0 _ a0 N
(O Of N _ _ f~
O O OD 1n O N a0 ~f7 f~ O O N M
h aD ~ O O _ _ fp c0 .
O _ _ ap f0 r~ O n v n M a> a~ so o o r o ~ a~ o o M
u~

rn N M v v a> m ~c o w ao a~ n N M ~ ao v Of N Q~ f0 f0 ~ O tD O
fD fD ~ h f0 t0 O O
a0 f0 ~
N N N N ~ N ~ N ~
~ ~ ~ ~ N

N aD 4'1 a0 Y7 N N N
N 07 N N M N N '-V N

_ O N N V _ u7 _ (D _ _ ~ O N f~OD OfN M OD O O O M N fDM
aD 01 OO CO O ~O f~ 00 O f0 h N CD ~
O O

a0 a0 W a0 fD t0 O aDO a0O ~O 1~ P M fDO O ~OO
07 N M M Of ~

u7 t0 1~ O tD ~sO~f~0(OO (Dt~0 1~ 07 O O1 1~tDcD ~l7tD
~O P h ~ ~ t~D t~D~ ~ (MDO f0 ~ f~0(~O
?~ f~ M M ~fMOt~Of~D
N~~Nt~Ol~~~tpO~t~OCM'IN

N N N N O N t0 N N N NN N N N N N N N NN
N N N N N aD N N N

l_JJ l l l_1J

L_L _ _ ~_L
U_.l L

_ r ~ ~ H

g O N g 5 d !Q N

U c a U U v c Z

L > > C N 7 (O

O

O M
O

O O

LL lL

a a c c . .

E o. E

o ~ o N

C = C
~ =

N N d o U o N

n ' n d ~

c c ' ~ ' ' m w m c C U C
O

U iN U
~

w N
H

N ~ U

Q o of O 2 W L m J ~D
. t ' U W c D
tv _v _~~?WO ~O ~~ ~ m ~ m _ ~ Q ~
Z c o ~

coW Z ~ c~ ~ C~ o~
c = m ~ ' v o 1 Z a ~ W

m 7 N L ' Z L a E j V 1 a~ L N
> Z Z
(n U

D U ~ O a ~ > 01 , N O
N Z 7 Q U !%) N
V

N
~

M E N Z O IA I U U M ~
~ Z U ~ .-. J V
' a O

O N O lL a C ~ r Y O ~
N O N - C O
~ ~ 7 N ~ = ~ ~ d O I ~ d ~ V Q ~ T d _ C W r ~ a N a Q

'ao C or~~ rn l of S ~rn ~vr Q C7 ~ m Q p N

~ Y Y
Z L p z E

m m m a o m m ~ao f- ~ N E
~

~ mm m a n 0 C7 y C7C7 ,n~ U U U C7 C7 C7 n IL o o !? ~ n c g ~ =

E c E E ~ , E E E E E
r ~ ~j E o L o d '~
~ a W a ~N U 'N'N n ~N ~N ~N 'N 'N 'N
a Z O Q a ~ a O j U ~ U

CC C_NCN~() C Cd C_ C_N~Cd ~
~ ' ~ ~ C_v1 d 'N N N ~ G) N d N 41 C7 ~' ~ N L N ~ a ~ J

0 0 o co o o o o o o ..,J J ~ n U ~n ' u.l a ~~, a a ~ a a a a a a d ~ N rc ~ " o ,~. t ? Z m c Z M J _ ~
, d p ~ N r d d d N d d N O N N M r N H
' ' O ' o o o -~ U 0 o o o o 'u~ 2 ~ n =m ~ L
o ~ c z z~z'm~~ z~"'->z'~az? z'o~~zQ z nH

a0 O N t0aD O ~ t a O N Yt0 O D

O O O ~ OO _ N _ _ _ N N NN

O t0f0O fDtD f0 _ f0 (D fDfDtD t0f0 t0 fD
r O r On 0! M vf7 h Ofr MO

Of 07O c~i OO O _ ~ N NN

K_7 ~_f_DO t_0t_D ~_D ~O (O c_0f_Df0 t_0t_0 c t p O

a0 O N _ ~? O _ ~(f cDtD01 f~a0 O~ Y M O OV N t0 O O M ~ ~O V!D

N M M cD apM O7 h W M t0f0 M
'M N Q~ N c0 N ~ ~tM O ~<O

O _ _ O 1_ _O N tD O V7Of elf N f~~OI~ ~f7m ~f N O ~f7O O O
A

N O M op OfO O h O O O O ~ OO
Of N ~ p1 t~N OD OO ~O c0 ODOO~ aDaD
' O7 ~ O N MV ~(f t0 f~ ap OfO ~ NM
-O O O O OO O O O O O
N M M M MM M M M M M M M MM

. N _ . iD
h m m M M O~ W h O m ~ n u' t0 ~O

_ f0 Of m O ~ M f0 O~ m V ? M
sf . Of fp~ m~ O O (O c0 ~(7 Of N t0 tD f~0 O f~0 m ~ . m O t~0 N tD m c0 N m Of N N N N N r- N N 4'f M N m ~ O N
m u'! 1~

M N V M O m f0 m (O
m ac ~ ri of ao mn ao o ccu~
so <o m n n v u N O m m O ~D O m N M
~ N ~ ? N M
~t . O M m m t~ 07 . m O m O m t0 1~ t0 m Y N
. Y N m ~
m ~O N ~ ~ N
'C ~1 m N N ~
N N tp m ~
N m M N
m O

_ . . . N O
N M N N N N N u7 N N N m M O O tD N
m ~ V

_ m ~ M
? O O ~

M m O N O m I~ M M 01 Off0 M 1~ m Op m ~ O~ O m f~ t0 O O
M O m V ~O N N
O vff M M
N

m O . A Of 1~ Q) O m N tDfD
fD O m m f~ fp fD e< N
N ? V ? 1~
N V N N 'C ~
~ tp M ~
N M

m O m tD m fD m . cD ~ ~
N m M m M

O N V N N N N ~ N If7N N (O
N M O N m N M
~ n m h M

N m f0 Q) m (O m O MN m 1~f h N O fh V 0 m O) N O tD O O m O 't O mO O m O O ~ 01 tD
m M M

M O~ f0 O) N O~ t0 O OO7 Of 1Dfp M O < m (O 1~ N u') V ~ N
t0 h N ? ~ ~D m m ~
t~0 ~ ~ ~ ~ ~
fD t~0 o m m V
O so V
m o so <o ~o m tD N N N N N O N N N N M
07 N m N N N
N f0 N N

Of f0 m Mit) m O op h W r m1~Mmm NO C~ O ~ I~
N r N ~ tp f0 (p Of m fD m m O N O 01O O !O m O ~- mm Omm O ~ _ fp m t0 M V' m M O~
M m M

N m M u7 mc0 O) f~ O m t(7 ~ ?m mNV V110N W m tD
O f~ ~1 ~(D t0 (D ~O n0 N ~~ ~l~Dt~0 ~ ~ 1~ ~
lp !O f0 m tD O ~ IA ~
tD tp N ~D <O fD
f0 ~ ~ ~ f0 t0 (OfD t N N m N NN N N N N N 10 NN NNN NN N N M 0 N N ~f7 N N N N
N N N N

~ ~ ~ W ~ ~

lW u W ~ 1J o 1J _J t C_ Ll L l ll Ll l U
LL L L L1 LL 1.

D __ _ _ __ __ _ Nt~ f~ N (~N NN

' N

gg g 5 gg eg g a o m m .
N

ZZ ~ A T ~ Z Z ZZ ZZ Z

V 7~ N , ~ 7 >
U

m N

N N .r M m O O d a a ~

c c _ o E

d v a E_ . N
.

d N v .. O E
. C
O t'.

d U d N C N d C N C N

.W Q .(C
O

_J~
O
~

O Q !

N V

d ~ C ~ ~ 7 m Z O - m U c m m J

D r v m Y

~ J ~ ~ ~ f0 ~ Q ~ ~
DN

a Q
n N Z m ~ ~ c m m N iy Q

O ~ ~ Q M m f~ I~ J
O

U ~ W M N Y
Z
d Q d C7 ~ c v ~ ~ m t1! j ~ j a Q
N p ? N

H o Q
' ' N

N U ~ a M o M ~p m m 0 7 r . a ~

J m o tO
M

N O ~ m Y fn O O N ~ LL
C ~ C -~ O O a V Lll ~ ~ d J

~ ~ Z c~ ~ n tn ~ ~ E v) Q
Q
~

r~ . - w . - ~ Q -O = v v a f-- -- U < d U a -ooH
- ~ - v a 'oo ' ao u~ ~ ' a~ (~ '~ 'oi 'o~ 'w o~~
~ j E H. ~ E ' ~'~
. Q U
U

Y Y Y Y ~.j Y Y J Y Y Y Y Y Y
O d O J y~ 7 ~ d (n IL ~ >

C N C C m C C (' C C C C C C
C Q V ~ ~p N Q T =
[yJ !n ~

N N m ON m N N ~ t0 N N t0 fCN
~ ~ m' J T C 7. E Q
y~ Q l1J m m m m H
~
g O O n r x ~
~ O , C7 C ~ ~ O O U C7 C~ U C7C7 ~ O ~; O ~ p Q m ' 111 UJ

E ~ E E E , E E E E E E
o v U W I >. d ~ H ~'~
E g Q ~
E ~
O
I-O

' _ 'N 1I! N 'N N 'N 'N ~N N 'N
Vl N ~ N ~ L N C ~ N X
~ H ~ Q ' X
U Z
Z

C C C C ~ C C C C 'd C C Q
'T d ~ N N LlJ ~ ~ C V ~ O
C ~ N O
N G

C N d r1 O _ _ ~ 'N _ 'N N _ a N1 Q N d D ~d N m 'N
a .e N M O N
~ ~' lL
O

O O O O O N O O M o o o o o o fn ~t ~p ~ ~ ' a ~ t o~
O N d =

a a a a o a d a a a a' a a o N " ~ a o - E ; '~
... z 0 0 a 0 ~

> ~ > >~Q i~ 0 >~ >NO > j j jg j.:~
c ~ 3 ~DD
d Z O 2' Z' Z Z' Z ZU Z Z Z _ , 7d 2' Z~ u ZZ
N

~ vW or= X o ~ c~ n a o~
C

aD O N~ t0 a p O N < mm ON~ c0aDO N ~ fD
N M M

M M ~ ~~ 10u)u7 1f710(O m fO fO
~o o soo ~n ~ ~

c o o ~nsomo~o o~o~o m cc o h W M N f s Of M mh m M Nt~m M

N N MM M M M
~~ ~

y o so~ cc ~ cc ~ ~ m_~ cvo ~
v N ~ t0 O ~O 1~ M hM ~I N 1~ p O N
a W P~ M ( p 1~ m m NoDO1~~p ON m m ~ m O O m M tD M O f~M mOfN Nm P m m m m r-m 0 1 1~ ~ m M? N~m MM P V m m V m N m mf~m1~~ ~f _ M 1 7i~Of m h O
f0 M m~ N 4'f ~ tD m1~1~ N m v O O
I~ N 07O I ~ M ~ ) O I

~ < m01 OO m W O M
m m 1~N m tD-01h 1~N1~ m~ m ~ op W Cf t01~ m O O N MY ~f01~ a0OfO N M

N N N NN NNN NN M M M M
M

M M MM M M M M MM MMM MM M M M M

O ~
~

aD O O < O V
N
~

N O
O 1~ M ~ t0 N u7 f0 N fOp f M N Of a0 1!f tD V O
aD O
M tD ~ N N O O

f~ _ 1~
M ID N ~ O ~ N M M
M

M ~O O O ~If f0 t0 t0 M
00 a0 a D
O . I~ O
O N 1 c0 a0 V ~O V

00 c0 _ O O
O ~ .
N aD
oD N 01 01 t0 aD tD
O f0 1~ ~O

ap aD ~ ~ ~ N ~ u7 OD O) N
N Of a0 f~ N N V aD
N N O M ~ M O

~ ~ ~
r r ~

M !D u O~ m 'f c0 O
t0 t0 ~ t0 O~ t0 aD
O

O o0 N N N O O N ~ ~ <O h ? ~ O V O M
O O 1l7 tD ~O I~ tD
t0 f0 O M

fD t0 N ~ O
N Y N < O t0 N N V ~

t0 N ~(f t0 f0 . f0 1~ c0 O
N N N a0 . ~ N N
N
N N
f~
m O M 10 N ~ ~ N O $ ~
~ O
~
~
~
M M O ~f7 tD O O f0 ~ N 10 O t0 P M M

O O f0 a0 M t0 O O N ~7 ~f O
~O 'Q ~ V M O ~ 0 O
a ~
m o 0 o o amn rn o ~c cc n pu c N ~ N ~ ~ f0 N M ~ ~ ~ N N ~

N N N N N N N
~
0 N ~O 1~ O ~ N ED
N N ~1 O ~ OfN ~ 1 M O u'fM M O M O
N ~ N M
M O~ O 4D Of 07 a0 O
~ N t0 Of ~ 0D h Q> h O O OO tD O O ~fJ aD ~ m 07O O O O O 01 O
a0 t0 O a1 ~1 M M aD ~na~ cc~c cco7 a o so c ~ n o o %

o~ o~ 00 > ~n o~ n c o ~ a~ V ? ~ ~ ~ _ 0 u7V o_ a~ s _c o c ~n ~ N M ~ ~ ~ CD < V
l0 f0 Y V

f 0 (O
(D a0 fD(Df0 O O t0 IC t~ u7 t0~O (ON ~O N
N N NN ~O ~D ~ a0 u7 f0 N N N N N
'- tD h N
N N N N N N 00 O N ~
N M ~ M N N tD

W N

N W _ f0 t0 ~ l _L

d o ~ a N N

~ ~ A g ~, o d U l :~ E

t ~ u t Z in Z O a 47 N ~ 7 . 3 N ~ L a f0 O d NC N N~
O
NC

_ O p O
O L
C

fC ~ C ~ lL
U m a a E a a m 'c T

c c .
C . . .
. V c C
N d !0 fC (0 fC
N L

a O C O O
G7 N ~
(O N
N

C C
C ~ a 'iJ
'V C C
C ~

N
~' Q ~ 7 N N
Q
J
O

J O Z ~ a C a~
a n v y o_ p A
~

car c_Y c_a EE
' ~

eo m = ~
~ m ~ a c ~

U U ~ U U
C7 F- C~
~

O N

(Q pj (Q
E o (~ O c E

='c n ~ ~ o ~ - a r E E

d ~ U U . ~ o ~
._ 3 o or ~ E o w ~cN o m n > N w t o 'm o> Z

~' '~"'ag~~' '~n Q~ ~a c ~

~' V v ~ O Z ~ U U
~ r " Z ~ o . u V _ o , u1 d j _~

a d ~ a p ~ W E E N E
o > H a ~ ~ m E 'H a r > > a v a> g a~
~ ~' ~ m c d _ _ y r o '''d ~ m ~ ~ ~
' ~ .~'a o O o~

W ~ d 1~I o c N U ~
N m o n GO ~ i~
O n O O' O C

N 7 ~ c ~ aov ~ r m v ~' U u=1 m .m o v N a ' cN.~N a ~ v V c E ' ' ' ~ ~
' 'c> 'a ~ ~ oia tL ~ w or w ? ~
u~ a~ u~ o ~ d d Y Y Y M O Y Y m H Y JC Y Y JC
~ t ~ C U p d C
W C C ~ N
' C
' m c C ~ ~ C C > J m s ma Q mE
N m mEZQ ma m ma m f-w Q
r m m m o o m cn H m m m m m d L o m M ~ ~ m ~
' w U o c7c9 ~ p O O c9 c9 C~
a ~ O ~ o, a ~
z E E E Q ~ E E E E
'o ~ ~ d o r r . . Z ' O . _ , .
.

c c c d ~ c c a V c c c c ~
H (~ O ~ ~ ~ n a O
~ ~ ~ ~

~ ao a? ,r ~ ~ ? o~ Z a'~ a: :~ r E ~ o~Z ~ ~ r t n m - N O o a N

0 o o r- o o o> 0 0 0 o Q
0 ~ ~ r_ d a a d ~ n ~ ~ ~ J
m d a a ~ a a ~ ~ ~ N -E o ~ ~ fD

~

O O O ~ C O O N m O G O C d 7 O m m ~ Z p C O ~
a ~ ' Q 1 Z Z Z Z Z
'o r N 'o~ r ~ ~ Q m Z 2 Z Z d U. U ~n ~ N. ci ~ Z
~ 7 0 ~ NN ~ 0 aN0a~0 o~DoOD 007 t c0 ~Ot0c0 ~Oa c0~D t0t0 ~D t0 t0 ~D

Is O) ~c'~~ 1~O> t~ ~ Is Of h m m aDap m Of r c0 (O fvt~1~ t ~ ~Ot0 cOtv tD tv f~t0 Dv c0 O)O)V M

1~c0 m O

O ~ VO M O ~

M ~ e-Of~ W I~ t0Np n7 M
N O O M ~ ~ 0 ~ 0 ~ ~ 0 0 1 C ~ 00 0 ~

m ~D Gr O ap aD N O 1 O

M M MM M M O ~ ~ ~ ~ ~ ~

f' M M MM M M ~ M ~

c, n M o v N O N
N

O ~ p M

O ~ N O

t0 c0 O
N N

N aMO a D
N

O O O t0 M N N
M

_ a0 t0 p~ aDOf f O ~ O
~f7 f0 ~ ~ (~D~ N
N

N N N N N

O) N N
O M 07 u7 O f0 O

O ~ ~ N O r ~

_ Y ( f O
N

N ~ ~ N N N O ~
N
N

(D N 1~O O tn ~ aD07Q1 N7 ODN <c0 CO fDW
r- O O O V N OD
O O
oD 1n f0 Of O NO O O tDO 07a0 aO cptO
O cDO O h tn c0 t0OfO tD i~t0 O M
W

Of~ c0 tAh (O (~D(O(D ~~ ~ ~ ~ ~ ~ ~t0 ~ ~ f0 f0 ~
N

fD f0 ~Dt ff f ( ~O

N N NN N N N
N

O

O l lLL11 O
L N

C _ _LLU _ L L
L t l11 L
L L

N N _ _fnw fn_ _H N
N tO fnfn p n p N "' S gg ' 3 5 g ' ' a ' ~ o' w m a Z

~ ~ r o Z ZZ ~ x z Z Z

7 c o~ a 7 ~7 ... 0 7 7 ~._. ~o a . .
c N O
~t0 v r o ' o 0 o o o c a a d a S

c c d C
~ ~
J

_ .E ~ .' ~ ~
c 0 0 0.
0 ,a v C C CCV
~

_ _ ~d O O N

O Of C
O p ' N

n d ~
ay acs c c c y ' .

o ~m x o o o d d U U U
~ ~ Z
o Z ar o ~

_. _ Q ~ d m ,n aw 7 "~ ~ ~ a t1 m ~
? >

Z
a~ , o tiJ a . ~ Z

U f' O

W r O O O W Z U O ~ ~ Z
U T in ~ E a ~ a Q

< o v U -y , c ~ o v o 0 _ _ ~ ~ aT ~ ~ ~ ~ ~ x W H N ~ ~c O
~ m N ~ ~ .
J

xw _a ~ N o> w z o a a z ~

I-. a o o r N o~
- n ~ V W H
~

cn ~ ~ ~ ~ ~ a _ O t0 J U
~ N ~ o g f- ~ V j Z
u O Z

_ _ 1~ t0 nff O F- ~ ~ ~ O O
> O llJ V N J

O N C . fn O p~ N nfl U
d' 01 ~ ~ ~ ~ -(0 O
' . T

I f N ~ I m ~ N M lL z ~ N 0 D ~ L ~ 01 I
C : ~ I : d ' .

~ o, ~ o~ o, w Q .~,~, ~ ~
~ oi c a = ~ .g ~

Y Y Y Y _ Y Y Y Y Y Y Y
Z p n Y Q' C~ O p r ~ O O a c c c c c c c c c c c c x '- m m a > > ~ ~ ~ x m m a '~ m O d i x Z
r ~ m ea uJ U
ui D a V

m o mM op s m m m m C~ ltJ ", Q
C~ m ~
J

- W C~ mZ m (D
C~ C7 C7 C7 . U' (~ (~ (~ (~ ~ to o~ ' V ~ m ~ N r ~
Z C7 Q > Q
Q

Z ~ = " U - y ( to ~ (~

E E E E E ~ ~n N ~ r- ~
~ ~ " o ~ ~ H E E ~ v cn M . d N ~ 7 ~ O Q
l1J ~ O ~ E
. a E
' m N
~

N N N , N N . C a _ _ ~ d d . a a~ C7 O V
. U ~ p N N
L

C C C C C CL C ad' O,W
d ~ d O a O ..d.Ø..O. T Ø.d 41 G) N
a w t f~ f0 h 4: H ' ~ N ' N H O ~
O x ~ ~
~

o o o 0 o o o o o o o u!
~n 0 ~ ao n a - o_ ~ o H ~ o N a'r~Q a~0p a Q N

>~ o~io=j a~UC7is >~ >Z~ >~W~ O=O
o ja Z Z Z a a ' ~ .O m ~ ~ ' o a N W
?

~ Z Z Z Z Z Z Z Z Z
ao aW c C~ oW ao n ~ C~ 0 O

W ~ 0 O O O O OO N V D o0ON ~ D p ( t a cn c 1 ~ n ~ n n n n n n~ N
~ c 0 c r I . r .

vi i ~ of ~ ri i nai-: ri uin of- of ui~
u r o~w o u 0 . r o~ ~ 0 a f f 0 OO _ _ f ( 0 v ~ v ~ C n v v ~ Cw r ~ v 01 N ~ O O h ~~ ~ ~ 0 0 0N K7 f7M
f 0 a ~

p ~ M a D O f~~0 l7 ~ < rO
O N N O D ( a n 1 O N

t 0D M O N ~ DV Of O M
O N O O O t 0 tV r ~ M O N9 ~ Ne 1 c _ c O O
O N W !! 0 O 0O O O O O Ou~ O v u t t f ?
O O ~ O O O OO O O h O OO M O N
( n O C O 0 0 0 7O O O M 0 Om n 0 0 u C a a A O O O N M ~N D ~ 0 QlO N M
C ~ O ~ f I c m < N Y7 O O 0 0 0f 0 0 M M M M M MM M f MM t M

M M M M M

aD aD N

'~ r 0 h O

~

1M c 1 01 O V1 c0 Of O~ ~~
O 00 _N
Of N a0 N
O~ O OI t0 O

h 4D 47 ~ c0 (O M
O O a0 N ? aD 1A N V f0 M
1~ M

u) 1~ V I~ aD M In OD f~ ~ ? V
O N O N 01 t0 M V7 1~ ~ O
M

N f0 M N h M M h ID ID V ID 10 N
a0 O> 1~ .- M 10 N
~D N
~

_ N M f0 ~ ~ 117 O N N 4D
N N fp O N K7 1~ M M 1~ N ~
M 1~ ~ O

aD N . N M t0 N N _ V7 N h ~ CD N M N (O DO a0 f0 t0 f0 O t0 . D 10 ~ aD u7 M ~W V O
IA 10 O l7 ~ ~
N Of c _ _ M 10 O n!W
~ 01 47 N O) i0 01 N '- O O
N N aD f0 P f0 M Y7 M V (D t0 C~ t0 cD I~ ID N ID 117 f~ t0 h f0 M
f0 ~ . N t0 f0 ~

I~ O Y O 10 tt OI CD V <r ~ ? ~ t0 M ~ a0 M GI 10 M N ~ h 'C Iff Q1 N E ~ M

f0 aD t0 _ t0 f0 t0 N
Of ID N 1t) ~ fD 4'7 10 N N N 1f7 r h N t0 f0 ~ N O 1~ N N aD
p0 O N aD N N M CD N If7 N 1~
10 N O M 0D ? O

10 N ~ ~ < M N aD cD f~ V
10 10 f~ aD ID O~
.

O N V ID ~ t0 10 t0 10 O t0 u'7 u7 O M
h t0 u7 aD tD
f0 f0 O O a0 0O t fD ID
O O

07 N M _ O O M M
N ~ N _ c f0 10 N
tD 10 N ID N of O a0 O V
~ t0 f0 h V t0 O
a O

(D 1~ . f0 O t~ O t0 M 0 ~ u7 N
N O ? N M ~ 0 ~ 00 N Of D t0 ~ N
~ N 00 Of N 10 00 IA f0 M
? O M M ~ U1 N 10 N t0 O 1~ O) aD a0 fp f0 N f N O) u7 t0 t0 N N N V
(D fD N 1f7 O N 117 N O N N 1~
V V 117 N h It7 f~ CO CO
N M

10 00 h ~ a0 N N O 10 ID - Y7 N c0 N Yl tD M
1!7 1~ ~ N h1~ I~ aD M 07 N O ? N f0 tDN
117 aD tf 4C O t0 O) t0 M M
ID N OW N O~

Ip N tD u7N N ~ ~ u7 O oO W O Of O O V
a0 hO M ~ t0 ~ 10 u7 O O~?
O 07 O ~ tD 10 u7 ID Of t0 M M 1~ N N fD O f0 IA t0 Of O
V t0 N 1 f0 tD

07 N N7 ~_ V ? ? ~ N
P7 M CO 10 N 11'J f0 N '? c ID V fD
Y N V ? N N N M N '? m (O 10 f0 t0 f0 O t0 Nf0 ID t0 O . . D N N N N
N O N M Of tn V In 0D N (O N N 10 N h N N N ap f0 h M M N I(7 f0 N N 1~ f~ N N N a0 c0 _ h f0 t0 01 ~ Of0D IA ~ ~ OfIA117 O f0 ~ h N O
M
aD

a0 1~ O 1_~O aD a_D aD fD M OO O O c0 O O ~ t0 O
O V a_0 a_0 O h N M 1 O M
O_f V V O ~ t0 t0 N aD N 10 0 N h Of 11~ ? N

f ON 01 M M M O O M 10Y7 O O u7 07O)1~ f~ O) V O O In O O O O 1~ M (D M
111 M O f~
O

p Q! u7 10< Of M M M u7 a0 V~f ~ V ~ ? V N V
t0 ? M u7 V W 117 10 N ~ fD 10tDV f0 117 V N ?
t In O
f0 f0 f0 M f0O tD W O Of c0 IA fD10 ID p N N N tD N N
t0 O t0 Nt0 c0 ID aD In u7 NN N 10 f0 N N N M O t0 N
N N N f0 117 N N N N 10 N
N N N N ~ M (O fD N
N

W W W_ W_ C tL <iL lL
t N _ tn N (/~tn fn a g g g ~ g U ~ U U ~ U

>. Z 1~ Z Z ,a Z

01 7 J ~ U

N N u7 O
N O r O C_ O O

u. ' u.

n. o a c a c o c E ~ E ~ E

o c o o a 'A a a c c c c c ' a~

'al o d E d m O U O O
N

a.~ r aw a E C

c c c n o ~ 0 0 o a a U ~ U Q U

w N Z O (p O n d C 7 N ~ a X M h OMy T

N _ n IO
M C

C Z N ~ O ~ O
S V O N

O V ~ d ~ N
E

j Q Qo E w E aI ~H
~ n l~
o, d ~ a~ ~ a~~ o a 1~

c O N O
O ~ ~
N

( D ~ O) ~ M O
p O ~ ~ ~ Q O
~

N N (n ~ N - tDO V a N O =

O O U ~ ~ ~ .p1~ O L
i0 ~ d E U
~

a ~ O n ~ ~ N lL C71v ~ .C
G1 C N C d N

r- ~ '~ ~ ~ - ~p '0l . a O O ~
... 'p p ~ N X ) ) C
L

y C y Y y Y Y Y Y Y
C d C ~ ~ n Q X C C Y
C C ~ C U C C O
UJ C ~C
Z
N

Q <i h m m N m 10 N N f0 tC
~ O d "' t O M 1~ C f0 m (j~ m V1 m m C L
h a a U' C~ C7 C9 C C9C7 U ~
o ~ : a~ '~ n c c a ,I > o n ~ o > U p1 _ ~ .
~

E g E a E E E E E E E o ~ n ~ ~ ~ ' n ~N ~ ~N C ~N ~N ~N ~N VlN Vl a O j a ~ O O
~ O

C J C N C C C C C C C E
N C d N N n n Q

LLI . . L W
~ . a o , .
C

O ~ O ~ O O O O O O O V
N 'a f O) N N
Q - p Z
C

a~ aM ar,~a aN _ a~aN a,Mnr c -'- a~w H

y ~ d ~ d _ o d d d d O
p O N ~ N O O
~ .O p ~
N
V

>~ >~ ~ >E >~ay 1 >'>~y >,~na >MU >NU

' ~ ~ a a a Q t ~ U ' z z z z z z z z z a o~ o~ N c>

O N~ ID0D O N ~ l000O N

M MM MM ~ V ~f ~ 'C~O N

n nn nn r r t~ r h h n r~

ci '~i Irin ai ' ri ui~:ai - ri N MM MM M V Y V ~ ~ 10 v ~ ~ r a0 cD Nh tD W r f0a0 ? M

t0 M1~ ID f0 W O f0f0a aD
O

N c0~ N01 O) 117 I~u7_ N O

O f~ hN O N M h O u7 O~
Nu7 OO~ O) Q1 N f0~fM O M

O a0M cDN O N O aDc0N 10 M

c0 10 07117 ap ~ O O~O~ O O
ao aoa~ ra~ ao rn ao r~n o~ ao ' 10 t0f~ a~01 O N M V 10 tp 1~
n IpIn n r n r 1. n h M M M M M

M MM MM M M M

N N

o~ r o~

pp ~ ~ N O f0 O N

N

O N f0 ~~ 01 00 1 r O N u7 ~O 0 00 f0 r N M C
_ aD D
c0 O~ c0 at f0 N N
Of c0 (WO M u7 N fD M N V
CD r O W M
V

M < V N M ? t0 CO O CO fD t0 r t0 CO
V V W CO f0 Of O O N N O
r fD
t0 fD

M N ~D N ~O fD N O N
~f V 07 tD M
N N

r ~O N O O M CO

Of N O 'C N M M
N N O) '~f V7 V O r N N O M cD _ i0 O t0 N CO N tD
~ 1f7 _ N
l0 r CO N O
O N Q r _ N N ~ N N ID N
M CO fD LO
O

M ~O ~O CD N M r tD
r r r O 01 r u7 N ~ r N O N M O N
tD V f0 N t0 M N V

O W ~O N 01 O O t0 N M LO t0 ~ U7 t0 fO N ~O N ~O
M ~O ? 01 N
CD N M N
N

N O

N N ~7 O ~ N N O CD O
N t0 CD f0 Of O
N O CD u7 r aD N N N CD
O

u7 r CO OI r r M O r N CO u7 tD M t0 O t0 O~ tD M

N 10 ~ N f0 f0 O N ~l O (O
M y1 t0 KI ~
M CO
~
~

~!7 O M ~ N O u7 O N t0 C~
r M N O) ~ ~ M r tO
f0 (O fD O
N N N N ~ M
O ~ N N
N

N N N (D V N N N CD O) N
N N t0 N V N r O
~O ~O ~

O N aD O~ Q1 01 of tD O <D O

c0Of ? VNN O N10 O N M ON CON MCOt0r M W N r O CO M O (O CO r N
CD r Ot0 O COOOf N OO ~O ~D CD OCD OO 01O N O CO CD O
07 CO O 07 <D f0 CD t0 u7 t0 r u7 Or f0 (DX11t0 N tDOf r O O_ f0V OCD Ip101f1O O_ r Q1 N? ~ V~Tr N V? ~ 1n r VV ?? Y~ ? r O N O ~O
V O) O N N 01 N ~ fO ~ N ? O V
~ < O f0 ~
f0 C
f ~Df0 tD (Ot0t0 f0 tDtD ~O _ CD <D(O tD~D t0tDt0t0 CD N t0 N fD N N f0 ~D M ~O
u7 (O

NN N NNN N NN N M ~ NN NN NN N N ~ N N N
N N N N N N N M N
M N

D O O O O O O D

l o lL l y l l l_L l_L LL

_ C lL _ C _ _ li Li LL
4 lL LL LL

. d N N ~ x IN N t~ f~
<O

g 5 g ~ g g g~ ~ a L ~ T N L V H
v Z~, ~ Z Z y Z p Z Z Z~, Z

N ~ > > a 7 L > > 7N ~ N

u7 c0 r N

o fD
p o ~E o 0 LL U. LL LL LL C
't a_ a a a a_ a ~ a C C C C C C C O
H N C

.N .(9 (C C7 .IC c0 .A n O O O

~ p ~
~

O O O Y O O O d ~ O ~ ~ ~E
p U

an ~ V_ ~y ~

N y O 'n . C .
H . . U
.

.C7 .01 d d G: G: N
L O C C .7 N

o o o o o o n E ~ 'E .,~ a ~

n n a n n a c a i, >, .~ m E
m N N N N N N N C
O N j O p y C C C C C C G =
E ~ ~ ~ ~ C ~
N ~ ~ ~A ~A ~
~A

(V l0 U N X O U
N ('J ~ C O 7 a C
N >~ ~E

o'mao ood a'~ oa 0 E

U U U U U U U ~
U a - Y- ii U ~

a c ~ o m a _ V ~

(D n ~ M r O C U

i ? M ' O N 'M f0 7 ' C7 .- V '- O
' V ~ ~n o c v f p . v , ' u 7 p ~ co o M ~ ~ L m r N Q
m N _ U V _ ~ O

O7 O H r Q H C N ~ O) >
C a ~

(O ~ d ~ O Y N
L U

m ~ ~ E n _ E j ~ j m a~ ~ n ~ m a c -~n D ~ n y ~ E d f0 ' ch a t0 ~D ~ O ~ M O ' CD N
> N O ' t0 O N j ~C N

O ~p M u7 r (D u7 N W N U
o lL E .-. ~D E cc u> r N v o a o o~
N

m v ~n O Q N
~ O O

E ~ N r (O ~ ~- r r U
N = ~ > = ~ N D a t7 C
~ ~> W

O f0 M O_ ~ N C_0 M ( 7 N M r ~ V N ~C N O =0 '- C C - C f~
C C

'w _ _ 'o~ ~o~ ~or 'oi ~c~ 'or~ ~or ~ o~ ~o~ U 'a~ ~ n ~5 a of ::

Y Y Y Y Y Y Y Y Y Y Y d C7 ~ ~ W O O y y C ~ C
'-' ~ E
C
~

a ~ n C1 l9 n L ~ O
C7 f0 CJ y n N N f0 O T

m m m m m O C O m O
V L ~ N ~ m m ~ N ~
.p O m m - O

(~ C7 U' U' C7 C7 C7 U' U'U' U N
~ 9 f0 ~ U a0 E ~ '~O~
a 10 E E E E E E E E E E E o ~ ,d" ~ a t ~ = ~ >'.Z
~ ~ ~ N

'N ~N N N 'N ~N N N N N C N
O O Y ~ Y T O ~
C n ~

c c c c c c c c c c p ~ ~ T n ~ v p d . . . .d . ~ .d N d C) L 4: d p d 7 O
E p C r ~ N
N

O O O O O O O O O O O C
4 ~ ~O d ~ < M a O
~ ~ N

a a a a a d a a a a a o L n v o " ' m o E
n C ~ O N N O E O L
E ' O

: ~ ~ > > > > o > ~ >
> N o o ~ ~'~' a~ ~'u~
d > a 0 o p o o o o O o o p :_ o m v r m ao ~ m v e~ a r c z z~ za z z~~ za zx za zaz~o>Hz E
a~ ~a <OCD O NVt0 CD ON ~ t0 CO O ?f0 COO N ~ tD

Nu7 tp fDfpfD cD rr r r r CON CDCO ~O O O O) rr r rrr r rr r r r rao rr rr r r r ' ' n ' Srin of ofai r~ of ri ui ~ of riSri nof ri ui ~ o u~um wncpco cc ccr r r r r aoao mao~ a~ rn r~ ~ r_~r_ C rC ~~. C r 'r, rr ~~ ~.r r v Mr r rrm n o>v r w a~v cc Mo v c r _ _ NM M NrN 47 rM M r r VN ~OM ~D N

G~ OMO N t0~ c0 M 01 OO OO <O N O N

tDM O O~O) ~ rM O <_OOM t0(D ~T01(Or O
~pNN MM fD ~ rr WO ON M M

OvCJ O rON M N(O O r M OKf rN N V '? N
o 00 0 ~oM u~ oo~ r r a> o~c o~M 0 0 0 O

apCO ap .-apaD QJ ~r ap r a0r rM ~a0N c0 f CD07 O NM y L1tO r CO W O NM VN ~Or CD

rr co aoaoeo a0 aoao ao ao ao a~as o~o~ Wo~o>a~ a MM M MMM M MM M M M MM MM MM M M M

a;
o~ o ~ o w c ~

. o~ ao O) i0 ~
O) N O t0 10 ~ CO h ~O f0 N CD N O 01 fD (O tD t0 . M tp h t0 N h N M h u7 1p N N N
N O t0 ? O W (O N

N O O vf1 N N V O fD O7 p f0 0) M N N

N O V 4D N m O 07 N M t~ N N
t0 M tD O O f0 t0 ~ Vf N u7 h N tD p M ~ m N N ~

N ~ N V N aD t0 fD u7 O M c0 h M N O t0 h t0 M
O t0 f0 tD M N

N N fD t0 M i0 N O ~f 10 1A (D
N In h ~ (p h N V N (D f0 N ~

07 M fD aD O7 N O O c0 t0 h u7 t0 h ~O h h O l0 O ~C M N N a0 f0 u7 ~O V N
N h f0 N ~ h O N O h N
00 N t0 f0 O t0 ~f M ~

7 _ f0 t0 N ~O h ~ aD
h a0 Of Of Of P7 Of N N h O~ N
h O M N O O t0 M of fD

N N m V fD tn M of _ O 10 ~
N M N O ~C) 0) ~O cD 00 t0 O
N t0 nff N O f0 ~ ~ O t(7 M f0 c0 M O u7 O ~

N M N t0 M N N h OW 9 aD tD N M
N Of N N O~ ~l7 M e<
~

Of M t0 u7 Y1 t t0 <O . O O
h fD aD t0 c0 N N V N _ V
h V M _ u7 N ~ c0 ? t0 N ~t (O h V M ~t N

h O u7 h N N (O M h cC ~D fD t0 t0 Of ~f1 t0 N tD N M
N ~f7 M a0 ap N M f0 0D
N O fD ~ N h 01 N o0 V N M
O M N
h M

N u7 a0 N O) . Of . . ~p r- O) U7 _ ~ N N ~O c0 N N fD
ap N O~ a O O O O M M t0 ~ ~ ~ O O
h c0 t0 G~ h ~O

0 _ _ ~ ~
~
h O
~

Y f0 t0 f0 f0~O
7 O t0 00 07 O O
t0 ~ t0 t 0 O f0 f0 10 f0 f0 u 7 ~ f ~l N ~ ~ N N N ~f7 V N ~f7 sf ? N
N ~ V V sf N ~ V N M tt N
f0 10 (O . f0 cD tp f0 f0 c0 fp t0 (p ~D
N ~ O N V N W V h N N 0D N N N N N h N O ~t 47 O7 N M O N N

07 O 1n h O N N M f0 f0 (O h 10 If1 h O
O

N M 07 h W O O> op op Oi p ~ O a0 O~M OrO07 h M N Of a0 1~ h N h M t0 N
M M O

O ~O CO O W et aD O M 00 f0 f0 N f0 O a0 c0O1n ~O t0 m N u7 u7 a0 M O aD O O ht0N
aD O h h t~7 f~ W Of M O h O h O O O N O O O m O f0 h t0 O O O
h V N N Q_~ N N M M '? WO ~ it C7 ~!7 srV
t0 ~ ~ O_W (7 f0 V N ~
a0 N ~O u'7 N O7 O ~ ~O O f0 ~
a0 t0 tD (O c0 u7 aD t0 N
c0 O

~Oa0 tDf0 N '- N N N f0 N N N N N f0 N N N N NNN
N ~ N N N N N M ~ N N N
r- t0 I W LlJJ

O _ O L_i_U.
N l1. LL

O fn N (n fnIn c C m fn ~ cn (ONy H g E g ~3~

= ,~ N U

C '~ Z T Z ZZ

Y U n 7 d ~ 7~L

O O Is _ O

O ~
N

a a a ~

C _ .
T C

C N C
.

~
O O O C N
p O O ~ O O p 'e d v v Q v E v ~ o c c m c ~ c .' .' ~ . E
'o .

_'. >. ?' O O ~ O O o T

O
n a L

E a~ - n v 0 _ C C N G E C
~ O
N

. .(O .C .N L .N
Y d O O y O v O
(~ t0 C

U U J U cn U
~ a ~e r J

.E
m ~ h l ~ N

07 m :=

7 h O ~

_ O
M N M N r N

M O ~ D
~

J C O f a U m '~

_ a ~
"

a a a m ,v c .. ~ ~ N

~ O O) h r f0 Of Z OD -O Q
v o Q ~;, ~ o ~
E

' ~ " ~ x i ~
~ d ~ o O
D N
d ~ Q . 'y ~- O ' Of ~p~.
c0 Y Y = .: Y ~G
C C J .: C C d Y Y
O h O t O O O f0 IN T Q

O ~O~ U~ U~ O
M
~

E E E E E
~ w H

c ~ ~ ~ m E
. . ' ' d o~ d C~ a c H
a Y N v c c c c N N H Z N d N
~
O

~ 0 O ~~ 00 Od a~n a~Q a d ac, w NL N

om o m ocD '~ >Q
= oa a ! r a Z
U ' N

Z Z o~ N Z Z a Z
oi o O O O ~ N ~t0 ~
O

h 0 O O m a m O O OWe-O O

O) 07 O O
m O
O

~ ~ ~ ~ O~
_ ~ m ~
M

O 01 10 0 n N10h ~ A n O 01 a fl W
r N ~ O N MOh ~ COQ~O
M hh O _ M ~ ~ O ~
~ 1 a0 ~

O f Os ~ ~ n Of O r p h 01 O O O ~ OO

O O O
M V V V i O V V<V
f V
V

- (O O N O 1~ ~ OD

< N O ~ O X17 - N M 1 M
N Uf CW f~ V ~ CO a (O t0 O f0 h ~

_ ~D fD
aOD
tD tD ~ ~ _ I~ . 1~ _ N ~ ~ .

tD M Of N N t0 O aD ~ N ~ ~ M
O ~ O~ V N N O
N
M

O O N N N N O
7 N u7 W M O ~ N O N
~ ( O W U7 cM ~

~ N M O O - ~J . _ ~ O O
01 M V f0 M N ~ o ~o ~ ~ ri ao ~c ao r w ~c m w M [a ~o a> o~ o _ O) ~ M O
N 0) if ~ N a0 N V h 1~
Of N M ~ N N
tp O
t0 c0 ~
O tD
t I

. t0 f0 _ N N ~ ~ ~ tp . _ D _ N
N a0 N N N ? t0 Il7 V
fD N a0 aD N M
t0 a0 ID t0 c0 f~ N
~ (D

f N
tD N O N N N M
? V
aD M N W (7 N M N N h O elf f0 01 ~ u~ ~

t M ~ O V ~ <O Y7 t0 t0 . ap 1 M P7 1~ N
O O W O a0 V t0 O M tD ~
fD lp Of ~

? O
N ~O ~ 1~ V O O f0 O

~ ~ ~ 07 V
M N N ~ M N

0 W f0 f0 1~ tD aD
p t0 v t0 _ u7 O O N f0 ~ O V V N M N ~
f0 O M f0 N V N (O t aD N
N t ~D ~O
N N f0 i~
f0 O

_ N - 4D N N N N
. O N
.
.
N O CO GO 1n N 1~ N N
O N f0 I~ M N N O

f0 ~O ~ O . . N . ~ O (p fD
OD M . O O . ~f7 O M O O f0 M V M u7 aD N M 1~ V 1~ ~
N V f~ O~ O t0 aD h 01 f0 t M V O tD f0 V M t O aD O O O ~
N t0 Q u7 N t N O) f0 Of 4'f V O 1~ O) (O t0 (D f0O~ t0 fD
V 1W f1 1n ED f0 1n Q O V V V f~ N
N N V
O N N V t0 ~ V f0 ~ 10 M r- N V N

. ~ f0 N t0 fD N ~O . ~p . c0 1~ (O f0fD
. tD _ H7 f0 ~ O N N 10 N N N V~ CO N N N N f0 1A N M ~ a0 ~fl N M N N

. aD aD f~ . . N t N I~ O
N . O~W~ . aD a0u7 Ofa0Of t0 O) Of Of N ~ O I~ 1~ aD r N M M O
W ~ O N N aD aD r <p 4D t0 N t0 O O ~f7 ~ ~OOO a0 O oDO aDOtD O c0 O
tD tD N P tD ~ ~ M N hOW O O V-c0 t0Qf1~ <O h O
aD O O
~ O~ a ~D f~
D W O O h O h 1~ O ~
a0 M m t0 M V

_ Y~V _ ~ ~ ~t VV ~ N V
Y f0 (O ~ h ~ 47 ~ 1n tfD~D V c0 tDt0 ~ t0~D ~t (O
i0 V < f0 V 00 t0 tD ~ <D M f0 f0 t0 f0 10 f0 ~ f0 t0 M f~ O 1n ~
~ t N M 1 M N N N N N N N NNN '- N N N N NN N N N
M N (O M N f0 N N N N

p p ~ p p p lL L N U IL lL
L J

l1 _ C _ l1 N N u' LL LL

fn N W cp tn m m tn 5 5 g ~,L L
N o ~ _ ,a U U

> > d v p ~ 7 va a ~. n N C

u7 O N OD
N 'gyp O T
~

m u E
a ~

aQ a . a a ;~
~

_ _ C C _ C
Z ~ C C
. - ~~ .
-.

p (V f0 f0 f0 7 '7 O

o o o 0 rte- E

.
-v a a a a d c_ c c c ~ ;~ ! r . . . .

~
O J
N

O O
O O d t0 47 ~
n~ n nc a N N N N
O O N C
C C C
C

L _ .O .~ .~ .O
N

o o d o "~' r o U
d U U U U
U t1 ~ H

c Z

r ~j Z

o ~ Z - ' O
~ O E ~ 0 n L Q H ~ o ~
o~ .n ~ 0 ~ ~o w d ~

c a~ Q Q c _ y y j c o Q C7 ~_ m =

U O d M N p U U
N U v a =

o O p. ~ Y
~ Z

E ~ Q Q ~ ~ E E o o ~j ~ ~ to ~

,U0 N ~
H-v Z Q N N ~ ~ N
v ~ o~ o X o N ~111Z O ~ 0~~2 _ ~
~Q

Zw=
.

a N a0 ~ a~~z~ N~' a~ W
~ J

- M N t ~ ~

~ N c i N O
O

as E or O D r orO O) O~ lY
~ ~ X d ~
n C H C C D C C C C C C
V ~ n O ~ ~
I Y ~
~

(0 O (0 (C O R N (O ~p ~p N ~ N N ~ d c0 V
111 N () .-.
W N

lI7 m m m m LI7 ID
' p f0 L ~ ~

c C7 C9 C7 U'- C7 C~ C9 U ~ o M ~ U' ca L co tL ~ . ~
~ ~

E o E~ oa E~ E E~O~ E o ~oz E m N ~ E

H ~ _ ~''~ ~~' _ ~~' _ 'n XZ ~o' ~' ~

X d ~ ~ Q O Y. CyU
c c c a c c c c c c Q E ul a r c , ,~ a m > ~ ~a~ ~~ a:a: ~ N yn L N O '~U L ~ Z
~ !o N a H

O.-. O O O~I~gJ p ~ NW
J Op a o ' ' ~t ~ O O O O
~ M~ d a a a a a a a o ao a, ~ ' ~
o r ~ ~ ~
c9 r ,~,>N=~ E >~HH ,'_'j >~ >~ >a ~
o >N 00 o=lillLo~ o o=111tH o~a oJ~ o Z ~ Z Z ~a~ Z Z Z Z Z Z
~ D 'p> c~~ci N Q 'c~
Y p ~ ~ ~
~

O NVt0 aD O N V iD0DO N ~ t0 N NNN N M M M M MV W f O OOm O m O m O mO O O O

Q) rMN 1~ O) M YirOf M N

NNN N N M M M MM

W~ ~ ~ ~ ~ O ~~

01 ~tND ~ ~ ~ 1~ MO N M tD

Y ft~ ~O ~ ~ r ~ Nf~~f~ N O~f OOQ ~

1~ __t0 O M N M u)~t0 N _ n!) OV1~ t0 u7 O ~ N M Of 1~ O

M ~lNO O ~ ~ MO N V tD

N OO N ~ O O ~ H7f~ u7 Of O~

O~ 00CD~ OD _ a0N O~M O7 f~ h O ~-NM W If t0h a0O1O N M

V ~_V V V ~ ~ V VQ
R
o ~ N
o ~ ' r~ a n rn u~ O ~ 0 co r co o ~
v cn t0 t~D fD (~ N N
t0 fD N
e<

N N N O
N N
~ ~

W O N p O~ u7 O~ O O cD
s< O

~IfO ~D N O V V
f0 Of f0 t~
it a O

~n o~ r se o so ~o N Y07r r r ~ N so se f~D ~n N
~ 1D D
~ N ~
N ~-t0 Of N N 00 N a0 t0 N N ~ N
N N ~

~ ~ 0 m ~

O 01 tD N 0 G~
M r V ~O~ 0 7 ~
r o M
~

u t t f f 7t00 0i 0 p OtD

aD C~ ~ ? < V N N
~ ~f ~J ?
V

tD t0 cD O ~O O
h r a0 10 t0 N N ~ O CD
N tD ~ N
N N r N
N

N O ~
O
N

r Off0 Of h a~ a M O ~ ~
O Df') N O m D f0 O O O
o ~n~o f0 a0 fD (' r r cc~ ~ .~
tD O O ~ f0 ~n O 1n r-r M t~ ap o~ o~ V
~a r ~c so o ~n o cc (D ~~ M fD ~ O f~ ~ N N r !D f0 f~O O N
fD ~ O

N NN C! N N a0 p N N N O N
~ N N N N N N t~7 N
N N u7 O 00 00 aMO~t~000C0~7(OONOOf<ONf0~~~ NOfo000 fO~ O W
N

Df o a~ ~n~o oam ~n u~oo~ a~ ~ ou~o o~o~ ~n ~ D
o o u~ o~ o~ o~
co r r r u~ a vv ~o c vhv ao m n w e v c~o v o ~ soso Wv u~ ~o0v 0 o <oso~ W o v u~ n v v o n o 0 0 v o 0 0 mn ~o o u~
o 0 0>m N N NN NC~ N NNN ~l7 N NNN N C7 N N o N
N N N f'7 M M
N N fh N
N

C

_N

O ~~ ~ ~ O~~ m 0 ~ O

lJJWW UJ lJJ LIJ~J~_J vp ~JW W

lL lLlL LL LL LLlLLL N LL1y Li m V) fnt/7N (n fn C !nV)fn I V)V) tn gg ~ ~ ~ a gig N g g g Z c UUU a U U U

2 7 ZZ ~ Z Z

N N > >> ~ 7 ~ ~ >>7 Q > > >

N t O

O

LL lL lOL
'G

a a a >

c c c L

_ E . E .E
c .3 m v a E

G C C
~ . V
.d .

N d O O O
O r.
O
N
'j N

N N
E m m c_ c c c E N
.

m . _ .m .N m m O m C C C
d d C
d _ UQ

UY U t~

Z

C C ? ~ C
fQ Z ~ n N ~ D

u' ~ ~ o x x ~ r ~ ~ ' ~ p o m L

O ~ ma ~ >
' ~

d c m p o Ma m c v n~
o r c ~

vc a r mm _ ~~ ZZ o ~cm cN ~ m ~c '~ o . D ~ m _ N
U

d m N ~ U 0 ~ o E ' inU ~
U c mp ~ '? E
c a ~ v) E o x Q ~ Q j E "r ~ ~ E w ~ D m 5 tn c Z

~C a G) ~ ~ J Q O1 U L a a ~ c N a ' N ' Y N Z a m E ~ N Q ~
OD O ' N O E
r 7 p W n ~ u7 Q i N ~ N O 7 O) fD ~ x lL p f7 L f O ~
m r M O)z ~

r O t0 (O W ~ J r N L r 0 N
' f~ L a E ~ p y a H

O ~ N O L ~ O ~ ~ ~o ~ ~
> a Q ,~o H a~
r N a _ ao N x N N N a ~ o r r ~ o r U N M ~ ~ E a~
.r c ~ c 'v - - - ) N~ W r>~, E .-n -c C M F~ ~ n N y c ~
d i = ~, m G a _ _ I O 01 m p1p~ p~
m a C
7 ~ ~

Y ~C ~C ~C Y Y Y ~ a - - D .~
r O m p ~ O Y - ' Q
m Q 4 N

C C C C C C C C C E C C C C
~ o O ~ n N U ~ ~ 7 O ~ a O
m c o O ' C U 0 -' ~ m m m m m m m m m m m m m m CU m m m > ~ C O m ~ D H N
m ~ N N m m Q m ~ Q N
' E a ~ a O p CM C9 C9 C9 N ~ C9N f C O m c~ C7 7 E ~ d Q C7 C9 C7 d m C7 o ? o 7 ~ c c 9 7 0 C H C d !' ~ ~, ~c c ~ ~ ~ 0 U ~ . ~

E E E E E E E E : E E E E E
a ' ~ ~ r rn ~ ~ E ~ A y o N r o ~N N -N ~N N ~N N N ~ N c ~ N N N
~ a v ~ ' d O ~ c ~N p V O
~ ~ ~1J X ~ ~N O ~ ~ L
~ ~ O
N U

c c c c c c c c c c c c c c d ~ 'c a c N n U ~ ~ c. E
Y D F- ~~ ~ '~
' ~
~

d d m a~ d d d d d a~ m a>~ a>
~ ~ ~n r L ~ N H m ~ ~ m c L
!~ J U ~ o N N L~

o o o o o 0 o O ~? N > y ~, c a~ m 0 0~ r o o o ~ ~
j j ~? a . ~ E
O Z ~

~G N U ~I ~ N U m ~c d a a a a a a ~ a ' a d r o o c, N o a = c a~ H a a ~ o N ~ " x o ~ ~ o d a, N
m ~ H d m m c Z d > > > > > ~ ' ' o ~ o d a~
~ a ~ _ v p .t O o ~ ~ O yn m O ~ > d J o - O O ~n C y O
O ~ O O O U ~ ~ O O
~ ~ N O O O N ~ J
V D N C
~

z z z z z z z z z z z z z z o~ Y 'm > '~ a 'o> ~o~ L a o~ E a ~
~ .- ~ Y a ~ a~ ~ ~
N

O NY 0D O N~D 0 O N~t00 O N
m nf ao c ota o a ~ ~
u~ u~c so0 ~

r rrr r o o a o o o mo 00 0 000 0 o mao0 o m o 0 a 0 r p7 f'~ nr O C~0 r O M~ r O f 7 0 v uI 1 1 I

v ~ nu~ o is~oo o c ~rr r r ~ o m o u s< c c a a o m_o mo o mmm p r aoaoaro ao m p o o a aa a a va~ a a c r O NN DN N Q7N~f 7 O C9 ~ON N 10 D r t tP C c r N 7 N~ Of0 O VrO f ~ O01f~7f tD f~ ~ Of u f t N O N

~7 ~ ON rN N!~h r ONODt O Qf p c p cM a ~

t00 7 f7 pf ~ ~DV 0 N DOM f _ t0 f 0 D
c t~0o O NNt aDQ)O ~
~r M r N O O ~ 7 O
O V O ~O 0 10u7r o ff OMr O aD ch ~ M
O O n eM N
O O ~
O

O O Ot0 O _ ~ O Of O 7 r m COD rD 0 N'-D ~ ~re-p r u N p O O0 0~ G N D
a O

f0a 0Q1 O NM ~ t0raDO O N
N r NN ~ l'~(h~ ~Pff'~) M
N C V
N

N f~ C 9 C ~f V ~ ~ VV V ~VV V ~VY ? V ~
Y V

?

_ r:

f0 ~
N

N

O
a Iv N M
n a N O7 _ N
M ~ O
N ?

aO N a0 ~f7 N t0 0 0 t0 O
a0 N N tD
f ~ M
a op tD
V

N N

~ M a0 00 N

M t0 O

~

O N N M (D
? O (O

t0 ~7 f0 O ~

tf ~ N
N ~ 07 fDN 07 O 07 N

~

~ ~ _ ' ~

1AO Of O O O N f O ~ 0 O u~7 ~~ 4 O

t ~ N07 t ~O t DO 0 DtD

ODe)'~ N ~ N N ~
~ N ~f N
O
N

u7N N N ~O ~ N
~ ~ M N M
~ O N
(O

MO7 c0a0 N u7 (DN ~ M ~ nf7 O 07 (D N
07 f0 oD O
~

mO f0O O V oDO~O O 4DO)O N OD O O
f0 O V ~
tD

(D~f7~ ~O f0 ~ Vt007t0 (Oc0O) ~ O 10 ~ O7 < u7 O

Q~ ~ ~ ~f N ~f~f ? ~~~ 0D N V t0 ~ f0 t tD~O~ tD tDf0fD u7 ~ (D ~
t 07 N M
t0 ~D
fD

~Ot0 tDD N (O NN N N NNN N N N N
NN N t0 N N M
N N
N

~

111 O N 111 WW W_ LL U C N IL lL __ l lt L
LL

w C7 O ~ (n (nN __ _ N NV) (n 5 5 gg 5 O O L N

N T T N '~ '~ ~

U U U UU , U
y Z m y o L Z Z ~ ZZ C C Z

d d > > >> ~C ~G ~ N

' ' ' ' O C

07u7 O. 07 M

o o o o o ~ a LLlL LL LL ~L
N p a d a a a ~a c c c 3 a c c V _ ~ ' ~

H c O
Y U

O O O O c ~ ' ' p O ~ ~ ~
N N m O m '~ tp c c c c c = m m d v ~NN d a ~N
N ~ Q v7 O

O O O O O
U N N C d n o. nt n'm n ~ ~ ~
U

O~~- Q E
'~

C c C C C

' c c0f0 N I0 f0 L ~' y ~ a LL A
' ' c 'c c c c c7E 0 N o ' U U v a U
C a n1~i a 7 a U

w _ d ~ E

of' ' ,~ ~ H N

c V
n ~_in ' ~ ri Z
c t7~ 111 ~ ' IL ~ N O
o ~ Q Ø.
.
' p ..<:,g r ~ m a0 ~"7 co w U Z
~ J ~ O

u7 o r cc o O M O ~C a a r ~ m ~ a d 7 Q Q ~ ~, ~ p Q ~ H ~ U
~' ~ p Q ~ v U

U ~ U d c o O u1 U M ~ Z ~ d ~ n ~ a ' y w p0 o ~ ~ ~ o W H
~ o U X ~ ~

E E z c Q a r E Q a a a o ~H m o a ' c a~ v m p v ...' n1 a~ c Q
o v7 y o ~

n ~ ~ O ~ W W ~ N U J
~ U ~ L O ~ 7 . M 01 J ~7 ~OUJ O t0 O Y J O Q' N y O ~ v a _7 7 u c~7a ~ O a ' V U e ~ ~ ~ ~ O
Y o ~ o n ~ d U
= Q c N ~ r W .r N I D v ~ a w r I
d ~ F E

'a 'aoc> QI 'oo 'orO U ~07 'rn ~ I = a o~ ~ ? ==~ m ~
a JL Y Y Y ~C ~GY U Y Y i' ~G Y
O ~ M ~ ~ ~ p1 V ~ O
c W
~

m ~ A ~ m A m N ~ m m m U ~
v ' a ~ ~ ' o ~ Q
~

m m m m m m C~ ~ m m m f~
O j N ~ ~ V W W C E O Q
O

t 9 9 C9 C7 C9C~ !? (~ C9 C~ C9 w Y C7 O' ~ ~
~

C~ C C ~ a7 a>v d m I
E ~ o E o E ~ _> E E
c~ E E o E 07 c7 E 9 z ~ a. Z E ~
a ~N ~N1/1'N ~ o ~ u N N N N
~ ~ a 'N IIlw u1 ~N
N

E = Y a O 7 O C d G
C~ C C C C C N !/J N C'~ C'7 C C
C CO. IL
QQ

N _ aU p L NU U ~ d Q
CI ~ ~ d ~ 0 d N
E N ~ 0 O Y O Y r O -. O . .. y~ O a0 O
p O O p ~ J .. .. O ~ ~
O aT O . O O ~ _ ~ a ~ O O Of H
r W E
W

a a ao a~a n a . a a a'"' amU
c%7 z a n ~ a Z~~ O

~ ~ m _ 077 M a , ~ <o ,7 J N c y c c~7 Q
01 U o Z Z

O O O O O N 0 O O Q ~ -~ -W
=Q m O ~ ~ O T ~
~

Z Z Z Z Z Z Z 'o~ Z Z Z Z '07 Z
d N 'o~ Q U tn Q N a 2 'or - a h- U ~ m H

ON ~ tp O O N~ffOc0 ONV (O ~O O N

WW O O W O OO O O N N
o~aO aDaD aD W 07O7W O7 O7OO O7 W Q7 01 Ofr M ~O ~ 07 rM uifv OfrM O ~ O7 opOf O O1 07 O7 OO O O O~ N
aDaD O ~ a~ aD 07~ ~7O_7 ofQfO7 c1 ~7 W_ W
o v 07~ a0O Q O Q7tD~pN N M ~ 07 O 00 OM aD M O~ 01N 07~D~ N u'f 07 ~O a0 f0 N (DN O O f0ON N M 00 f0 NO a04D O M~ O M OM ~ O ~

O M M tD M M(Ot0N ODtpM aD tD ? QO
~aO ? N t0 VN t0u') O~L7a0 O O N N
~

07W O O ~ O N W MO7W 07 O 07 O
.

~~ (DOD N 07 N~ ~OM ~-~~ ~ OO ~ O

u'7t0 ~ m 07 O N M ~ OfD~ a0 01 O
~7 OO V O ~O ~1 t0 10 V Q ? < v vc 7 v uWO~ v a v v v vvv o w o N ~
O) O
p N

t~0 ~ N

N N O M
r N

~
~

O N ~ 01 p N ~O

f ~ N O N
t0 aD ~t O t0 ~ N N N N

N O a0 r c0 Op O) O
N

N _ ~
~

01 t0 O N ~ Nat O N Wlf (D V a0 ~ (O
~ (~O D

~ ~? ~ Nt0 V <D a O t0 M ~O N
N N N N M
N N O ~
N O
h !D n O O t0 (OCO M M a f0 4'f t0 N D O
r t0 CO
t0 O ~D O f0 a0 VO g f007 tD
O M Ym7 f a0 M t0 D
~

~ O ~ ~' ~ N~ p ~ ~ (~O
~ ~ (~O 40'7 ~ ~

O N f N N N N N M N
t D N N N N
t N
O
N

N ~ ~
N ~

r v(7 ~fr ~ ~ p Ot0 aDO V MO ~OfD O)O
r at ~ M N
f0 a0 M

7 fM0O t0 r Of0 O O tM rO p f0fDD M t0O~
~ a Y ~O 0 V r f0 aD
t0 f0 V f t ~ f~c~0t~0 ~ ~ ~ t~0t0 ~t~CN~t~O~ (~Of~0~ f~0t~Dt~DfD
~ ~ ~Nf~O~ ~f~0 ~

N f pN N N N N N N NN NN (D NN N N NN
p N N ~O N K7 N N
N N
N

~ uJW
UJ W W L!J L W l_LW111 l_1Jl_11 IJ A

ty l1 l O lL _ L l_LL_LLL C L_LL_L L_Ll_L

L
L

N (n _ d N _ n fO fnN 47 NN d Nfn (~ N
f cn ~n~ ~ cn u~n o c cn cncn o cwn c E tncn <

5 gn o g 5 g ~ a g gg a g~ ~,o gg U U U~ N U U U L ~ U UU ,~ UU ~ ~ Z2 Z Z Z,_ ~ Z Z Z ~ m Z ZZ r Z2 > > >'cg > > > , > >> c> >> v E >>
H

~ ~ o o ~ v d ~

O O O
N C O

o ~ ~
d ~

a d d a o a~

c c c c n Z .

.E d .E .E E
c ri m of o?:o~ od V C
N C

C
C C C d U .N

C N N d .N d 7 O

o . o n o a v 'E

~ _ O n n . ~ N
N c c ~
E

c ~ c o 'm .
.

.
W "A"Nf0 V

c a c G o ' ~
E

U d U U U
U ~
v d w=Q ' p ~ a fn Z . , -Z uJ U ~ m n Z ~iv ~ m ' t m M a _ E E

m m p Z Q Q C ~ Q pp f0 M o Z a ~ m N ~ ' N

~ cn U U U U o E a o ~ ,~ N o 2 o Q

W IL V a a ~ a a rn p ttJ 1L 'in o ~

O Q O ~ ~ E E p E E C7 ~~ ~ Q
~ o ~ ~ E

~ O E d d d d = V , ' ~ ~ d ~ > I H d o ,n ' v or , ~ N
a ., ' y a 'n a Q v ' d O N. w r n > N ~ M c U o r a> tn a ~ ~ v U m o U ~ cn U N o v Z L 0 Z ca o' a U ~
m ~

~ d Z = ~ o o o O
~ ~ d = ~ m ~ o .

N N ~ ~ m _ N 111 aD n fl) ~ j N N ~ C
~

O n- c0 ' l ~

~ v Y Y

~ Y Y Y Y Y Y d C C C C
y O O N U p C ~ ~ U
U ' ~ ~
~

~ C C C C C C ( O (0 O O
L E O m O (0 yJ N C
d G O
f ] r J = f0 l0 l0 N 0 U C~ CD ~O O
~ Y m O m ~ m m a' ~ C
C m n O O T CY1 m = m O
.

p (~ O O C~ C7U C7 C7 C~ O O
(~ , E T ~ T ~ ~ ~ o~ ~ o ' ~ can ~ a o ~
~

~ E c E E E E E E E E E
w = E ~ V ~ ~ r ~ Z N
E v O = ~ Z n Z ~ a n ; ~N _ N ~ N N N .N ~N ~N N
' '~' ~N ~ a E ~ ' a z N ~

N C C C a C O C C C C C
a N ~ ~ N C V C d N N ~ T
C d ~ U ~ O -N Z

= ~ d N
~
~

Z p ~ ~ O O O O O O
Z O ~ ~ v0 O N W ~2 1~
Z O

O _ ~ a' W a n a d d a d a a d ~ ~"> ~ ' ~ M ~ -w Z O

a ~ a a a , . ~
N n M J Z O > > > > > > > > > > >
O ~ M N ~ '~o ~ ~ ~ ~ 'S
O O o tn O M ~ O O O O O " O O
~ O ~ O J == O O ' =~ ~ ~ -L

O O O O Z Z Z Z Z z m Z
Z Y' Z Z Z 'o~ N Q 'o~ a 'a z E
Z 'or ~ X a N n_ U a V a tn a U

V t0 oDO N V t0a0O N Yt0 aDO N Vt0a0O NV

N N NM M M M M ? ~ V~ itp O ~O ~ O pO
1 O Q)O~

O Of OfOf O O Q707W 01 01 OOf Of O)W 0 M h rO) M ~Or W Mp rQ~ M10r Of M

N W V~ ~ ~ 1 m W EW ~ ~ O)v ~ ~~ O) W v O
v a n o m ~ aor ~o aoM ~~ r MM soo~ m.-_ v0M M O N ~O ~f7 M01 c0~D ~O MaD~ N h ~ ' r ~f0 ~ Oh O O N ~ r M ?r Mt0 a0 O? r O VO
~ 01 N O N r ra0 M M ~JM O~

p Of ~fO fD O ~ON O M ~~ O~ ~ rM a W N~O
O D

r MO ~ ~ ~O~fWf1 01 UI u1< _t0_ M f0O
O r OO ON O)O)O O! O)M

r O NM O O N 01a0 aDN aDa0 ~ rh c0r ha0 r a00D N aD ~ r-~O t0 r a0OfO NM Y~O t0 raDO O N
o so so ~o <osor n rr rn r rn r ao aao o < v vv v ~rv v v ~ v v < v< a v v v ' ~
o o .~ .
M o~ a~ a~ n ~

O nONn O<N ON47 OO
a t O a0 t0 _ n O ~ N D f M O V _ 07 M f0 N ~
M n tO
M O fD n N tD N n 01 G1 ~
N O N O) n O ~
m O O
~
tD

N N N ~
~
O

N

O tD N i(7 In t CO fD 0 f0 W ~ f' ~ N N 7 O O) N V N
N N M M

O N

o0 M N N N M a0 Of c0 M N O
M M m N O tD t0 CO O~ N
t0 O
a0 aD

n n O O O M Of O n a0 O 10 n (O Of N

N W ~ N O V V Y 10 M
0 CO O ~ tp (O
cD O fD N (O
~ O ~ h N f N ~ t0 N V N ?
N N N N W N M
N M

N t0 . cD . t0 n t0 . f0 Of N N
Q~ c0 N N O M
M N
aO
~

(D ~ O aD a0 O O N
N N N
N

n O N M O N N O~ < N
(D M N aD O < aD N
V 47 M f0 V O n V M ~ aD u7 f0 N V
Y

O f0 O tD O t0 W ~ (O O
t0 O f0 t0 O
OO

O_~ ~ N N ~ ~ N ~ M
N N ~ N ~
~ 10 ~

N t0 t0 M N N M N N
t0 N N n N t0 M
N

O V' OfV DD(O O~O W Of Oa0_ N t0 ~ M Of O a0 V Of aD

O O) ~OO Ma0 M aD ~D OMa0 f0 O O O O
~- O f0 nl7 O M N M
t0 o o ~c ~n Mse ~o~o <on o> n ~n~ov a~ o~ o co 0 ~~ ~ M !D f0~~ n a~ so ~ ~ t0 n a 0 n N ~O 1107 W O O t0 f0 f0 ~ f~0 ~

N N f0fD O(7 N f0 N NNN M N N N N N
NN (N N N N M N N
Nf0 fD
N u7 N
N
N

0 ~y O O~

I l1!N l IlJJ

_ C _ _ (O (~O G fn !n(n p N
g g~ ~ ~ g gg a N

N O N A
c a ~ .

> >a Y U > >> O

~ N O

f' a0 ~

O ~p O M
O O Q

a a a a ~

c_ c_ c c . ~

N
E E

O O O O
N a a a C C C C C
~

_ _ . .d d .N .N
N f0 C X

p O p O O

d G a n d ~ G L

j C Q C_ C
. ' .
.

(O fp ..N.
C' r X

T
U U

U U ~

X > j m o a , ~ _ to .c m' N ~! _ ~> c ~d v Z
a C , _ ~ 7 ~ O

t0 u7 N O n O n ~
y ~ ~ o ,n n_ ~o _ tn ,"~ m m c M ~ ~ ~ Q c ~ ' U
D o N ~ a tit U m U U o v ' U U Q , ~ 0 v ~ U o~ Q

o a ~ a y ~ ~ a ' ~ ~ ~
~' m ' a a ~ D
~

a ~ ,~ c~ _ _ E Q E a a , E E H E a r ~ a; m Q $ o n d o a - a~ a> o a~
o~ vi ~n n o ,a c ch' ~ ca y E ~ .
c oo o ' N O
~

M M N d n N Q E o o o ~ _ d o m n m E o ~"~ (D N c J
O 1 n > ~O O
>

M 00 N > N _ N x ~ y N O 0 ~ O O , V N o~ N a N ~ N ~ o O x E

m ~ N aoo a~ ~ n M U
o n m m N ~ ao N ~ ~ o -a ~

N v u7 4'7 M a0 N 1A N N N ~
M t y ~ N G7 d ~

C I
.oo'd.a .or .'o~ .o~.'o~ .o~ .o~ o :w :o~Z
c m : o o o ~ x a c O

~ m m m ~ ~ ~ ~ m m ~ ,Gy ~ W
n p a ~ ~o ~
~

CD m m m O f11(D m m v Q ~ ~' O

C7 C~ C~ C7 U'C~ C7 C7 t C~ C7 (~
c~ Z a o = = r H N
~ p E E E E = E E .~ E E 'o E E E
r '- a ~ o o c ~
~ x 'N ~N ~N ~N .NN H ~N T H H .H
~ ~ O O T T ~E a N O

c c N f~ c O cz cr cr cQ ca4J
o. ' cd c Y c .
c c _ _ _ _ _ _ ~ ~ O r d d m ~ _ ~ M ~ ~ O O O H
L ~ V V N N
N N~
~

o N o o n o o Q a o u~ o 0 0 a o H a~ v 0 <o d o =

a d E n a a o a o .
'~ o N E o ~ N
a' a ~

~ ~ , o N
~

j j > ~ 7 > > > ~ > > >
C J j m ~ ~ O ~
d d d O

~ ~ ~ ~ a ~ ~ ~ . O-x ~ 7 ~ ~
~

N Q Qfn Q~ Q >' Q Q Q z~ z ~ z z~, z..' z_.zL z...... z.r z...~ o~a z.r..

l0 aD ON Vt0 ~OO N ~f0CO O N

cc cu nn nn n m w maom o a~ rn W Of OOf 01O~ 0 Of O 01WOf O O7 O

n 01 MO n C) MNn O M
a tc co cc~ nn n n ao aoaoao ao ~ a~

~ o~~ ~ ~ ~ wo>~ ~ a_~o>

tD t0 ~N OfM O ~ N VN~ O ~t~

O M M00 _ ~ _ fDVO O) N f0 ~ ~ n NOtD ~1 (O (D

M a0 NO~ MM n ~ Nf0 m M MN

Of 07N _N tD~D Of NC1N N aD

O ~ OO ON O uM'7 ~ n~n O a0 0D

N a0aD rp7 O ap COr-m O n n M O(D naD O O NMV ~ t0 n a0 ~ Om a0m a0W 01 O)OG7 O Of Of Y V ~fV ~V' Y V ~ V~Y ~ V V

m o o ~ of ~c o rn ~

o~or'r <o~~

. N
.
aD ~ V N ~ ~
N N ~ N

~ N N O N N w7 W
f0 N N N

~
h r Of O M r f O t0 aD
N O O V7 ~O
a0 N V O V
t t O
~O O 10 D N N
t0 O~

N
N ~t M N V M
N

~
u7 t0 t0 (~
~ Of N N ~ N N p N
~ N ~

~

07 t0 '- r O t0 V
00 m t0 a0 V t0 O
t0 O V O t0 N ~f M V

1C) O 10 f0 f0 O!
f0 r f0 f0 ~C

M ~ ~ N ~ ~ N
N N ~ N

(O N N N N N M O O
O M N M

N - - O . . O C~
r N . <D O 01 OfO c0 QO ~ O V r ~7 ~f r N

~ O ~ r O t0 N M a0V V
~O t0 M ~ ~O t0 c0f0 O
M Of O N t0 r M Of t0 ~O

~ M ~ ~ N N ~ ~ N N

N N N M N N t0 N N O G) r M N u7 . (p ' . . a0 01 M O~
of ai ai - o ~ ~nao a> ~ro~o v ao aor ~ cico a~o ~o r rn u~ ~:
M r O O O O O f0 O O aD o0 a0c0~ O O M O tD c0 a0~
cD N M aD t0 t0f0(O r I7tM O (D O a0O t 0 M r0 N O Q1 ~ t ~0 t f 7 O tD t 0 1 0 O ~ (O f 0 r ~p ~ <D~ N ~pet~Ot0f~0 (~O ~ f0. ~ ~ N~
~ ~~ ~t~0 ~ t0 ~ ~ ~
~Of~O~~Ot~O~aDf~D
~O
~O

f N N N N NNN N N N N N N N N NN
t N
t N N N N N N
N N N r- N

~ lJJ ltL t!J t tlJ I_JJ L_L

_ ___ _ VN tp d ~N~ tn tO t~ t~

y lO !O ~ fnN(O (n (n N !n N y g g ggg g g 5 g 3 m U U ~ UUU '~U U U U ~ U >, E .

Z Z O ZZZ 2 Z Z Z Z ~,Z E

N > > N ~7~ N > > 7 7 U 7 f0 N t0 V

M ~ M M

M O
O O O O

O O O O

a a a a ~;

c c c c '~

d E . .
~

O O O O
H ' V O

C N C C C_ .m N d .d . N
.~
O

O ~ O O O
j ny a~ a a N j~ N N N
C x O ~ . C_ C C
t C
.

l0 O l0 lG ~0 n m C

a N L
T

O l0 O O O
U U L lL U
U U U
a u~

N

m _ ~ M ~ a a ~ v r O ~ r' ~ J C LLI
T

G) t0 ~ Z Q N Q U C
~ U

, N C M Q J = Q ~ T O U
C ~ > O >
m N O aU, ~ O

as m m p O -' _ ~ o~ao ~
c cn - O

f0 M Q " ~ ~ Q r. ~' O <O N
N Q - L

' ~ ~? U J a Z O H ~ N
~ o N w N Q

v ;~ a ~ Q ~ ~ d ~ v v _ n m ~ ?

, ~n~ mo ~~' V ~ z a > >~ 'Qd p ~ o o ' Z c ' N o n ~ E n m a, a y ~ . ~ " o r O ~

n o Na c a Z J~ ~o o n v v c" w E
O

m m ao ao i O a = c v r E m j ~ r ", a O c f7D N

m i v I U ~ V m ~ ~ N
~ E n = ~ L
N

~ 1w _ _ o ~ ~ I I m ~ ~
O N

O) 01 m p1 ~ ~. N O7Ol Ol L N N ~ C m M

Y Y Y Y Y Y Y Y Y - Y
~ pf L Q Q' m ~ ' Y d Q Z Z d c c c c c c tn c c ~ c c m O y n U H p m c m m m m m m m m ?' a ~
o N m m m m m m m m N m m m m m ~ ~ cc o w m m m n o ~ g ' U' ~ C~ C7 C7 C7C7 C7 C7 U C7 U
, G1 d , m .- m o v o ~ o N O

~ E E o ~ E E m ~ r ~ ~~ Q ~ ~
o Y U

E O "m' E E E ' a E E E
' V ' ' F M lL ' ' N ' j a - . O
' ' a y1 uJ t/1 fn y)W N N N N y1 . _ V1 y! ~ l d Z 7 a ~ Z' C C C C C C N C C C G C
' Q n G! N ~ Z N E
~ d ~ C 4% ~ ..~. ~ ~ O ~ d ..4: 4:
y r ~ O Z N Qf !4j N
lL (n . ' tD
H . ~
M

O O O O O O (O O O O O O
C et o O ~. a0 ~ n m "' O
N

a a a a a d a a d ~ ,~; ~ cn o ~ N
O ., J ~ ~ ~ N 0 p ~ ~ ~
~ J V ~ V IV ~ C
01 ~ F-Q a ~ ~ 0 - ~
~ S ' ~ ' ?

z N z z z z z z z z z z E o a ~- o~ o E E
~ Y >

N ~ !Da0O N ~ f0 e0N V 0 a0 O., O t O O O OO N N N N N MN
t0 a0O O O OOO O O O O O O O O OM
O

O O O r- ~O

M u7hO r M u7 O)r M N r O
r N r O O O OOO '- _ N N N N N~
O W O O O OOO O O O ~ O O O O OM
O
O

O O O_)~_ _ _ _ _ _ _ _ _ _ _ _ '-O
V _ a0 N O ~ 10 M aDN a0 < f0aD~ V u7 O

ap N ~ M r a0Nt0QfO~ N ~Or O O OfO
N 4OO etMO N elf V (DW f V aD u7N
M
V

aD<Do0 ofrM ~ _ c0N O r M NO
M

m M r ~ N cDa0O nlfu7 V r N O 9 _ <ON
O ~ O p O Na0O ~ < <O r Inu ~ c0 ~tp r M
M
M

op ~ M O OOu7 O W ~ <DO O W Of0D
ap N a0 N~O ~ N r ~ ~ N r r rO
aD

a0 01O N MVu')t0r ~ O ~-N M ~p i(ff0 O

f 10~O 10 10h101nl0 In 10h 47 f~tA 411n 1 t a;

r "~
i o W
n ' a r on o o n a o t c v ti ui N v - O M t0 ~D fD ~O
t0 M

_ aD
M O~ r ? t0 N V
O N aD M M
~
~
O

N ~ N
t 0 O M r ? N
fp r sf O

tD r N N V aD O
N ~f N ~O

~
N
O

( ~ NO
0 ~ ~
(p ~
~
N
~

r f ? 0 N f0 V7u7 Ip h O) of O ~ N N N
V r M N 01 ~

tD aD N (D O ~ f0 t0 N t0 N if pp N~
N r 0D Of ~ at ~ aD N
N O O aD t0 O

NMU07f~DNNOOfONn~n N M M N t0 ~O 47 tD N (O N N M

~

r N tD N M V N ~ u7 N
t0 O
r N W O OD N O O N r NN
r N n 1n N
!' te (A

_ W aD aD N N O !D r a0 cD
O a0 M N
r O M N O O a0 O
IO u) O tD M

O N H7 M r N h ~ W tD tA N
(O O t0 ~

M
M
0~

0~P t~0 f~0 N ~~
'lr ~
7N~NOt N~Nf t t NN pM~~~~ N N ~ N0 N
~
N

t t0 10Na CO r _ 07tn Vf O N r CO O1 O r ~pp _ j u7 W N a0 r u7 r r M e~
' O N ? N ~pO O N OfO ~ f0N OD OO
O C 01 t0 CO 0D !D N
t0 N ~ 10 N (D

V ? N N M 10 O f0 rf0 07 f0 O O)r rC_OO fD 10~
Y7 '?tD O O In C_O N t~0l0 ~ ~ ? < ~ ~ ~ O
V t0~O ~t ~ M V O '- ~
t0 ~ tn ~ ~ ~ O t0 l0 N t0 O 07 tD r fDO cDt0 N N ~ N f0 N N N 0D NN N N N N N N~ N N NN
N N N N ~fJ M ~O N
~

a d D m W v W WW W

W a p WW

LLC lL N LL l1lL tL ILlL

I

= a g NI 3 5g g g5 ~ m E U I m N U o c ' c z a z zz ; z zz 7 a Y ~ Q > >> L >

N

M N
N

O
O O

lL lL
a c C a . a ;z c c c m a~ .
.m .
i o A m ~

o a o E
~

a o c a c _ _ c ' G ' ~
~

c o a v o NQ a?~ n E

~ Z N
0 C a ~

o ~ C
'~ '~a r c ~

UQ a a U Ut h d _ N O
d ~

n ~ , v ~ r N ~O f0 O O tD u7 N M M a O ~ N V O Q
E ~ 111 m o ~ Y p M m ~ ,~ Z N
~ N O fn y Q
O
g U 00 Q m N c O ~ Z ~
~ p o ~

N m , O m ~

Q E a V ~Q v d 'm ~ ~ d v ~ t ~' 'u O
i Z

n t c o in ui u1 o o a ~ r E
'o ' Q H o ' - Z c c E , y o ~ o ~ -~ ~ O O n S N E
tL N t L st c0 t0,_. ' - - O
M N O U ~ N M O J ~ O
O O N V ~ lL H Z
~

' N d ( ~ lL
M D
Z
O

Q1 ~ tD d ~ = ~' ~ ip j Q N N
~ ~> a m ~ NO C

N opK7 'a I YI N ~ ~ ~ O W V N
.= ~ H V (O Z N
I

O

Y C C ~ C M O Z C Y
Q L a ~ X C

C ~ C ~ C ~(7 C 0 m ~ N L C
O ~

m m m O O ~ O O ~ ~ O O O
C Q~ m d C C ~ G c m m m m Q .t c, ,~c9 = O c C m m m C7 C7 ~ ~ ._ ~

E C ~ ~
o r Ed E=Et., E~C9Ev E~: E= Eu~.d~.'_-T.~ E~ En Eo N N ~N N N N ~ N ~ N N
E N a a E N C N ~ .
Z ~ ~

C_ C C m C C C G C O ~ C C C
N ~ N H n m ~ ~ Q ~ L
F- :
d ~ Ø. N ..d.r _ r .-O. N N y r f0 O ~ CD f0 H N Z
~ ~ ~ C ~
~ ~

O O O O O O O O !D O O O
M N Ip d O C ~ CO
lL N ~

a N _ d d a l L O ~ d a a d N t N ~ a0 p M p O~ H D ~
(n > > f~ ~f ~

p p m j j j > ? tD j j j p ~ ~ a m 7 JO n C O
d C =

Z Z Z Q Z ~ X Z a N m X Q
d ~0 L Q N
~Y

h- Oi c O a D

O ON ? D D O N
M 0 M ~~ t a V K1n ~~ O N
f ~ f V t ~ OO O O O

M u7M O M (f r O MO r n ~M
v t O O O O~ ~ O ~ 0 0 00 0 O OO_ W M p ON0 O O 0 O 0 M
a a a O t _ ra 0 M i0 O

M M O N ~~ M D N
O

N O D 0 7O ~ M N 0 O ~V C O NO
f t C O

t0 ~ a~~ o o 0 0~o o~ r o 00 a> o o~ a - t u a r~ o a o r M coo aorn a t~

N N N N N rm O N
O

u v n N~h ~ ~~
~

u 7 tf u u ~ u~
i f c o~

O

? O ? Q0 N Of aD W
~ a0 V

N O N O N

C7 V a0 ~ l' C~
~ 7 f0 ~ ~
M

W 1~ 1 N 0 O N N N
~ t0 O i~
f Q1 N W N M ~ ~ O N O
1'7 a0 O

O O ~ 47 f"1 a0 c'7 O~ f0 O CO CO
f0 N
N

0 ~~ N ~N a00~f~0aOD~
O

Y N O ~f N N N~ N
7 N ~ O ~ ~
c~ N O

07 ~W ~ O O~ 1~1~ O
f~c'~ N V ~
~ O
N

47 O < YN ~O N h a0 Ot0 _ t0 O a0 O f0 N N ) N

I~ ~D tD hN (O _ tD OO p O u7 10 fD

~ N ~N O Of f~0 ~O (~O
Cp~7 f0 N
O

tD <O O f0t0 f0 ~ c'~ N NN N
N N a0 O h N
N N ~ ~
N

Of ~ O~ NO W h Cf 0O aD ~N ~f7 a0 th O~ O ch N Of t0 O

~ ~~ r N O 0 p h n ~ O

O Of O t0 O 7 ttD f r 0 0 ~
ff O

(Ot~O N ~NNt~OMNIO NtONN t0 t~0 ~t~0 ~i~0 ~

N NN f NNNN~N N ~t N N NN NN
D ~Nf D

1~ ~ fD r c0a0 aD N Mr O NO ~DO a0 47 N f~ h 1~ _ ~ O~
O~ l') N
C~
4'f O O O ~O Ot0 O O O~CD OO ~OO a0 ~fl t0 % ~ a of % t0 ~

on a~o> o o~ e so ~no ccc ncc cc v r > o v m o u~
c t0 t~D~ _ f0O O ~ t~D_ fD ~<D (Df0 ~ CO f0 OD
O ~ f~D
N
u'!

N N N NN N N N~ N N NN NN N N
N N N N ~O N
N ~O

a _N

p ' y OO

lLo O N tLl1! N UJ
-lL~ U C lLlL N LL

N ~~ G1 N

(~I G Q ~ NN !~

~

~

Z H a ~ ~ d ZZ < Z

7 Q ~' v r a E

o ~ ~ ~ o m Z

n a a .a ~o _ _ _ (0 C ~N O O N

O Y O Y O y' a C a O a N

C ~y C N C

~N O G7 Q ~d N

o a o c o U

d U d m d .

C C O C Of O . C

~o Z' m a ~o ~i ~.

~0 ~

O 7 O ~ O

U u1 U a U i.1 c~

c ' ' a ' ' N

O) _ E Q ~ ~ _ C p M ~ I- U ~ f0 ~ d f- Y
C m ~ ~ (~ N
' I_' o N o~ a U Q , a Z m ~

~ ~a w v .~ a ~ m ~n c V O Q O N Q ~ (n ~
~

E U U n f' ~ o T N Q U
m c v ~ ~ y y U o Z o c~ V Q E
.

E o = x vm E E~ a~ Q' ~ ~
E ~
'~

--~ ~ ~ n N a~ , -o c U m t t r u Q

-'~ $ ~ Z , , v i ~ so . m c a o ~ Q N ~ v E - - ' N
H ~ n ~ v ~
Y ~ ~ <

O c r U N N M m - N
U 01 lL O
U ~' Z H
N

M (p ~p ~ Q O ~ ~ r ~ O
a U ~
o ~ n UJ ~ lIJ ~ Z p m ~ _ ~ ~
N ~ "' lil a c a o y ~

S N ao u~ tn ~ r ~ p n Q I U N
LL ~ E c m I m n0 N O ~
~d ~ ~ I c~ t N
t-f O i C

. O n U N
~I Z_ ~ .~ ~~ ~o~ o ~ 'c~
'a~ y o A

N O Y O Y Y ~ Y Y ~ O Q
O ~ Q a n Y Y d Y
: H i a J

Y Y Y Y - i m mp m r ~m n O m~ mr 0 m= ~ ~
' "~ ' m ~

m, A E o0 ~ t o ~ v ma ~U
o ' n ~
~

m m m ~ ~ m m n m m ip m m m m m ~ ~ o d ~ ~ ~ ca Q . N c~~wa c~a ~ r Z a ~ o c~ N
~ C~ c~ c~ c~ ~ c~Ma ~

c~ c~~,cN ,~ a, M r z w O p N Q' ~ E c ~ O O N O y E E Z E
E ~ [y,1 Z 111 E a m E
d E E E o m ~n ' ~

~ ~ ,~ _ E U ~ E o ~ ~ ~ X
~ ~ u~ .

N u1N (0 n N d N N - N N N N d N
~ O 00 E ~ J d ~ T d lJJ C
E Z N Z N C

C C G -E G ~ O. G G Y C C C C N C
O ~ O N U~ H1 C L O ~ O
O D O ~ N y Z
O ~ 0 0 r ~ Ø. Ø. r .O-. .. .. r <O (OW J E ~ H P7 M m V . .
G1 V a0 ~ .O. 'y~ ~ ~fJ
r d ~ O J ~
M

O O O m O O O O O O O O O O off O
P7 p ~ m N f~ M E o~ O O
VV f- O
~

d !L N a a ~ d d a a d d p O .
N ~ Q ~ Q ~ 0 ~ ~ n U d ~ C Ct - O 7 d -y ~ ~ ~ N' m ~ d ~ o ~ -y ~ d ~
m o ~ a v ~ ~ < o o ~
Y ~ d 5 ~ c_ d _ a T U ' ~ ' Q a a ~ v ~ U 3 Z Z Z N W Z Z Z Z Z Z Z Z Z
ow r o~ or N o~ a o~
~ Q a ~
m t0 c0O N ~t0 ~O ON e< !DaD ON ~ t0 ~o <or~ n rn n ooao ao aom o~a o>

o_ o_o_ 0 00 0_ 0_0 0 00 00 0 0 Sri r;of c~Sri ~ of- ri Sri~ of- of Sri o cc cccu n nn n nao ao aoao ao~ a~ o~

o_ o 0 0 00 0 00 0 00 00 0 0 v o n aoc~ o~ rcn ~c ov g~n ccu~ o v<o <c ncc M a~o~

O N 4_D N <O~ N ON aD N ~OO u7 W
aD t~ h (O I~N N f0f~ ~Of h <

tD f0V O ~N 01 C~(p 01 Ofh ~f h 1~ M fD O a0 M ~O1~ N I~V ~N O
f~ N 01 W ~t~ aD Oh ~ OfO OO N

CO OD1~ 1~ OaD N 1~m O t~N a0m c0 M N ~ ~

t OO
fl m 41 ~ . N r O

O i0 N
. ~ f0 t0 . _ tp W
Of r a0 ap at N ~f r ~ O aD
O

GO N r- O U7 _ (p (p O N V ~
r N M O Of ~ N
O t0 tD r aD

N N (~ t1~ Of O ~ N ~
N . O f0 O M f0 ~ ~ r N CO N N ~ OO
t0 N N N ~ f0 . o~ _ . M o r . . ~n ~c r Of e0 r O ~ a0 ~ t0 N ~ t0 r (~1 r '- O N ~
N r O M aD e-a0 N V h O _ _ fD ~ Of Y a0 N tD V O aD O a0 fh O
tp t0 r ~
O

_ A N 4M'!
CD N f0 N N O
N ~ N ~ N O

mOU MtOt~DNtOON0~0 ~

N Of it O C7 N N N CO N
N ~n r N C~ O N
r ap N (O c0 f0 O r r W

u7 r aD O) N a Of O fD
O 07 r O t0 u'!
u7 r _ O f~e< O
V N t0 01 t0 fD O f0f0 f0 07 ~ f0 f0 N
r N M 10 Y7 O
c'~ O t0 f~ f~
N

N N ~ C7 ~ ~ ~ ~ ~ N
O_ N N f7 c~
N

t0 ~ N N N N N N N ~ N
N ~ N N ~ f~ a0aD OfO tD N a0 00 N ?
a0 07 Of a D O
r V W r O N ~

_ a0O a0~ O fp O 0D O c7 _ t0Of t0e-p7 r tn _ aD aD ~l7 10 aD
f0 r ~ fD N
of r N C~ 07 O
r f0 O In p aD
c7 N fD W ~ f0 f~0 ~ ~ ~ ~ ~ (O ~ t ~ ~
(~O ~ ~ N n O

p f N N N N N N N N N N u7N N N N N 0 N N C'1 10 N N
f0 N ~ D

W W W O N l L

C U C _ _ ~ lL LL

N N N '~

or ~ t~
g p o ~

g g d n c~ a Z Z Z T C ~ ~ y Z Z

> > 7 rn~e a 7 o n c a '"

o o ~ c >' a a a~

C C d N
.O .O a N

E E ' :-' O O ~O
a N
a > c c c 2 '~
=

d m a ~

r a ~ o N
Y

C C t n m m n =

O p!
O Q
C7 O t U U n H
ul w a> w _ _ J ~ Z Z _~ Z uJ -, m E t 2 ~ ~ , O w ~
m Z c " .

o zg ' ~' "'" o ~

_ m Z
M U ' W I= V H to ~ o a r>~ cn - ~ N Z o w a Z a n ~ m u1 o av zZ- ~ " Q
'g ~ 'c~gapo _ ain ~ ~ a ~ '> , a ~ w ~ c m ~ Z
m ~ c x cc O Z o~
Z _ a ~ J ~
d p V O M ~ O ~ N fn a ~ C
x ~ ~ l1J

a c O z > o z O
a ~ T o ~

'"' E ~ ~ Wi ~ R ~
x m '~' U

~. ~ a ~O ~ io "-' ~y~ZZ a i ~ N ~ '' E m ~ ~ ~ U - ~ Y a >' N
I-' > VI ~ a Q

-Y Y ~ e ~e ~e Y Y W Y
~ a~~ m~a ~o O f'~
~ ~O~mz N

m m m oH~ a m s ~
~ ~ m m U Q m m ~ u~
r u1 ~ Q Z W
c o O a U' O O O o ti U' ~ C7 ,.'~~ C7 ~ ~ ~ w ~ cp Z ~ ~ g ~"~
~ C7 ~ W y H ~ C

o ~ n o~ ~ c a~ ~
E o Q ' E E E o ~ Z E E c x u1 t ~ ~ Z E o H z E d z a $
a H ~
~
m ~
~

C C C C C C n (O C C C N C
~ N N Of a, N C ~ Of ~ O N ~ ~ ~ Z O
(/~ C O G W G
a 07 ~ --u 4: r;N N ul N I d 7 o a~ M o O lL O o o o can o Z p'o o W ~ 't ~ >~- ~
o ~ N x U N ~
o~ S j ~ E

~ E U~g a N 4 d a m O a a a o >~ d c ~ o ~ ~ ~ o d c ~ m ; N . a ~ o O Q m c . c? ~
. x >~zz > > >~j J= > >o >
~ . .~ ~ r ~ a -~zo ' o o..m~Q o o o--~Oaur' oQ~ o-tup~.U
m oa ~ c ~
~ ._-ur Z ... N Z Z Z Z Z Z Z Z
or n ~ o~ C7 rn v o~ ~ x or F- n ~. ~. ~ tn ... Q
H

e0 O N p O O r Of O O

O

C~ O~O O O D O M O r O O

O ~ O 0 7 r r f W M
N v!
r N

Q~ t0G~ D M ~ ~ M
a O

CDOf N 0 D D r tf f a f ~ O
~
N

O t 0 t p f u 1 n O
O
~

01 ~ D f O n ~ ~ ) N O
1 0 O a 0 O

N y l) t 0 a D
~ M r h ~f~ N u 7 ~ u f ~ u ~
u ~ ~

N
N
M

f0 O
O

u7 nj N
N
r O

O O Of N
~

1 h N O ~ 07 ~
O

fp t N ~ O
N
N
M
~

fM0 f0 O

u7 fp O O OW O N
O ~ ~
f0 fp ~
N

(Of0ff f N 0 0 fD
N N oN
N
N

M OCfO N O N O) IA rr N r fDr Y7 O a0N
M Of M
O
h tD

a0 Oa0 W O ~Oa0 f0 a0O tDO MaD O f0 MaO
ap o o O r o cofo fn rn cofo ~f 0 coco~ In al ccfo u~ oof o so fo r NN N N N N N N N ~N N N NN N M NN
N
N
f0 WW W N u N W

__ _ _ lL lL C L_LC ~ l_L L_Ll_L ~ C
LL

__ (n d fnd n (A V)V) N N
V)V) d g~ ~ N N ~ ~ ~ ~N ~ ~ ' ~ H
n UU U T = ~ U U U U r ~ G

ZZ Z y ?, y Z y a Z' Z Z o d e 'o >> 7 a In L ~ a ~... 7 7 n a m o ao a c o o m m n o 'c 0 0 0 0 a a a a a a C C C C C
=
N

E
Q
x N
E E E E

m oz 0 0 0 0 0l a a a a a c c ~

N

d ~ r d ~
C ~ N O V
0 0 o o 0 0 $ ' na o n a E ~ o n c >, d Ul N O
C

N N C E O
C ~ O C C
C C O N
W Y

'm 'm 'm m = m 'n a ' o d O
cG (U
y O O O p U
m U ~ ~

U U U U a Q m ~

Z

Z ' ~ J ~ - N - - J

a ~ ~ ~ U
o ~ ' ' N O A ~ a rn ~ ~
~ ~a O r m U Z o~ v. t .. u r N M ~Z p u J m _ Z
~' ~ ~~G

. m _ Q N N M Q ~ m Q Q O Q Q O
U O V p~ ~ 'p a l1J
m ~ p ~ U r ~ = v a U U a z a H ~ a N ~-O o o m a _ tA C7 o Q a a Z
D a v N tn D .N ~ O
! n ~

~
Q Q D y ~ ~ z y ~ d d ~ E x Z a~ i m ' 1 ' In ' ~ N .

10 O 't GD d O W M N
p fUU O D H N
O) (p m ' cp N C N In ~ () Q N J t0 N V
Of M ~ y O O ~ N ~ Z
N f' ~ N

v N o~ a~ ~- Qw o~ U r m fn _ E o o orsv lMnN o? ~ NU ~ U V O ~Z
:'o ~ ' U T

v N c~ < - v~ n. v m fn fn 5 v c y Q E o L
2 ~

'o~ 'oe'o~'w 'oi ~,~ p 'ao Q~ 'o1'rn a'o E H m O m o a 4 ~

' .
Y Y Y Y Y Y Y Y Y Y Y Y Y
~ ~ G7 VI Z (r M = O
O ' C C C C C C C _ C C C C C
~ O N ip V Q' C ~ 6. ~ ~ j 4' "' ~ ~ m m N Q
~ O fa N N l0m N N N N N O O
m m H ~ d f0 N m C m m m m M ~ m m m N m m m r Q
~ m L m Q O O
~
' (~ p p C7 C7 _ C~ U C7 C7 C7 C7 o $ co a~ X C9 fr., ~ ~ N Z 0 c j N Z ~ '? ~

~ _ o C _ _ ~ gZ E E E
' t E E E 9 E E EM EN~ E E_ m o a H. m U E ~ ~ ~ : ~ O
' ' ' ' w ' y~ y~N N N N N N N H N N
U l1J~ N d O d Q 7 N ~ n U N N

CTC CEC Cn C~O C_NN CnQ C_n~ CnU Cd CCU CNN
~ ~' ~

a: r :!a: a3 ~ ' ' ' r ~ :~ Z
In 'f Q N so c M '!~ r H M ao o Q o ~ U w Q ao 0 o o o o o o o o o o o 0> M M o, c N rn ~ ac E
E ~ .. Z = E ~
o o ~' a a a a d d a a d a a >, ; ; ~ w U ~
a In n ~

d d ald m d d ' ~ ~
~ ~ ~ o o , ~ f ~
h- ~ ~ ~ Z
~ D

> > > > > > > m J
N T y m J L f~ J
a N U ~~ ~
H

z" aa ~ a Q ~'r'z z z 'o~cz z z ar ' 'o Q~ z ~ Q 'o~a a ' c~ z z z z z o ~
~

O N? tD Q)O N V i0 GO ON ~ t0 ~DO N V t00D
O OO

N NN N N M (~ M M M V~f ~ ~ ~O O

Of ~M In r O M 1f7 r O M u'7 rO M IAr O O ~O

NN N N N M M M M MV ~ ~ ~~

M rv O O f c0 InM r r m v Nt0 f0 N rM
D M N O V O rN

M COf0N Of_ CO 10O O NtD o0IA InV N ~r In V M tp a0 Ofr c0 QfW

tD MOD (O~ M O (D OM (pu7 f0 N r f0 OfOf(O t0 N (Oa0 O rW O Nr a0 N O
O r 117O ~ r a0r O NfDr r ~ M Int0 ~ Mr f0O MM O cp 07 Ol 4OO) O O~ O) f0tn ~ r ~ M rr M N N tD
a0 Nr r In O

O N M ~ IA f0 r a0 O O N M ~If7 (D r aDQ~
r r r rr t0 f0t0t0 t0 fD f0t0 tD rr r r hr 1A u~ u~u7 1 O 1n 117 u~47O 47u7 47 W O W f70 M Qi ri N O M

? O O fD
tD W O vT

Q~ (O t0 O

(O ~O ~ N N
O h M N O fD
h aD

~ O
~O h O M ~O off N
W
f0 N tD ~ ~ '~t t~0 O
~

N ~ N
~
N

M N O N Of N ~O
M
f0 ? - t0 O u7 cD h tDn O - O~ N
M
O~
O~
t0 N Y7 n O tD tD
P

N ~ ~ t~D N ~ N
~
N

O N N N N h N
N
~

~D O
Of V h t0~ 1~N N . O N h M
O
I~
t0 f0 (DN O O O 01~ O t0 O
u~ ~n~ o~soo so cca0 o~ n ~
~c so ~o M t~Of~D f0~ (D~ O N ~ t ~ON

i p M
O N N N N N N N f0 N N ~O
N
f0 O t0 ~ aDa0aDO O 07 t0 N w 0 O tDNaO M f0O
a~ f~ O O
M

f0 O N 07 00~-O O N ED O O)1~~ O fp M O10 O O ~
10 ~O ~ M

tD101~

N tp~DfD ~ t0~ ~ cpN (Of0(p~ ~ ~ M c0 t~0 ~ tp aD

N N N N N N N N N N N N N N N N N NN N N N
N N N EO
'-O p p p p p p y p p pp p p l W llJ111 l1!111 lLN N W L llL l lL

_ LLlLlL l1lL LL(O C LL _ _LL _ li LL LLLL lL

(n !nfn!ny </)fn (n07 N (n fn!nN fn (n v1 r cnv1InH InIn v1E ' cn u1~v1 In cn U U U U U U U T

~ '~ n.U

Z v ' Z Z Z T Z Z Z ~ = y Z Z ZZ Z Z

N > > > L ~ 7 ~ E ~ 'O ~ 7 >> 7 7 n v a c c E
E

v v c ' c d o D
N
O

N
O

C
O

~ ~
C

E

U

Z O

p c J - ~ - ~ ~ ~ Z a ~ - Z

..Q '- ~ e- ~ N
U N r ~ U

~ o h vi o~ ,; m ~ v E
~ l n U ~ cn7 ~O o y l1J m ~ U v l ~ ~ ~ .v J r = M c - N
Z f ~

n i F~ ~n Q m Q ~ ~ N W 1 X p - ~ ~ ~ d Z H m L
L

o a ~ a ~ a ~ N H u ~ ~ N
~ o .~ v l m p om = ~ E m o j w Z ' p ~ -W A r Q H ~ ~ E n ~ ~
a o d N d ~ d O) ~ 01 a0d Z M In .
O E O M O W ~ 'C
O M n Z
(p C

c ~ ~ c r m E o~ ao ~c, O w ~
E ~ o ~ ~ d O N c h N W M a J p Ill O N O .G C J O ~ ~
p ' ~ ~
~

v U ~ ~ a ~ ~ ~ U N O N
_ U o ~ O M m 0 = O Z U

~ y M ~Z ~ s Q ~ wUmu1 w>~
c c E ca c ~nU o c l N
' c . ~ . ~ .~ ~ .~ .~m U -a; ~ ~ ~ ~ uJ
v Y Y Y Y Y Y Y Y Y lL Y Vl Y
Q ~ O ~ O w Wll p O
a ~ Y
Y

C C C > C C C
r m C Q. U m p cr ~
Y ~ ~ m U U
" ~ m Y

m m m m ~ m m m ' ~ m ,~Q o ~ m ,a c v 2 m d m m m m m m d U Q
m ~ '~ D m lLJ
m -,n ~ N
C 7 C7 C7 U' U' C7 C7 U'W U' ( ~
~ o ~ O U !~ i.C7 ~ "~
Z U ~ ~ U
o g _ 0 U = m c E E E E E E E E E o IVIJ E v ~
, n ~ a ~ ~ ~ E w z ~ ~d cow E o w V
a ' ~ 'N ~ N ' N 'H ' y~ 'N N H a d N a y a Y O d N N, a ~ O E N Lil N l~11 c_EcHO S ca 5Y co cd,~c_oc_ c ZN= c ~ ~ ~ f... ~ ~
~ O

07N GI G) N d ~ O fn O N N N
f0N M O ~ f0 f~W Q H
lr a~ in (9 O N N f' a o N Z

o o o o o 0 o o o o rn o t so io a~ ,~p x z ~
r ' o a a p a~ ;~.-.ao a~ a~ a o a.~ d n a a, , E n a~~~ =N d 7 p H Z

> > > > > > > i ~ ~ ~
~ N m ~ m ~ ~ n i ~ > ~
Q a E

p Z Z Z a N Z ' ~ Z
' a a a u N c a N ~

Z o r Z Z Z Z 2 n v oo ~ a O
U Q

O N ~ ~D 4DO N Y c0ap O N ~f~O aDO N ~t0 aD O N
w ~o cc ~ r h - n r o n m m aoao corn as a~ a~ 0 0 _ __ _ N_N

01 M i0 1~f M v0h O) M N h W MO h Of O n u~ reo Ic <co h n n n coaoao ao0 0~a~o~ o~ a~o s ~

- N

f M ~ N V ~ tD01 O~a0 O O t~m N
~ 1 ~ O

_ M Of N O aD7 M N N ~ ~OO~ Off ~ O M t0 ~ a0 ~ ~ u M N 0 O ~

f D M _ a0 h f0 M O ON fDV
01 O f u') h h A 0 ~ M OfaD N ~f ~ OfO N f~O
O n O M ~ N ~ m I~O 47O a0< <D aDu7? aD v0 O N O M c0O N V ~Oa0 aDP7t0M N O O N_ M M 0 f O 07O O 01~ c0O O O~ O)O M N O O M OV O O ) t0 n 0 n O n M m n n h ~ '-CD N ~ aDOf N O h a n ~

O N M Y O O n O Of O N M i0 1pha0 O O

a~ a0D a0 a0O aD0 apa0 077 OfO7 ~ 01 O OO G7 O O
a 0 0 h 10h u7 O N O 7 47uW O O ~OW n W O ~tfuW n ~O0 u ~ t WO 00/58473 ' PCT/US00/08621 O ~ N N ~

~ p O~ 0 t 7 f0 ~ 1 D Q
~fj O M
a ~ 01 M O m a O aD ~ O _ M

N
M O h V M f~ M
M ~ N N
N O p M M M
fD O O

N 4f M O
M
) N

N O
N ~ aD N N
n N
r N
N

tOtNO n N t a O
O(O
DO
M

N
N ~

N N N
N Vl a0 O O

f t0 n p M f~ ~ Of u 7 a0 aD M O a0 N 7 vf7 P fD
aO h t0 t' M O N elf (O
M N ~7 ~

~ ~ ~ O ~ ~ 'Q ~ M ~t O
~ ~ ~O a0 N M
~ O p N N t0 N N O

a ~ N N N N O D N 0D CO m a0 N N
f N h O N O O
D

N

~ O _ r ~ ~ M N M
M O ~O

O 7 N N fD M
V M M u'!
V

W Gf D ~ 0 N O M Of O
IA O t O O t0 V
~ tD M N f0 N N
t0 N
t N N

~ ~ ~
~

N N N N N ( O 07 N O N
~ O N t0 N
CO O ~ 0D
' 1' NCO~ ~ O N u7 N GO O pM O u J t0 1n N
C O r 1n tDa0 ~ f1 h O ~ aO O
t0 t0 O O O N 01 <O ~D ~ ~O N e<' ~D ~ N 1' f0 M ~ a0 O
O

O p~pO h O a0O ~ O MO D O ~
NP(O CO ~OO Of ~ f 0 M ~ t 0 N ~ ~ M ~
~ u'7 ~ uN7 ~ V
t0 I~
fD t0 ~

O f~0 ~ ~ ~ f~D ~ ~CO ~ ~O 0 f0 t0 ( f ~D O
~ N ~ tD N O
~O M 10 t0 ~ f0 M M ~ N N

N NNN N N N N N N N N~ N N ~ C1 N N N N
N N N ~O
N N
N

W W W W W_W_ W

lL lL _ u-~L

VI ~ V) fn fnV) N V) N N

U U U U U U ' Um ~ ZC c 7 > C ~Y N

. -. a C

C
p O ~
'N

V O _d LL ~ ~
O t a a ~.- a n a Q

c c c ' a c ' Z

. 'E .E
c ~

E o c " ~ a a a a a c c c c c -.

c m a> a~
. m o d : o m ' o o O
c_ t a O
d d d .
U ~
.

C C C C Of N
O O (n . f0 C
. . ' ' .

(0 f0 C 1..
a -C O L
Y l' O U U N 'o Q >

(~ U
uJ 4.

C

N ~f W
a w s ' ~ -U r m 0 Z Ii ~a V U v ~ H M E I- t~ m ~ ~ u1 U
m m l1J t0 W ~ N J ~ H Z
~ ~

Z M H Q ' or C7 O O N
a O n M
U ~" O ~? ~ a 7 N

- o '~ Ii c ~ a r a ~ a O 1 ~ ~ 1 = d a Ill 1 7 C l11 U
c1 a~

M

Z j ~ ~ M m rn a Z ~ ~ 1-a ~ ~

N lL , = ~ M _ ~ ~ ~ Z O
Q ~

a ~ p D ~

~ =~ a =a w M'=d ~ ~ aw M ~ ' i or~c - of i J c1 Z IL
N

y Y r o, Y .~G . ~C .Y C Z J Z_ c aOp Y Y ~ ~ ~G O J
.~C C wj C C C 4~ N A a Y C J N p O
' C L
C M
~ V

C ~ 1 ~ ma ( 'c m~ m' O p V p m m o m m~ ma m N v m m U O
o r - U a U U
' O O c~ (9 (9 C7 ~ a ,~p o O m y ~ M ,n L m g E Eve E~ E E~w E~ E~ E,n E~ ~E
~ c ~ o a Ua ~ H ~N N 'N N 'N ~N N C a a ~ N a ~ N v7~ a Z O
Ct t.. ~j N 0 d ~ C CNO C~ C~ N . CHV-D
C C~ WIII
C

C C J _ ~ r - _ d -= C d ~ m U fa r NfnNI~Nlll ~~ ~ d d . ~

m~ d d A .. -. .. O h ..
N 7 . . . Q .
~ d M O O O O ~ ~ Z

O O ~ O O O O ~ _ Z_ O N O a a d Q, d ap O ~' lil M N a h N N ~ ~
d y ~ r N ~' d a V
w u7 o ~ ~ N 7 m Q H
lL ,~ Y d N ~ U
s ~N~o? rn o~ om u~ I~~
c c o oNU
a ' ' ~l " z - z'o~zaa a ~ ~ , z omlc~

z z z z z z z H
a 'c~ w = olo~ rn O N < t0a0 O N ~ a0 O N

O OO N N N N NN N N
N

N_ NN_N N N _ _ _ _ M NhW ~- ~ t~ O N tnN N M 1M'1 O OOO N N N N N N N N
N N N

N NNN _ N

M ~ ~~ O M N

~p c0A N a ~ O C
D f S
p O f0 f ~ ~ O ~ ~ a0O ~ c~t0 N t0 N

p ~ ~ O ~r ~ NOpf ~ ~

1~ ~GON c0 01 '-aD P t0 07 t~1~ M N W

O O O ~ N MY off t0 O ~pO 0 ~ f0tD IO f0 t0m ~D m <O
t0 t tf t D pD 0 M

a;
o v ~ t0 ~ N N
Y

O

cp t0 O N N
fD O ~ N
N
N

< ~ O W
~

07 (O n N M N

N W OD M O
tD N

~ C07 O O O ~ M
h M ~ M ~ ~
a0 O O
~ N 0~ N N

N f O

~

aD a0 N elf N N
O7 oD
O

~ O aD O fv O h ~ N
M O
M u7 O
h ~ ~ ~ ? ~ O O
M V

M f N N ~ ~

N N ~ ~
M
a0 47 aD N N ~ N
N Of <

M O ~ ~OO <Dt0 07 aN0 ~ O cD O c0 fD Q~O~Oft0 O V t0 u O t0 M
V
1~
c0 7O O O) a0 h aDO O 01 h O (p aDOf c0 O~ V 117t0 O~V1 (p M O fD 07 ) a0 N O
O

_ p O 07 hO(Ou7 O ~~ V ? ~ M V ? V M 1 W(7V'~f t0 f0 V
V

tD O (D(D O a0<O t0 (p (D (D c0(p(Dt0 N M N NN N N N M N N N N f0 NNN N
oD N N
~f7 M N
M
~

W O ~ O ~

W W L l IJ!J

IL _ _ _ _ LL _ _ LL LL LL LL LLlL

~nv~ E W W a~ u W n W W

a gg =-t g g 3 ~ d g g g g g a 7~ ~ > j ~

v ~e N ~ 7 > j ~

v m c d a v c c a~
-N

N (O
N
C
p O Y

~ ~
C C
.

_ C .N
.m .d E o o o v n O- O_ Ur U
' C_ C_ C_ O

f0 C

C

U

J U
lL

m U o -y N
r U n ' l ~

V IL - V N J
~ O Z

z a ~~ ~ ~O

'' a ~ " v ~ H U
z o ~

. ~ o m V J ~ _ f7 W j a 7 U a V ~ ~ U o U v o d ~ W

a i.

d ~a ~ ~ U yN Q~ Q N ~~ a c9 c r , Y ~ _ Z ~ _ _ O

O ~ -~ 1f O LL n0 O D O O W
N d M .
N

~j~ o _ ~' v ~ ~ =Y ~ M Z
n c o~~ O c g ~ ~ Oa o U ~ c O
U o U C

D ~ a d a'o wU o~Z_ ~ M
n o ~ 0 H

~ N - ~ fV ~ ~ ~ M
d Z G1 W I
f ~

~ N _y~ ' _ _ ~_ O

C U ~ ~ O a O a O O
~ O

Y Y Y Y Y a Y Y Y ~ Y ~L
_ fO 7 (jU Y Q (~ Y CJ
fO . O ~ Q' H

f0 fC A f0N l0 f ~ ~
E D N V Q a ~ ~ Z
~

N V 0 !0f0 f0 N f0 m N m m m m (n ~ C~ CO 61 m Q 7 N ~ ~ > ~ ~
Q a f LL

C7 C7 U (~C7 (~ C7 ~ C7 ~ C7 (~
N N -- ~ N a~ N ,N " ~
= tn C~ Z C~ Z
= C

Em ~'ncan~ E' EvE'NtnEo ENN E Eu~Z~? E E~Z
~

. N O .N H v, in in in,~ ,~ ~, ,~
O ' m a T a ~,a ~ N a O Z ' H ' w ' ' ~
' ~
Cd ~ Cn== C~ CCC_~[yJCL CaZ C GNQ'C C G
~ ~

~ Y N ~ d O ..~.Ø. _ d. r _ ~
d 'T r M '~ H d M C ~ N
a U U ~ U = V Q' ' O O ~ 4 O O O O O .. O O O
M Z v O ~ N N O ~ tn h o Z O ~ ~ a ~

ao M o r co o~ ~ u> > ao m vHH ~ n'Nm I E a d a d a a a ' E ~
U

c o N ~ ~Z o oY
~ U a ~
' > > ~ > > > ~ ~ > ; ~ ~ a, o O ~ ~~~ ~ ~ > r ~ 3 ~
y O d d ~ ~ ~
c z' _ aa ~ a z o~ z z z z z z z z z z Q ~ ? "o~~a? 'o~ ~ 'o~~~ ~ "om 8 H ~~

CO~ ~ ~ VV ~ ~ ~ ~ Oa D O N-.- ~ t0a00 N

N NN N V N N N N N N N NNN N
N

_ _ _ N_ _ _ ___ ~7 n Gf c~ O n Of M ~ n O M ~f7hO
M M

M ~< ~ V Q ~ ) l) y f! D tD tDf0<O1~
N u v t t N

_ N_ N_ N_ N N_ N_ N_N_N_N_ M V M ~ rh m v Of M ~ O N D ~ O Nt0t0v I f ( f a V N f tnN OfN O ) O O 0 Of 1~OO o0 N t N h u i N

~ t 0 0 O p I ~ a0 1~aDu701 N M O c ? I t O D
~ N ~
~

C N p CO M ~ 1 n M 1~aDV O
'f a ~ m m n m n c o~ v nMr <

N O~ ~ O O O 0 ~ 0 aD ~fO~~ 01 N a t O O f M N O 1 Q~ O I~ OhO Of N Of m apN a p 0 N ~ M N N a0~~ I~
a ' 1 f O

( O 0 c D0 0 D 0 O O 0 m f tc ~ t ~ ~ t t 0 0 O (O 0DO t0 t ~ t t~

M M Of O a0 M N M~
aD
V

.
~ N ~ ~ VN
cct0 r a0 N N NN
N N M
a0 M O

u N (O Oft0 cD
7 f0 a0 r O

~ ~ (~D t0N f~0 ~
t~O
~ N

N N N N Nr- N
N ~t O

O ~f DD M O)~l1 N (O
r fD V ~

O a0 O O~ O~ M fD
V ~O st ~ O r t0 O)O (O r ~D ~ t0 ~O

N ~ ~ ~N
~ N

N N N N NO N N
N M N M
~

. O _ ~
CD V O aD N t0 aD rO Yf u7aO
r M O~ u7 t0 ~D
fD
M

O O r O fD~OO~ M OV 01 Ou7 t0 M ?
~ a0 W 10 O O 07 rV~O t0 O~)f0 u7 t0~t7 r c0 M f~0 ~ ~~0 f~0 f0t0 ~ ~tp0 O ~0~ NN
N

aD t O t N Nt N N~~ N NN
NNNr 0 N NN N
~ N

_ f0 N 07 M ~tO iff0~O~O ODf0N n!7O f0N Nr fD N h r N 01 (O
O

O O M O O (OO a0O OfO O raDO O4O O 07 OItf c0 M t0 N ~ ~

Of 10 f0 O fDu7O) f007u')O~tO Oft0f0 O~r Qru7 tD~l7 r Of ~ ~ tD ~ ~~ ~D Dt~0f~D ~DO f0fD ~l~0 ~l7 ~ ~
~ N
1 ~
0 ~D
~

tD t0 N D ~D fDfDf0 Nf0NN f cN N NN N N NN
f t N N Nt N N N N
f N 0 N

N N
N M
N

O OO OO ~ ~~ CtCI CI ~0 O LLWUJ L1JlL p l1JILlL LL111 LL ILl1J
' m LLLLLL LLlL U lL lLLL LLLL l1 ILLL

N ~ ~ ~ ~~

d E ~ ~c ~c a cn cncn Nc ~ c n n n n -'' g 5g gg ~~g gg gg g w 5g m ~ n U UU UU '~U UU UU U '~ UU

m Z ZZ ZZ ' Z ZZ ZZ Z A ZZ

C N ~ > >> >> > >> >> > ... ~7 t0 M M

t0 N U1 '? O

_ O
O O O

LL LL li.

d a a c c c E E E

c a c_ c_ c m ' N N 0! N

O O O m T n n d ~
.

N N N N
E N c c c c ~~ m m n C C C W
n Y

U U U Q
cYn Q

c ,.,~ a U

a o ~ v = o U ~
H

c E ~ _ o o ~ o m . Q ~ ur i n 0 00= W n a = Z v) d y a m m 'r~L ~ ~ Q U ~ p a c N y ~
V
'd ~ m ~c d n.
a0~ d ~
o a a .ni H U O
o n d ~ d a ~ F-a , ~ m ~c a w O) V N aDM M U7 7 C O ~ (nm J f... , (O N OD tD
N p M y ~ E m Q J

a 2 N Z ~ r O V Q
m ~ ~ ~ ~
~

o I I ~

~ ~ ~ .-C Z U I W ~
~ a)U r lL
"

Ol Ol O!0) ~ 01 ~. M U H Q, Q ~ T ~ O fn N

Y Y Y Y Y Y Y Y Y (n C U N C - ~,.~C > O Q
f n jA C ~ (n C C J =
C C C ].
~ a M
' ~ r _ m m O m a m m m m ~ a a m N o ~,.~ ~ ~
m m m ~

(D 0 m m m m m m m CD r V p Q O O M (O W
a H ~' l1!

O O ~ ~ O ~ ~ ~ ~ O
~ OIO N p fn Z U

E ~ ' O 7 E E E E ~
y E f' ~ o U u a E ~ E E
~~ o ' g Q Z

w c ~N ~N N N ~NN ~N NO ~
O - ' z 0 acs m C V N CYO CNC_~ CND CNO CnM
Cd~ CCN J

a? d Wn a?? ~ d > ~ ?? H
a~m M o r Z J
m N ~ O

0 o o 0 0 o o o a r v 0 m O r ~ U
4.

a ~ a n.a a a a a a ~ w m ~ n ~ ' ~ ; f- a c r o w N v N n o E v N o U J
' m ~ ~ d Z Y o ~ ~Y m U ' ~
a p o ~ ,~, ~"~ ~~ >M~r d p p p p O _ ~ f~~ '?

p O _ ~ O -D O O -J
p ' ' ~ -N U U
- ' ~
~

Q Q ~ oi o~ rn a C7 a Q ao Q Q
J

V (O (aO N ~tD oDO NV f0 ~O N ~t0 a0O N
ao ao co ~ ~ o0 0 0 0 r r r N N NN coo oo~a~ >M M MM M M MM
N N N NN NN N N

M 47 r 01 r MN rQ)rM 10 rW r e)N r O rM

r r r r c0aDo0 a0aDOO~O 07O)O OO O O
N N N N N NN NN NN N NN M MM M M MM

t0 r O O a0rO rr MM 0~ rtDN Vr O N WO

O 1A r 01MN (DO CDCDN ~ M O~ EOO M

r ~C N ~ M rN MO OO < VM O rO~ N f0 rO
~n r v o~ ccao< ~o wr r rao~c ~v o o ~.-c o o nf7 Q7 O N M Q7_ 1n (ptnr ~O r _N _ N __ O N Of fDa010 rO ON O Nr r ~ O M ~l0 N Y O r O Of ~h OO O O~ - ~1N N Of OO
a0 m r ~aO ~OfaDa0aD aD~ cDaD Ofr c0N

r CO OfO NM ~10t0r a0 OfO NF1 V off tDr ~

M M M ~ ~ ~? ~~ V~ Y VO N~ u71W OKf ~O ~D tD~D ~D t010~Ot0 f0~O~O t0(O t0t0 t0t0 o r v ~ ~ o oNO o ~ o ocon ~va'no - n cc - cc ~o n o 0 O ? ~ O O M ~ tn~J N N ~ tf7 N n (D r- N c0 . ~ _- O
O O aD O N O O 07 M f0 N f0 Q) n O O aD O a0 M
N M ~ ~ a0 00 (O a0 c0 ~D ~O O_ f0 OD M N ~ ~ ~ ~ O (O ~ (O CO <O
M Of o0 N O N t0 O N N N r- N
~ °o °< co ~ ~ ao c rn n M oe o co ao ci N ~ ~ N f0 r- O M N O) O tD O M O
f0 ~O O ~_D tD M N ~I O) n 07 f0 cD
O N N N O O ? aD N V ~f V ~ <
? - ~t f° n t0 N c0 (O ~O (O f0 (D
O n A n N O ~ M N M n N N N N N N
M O O W ~t M tD O O off M n N fO ~7 O f0 07 N n tn u7 M ~f tO O O o0 O O O O M O aD O~
~c co ~c ~ o n ao o ~0 0 0 ~o °~> o~ ~o o~ ~ec~ ~c o 10NNNNfO~'- ~f~°00 t0 t~° ~~t~° f~O~t~D f0 t0 0D sT c0 V O N off N N ~ N N N N N N N N N
O~ N a0 t0 n O) t0 O aD O n M W n M n O ~ 10 ~O 47 O1 O n O ~O M c0 W f1 fD O O O O
oD n f0 c0 aD O aD t0 O M O O tD O O eO O O M M O tD C1 ~ N
n e%~ ~ o o n o o n u~ c° ~° ~u o n c° °~ ~o a~ ~o ~o m °~ n c° o~ n ~n N M tD O~ r- N u7 ~ 'C f 'C ? ~t ~ (~° ~O f~° (O ~ f~0 f~° ~ ~ ~ f~0 (O (~°
N 07 M ~ a0 N t0 aD ~ (O (D fD tD fD
N N M N ~ N N ~- N N N N N N N N N N N N N N N N N N N N
O O O 0 y O O O O 0 t1l 'p IL IL LL N IL UJ W W 'p U_.I
t_L U lL l1 LL C 1L C L_L ° l_L LL U L_L
N ~ fn (O fO d (O N O N °' (O (n w N
g ~ g5 ~ ° g '° ~ 5 E gN g a g ~N !v N O N L N
Z ' Z Z Z y Z O ~. Z a° Z ~, Z ' Z
O 7 ~ 7 ~ ~ N ~ 7 7 N >
0 r O 47 N
0 o a o °o ~ 'o a a ~ a a c c ~ c c E °' .E ~ E o .E
O V' O = O J O
N ~ C ~ C 9 C = C O C 'N C
~N N .N ~0 ~G7 O d o U p o o n o n ~ o- :.._, a ~ a ;a a C C C U C O C d f0 G ~f0 N _~ ~f0 N fC
,n°
U ni U H ~° U ~ U Q
n C Q ~ ~_ M g n > ~ 07 U1 ~ d N ~ fV O N N
M N O CO .Q (O Z Y 01 y O N U '~ O N
O '' M aD ' n ~ = O V n O ~. v~ O ~ 'H
M V ~ W N N ~ n f- N N E p N
O N n Z fD y O O O ~ Q L ~ ~ O ~ V M 7 O d (O O M C
d ~ ; ~ 'E N ~ M M n .-. ~ O 0 ~ N ~ O
am ~ t~ Qua,na'~ aZZ_E~ aoE~ Q~n jm Qm ~ N d Z ~ E ~ f0 D T ~ ~ ° '~ U ~ O U j ~ Ø.
M O N ~ O ~ ~ O C dp U ~ ~ O O - M N ~, O 7 y~ y O) E n = Q~' d N ° a~D t ~ ~ O CND N m .O m J 1i~ E ~ U1 aool ~~.~ Un. _ aoo '°~ y mUUU~o > a°°o Nao_~ aNO ~
° M °
~ C N m O 4' O 1~ O t° T a ~ d' M ~ ~ U M O N ~7 fV N lL m - ~v_) a c-U=tn dad-S .-,,.= a -N -o a o o~ .. ~ y N o~ cr ~ m 'p o~ m - o~ cy c a c ~ c Q w c ~° .~° c '~t c N c O ~ ~ c ° c ° c E c °~ c c o c°~
m o m ° m N ~ m ~ ~ m o m T m U cn cn ~ a ,a a ,a ° ~ ~ m o m ~
d m n m E m Z m N m ° m ° m o ~ ~ m ~ m ~ m ~n m ~ m v m m C7 o C7 . C7 o r ~ C7 p '~ C7 C7 ° U < u~ w C7 cv (~ ~ C9 a C7 c C7 :~ C7 ~
E~ E_~ E~_~U E_~a E.'--° Et E_~°~~ E °' Em E ' E_'~
E ~ E_~t H ' H a N O. V) Q N d C N 'jn .N Q ~N d Z Z ~N p .b O ~N O ~N r H N a 4 c Y c c c a Z c ° ~ c c Z c a ~ ~ c o_ c c ~ c !o c 'c c o °
d G7 ~ N ~ .-p. 0l Q O ~ ~ O d N .O-. L N .O-. 4D .-O. ~ O .-O. N ~.O-. 1f1 O O O ° O O U ~ O N O M O O J J O Q O M O ~ O E O C O a0 H

O aD 7 N ' M ~ e~ O ~ 10 ~ T A N C
a °~ a a a u~ a ,~, ° a ~ a ° a ~ r r a ~ ~ a n a ° a a o. ~ a °, ._ NO ~ ~ ~ ~ ~ H ~ ~ p ~ NO ~ O ~ f0 I I ~ N ~ y ~ y M V y ~ y M y ~ .-Z Q Z c Z 'w Q Q Z °~ L Z Q Z ~ Z 'o~ ~ ~ Z N 3 Z a Z a ~u Z !~ Z ~-' Z o~ m tp O_D O N V f0 C~ O N V f0 a0 O N ~ t0 OD
N N N N N M M M M M V ~ V ~t ?
M M M M M M M M M M M M M M M M M
~O n 01 r M ~O n Of M u) n 07 M n0 n N N N N N M M M M M ~ ? ~t Q
M M M M M M M M M M M M M M M M M
vlf M N M v O N M N N v °~ ~D ~D O
(D N N M 0D 1n ~ O Of ~_ ? ~D n O U7 W fD °~ O n O W O c_0 aD ~O M_ M n N
aD n f0 M aD ap O M n fD ~ ~ Qf (p O N tp N O n O M u7 f0 M O M aD O
n f~ CO O ? tD t!7 O f0 fD O O N 10 a0 N
n n ~ O O O O O QJ Q _ N N O O~ O N 01 cp 00 aD a0 N N a0 a~ 1' Q7 4D ~ aD n n (D n ap Qi O ~ N M W O ~O n aD Of O N M
p ~ ~ ~ ~ -~l~ I~In I~ Ir Intel ~ ~
~
o _ n ~

N ~ ~ o rn N
n ~ ~
n o c a _ O
Op N ~ 4D
N O ~
~ ~

f0 Of Of N t0 N ~
Of N

t0 p ~ fnD ~I7 ~O N N
O N
~ N
N

f If1 ~fl V a0 N
0 tD CO OD
a0 ~
r N
<

~ t0 t0 tD 10 N
u7 t0 aD

N0 N aMOaMOOMON ~ O

'1 ~ f0 o0 ~ ~ N O
~ff j O O M ~
~ V V O ~
t0 O
h M

( ~ Of O O r fD
0 f tp 0D
1 f aO
0 M a0 ~ ~ ~ <O (O ~ O N
O O O
O O

t N M N N N N O O
0 ~t O CO N
Of r t0 N
tD

O ~

Of N N ~O Nr r nffa0 O r W u) a0 M oD OO fD MM u7 ~ tD Of M M r ~ V
O O ~O
CO e<
~
ef a0 ~o so ~ coa~ a~ o~ w u~ ~n ca O r ~o o r O o tD ~o M
r o so r <o ~ ~ ~ ~ N f~0~ fD (~O~ ~ ~ N N
M N N
N
N

N t0 N N t0 NN N NN N N a0 fD
fD a0 ~ N
N N C>
N O
N
N

a0 O m O ON WV ~ O Mr ~D O r~ O Q~
r N r O r N f0 M
r r (O r M

CO O~ ~ a0 OO QfM O OM O~O O ~ON M a0 O r t0 N 00 f0 <O

sT O ~ r r t0_ ~f0 t0 Oft0~OQ~ O) ~ r_ t0 r ~1 O O O t0 f0 O
tD O
t0 V V W V N M ~~ ~ ~f? VV _ V ?~D V N
O (O t0 ~ tD N ~~ (Dt0 (D tDfDf0fD ? f0 t0~ t0 N
~ cD O 00 t0 ~ O
~O
N

( N N N N NN NN N NN NN N N N~l7 N N
N N N N '- N
N N
N ~
N

N

N

W o 111 W W_ UJ I_J!W_ W

LL N LL l1N l1 lL LLLL LL

O

I VI VIm N ~ V) VIU) VI

g ~ ga ~ g ~ gg g . Z Z Zz z z ~ E Z E zL d 7 Q ! ~ ~ ~n a > > 7>

ci N cc r=
~ ~

N 1A Of1 OD r O
C C ~

O O O O O
O ~

O O O O O
O =
. --[y, lL LL lL lL
O ac Q.~ d aY dd' _ d~

_ ~ ~A N ~ C

C C C C C y . A . . . .
. o .
o E E E E c E
H E r a v v v v ~ c E
' v Cy C . CCO C_=
CN y CnC

d _ d d N
~ N ~ ~ M
- (p D

o = o o o o o u. ~ 'v y U
E a n! n~ aW n~ amp n~

N ~ N N ~ N N
~ CC CC N ~ O
d C C
V p Cn C .- ' C
N
r..

C C C C C C
' N Q V
A D

~ E E O O O

~p ~p ~p m C

U O U U U U U
.~ J O ~ tv S > v ~ w W r a r C 9 d N ~ Q
O y ' ' E ~ r J a O r' ~ U
m o N O o M N O! V m (p M O m ~ I
T E fp E

o ~ c n Q ~ ~ V
o j o o E Q is ~ H ~ U ~ O

p= H r~ N U_n C _ U_~ N ~ J~ ~ U a d m ~ ~ ~ N E ~ a ~ ~ ~ a = a H E E
. ~

E a '~ a m W 9 dH Q a U dN E

r j v m J O '-' a O N r ~ (O M O O ~ M (D V) U d C ~ N N N
r O V

O E ~ ~ ~ Wn ~ V ~ 7 = N 2 (A
~ U Q

U ? M n n ~f7 (V ~ I ~ ~
y1 T N v r = N y I
w c~ ~ 'oi o~ w ~ or of ~ o o Y ~ Y ~ ~ ~. o Y Y Y E o Y Y Y
~ D Y Y Y Y ~ L Y Y L ~
U U O ~ d C ~ ~ C C C C C C C C C C C C
d C H m O O n N (A d L C7 r O ~p N Z l (0 (9 ~0 l9 ~0 f0 c0 c0 N N l0 f0 0 N
M () m ma p p (D m 7 ~ ~ C m N fn E m C m~ ~ CO m m m n~ l0 O OV L N N~ L f0 M
7 7 C7 U C7 C~ C7 C7 o C7 C9 C7 C7 C~ C7 I C c w o E o 0 o y ~ ~ 0~ ~ n O Z
- N C

E~ EaZ E~ E~ Em EZ EZ~ E E E Eaa E EI'EoH
c ~ a~~ ~ r-r-a~ d ~

N C N N N N N N N N N N N N N
~ O N j ~ ~ O ~ ~ O
~.,.~~

C~!~ CNH C_NCt C_n C_d C_dOG G_ C~ CND cn c~ c O J p ' ~

N ~ G1 O 01 C7 G7 ~ G1 N d C7 07 N N
~ C L ~ ~ N ~ E f0 ~ ~ = tD
~ d O t0 O O O O O . O O O O O O O
~ t0 L ~ tn Of O ~ V tf y~ M r ~ O Q
.

d O N- LL c a a a a a a d d a a N M ~ ~ ~ ~ 2 ~ f0 ap M M
O -- r M U
o N ~ N d G1 N d N d d d N N d d ~ ~ 'C p r O N ~ E ~ N ~ fD
V V ~

r Z
O O=J O OE OJ O~ O~ ~ O O ONfn O~ O~ ONIL
~ O O O E

~ ~ Z Z Z Z Z Z O Z Z Z Z Z Z
Z ao 'rn L ~ a 'oi ~o~ Z ~ or ~or a X 'o~
m U' U t a Q C7 p ~ ~ 0 ~O o~ ON V~D e0 O NV tD a0 u ~ ~ t~ 0 o rr rr r ao coo ao 0 '1 0 M_ M M M_ M MM MM M MM MM M M MM M M

O M N r O MN r O) M~ r O M ~ r o um ~n u> m<n cc~c in o~ rr r r aao co 00 M_ M M M M MM MM M MM MM M M MM M M

O r N O ~O Yr tDO r N~DQfN tD O NfD t0 M

r O _ O O N_ raD t0 MO N_ ~ ~ OM ~- ap aD (O M N aD VO ~~O M rt0tD~ N r MOf O

u'7 W ? n!7 a0 t0N NM ~cfc000~M ? Qf VaD tD ~
Of O~ V N !D NN 01aD t0 YO aDtf~~O a0 ~O c0 ~

Cp OD !O N m rM MO ~ NN OCD O M DOf0 N et r a0 V Of O~ ~O OOf~W o0 O M Of N
' M r N m r N01 -aD N o0r r aD a0 aDa0 r op Y! f0 r c0 O O NM ~ ~m rm Of O N M ?
o r r r r r aom aoao m coaoeoao ao rn ~o~ o~ o~

o co cu cu ~o ~o~c ~oso o ~oso~oca o 0 00 o cc o ' N t0 N

r N O
~ O
t0 O O ~

~ N
p p N O~ N
N
~

t C
D

O O
N

01 ~
m ~

f0 N ~ C~ N
~

<O f0 O f~ N N
aD
N

~ O Of O ~ NtD 1~ O
O
aD

O

~N

O ~ C~ N O Nf0 N N
O f0 N

~ N N a0Nf'~7a0Of~ aD tD O c~7 f0'701 Of (O aD
aMD O u~7 O

N O aD c0aDO~aDO O a0 O O O OaD fD 01 O O
aD ~ 0O c'7OY7 aD 07 t0 f0t0cDV O~tp N O f0 (D t ~
fh ~D~ ~ ~ ~ ~ ~
O ~ ~N
~

tOOi~~ ~ ~ ~~ f ( f O f Dm f fD
D(O O 0 ( D
D

~ N N N NN N N N N N N N N~ N NN N N

N

Lll l 111l1J l lL LL LL C
JJ 1l l1 _ lLlL _ lL l1 LL G1 lL lL

g g 3 g g ' g g n n O N V O

~ T

Z A Z Z Z Z Z % Z Z ' n 7 ~ 7 > > 7 O ~ 7 N l0 L

C -O O f~J ~ N
E O O

O O O O O
O Q
O
a a a a av a _ _ d m C C C C C
T

C
. A .
.

N
O

O O O O O
a a a a m c c c c ~
. .a .a .a~ o r .d n m ' ~ ~ 4 c O O ), O O N N
~p G n d - _ ~ H !0 ~ n ~N
N

N O tA
~' V

c c c c S
~ Q E d . . . .(0 .-. 0 ~
f0 O .~0-. f C
N L d C U

c ~ o U U U a Q Y ~

U H U
>

c a J ~ E

o; a v ' w ~ ~ ._ ~ ~ o ~n . r r~ Z L n ~ n a d c lJJ ~ (n n W ~ C~ t T W O
.~ ' ~. O .-.
~

2 0 O y o = ~ _ ~' ~ U
o 0. U ~ a c o ' ~ c ' Q a~ O H n ~ V y Q
CJ

U o a a o m d H U U ~ H
y ~

r N tn ~, ._ r ~ a a m ~ o z m fn ~ o -E = . , ,1 - = , E E o a a~
a - '-' a !~ c a v Q c E

y Q ' a a ;~ ' . o~ a~ a~ .- , c c, m ~ in ' c ~n ~oncl~- ~y ~ "a U y On ~ N~ ~ ~ T

U N O o o Z o m o ~ ~ ~
i d ~d d N a o , ~ o, QQ

p (O ~ O VI ~ N fn ~ O O J ~ m d ~ N U Q ~ ~

V N I - (~ M yn ~ t~ c7 c_7 d I a n a C f- V n Q

_ .0l .0l X 0l .0ln .O .0l0l E N d .0l .d Z IlJn V01C
N

N O C M N w Y Y N Y Y Y Y Y Y Y Y Y Y .
O d Y O O Y ~ O O ~~ N ~ Y O
r = O N N

c c c m m m m m ~ A m m m m ' E a ~' ~ ' o r n E M a N v ~ m m m m m m m m m m m m m m m p d ~ A M ~ ~ ~ C O n D ~ ,..
~p r ~ J N L

(~= U U' C7 U' C7 U' U' U' C7=C7 U' UO~ U
'~ ('0U U coNO c t'N ma ~ o ~o Of m E ' E E E E E E E E E l I
U ~ o r ~ ~ ~ a V '~ ~m E
~ ~ w ' Z

' " ~ 'U ~ . o N N .N N _ 'N N -- ' ~ ' m 7 ~ ~N ~ Z
E .
~

N N N l N N N - N C C C - C
~ U ~ ~ ~ ~ ' L." Q E 1 C ~
j O C N
C r C C C C C C C C C -- ' ' ' d ~ (~ N ' ~ ~ 'a H o ' '~ U ~~
'- ~ O Q ' O 'a o -' ._ ' C~

y a~ a~ d m a' ' ' ~ ' ' cc m m c -- Q M = "i E m N o~ ~ ~o n ~ m ~

o o o o o o o o o o 0 o o o ~
c d v c~ H ~ r o ao 0 ao ~c a ui d E to ao ~ a'''o ao a~~a a apo a" ao aN n.ma a~Q aN,, a ~ ~ c-~ N L
a a ~ y ~ ~ y m -y a~ -y -y y m y o E ~ o a~ 'eo N ~' o N ~n o E
' Y ~ m Y ~ ~ O o ~

o o o O O O Q Q Q
~ ~ N p T M d ~ ' ~
~ X N N
' - ' Z Z Z Z Z Z Z Z Z Z Z Z Z Z
rn oi ,. of U L c> o~ rn c~
N O a> u~ ' Q Q
U

O N < <OaOO N t0 C~ O N Q f04D O NV tD CO

C! 07 W W O)O O ~ O O _ _ N NN N N

t_~ M c~ c_')c7V_V <__~ ~_ ~_ Y_ _~f _~~ ? <V

Qi t~ O n07 C~O 1~ Of ~ V Or 07 M 47 n f a0 ~ Of W OO O O O O O _ NN N N

f~ M M f_~7f_'~c~V__~V V V V ~ VV ~ ~f~t ~ Q

Of N O) N 4DO N O O V ' N N NOf C'fa0V f0 e~ OD t0 N O

V CO a0 ~D1f~O~~ aDN N _V cD f0 Of'C f0 ? _ t0 ~0 a047O N t~aD N O O N

a0 W f~ O NOfO ~ t0 N N a0 00 00 O O M n h O

c~ (D O aDc'~f7 c'~c0 P7 OO u7 CfN t0 ?

a0 1~ ~OOtDN a0~ ('1 Of N t0 1~O c7 WN N t0 v o~ ~oa~a~o o~o v r' o o om ~ m _ (p1~t~c0I~N W N N Nm ~O 1~ N

O fD 1~ a0OfO N (h ~ to tD I~ ~O O ~N fh ?

Of 07 Of 07O)O O O O O O O OO
~ ~ ~~ ~~ n so cc ~c ~oso~ r'r'r n ~ n ~ r~

O N ?
O

. t0 M

<p V
01 r r N CO
t0 O
M

. (D
h ~
M

00f ~

1!7 N

op .
_ aD
I~ V
N N
M

N elf O) c0 N M O
fp O

N

~

0a0 Ot t0 0f ~
~
N

a0 t N

O ~ N
~

r f~ n f0 M

N t0 O) f0 f0 O

N ~ ~
N ~

N N N N N
~ ~
N

p1 . _ _ h Nf0 _ <O r- aDOf O 07 NtD<r OV u7 . aD
M a 0 t0 M ~
M

O O)M _ ON _ O) O OM M(O 01(O O Q) OO
4D a0 OD M
OD

O t0t0 O_ O O O)fD W (O Of O)tplD~O V1(7 t0 N (Dt0 V V~l tD O_ U7 ~~ ~ ~ ~ ~V <V V< ~
f0 O
u7 ~
~

OO
tD ~Of0 a0 O t0 NN c0 t0 tD ~O(Dt0t0 (OtD N N
N NN O O N N N N NN NN NN NN
ID Ofd ~ N N
~ N
~

O ~ ~ ~ ~0 0 C) C1 111 N IL IL lL lL111 l LL l L JJ

C _ _ d V7 tO cn v)N (Od tn f~

(O O Cn N !n N NN NN N Nc O N W
U U

U L A U

o ZZ Zo Z ~ Z

V .Y 7 7 ~ n 77 ~N 7 N ~7 C

M .gyp M

O O

C

u. U ~
a~ c an c c Y E
m m 0 o a 'u c ~ c n o A o >~

na ac N d N
- N

C C
N ~ >.
C
N
O

N
c ~ c E
o U U

' >

y v J _ U N N lL > ' i ~ n ~ N m N
m E a s _ O
~

J MV W OMD C O M n ~
N ~ O O N E

N m O) F- O W '- N = i O
Q H H V ' H

m m N
W Z UJ Q a Q O ~ ~
111 O D ' d L
lL W

O m U ~ Q V O N U M V 0. ~ Z U
0 O Q Q r H ~ v o U D v C7 Q m o ~ n Z Z a tn ~ ~ N a O r- 1- a O Z Z ,~ >, m 7 m E N o ~ ~, E ty E ~ v U E
0 o E o g Q N o O c Q i N C U N _ > U1 ~ C7 ' a ~
O U U d C l1J N
U

~f1 Z O N d ~ ~ ~_ O g N O
._ r G) d N ~ N _N ~ O
r o ~ C ~ ~ ~ O O 01 111 fn V C C t0 N M ~ O Z (O
C ~ N M M
f N O a M
O

O Z ~ Ol O_> g~ ~ ,~> ~~ M ~ ~ w D Ol Ol ~ ~
m O

V DI O N al ~ N ~ N ~ = ~'I N
O ~ ~ ~ ~ (n ~ N ~ ~~ M
L ' . ' x o> 'at ~o~ 'ci J Ol N O1 .. .' ~ '~ ~ d a N
(n Y Y E E E Y Y Y Y Y Y Y Y Y y L Q E O a O O L Q a n = Y O ~ ~ Z
~

C C C U ~ C C C C C C C C C C
U (' O O ~ E p (~ Q
Ill O () O

f0 f0 (O w~ N ~ ~ O O O (C (O f0 ~
N O .w. n = n O n H <L U
~r W LL

m m m ~ N m m m m m m m m _ m Ill M N N T U m J N L N f-'~ ~

U Q C~ n (~ C7 O O C7 C7 C~ C~ C7 C7 U ~ ~ U N U 7 g O d '~ ~ ~ ~ D. a E

'a ~ o d ' a~ H l ... o o E E E E E v E E E
Z Q a o u E

~amx E v cg EL _ _L _a 00 N a n c1 v o ' ' I ~ ~ ' .

N N N ~ CD N N N N N Il N N N N
' (n f' O O a O O N ~ - (' T
D N ILI ?
' ~' C C G c c c c c C C C G C
N E r ~ n n . a ~ E H a N L
~ o_~ . 0 0 ' ~ Z
(n rn 0 Ill 0 O N

.O-. .O. .~.. L .Ø. . .. . r ~ . r V V 'N 1~ N N Q .. . -. O O .. ap ~ ~ V Q' . L a N ~ N f0 ~ ~ O O N tp ~
I~ O O
Q V

. O. M (O O a d C 0. 4. ~ d a d d Ov a ~ O d a ~ a N N d j m ~
~ Z O O ~ ~ ~ ~ ~
+ D ~ O j ~
V

o ~ ~ ~ m ~ ~ > > > > ~ ~ ~
v m m ~ ~ r > o~ v '~ 'r V m ~ Y a ~ to O g O O O r ~ O O a_ ~ O O O O O O
N ~ L~ O -J O O 0 O N ~ ~ J
~ ~ a y O d ~' E
a a Q ~ O
~

Z Z Z N tL Z Z Z Z Z Z Z Z or Z
L ~oW uJ uJ N 'o> ~ n N o~ m Z Q
n uJ ~ C7 . uJ Z

O N? (D m ON tD ~O ON ~t0 c0O N ~ (O~O

M MM M M VV ~ ~ V' O~ ~~ ~IO f0 ~D tD1D
v ~v c v vv a v v ~v vc vv v r ~v _ _ _ _ v of of Sri ~ of ~ Sri t' of~ vivi r~of - c~ ui~

N MM M M Wf M ~ ~ ~~ Wf1 u7u7 f0 t0 f01D

? VV ~ ~ ?it ~ ~ ~ ~< <V ~V ~ V ?

_ v M NN m ~ ~O ~ Ol of ON N MM O u) Of1 N f~~ IA (O COaD M Of Of f~a01~h 10P ~ f' MOD

~ OaD (D O t0 O u) p (DN a0V fvM 1~ a0W
07 Q7 G~ O O ~O ~ ~O a0t0NCO MO a0 aD cpu7 M u7O 1~ V'N N ~ N rO Nf0 OO ~ t(7 ~M

f0 ~~ M IO NO c0 I~ ~OO ~N NOf O N ~V

O) OO1 of h Qi4'J op Of O OM MO r-Of O O OO
1~ f~1~ O h~ 01 1~~ e-N aD a0 NN

4'ft0f~ap OfO N M
O N

NN N N NN NN NM M M M
1' hf~ 1' h 1~1~ 1~ 1~ h f~A 1~h 1~1~ 1~ f~ 1~I~

N a D I ~

_ U7 a0 M p ~ r 00 < D r M M O W
~ _ M

_ D ( O O 1~
O 1n u'1 _ c0 O (D tD
( ~ tr V N N ~O
O N ? ~
f0 tD
07 t0 ( D tD f0 0 ( O N N
OD f0 ~D N
M
N N N N
fD N ~

r~ ~7 O O O O O m r aD cD N M
~

t D0 m ~ 07 0 t O 1~ N
O t ~ ~ n NO N N ~ N N O O N N
N M ~ 07 N

f D
V~ h aD O~ 01 0 ~ r <O
O ~D O t0 O) V
a0 t V ~ O
M

~~c ~c O O O (O ~ c c ~n cc N t0 n ~
~n o 0 o ~o o n ao r u~ s N N ~~ t~D ~t~D
~ f~DQ
~

N O O ~ M N N
tOfOt N 00 N
O ( O
N N N N
N N N

V~ Q) O m 00 O 01 01 N O OD (O 01 aD n ~ 1~ ~ OD 1~
~ O aD
(O N
M

n~ (~O Y7 O O ? ( O O N
X17 ap M O f0 ~f M t0 0 M
N 01 O f0 P N f0 tD 1l7 f VO N ~ V ~ V N N ~
( '? N V V O O ~O
? O

N N N N ~ I <
N O N N ~ N N
N N N

~? 0 O o0O 1 ~O~ aD a0 t~ N M ~D O ~ ~ 01 O
c M t0 M M N O M M ~
~ ~ O 4D
fD 01 N

o a O~p ~ to O Q1 00 O o 0 o n c pp t0 aD m 0~ ca ao M t0 o v rn Wn 0 r~ o o ~n o> o0 c Y V V ~ ? V V' r Y ~ V
o u ~o M ~ V ? o 0 ~ ~ o a 0 ~o 0 ~

c o ~ ~c c~ o o 0 o a 0 N tD N N
e cao ~o o ~o 0 N N N
0 o N N Y7 N

N N N NN NN N N N N N
~ N ~ N

W W W W

l1 lL L_L C

O

VI VI VI ~ ~ N G7 g ~ g g g o U ~ U U U v ~

Z ' Z Z Z

x p~ N O

O i CO

aD ~ M ~!1 t0 O
d 1A O O 0 L p N O
a omE o~ o od ~ ~ ~ '1 E a : m c a o a o a a Q
v c C C
C C .C
C .N

'O f0 D N
~ E

E E ~ a ,~-r o ~ 'a a o o v ~ w a n o ;
E

c c c c a o C 'N ~N _ d O (' Y ~G7 tnn Q ~ O
C

_ ' ' O

d 2 N
C N O C
N O O
O_ N f0 C C .f0 C C .A U
E .
.

(C cC (O c c f0 N
c c rn E

~ E .n N o ~
c o U o U U U U
m d O
N U
~
v a' w m O

OD Z , - H f z ' Q _. Z Y n g N r', r N
~
o w~ -~

U- Z = o a E o v a D m f. V m o H U . v~ N
.. ~ 'a C7 ~ d Z~ ~Z _ Q ~ ~m ~ o r WOW ~ ~ ~
C C
N

U ~ ~ O Q _ m ~ E
~

~ V- ~ Q ~ ~ ~ U .-. O ~
N ~ ~
v r d ~ ~ ~ Q ~ a w O '- ~ n A
m o a ~ ~ . U . ~ N
9 ~ ~
' I O ao v E to ~ w m a C ' ~ ~

O o ~ ~ ~ m n Z D n U ~ _ Z ~ U Qf a a . a. o ' N

O W ~IU~ N ~;~w~v mZZ n ~ cw Z ~ ~M o o U-~ g c ~ ~ _ -~ O ~
~

S ~ ~ ~ ' ~ ?_~ Q of rn or ~ c Z p OD ~ ~
~ U
~

y Y Y O y Y O Y m ~ ~ C C C
H d N E D ~ ~ H
a I O v C C ~ f. ~ ~ a ~ ~ ~ ~ (n W N N OD
V O ~ V C1 [N ~ d ~ f- J O

U ~

~ C7 ~ ~ U U ~ ~ m U ~ U o ~ ~ ~ ~ y Z w ~ A
~ ~ ~ rn E ~ M r V E ~ Q N E E E
U ~ c w m d oy ~ y N r 'N ' 'H d 'N CD ._ ~N ~N
Z ~ Q. ~ fn N ~N ~
. M Q fn r (n C
Q

a c c ~ N c d ~ c a lL c c c Z a Q c ~ ~ Z c ~- UJ c . 'c v ~Y1 ~~ w N ~r ~ Q N N N ~ G7 d CO
N N ~ E E O o g t' A H o n H ~ ~ a O o ~ ~ a 'Z f0 a o ~
t o o o o o o E
N o ~

a a o N n. c a ~ z = E r c "' o j N c m ~ Z

a~ a~ d in ~ ~ oo ~ N F- _ > > O
o X ao U ~ F- j V
d ~ T
C
V

O~D p ~N QEON O-llllL O~ON Oj,O
~~ SNOW p Z O Z 'rn Z v Z 'or ~ Z Z Z
'o~ Z Z Z U c~ ~ m a Y o> ~ w To n n n N m a'o n ma O

ri uin of- of ui v v v v v ~ vv cv v ~

_ _ _ o a ~ in ~ u N M N if N
o v M

~ ,t0 vvN f~ ~ ~
M u7 O

M N r ~ N O ~

fM ~D O7 ~ fD
O

O ~D I~O O01 N N . ~ ~

n ~r oo ao m n ao v v v n n c nn vr~ n n ~ n ~ r ~ cc n n rr~

N O Qi M
op O
~fj ' O N M f~0 ~

t0 tD

n V ? I f~ ~ O
~ ~f N
U

M N N M aN
N D O
~ t0 N

00 ap _ O ~T cD Qf O t0 t0 07 ~ O
~
O

O _ C~ t0 N
O f0 (O
f~7 in m ~ ~ ~ ~ ~ N I~
t0 f~0 m N

N a0 _ N N N O _ N O O
~ N

M
OV ~ ~ ~
M~

O O( ~ f N
u) f0 ~O O ONaO~
O~
t~
0 h f ~D f0 N fD O
? N p N fD
~

tD (p ~ tv f0 t0 ~ f tp 0 ( N
O f~

N O N N N 1~ aD 1~ N
N N N O

Q1 h CD O (O OO u7f'O~c0 ~ O f~7 N O ~ V N f~
O O
W

O O O O~a0 a0aD c0 ? m O
~f1 Of O M ch f010 t0O f0 a0 cD t9 ~l7 t0 O t0 f0 tD c0 tOf1 ~ V V ~V ~ V c0 V R D N N
~O V < N
ID f0 f0 t0 f0 tfO t0O O . t0 N N c7 N N N NN
N N
N

N N N r-~ O ~ N a0 O
D O 1 0 W D7 N~ ~ O 0~ h O O O O a0 M W N M
P . (p O
aD OD
'-h O

O O u7 ?f0 a0O a0 O aD fpO O O
c se cn .n o (O N (p rn M O~
n ~n o n ~c ~ vn ~co ~n c nrn co ~o ~D ~ ~ ~ ~ ~~ t_~
~ o o n ~
~

f t t t0(O (O O O t0f0 ~
N N N N N 0 D f0 0 f f0 tD 0 f N

N N N NN NN N N f0 NN N
N N N N
N N

Q Q Q Q Q QQ

_ W LL l L W LLl l_L lL lL _ _ L LL_ lL LL L LL

N _ g g g g g g~ 5 a g~

N

Z Z Z Z Z _ U c UU
'' c Z ' x 7 7 ~ 7 ~m 7 ~ ~7 G~ N x O O O N
C N D N
O A
. .

d LL li LL
O

a a - a ~

_ C C C
N

t0 N
f0 W

IQ
o o ~ E
Y

d a ~

C C_ N C
y .G1 m .d ~
O

p p ~ ~ N
n O

d d d U
.

O m m H

C C C Q
. .
~, ~ 2 (D f0 A C N ~_~p N

O C

U U Q a uJ

Q

_ Z

a Q Q u' Q ~ ~ .
~

U ~ o O

Z Z ~ ~ o Z ~ a ~

O N o w m Z Z ~., ~ m N E ~ .p y ~ U v E 00 ~ Z O E ~ co '~ n_ w v > m Z a U Q v U t X O ~ ~ C~ U us o m o c Q X ~ 2 _ _ m a v m w a ~ ~ a a 'a H d ~ ~
O v O d O til E E Q E ~ a Q
of m o U ~ 1~ > d r '~ C) O a ' O Z Z fn N G7 N

N
r W Z ~ U N m O M U 10 Q ~ N a N O

~ ~ m t S ~ _ ~ v ~ a~ v ~
Z D d C7 ' D a ~
Q

Q Q I W C~ V N f~ N M T
Z Q ~ C L ~ 'C a ' ~

W ''. p ~ ~ C7 c> m m rn a ~ o Y D ~ ~ o~ o ~
Y Y

Y ~C Y
Z a C C C C O N
C C Z ~ L
W

lL 1n m C d C A C C
Q V d 111 m C~ N m m m m m C m m N Z !n ~ ~ C7 U N 00 ~ N Z O n ~ ' ~
O

C v U C9 U C7 U~ ~ 0 U' ' M N N ~ C7 ~~
' v ( U
E

p Y ~ = N ? >_ a O O
2 N ~ d Z E N E E E E
H ~ ~ ~ ~ m E ~ a a ' ~
~ ~

d ~ a , E ~ ~
. . m ~ ' ~ m a C C C d N N N N d N N
O ~ ~ Z Z ~ 7 7 v 19 .C N E
a O H C c c c c E c c ~ O o. 'n m 'Y t 4: ' ~ ' e0 ~

1~ ~: . .-O. d N d y ~ y O
U a~ -.. N O ~ ~ C N V
y ~ ~ ~
~ ~

J O O ~ ~ O O O O O N O O
a O ~ M O C ' I~ N
y d E N
O
' O a a~ZQQ Ym p a'" a a' av a ~~ W O_ o o ' ~ T
a l f ~ 7 O c o o ' ' N~~ ' ~ ~~ ~ ~ >
pz 'n'~-~ ~ ~

- o o o ~ E m vo ' ~~ t ' Z Z Z Z Z Z Z Q Z Z
o~ o~ oi Q o~ u a c 2 Q a .~
~ m Q Q ~ N a a Q O

c0O a 0 ON V0 D O NV 0 D
OfO O ta c a rr r~ r r r r r r Isf P1 t o n Or M7 h O f9 n n O 4 t o < n n ~ n W m nn ~ ~ N
~ ~ iu ~

_ _ , O ~ 0 Mn 0 ~ M Y

M ~ ?0 t D 0 tD O
a0 a V

W 0 D O a ~ 7 t ( t t ~t 0 O O f O
~ O O

? N ~ p o DCI OCO n N rN
t t O ~ t0 ~~ V D a 0 N 0 O t O i N N _ ND ~ N ~~ ~ O O
N C r Q 1 pf ~~ A p aD N
I C M

Of N V ND aO O O N M
O t n n n n n n ~n ~~ n n ~ ~

n M

N

O O_m .m M
h n0 O m tD t0 m m M fp _ ? K h m ~ m r c0 O

M N ~ t N N O
N a0 D

~

m O ~D ~ O O N
c~~ N
N

rn o~ m <c m ~ Of n0 ~ ? m 'K N m m h N n NN ~NVN N NVO aND

0 ~

< M mQ1 mml0m h_ f0 O_~ M
N
O
N

~7 O m m O t0 O O
f0 < N

p ~ m m ~ n ~ ~~ ~
~

f m O f a O t f0 M ~

N N N N M
N N N
N
ICJ
m h (O N m N O
m N WO h O O O h O ~O
m m off O t0 ?
O~
u) tD
h O m WY O 10 V7 O O h N N O m N
W

a~ h u~cc a~ n o <c a~ u~
~ ~ N m m N m ao uoN
M ~ ~ tD
~ ~ ~
m m ( ( fp f0 ~ N
O O f0 N

N N N~ N n17 ~ N N M N

m M

1A 10h Nh nfl 10 O O01 Nm h ~M h U7 m O 10O M M
f0 h ~ M 117 W O
O

O O O Q~O O N NO tA ~p O O O O N M m O O
m O O m m m N
h 01 m Cnm m _ OfOm u7O O u)m O) 07 m O m CD (D u7 h m f0 O u7 m m v v c ~m v v m nv mn o vv v v w n v m v o m f0t0 10 v m m f0m mm ~ ~ v v m m tD
tp m M

_ tDf0m m f0V7t010 O m N N N Nm N u7 N NN NN N NN N m N N f0M N N
N N N N N
N m ~ N
M

I_lJUJ W V! t_iJt_1Jt_iJL!J U! l 11J W
L

lLLL U~ LL lLlLLL LL lL _ [L [L
IL

fnIn In fn fnNfn fn fn In tn In fn!Oa1 (O V7 In(~fn (n N N N fn fn C !n g g~ g ~ 5 5g g ~ 3 ~ 5 g a U Ud U U U UU U ~ U = U U ~ ~' U

Z Z;~ Z Z Z ZZ Z o Z c Z Z ~ c Z

N 7 ~GI > > > >> > N ~ N 7 ~ N

h m O ~

O O M_ O
O _ O
Z O
~

O
IL LL LL

Q' d Q. d d a _ 2 C

y C C C
. i . C
. .

R n IO t9 T t9 .f0 0 0 0 o a a a a ~ c a C C C C
= N ~ C
' ' ~

a~ d d ~, M 2 .__ o o o c U '> o ~

a n nU n' a ' ~ o O N O N
Z

C C C O
c . . c G E c : m :
'._ m t ~ ~~

U C C C C
m n V E
~

U U U U
w S Y E

N a x a _ a M

V ' K7 V J
, C ,-. ' v O
E ~
?~
.

c p ' , , a ~ o o m im y ~ ~ UJ
N d rn M N ~ ,n o m m p , n ,N U
p E a ~ Q

o~ o UE h v Um y ~o o o p . ~ i t o ~ " t a ~ ~ ~ V
1! N I ~ ~ ~ Q
a ~ , d ~
' aM ~~ a~ ~~ . ~~ ad g ~a >

M n ~ a m a ~ O h nfJ
N. t (~f O >' U

N
M

~ ~~ NN VE c o ~ vc ~o " p n~ %

v r m M c> Z v c m n U
a ~ o v u~ tn M ~ N N a n a'~ - _ ~ w C N ~ O ~ E v ' d ' ' ~ ~ ~ ~ ~ _ ' ~
~ ~ ' p~ ; ~ p~ ._ oo ~ m o~ or r ~ ~ m ~ ~ a H N

Y Y Y Y Y Y Y Y Y Y Y
E ~ n m C ' N a C O

Ca C~ C C~ C CAN Cad CTO C~ CC C('O
la l0 l N Y
~

(a M L 0 f0 f0 f0 l9 N f0 f0 O m m r C ~ M O O 41 ' m m m m Y m m m d p~ a1 m ' N -C O ~ p d Q m C7 O C7 C~ - O ~ 7 (n ~ C7 O

m c c ~ ~ ~ C C ~ (~ C7 ~ o c ~ N ~ o C D Z

N
E E EZ E E~ E Eo~Q
o ~c E o-'' o ~

N ' N ~fn N H ~N . N ~N ~ N ~ N N
y a O ~ ~ ~ T O E
N O E ~

c c c c c c c c c c c E c n o, n d N c c -~
o ~ a ? u1 c7 r N Y1 .d. 4: ~~ :~ ~ N d of U N ~ .p ~ - ~ :fl = N
~ ~ = p ~ d "

O O O O O O O O O O O
>, . M . O h fO 'C d " m E E m U ~
Z

a a d~ dr aa, do a,~ ara a aN~a~aw o d ~ a ' = o m a o n _ ~ -N N d N . o ~ o ~ d cho L O p d ~ d d d U
h N N N C r a7 N

O O u7 U ~ P7 p 0 ~ O > > > > >
M n ~ > V O N O
p M 'p O
~n z zr za zt z'~n aa z' a~ ' u '~
w ' =
d d z c> z z z z n .

O N V mm O N V 0p ON
f a h NN O

M M M MM ? ~ Y V? 47p f ~ f0m O A
m 470 N7 y l7mN t0t0 l7 NW Q m W O 4 1 4l 1 O

7 0 A 1n O M 47h Of M mh m M mh O u7h 07 M

N M M MM M ~ ~ ~~ ~~f7 m mu7N (p M m m D h h t ~O1 l0N 0 0 In470 In!f7 7 4]471I1 47 D ~ ~ 47 7 In V 1 1 1 4 ( 4 _ _ _ __ _ _ _ _ _ m _ v h V N O~ h O N MO M m OV h Of _ h N V
' ~

O ~ m ~ O t0DN VCf h N m ~ ~ OfOf~ ~ t0 t O

M tth Ofl m n M M (p M M_O 07 N h ~ 0 m M
t0 h m 1m 1 O Nm ON O < m O m O t M m c0 m h N _ W ~m N h ~7 N~ m O)m ap u) m ~ h M u7 V

O ~ N ~O ~ M O Om 47Of 1 mO N N m ~ O O N
O ~

O N O OO O ) m mm Om f OO 47 O h m O 0 O
u O f m m ~ hm m m h hh Nh h Nm W m m e-m W N m I
N f0h mO O N MW OO h m01O N M V f7 m h < 1 (O t0O ~Dm h h h hh hh h hh m m m m m m m m ~

h h h hh h h h hh hh h hh h h h h h h h h ~ o c o f~0 oODt00 ~ N M rN (~O

N t0 N r f0 ~ N
O O
O

O O V
Of O t0 N O~ t0 (O a0 Of r r O N
N
N

O r (O (O f0 O
a0 ~ V N O t0 ~
r O
N

N ~ N

N N N 4'1(O s! N
aD ~ O
o o ~ ~

ri ~ m ri o_o M ~c co N r ~ N ~
~ N
~

c0 tD O tD ( fDt0 O
r O

~ ~ ~ < N O N < ~ ~O
tp N (D c0 ~ ~l7O t0(O (O
N t0 f0 N t0 N CO N N N N ~ M N N N
~ N f0 ~ r -O O

N M u'1 V'O O aDO e M
~ O~f0 fp O

O M O M O fD a0 ~ f0 aD O) t0 f0 t0 ~O O ? u7 Ofr 01 O tD
N 10Of f0 V
W Of10 O
t0 N ~ ~ ~ ~ ~O N ~ ~
07 ~ N N
N

N Qf N N N M O) a0N N N N
N N M r N

O r ~ r M M N N O r O ODOD h NO aDQ1 0D O)~ ~O ~ r ~
r M

O O a0 O N 07 O a0 N O QOO a0O O O~ O t0 r- M (O tD t0 f0 ' t0 tD

rno r o o co wov M r w rn v~ rn ~c~m n r n o a~ u~ o uo o u m NInO V O ~ ~~t~O~Of~DN~f~0(~D f~O~ ~ (~OfpO ~ ~ (~O
7~ ~f~O

N N _ N N N N N (O N N N NN N NN N N N
N N M N N N
N
N
N

~

lJJ _ O W

t C LLy V LL
L

_ x N N :~ N m N (n p ~ fnT O.N fnZ

~ x - ~ g N

t O U O O U ~ N UN N

~ Z i. E o Z ~ 2 ~, ZR 2c , 7 _ N L O U N ..L O.-. NY
N O

r o if m _ O

O O O

a a a c c c c ' 'm m E d o m o o y c a c w c S c c E r . H
.

y ?
o o .c o o a a o n $ o o _:

, x m c c o ~ m o E

G 'm ~
m d ~
m ~ c ,a c E c E o_a U U U

v y c -_ ~c . ~ d C . , . . V J
E ~E 7 ui ' ' a cu a n v Q U ~ U
d ~

O p~ a0 C ~p O aO ~ r ~ H.
N V H ' 2 a m ~ a o u ~n o o w ~ ~ m ,~ v O '~7M _ N ~N M O _ M"N_ O~ ~ I OC
~ r H.
M n aD CD ' O N C~ ~ m U F-U N 7 n1 ~ U O
O

E Q ~ ~ O Q U Q T ~ O U d ~ 7 v U ' U c0 tn U v U N

o M m a ,~ m ~ ~ a a ~ ti a J r ~ d M ~ N ,~ o a c y a O
M .r .

Q 7 a E a a ' E E E E a Z E
' ~ E o ~ ~ ~ ', a>

~~ v d v a d d a> d . ~ ' W r N O

OfOf 00 OD c0 d ?? r O 1_~ ? Z N lL
~ _ N ~ J U ~l N N T

r ~ r V ~ O C M st N (f ~ ~ ~O ~
O OD M 01 Q) ~ a0M v1 W > O O Z
~ H Q ~ d < U

,om cp a> % m aor m n r ~ .~ Q v Q
u ~ Z n r E O 0~ m E
a o m cp v ~ o co c v ~ ' 0 G m Z
r = . ~ ~ y o ao rn v r ~ = r U
M r o rn M ~n Q . c a ~- a N N 1n N (~ - - ~ (V < N Q OI N ' C N ' ~ E 7 Z ~ O p r vc,vc,y, 'oi 'or'o~o~of 'o~ 'o~ of r. Q ~o~ ti m ~ E ~ ~ ~ E c U
~ ' Y YO o YdQ Y Y~ YOYN YC Yj0 Yn Yra Y= YC YZh YE

C ~0 AO~ _ N m~ _ N mV IGON Ar A~ Nor N E NO U

ca1 N A Aa ~ m (O O m N m m CO
G O m m m L O m m r ~ N
7 C "' H N O
N

O O O O O O O O O O O
O f0 D ~ V ~ L Q ~ C
V U a E E E E E E E E E E E E E E E
' ~ ~ 'v ~o ~ ~ a n ~ a =_ Q
~ E m a, . w ~N'N 'N ~N N 'N N g .N ~N 'N 'N 'N 'Ul ~N
j W Q ~ ~ E L N O T C O E
O

C C C~ N C C~ C CQ C~ G Ct C C_ C C_ O.V C ~ ' ~ GO ~'y N~ O HO
d ' ~ =
~

N d 07 N N ~ N d d N d G: O 4:
C y ~ M j Q ~ ~ V ~ ~p ~ N O ~
. O
~

0 o 0 o o o o o o o o o o o a c ~ ~o ~ ~ ~ ~o p ~ ~n M o 5 E in Z

a a a a a a a a a a a a a a a ~ r ~o ~ ~ o " ~ ,'~; ~" ~ ~ '' ~
o - ~ ui o N N O ~ N O _ r ~ _ d d d d y a . N O r O M
N ~ ~ ~ ' Y
M
G

N d G7 N d N O d d > > > > > >
> > > > > > > > > ~ J ~ O ~ N
N jp m J N N V ~ ~ d a Y 01 ~

aN oa o0 0 o o~ oQ oQ o o=~ oQ,~ac ~ c ' ' ' Z Z Z Z Z Z Z v Z Z Z Z Z Z Z
L ... ,-,._. Z H c> oi H v~
n d (Oa0 O N V (O aDO N V !paD ON ~ f0aD O N V

r r a0 aD a0 00 oDO W O)O1O) OO O OO _ _ ~ yW ff ~O u~ u~ ~ ~ u')~ O ~O t0~O ~O ~OtD t0f0 ~O

nfiI Of M tn r W M ~lr O M n0r Ofr M

r r r m co ao coao rn o>a~~ rno 0 00 0 o D

~1y n ~ W ~ uWn ~ uWt7~7 ~to tD tD~o t0t c ~?~O ~D r t0 O ~ cD Oft O!Of a0 O01 M M N
O

_ _ O N ~O M 07aD N aDO NOf O~ NM 07~

_ pp~ ~ tD r r N O ~ r N 61 OM 1A 117N 01 CD
r ~ V aD c0 O)~ Of N r Of ~ r< Of~f O Of op W O M M r t0 r <O47 rO t0r 01ap a0 u7N N t0 O (O aOO c0 r a0u7 OV o0 N ~ M
~o c r cc ~ o a~ o cc r o~a~ ~o o~ o~0 0 pp pp O ID r aDaD OD apr r ra0 r N~ r aD aD

00Of O N M N t0 r a~O O N MV M ~ r O O) ~ OO O O

a0t0 Of W r r r Of O~ O OfW co0o ao OO O ao ao r r r r r r r r n aoao ao O I~_ N _ Q! N
In ~
tD f0 '- a0N aD a~ t0 O
O (pN ~ tn M O~
m _ h O) fD
f0 1n V O

v ~ v ao M ~ a o~
v r Sri v rn ~

n M v M ~o M N M O P fD ao N N 1~ O t0 W
N ~f7 fl 00 M N O N t0 M
N ~t '? M
~

O 1~ N O O O O tD M
M a0t0 ~O 07 O~
c0 N Imn aD I~
O O~ V N N ?
O
M

f0 O fDN t0 M O t0 (p f0 P i0 (D 1~

~fQ~ CD N ? N et N N N ~O O
M M
t0 f0 f0O M (D ~ ~ tD
? fD N h N e- N
<O 01 M 00 M O
N N 1A t0 M
N M M N
N O
t0 ~O cD M O ~ ~
f0 m N EO
<

1~ QI K7t~ O O~ O O ~ 1~ O
N a ~O
O D h N O a O
O t0 t0 O O _ , <O O MOf fD
O _ ~O
aO N N V t0 ~
<D Q7 N

O O fDN (O O O ~D (Oc0 h 01 t0 V 10 aD tD O ? ~tf tD N ~O N tD aD
~ u7 O O
< 1 ~ '- N t0 <

t0 t0_ O (O t0f0 (D
f0 N ~f7 t0 tD
f0 fD f~
f~

N N N aD iID 10 O N NN N
N N N M N N N 1~ N V'1~ t) N t0O ~ M
cD O M Of cM'f n0 O 1~ ~O tN0 r W c0~7 O
O
~

O O O ap M ~ ~ _ O maD f0 O M a0 N < O N
(D O
aD

t0 O) tD1~ 07 t0 N c0 ~f0 1~
Y t0 f0O O t0 O aO ~ etet (D 1~ < t0 h ~O
V V N N N f0 N
~ 0 10 ~ u7 N
if N '-t0 u7 (O

t N t0 t0 O f0 tDfD f0 N N t0N ~ 01 N N N NN N

N N f0 M
M

01 a0 01 a0Nt0u7fp aN O ~O N O O O OO O
OD 010 ? ~ r CO O
1~ O c0 O
W

_ _ _ O O t0 O7OfO O a0 fD f~ O O ~t t0 O O
Y7 c000 N h M N
a0 h (O

W O M ~OfpO~W ~ M V Yf f0~ I~ M t0 O u)U1 O
~t 1~ ~ ~?< h O N O u7 ? u7 if ? ~~t ?
fD t0 f0 ~ ift0 ~ 01 ~
~ V V M fD u7 N
V ~ h c0 Y o0 < t0 tp f0 (O
t0 O1Dt0f0t0 01 01 f0 ~O (D f0t0(O f0 N N N NNN t0M tD f0 N N u7 N N N NN N
N N t0 M f0 M
N N N N N M N O
N N M N (D
~O
M
M

~ ~ ~

WW 1 W l Li lLlLl1. _ _ _ _ _ lL ti. 4. lLL~

~

a g gg~ ~ g g n 3 g ~

U ~ UUU ~ U U ~ U U U

>>> N ~ 7 ~ > > >N

O

n ~

O

O O
O O O

LL C

~ d _~' a v 'm c c c ~ ' E
' m m m 0 ~? ',~

E

v v N ~
n c C C U C
O . C

d d 7 G1 L ' O O O
N O r ~

G O_ U
a o U

N ' _ . .f0 ' .
N

N C
C
~

U U Q U
ti ~
v Z c N N
C

' O J ~ O ' n ' O O ~
Q ~' E

~ N

nD HZ ' ~ c 'w o ~~ <paNN 0 t o~ ~

~ ( Q N Q ~ Q H ~ N d ~ O Z N E

U N
aw o m o c ~ a~ ~mm0'c' a ~

~ Q a, ~ N
"

N N ~ ~ Z ~ X m ~ 7 in W

d d '~N O ~ ap N ~ f0 N
Q~ ~ ~ Z ~ . _ N

O p J J ( D f0 ~ r ~ M ~ ~ ~ d O
. g ~ L ue H CI O

U Y O ~ ~ c a ao ~ o U aro y o O U o o I > m d h in tn m - _i cn w ~ p ~ ~ > m M
~ ~ ~

Q ~ c ~ N , ~ c D Q ~
w E

U ~ ao ' orw ? ~ ai p~ H~ 'w o a3 'ci Z N cn ~ 'y n N ' Z m ' V ' c c c Q c O c c ~ J O c Q g Q '~~ ~ c c t Q m a ~
a Q z o_ ~ ~ cn CO CO m ~ a 1 07 ~ O D O D m N N f0 O U ~ O ~ "~ W
Z O

C7 U' C 7 C~ O C C C U' C7 ~ O
r U' ~ j C') C7 C ~ ~
N U o C~ Z
N

= i. ~ _ m a O
~ D Z .
Q

N N N H N 'f E
~ U H

N d ~''A c L a U ~ . F[y~-S E c ~ S ~ Y c c c c ~ ~ w c , a y a ' m Q c d Q

4: O ~ N . 0 . _ ~ ~4:~ _ N
N f0 0 L d r Q N ~ d O Y
O a 0 L ~ Z O
N Q

O O O N . . .. O O O O O V O C
O fn W O . ~ O ~ Z
Z ' C O N a a O a 1~ N ~p N t0 ~ H V a O ~ 2 a a a d d . N ~ 1f1 M 4. Z N m U M
Z M ~ O N O d i O

= N f0 c Y a>
V . p o ui o o o 't o o m o o o o c ~ o o ? ~ X Z ~ ~ "' ~ o ~
~ ~ W a ~ d Z Z Z 'p ~ a N ~ _ N X
'o 'o O ~ d ~ i ~ Z Z Z Z Z Z Z Z
Q m ~ d o~ ~
r. w or c 0 O N~t0O O N ~ 0 aD O N ~0 00 D a t t c _ N NNN N M M M M M ~
t0 0 D f0(O100 O
t t t t0_O _O (O _D __ _ c f t ~O A 01 Mto~ O M 0 h O Mn r NNN N N M M M M M et<V V
~O O 0 ~Of0t0O
L t t D f_DD 0 t_0_D tDOO t0 f t ~

~~ M O 0 O P D O O~
N t a O

f D a0 O O r m N ~ Nf0N u 7 O1M D ~ D ~ M
1 ~ ? O M f 7 N N
v N a ~ u7 O O Of1 ~ _ t ~ 0 _ ON<D V a N O7 N O r N V
~O O OO< ~ O p O O O O W O
O O ~ O
O ~ ~

M 0 O Ov-P 0 ) ~-O~ a0 0 n 00 m a a O 0 Q O ~NM ~ I7 f0~ O Of N <
V 1 a O M

O __ _ _ m _ W O D ma0m D m m O O m aDO0 O
a O C c f0 ~ N ~

O _ _ ~ M at Qf O aD ~O t0 O
~ O a0 ~t ~ c0 M et M
M M O

~u a~ n c cc r . c n . a~

N ~ < m ~ N M
V M OD
. t0 t0 <
N t0 M . M
O f0 O N N t0 N O 0D
N CD (O 4'7 N

~ N 10 07 O M
~ < O t~0 V N

r N ~ ~

u7 t tD t0 ~ 0 t N t~0 10 ~ N f~D
Of f0 O ~D
f~0 N

10 N N O N 1~ N
f0 N N O N
(O

O . . sf M t0 .
. _ (p t0 O O
07 O O I~ O
t0 N aD 1~

O O N M V (O tD M
47 ~ N of Of ~O . f0 1~ O f0 fD 10 N V N ?
(O O) ~f N Y < h N ~f ~ V N

fD ID ~- (O ~ t0 f0 f0 . tD
.

CO N N O N N N 1~

M _ V7 O . . ~ _ . . (D

~fl a0 V O~ N if O~ ~ t0 a1 O) O f0 ~ h N

O ~ ~O M~ V O p U7 ~ N
M M e< tD t0 10 t0 f0 u7 Of h ~O O
f0 10 O~ N
c0 01 W

N ~ ~ M ~ N ~ ~ ~ N
~ ~ N ~ ~

O N N a0 N I N N N 1~ N
N N tff ~ M N

c0 . _ _ (p . .
c0 N u7 M O 1~ ~ a0M ~-t0 N O ~O ~f7 O) u71~ fD N
07 O O 1~ O tp u'7O ~O O O a0 ~ OfCO O (D
M h Of ~7 O Q~ tO M
(O M M nl7 aD O O

O ~

(~O ~ t~D ~ f~0 N t~Dt0 ~Ot0 ~ ~ p f0 ~ t~ fp fp ~ (~O tD t0 0 O f0 N N N ~ N N N NN (ON N N N N M NN N N
N N ~ N N
N

0 ~0 ~ d t W lL L!Jl LL LUJ l v JJ 1Jl JJ l! L

_ L_L __ l_1_ L_L _L_L _ y L_L t_L~_L L_L l_L l_L

(n V) Infn fnfn !A fnfn fn C

g g g3 g5 g ~ a 5g g U U UU UU U ~ ~ UU U

Z Z ZZ ZZ Z c c' ZZ Z c 7 7 77 77 ~ ~e ~7 7 v r=

N O

N O

O O
(' O O

a a~

c c 'm 'm a E E
=

a a c_ c_ ~ _ N y N M

o o c U

n a ~e N N
N p ~

l0 l9 > w C _ ~ C
V

O O
>. c U U
d n1 c Z E Z ' J n . a n L U Q

V o~ cu ~ ,n N ~ U c ~ y ? E u1 a o o ' ~ w H r w a ~ 1- =
o ~ . j a o a S ~ ~ !_ o m _ d ~. .
U r v ~ o o d O
w U ' d ~ U~ U ~ o o= ~ ~ ~ ~ ~~ d c o a E E d d .n j = a g ~ d w E a Q >- j ' ~E
N ~ E

d d ai ~ d , J Q
o U

J p N ~ C M O a O In ~ H
Z M C y N Z
a r N O O a O
~

N O f0 ~ O O O M F- r ~ f U

~ ' r m U U
~ Z

I ~ M v ~ m I I
Q a> 'rn 'o r'a g r '~ a o a a ~o i a > a ' ~ Q
E

i d r , l . Z

Y Y Y y N Y Y Y Y Y Y Y Y
[yJ _a N c N p lL d ~ C7 O c c c O c c ~ We c cp c~.Q
Q c ca W
c ~. X y F. . _ M
~

f ~ 00 m A t~ m m m m m m m b ~ ~ ~ ~ cV ~ p N U O r Q

(~ ~ C~ C7 E C~ C7 C7 C7 C) C7 C7 C~
M d N y U N O (~ 0 an o - ~ U
C

E E E E c E E E E E E E E
a a ~ ~c L a a ~ I
w o ~

'N N 'N N a 'N 'N 'N 'N 'N 't/1N N
- ~ ~ - ~ Q - ~ a _ _~
~ ~

CNO CL ~ CQ~ C>' cn CNJ CH c~ caV CNO c'7 CdL

N d ~ O ~ N d d r O r N d O
~ c0 ~ N L t0 d a H ~
N U W ~ ~

o o o o ~c m o o o o o o o o M ~ i O m c:> ~ r M u~
a m ~ w a LO N M OD Of O V1 tD ~ f~
N a O d dM dOQ lLrW Q.O daOZN.~pOdr a E 7 o N

N N ~ - O c _ ~n - o~ op - u~
Y ' N ~- ~ o ~ J rn ~ Y

> > > > > ~ > ~ > > > >
~ i ! ~ ~ N N c ~ N
'n a> v a ~ 2 U o ' 1 ~ a ' ' z~ z'- ' ' ? ~ E ' ~ a E

z z z z z z z z c> z z rn~ a a a ~~ ~ wY o~o m O N fp ODO NV f0 GD O N QfD OD O
W

m n n ~re re~e o so n n nr r ao o o o ~o coso cco o ~o o ~o ~o~o ca o ~

ai c~ ~si nai .-ri iri n ai ofui n of W ~n un ~c~c ~c w o ~ rr. r r c c o 0 00 0~o o cc o o cco 0 0 O h h N ly l7N V N N N OM t0 O ~ tD aD nff~O

O N Of MN N u7 tD ~ N M NO VM (O h ~f u7 ~N 00 ~

c0 N ~ <D Nf0 ~t0 (O aD O ~D O~ O~

M ~ u7 O ~p M N N ~ N ~O p u) f O O hM r-Yf 1~ V ~f~ tD O
fD

0 0 ~n o nrn o v cu ofa~ o~ o N a0 Q~ a0N ~O~ N N O fD hh t~ cD
~

u7 0 1~ m OfO N M ~ ~ t0 I~a0 Of O
t N N N N NM MM M M M MM M
ao o ao ao aoao com cfl m a~ ao mm co a v M c ri v ~ . so r cc ~ci ao r~ ~ of co co so m ai m ~
M m o u~
N o~ ao M r r M ~ <v a~ r u~
o~ a> ~

m _ O ~ G~ O) c0 O V ~ V' m m r O M N M 10 V ~f M
t0 t0 O tD
fD N
f0 f0 m r M fp m m ~ O

N .
.
.
.
.
. ~ ~
m r r O~ M V r M ~ N N ~O O O O N
m O M f0 N
m ~ tD 07 u7 u7 ~ O
m m m _ ~ . .
. ~ ~
Q7 N N ~ r M ~
M N N N t0 O~ O N O 01 O ~ O 01 -.- N r ~ t0 ~ M r m O t0 O

f0 m N N ~ f0 N N W N 1D u7 N h _ ~D
O) r N N V 07 N ~ N ~
O (O r tD N r t0 O M M m O ~ 10 m m _ O ? Q r N ~ fD m O N N N (O N ~ m m fD
Of r r ~ N N ~ N

O tD m O O . N N O~ O) _ M O O . tD O
u7 N tp r ~ N '- N f0 f0 O . N M
~ O) 07 O m m ~ V tD V V O O N ~
~ N f0 07 u7 N N tD ? m V

f0 . m m O ~ '- fD fD O O r ~ . m tD
N (O . m ~ . . t0 ~ r ~(7 O
O r r ? M M ~ N O ~O W N O m ~ N
N N7 ~ Of ~ M m M M Qi c0 O . m N N ? M M ~ _ ~ . f0 . tn ~ _ tD
m O r- ~D ~ N V ~ m f0 V N N tD O) O) O f0 (O O M W f0 O
~ < N r O ~ m O r O O ~n ~O

O ~ V N N N N N N O N '- M u) N W m t0 o ~o m t0 N M O r N tp ~ M ~f7 so _ . o~ . a> . n . m m r m o .
_ r m . . m _ ~n tl~ N N 1!7 m r N 01 m V ~O V t0 ? fD N
V V V O m r ~ m ~ M ~- M ~

tp . r m r N m N t0 M (D u) cD O . (O
N ~ tD (C '- f0 In O M tD tD . N m m r 1n N ~ m N m N V N M N N r N N
N N r Q) 10 M N r Of ~ N

. N O N (D '- ~ N r- _ N . M . ~ ~ .
1n m fD ~ _ fp ~f7 N f0 m u~ m In Of m M M M N m O~ M m ~ O N N 01 O) O ~ N N m Q~ t0 O~ (D

~ _ N
n ~ ~ ~
~
r Q1 M ~f7 f0 ~l7 tO
V M ~ 1D
N O Q7 O O) O) t0 O O r t0 t0 c O tD
(O ~(7 M N N c0 N ~ ~O u7 tD V ~7 N ~f V ~f V N ~O ~ ~ N M N M

t0 O) N . . t0 . t0 . fD . . m m m tD .
_ . (p (p N N ~ N f0 O O ~ N N N N N N V O N N
M N N r Q) N N O ~f7 W LO N
N ~ _ r O 07 m N In _ ~ _ M _ 10 Iff . . (O N _ _ O
fD (O r u7 Or OOmO _ M m ~f7 O) Of O m O r O m r ~ O) ~J
m m m r (D N O In Ifs O O _ NO ONt0O m V m m ~ - (D O V O '- O Of m f0 O
r N O O t0O~ 01OW07 V m t0 tD m N O~ r t0 ~ ~ M f0 O ? O m h m m ~ cp m ? r r r at M O~ ~ V O M u'7 O t0 r V N r O

V _ sf47 V~ V10er _ V
O ~ D t0 (OfD (DfDO~ < N N N t0 M tD ? tD ~ V 'P ? V < f0 m V O) nf7 sf f0 V N m <
f0 t0 0 M r t0 f0 t0 tD ~ 01 fO (O M r O ~7 f0 ) ( N ( N NN NN(N u7 N N N O N
N N N N ~
N f t N f0 N N ~Cl N M N U7 N (D N M m N N N N N N N N M N N O N

O W_ O

U L U LLL
L LLL

.fir_ w ___ N (nN(n d ~ d ~~ 5 ~ ~ 5gg U ' ~ ~ UUU

l' ~' ~ N Y >>7 (D O O tD O m O D r O N O
t _ O O O O O O
C
t O O O O O O
d tL LL LLLL lL LL
a. a a a a a c c c c c c ;, o ~
.E E E E .E .E
a ~ " n ~ N

o o o o o m o ~ :~~

~ ~ ~ ~ .O 9 N C C N N

C C C C C t C G
= N O =
' ~ ~

Y N N G1 N C d 'N
N G7 a N

o o o o o N o U a 'cU

_ d d d d y d O
d O N

N N N N N C N
~ ~ C ~
O

C C C G C ' C (J
C C ~ C m ~ W
- M ~'w Otr Ay C t~0~ t~p C U C C o O
U d d U

o O O O ?
c C N S
f~

U U U U U C7 U .
iv i.~ a i~
U

c~' Q

_ n ~ Z
N

Z r N V > O
~ 7 O u)m ,N

G> ~ O O~
U

d N
d c f0 ~ I
o C

L N ~1J

a d ~ ~ N = Q C
C fC

N ~ ~
N H

m ~
o v E d ~
J J

= N ~ O
(9 p c 'm~N O y ~ G.
N C O ~
O

~ _ ' _ ~_ ~ ~ o ' .o~' ' ~ o Z o C C a C ~ C N
C C d = C ~
~ U n m > m m m m - m t0 X , N O m uJ
m O ~
O

~
c N N N N f9 H a N
a E d (~

c cy cYCY c0 c_N~ c_d . . .~ .

E Wifd ~ O u~ ' o ao Z

O O O O O O V O M
u7 M V m l~ N d ~ d d 1 ~ Q
O W

!L d m N .
~.

> > > > 7 > m M m O O 7 =
Q

O O O O O O m ' m m m O J
U

Z Z Z Z Z Z of Z 'o~
'oi ~ Q a ~ C~
J

N ? O m ON ~(DaDO N V
( m 0 m m Wf OfOfO O O
a 0 m t0 OO f0<O~Or r r fO ~D
t ~

M N r 01r MNrOf M

m m m m mO O07O)W O O
~o o e so ~nm cc~c~cm r r < ~

m v r o~ v~ mmro> M ~o o n d v ohov c~con~~ M o ~ a o c c cc m N <cM mo>sor ~ y o r r r o v <c o~mu~ N
c o M o 0 0> Mm mvrc M
0 o r r mrn mmo~o~ ~n o m m m ~r rrrr a~

~v v ~ ~ $~ ~ ~ n m m m m mmm m m m - ~ N
M N . N _ Ir n M 1t) m m O O N m Of O O M O V M N

m m _ V 01 N O W O M tD _ m ~ m O
m M In of ~ '? O
~t N N at O

m u7 M ? m fD O m N M
N N N m Q) M O f0 N N m O N
m O m (O N n N m Of N N m N m m n f0 t0 m n N

O N O _ N O N O ~ O) N ~
N ? N M N

YO m u7 O~ ~ u7 O fD
m ~ m _ m ~
~
~ r ~
N
N N

~
N
O

N N N ~ 0 f ~ f f 0 f M t m N M 07 N N N ~ N
m n m m N O

ID n ? of t0 . _ m _ Ip N vto m M fp N at . O~
al m o In n ~ o o m n n o m co n o cc nM In m _ m _ N to M o v aWn N
In N

m u7 Ofi0 tn O . O 1n 01 n O fD
~t m M~ ~ ~ ~ . 10 N
M m 1l7 m V if ~l m N In N N m ~ N

tD cDt0 tD m O N N m m m _ t0 . . N O m N O m NN N O m m_ N N N n N
M m 't W ~ n N M
C! m ~ _ m m m W m M NO n nm n M M m m Of M M
N n n n m O ~ m ~O IA mM N M M O O O m O 'C
m O c0 < ~f0 1(f mID it OI N M N
O N O O 07 O O ~f m m m m m N t0 M

117 N N ~ ~ ~~ N N N ~f IA N t0 m m m~ m m(O ~ N N fp ~f V
m m m N ID
~ m . .
N N N NN N NN O
~ ~
N N N N 1!f N
N
N m (Ot0 N O m Of01O O. Wf) m 1AOfIf7 M N If7 M ~ M ~ N
m N
M N m m u7 O
m fD N M N ~ er u'7 01 of M Ip WWM O N mn Om InM m OO OO O _ O7 m~u'1m111m m If7V.~~ t0m NO N fOO mf0 m f0 O O C~ O m V M u ~ ~~~ O ~ m ~V ~I (D M M m 7 O O D Q7 M M W IA O 1f7 ~ m m O ~
~ t ~

( fff mmt ~f ff tp ~ t~0~ 1~0f~0t~D ~ m ~
D 000 0 ~7DDm 0~f~0 t~
a ~
NOMfOMf(~Ot~DtOC~Df~OmNm~fO~

N N NNN N N NM NN NN N NN NN N M N N N N N N N ~ N
~ ~ N In N M N N N

llJt_L t_Ll_1! l_11L_1J W W l l L L

_ _ VIVI ~(~ N VJ ~ N ~ N

~' 5g gg 5 g a 5 g g UU UU U U '~ U ' U U U

ZZ ZZ Z Z ' Z ~ Z Z Z

77 77 7 > > 7 7 o~

n o~
v o a a-c c ~

~
d E E
n a a N

c c =
~

d N
N

0 o U

a c c ~

N N
f0 C C
~E C

IC N
O k-C C
a V

~

U U
v nN

al d ri a> a Z >
-_ C UJ ~ to m ~ Q v a p ~ n a a ~
-O o a~ Q ~ n E y n ' 10 C a ~ ~
~ N U QI

N CO C ~ Y ~ u1 N N ,~ al UE ano~o UT ~ tr-w U o~

~ a ~ ~ 0 E ~ E ~ _ E
E
o y ~ y Q ~ ~ Q
,a Y n _ a ' a 7 m N ? H O V
y M N d N m O m Ip r N m O Q N

U ~ 7 M

N m Q N I h U
C

t~ c~ Ire n co ~ ~ al ._ -.OI .01 .O .O U -N d O O ~ 01 H N
N n V O=

c c c c c E c ~ ~ =

~ c m ~ D U
V p y C C m m ' C7 C~ C7 C7 C7 C7 U g C~
n N O y to o '~

m o o ~ o E d E E E E E c E
E a ~ y ~N ~N ~N N ~N ~N ~N a ~N
O V T ~ ~ ~ C
~

C C C C C C C R
y ~ L N N
t N ~ e0 a . . .' . ' . .
n ~' r ~ O E
E

cc Wn n m a a a ~ a' a a a n_ m E
M w ,~ ~
o c o, O
O

N N d N d ~ d ~ d Ip ~ N ~ V1 ~ d ~ N ~

O O O O O O O O O
p '~ ~ ' -O 7 H M ' Z Z Z Z Z Z Z x Z
r U Q of .. ~OI O
m Q ,.. I

fDaD ON~1fDm ON <D mO N VIDmO N ~ (p f O O NN NN NM M MM M? W t nnn n ~

n n nn nn nn n nn nn n n n_ wi~ ai~ofirin of' riri r~f - riui~ai - ri Iri I o O O O N NN NN M MM MM V Q
n~ ~ ~ ~

n n n r rn nn nn n nn nn n n n m Of0M O v GWf7n ?O v N? mv ~ V m ~

m M MMm _ etp mM O M Om OIn O ~ N

u7~ r-N Q~t0nO ?G1 O O VM Qm N f- n N N VO m m n O7Of M~ N N~ NW m n p7 OW

M In vo>~ v a~~Innn M m_ mn mc n o_~ m_ O O m1'JN N N Om OM v OO ON M
1 t n O

M O O~QfO O OInOO < O OO OO O ~ O
O

- m n~n m N mm mm 07a 0 m~ mm N Of N
m M ~ ~mn m OfO NM Wf m nm Q1O N M
i u~um Inu~u~Inmiomm m m mm mn n n n m m mmm m m mm mm m m mm mm m m m m m c0 N O fD

tD O r u7 (O u7 Of N O

f0 07 f'7 M
f' O
~ f f0 f7 pp f~
f'7 ~

W N fD . f0 u) fp N fD
~ n ~ ~ N O
M

( ( 0 D O Of 0 O
N N O t0 ~f1 c0 r O

N ?
~

fD O ~ t0 ~
N N

N a0 O~ N
~

N N p~ ~ - fro N t0 O aD

O ~ f0 fD O
r c00 ~ ~ Of O O WC1 O M

~ ~ N ~ N ~ N
N M M

( f aD ( c0 ~ N
D 0 O 4'f ~ r N N N (O O
N

_ O C~ r O 07 nrff a0 c0W cDfD N O O a~ f~ O~
fD aD ~ Q~
f0 f~

O ~ O o0 fD N t0 O O~ N('7 O O)t0O O N
" V tD f0 fD fp~ Q7 (D fD
f7~

f0 N p~ r c a_0 O ~ u7~ pf ~ V f0~ ~ V
~ M N 7 O r V V~ < t0 V N
u7 t77 N ?

? (D V N fD <D t0 tD f0tD (O~ fD f0~ (O c0 fD
f0 cD ~ lD u7 ~

N N N N N ~C7 N N NN NN N N f'~N N N
(D N f0 f~
N

a fu m OD ~

W W N

LL U N lLlL lLLL LL C L_L

w N (n tn m c fn(n Ntn N o a g5 g3 5 U ~ ~ a L UU UU U L U

Z cc m H ~ ZZ ZZ Z y Z

Q v >> >> > a 7 W o ~O

O N O
O c7 O O O

O O O

a a a c c c E E E

v a a c c c n'~ ~d c 0 'o o 0 w 'a n n n N U

O N N
C C a C_f~C_N C

N N (O
Q O

C

O O O
m Q ' U U U
Q C~ Y

_ c~

c a fu , , .c Q' E
, . ~ ~ ~n ~ ~

t0 , H M ~ N _ t0 N t0 O ~ r Q W ~

OD T Q O ~ 00 47<r (h f'7 O N C O 111 m E V

LL ~ o O ~ 01 F- d r t0 O ;~N O Z n a Q O H I- lil N ~ m ~ O y V) fn IV m ~ o N
VI ~ O
w to uJ

~ ~ a ~ d M ~ U U U U ~ ~
Z 7 U ~ o n v o ~ U U

' t O 2 Z 2 Z ~ a a a a m pp U
' Z ~ . ao r _ cjj~ O j ~ y ~ ~ a ~ Z
L F- ~
a D D D

W ~ Q a7 , ~ ~ ~ y y d v a E
uJ ' ~ ~ ~ ~ d C ~ y N ~ O
tn 2 E ~

, Q M O O ~ . _ ~ o o r v n a ~ d c U ~ > ~ N w o m Ei ci ui p o ao ~ a Y E U o o f., f>o~ c~ W
~ ao ~ o d ~ m c r ~ E J o c c a - M a o ~ UJ

<n o N 2 c~ a W o o o aoc~ c~ f o - Z ~ ' ' ' ~ m U7 N ~Y U ~w ''Wn O~ f . n rna ao c n cn N ~ a ~ o > ~ o= ~~ 2 U a ~ ,~ ' o p Op fU fc _ o fnfn ao ~n ~ ~ ~ N N ~ y ~ ~ 1(7- >
~ ~ ~ (V N C ~ l1J O
y O H
(/) ..

m ~ f~ ~ ~ f~ C ~ N = C U .- ' ~01 ll~ ' ~ O w y ~ p E ~ O 1 Z d ' L ~ ~ ~OfZ
' F- ~
O a 01 O 7 O

Y p~ p~ Y ~rj 07 Y C1 Of O7 (a. 0 Y
~ Y ~ m Y Y ~ E O ~ Y ~ Y . Y U y N Y Q Q E Z ~' Y I9 Y O Y O
C O ~ ~ O ~ N

C C C C C C O ~ C C C C C C C [yJ C
U W ~ Q' r ~ ~ Q' C E N ~ n Z L
g (0 (C f') y Q f0 l0 d t0f0 N f0 (9 ~ (O t9 C Q ~ fC
N w ~ f0 J
J O
~ ~

~ m m 7 ~ m ~ ~ = ~ N V O m m m ~ ~ m m ~ ' m m m m m ~ m O (~ "y r ~ o ,n ~,N ~
U r .~
m F' c~ C~ C~ o C~ C7 C C7 C~ C~ C7 C7C7 U' p r. Q C~ ao N ~ ~ Q ~ ~ o a E
~ ~ Z U ~
ul U O
,a E E E E E E ~ $ E E E E E E E O E
o ~ o ~ a ~ N ~ o ~ r ~ ~ g Z
= ~ ~ a Z a ~
Z ~

~N N N ~N N N N ~N N N ~NN N ~ N
y ~N

O

C C_ C d N C N O C C C C C C E a C
Q E C W Q' N " C O ~ T N Y N O
111 ~ ~ C D n N . U
C7 g C~

d N Y C1 _ ~ d r N d .~..- ~ ~ .~-, N ~ ~ tn N O E N d ~ ~ (ON OD
Q N = ~ t) O C L Z
d O 'y~
O

O O O O O O p p O O' 'O O O O O ~ C
Of ,~ .., V 0 O ~ Z ' ~ ~ O ~ Z M
= ~ H ' ~ Z Q
N ' af:,aa a aor a ,UU N a a a~ ao a a~ a uW-r,a ~ a> x ~ ~~ S o m a,, ~Mp ~ ~~ ~~ ~~ ~vmm r~ ~~ ~~ ~~a ~o~m ~mp~nZi E N ~ ~ ~f ~ '~

~ _ N _ a gg o Z~o~dZt Zva Z'o~aoZ~rn~ZNWW$~ Zwaa z z z ZaZQ ZQd~> ZX
~ Xm ~~

aD O N ~ f0 fD N~ t0c0 O N ~Cf0 aD O

v u n m n ~o o fofo fofo r r r r r ao r_ r r r_ r r fo rr rr r r r r r r r of fo ~ci n ~ -ri Srir~ ai - Niui n of v W m m n of fofc fnfo fo n r r r r r r r r r r ~n rr rr r r r r r r _ _ _ _ r _ _ _ _ _ v N fD r a0 O N '~" Ne- O r c0r (r r r 01 ~ ~ ~ a0 c0 O N tDN ~ f O fn M
h ID ~ ~l N O P7 O WO V _ f'7M Of f~

r aD ~ N r a0 _ Or Nr N W _C)f'~~ ~f r O fD O O N O~r O ~1 aD o0 cO O
~

O t0 ~ m _ C~ Of NO O~ O fDf~O ch 07 O f0 tD r O ~ ~ O(~ O ~ < O O Of aD a0 m CO CO Of a0 r~ aD e-fT~ N

V~ u7 fD r a0 01 O N cHV ~1 t0r f0 O) O

r r r r r r ao oao mao ao m o ao m (r O O O ~ O ~ ~ ~~ ~m m ~ ~ O ~ fD

1 N h ~

N _ O) _ ~ m u7 N Qf Of nf1 N ~ m M
~
~

t0 N Of V ( t0 c'7 fD D
_ N N
O V t0 tD
(D

t0 V N ~O _ V
t0 O f'7 N ~ N
t0 '?
m (O
u7 N
f~
V

M r O O O) y f7 n O r N

O ~ C (i O
~
~

f0 u1 Ih ~ f 1 N O ~ 0 0 ( m N ~ O
NO NNO

~ N a f N O N O
c'~ 0 0 01 N m N
N R

~ ~
~

~ O off O (O M N N m V
r O ? f fpO O ~
O 0 ? m N O u7 m f'7 m N
~1 _ O ~1 t0 O tD tD (O O (O
O (O
l0 _ W O V N 07 ~ ~ ? N r- N
W (D O f0f0 (O if N m N
O~ O _ m 1O m t0 ~

O N N CO N N N N ~ ~
N O t~ N N 0 O m On t~ O aN0~ ~ N m m O 4'f ( Qf r N t7 O~ 0 tD a O 0 t0 N O (O O ~ O O O V 10 O ?
(O 07 m c'~N t0V O t0 <O t0 h O cD O ? m N O) N c0 fD f0 I~
f~ h 1~
t0 <

N ~ ~ ~ ~ m ~ ~ ~ N ~ ~ N
~ N N ~ ~ N
N ~

N N N N N n N N N N N N
~ t N N P
p N

~ n 1 (O 07 Of mm Nf0 N O)f~ O O ~O O1 47 N00N O
c'~ m m hO tm O O t0f~ Of m 07 ~ O O~ NMO O
O 1 N O O f0 1~ ~ m aD ~O O
m O f0 ~ c'~

tD i~ ~O Of~f7f0f0 m (DI~07 O O 10 t0 O u'1 P7t0c0 O
01 O f0 f~
O O~
O t0 N V it th~ ?~ m ~ V V V c0 if ~ ~V~ W
~ tDc0mf O 0 0 m ~ V m ~ ~ fD OfD t~
O m t0 u'1 fD <O
0 h ~

~O N fD fD NN N0 f0f t N N f N N N f0NN N
N t0 N N N N N '- N C~ N
~ In N C~
N N N
N
N

l U l l L llL
L L L L LLL

_ ..~_ _ _ N y _ ___ fn !n fn N N(nN

(n Q ~ V) VI C N ~ N ~ V)fnV) 5 ~~ ~ g g a ~ ~ ~ g gig ~, o U ~ ~ U U ~ ~ E ~ . U UUU
~o Z ~p ~, Z Z ,y~, O c ~, Z ZZZ

N ~ 7 N N ~C L > >>> N

1~ O O

_ O V f7 f~ V O
N

O O O O O
O N

lL Q lL l1 lL LL
a d a a a d u~ m a ~

C C C _ C C
C y~ .O_.C j, N N (O fa O _ l9 '~ ~ C l0 .~..

O 'e O O O O O O
Q V ~ a ~ 'Q
'O a ~

N ~r V E
C C C C C C
T

C H O
' ' ' ' ' ' ' ' '' ay d a, o a~ a~
y m E d . v O O O O T O O
a N ~ E

$o n~ a a'E n:. n ~

~ ~
rn C C
O ~ N N C
V

C_ N C C _ ' j (p ~ r ~
(p H C
~

N

r C c O c c Q c m ' m c E Z o O (~ o, O
O O a C O C
~ O
U
~, U U U U ti U U
~ Q ;e Q O
r m 'o ~

, O

m ~ w >

_ N Y d' O O m N_ O) m J lJJ !n N m d _ M O Z ' J N N O N ~ ~
~ Q N C C

d l1J O ~. ~ ~ N Q r y (O
aMD r J

G1 H~ ~ Za '- Um Z o U ~ am ._~? M

V

~ I Q ~ ~
~

Q N O Q j v E E v Q E a a m U 7 ~ ~ .x a ._ ti ...Q a~ a> a'~ Q . ar a ?
a m N m m ' ", m ~ ' ~

m %- u1 N > 0 N a ~ o v N
,a > C7 ~ m a c N
U

't N J T . ~ L N O
N ~ m ~ i E
~ =

~ o y o _ o m m a W a u~ E U N co ~ m m W ' m d ,r, ~ n r c~ o O o n Q u~
o Z r Z ~ rn ~ in E m v Z ~ U

W n O~ 1 ~ ~ C~ N 'c (] c~ c7 v g a Q' m d H

~o~ ~ .o~Qy- .eyo.o~ ~ ~ .o~ ~a~.c~
~ v w a v o ~
m ~ E

E ~ r ~ a ~ , o c J _ c m c c J C C c c c , c c --a c ~ E ~ v o o O O m m m m m V m ~ CD m m M L m m O. Q CD > N E
N m O O Z O f07 d m w Q
V

d ~ V ~~lll~ ~ ~'P ~ L7~ ~p ~Q ~ ~~ L1L
9 ~ C ~
V V

. "'' ma ra o E ~ ' ~ E
~ o E~ E E E E E _Y _ E~ E N E
~a m oo . _R
N O o N N ~ N N N H u1 _G a a N
O N O N a H H a w lL 7 Z t0 a C 'a . C C C C O C C C C C
C T C ~ H f~ O d O N (n y - L
~

4: ~ ~ r ~ r ~ r r Ø.4: 4: ~:
t0 N aD N Of T N O 47 ~ P
O ~ ~ U ~ U
W

O O ~ O O O O O N O O O O O
O~ > m 1~ N I~ O u7 ~ M
= N ' ~ W E . m O
Q

M a C (O N m a a c:~ m N m Na a N J a n. ~ n. a a .n a, a 7 N o m " o Q, = L
x ~

C O _ N ~
O O

O N m > Z > > O j j ~ j ~
O Z ~ > O N O O O
O W ~ r L

4 O ~ O O O O O Q O O O O O
~ t0 N m M Q ' ~ Q Q Q
~ T ~ ~ (A
~ V
' Z ~ Z Z Z Z Z Z Z v Z Z
o~ Z .- w o~ oi p> Z ~. ...
m U7 N t Q

N ~ (O mO N~ t0m O N ~ t0 m N ~t0m O

m m m mOf01O O 01O O O O O N
o ooa n n n rn nr r n m m m m m ~ c cao 00 ~

ri ui nof'ri ui~ ai' ri ui ~ ofuir~ ai '-co m m mm o~a> a~a~a~0 0 0 0 of r~ r n rr rr n n n m m m m o ao 0oaoao ao v m V

Of P t~ O00f'~eh OfP7m O t0 m ''' c0 Nf~ fD

h O t~f ~tDON O (Ot0 O O n M N OmO O

a0 O Nm m07 ~ f~V f~ N O_ m t0 N~Of N
m ~ m NW h ~OO O~N c~ O V N f'7V1~ t0 M cD Ot~~O~ O O O O O c0 O m 47 n0N f~

4'f fp ~N 1~O m ~-T u7 47 O V W O Ohh 1~
M 1~ O ~O W~ t~r O O O N O f~ O f~~-O tD

m 1~ ~m 1~O m r m m OD m N Of m m~N

N t~ N mt~ t0OfO N fh 'Q' O O

01 W O ~O 07Of O~O)O O O O O O O O O

m m m mm mm m m O Of Of Of O O~ O OfWOf Ql M

o c~c~o o _ _ 07 N ?
f0 ~c m r n O N M
M

N O N
O
O

_ r t0c0 _ 1~0 O
aD

N ~ K7 '-c0 O
N N
~

I~ O ~O M
N V O O) (D
f0 O~~O M
O O

N tD ? O O V
M ~fl M V aD (O
~O (Dfp O
f~~O O

O O~ ~ ~ _ N
N M N tD
a0 (p N N NON
O O ~

< OO ODN O4D O
f0 tnM
h h O N M a0 OfO M
t0 O N

N M ? N~ N
07 ~ tD N~
W CO (O
f0 (D

N ~ N N NN ~h N N N
~

O Of ~O M u7u')Oft0 a0 O OfI~ O M Of O~
a0 O a0 01 M

1n ~ M CD 01O 47O O O O _ O ~- (D
O N f0 00 O 1n fDf0 O ~I7(DN O ~ tD O01 ~7f0 r ~O O h ~ ~ ~fD ~ < e0 (O u O
at Q

~7 ~ ~ V _ ~ ~ V 7 fD O fD<O t0t0 ~ ~D
~O 10 tDf0 Q tD~ ~ f0 a0 tDf0 a0 ~ fD(D
c0 N N N N '- N N N N N N NN N N ~ N
N N N N
N ~

L W W W
L

O L _ _ l_1 l_1 L L t L L

y _ y _ _ y tn N ~ N

g N g Z Z a ~ Z

a Z a 2 c L ~ ~ 7 7 N d > > d 7 n M

O

O

a _ C
N

'gyp E

a a y c ~
v o .-o, o a~

N
U
C
~

A
C
C
O

o a U

W N

y Ur ~
N

J . ~ ' . i ~ r fD
U >.

r g _ O N u7 r Q
~ ~ H E

O ~ [L cp h O O O~ W H N r lL N
U V ~

q O o m m n o m ~ Q N Z W a > can I ~ t $ U

D o U n. D
= ~

w m a a a a ~ n m g O . N N

O a d n o a ~ a E E E ~ W E ~ Q a to m y N ~Q r f , O N D m ~ p w H
~ w ~

co om a a d d a~ a ~ - w v ~ N ~cc ~ t ' w ~ ~n Q a ' i ~ ~ Z o " d' Q ao ' _ ,c ' O a ~, x tn D O N
~ uy ~ O _' J z r ~ a N E
O U n C O w a J :
E

0 J u~ ipO ~ w o ~ ~ M
o F- o> cW coo~ g d ,~ O = ~ O o v > ~no~ o O O N
w v a Q
p y a ~ ~ ec ~ ~ 1- m ~ ~ ~ Y O ~
M = ~ N d ~ ~ 2 I 2 T lL (n Q C

p L ~ C _ ~ If O a Q h- ~ ~ r~
~ > I D 4' U a c Z M

N U ~ ~ - s U d Ol ~ ~ a ' fn ~ ~ ~ f0 a ~ w ' ~

c~ ~ m w w c> ~ Q ~ ~c Y Q p = ?
a O d o ~ ~ ~ v, ~ ~ ~ ~ d a Q Q ~

Y Y Y Y Y Y Y ~ Q Y Y Y Y
[~ c Q' c ' c E Y c m J ~ a 111 c c ~ = a c c c Q t c c d Q w J c X m p m U
a f=

m m m m m m y m ~ m a m m ~ U ' m ?, ~ n m m m a w y ~ ~ N O N
O E r m m m m m m m m - m m m Q J m D ~ a> c Z ~ ~ O o ~ Q

Q U U Q Q U aD U U U Q
O ~ C N W ~ ~ lL ~ OD
W . J a (~
J

E E E E E E E E ~ E E E ~ Q a E
~ a ~ ~ ~ L m Q < r ~ ~ N O
~ ~ J
j ~

~N ~N ~N N ~N ~N~N 'j/) N ~N N d LL N
M D O ' O D ~ ~ N ~ Q ~
~ d Z

Cnn GU~ Ca~U CY C~ C~CdM C~Oa~ GA Cd HU~
J

r 4: :~ 4: ~ O ..d.~ aD . ~ ~Q
H I~ H O d c7 a llJ 07 N O Ja J O~ J Q U .O. O Z
m W
U

OV
o o ~ o o o o o v o 0 o m ~ ~
~ W o ~ ., <o a Q ao 0~ = N "
2 c n M ' d~u~aoi a a d~ a~a~- a~poO ., aoz d aa ezz ,~ o ac Q~=a~J
>

m a> _ d ~ ~ ~ --y ~ d ~ rn y o d o n o ~c M r U J N >.
H- 'c ~ O v Z Z_ ~ r O Z_ O

~ O p ~ ~ Q ~ ~ =~ ~ p O N m ~ V m O J ~ '2 J N d' U =
~ m ~ = J
~

O a _ Q ? r ~ ~ a ' U O
~ - Q aQ J a ' z z z Z z z z z Z z z aoaaaaQQZ
o~a omU ~ o~Q mU

N V t0OD O N ~ 10aD O N <10 a0O N

N N N N M M M M M ~ < V O ~1 u7 O m GDm O 00 00 ~CD ~ O OD m CO 0_D COiD

M N r Of M N n Qf M~ n 01 M

N N N N N M M M M M V ~V ~ Y ~ N

a0 O Q~a0 c0 O c0W a0 4D a0 a0 a0a0 a0 aD

O M I~ M O ~1~ elf V ~O N I~

t0 tn1n O W ~0O cD O M OM V M M O

M aD M M r O O)1~h O tD (Oa0 M M fD N
aD OfM f0 < 47tD(D t0 OO Nu) O 1~ c0 tfJ ~ f0CO O ~ O N M O ~ ODO M M O M

V f0 < N ? c0 cD Q7t0 V f0 M O
n n o~o o ~ a> aoso o a n _ a N N 1~ a0 1~N OfaD f~ 1~00 N N 1~ M
O

N M V ~ O n ~ O N N N N N

Q) Of O O Of O OfOfOf Of N OfN 1 N O Q7 Of O O

o ai ao ~ ui o o v ~c cu m M

a>' ~n O n n ~ r V N V a0 V M

~ ~ N
M

N O t N N ~ N
N ~ D a D
' Q1 N M ~ ~O t0 Cf M
f0 t a0 OV t0 0 t O f0 OD N O f~ f0 (p (O N N M M

? c0 sf N N aD O N ~ N O N
N tD t0 N N
~0 o ~ t f0 M M ( 1~ N M Of ~ f O ~! N aD
p O

O Of Of N O 01 OD aD O
O N tp fD M M
O f0 t0 . O~ 10 t0 t0 tp v v v ~o M f0 f0 v v a n CO
v a c M
v ~o co cc a~ is ~o ~ ~c ~ ~ N N ao cc ~ N N
N N O N N N M
N h M N N i0 t0 Ici cc o ui ~n <c o ~ M
of n o 0 0 0 re 'v ~

O CO O) O _ _ CO O O
O N N O (O Iv ~ ~ M N ?

~1 of N 'C N O O 1~ t0 (D (D
N cO 1n f0 ~ ~
~ f0 ~
~
N
~

~O (O N (O t f t tp f0 0 ( 0 0 D c0 M
f0 ( O

N N N N ~ N N N M N N N
N O ~f f0 N N tA
f~ N 0 p M W t0 aD a0 07 V 0 a0N Ou') r p MOO r N M M 1 pyf W r t O m M

O O u7a0 O O t0 O aD 1~O OO W p N Off0O O
f0 t0N Q O cD M p M M a0 aD Of ~ tn f0 O
O f~

_ c0 t~ W (O t0Q) ~ h u7f~<O u7 Of O
~!~ ~ ~ O_ M M ~ V1~ f0 V N ~ N fD O
a0 V V
' ~ ~ ~f ~V< ? ~ N
fDt0f0 f0 tD cD N fDc0 t0P Q f0c0f0 ~O ~O ~
t0 CO W N (O t~ c0 aD N tp f0 (D o0 O
N N N N N N N N N N N NN N N N NNN N N N
N ~ ~ M N N ~
~ N

lJJ W <L W t wW W
1l G lL LL <L <i _ tLl1 lL
lL

O NN

VI N C (n fn fn N (n G VI(n a1 tn g g g ~ 3 ~ 5g L U ~ ~ U U U U ~ UU U

y Z ~ ~ Z Z Z T Z ~ ZZ c Z

> > 7 N ~ 7 >> N 7 n r N p p M t0 _ aD

O O

lL 1 O
a 1 a C C C C G
N d y y .~ E .~
m d ' o o ' -', a~
N

C ~
~

C C X C
. . .

O O ~ ~ 'p O
~ C O C
O
O

d n O n ~ n1 y _ f0 O C

C~ C C.r CV
. . -,,~

c0 !U .(Q .7 C ~ .

C a C
C

~ m U U U ~ r CJ
~ ~ v d W . _ W n tn Z
c r : r ~ N Q ~
m Q
O

G ~pmv u~o ~i Z ~ ~ n ~ U

.r n v m ~ > m ca ' H
. a x v ~ .n m O v Z m ~ c ~

N U
~ I
~

U U ~ N o C7U m , a I-" c ~ c N n Z -~ t%i O
o w - s ~ m. U ~ n U o E ~ ~
'o a ~ 7 O a d _ Q , ~ ~ ~. 1 ~~ C
> a . y o~E ~ a a ~ 'a~ d = Q
'~ ~ ~ ~ " a t ~a~ ~ M " m fD M ~, o o ~ =
O f O

Q D N O N e- (p (G< (D C N Z
O)fD M E ~ a0 (O- E N U N
O a 47 O N 1~ J
O ~~7 Z

f0 C ~ aj a~ _ ~D O ~D O d Y
~ ~ U E Z N (O M U
O

y 01 t0 (ON (O ~ M
.n v v co ~ v M m d ~ a U ~ r Z ~ a .- v v ~ p ~ a~ r N M ' ~ ~' i m o E c V a >
~

o~ 'c>'or 'w =-' o, ~o~a 'o 'rn o E d ~ =
~ y m .m H ' n 'a 'v Z O
~

Y Y 1C Y Y Y w O i N U
O ~ O X

~ C ~ 0 C C Y Y Y Y Y Y Y
C C . p G Q' C C O C 'e O. H ~ C
N C C C C G C O
N . ~. C O
~

N O m ., N W N f0m fa ~ H A to f0 A lap ,. M a N N ~ J O
. > f0 O ul m m C
= o m m . . m m m m m m c~ m m m ' y ~ ~ t ' -- ' ~ O
N

C7 U C9 C9 C7 C7 C~ C9_., C~ ~ ~, (~ (~ Ur ~ ? ~ O_ ~ ~ C7 ~ n o ~ ,c Q' Z

E E E E E E E E E .' E E E
~ o ~~ ~ ~ N ~ L o z ~
N ~

c a ;
'N ' N 'N N N 'N 'N N ~N N ~ 'N = w N O a O U 7 ~ 'N N
U

C C C N C C C ~ C C 7 t C G
~p Z ' C Y > ~ C ~
V d t W
C Z

_ ~ C
N ~ N 4: ~: ~ N d ~~ 'd V d N Q
C ~ ~ O7 t0 Z O d 4: Z O
O y O O O C ~ . L N ~ ~
~ O~ M ~ H ~

N p E O O O O O O N O O O
N f M
0 d a a a a a Q. O. a a a "' o a a a a ~ ~ ~ m Q >. ~ m o n "' o c Q o ~

_ N L N d N N d O d p L N d N
d ~ d p O Z d ~ ~ n ~
>. ~ y D
~

> y O O ' O O O O O O O ~ _ >
~ J m ~ ~ V O > O

d Z Z Z Z !L Z Z Z -Z a Q a Q Z ~ U r Z a ~ O.d ~ O~=
v N ~ . Z ON Z
m Z o~
~o rn M
~
Q

<O aD N V D a0 O N ~ D aDp - c VY0 ap O N
m n o c t ~ t t c ~ o ~ c n r . ~ rao a ooao ao a~ o~
m p D p m 0o a a r r o wa a ~ o o o o ~
c a _ _ _ a_ __ o_o_ao a_o _o ao m ~ a a c U1 ~ M f7 h Of M 0 ~W MA ~ Of 1 O~O 1 D 0 t I 11 ( t 0 !

f t D n n n nn p ppO p p p a0 p N 0 O W 0 m 0 D O mD a p p a a a t c a ~

_ _ _ _D_D_O O_ m _O
_ r-0 _ _ a a a _ 0 M ~ N _ M M ?N VN0 0 ~ N
N ac 1 f ~ D M D O O
tp a ~ ~
M I t O O M '7 O 0 O M D O 0 ~V o ~0~O N
u t f c t 0 a p 1~ M 0 ~ N N M D N 0 N ~~ 0 1pa t ( 1 1 O( O D O N V M O O O N O O M~O N O N
( O O ? O O t O O O O O ~V ~fO O O
a0 N N f O

D Of 0 D 0 D W -O7 ~0 O O r a a o a ~ cC O

c0 OfO N M f ~ 0 ~ p OfO NM y l7 N N M M ~ t 1 a M

M M M M M M
07 W O ~ p 7 f f M p W~ ~~ ~ ~
O 0 C O p O

~ O fOf f 7 W
O O

c r' O N (D O u7 N

O 01 O O tD O) a0 M f0 n n O~ N aD

O m Of n n ~ M O O ~ M
f0 ~1 O M M t0 1D cD O t0 f0 fD t0 c0 ~t t0 ~O n O

p ~t t~ O O _ ?
~ O N O N ~ < ? e<
f0 O ~ M

O f0 N ~f 01 ~0 f0 f0 ~O
~D O _ Q) f0 f0 f0 N
p N t0 u7 (D N ~ N
N N t0 t0 N N N 47 (O N
O

N N < N O
fD N n ~O p O O tD aD
aD ? V O n t0 O~ _ fD _ M W ~
t0 N W 1~ t0 m ~t ~O f0 n t0 N OD t0 M M N
M N

n n Q1 N _ (D O n n Of n V _ O f0 n t0 f0 M
~ t0 N N ~ V ~ ? f0 Q) GD N V ~ OD
~- N 1fJ tD t0 f0 ~ 4'1 f0 f0 aD
a0 O~ ~O
tD

O (D ~O ~1 N N N N
c0 n M O ~ N N N M
p N X17 O
N M Of ~ O N C~ _ Of O ~ ? N
M c0 p r d0 O f0 N ~ 1~ O
~If N O N N N N ~ O tD ~D (O
t0 a0 M M
00 o ~

o~ o ao ~_o ~n n r co n ~a o ~ so a ~O ~ N ~D O~ cc V ~ ~ N V ~ V V
V ~O < ~ ~

Of n N aD ~ tD t0 tD
f0 f0 n n f0 (D f0 NN
t0 ~1 CO n O) N N N

N N CD CO

~ O M N M
~
~

Of C_O N Of O M n O_ N
e_0 ~O Q1 00 O Of ~f7 ~O a0 Of N O a_0 M f0 ? O fD aD
M ED N N M of N

N O t0 Q) M O 10 tD O) O n O01 ~D
O u'7 O 10 t0 t0 O O fD
~

N ~ K7 N N V N V N ~ Y _ O ~ N M N p ~ ~f N O t0 tD ~O N N tD fD fD
~D O f0 O f0 fD ~O

~ N fD Q1 ~ ~ N ~tf N N N ~-N N
N ~l N fD N N N M
N t0 N

M o0 cp'7 ~O M V O O ~D O aD O) N (7 Mo0 N O a0M
N O V N n aD ~ M
M n ~ O W
n aD 4D N < ~D O _ O ? O O f0 O OO O ~On Of O N N N t0 N M N
O ~ M tD
O

O O M o M t0 t0O ~ ~ Q) W n n fD fDO~ tD N O n O t0 O O O ? n tD t0 tD O aD ~O
f0 _ _ M ~ ~ ? 'C O V ? ? V 'C V ~ M ~
N < V' 1n f0 tD (O~O t0 ~ ~ t0 t0~ ~~ t0t0t0 ? 1n CD ~f7 cD ~ 10 cD
t0 t0 ~ c0 t0 ~
~O O~ f0 tD
O N
(D
tp c0 aD N N N N N N N N N N N N NN N N N N
t0 t0 N N N h N
c0 ~ (O N
t0 ~ N N
~- N ~O
N
N
N

O y ~O 0 O
' p LL N ~ lLIL IL I_LI

O U It C C l_Ll_L l_LL_L

f9 .w~- V) N D UJ(A (n !n C ' "

a ~~ g n ~ gg 5 g a c U L c t l o ' co ZZ Z Z

n ~ ~ in 7 'cy ~ v a 7~ 7 7 a~ c0 ao co OI M n T

~O LL lL lL
C

a d a' dY
o y _ C _ C ~
C ~ C
O

lQ G f0 .~
.

T c v c a ' EE

~ C C
~p N d G1 N O V

0 c o o .c Z
U d a o a o. a o~
' m ~
N E N N ti) V
~ 'O

C C C C y 'p G N .
_ .f0 O f0 .f0 c0 C ~

~

p O O O Z m O C

U ~ U U U ~ ~
nI ~

' c c Z .u> tL

n 7 j C r d J O n Z_ n O

G1 Q7~ Q d u~ J O
.-. ~

E (D ~ ' C ~ ' N
~

r f- Q n d p n O p N

~ L1J M U. p E ~ 2 H m M
U

o M p o m ,n ~ m D p O y U O O ~p~p H N
C

~ y a C ~ ' O C V fn ~ ( C~ O ~ ~
~ E a ~' O y ~ u1 ~ ~ -d c f- E E
d M Q a ' 'n ~ ~ = a r o a> o ~ n w o y N y " , ' u~ U d U ' .
.o F...m o p m rn a~

n N W N f0 (Om J (O i ' ~ t(7n E J ap Z y N d L
O

> N O M
O p N E Z ~.GN N ~ f a ~ Y M N
N OL ~ j O

C O N _ _ ~ (J~ to d v~ E J E
N Z ~ I~ d I N

d N ~- O T Q NY N N
~ ~ ' ~ ~ O

'c~ or o~ n o~ o~~ 2 ~ ~ or u. rn cr o a ~ U d c y ~
J

Y d Y C Y Y Y Y _ Y Y Y Y Y Y
N O L Oj Y N d (r C C
N ~ lL C V d ~

C C C C C C C C C C Q, m m C f0 l0 N n r f0 m ~ V m ~
~ N U N ~o m (p U c (p f0 m m m n m m m p o m m m V m . r N ~ a~ m ~ v m . m a ~

(~ o, p C~ C)C7 Z C7 U' p C7 , o (~
d C7 'H C7 - d '~ C7 o ~ C7 C7 '-:
O E ~ < U

E o E~- Ea E E E~ EaZ E~ Ea~ E~ Eo E~ Eni ' d ~

'N ~N ~ 'N 'N .N~N 'N , N ~ 'N ~N 'N 'IA
T ~ ~ O ~ ~ 'N ~ g M
t Z

ct c c_m~ c~ caco,ycNp ca cd c_~ c_,~Wc_cc_U
~

tn _ m d N N N G7 C7 N N N O
O~ y O d C OfN (Y a ~ E ~ d ' ~ N N n O
N ~

O Of O N O O O O O O O f0 O O O O
p W ' 10O p '~ f0 = ~ d a ~ a"o a a a a o n- d~ a ao~,an-~a ~ ~ ~~,,,ha a ~ n a o N ~ d 01 _ _ _ _ _ N N ~ N d d N
m N G1G1 d O n O m C
~ Y ~ O O Z
C Y

y m 1 > > > > > > ~ > > > >
O N > O N M ~ ~ ~ r ~ it ~ U

~ a Y ' v _ N U
' Z Z m Z Z Z Z Z Z Z c~ Z Z Z Z
? vW. i ai or m or a ~ ~

t0 CD O N ~ (O O N ~tD OD O N V

O p Of O O O O a~ N N N
c m aD p 0707 p O p p WOf p O O Of O

_ p M ~ n O7 M u7 Q) Mu7 n 07 M

O p Of W O O O n O _ N N

c CO a0 a0 O~Of O O O Of O~O~ W Of07O) O

_ _ _ _ _ _ O _ _ __ _ _ _ _ 01 ap f0 N V M 'r O ~ t0f0 n f0M CO

07 M QO _ f) O t0 _ N O~ V O c0 W

tp Y7 n a0 ~ 01 O N ~ N N~t f0 < M M

N u7 ~ (O fD M M_ ~ t0(O t0 1nn p O tD c0 aD N (O p M f0 u'1M N tDO

c0 O ? V O Of M O OO O a0~ M

m aD Q1 O p O aD elf O OO O n O ~
pp pp CD n N n Of 07 ' aD aDCO a0 M N ~

n m 01 O N M ~ ~ ~O na0 W O N

V V ~ ~ ~ N ~ u> ~ ~OW O t0t0t0 W p~ 07 O~ O Of O Ol 01 W O01 O~ OfW O~

. ui c Q7 aD co 01 N 01 O) ( O C1 aD
fD

elf N t0 O t0 O OD P7 O n0 v0 ~l7~ O f~ fD O
~ a0 h O .
!O f0 c'~
1 aD

~ t~0~ r N~tDrf~De ~ ( ~O
tON aMO

( N N Of f N N N
O Of N W N O
N O t0 O

N ~ N N . u7 ~p ~ ? 01 07 N ~ N V ~ 1~
f0 _ aD t0 I
~ . aD

elf P7 O ~O a0 01 O f'~ O O ~O
K7 c0 (O ~ N N P ~ tD tDO W
~ O 01 O _ . Iv .

~ M O O ~D O t~D ~ t0 N fD

N f0 D (O m ~ N N N N N
N N ~O O P N O
M h O O

. GD ~ N . ~O O
elfO op Q! l~ t0 '- M O a0 f7f0~Of0 t0 t0 aD N h fD
t0 t0 O a0 h 4'fa0 ~ W ~ N O N 07 ~ O O ON
~ ~ O r w n o mn ~ ~ 7 ~ M
M
o m cp sr u N _ N ? ~ O ~V
~ N . . ~
N . .
~ 00 n0 ~ N ~ CD

(D f0 (p . Of 01 f0 N fD tDt0(Of0 N N N . ~O t0 . 1~ N N N N NN
N V .
N f'~ O N

O

. O a0 GO .
a0O N Of f~ Of CD aD O (O N D N~
N ~O aD ~
t0 ch O 1~ fD

a0 Of ~ N O aD N O O tDO~fJ
O O 47 00 a0 N O f'~ O O tD~ c0~O
~ tp ~ aD O 1 O

N ~ ~ N r N ~ P7 O tD ~ ~ f~Df0 N ~ N ~ ~

N f (p N tD N f0 N aD N N N N NN
0 N V ~ ~ O ~ aD
N V

O r N 0 ~
~
~
~
M

O N aD tD O c'7N aD hh? u7OaD f~ t0 O ~ ON
tD~ c0 aD f0 01 tD f O~7O t0~O f0 O 1 t0OOf ~- ch O 01 ~ O
aD fD f C~ ~7 ~
CO t0 N
o0 aD aD
c~ aD

i ~ c rn n ~ a~ o r ao 0 omca anmn ~n ow n n coso n n o cc 0 o cp v co 0 ~ ~ t~OMf~O~t~Of~O ~ ~~ a~Nf~0o0aOWtD(~Dt~O f~O~~ t~0 t~Dp f~0 t~DCO ~~c~O ~

N N N N N N f7 ~ N N '- NNN N NN N N N N NN
N aD N N '- N f-N

0 ~ 0~ ~ 0 0 00 m _m m ~ m_ n uJuJw w uJm wm LLLL lL LL N C_ LL LL L1LLlL lL LLL lLLL
l (n fn cn m N N N t/7tntn (n (nN cntn a ' r g g g g a a E ~ 5 3 3g g 5 g gg Z Z 2 Z p ~ ~~ U U U UU U U U UU

L m c Z Z Z ZZ Z Z Z ZZ

> > 7 7 a v 7 7 7 7~ 7 7 ~ 77 ,~
c o o ~

.

a a ~

c ~ c ' .
.

d a E E

' O

O ~
N

C C
O x ~

O N
~ N

o o d U

ny n~
H N
u1 C C
C C

f0 N
d V=

C C
N C

U U
~ n1 ~ Q r N (n ai n ci U co ~ o~
.-. ltJ
' O

wj I~ a D N I- 00f Y
o _ ~ a O
' A ~ ~ 0 !1J N p Z LL N O~
N l m U r w ~ ' w E ~ N ~ ~
a ~ M ~
~ c ~ m n ~ .

U w o U a m H D r .m a ~

m a a n r Q a J a . > a ' t4 O
Z Z

Q E U . m in E E x E ~ a r E
L H ~

a E o o c m L ~ W X
a N d C) N n N (A N
W ~ N O U U > G7 E
' r -N n H is ao Z ~ . _ ~ o o d (~ ~ E ' o.

N 00 C 7 1~ Q C C v J O
E J O N O W F- N
O

O O Y d _ ~ C Y O W o C C~ 01 O Q
O

lL ~ ~ = ) ~ r tOfJ

) D N r u1 N
N

- N
~ ~
~

p ~ r ~ ~
O) 01 x 07 O N Cf Ol Of r ~ (n ..... 'N

Y O _ Y Y n O Y Y Y
~ Y Y O a Y Y E E (n C O

IL

c c c c c c c ~ o c c c a o- ~ n f0 y o a > 'y m l9 f0 H f0 ~ m a H- ~ a N f0 N Y .~ m ,~ ~... X
m a ~ IY7 m m m CO . m m CO
L ~ ~ In N N ~ ip ~ ~ N
N N

C~ C7 C7 7 C7 U U U C7 C7 ~ L ~ E E E U a 'H
d C

o o E ~ E m v ~ ~ E E
E Z E o E N
o ~ E a ~ a ~ ~ a ~ _ ~ a? O ' ' ' v o ' ~
~ v v Z
' ' N N (p Vl N N N O O N N N
Y O H N T ~ n v ~ T
' ~ a ~ Q

c_ c c_ c_ c_t c_ c_ y_ c c_ cv N L N aonn a - ~ ~

d : ' > a~ d d Q ea :: _ a:
ip rn n a n a~ ~ n H ~ m U Y c Y- Cf O O O O O O O V N O O O
O ~O O ~ ~ ~ N ~p t0 !~
= Z Z

a d a a a a a a d a cN.~m N ~ ~ ~:, ~ r ~ p o ~ o u~ ~ o O

N ~ C'1 O) O N , O Of Of Z h- [v J Q' J J

m ~ O O O O O O ~ O O O
~ ~ O ~ 2~ ~ ~ O U
~ d ~ ~ d O O ' ~ a ' ~~ ' r ;~
Q Q E

z z z z z z z z z z w rn L w w rn ~ a w O

f0CO O N ~ 0 a0 O N~1D 00ON ~ (OO ON
c C

N N C'1C~ M '7 C1 ~ V~< ~ WO u'1 In0 (Dt0 07Of O O f O Of O 07OfQf O101O O 1 O 01Of QJ O

n0h O~ PI O n O rM10 r 07r M 47n Wer ~

N N N CI f9 ~ C7 f"1 ~~~ e<~1A ~O K70 u7!D
O O W O C f O) O~ WW01 W OOf Of 1 O OO
07 Of O

~ O u7 u'7 ao f O n OVr7 M ~N C~ r O aDO
f O

f~_ 00 O O 1~ ~ f~O00 O ~V ~ N N Nu7 c')O Y a0 ~ N V C~ 1~1~~ ~ O1~ fh OfD OfN
h 0 O N O N ~1 O O_fu7 O)OO f~tD~l1 ~O t0~ ~Oc0 07c'~N OW O D a0 '-h N 01O ~O f ? NQ~
c N

n!7aD N N N I Of O O71~c~7 O ~N f~ O ? OO
O W ~O ~ 1 Of 4'7 GOOO O OO O O O OO
O) a0t~ O Of 1~ ~ t~ Of f~NN a0~aD a00 a0a0 1 c f~~f nlf(O 1~ m Of O ~NP7 ~ 10fD 1~ a0O O

w cc ~o co ao n cn r. rrn n nr n n r aoao a~o> o~ ai < W as o~ o>o~o~ a o~w o~ a~rnrno~
o o m o In o In tD O O N N
1n O a0 11'1 10 f~ 10 N V aD
O

r 07 01 O f0 I~ m u'f O
M f0 tD

t0 07 ~ W !7 N Y7 V p ~l1 aD V ? ~O (O N t0 o cc v v M In so ~
m so v r o N
~

<r 47 N (p fD 10 1~ Q! N
N 1~ N 1f7 f0 CO N
00 1n t0 ~
N N M 10 t0 N m0 p co vo v e~ o ui r u~ 0 c~ 0o In Ic o to ~

N O IDN t0 aD N ~ O ~O Of '~ O f0 I~ 00 N O

o n Ina~ a~ ai ao 0 0 r o~
to to 0 In In o m o a0 o ~V Of Y ID N G~ OD Ql 4'7 V 07 47 N M O V
N ~ ~ o c o o m o (D Icto ~ In _ a so Nto c r 1~
N N ao so c t N
N I~ V 10 W 00 p N
N N M 47 10 Of N

~ O ?O~ N O~ OD N 1~ t0 N
c0 10 c0 aD h ~ 10 t~0 O
CO f0 M Of 10 N N O N ~ (O N N
~ Q N N t0 N N MO o~ M o o r o~ Ic o I() o ~10 m . ~f r ~ o N 1~ V ? N n!1 c 1~
r n ~ Q7 tD N N O 10 cc < Q

W N ~f~ 1~ N t0 O f0 _ Of Y ID 10? f0 t0 ~ O N f0 N c0 t0 f0 h tG
ID

u7 O N NN ~ CO N (O 10 DD 07 N N N N f~ M f0 In N
sf O N N

N N D
O GD
r ~
~

O 10 O t~aD M p t0 M 0 OD aD 1~ M f0 O
t0 M I~ N f0 CD
o f _ O O N M O 0) ~ 10 O N
OD O) N ~ N M N
~ t Q1 p t0 N 1~ tD

t0 N ~ OO) 117 10 Q! W K1 fp N N
O ~N ~ D CO ~
t0 ~ 1 ~
M ~ fO N ~ ~ N ~
~ ~ N ~ N N
N

N N N NN N ~ ~ N N O N ~ ~
N N N ~ N ~ ~ ~ N
M N N

n u elfV c0QfOaDp O)ID 1~N M O ~ V O 0O O N u7 7 p O O OO f~ M a0 O ? u7 p 1~ t0 aD N O O) P ~ O
O 1 V tD O~ 10 M M
M t0 f0 tD O
O
a0 V ~ ON OO OO0 W O m10 O M O ~O N O 1~ Of 47 O (OaD W t0u7t0 < O t0 p I~ N Of h t0 ~ t0 f~ N O
O M
~ IC7 V N < ~~f? V ? ~~ ~ ~ ~ O ~ ~ M 10 ICi ~0 ~f0t0f0? t0f0 (Of0 01 ~f fD M 117 ? t0 t0 ~ a0 O t0 t0 M ~ 10 f0 10 ID 10 W M ~
tD M f0 t0 (D f0 OD

tD N Nl NN NNN N N NN ~ (D N N M N 00 M N
N (O ~ N N N N M a0 10 N
M N N N
f0 ~-N
M

L l L Ll L t _ _ _ __ _ _ O
1L tL lL LLLL lLLL

N ~tp ~ N N

V V7m !n Nfn N y m w N _t0 N d d U N m U ~ N N

Z 2 Zm Z ZZX Z Z a y L

N ~~. ~ 7~O 7 7 ~ L

V ~ O ~ ' _ v O) O
N E Q p N ~
Z

In O O O O O
p (C ~

O O O O a ~ U V LL
l1 IL LL
C T

d d d d ~ d. d j ~N U C f0 _ _ c c c c c c 2' ~ .E 3 m ' m _ ~E ~E
m T m y ~

N y O O O O Z O O
N A

a a a a a a m m ~ s o C
~ C
N

C_ C_ C_ C . .
~ N U . a . y C
. .
.

47 N N d L d O
y1 N a o C
o o N o ~ o 0 ~ c c E o 0 c ~ Gf0 d"~- dC dda dV
" O

C f0 C
C O - O
a C
d O
C U

a:.. .~ a ..
y c c c c ~ c c ~ n: y N U
~ C7 p O O O Z O O
~' G7 a D m d Ip -~

U U U U In U U
C7 m Q d Q

- H , U 2 ~

"~ ; d g ~ Q U
E ~

, M
E

m N a ~ io ~
~ o v .?

Z

O

U ~ U o U o ~ d o 0 o t ' o -~ n o o N o>

E m E Q E Q a N Q v x ~ ~

d ~ d , ?~ ~ , o -- L , ,-, in to -N W O ~ V Q1 ~ p O O
U J ~ ( v ~ ~ o ~ ~ O ma M=

p C m ~O O) (C N 5 ~ 'r v ~ p ~ Ii N a v y' ~ ~ m a ; 'a 0 M a N M . _ I
G J a O U .01 0f X
.Of01 .01 - O! G1 O d' L U <V ~ N Q
n y y y y y y y O y y .
U , d p O N c y ~U

IcouJ~m m mo mn mm mIC mm I ~
1 ' oc ~

m m - m m m m ~ m m m ~ m ap ~ ~ Q ~ ~
. c ~

c~ Cs c~ c7 c~ c~ c~ o , c~ c ~
~ ~ L ~ v ~ N ~ a ~

E E E m E E _ a ~
U O E L ~ E
~

C ~ N _ E 'm N
.N .N .ill .N .N N N _f0 O ~ ul a T N O G7 a H
C Cm CL C C C_~ C X10 C= CQ C
N ~ ~O d . O

w O. _ N 4: ~ d ~ ~
C ~ 4: L O ~: N O H
I~ 10 N
O

0 . o o 0 o o n ~ o o o 0 ~ o 0 d m C ~
~ d = ;~ a a d a a a a a a o ~~ d. o a ~ c o ~
o O

c ' O n j j j j j j > C > > >
O ~ O n ~ O ~ Q C N
G ~ y ~ -J
G

_ O OM O~ Opd O: O O O O
O p1 ~ ~ N N Z 1~ Z
' ' Z 'o Z Z Z rZ Z Z Z Y ... l t Q o1 N ~ al b a 3 ..

f0 a0O NV f0ODO N ~ fD00 O

to Inr nn rr.ao aoao aom a~
~ oaa a~rn ao a o~ rn a>
>~ ~

o_~a_~ o~a~ oa_> ~_~ _ __ _ ~

M ~ P01 M InIsp M 10I~ 01 M
~ o Ic co In~ rrm.nn o ao aoeo ao aa o~o~ o~

m o o~a~ ~~ o~o~o~ o~rn_ : n~ % cNv ~ ~o > cc I o o n o~ tDM tD O~ Q~
a0N ~

(O O 4DM N1~OO10t~ f0u7 '?O M
1~

10 10 (O O Of O10~p~ O < Of N

~ WOO dD aDO M O ~ M

1~O O)aDcD O p O~ V
apOOf Nf0 a01~e-COa0 ~ h 01 Qf CD

N M ~Vl On ~OfO N MV O O n O
p a0 O m OCDpaDO 01Of 01Of Q1 ~ ~ O
O01Of p 01 O~OI O f W OI OfO pO~

rj N
~

t0 t0 O
t0 Qr ~O (O tp V_ cD tp O N
W t~0 Of N N O N
1~

Of O ~ ~O
N CD

V ~D
CD
N

N ~ N N
?
~1 N ~ N N

O O
N
a0 tD O ~O
CO ~ ~ N N N
N ~
~

I~ N N O 1(7 aDO) N

t< O N OD 1 O) 1~O
( f0 N
p 0 t~0 M t0 N ~ t~0 O(O
t0 t0 1~
t0 N ~ ~ ~ N N O)N
V N ~
N

Of N N N N N NV
N t~ N
Of N N~ O W (14D 01IW 1~ N N O O aND
M 01 u'1 r a0 ON O M O u7O O O Of t0 l0 Of CO ~ O
t0 t0 fDM O O t0u7 N O O ~O O~ 01 u7M
~f0 ~ ~ ~ ~ ~ ~ Of (D t~0~
O ~~O'1~~
~
~

N (t f0(ON N N t ~D N N M M NN

Nfp N
N
N

~ ~

lL LL lL LL C LL N lL

" N p g 5 g g g L
n U ~ .L..H T V
l z zc 2 z z ; ; ~ ~ z t z > >Y N > > , , Y ~ ~ n N N

O
M

N O) Q' O ~7 O
=

O O O
~ O

lL lL
N

a a a ~a c c c ~

'm 'm 'm o O c O O
Y

a a a o C C C
N

0 o o c a o.'m a ~

m c c c a o E
~

'm 'm d a ~i a Y

U U U

o a W
-N
J -_ n- N n n c0 C W

Q n Z n r r ~ O -.d N
N of T

V c~ J n o o Q n ~ ,~
,~ ~ t o >, M Q M T (D ' ' ~ N
~ T N d ~
E

L O M N V E u7 O
LI x E r H
O O
N
O

O O (D -..
G) Q
.

~ U ~ ~ o m ~
~ ~ N

~ Z ~ ~ in U ? Za m~ ain , , .~ a a ~ ~ N
~ m 0 ~ a a N N
a E a_ N ~ p 01 N
~ N d ' ~ N

Z O n K7Q O n 1~ N 1 O
c O LL C N ~ M ~
O r O 2 C

N F- (n O ~ O) -. O ~
n ..

Q ~ m O'J NN a WC (D NC Oc R ~ DT w0-N ~ U O c0 (D I~ ~ ~
~ E N N >' ' L
~

I N > U V N C~ f'-77gyp _ N I QOlL ~ N ~ E N M
O N ' C ~
T

'oi r 'oww 'vi o> 'o~ o~ o~ w E ' ~ - o m o~ ~
d I a Z

Y Y Y Y Y Y Y Y Y Y Y
~ = S c F- ~ f0 ~ O c G7 c c c c c c c c p r N c n c ~ L d a y ~. m ~a m ~ m m m <a m ~
~a d c ~ ~~ ' o ~ ~ Q ~ .__ c m m m m m m m d m 3 m C
~

U' U' C C U' C U' U' U' 9 ~ o 7 7 ~ 7 o o o N
E ~ ~ d c ~

E E E E E _ E E E E E
v O E i ~ c V ~
~ ~ E v ~N ~ ~ = o N o ~N ~N N 'N
a 'N 'N 'NN ~N ~N d N
n 7 d a N C E = ~
cNO cY c c~f~ c~~ ca c~ a c=~ O
c cc corm d _ n ~ n~ d j N ~ N d _ 1~ r ~ r 00 d C Q ~ ~
p N N O Q ~- ' ~
p 1~ _. o 0 ~ .. p o o o o o . o . -. a y ,~ m a~ o M o . o Z r M o = c a~u~ a aN a"aoa a~~ a~"-a d~t a~ dN
M. o " o N , d N N d d N d d N
~ c ~ ~ ~ O ~ d = p ~
~ d y V n O E C
O U

Z Z Z Z Z z z Z Z Z Z
'o~ Q 'o~ X 'm a a ~ Z ~ a d a a U ~ = d U

aD ON V (Oa0O N V~ fp aO O N V' t0a0 Q~ OO O O O N N N NN

O_f 00 0 0 0 0 0 0 0 0 0 0 0 00 NN N N N N N N N N N N N NN

n Ofr M u7r O ~-M N r Q~ M ~7n ~

Of OfO O O O O N N NN

O WO O O O O O O O O O O O OO
_ r-N N_N N_N_ N_N N_ N_ N_ N_ N_ NN_ h ~ M 1~V O ? Of 1~ ~D ~D NaD

~f ~M O O GO~ N P p 00 M ~p PN

O O fD? W ~ CO V N V1 W V ha~
oD hM O~M ~ I ~ O ~ N f0 < ~OaD
~ p ~D Nh a0M _ _ N O ~ 1~ V C) OO

P 1~!D O)M ~D aDtD O ? fD ~7 N Of0 O~O O 1~f0Of 1~O) aO P ~ u'1 4'f f0t0 NCO a0 h M 1~ ap ~ t0 Qf CDaD

O N M ~ ~Oh 00 Of O ~ N MV
~

O OO O O O O O O O

O

O
O
p N

t ~ N O
O ~DNm N N
C
O
h m N m O O
f0 O O

~ N 01 m N t0 1' n O ~

m M O 10 f0 M

N O O O
NO~fpO(~OMNy O

.
N V N N m P f0 O N

O~ N O
N

MMO M ~N
ONNmO O

_ O
~ m O O O ~ N ~
O O O t0 ~

O f0 N N
M

~ M
U07MvfmNONm~N N ~~ 'C

m O
W m O O M ~
N

NN~O~OOMa00N N Dm ( W O~ u7 V O m N
N P N Of V

O f~
m ~O M O I~ M V tD M
(O N M (O O~ t0 ~
O O
O
O

I' N. V ~7 O W _ O < m m O O M m m < V
N N V t0 O 10 0 V
m t0 D M
fD
f0 N ~ m_ f0 M fD O) Y7 f M
O (O N U7 C N f0 f N
N N N M W N ~ N N
N M M ~ N

m < m ~ N ~ N ~
m N
N
O
~

7 l ~ m fp ~ O O 01 f0m O) m M ? M N I~
f1 m ~ O) O m V (D M 10 fl M
~ 01 01 01 1~ M P
I~ 1~ O O O

m m O M tD f0 m O m m O m c0 O) f0 01 O
~ f~ ~_ t0 (O fD h f0~D h m W ~ t0 (D O
h f~ O) M O m O d0 O O WO W O ~
1~ O
~

N N ~ < 07 n0 ~ ~ N ? Y '? ~D V m V ~ O
m m (O 00 ~ ~ ~ t0 N f0 t0 ~ m ~L7 m N N f0 O t0 fD t0 N m f0 (O M N ~J N N N
t(7 M 47 tD N N N N t0 N ~ u7 N N N fD N N N ~
N In M ~f7 N
N N

C

d f0 O O

N N

p l f~ Z f~
A A N d ' a ~ L N d ~ ~ U
U

~ ~

y 7 N d Q O L
' O n n p m 01 N
C

O~ >. N
~

O ~ ?
C O
.

O ~9 lL
L

" a -' r.
'O

C .f0 C C C
N (C .
.

. - E E
' .

E o E r m ov .~ v v H

v = v - c c u~ r c c a> a a~ a~
'd a a~ o.
m -o ->~. c c ca E

n c n n a~
d o ;_ N

C N C C
C
C
N

.fC C .fO .f6 . O N
. ' 111 .p-. c c G C N
U O
O

o ~ U
' IL
U

U ii a U

E

J ~ -J - ~ ~ j ~ LL
~ p C

LLJ ~ e- N f~ .V (D
L ~ E .N
IJ

_ o' " ~ ~ ~ U
~ c N ~ o N O~ O O U O J
L' ~ d Q Qi M O O N lL
O d O N

o U r' t~~~ ~~ Qn M ~ = o ~ o O

U o ' ~ ~ m ~ Z d a a ~
J

d o N
o M ~
M

~ ~ : ~ 11l~
o d Q
a~

d M n M Q O

, W O ~ ~ ,~ r o a~ X ~ c N
x o V 1 1n ~ Q GI - fh M O~ G, 111 L t C lC C d .C O

01 d O _ ~ T _ Ol O
~ T Of 0) d O Of ~
a _ t C V
C
~
W

C Q C H C ~ C ~ ~ ~ ~
E U ~ Q ~ O m ~ 0 C

CO m m Cfl m CD C~ (~ m r ~ 7 ~ a ... N
~ ' G7 U O
V

C~ ~ ~ ~ U ~ C9 U~ U U U
< ~ ~ y U N ~ N of Z > ~ d o N N N N N ~ N N N N N
a O N ~. O Y~ 7 O C
O Q Z E N N

N W Cm Cd C~~~ Cd CQ Gdy CN CN_>
C7 Cn - = .

d V O~a~ ~:07ad~ d:f~~ ~L'p. ::~U.O..N.p..m ~ N C C
d O N O O O E O O . E E E
tD i0 1 y O . M ~ n Z N O O E C
= E ~

a ' a a' a a M a a a a a ~ o ~ o ~ o o ~ "
u~ ~ o~ c , ~, a 2 E o o ~..~ M E ~ ~ -yy ~ ~
H . o m N ~ r "~' tn m ~ o j j j > ~ > > > > >
N a ~ L Mm C O ~
O .p..~ 7 ~ N ~
O .U O

O O y O O O O
" ' ~ N ~ Z Z G
a ' a 'O Z
a ~ ~o Z ~ z z Z Z Z Z f r rn a a c~ ~ ... m a ...
~ ~

p N m a~O N ? t0 a0 O N ~

~ O O O ~ O O ~ O O O

O O N N N N N N N N N N
N N

O M M O ~ ~ W O

p M M M O O ~ V ~ O O O O
O O O O O

N ~ ~. ~ N ~ ~ ~ v < M O h N M f' Of O f0 V

r Of M O M ~ N ~ N O ~ M

N ~ (p~p N t0 M N O N
~O N W ~ ~ O O

Q) O N M ~ M O O s1 V N O
~O 1' O

f0 M O 0 0 O ~ O ~ O 0 f O
1' m ~ m M ' CO CO 1~ m O O ~ m O N ~ N N N N N

N O O O N O O
O O

p O O O O O

M

O Of a0 O

O t0 t0 t0 ~ ~ Of ~t ~
~

~c ~c - cn cn N n7 c0O N
r N
N
N
M

a0 . a0 <pN
N ~fl O f~(D M
N O
O fD

_ ~N
_ N ~ a0 t0 ~D ~ M ~
O ~
p O
~
~

( ~M c 0 N O a0~ 0 N f0 N
N
N

_ _ oM
r rn u~ mM v n 0 ao of o M

uo ~ 0 ~

a ~ 0 0 ? V c Nt0 V 1 ~ V N
~ V

f0 f0 _ f0 (D
f0 f0 Ip N N t0 NOf N N1~
N N N
~ c0 O OO _M
CO c0' _ ~OfV M t~ Nc0 V
r st a0 Of Q1 O~
<

O O ~ N~fM 07 ~O O~ M
tD M t0 re~e o u~ cocc ca a> c~ V
o ~o o n n o N7 V N fvN V ~ V ?N
V V V
N

t0 f0 _ f0. t0 f0 (D ~O_ tD
fD LO t0 fDatN N N N47 N
f0 N _ N N N
N N
N ~

~J _N _ .N
O Of~ N Of - t0 N~f7aD~ N ~ t~ u'1u) t0aD t0 Of 1~ u~ (D
O O DO h ~ O
t~
M

O Q1O O op (D O O~Or-O O~07 O O fD O~ aD t0 a0 O aD
f0 K~ M f0 0D f (OOfM t0 <O~O O~ (OO OM (O 1~ f0 O t0 IO W oD O O
O f0 O~ O
O c0 tD O

~c~OtOC~O~~(~D~t~DaD~t t~O~~ tpO~~D(D t~D t~0~ c~DQM1 c~Ot~0(~O
~ ~

N NN N N M N NNN N N N N N N NN N N N N N
N N N N
N ~

O OO O O O O O O O O O O O O

uJ uJW LLW W W W W IL W uJ uJ uJ W

fn fnfn Infn (n N (n fn fnd In fn (n In In N fnN fnN In f/7(n N InN C (n O N (n N (n gg 5 5 g g g g g d ~ a 5 N g g g U UU U U U U U U U E ~ ~ U ~ U U U U
~

Z ZZ Z Z Z Z Z Z Z o c c~ Z y Z Z Z Z

77 > > 7 > > 7 ~ H Y 7 L 7 >

O 1~ u7 O

M 1~ M_ O N
O ~ ~ O O
N Z

O

Q. d a n. a N c c o c C
c c : E

. . . . .
.c N

E E E E E
o O O O O O
~ a p a L
a c a a _ ~

C C C C C
T A Q ' 'H
' C

d d y y 41 E Z T
t0 o oa 00 0 o n n a .
~ N N

N N N V) N = O C T
N C C C -N
C

Y J ~. N C
fC f0 c9 N =
Y0 ~ fC '-' f0 C N
N O
C

Y
~U

U U U U U
Q Q Z

t d d a?

H
C . ~ N ~ U
~

O N . ~ ~ p , ' M ~ U Q N M _ ~ , - T S
~ M ~ Q) N
U E

O y L ~, N Z 0D O N K1 1~ ~ h 111 V O

O N ' N ' ~ T O O M M N -O O (DO d M a I~
i N O
O

m N E n N ' N (Dr m ~ ~ O n C O a O ~ N N
~ O

L ~ a N M
~ N O

~ o 0 0 o ~ o U U U ~ ~ U o N ~ T o E

~ ~ 0 o ~ E Q
~ 2 E o~ Q o M Q j a E E E E a _ o E c a ~ a v d ~. > v ._.~. a ~ ar > a _a~ .
' N ~ n d O c =~

Q! O = ~ r Q71 O O Q N
N Y N ~n o~ ~cN ~ ~ ~n a~ ~n ~ ' '~
o o> a~ M rn~ ~
a > . ~

,~ V n ? J O O) OfO n N U ~O t0 ~ ~ M
~ U '- I V E o N N O
E

o o ~ ~ ao~ a~ o o M
~ ~ ~ ~ ' ' ~ cn r U ~ o o~ o M N o m ~ ~ c~ v o j o~ ' r r ~ ~ '> c ~ 0 n (V a N ~t 1 - N N M N r ~ aD V N Q
W f0 ~ d ~ a V7 YI N O M L
.-OJ Ol 01 Ol 0101 Ol 010l 0l Ol O) _ N
d V a A d N ~ O O ~ O!
~ N O

Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
~ ~ . 'C ~ l7 t O ~' d d a d O

c c c c c c c c c c c c c c c m m 5 u~ ~o m o Y m E m m m m o o m ~o is m m O m ~ L ~c ~ ~
v r a o o a>
~

m m m m m ' m m m m m m c9 U' U' U' C 7 C ~ ~- C U' U' C ~d c C9~
i. o ~ w N '~U' N '~d = 7 .7L o H ~ E

E E E E E E E E E E E E E E _ ~ Z ~o N m ~ ~ ~ ~ ~ a = N Q E
~ ~ ~ ~
E

N N N N N N N N N Vl N IN N N N
V ~ ~ N ~ p d Y T ~ T

Ct0 Cd C_n C~ C~ CdCN CMU C~CN C_L C~ CO CL C
~ . ~

d ~ ~ d 4:~ 4: ~ O O 4: ~ d Ø.
u7 O L N d ~ Q E N ~ M N f0 C

O O O O O O O O O O O O O O O
~O O V C N t E O ~ M M M M
a O a O Q) n M O N f0 d ~ d N . a a d d d d d d O N.
M L N d O O O N O 07 d C
~

> > > > T 0 O
C N

J ~ Q Z > > 7 0 > > > > > > >
O O O O O > O > ~ ~ O ~ m ~ ~
O O a O O ~ O O y E
c O
C
O

Q ~, Q. C ~ ~ Q X r Q X Q Q O
Z Z Z Z Z .Y Z ! O p Z

a t ... Y Z Z Z Z Q Z Z Z Z
... v Of a tD f0O N ~ D ap ONV O 0 O N Y t0 NO N Y (O a0 O
t ~ a ~o ccc a <o nrr n r ao o ao00 coa~ o~ a~ o~ a~ o a N NN N N N N NNN N N N N N N NN N N N N N

~f1 f~O) M O Is W M f7 ~ O M u7 f~Of M ~ f~ O~
t I

u7u7 10tD 0 t0 Onn n r r O O O a0O O 01 O Of O
t O OO O O O O OOO O O O O O O OO O O O O

.N..~ N ~ ~ v NN~ ~ N N. ~ v v ~~ ~ ~ ~ ~ N
v c0 OM 1~~ O h u7ope0O O N ~l~D NN N aD O a0 c ~

N OV 1~ _ M u'7ON N V 0 h M t!1aD tp O O O N
~ c 07 OM N D Of MOfO O O aD O M Of~ c0 N W f7 t ~

f~ ~O~l7 OfM ~ Yf f0Vf0 O fD 0 ~ 1~ u7~l7 V f0 tD
W (OO a0f~ D ~ ~OO D D f f7 a0u7 N N M oD u7 h t a t N
n N tDO N cD ? N WCOW V N O O O O~ 1~ O h O ~aD O V D Oi OOA O h O O ~ O ON f~ 01 O
N CD O c D Iv 1~CDCON O W r OD OD10 M 1~ a0 h a O OfO N M ~f ~f01~0 f O N M V10 f0 1~ a0 Of O
a O

N NM M M M M MMM M M V ~ ~ ~ ~~ ~ p O OO O O O O OOO O O O ~ O

O O

o ui ai r~ ~n u~ .

~c _ in ~o o~ r M r N ~ f0 O O W t0 h O r ~(1 N tMp a0 1 O N (O ~ c~ a0 aD

_ N O
~ N N N N N ~ O
N ~ ~D

O ~O M . . N 10 00 tD _ f0 aD N . N
a0 IA N ~f7 a~
fn f0 N N V 1n c0 ~ . cW l7 r N tD O
t0 a0 O . fp ~O

N ~ < V O t0 ~ O N
V t0 N u7 N N t0 O
<D (O ~

tD t0 O

O N a_D aD ~ N ~ O O
N a0 ~ N ~ ~
p r O r c'~ t0 N u7 t0 t0 f~7 ~ t0 N r Of ~

N O P7 1f7 f~ a0 N ? a0 O c0 47 l~ N f7 t0 O
fp N ~ N t0 t0 O . . O N .
f0 _ N ~ N ~ ~ ~ a0 ~ N
~ ~ N N ~ ~

07 N ~ N r u7 N ~O
N N O O O r (D f7 n0 O Y7 aO
r h tD f0 oD . O v r N _ N W t0 O
~ f0 f~ 1 ~D O O cD ~ O
~ tD ~_ O a0 O ~
a0 t0 ~ O~
O) ~ tp ~O r O N r r O tD ~c7 O
t0 r V N u7 N f0 ~ ~ N N CD (~O P7 N
~ ~ N N ~ ~

~ N ~- V r c7 N N O N
N r N N n0 W
N

r m ~ ~ r 0 N YO ~ ~ ~'7 a0 r ~ O
~

C a0 t0 r tDO t a0 (O10 M 01 O O
y O O f0 tDr O
O O

~ a0 t0 ~ t0 O ~ N e- O
O) r-O u) t0 o f~7 f0Of O) fD r01 of t0 off u7 0 o O) o o O) N
tp M

.n v v rn M ao vv v v v v m n v t0 mn v M tp~o tp ~O ~M Qf tp O ~O (O
m O ~ O ~ ~l7 t0 tD f0 ~D c0 M
f0 O

~ N N N N f~7 NN N N NM N N N N N
N ~l7 N N ('7 N N N

Q y Q Q y L11 N IL ~ IL p N

L_L C It m L_L U C H C

(n N !n N N w ~ ~ d N o m~, E N n o ~ o ~

N T n L

U >' U~ n U '~ ~ N T

Z y Z~ ~ Z ' T L y 0 7t E 7 c~ n a~ o 0o r a a x a~

c c .~ ' o T

L

O O
N L

O

C~ Cp -.~ 'd 'y d V
N

O O
a =
C

n W
C C
N Q
O

_ E fO
~ Q

O C
C
N
t U U
O O
v N ~ ~ LL
'0 ~ O -~ C

0 ~ 0 N
Q

f _ 0 E r ~ ~ p w N
r U m a ao o Q W o ~ Q f- Y
0 d --~ Z U r O

C~ ~ o r'> U U ~ n uJ t > ~ 1l Q

N , ~

w Q y w a o Z a 4. ~ U a O aoo v U ~
H

_ 7 Q ~ c ~~ ~ o ~~ j aM0 JO OU o c d o m U J N w Z Q
~o C7 Z 1L

O y X Q 9 ? ~. uW Q Z a Z N ' d ~ m ~ ~
~

u Z

O C ~ I
O

(O d ~ o aO - ~ - O -O ~"~ ~ N 7 ~

U v m ~ > ~ O X U
y " Q v ~

m ~ U ~ O N ~ Q ~ O U m Z N
~ E E L C~ M lL r' ~

~ u~ c Q m - Q~ O ~ a ~ 'o = ~ m .N = w Z .- ~ N Z

~ 'v~ W oy o~ uy (~ oW o Q w ~cr ~ o w g ~

Y Y r. Y Y Y Y ~ Y Y Y U Y Y
[1j ~ N C C7 U U N
r ~- m ~

c c c c c c O c c c C7 c c N N o m d ~ ~ V w d t0 u! o m IC N e0 N Q m H N p X (n -m N N N m m m m m m m f. m ~ m U m ~ O N
m m ~ =
E

M m oo C7 C~ o ~ ~ y , w C7 C7 C~ C7 a U f U Z_ O
O U O N

~ E ~ c ~ E ~ ~ U ~ ~ ~ N ~ E
E E a E E < O E ~ UJ E
~"> M ~ ~ j ~ E ~ ~
E Q Q ~
p U
O

U ~ N
' y i, ' n. 'H L 'N O a ' a ' y ' C7 N Z U
~ ' ~ ' '~

Vl ' f9 N N N H ~ N N
4p H ~ W

E ~ ~ E ~ S 5 ~ ~ ~ H E 5 N ai z d N O H o C7 H E
(~ m C7 o Q a U
~

:: d ~ ~ _ O :: O ~
N 4: d' C :~ L d p 0 ~ Z
=

u) ~O a C ' t0 r E O p ~ o p o~ o H LU a ~ o r (n o o ~c o O
ao o o 0 o o o Q m o ~ ~ a = 0 p ~ c ~ ~ ~
~ E "' ~ w a a~ a< a a n. ,O~ a a a H
a "Q o C~p da ~-- DV H

'"p ,oz ,oz '~ ,'~ ~OV ~~w ;~N >~zr~ ~ 'v ~ ~

~ ~ O y > > ~ IL >
~ ~ ~ = ' ~ ~ ~
N N
J

O O Q O ~ O J Q Q_ O O O O
I a ' O O T ~ ' d ~ ' ' ~p z z z z...~z~ z z z z z z ma o~m mw~ c~csa> ~o <n m~Q

N (D aDO N ~ t0t0 O N ~ m O ~ O O~- N N N ~D N

_ N N N NN N N NN N N N N_ N

N

C 10 rO cW Or Of ch r O 1 O OO N N ~ N
O

N
N N N NN N N NN N N N N

_ _ __ _ _ __ N

N O u7aO O t0 ~O~ N ~ M

t0 a W ~ N~ p f c1 N Nr 0 01 CO r N p OV N r c0N ? r Y

r v in aoa~ ao co rcc ao n co 0 0~
~o n ~ o~ ~ ~ v m o N v a ao ao o> rco co ao~ ~ r r~ ao o r N f~ V~O t0 r m01 O N f~

h ~ ~ t0Y7 N N u7~O fD c0 c0 c0 O O O OO O O OO O O O O

~
~
v .r _ N .o N N N
~ N ~
~ Y

~ f a0 ~O
O 0 ~ f0 ~ r N
t N
0 ~
~
lD
N
N

~ V f0 ~ O Q~

(p Of cp f0 tD f~
OD O tD h CD OD
~

~O N ~ N t0 N a0 V O
O O
N V

N N O
N M ~ N ~
O O V
~ N
cD
t0 N O ~ ~ N

~ N
N

~
~

O 10 h Of (D 1~ 07 ap ~ f0 M ~ O 47 ~ N N 1' N ~ V f~
tD a0 t0 N M
O O
fp V

f0 O O N h t0 O t0 t0 1' W
t0 N fD O N N ~
fD ~O N ~
O aD ~
N

N ~ N ~ ~ O N
N N ) N
~ N N
N
N

_ O

N M O aD I~ 1~ O aD
O~ a0 t0 V
Qf O P
tD O

_ O c0 (O a0 N ~ O f0 ' ~O N ~ M
O N c0 M
O O f0 t~
~ O ~O
O ~D
O aD

(p O 1 t0 N N N ~
~ t~0 c0 N ~
f0 ~O t~0 c~0 O

N aO N N ' 10 V ~ N
1~ N N
N N N
N N

n O 47 O O O op ? V N 1~ 01(D O O) ~1 O M ~CO a0 O f0 M O
N aD (O
O aD

O O O aD O O O W OO V t0 O O a0 c0M v0 V7 Of aD O
O N M
O~

tDO O~t0 fDc0 t0 c0 O)O 07 1~ Of (DO (OP I~
O~ N O O
f0 (O Q) f0 f0 ' Y O ? ~ ~ ? V 'Q V~ Q7 V V ~ ?M V
t fD (D tD O V t0 fD N f0M ~
< V OD V
< (O ~
fD f0 fD
M t0 fD
f0 t0 O tD

tD(O f0(O 0 N N N NN u7 N N N ~ NCO N
N N N N N M N ~ N
N N N
N N

V

N

N
O O . w w ~

w w w_ w o W

1a.l LL LL ~ 11LL lL LL
L -y m _ (~ m N m m (~ m fn ~

g g L g L g ~ 5 5 g g N N

G T a Z Z a Z ~ Z h- C Z Z Z Z

, N 7 , 7 Q Y ~ 7 >
p (/l m 07 O
N O

O O
O O

c c 'E .
.

m m w N

v v C C
U C
.

. O
V E

O ' ~. O
d d' d~

u1 N
O d C C
d Y

'(p fC
Y

O O
9 (~

U U
Q uJ

m m O d Y
O

_ E J ~
Q a (~

+ ,~, ~ O m ~ o U co u~ E

~

N Z ~ ~ ~ ~ ~ ~ ~ N
N V N

N Q N Y x >
g ~

C7 ~ r o ~ n0 H ~
E in c m w tip U ~ w c o~ U a Q U
o ~ N o C7 a~
~

cnQ a m C7 ~ v a y j a a x a . Q c ~ o -Z _~ ' ~ x a E
m O E ~ ~ j ' E w o H m ,a N
~

~ 0 O

m J (D V ~ f M ~ O Q' O
.O N E 'f Q N V
C

0 O r- rn~ ~ ~ U O M
o W m a E r O ~ tn u ~ a ~

p N r V f~ ~ I M
C = ~ H x > O

~~~ o ~o~Y~ 'o~ of rn U p o~
o W ~ ~'~ d ~ E ~ O E

Y Y Y Y Y Y Y Y Y Y Y
p Z ~ (' a C D x ~ d -~ a ~
C

C N N N (O f0 f0 l0 (0 f N
E ~ X J p C r 0 O
U Z ~ ~-00m m m m m m m m m m L N, O ~o"N '~ E 'u, N ~
Z H Z ~

C7~ C7 C7C7 C7 C~ C~ C~ C7 C~
C7 > o M N o ~ ~ L
o O
O

~ E E E E ~ E E f > E
E ~ ' ~ E ' n Z E o m m ~ E ~
< ~

m ~ a N ' ~ ' a T
' ' G) O a ~
~ ' n N y) H N N N N N
Y

CHCNX c c_Gd~ C~J C7 CQ GHO GNa CL

Ø.~ ~ O d: ~ r ~ ~ ~ ~
G N c7 M N !a U M h O
' O H E ~ Y

o o o o o o o o 0 o o ~ <o c ~ ~ o w ~
m Q d a a~o a~ a~aU a a a, ~o a~~.,o aN
~. o H a o N J dp N NN~ dL N G1~ _ dpi N~
O 0 V d N~ U
n >ONy >JN O > >C >' > r >V >Jd 7 >m~ >~
>NO M

O O O O O O p O O O O
- O Q =!n O r -~.j -Y
' ' ~ ' a d ~

Z Z Z Z Z Z Z Z Z Z Z
rno~ a ooQ m d c~v crx U
U

O N ? t0 QOO N ~ f0aD O N V ~Om ON ~

M M M M M ~t Y ? Cof ~7 N O O O ~Ot0 ~D

N _ N N N N N N NN N N N N N NN N
N

W M O r Of M ~r Of M N r O M

N M M M M M ~ ~ tV W O ~O N ~fW f7t0 f0 N _ v ~ N_ v v vv N N N v ' Nv v N

apO a01' ~ N O~ O ON M ~ ~ ~ O GOO f0 n aoao m o r n ~n 01rn oo v oa~ rn N M a0Yf O f0 N aD O O ~O u7 ~Of N
f (O N N N _ O f0 tN O f' _ O 'C 1~h O

N O M t0 O O ~ O N h c~ c001 t0~ O

O aD _ O O _ N M o0_ a0 ~ O N V I'1' ~
O I~ O N M N O N O~O - O) O O

aD ~ a0 a0a0 N a0 haD aD aD 1~ N a0 ~O~ c0 N t0 1'm OfO N M~ O t0 1' aDOf O N

f0t0 f0f0 fD1~ 1~ h 1~A I~ h i~ 1~1~ ODf7DOD

O O O O O O O O OO O O O O O OO O

CD N t0 f0 O f0 O
1~ _ f0 h (D
t(7 f0 Q O O ~t V ?
O t~ t0 N O c0 f0 . t0 O f0 M N O t0 ~ N N h N
u7 f~0 O N t0 ~ M O N M ~
N a0 N 47 N O O f0 aD O
. oo so . ~n . o o r o cc f~0 r h N O ~ ~ m ~
t0 Y ~ h N O 07 aD ~ N N ~ t0 N
O a0 tD aD . ~l7 tD N . . a0 . M
O f0 M M ~ Q1 to O M h h m ~ M ~O
a0 ap ~O M t0 O Of O N V O
~O N O O_ O ~ . ~ t0 Y7 t0 M ~O t0 N Qf u7 M O M V ~ ~ ~ N ~ N
. a0 N c0 _ r _ (O f0 . cD
v!7 O ~- fD h M N ~ M 1_~ N N N N N N N
O u'7 . M a~ Q7 . fp aD _ aD _ m Of h O t0 t0 tp ~ 1~ O W M h V tD V N ~O
00 ~f O <O w7 O O O M ~ O ?
tD (O t0 ~ ~ cD t0 O aD Of t0 O ID tD 10 t0 t0 N N V N N N ~ Q Of ~ f0 ? ~ V < N < N
. (O . fD (D ~ ~fl t0 ~D t0 t0 . t0 O O N 117 Of h N N N fp M N N N N M N f~
1~ N . M N N . aD
e- N O 00 07 N c0 t0 t(7 00 Of W ~ 1~ tD 07 N f0 (D M O r O O O f~
C N c0 u7 t0 N o0 O O aD M O M t0 f0 O aD O O f0 N O 47 ~ a0 N M h Of n M ~ M O ~ c0 M tD fD n(7 1~ (O f0 O tD h M c0 O~ O f0 ~ in ~ O c0 O~ t~0 f0 ID N t0 c0 ~ ~ f~D f~D cp0 ~ tD O t0 ~ f0 f~0 (D f0 N M N f0 N N N N N M N N N N N N N N N t0 N M N N

L_L W t_11 W t_11 l_iJ l_JJ
l_1 l_1. O t_L L_L I_L l_1 L_L
N n U ~ N tn N
N (n O (n N (n N (n N O N N
E N N N N N
U U L o ~ U U U ~ U v c U c > j ~ a t > j ~ c 7 c H 7 n ao m ui c a~ o ~n ~
M OD ~ N M N O
N M M 1~ V
O ~_' O O N O .. O O 9 ~ E ~ ~ c u. j u.
a ;~ a a m a a a a c_ c ~ c c p' c Z N c c ~°' .E ~ .E v E c .E a r .E .E n 0 0 0 -~ o m o z o 0 o Z, v ~ v c c E v c M v v o CLC~d CO.o C'~y~ C_- C_ N U .N O .N Q' E .4: V N d N .N 7 O~Od O=O O' C O~ 00 d C O. d V 'O d ~ y O. N d f0 N V N E Vl '~ N ~ O N U N
C C COd Cl'~ C_7 C_ N ~ N N (9 E ~"' f0 ' V c0 C (0 N T.
d O
o U o a o r O o d d o c o m ~E
U H U ~ U ~ ~ U ~ ~ U ui U ao w°
c Z U J ~: D ~ J O - - N a a 3 a = ° a ~ a c~ ~ . N ~ 8 W U~ t c~ ,~T My aoo N~ ~U ~ TOO Z ~H
O > W o c m ~° a a'> E H z ~ o o m d 1- ~ ~ ~ x o d ° r o O w in ~ r a Z_ O a H Z m N o ~ p w '° Q ~ ~ ~ Y ~ ~ o m c a y p o m E a ~ ~ E = W E ~ a a. E ,n O ~ J
a c ~ a~ ~ E , ?~ in ~ a~ ' a cn d ~ m a (~
7 ~ O 'N (n 00 O u'7 O n .Y O Z fD y N f~ j, ~ J
J O O Y O Q-' ~ C n O a0 N J O L tt N OD N
rn ~ r o = i~ m p a n m ~ w o ~ o !° ~ a a~ U <c U ao E o ..: o ~ = cc o o ao o. U O
U ao m o~ o u.l rn E o m U
~M UJD -~ a~ v > wt Q ~ v D ~O. r"=TV °' m wa Z c~~ ~ r 'e, ~ v 'c, o '~ N ~ ~ 'oi ~ ~ m 'c~ d 'o~ o 'o~ c m~ a~ Z
Y O r Y a J Y E Y J Y ~ Y O Y ~ N Y O Y J ~ Y V Y L Y C Y _ Y C7 ~ A ~ ~ A y !CO ~ N M (0 d A N O f0 X ~9 r Z l9 d f0 N (C ~ (C m lL fC Q fn n m t0 m y m <O ~ f~ O m ~ Z m V m = m e0 m ~ !A m O
C~ u~ U U "~ c~ C~ H C7 ~ p ' CW n C7 M C~ a~ C~ ~., C7 ~, C7 Q C7 a~ C7 o a o Z o to cc r. :? O M >_ r. Z ~ ~~ ? N t' N w tn E E N x E o E_ ~ E N E o E ~ E ~i~ E r E E E ~m E_ o~ w E o ~ c9 'N a ~ ~N a Z ~N f0 f/! n ~ ~N ' H ~N O ~N a N ~Id j ~N n ~ ~ ~Vl L ~N ~ ~N O
H
CNp Cdr CC_CN CO~CV CO~p Cd C_Np CCC~Cd CQZ Cd N (/) v.. O d (p J d f9 ~ ~ Ø. OD C ~.Ø M ~O N ~ p ~ Ø. ~ r CO ,~, '.Ø
N ~ ~~ N ~ W
O ~C a O ~t O O O O ~ Z O pp m O O~ O f0 p~ O ~ O 10 d ~ O N O O N O N O t0 H
N
QW O QW O N O N 1~ N ~ O O N tp O O M J a d N ~ d M N7 d a N l1J a pp d L O a ~ a ~ p a 1f] ~ ~ d ~;, a ° d Q, -o a. ° z_ a ~nY ~°_°O ~ c~r5 mnH boo E ~ N a ~~ TE ~o a ~vYU --yo ~°<
~o a --y~H y~F-H
o =~ o ~ U o r o =~ O J O O L N O ~ N O O J O O N of ~ O J O O O J O O ~ ~ o =U ~
z 'rn c z 'v~ a z fn z -oo a z a = z o. m Z 'or v E z Q v z 'oi v d z a z ~ z a v z 'o~ m z of a v) f0 aD O N V tp ap O N ? t0 aD O N V f0 t0 tD h_ n Iv 1_~ r a0 a0 a0 a0 a0 O_~ O_~ O W
N N N N N N N N N N N N N N N N
W h Of M ~ h W M O h Of M N
cc ~o so n n r~ r n ao ao ao co ao o> o_~ rn N_ N_ N_ N_ N_ N_ N_ N_ N N_ N_ N_ N_ N_ N_ N_ 1_~ t0 OD O O M O ~O f0 ? N O h O V
O (O fD f~ t0 O N h aD O 1~ ~7 h f0 N
f~ M M N Of O OD aD V N M Of N W f7 ~
t0 Of u'1 00 M ~ t0 M 1_~ N t0 O I~ ~ Of fD
? Of f~ O O n0 a0 u7 Gf c0 u'7 N M c0 ? h V tD t0 a~ N O 01 N a0 < O N
h f~ tD O O W O N O ~ O t~ O O O
a0 M O n h r c0 m m m O r A
M ~ ~f7 tD 1~ aD Of O N M y17 l0 1~ CO
c0 m a0 N O m aD Of Of Of O) O Of Of 01 O O O O O O O O O O O O O O O O

N M N
M

O O t0 O~

~o m n N m O N N N
N

t0 O r- ~(f N O O O
m m m m N ~ n t~0 ~
t~0 N N N
N

'- f0 O
O N

N ~ M ~ O
t0 tD m m tf7 O
n t0 ~ ~

tD tD t0 t n f0 N N n 0 N N N N
N

m0 N

t0 W O ~01O ~ M n!) N
M O O mm m O tff ~ ~7 W ~ W O
Of m O fD

m O - Mn ~ m ~7 (O m n n m ~

f~D N ~~ c~0f~D (~O
N t~0 f~0 N N N NN N N N O N
N N N N

N __ _ . . n _ M a~ a~ on . mwm . N . M mo m mm m mn m ~
m ~
m O ~ m ~u7 ~ mVIO O O O m OO M mO
u7 O O m M

m N n On M u7u7O O m O O_ 01~O m c0O
O mmm f0 coo m m ~n c~ ~m ago c'5~ m c~o~
~~oo N N N NN N NNN N N N ~ NN N NN
N N N N
N

Q Q Q Q Q d Q

l1J 111 LL LU IL N IL

lL LL IL LL LL C IL

O
fn "~ N fn (n N fn d fn ' ~ ' g g g g g j O N
d U N E U~ U U ~ w U L U
~

Z. y o Z Z Z ,~ -y Z y Z

C '~ ~N ~ 7 t ~ a U

C

~ N

M

o U

~ o~
a c ~-v c c ' m a o Z

a Q

c o ' d N
O A

d p C N

O y O C

U H
c r z ~ s . a~ , .c a z m r ~

Q " , ui Q

~ tn O m ~ m m ~ ~ r m g ~ ~ ~ ~ ~ ~c c n w o a m E ~
~

U7 ~ ~ o~ u U~ o U$ nU
j J ' Q
_ a p ? ~ a d E Q
a ~ a ~ w ~
a E

111 Q llJ C ' N ~ N d ~ ~ fn L r. N U
fn - U
.

' C ~ Z O ~ ~ O ~ n U
C L
~07 V ( Q O ~ V ( N N
~ Q

d ~ ~ N m I- N
O

Z ~ Q_ O M C ~ m O N. N
~ ~

pI 111 pI I ~ ~ N l N N M m ~ V Z C ~ Q E ~
~ ~

d to 0~ oo r 'vi ~a~ rn or u1 m U ~ N ~ a~
j o ' JC ~ Y JC Y Y Y Y Y Y Y
~yJ U O ~ ~ a >' ~ R
W O ~ N
W C~
Q

~ ~ ~ m ~ m m m A m to a O a, m ~ H fn ~ v) ~ Z ~ O

_ C~ m m m C~ m ~
m N m O Q ~ O
~ (~ O L ( f.

O U O ~ C7 7 O O O O O
.~ z ~ Wo o ~ ? ~m > o mu f- C ~ ~ E
N

, E E E N c E~m E E E
E Q a N ~ a o " ~~ r ~ ~ ~ ~ ~ v ' ~ N ~ E w E

_ N _ _ _ _ yi vy= _ N
H Z til '~ H m ,n 7 c N
Z ~ y H 4- ~
.- ~

C N C C H C C C C C C C
J N liJ E O H d O 'd C
'a; (p j : y Q N ~ d E
~ ~ H 'a; ?: ' 'a? '~ N a~
~ Q ~ 2 U m E ' ~
~a; ~ m ~ m _ , O ~ O O M O O O O O O O
= H U7 O ~ N m C m H ~ t O p a ~ a a ~f d . Q. d a d d n w M ~ O V M N f'm~~
r r H ~ N fn ~ ~ G M
O

_ O n O r = U U
O ~ ~

> > d N > 7 > > > > >
' f' N > O ~ ~ O y O O
H mtLU O-OZ O ~ _~ O J y rlIJllJ p O~ OJ N N
p Z of ' Z Z Z Z Z Z Z Z
Z ~ Z rn Q N ~a a d Q
~ '~ i- ~ F- ~ ~ U
D LrJ
Q

m O N ~0 0 ON~ t0 a O N ?m m~ ON
ta O

Q1 O O OO O _ N N NN N MPI

N N NN N NNN N N N N NN N NN
N N N NN N NNN N N N N NN N NN

n O Mff n OrM N n Of Mm n Q1r o O O O 00 O O~ N NN N NM

_ _ N NN N NNN N N N N NN N NN
N_ N N_ N_N_ N_ NN_N_N_ N_ N_ N_ N_N_ N_ N_N_ m n Vf ~ OO)m O7 ~ V mN ~ MN
O

M n ~ ~N N~ ~ V ~O~ m~
m elf m t0N ~O m m u) n OM O u)e-M m nn W Cf~O O ~t M O_m m O
N M O ne O O~n P t0 O n N O t0~
Of n ? nm O NM~ ~ O N O OT W nm W ~Lf O Ou 'f OOO O O O O eN ~ ~O
o ~

M m m no ~ mnm m m m m o~m ~n a O O NM y C7mn m Of O ~ NM 47m Of O O OO O OOO O O

O

N N O~ M tf c0 00 tD N O Of ~ O a0 O1 O~ N M N

O 01 . N 1n N CO t(1 h . f0 Of f0 O
tD Q7 (O tD t0 f0 07 O) ap O N_ O V of ~ V t fD t0 h h O V N h f0 (D OD a O t0 O t0 t0 (O O (D h h tD N (D
t0 ~

_ N
h h M O In h O N N 0D N O N ~1f N -~ ~ ~ O O N O aD 01 N N N M t0 O fD ~D . M u7 (p (p ~p p~ N N ~ ~p 01 N N a0 O u~ 07 1O ~f1 N V o0 tD
N N N ~ N N h 10 O (O h h a0 N N N M ~ ~ O M v(7 N O (O f0 a0 f0 N N 01 < N M

f0 t0 a0 i0 N ~l7 M h t0 ~ h Iv h c0 aD O (O h _ V
V 4'f h If7 1A W N O N ~ ~ V ~ ~
O V '? 00 f0 O
OD h ? N n!7 fD 01 W N N 01 if) ~O O fD 00 fD
f0 fD fD

_ tD
h f0 t0 h fD (D N
N Q1 C~ N 00 C
O CO V u7 ~ N t0 N O N V N N < ?
N h O N tD N N

f _ a O f0 N O
D M _ h . tD . tp tp (p K7 cp f0 ~ h h CO M M IfI N V N ~t (O K7 N
N N N W O O O M m aD

07 N N M M V N M 07 O fD O a0 CO aD
aD O
f0 Of ~ ~

_ O M O
O N N M Q1 m 1D h aD h c0 tff III
M tD aD t0 LO ~ h tD u7 f0 ~O h h _ M N N M N N N O O O ~f ~ M ~ Q of u'7W
ap eD ~p N M O et N N (D O O
f0 _ O 07 f0 O h f0 tp O t0 t0 t0 tp t0 h tD

_ N
N u7 u7 N h h M ~ O ~ N N ~ N O N h N V ~ N Is ~ N N O

h h a0 aD (p ~ N Q~ tD (D O ~ c0 fD tD c0 aD O
aD Y

_ a_De- ~p N
OD N O 01 a0 ~ N IA N f0 (p OD 07 M (O
O N O OD N N O h h t0 N M a0 a0 N V u7 Y f0 V 1A M Q! O In ~ In ~O a0 Q1 h h ~ a O N MN O
O O N M ~ f0 O ~O O M O O f0 V ~ O
~ W fD M O V N cO u7 N

_ ~ M t0t0 O
Of ? h M O V O M N ~t O ~ ~ tD aD D
aD O 0 N < t0 f0 t0 fD t0 t0 O7 W O ~f O Of M M ~D
~D tD M t0 O
01 O fD M

_ ( c0 u7aD Of _ c ~ ~<
M N
N ~ ~O N !O N N V f0 u') ~ ~ CO M ~
N V aD N ~ ~t N N N N M M

t0 N (O ~O O u7 (O ~f7 . c0 t0 aD ~O t0h t0 h N NN N
N (D (D Of at Of O N ~ N N f0 ~p ~f1 at 01 N 47 ~ N N ~ t0 h N M O V

O O f0 07 N aD h . 1(7 1l1 IA (p N
tn . N O
!D

_ _ ha0 M O7M OO tn N ~
M M N W 00 N Of O M r- 01 M N h N t0 h O M OD h a0 h W .- O N

_ O OO c0 MOf O O aD
aD aD (O aD N t0 O O O O~ C~ f0 a0 tpO1M D (Df0 01OfO tp~
fD a0 a0 t0 a0 tD ~ N h h f0 1w O O Of h M M u7 u7 C~ N O ~ ~ O f0 O h O
N h t0 O O Uf M aD

_ ~ M ~ ~~ ~V V V
~D N M ~ t0 V < N of O N t< < O 0D c0~Of c0 f0tD < ~
~ t0 tD V O
aD 0D 1f) N C~ O M fD f0 ~ tD ~ t0 h t0 t0 OO tD ~ ~ If! (D M M h DfDf0 t0 M N N t0 M N N N N N N N aD N N ~ N NN N NN NN N N N
N N N N O N M M N t0 LIJLIJ 111W Wl W
1l L_LLL LL t_L l_1_ 1_1O
L_L

VIIn V) V) fnfn fnN

' N

g g g 5 gg g ' U Um U U= UU U E

, t c r > >U > >N J7 d ~ O.

O M t0 h h N

O O O
O

a a G m c a c R T

:.

C O C C

~a~ 'a~
m 0 2 0 o u'~

a a n ~ E

N D N N
l0 T

' c c E o 'm 'm o n v o to U U
Y D

v N M

O

to u) G

O r2 cj y M
N N

a~ o E . , m Q m ' U a a U
~ o _ h p o ~ ' d ~ cc g ~ a E m _ ~ ~ ~ o d o ~ d W a h o ~a . v 'm M r m O '- v 'J-' c o X r ~ ~ d O ~ O I N
C ~p ~ t~Da00 a O
U ~ -'n ' a "
T ' _ -o =_ U m -w ~. , w '- ~ o ~c~ oi c, o w O ~
c c c c ' n ~ c ;" N a ~

N (p m N a H ~ m m m m C~ a t N t ~
~ ~ ~

Q c c~ c~ c ~
~ ~ o H

E ~ E E c y N

E ~ Ea 'a ~ ' ~
~
' N N N N fd O ~ N a Z
~ a C C C
~ l9 ' C ~ C
d Vr d N
N

O O O O O
1n ~ Q V M
~ Z

d~ a a a"'w a o a ~

d N GI d N aD y t < C ~ F
v a ~ ~ 'o ~
= a z z z z z ~

~ M v <v W ~ ~ ~

c v c p N ~ N u N

N N N NN N N O
N N NN N N ~
N
N

NN N N N

~ ~'1 ~ V ~ofO ~ n M f V 1 ' N

N NN N N NN N N f v N N ~C

~ N.v Nv ~N ~ N
N M O ~ N
O

(D V ~tp C O
O ~ ~f f ~

M <V h N ~a0~ G~D
O M NO t D ~O 0 a D
h h O
a 0 taO~
~

O 0~ ~ ~ X001 ~OhfOh) ~M

O h rh h h hh h r-D
h a ~N N
M

N (y NN N NN
r (p M ~ N aO O) O ~O O O f~0 O) t0 f0 (O N _ 07 N ~ N
~ N

t~D Ot0 O t~00NtM0 N N O

N !D M N O (OM r 01 O (~O

~ ~
N

N t0 t0 f0 O t u7 t0 N M ~ N 0 ~ N
N ~ N

M N ~ ~ O N t0 O N m f0 M N (O

~
~

Q7 O N 10 O7 ~Or N
N O O t < O f0 l0 M ~t a0 N

t0 (O cD fD (OO O~
r .

aD N V O N N V f0 O ~ (O V 10 O N

O

O (O N 01 f0 aDN M
N N a0 aD O aD ~O O
t0 r O <O aD ~ M O~~O O) O~ ~O r M 01 O) r O

t0 N ~ MO O N M O V M aD
w7 O fD O W
tD

r N (D ~7<O Of N M f0 t0t0 t0 p 47 f0 ?< ~ r u7 ~ N Q) t0 N N N V ? ?
~ V V M ~ f0 t0 t0 t0 t0 f0 (O f0f0 N O (O N O N N
N fD tD NN a0 t0 CON N
N N N tD
V N

r n(7N W a0NCO t0 Q7 Of CO M MO~ WOu7 NOf r N V N O ~D tD
M O

Q~f0 a0 O O a0 O O O O M N M ~f0 u7O~ W
O O a~ a~f0 a0 N ~ Of O ~OO r O u')n0 01 r O O t0 OOt0a_Dt0 _r ~N u7 u7 ~f0 10 n0~< Y (O Y ~f ~4'f< t_0N ~V ~f~f t0 O (O r fD fD t0f0t0 V ~ ~Ot0 ~f N N u7 (O< V
V ~f r f0 t0 a0 f0 N
t0 cD
t0 fD fD47 N tDf0~D N N N N NNN 1f1N NN NN N
N N~O fO N NN N aDN N
M aD N N

N N
~

p pp p p p p p pDp p pp W ILW W uW1J uJ uJ WWuJ W uJuJ

NN ~ ~ N N N N~~ ~ NN

~m ~ m N N c U ~m~ N NN

g 5gg N g gg U UU U U U U

~ ~ U UUU ~ U UU

Z ZZ Z Z Z Z o 2 Z ZZZ 'kZ ZZ c > >7 > > > > U N 7 777 O ~ 7~ Y

O O O

r ~ O
C

O O O
O O ._ O
f0 o a d a a c c c ' o O O O
~ T

'O O
.r c C C
O C

'u~ _ .~
'n ~ c o o c o ~- 0 a a < n H H

H N E N
c O

c c o c ~ a 'm 'm p 'm -- E

c c ~ c a U U a U
H

a a~

c H Z > .
E

' r o ~ d _ ~ ~
~' ~ U

_ a ~ a U a W M
E ~ U o ~c c O ao I . O N
r ' 1J d U

N n ~ O c%~ cn0 ~ ~ W r O n ~ ~ a m ~ ~ ~
a"o m E w o' d o '' U c M

O M Q O p N H- ~ T
(n ~ Z N =
~

uo1 o Uc u~ o aC 0~ Uo U~

_ r >- = a E
d ~ u ~

a Q j E Q ~ ~ Q E i m E Z ,n c n v , ._. a~ ~ o~ ~ ~ v d Q m a~
N O y y ~

u7 ~ N ~ N ~ N ' O. O ' Z V
O d d Z ~ N Q O

ao r u~ r_ ao .~ E H c o ~ Y n E ~ a o A Z_ p W p N ~p ~ O a0 O Y t0 i J a ~ ' W
' ~

ao O t M o r u~ N U a~
= ao ~ d a~ r w ~ . a c ~ > ~ a~ Z ao o .

o Q - ~ Q p o ~ o? c~ ~~ N
m L '~ r Q a ~ a~
d E ~o~ 'o~ ~ o~ m ~ c~ 'vi 4 ~ 'or a ~ ao c Z ~
~

Y Y Y Y Y Y 0 Y Y Y Y = Y
~ ~ c T ~ c U '~ ~ Z d c .= c c ~ c c c c o c r ~ c ~
m =

. ~ m m ea p m m c ~ m m ca ~ , m y o m m r o ~ g C7 y m m m m m m m m m m N m ~ m ~ Z ~ W ._ E U ' ~

C7 C7 C7 C7 C~ C7 3 C7 C7 C~ ~ J U
O M Z M M - t_ U N
A N o _ E~ E E E~ EY E~w E E E~tZ E
E H ~ 3 $ o ~ _ . N __ N ~N 'V1 O a ~
Y

of W U) N N N G N , ' w Y E N O p d N
f-~

c c c c c c o c c c c c ~ ~ v ~ ap ~ ~ r ' f' p O .Ø. Ø.r-O..Ø Ø. Ø. ~ N ~
L ' ~ O N H
~ r r 00 ON O Ot O~ Oa Oral O ON 00== OO
A p C p V 7 p a a a O n a' N a n a a d m ~'' '~ ~ N ~ ' - C p d a ~
p . . M . ~,, o c , > i > > > > > > > > v >
o ~ E o rn cyn o O o .3 v d w O d p O O O O O ~ O O O O N O
m ,p J ~ ~=M ~ ~ 2 J
~ Q y ~ S a ' ' za z z= zQ z za z z za z o~dazQ~
o~ u m~ ~~oa aD ON V t0WO N ~ (O W ON~ t0a0 ON ~f0 a0 ~O fDt0 cp c0t0r r r r r aDapaDW a0 OO O~ O

N NN N N NN N N N N NNN N N NN NN N

N NN N N NN N N N N NNN N N NN NN N

r Of M N rO M u7 r O M O r Of MO r N ~nso ~ ~ so~o r r r r rcom m m aoo~ mo~ a~

N NN N N NN N N N N NNN N N NN NN N
~N ~ ~ N~ ~ ~ .N.. N ~~~ ~ N N_N_ Nv v v O aD r t0M N r M a0Q~aDaDW NN M m a0 O01 ~ M r01 i0 O f0 fD u7 ~ t (D (DOf fDM M

Q M N ~ MM O O n0 MOaD O7 NO ret v N On!7 N O V7O N _ M OODO N O ON a0 r N NW (O Q)MN ~ M ~ M aDMM t0c0 !D r~t O

?O O N NO a0 Of ap c0 QtD~Or O tDO OO t0 O OfO N r OO C~ O O W O)OO r O ?N OO
ao rco ao - mm r a~ r r Mr~ coao ~co aoao O1 O N M YO tD r m W O N M tf ~O<O raD 07 N MM M M MM M M M M ~~f< ~ V ?< ?'P V

ai cc o aD t0 OO N
W h O < ~ M O N (D
O ~ t0 M
a0 O

(gyp c~D h a0 O ~ O O
~ t0 (D 0D
M OD

N ~ N ~1 ~ M V O 07 O f0 (O ~f ~ ~ O
70 M f0 M a0 ~ W f7 ~ ~ N
V

ap Q7 N N W W O N t0 N O 01 h O
~p t0 O M M

N N ~ N (~D
n N 0 ~ O
N ~

07 (p ~ ~ M f a0 t OD N N ~
tD
N

fD (p0 h h r N O ~
h ~ (D
fD O

N ~ N ~ QO CD O1 O
V 0 ~ O h aD 00 h ~ N V ~
47 ' W f0 f0 M ~O
OD GD

tp f N O M
fD N N N
N N

O O n M a0 07 aD t0 a0 O
(D O

O f0 O) h CI h ( O O h ~ M
M ~O O O f0 h 0 N N M
N N N
O

Q) ? ~ ~ cD ~ ~ n N
OW u O
D 7 h a0 V ? N V ~ V V h ~ N Of ~t sf ~ N ~ f0 C
O ~ Y
' <O c0 fD ~D N N c0 aD u (D t0 1n O (Ou) NIO7 f0 f0 NN NOD c WMM tONtOONCD
DC
DO

~NNN ~ N ~O _ O a0 t0 00 N
_ Of O 07 Of ~

'NMaDtD O ~ t0 haO NC7 MOh O)MOlDVJIONMOOCD117 O c0 ~

a0 In M O f0 M ? M V V
M f0 10 V f0 Of O
N W f0 t0 M
a0 N t0 f0 O7 h u7 fD 07 h Of c0N N N
O ~O Yf i0 N ~ (D N
h N N M
it) M N ~ ~
N ~
N

M N N N N N N N h W N M h 717 N N ~ f0 O) ~f V N
N U7 07 w7 h N N O) h ~ M ~f7 OD N N O~D OM tp (D h U7 OM OD01 N O
O O) M ~Oa0 f007 tD M CO V
t0 O O aD M O h a0 < aD a0 M ~ a0 00 M h ~ N t0 M ~O V ~
a0 t0 N
(O

c f0 07 aD OfO 07O O7 O f0M Mfp M O t0 _ fp Y7 ~ O t0t0 t0 O M V O ~ 4D
,t O O O V
p7 07 h ~O

Y < V ~ ~N VV ~ _ 'CM Q~ M _ V ~ h O
~ ~ ~ ~ _ V t0 Y Of t0 N

t0 (D f0 ~Dtp ~OtD t0 t0 t0Q1 t0(D O a0 t0 1 (O
f0 a0 O 01 a0 t0 ~O aD - fD O
~O N N
M

N N N N NN NN N N N N NN N ~ N N
N N ~ ~D N ~
N ~ N

a _d U
w w w w _ _ C lL LL l1 LL LL LL

~ ~ ~

I o ~ r ~ ~

g g g U

d E v U U~ U U ~ U

. T Z Z Z Z Z (p Z

Q c. c7 > >~p > > 7 7 b N

N

O

O

d_ G

E

O

a C

~N
N

O
A

2~

C

W
C
, O

U
lL

> o m ,n M ~

'a ~ ~, - d Q C
H o M Y Q M Z U I~LI 1 o E N t O O E O D

Q7 h O Z 01 H ~ M h ~ O ,p =

p c m y D n U w ~ N n N T w ~

r p Q .- ~ p ~ O ~ ~ E v ~ C
'~ ~ IL ~ y N
I-~ a ~ ~ m U O r m m . ~i ao a a Z w ~ ~ U m ~ a?

o a E ~ ~ a Z d = a a r a a m ~ O Q m Z Z ' ~ ~

rn a7 tO a N r ~ a v ~ ~ v N
N N c.7 N ttJ ~ m o~
Z

rn N ~ d N W , = H o v cn~ coo E
a D E ~ N m ~

, N c7 H 'r M r .c7 d' ~ ~ ' o ~o a d ~ ._-. .~ U o v -~ ~ U 1L r ~
' -m - n v .p = O c c N ' c N U H ~ .~ v 'r Z U Y d z pp M OD N ~ tL I - c~ a Q v ~ - N d N c m c of ~
X

N v ? c v I w U ~ ~ L _ ' ~ ~ r I 07 t.1 ~

p1 Ol 07 ~ Ol Z m ~ Ol O Y~r- Y
7 ~ Z N ~ ~ ~ N 7 ~ Y
E= ' O Y Y
j Y N Y Y Y YN(n Y Y ( ~~~h c ~ a ~ Q r~ ,7 ~ d m m~ mE~ E m m m m m - m r ' m~a M a r ~ ~ m nN
O a Z N m m N
U E

m E m N O m . m m m a O o0 C7 T m N m N n 7 ~
O ~ U o M
U O

U H U U 7 N (~ C7 C7 C7 C~ C7 C C 07 67 ,r 07 r M h o .- I D o a E o a J o ~, m o U Z Q
E~ EQ a c E E~c~ E~z E'n~ E~ EN EZE~~ Q
~, E~'Y ' ~ ~ ~ ~ E ~
~, ' E

U _ ~ y~ N N N N N N
~ ~ - d ~ W O Y
N ~

C_H C_O C_ayNlO CY CdHf~CQZ CN~ C_ C_aC_NC_~~ C
~ V~ ~ ~ ' E
~

.-. N 'd O a G7 d G) O O ~ O 07 rn ~ N O O N Q 'y~ N 70= o M
M E N tL a o o o o o H o ~

o H o _ o o o ~ ~ ~ M U :
E o 0 n ~ o~ ' ' a H

Q a i'~'" a d a o a a a a 7 ~ v7 U o c ~ O , ~o ,,~,, a e o ~ '~ cn O a N a a a a .

N o ao ~ -yy y d y ~ ~ ~ y d o J .t N ~D -y ' ~ ~ ,ono y z Y ~ z UJ

_ o ~ ~E o o _ cr o o v ~' o g Y in a ~ ~
IL o ~ v ~ a ~

zul zaN ZN ~m za z zwY Zwm ~ z...z'o7z'o7m z a ~~~ z...N
-O N < ~ c000 ON V f0 m N M N~

__ NN N N C

NM M M M

M M M MM MM M M N N N N N N N
N N

N N N NN NN M O h O NM u7h Of Oj M u7n Ofr .

Of O O OO O N N N N M
M NM M M M M

N M M MM MM M M M N M
N N

N v N N_N_ N_N_ _ V _ v N

V V h M~f7ODM ~ h O 40'7 ~ ~ p h O7 ~ O M~ 00N D
V aD ~M aD aD

O c0 t Of Oo h (DO _n0 M O
f1 ~0 h O O O hN ~ aD ~ O N hM (D~f7 07 07 NO ~

N h M OO ~ N ~t _ N _tO ~1~D ~ O

M O N OM 01h t!7 N C7 V07 07O O
O O

aD a0 c9 aDaD h~O G7 a0 h Q7 h!~ h h aD cD

O N M~t ~7t0 h a0 07O N M ~ ~7 O
<O f0 47 Y7 i1) ~u7 u7u7 u7 ~ ~ ~O t01D f0 O ~ O ~ N M
a00 (~O t~0 N ~ ~O C'O~ ~ tp a~D
M 1f7 V N N N N W_ M ~ N N CO
c0 Os LO N N O O aD ~ N r N N O O
Ifl u7 V V < ~ N O~ ~ M M ~ N
M O M t0 N nff ~ N N O (O ~ N
O ~O N O M OMf N O ~ 1~ f0 O M N f0 fD O 001 ~ N t0 ~ O t~~O
r M O N N ~ M OD 01 r (O M N M
t0 Or ~ O M O O 100 O O 1A fN~ O
c'M~ ~O c'~°~ ~t OV O 01 ~ N O f0 O M cD c0 ~ ~ ~ M N a0 O u07 (00 N M ~ N N N N f0 N f0 u7 ~ N N M
t0 °1 Q~ ~ N t0 ~ c0 N O Of O ~ aND ~ ~ O t0 O M aD r_ r °1 N r W nf7 ~ 07 O u7 O O M O O O O of e- r cD N O O~ O M O aD O (O
V N O t0 t0 W c7 f0 (O <D Uf tD r M u) O f0 h r fD f0 O O tD t0 O
f0 f0 ~ ~ ~ u~'7 ~ ~ ~ (O f~D ~ O O M O ~D f~D N i~0 ~ ~O ~D ~ ~ c0 N N N N N N N N N N N N N t0 N M N N N N N N N N N N N
a _N
CI Cf Cf Cf I_ll UJ IL W LL N vp W_ W_ u. ~ ti u. ~ ~ y N u. u.
O N C
~ g55 g ° o m "' '° N ° ~ g c Z Z Z Z 2 L ~ c ~ a ~ ~ U U
Y > > > > 7 ~ U N ~ Q ~ N
, , , O ,-N E tn ~ C N
O O O O
O
lL C L01 C LL l01 lL y l01 a N ~ -_d a N d !L
C d C ° C C C C O C -N
.E a -E v E o~ E .E R -E
° N O d O O
O O j O
o a ;a v a a v - V U
C_Q C~ C_L C C~OC_C7 ~~ O m ~ ~ N ~ N GI f' .~' N A
o ?, o "~ o v o ,~ o E o c as $d;' n~5 N d N L N O N ~ N N
CC_ CC CL CQ CANC
.(4 .E .(0 N .cp O .m N .m C7 C .IC V
C [1J N T
O L O ~ O L O r- O A O O d U H U Q U ,n U u1 U m a U O
m E -' L U V N L
N ~ O 111 Q Lll N ap ~ d °j d f0 O N , E (D N ~ ~ (n a p~ OD aD T r fO N
o ~' a~ r_ _ > y m ~ L C ~ ~ E c° ',a ,~ t , N 7 ~ J N H M ~ U O U ~ a ° n m E M
m U ~ ~ yL ~ ~ ~ ~ 0 E ~ ~ -N ~ d Q m M y a~
c~ m -o a ~ O W ~ ~ O U ~ ~~ y a ~ a ~ a ~° o o f!~
a ~ Q tO v E d °' Z J ~ L c%~ w E N E '-' E N E t Q
a O c ~ Z ' m a> a'~ o~ d N n o v ~ ~ T r ~ , o o N a u1 , N o a v =°- r 'a~ r o ao d m ~ o a o E J Z ,N a~ g w ~ v o ~ ~ ~ ~ ~. ~ a r a U ~ o ~ ~ ~ ~ ~ c a Q ~ U o E ao T o c m r m .n o~ a ~ ~ N t0 7 ~ L N 10 Of N N_ O
'0l N '0l N n '~ m (V V- l1J (n - N N VI U ~ _a m (V y (V C In ~O~.l V V (V j Y H Y O Y r Y ~ Y a y al ~ C N C~ Q lJJ ~ ~ O) ~ O) GI O ° p~ N p~
O Y m y Y y (p(p y L Y ~ y ' I0 l0 O N M W O !0 j, c0 Q O e0 ~' N ~ Q' Q-' (CV ~ N Ip V (p C ~p H ~ C
O
C~ _~ C7 o C7 ~ C7 ~ U 't ~ tm.7 T o Cm.7 M Z U m o v m >. m ~ m t m ~°n m v I ~ <"> ui E a v O °I o, C7 ~ C7 o C7 n C7 ~ C7 '_'.
E E g E Z E '- E H E N U m E ' = E N H ~ E Z n E a E a. E a°> E ~
E N
'N d 'N NN ~ 'N E 'N E 'N a W ~ N T E 'N a ~ U -N O. 'N a 'N ~ 'N O -N d ~N f9 c U c D c d c m c E c O ~ c H o c ~ Q c ~ ~ c v c c c a c d c .: °' c yc °? N d cc d ~ w X d a° ~ 'a~ H d -~ 'd ,~ ,n 'd ~ 'd 'm 'd °' 'm U
o ~ o °~ o w c Mo o ~ o ~ Q m o -o ~ o ~ ~ V o o~ 'H ~ o cn o ~ o o ~ o v o v a a ~ a ,~ a r a a ,., > ~ a' L a a r w Q a ~° :? ~ a ~;, a ~ a a ~.'~, a o a °H' < p Y1 O N f70 J Q O. O O Q' M N N O U
> n > ~ > ~ > m > ~ > m U > o '~ > m ~ > ~°n- o > > i > > m >
00 0 0 0- oQ oQ o=Y4J ot~ o=QuJ o ~ oQ oQ.o oQ o ~ oL
Z ... Z ' Z 'c~ o~ Z Z Z 'rn a O Z n Z 'c~ U Y Z 'o, cry Z Z v Z Z o> Z v fD a0 O N C t0 aD
M fM~ l'M7f~~7f~~ f'~~ ~ ~ ~ ~_.~ ~ f00 ~ fOm O
m ~o r N N N N N N N N N N N N N N N N N N N
V V V u7 ~ t~ nff N t° tM0 (p fD fD
M M M M ~ M M ~ M M N M M M M M
N. .N.. N N
N o0 M ~ N ~ M r r ~ r O tp N ~ ~ M O
V c~07 N
M '? N N V O u7 r0~
(O Q~ O M M M O ~ N ~f1 ~ < °~f r ~ O
000°01 000 O O ~f O r n~07N0~7 r a0 ~ N N r CO N N cD pp O aD '- ap r IA r o ~o cc °r r r r ~ m r r r ao ao aNO aMO ~ ao °° o M
O N ~ n OD
N '~ O O ?
c0 O N c~~ 10 N
O c0 N
O Of tG
O f~° ~ O n 4D
c0 N tD
u7 N N N ~ O V
M ? 1~ N M N
O
O ~ ~ O7 Of t0 00 O ~ Of O
O tD ~O u7 ~O N
fD ~ ~ ? N ~ V
N M MN N NOaNON
O (D N c0 I~ G~ a0 O~ h Of f~ 00f M M
Y7 O O O ~ ~ M n O (-p ~ M CD
~O O~ (O O
N (D fD tD (~° (~O (D ~ f~° O ~ ~ N V
N N N N N N N N N N N ~f ~ N
Of aD ~ N ap O (D tD aD fmL7 01 V M O O f0 O aD tD f0 ~ (O fD ~ aN0 V
U7 O O~ O aD M 1~ O O op Of ~O M 07 f0 O t0 ~ f0 O O (O (D O (D N O r t0 ~ O7 n Of 10 1n M M
? M V V to ~ .Q M u7 ~ V ~ V ~ ~ if V V V ~ M M <
t0 Qf f0 (D f0 ~ (D fD tp t0 ~O f0 ~ O f0 f0 tp fD f0 t0 ~ ~O ~ t0 Q~
°> t0 N N N N N N N N N N N N N N N N N N N N N N N N N N N

L_L L_LI 111 l_L IL l_L L_L W N W_ ~_ W_ W_ L_L l_L l1 LL LL l_1 U_ LL C Li ° lL LL lL
N (n N fn (n N N N d N n U U U U U U U U T ~ ~ r°n Z Z Z Z Z Z Z Z y Z ~ ,°° Z Z Z
7 ~ 7 7 7 7 7 ~ 7 U ~ 7 7 CO ~ 1~ ~ N
O O n O 0 m (L ~ a ~ N
a c C d C C N
.c0 n .W .f0 O
c a E° E n v ~ c c° o c m c m ._a> d ._ar c ° °' ° c .o nv_ N E N E n N
C lC C O N 'U1 'f0 9 C °
U u~. V V .° a m U Q w °
> N
(ND N
w °I Z_ U
(n It ,-, m W
N
pMp ~ tJJ Z Z O d ~U O et ~n cv ~ ~ Z d Y U ~ ~ m <Y
o v) ~ ~ ~ m o L w v u°. U V w Z w a O °~ n d m No 'or w~°_°~ ~ a a z w m ~ :°-M ~ '° ~ ~ V W d ~ ~ ~ m N N W ~ ~ c O V O 7 O ,-_, (~ ~ Z ~ [yJ ~,~. O lL ~ ~ .Ø
'° ~ ~ " ~ Y cn c m ~ tn Z ~ m t ~ d ~ V I O = _I f~ I (O y N I ~ N
~C d Y ~ Y L Y O = D. y Y ~ Y Y ~ ~ '°~ N p U j ~O) C
~ i. 'c L c ''-' c ~ to ~ c d H '? c m O c ~ ~> ~ N ~ ~ °:
m (n m ~ m L m ~n o m cn v) a pp W = m m Q m N >- pp a U c p E p H ~ o H ~ U ~ Z to U ~ g U c o C9 a~ w C7 E ~m E = E w E m Q Q E ~ .~ m ~ ° -~ ~ a o, E ~ ~n .C _O 'C a0 N N ~N n a UJ ~N n O Z .N a m ~N ° ~C ~N a V) H C
'y '~ CO .~ t0 .Q N V) O .a N ~ Y .a N ~ ~ E C C N Q C 'C
O ~ O 7 O tp O ~ O N ~ ~ O n g O ~ Z ~O N O ~O >
~t aMa ~' a~p~ ao~z_ a~~a ~ N do n a~°
> ° > ~ > ~ > ° Z = > ~_ O p > 't p > ~ ° °' N ~ >
is f.. ~, E >
z° r z° x z° ~o z° 'ou o z° 'rn a a z -or =
z° ~ :.~°, z 'o> H z°
N < t0 a0 O N ~ t0 aD O N V tp 0D N ~ t0 ~ O N ~ 10 ~ ~ n n ao ao ao ao co o> °~ °~ rn o~ 0 0 0 0 0 M M M M M M M M M M M M M M O ~
N N N N N N N N N N N N N N N N N N N N N N N
M t° 1~ M u) 1~ O r M
nn~ nnao o'~o a'°oa~o m ___ M M M M M M M M M O °~ O O 01 O O O O O
M M M M M O ~
~N~.N..N.v N~ MN
O ~ M m ~ O ~ ~ ~ ~ aD 1~ e- O f0 ~ ONE
O O ~ M n N ~ M O M O N O O ~° O N O N aD M N N °~ °~
°~ ~ N
N N o0 c0 O~ M u7 '_- oO ~ O °~ 07 00 aD O 0~ N O M ~ .p Nn~ nn~ M ~n N M~ WtO ~m a00 aND aOD ~aODn~
aODa~D~ aOQ0J0 ~ O» °~°f ~~ WQ°~7 00 O O
O O p O
N N N N ~ N N N N

co o ui ~o n ~ _ ~n o N M O c t0 1~ fD
tD .
O

fD V !D N ~
~ M 1~
O

M fp ~ . fp M tD ~D O 0D
N O N
N W M
(O
h N O CO
O N
O
~
N

M ~ M
O Of Of u7 O
M N O
N

t0 N aD t0 fD
t0 . aO

V V N N ~f t0 ~f N M t0 tp V _ t0 .
N
M

N N M O N

t0 ~ O .
V1 N aD O I~ t0 M
G7 V ~
O~ ~O
~
f0 O ~ ~
N

fD O M O 10 (~O t0 f0 N t~D ( c0 ~ O
~ ~O

N N N N M N N
N aD O t0 1~
N

O . _ O W

CD

a0 MN f~ _ t~ M O~ O O
a0 O7O 10 O M O~ ~ N M
O M O~ O
O N ~t a0 V
V
t0 V

f0 f0~ 01 t0 O) Of t0 O fD
t0 10 ~f O
u7 t0 _ t~D~D (D t t0 ~ N ~D f~0 LO ~ N a~
~
N

N Nf N 0 N f0 I~ N N
N N N N ~7 ~
N
N

CD O
1~ hr O O a0 W ~ N r- - - aD M M
r ~O aD o0 V N O
~
O
~
O

aD OO~ a0 O O O O O O ~ ~ f0 O OfO~
07 Of N tD
fD 1~
Of t0 Of~ t0 01 O O t0 O tD aD ~ 1a~~t0 W (7 t~0 ~f~ (~ t~D~ t~ f0 ~O t0 O ~ ~ ~ h N 0 u7 ~
~ ~O t~ ~
~O N
~ f0 c0~7 N

0 O tpD f f t t t N NN N N N N N D N ( 117 N N O O
f u7 N N N
N N M N
N N
N

W W W H

L _ l1 _ C ~ N
L u L L
' ~

N _N _ fn1~n _ d _ m (A V) VI fn ~l' N fl)l' ~/I O y N f0 C

U U O L O

U'~ '~ U '~ ~ ~ U

Z(cp C Z Z ~ Z y G Z t C

Y 7 7 7 a O 7 O. ~G

O N (p N
C U

n17 _ m 1~
d O ~ O O
d n ti a a ~ a a n _ C C 'f C C
p .fO -N . .(9 .(O

O

O O R O O
~ a a a y a G
~ N ~
N C
~

G C _ _ d N ~ N N
~ ~p o o ~ o 'o E o c n n a n r, 'm p ~ n ~ G

C C j C
~ V
~p .

f0 tC ~ f0 f0 N N
C

O C (C C
Q C

N
U U a U U
X d w F-d Q

Z , m ~ H ~> W r7~ ' ~ lL

-Z CW ~ N O ~Z O W ' Q

O _ O n N ~
~

L1J ~ m p M m ~ ~ C Z_ Q
E Z N N

(D Q O ~ u) N Q Z ?' = a N J >
~ Q ~ C H Y

O o U ~ a o U
J " v Q i a a J U ' m .n ' a ~ d o . a z y y n ~
N a ~

v EEZ~O - a~ EO~ pjH ~ aH 'acQ u ~
' N 0.' n N - U t . J

'N ~ O ~ Z J O ,n WD r fn ~ ~ ' ~ E O O N
' -Z 1f1N d O N (O M '~ W tD E a0 1~
O N C N U N ~ E Z z ' U J ~ o~

o~ cp a rn n ~ v c co Z O
O O a O ~
O m Q = a O N N Z (A O V ~ Q' Y
D w m O '.'~ m = f-O v~

.- ~ r U
N ~ C ~ ~ ~

I ~ O ~ t N Q N I ~ U V
O j ~ U

~O~07 ~ 'O)~ Of' LL ~07 01 O) ~
~ ~ N = p Q LIJ U .Ø , (n E ~ fn Y Y s' ~ ~G ~e Y Y ~ ~ ~C ~G ~G ~G ~C
7- ~p ~ y !A f0 C Z lL N ~ ~ = ~
C C O Q C N V C ~ VI _ C C ~ Q
C N C fn C n Z C
G H
d =

N (O IC C N f0 (0l0 ~ ~ p O ~ !C
x N ~ E N ~ f0Z Z O M ~ V7 a .t v 7 C G. Z O O H
lL
/.-U y tn f~ m CDm ~ ~ m m CD CD m OD ~ ~ O ~ ~
N Q Z J
O

U U ~ ~ ~ U ~ " Q C7 C7 C~ C7 C7 '' c : N E ~ a i ~ 7 o o ie ,r, E m Y C7 ' a O . oC7 E E E
' wa E E_ A E~E~O~wJ E_ ~ N ~ ~
=~ v E~ . . .
~ E

O M O) H N U!H a U N N N N N
H U C v Z ~ O Y f0 d ' N ~
r ~

5Hw G GdEH~,'~~y ~o~ ~ ~n>> com c c ca~ Su-;a ~ ~ iQ

~
~

t: ~ 4: n r W 4:Q. ~ . .. .. :~
M V C J ~ f7 ~ .. N L p _ H 1~
~ t0 f~ 'U ). ~ . . Q (~
. .
' H' O O O O m O O O O O~ O O O O O
M . 1~ N op U N O ~f7 N
~ p =

w a a ~ :E a a a a ~N., a a a a a d g ~ m ~ ~ > O ,n o n ~ <<"
O N ~ a a "., g N d d ~' ~ ~ ~ ~ 1~ y d N ~
~ p Of W N N f- m ~ ~ ~ ~
~ J J m Z -~ a !n ~

C ~ C ~ ~ O O O O ~ O O O O O
~ ~ O N O ~ O m = Z
~

- O ~ ~ y ' N U Q y a j ~ -' T ~ Z ~ I ' ~? ' W
-z zr z z z z Z z z z z z m ~mm m ~J mQU~w a c c>a~ o,x a ON ~T t0 to O N ~ f0 CO O N V' tD
D

_ NN N N N M M M M M V Y ?

<< ~ < ? V ~ ~ ~ V Y V ~f N NN N N N N N N N N N N N N N

!~ Or M 4'i1~ Of M tff A O M ~ P

f-N N N N N M M M M M of ~ ~ V

~V ~ ~ < ~ V < ~ V ~ V V < <
N_ NN_ N_ N_ N_ N_N_ N_ N_ N_ N_ N_ N_ N_N_ N V~f1O M t0 t0~ V O N ~f ~f7~ f~O

V a0O N M O O N ~f o0 Kf N h fD

h aDlD O (D M M M (D N u'1 O aD
K7 fDh 1~ Of V O 0D M t0 ~ u7N

cD N!D fD ~ W (7M Qf 'C '? ~ M
(p aD O p O O N N O I~ tD

c0~ ~ O O O O ~ _ M O r O
I~ InW 1~ 1~ 00N 01 01 O OD N ~ c0 O~ N M W f7t0 t~ a ~ N
O

0 _ N N N N

N NN N N N N N N N N N N N N N
r N
n ~ p aD N t - o f' p ~ n .n cc tOM ~ N
N
M

~ ~j f O 1~n O( N O
O h ~
M

M
O aD M f f O
O

tp N~ ~ ~

N
t N ( N
J0 ~ O
N CO N
In N
M

O f0f0~ C07 Nt0 M O 00 00 ~ O
M
1~

a0 M ~ 00 a0 ~t0 M O M O
~D I~O O c01~ V I
h O) Of V
t0 ~

_ ~ tD Of V a0 ~ N~ N ~
N N
~
N

t N N r~ ON D N N
h N
N
c0 V O N r- W a r V 1~
O
t0 O
O

nl7 t0 fD t0t0 h _ 1~~t0 O _ ~f7 t0 O

O~
f~
f0 N ~ ? ~ ~ cD~ ~ M
Y ~
~
n N N N ~ N N N N ~f7N N N N N
N N
n N
CO

_ a0~ c0 M ~ 01 a0O h_ O V am O O7 07 Of tD
~DO O O O)O O O D a0 n aD 00 O

O M _~ ~n u7 O f0 O O
h Of O) c0 f007 01OfO O tpOt~ N O ~ 1~ t0 07 10 a0 O
~f7 ~
N
~
N
~n (~Otp ~ ~ p ~ V ~ ~ ~ ~ M~ ~ ~ V ? ? V
fD h t0 fD O O f0f0f0 ~ ~
t0 ?
V

~D t0 ~O f0 (O
N N N N ODN N N N N N NN N t0 (O N N N
N (O N
t0 N
N
N
N
N

p ~

L_L W_ W W

O L_L L_L lL L_L lL C lL

H fn (n fn (n (A _ N

5 g 5 g a m n ~

U U L U ~ U o U ~ U

Z Z c~
a 7 7 ~

7 7 ~ ~ r o~ o ci ep ,n o 0 n ~ N O N
O T N
O

_ 'E

d :- a a M

G_ G G G G
C =

p I0 N
m n O O O
= e0 ~ d a ~
n G C G G C
l' ~ N d t N N N N N
U = ~

O O O O
O C N

2 d U
p C n C C C C N
~ V N G7 C
' r ~

m 'm 'm E
~ c 0 d U .
_W
..

U U U ~ o Q H U

U U
~ C~

Z

a Z U .

t g=

' N w ~ m c~ ' ~a ~

w ~ in n U m ~ g ' ' a m ' z o ooh o z Q ~cn w _ M H
~
l m J W = 0 N = m l1! M 1 Z
m L ~ H 7 !n H F-Q J ~ U ~ 2'~ W ZWIIJWW ~ O ~J ~V' O O

m m O ~ Z a D T Y ~ ~ O D Z
~ Z Z Z
Z

pppp ~ ~

o ~ ~ JH
N d d U p z ~ a ~ ' o N' ~ e, ~ o ~ m ' ' ' E ~

I ~ m = m ~ Q ~ C N ~ O~
U a N N ~ N U
- N

G I ~ I ~ . v ~ . . p I
~ ~ ~ ~ ~ UJ
~

C O I L

G N G C C = C O O O ~
lL = V d N O
~

w m ~ m m U N m m m m m N N n O ~
N ~ F-' Z

U' C7 U' U' C~U' C7 C~ ~o (~ (~ U ~, c~ ~ N ~ E i.~ pp N N m o N ~
M U N a~ 111 O

Et ~ o o ~ o c E E ~z _ Ea E N~n E~w Eo E ~' Ex u ?
H ' ~ ~ ~ E ~ U U U .I Es Z ~ N E E
~ ~
~

N N N N N N N f0 N 'N 'N N
c G c a ~ Z ~ ~ M M O O a a a a ~ a a u n y ~ u1 ~ a a m O O O G c c c c ~d O ~
t m O ! G7 ? ~f7 ' N . N
U ' ~

N aD f0 r ~ N N O j y ~ y ( O y ~ d . N N
O ~ Z Q

~ ' ' O C ~ ~ ~ ~ O p M ~ O O O
n n ~ ~1~ ~ M f ~ t0 O fh a' ~ 0 ~
' lL
' d a a a a a N a ,~ f- a a a d M (D ~, ~ y p p ~ p ~n M
7 ~ ~ p ~ _ a ~
. .

> > > > > > ~ 7 j O m ~ O - _ ~ ~ ~ ~ M N m m IL
W ~

~ m ~ j j ~
~ o o o o o =C7 o o n ~ o ~ ' N
o =~ - or~ I' ~ ~ H Z
~ =p =
~

v p a 0 o o z z z z z -a z z ~~ z z z ~
z W .r 'o~ Q z '6, mm u.I a a "o~ z a ~ ca o 'o~
? <n O N ~ p ODO N ~fO pp u n t w n c ( nn n u~ c c o c c o < n n o ~ v c v ~ v ~ v v v v a v av v < v v v N N N N N N N N N N N NN N N N N

N
O M O h O ( Vj~ ~ O -M ~ O
'7 : 1 V V V ? V ~ O O ~ c c r n n r ao ao v v < ~ r vv o v v v v v v N. ~ ~ ~ ~ N.~ ~ ~N..~~ ~ . ~ N ~
rN

. .
1~0 D ~ 7 h 0 ~ N N r ~' O
a a f u M ~
N M N

< M O M p N ~aD

N V hn ~ ~ n ~
M O ~

M N O N ~ f W ~ O
V N < N M ~ 0 0 N O
a a N OfOM ~ ~ O
~ ~ ~ ~ n O M 1 ~ N O

Wd0 O faO a D Q n ~O O ~ m ~ n M 0 ~ 0 ) O N N
t 1 c O N M M M ~ M M Mn' N N N N

c7 N N N N N N N N N N N NN N N N N N

m M O t0 O . f'M7 t00 n (O
O <O ~ N M ~ fD N V
O O . . a0 . N . P
fD ~ tD O ~ O N a0 N ~ M
N V . ~ YI ~ OD < t0 ED
V fD 01 O M Op M (D (O 1~ O
4'> t0 N O ~O aD ~ O ~ N
u7 u7 . O f0 O . tD (O . f0 a0 aD V f0 W N ~ t0 < N N N
N f0 N f0 . aD 1~ tD . Of O~ N a_0 N ? ~ M N (O ~f t0 N N
h h Of M aO 1~ O O O tr'1 ~ ~ ~ N a~
M h M M N t0 t0 ~ O a0 ~f N P ~O O
~n cc o~ ao o n ao ~o o ~o . ~c ao o, h V ~ N V 01 ~ r ~ N P N ~t ~o cc . o ~ <o _ ~n ao . u~ . n o O N N O N N N ~ N N O_ 07 O N N
n!7 u) . _ N CO . O _ O~ O~ f0 ~ N h a0 O O M O_ f0 M Of r c0 O QJ op 00 Of t0 O M O O 4'1 t17 CD 1' O 0D ~ 0O 1~ M
~l7 01 t0 tD ~ Q~ 1~ O (O O O O c0 ~ u7 ~D ~O O O ~ t0 M ? N V V 10 N U1 M ~ N ~fl N t< 1n M ~f fD t0 t0 t0 a0 t0 fD (D t0 f0 ~D ~O
~ N N N N N N N V N f0 N N f0 1~ O N f0 N N N N
n . _ a~ _ . ~n . _ r ao cc ao . n M aD c0 V a0 M o0 h o0 M O aD M O~ O M O N 1~ O) (O N 07 M V N (O V
aD O O~ f0 O u7 aD O O ~ OD M O CO 00 O G7 O c0 fD M M N f0 tD 01 O O M
o u~ co r ~n n o ~n n o o cc o~ o ~c o~ o co o~ o c° co M n o o co rn <o v v v v v ~n v < v v v co a~ v v v v v ao so c° ~c <c c~ ao ce ~c ~c ao ~ o ao co c~ ce cc ~n ~ so ~o o ~o ao ~e ~- N N N N N ~ N N N ~ N N ~ N N N N M N N N (D N ~ N N N N
0 ~ 0 W W V! W LIJ LL W LL l1J W 111 W
LL It lL lL LL LL C l1. LL l1 lL LL LL
<n N N (O tO N ~aWO N tn N cn ~
In fn !A fn C In fn p fn In fn fn (n fn U U a U U ~ U U ~ U U U U U U
Z Z 'x Z Z ,a Z Z T Z Z Z Z Z Z
> > O 7 > > > 01 7 > > > 7 ~
O
N
f0 ~X ~ N
a_ ° a_ o C C C L
.E O .E o.
N
O
D C ~ d C (p C N
d () d a O O ~ O fQ
d E ~ 2'-tn O .-. N
C L C N
'N V N '(0 O
U U o U ~
u:, a d ~ H z ~ . H c _m c_'=°-v~Q_~Z ~a'~~v.'-°
r 9? X ~ o a a ~ a o ~~ p Z c ... o m_ Q) H _' y 00 _~ u1 O_7C MON ~~~ f_OV g= ~~.O..~O~~VN
(O -N Y N O O ~ ~ IA O N 'y) O O ~ m ~ L O fp U a ~ U = Q M UC N
in ~ m U ~ o o > ~ U T M w H ~° ~ N ~ U ~o o m m o ~ Q ~- ~ ° N ~ ~ ~ o c a E'° Q as E u' Q ~ ~cm'o EM Z~w a E ~ d E ~ ~ e~ is a> ~ r- v 'x d Q Y ~ a> n D ~ >_ . m ' E d v a a Q
e- U ~O o0 O O Z V Z ~ LLJ Is ? d M ' t0 E
r ° ~ M v ~ ao E Q u~ cn o - ~' ~ N o '-° m d o o ~ ~ ao T ~° ~ ~ O a v ~ O tw ~ ~ $ '° a ~ v ~M., E ~
_y 7 ~, m a~ c U Q H c c~ o a~ ~n rn u>
f~ ~p N ? M ~ O N V = U ~ N ~d W ~ ~ ~ ~ ~_ O N U M d p O) C Ol Ol O ~07 T V ~Of p fOl ~ LL O ~ I ~ O r ~ O O 01 E Ol ~ Q
Y ~O Y Y O Y C ' Y C Y ~ ~ Y _n Y C7 V U Y ~ ~ Y Y O Y a C L C C y C N d C A C ~ C C ~ C C T C n C
N V ~ N N E N L O (0 y f0 - ~ N ~ f0 ~,.~ J ~ f0 ~p O_ N ~ f0 O f0 a1 ~ O m C~ m m d U m m 1~ 07 ~ m W m f0 m . CD m Q

U ° ° U d N U °' U v W ~ U °' U °o -U
N U ~ o C7 2 C7 N C9 o c E c ~ E E o ' E ~ ~ E c E o Q 0 E o E ~ z g E ~ N E ' E N E ~''o ~V) R N ~N (/l ~N ~ 10 ~h ~ E tn 'y 41 a f' _ 1/1 T ~(A a Z ~ ~N ' ~N d ~N ~
.N ~~ O.
c a ~ c ? c ~ ~ c n$ c o c ,any O c L c atL U c ~.. c E c n c ~ y ..°'. " .: ° :: ° r ..°. .°'.. '-' ~d N O
'a~ N E ~~ °' 'd a~ E Y
U h O O M d 2 ~ ' U t0 Y ~. c0 ~ - .
O N E O N O O E o ~ o c o o cn a o ao 0 0 ~n g ). O Iv y .~ O C O O O ~N
oa Ea~~°a"'ina oavOcn a~ °d~y~ ao ~ °a ~ aN a' ca >° d > j >m N ~°.~ ~L ~'_'~a >° ~ >~_HQ ,~ ct >~°~
>o >.~
Z a ~ Z ~ Z a a z a a z m Z 'o~ m ~ Z a ? z "o~ ~ o Z 'vi E .. Z n Z ~ Z
c°~
t0 ~ O N V iD OD O N ~ 10 a0 O N Y (D N~ O
m aD O) O Of 01 01 O O O O O ~ N
V V ~ C V ~ V u7 N W n O ~ M N 0 0 O
N N N N N N N N N N N N N N N N N N
O r O f~ O n Of M u7 n O r M O n Of a~ t0 c0 Of O 01 O O O O O O O ~-~ V V et ~ ~ N O O u~ u~ u~ O ~ ~ h N .N.. N ~ v ~ ' N ~ ~ ~ .N.. .N.. N
aO M M 1~ u7 aD h h o0 GO O O N tD
47 N O N M u'f u7 c0 ? aD N fp N O M O O
vt a0 M a0 M ~p M ? O I~ 1~ u7 ~ O tD
07 f~ Of O f0 ~ O ap O f0 W O~ ap t0 ~t 1~ ~ M O ~ 1~ ~ O 1n 10 10 t0 OD O O CD CD
f~ N ? O O O O (D a0 V O 1~ m N 1~ O
Qf O O O O aD O N O~ Of O 1~ Of h O O O O
t~ W aD OD a0 a0 1~ f~ a0 a0 1~ t0 OD N a0 00 M y(7 t0 1~ a0 Of O N M O tp 1~ ap 01 O
? Y ? V ? ~ O ~fl 10 10 ~ ~O In 10 N 10 t0 N N N N N N N N N N N N N N N N N N

a; _ ~o o;
M

~ O M

~ f~
~ ~ O
~
~

t . t D
0 0 _ t N ~f ~
N O
N N s< N
O c~ O

~ . aD _ (O
~p ~ Op O N
~ O l' O Q

M _ O
V

P O 10 O h O) ~ ~D N
~
~
r N N

~ t (O

t0 N ~ ~ N c7 N
~ h ~

Of NQ1 01 N ~t N N
a0 O M

0 ~
m O

f O~ t O) W
'7 0 tD ~
~
'1 ~ O t0 (D
f~ O

t0 (N _ N N N c'~
tD
N

~ ~ ~ ~
~

f0 N~ O O f~ O N ~O N
N f~ f~ 47 rn ~cn n ui ~o ui a>a~rn ao of n o ~

O f~10 N O ~O f~ O O Ya0C7 O
OO aD O) fD <Ot0~D G~
N ~ 1A ~
O t0 O

t0 (01 N N ~ N IV
N ~ O ~

~ O O O O O
V NN a~ P N O N N NN N N
N N C7 ~

aN0Q N? c~t0O ~ aN0 O) a0 O OfDO ~N Of t0c'~ u'1(O
W N aD 1D
tD

~-a0c'~OM t0t0~fI N '- O a0 O _ <OaDO OO t0 ~OO O 1~
c")t0 tD~D u7hN aD C~ N M O Off0~ OWO c'7u'1tD t0 O~
~O aD
O (O f0 u7 V
O
C~ O ~

f~ ?? VVY _ ~ ~O f0 ~ ~~ ~ ~V V r7 V ~ 0t0 _ t0 O u7~ ~O t0~O t0 OtD t0 f0 ~ M ~O ~
V ~ ?
M Of O n c0 t0 f0 tD

W N fDt0 tDfN ~ N N N N N f'~N N NN N NN N N
f0 NN NN N N N N
N
N

C

N

(0 ~

UJ WW_ lL W N pv W W_ _lJ
L

LL lLlL LL IL C N lL lL LL LLlL

f/~fJ~N N ~ ~

07 ~ fO (O N MfO d N (p UU U U U UU

t U ~ n U T a U

Z ZZ Z Z

7 N >>~ 7 O ~ Q > >N 7 >> N N
...

C~ C~ V M

O N ~ n O
~T u (pd 7 p O O E _ O
~ O

u. u. u. ~ ~ u.
n ~

a a.~ a da a ~

c c c Q c c ~ o ~

E E E ~ E E
~ ~
~

o o o ,. o o d G

x c c "~ c ' .m _ .
c c .d N c .N
.d U .N W E
7 .N

7 _C
. O ~ ~ O
O O N
O

' C ' ' U C Z

n na a ~ nv n m y o N N N (' H t/1 V C c t n c N c c c = r y _ E l0 fC j ,o ~p fC O
U

f0 V , ~ ' 7 a ' i U U Q U U
~ 2 ' n ~ ~
U

N

O - J ~ r r ~ Q J
~

O a U o a~ U - C7 a E E

t~ M ~ e~ Y U H
' o ~ Z

c~ u~ ~ ~ W ~ U ' ~ Q

n ? ~ ~ d I O O COfi7 = ' ?
y U ~ C

~~ ~' _ ~

o ~ v ' a v ~ ~ o ~, v ' o 00 ' o <n a o y ~ i." cn d a ~ m ~ ~ ~ a a c~ Q ' N Z a w ~ 2 7 E
:o E o E E E uJ ~ N

,o v) r. . N O N ' 41 I n O N
N ~ n ~ ~ ~ y v N

- - co E -~n E - ~ ui ' co ' r~ E
o ' cv a ~ m v E a . n n o v o o~ t- cc ~ r- Z y o E o o U rn ~ a u ~
v ' r c~ n O O o~ o v = r~ U cc O v . ~ a0 O ~ t0 V u7 O W y a ~ u7 N O) O) N ~O a0 aD f'7 W f1 1!) N Q N f~
m ~ > O A
=

~ p C C ~ ~ O a = O
~ ' m Q7 M O v a> M p W N v c ~ - - - d o - a - ~ - Q
- - c N ~ d -a ~
~c _ 'or 'rn 'or ~oi 'or p 'a ~ 'o~ ' 'o~'a 'rnE ~ ~ '~ U ~ o c :: (~

Y Y Y Y ~C d Y Y JC w Y .Y ~C Y
~ O ' n O p 3C a O N
a Q.
E-Z

c c c c c ~y c c c c c c c c n a f0 o N f0 r N t- N ~. ~ o N N (0 ~ _ n I f0 c9 N
H N UJ
N

~ m (~ m = m m C m Y m Y ~ m d H

C7 C7 C7 C7 C7 L y C7 C~ C C~ C7 ~ C9 o ~ y C7 ~ ~ C7 ~ ,'~ C7 ' = U ~ u~
=
O

N d O ~ Q' ~ a E E E Z E E i E
~ E L ~ E

~ E ~ ~ E a E d U ~. a E E
~N o ~ d n ~ ~N a ~ .~ ia ~ ~N _ ' N N N N T N ~ ~ N N f/) N N
Y ~ ~ U T a f ~ O j N a 7 ' Y

C_ C CN C_~ GL CL CHO _C_d C_QHUC() CH C_aC
~ -N N d N N ~ d N N GI N ~ 41 y..
~ l0 2 'C n ~ t N IL M N 10 ~ Q !L~ = =
O

O O O O O (p O O O O O O O O
V O 9 O P7 N fD O h O tp ' f0 a Z Z
=

a~ _ a a n. "' a a a _ a N o O ~ ' n. a a w p_ d f ~ O 7 N 'n ,~~,a m d fO N u, p I~

d d G7 G1 d ~ d ~ ~ y d C7 d N
p p ~ t7 M ~(7 fh l"~ C ~ L n G U Y ' H ~
~

> > > > > ~ > > > > . > > >
~ O ~ N ~ ~ > O C O
C7 ~ O ~ O ~
[y~

m ~ ~ _ ' Za Zt Z Z Za Za OIIn ZN Z Z Z Z Za EU U Z ~ Ofa= c oW H

N < tDm ONV f0 N O N~ 10 aDO N V~O N O

N N NN C7Iht t~ f~ ~t ~ ~ ~~O uW O10 47 t0 1 t0l 7 4 01 ~ ~O ph O u7 N

u7 W l70 ~NN 4 7 1y N0 N NN N NN N N
N N NN N N N N N

fW Oh Ofrf~ N f~ Of r-f~1n 1~Of MM 1~ Of N N NN NMM C~ f'1 f~1 ~? at ~~ K7 ~O~ O ~O
11Wf t0tW ILfN11~ 1A 1n 10 t0~ 1n 1l7u71C1 1n In N_ l N_N_ N_N_N_ N_ N_ N_ N_N_N_ N_N_ N_ N_N_ N_ N_ N_ N Of ht0 Ofsta c~ ~O O W001 Nth V ~~ tp O~
O fl O c0 01O~ f~O_ 1~ tt N Of~_ Of0 ~ 01~O O off O O Oft~ ~Of001 W V ?O M a0r c7 n O
~

N ~ Oc~ c7V~O ON O OO a0 op00 a0 O

O aD 1n 10 1~ N C7 t0N f'7 V f~aD
V u')1~O NOf10 aD O ~~ N O1~ VO tD c7 1~ M OO OOfO 0D O~ O O~O)O ~OO O~ O
c0 NaD a~haD OD h aD h1~Ep WN N N~ N 1~

N f'1of nf7t01~ aD O1 O ~N t~ ~u7 ~O n~ W O

f0 t0 (Df0 (Of0tD t0 t0 f~ 1~A h 1~!~ h f~1~ 1~ a0 N N NN NNN N N N NN N NN N NN N N

u') O ap O N pi V

Of Of > O
O~ O
0' O c0 op tD
t0 _ tD
N O OD
M u ? N

O ~I7 at (O
OD V

n ~ O N f0 t0 ~ O t0 tD O
n O c0 ? N ~ ~ N N ~ 10 N
1f7 V 10 N ~p N
O

M 10 t0 1D . t0 N 10 n a0 W N7 _ t0 07 f0 N 07 N N ~ of 00 N
M N 117 10 N ~f n M OD O f0 < GD n N ~~O
O

M n h Oi O O n M N 07 OM
O o0 N t0 M M N
M

4D aD V O W V ~O M ~O ?a0 C~ N aD a0 aD N

c0 fp 01 O t0 Of tIf (OO
O aD f0 n f0 O M O N
~D ~ O N V ~
~ N N N ~f V ?
fD M
~ ~

_ c0 tD N tD ~O a0 N aD CO CD ~
N N N N
N N

~ O N
~ ~
~

f0 n tp ~O CD N n Of aD Q) MO
t0 tD n ~ O O) M
a0 t0 n N t0 ~O V O ~ ? V t0 O '- Qt0 'd aD M t0 u7 G~ M
c0 o~ n co rn u~ <o n co o~ on OD M c co o u~ u~ ~ o co N
N f0 ~ u~ o D M
N N N N ~ ~ M 1n tD M ~ ~ .~ 00 ~ ~ Q~ ~
fD c0 O f0 t0 . t c0 N N n N N V7 N N N N N a0N
O N V N N N Q) O

M Of O N O Is n h M a0 O t0 O~(f Cn'7c0 ~n'7 n aD fD ~
n M

M t0 M O O O V a0 f0 O M O Of NO
O~ (O t0aD N o0 to fD O f0 (D ~
(O ~ m O f0 O O
O n O O ~O W
O

N f0 N ~ ? N V O N < nf1 ~ n a0fD
u7 V f7 V
~ V V N
'? N
~t t0 f0~ 10 t0 00 l0 tD t0 (O u710 a0 t0 00 tD t0 tD
~ <O

N N N N N N N ~ N N N N 10N
N r- N N ~ N N N M M
N

_ ~ . O
aD o0 u') V ~D n0.- O f0 - V O n M t~ N o0 ~ON O
O N O a0 f0 Of c0 O
M t0 cN~7 N

O O O cD O c0 t0 O ~ n tD M (D O O O O OO cO
O t0 0D N N O N N n 10 a0 ? ? ~ ~D O ~ t0 O ~ ~ h V ~ N~
< V V ~ < <
V

V ~ < ~ sf O fpt0 Y7 ~ f0 M ~ ~ f0 f0 tD fOf t0 f0 fD ~D O tD t0 t0 0 t0 O ~O f0 ~ t0 M

N N N N N N N M N N M N N N N N N N NN N
N N N N N N N ~f7 M
N N

W O W N

LL l1 LL LL lL V _ C
LL

(A ~ !A N (/) C (n O O. fnd 01 N y N 9 O
U U U U .

L ~ m U '~ ~ Vc n ~

> > 7 N ~ Q U ~ E L 7D

h M tD ~' ~ O

O O O n M

0 ~ O O O
C

_ .

a ~ a d a a E

c c c c c c c Q -' ' ~ ' ~ ~ ~ m m m d 'm d U

0 0 0 0 o o 0 ~ d ~' v ~ v 9 ~
~ 0 2 ~

c c c c c c =
c ~ ' c a~ ' ~ - ' ' a? a~ d d d d N
'~ c ~ ~
o E ' o y o c o 0 o U
a D 0 w a n.m a n a ~
o y N
c o ~ ~ E ~ ~ ~ or a E a~
N

C O O u1 . . C
7 A l0 ~ O N (O
~ C
0 f0 V
'gyp .. O o ~ O o o . n o ~
o o E
E

~ ~ -- a~
= o U U U U U U U iV
Z n I
~. ~

a'>

a> o m c o~ vi n - i U O E d n i w r C

'C d O J u N O U ~C M
j C
' ~ ' Y 7 Z O
.C

H d U t M N . ~
n c0 t0 W O a o ~ D
c0 O ~

Q ~ Q O Q m O ~ m ~ m 'N

V et O n f- U o d U m ~ U
~n n U ~ n c N y M iy a ~ Q a ~ ~ a cc u. a ~ w '," c7 !~ ~ R m - m 7 Q E Q = o Q > ~n '' d a-y o~ ~ U - ~ a~ ~
?

O ~ N N V f.. ? N M
y~ N ~ W ~
O ~

Q y ~ ~ n ~ n n cn ~ ao ~ co n ~ n D a ~ ~n ~ v N o cv > r ~ ao r > >, ~ ~ O J . M N ~
p O U L
~

O~ M N O Q O ~ - O N 1~
~ M N J . - V ~ ~
C ~ N N
E

'O ~Ol.01 O) ~ '0l ~ C ! ~_ ~
p ~ ~ -U d N ~ U Ol Ol ? O O
Y Y Y Y JC Y Y ' ~L . Y N t C O m Q. Y ~- Q
(' d Y JC

_ O
m m m m N C O C C C C 4f C C
O n N m Q U T O
= V
N

m m m m m m m N ~ m m m O m m ~ E ~y T ' D M ~ E p ~
' Q t O

C7 N U C7 C9 C7 C7 ~ , C9 U C9 C~ C7 N U t_1 N ~, U fl 0 O a N
, ~ c Q' O d O ~ Q Hl O T 7 l9 _~
~ d !0 N
.

~VlN N N H N Vl E N N H ~ N H
~ ~ ~ ~ a a ~ d ~
' U N

C C~ CO. C~ CdN Ca CEO CN~ CL C~ C~U Cd L

y a? u? ~ d _ y = a~ _ a~ or ~' a Q L N o ~ a~
~ ' .'~ ao ' ~ o o o o 0 ~ f c d 0 o v ' ~ :-a ~ a a a"'u,ao o o o o o o ~ a~ o "'. a~J aN a ~ v ~ o a c , n E r= N ,, so c a~
o ~ v- , d a ~ m m > > > > > > > ~ ,> - ~ ~ o ~ ~
o ~ ~ ~ ~ ~ 7 ~ ~ o a Q ; ~ d n o = ' N _ d ' ' Q

Z Z Z Z Z Z Z Z Z Z a Z Z
~ ow ~ oi a U N o a ci ~ ~

t D D O N V 0 a0O N V tD0 O
s C f a o ~ o n n n n n o ao o coo rn m m ~ n u~ uoum e n 0 n cn u~
m ~ um ~

N N N N N N N N N N N N N N
N

M ~ n Of M 47 n Of M N O
~c m o c c n o n < c ~

n n n n a o m~ 0 m u~ u u ~n u7 m a u7 W s0 u~
n uWn N ~ ~ ~ N ~ .N..N v N. ~ ~ ~N_ N

~ ~ n n D O t00 t t a 07 W O N M c O ~ O N _ ~
f D M M 7 N ~ M Nl D
M n D D n ~ n O M 0 O Qa f f C t _ M nn 0 N M O M N 0 M N n N ( tf D
( f Da N

v n o 0 0 $ ~ M ~ ~ v n ' ~ O ~ 0 OfaO N Na D N O 1 a O a N M ? n p n 0 O O N M
O 0 0 t ~ a V
m a a c 0 0 O O O 1 O) 7 01O f N N N N a N G N C 0 O
N N

N N N N N N
N

h .h 1f7 W M M

N

O O ~ ~ O h tD
~ N N O

O u ~ N N u07 '1 t0 N ~
tp ~f O f0 O ~ O ~ t0 h O
i0 O N . N h N W
t0 01 h O O
N c0 h . Of . f0 _ O O r- h O
. M

a0 OW O fp ~
Gl n N O M
O M O
Qf aD N M aO
t0 N _ Of O! h N N aD O
N ~- ~p W O
fD h O f~0 N h iD O~ t0 <O O h ~ a0 t~0 N

~ N N N
N N
M N

O h ~ O ~ ~
O

h aD O) N aD
V u7 07 a0 h N O M

h N O N p aN0 ~ N Of aD V
N O N r O
m V

_ N W !J Gp aD O M
N fD t0 h N

O O t0 O N M M . h HI M
~O h ~ W O U7 Of O M
W

M O O u7 Of ap M N O N V at t0 t0O~ t0 U7 O c0 ~ aD O~
ip iD
Of h ~

N O N f0 O
N N - N f0 N M
M N N N tp N N N M f0 ~ ~ ~ ~ ~ ~

N CDN N N f0 47 fp CO f0 N N N h M
Of ap 10 O
N

_- Y V aD Of O) O i(7 M M CO1nfD u7aDapfD(p h u7 iDU7 f0 f0 N N if) M
N O O
h O~ O~ ~ M
a0 M ~D O
h CO M
O

O~W a0aDO O a0O OiDM O ~ O O t0 aD aD (O M W Of 4'flO O V (O01 i0O)i1710(D 7 1f ~ O a0 c0 t0 tD h u7 aD

_ O 7 O (O O) h O h < f0tp V ? ~l~ V ~D ~~ ? ? ~ ~ h O M fD 'C
O h V7 W O
c0 N V N
< O
O~ N

_ V ~
f0f0 COf0fD~D i0~ f0f0~D f0~ c0iD 47 N t0 ~ V 10 tDiD
c0 N 10 N Of O
tO 07 M U7 aD

N N N N N WN NN N N N N N M N N N N t0 N N
N N N N M
N N M ~

0 Ct ~ C) ' p LU 111 111l 111 Q1 L

_ O J LL LL l>__ lL C O N
u. lL

~ H '~N cO tn N y ~ a a c a tn cn (n N in C N ~ m d v ~ n ' E
V U U U

U N U ~ ~' ~ H
' G ~ Z m o a ~ ~

7 a in 7 7 7 ~ d ~ ~ ~ 'c 1~ N f (O t0 Is D

f0 _ M M O O aOD O

O O O O O O
iY L O Z

L lL 11 lL ~y c d c N a a a~
as c ~ c c c . . . .' .

E E c m ~o m E E a a v v v N v c a o o C C_ C C = C ~d C
N d d ~ ~

y p N N N O G1 o o V o U M
o U
~

~ o a o ~

n n a n ' a a ~ x c c c c c c E c x a a ' GI f0 f0 ~ ~
m ~ N

~ N N
W
d O O O O C O ~ C
~ ~ C c O
G

U U U U iN U ~ U
~ Y u1 i~

-..

T N
U M

, c0 O C
~

D M N h Y U M n O U W
7 ~ N
~

O O .; O cOp N y ~

N , O N h ~ ~ ~ ~ ~ O O
T V o 2 n a~ .-. Q,in o , ,r m i E x ~ isE

o a ~ a Q ~ m ~ N ' = o N ~ O ~ c v Q D O ~ N
'~ ' H

O U p N U ~
U . ~

a ~ Q a E ~ ~ E = Q u.
m a ~ H v N

N . r - y O O Q
N . .. V V1 O O M M N v O a 0 d n M
O N O Y fD ~ LLC O
O M n -' ap ~ ~ h N N ~ - 01 N
E M ~ C N V ~ 4: C ~ N
m N N V (~N
O O

~ N 0 ~ ~

LlJ O O ~ u 7 ~ ~ ~ C
L d ~ E m Q - ~ f~ - ~ 1_17 V d Q N_ N _ C O C ~
~

O7 OfO 01 Of O ~01 ~ pJ .- ~m ~ OD N H N 7 Q 7 Y Y J C Y Y Y Y Y Y Z JC ~ Y
~ ~ N Y p O O N 7 d C . ~
C

C C C C C C C C C D C N C
pp ip fC(p ip i Q C U
N f0 G77 d 7 i9 C ip N1 m m m p ipm m d m ~Q C (~
W ~ a j ~ m m .O~- 7 ~ i0 ~ C
t0 y U C9C ~ U' C7 U~ C7C9 C ) ~ U M GI C7 p G N N U o N E
E ~

E~o Em EoEr~ Er E'aEcE~io Ev E~.m E
U E ~

N ill Vl1/l N N N (p ~ N C M H N
d Q ~ j N ' N

C C C C c C C C C ~N C ~ O c ~ ~ ~ ~ = O ~ d ~ n "'O_ C
~ ' C ~,.~
' a~ d a>a~ d a~ a~d ~ d ~ d E ~ ~
, ~ a ' _ a 'y o H
L

O O O E O O O O O ~ O M = O
<r ~ N O ~ .C ~ ~ p D M

d d d _ a d a a a Ifl a ~ a N a ~ a ~ a ~ N a y h j o ~

O o O N ~
O

V > > > ~ ~ ~ > > > O j N C O m N ~ p O u' ~ O G1 O O M N O ' J n O
O O O
~

Z y Z Z O O O O O O O
c Z ~ a N J C a Q N G
a d v ~ w Z Z Z Z Z Z or a Z
~ ea m i.
-..

N ~ O 0 O O ~ OO N V 0 p O N V t0 app t a E f f O (7 ~ K70 0 t (OfD0 fD0 D ~ ( O c p f 0 t f t 0 f t c O 0 ( t N N N N N N Nt0NN N N N N N N N N N N
M N h f MN hOfr M ~ h 01 M t 0 h Q1 O

u0707 ~ N ~ ~ ~O O0 N ~ N ~
u tt 0 t0D 0 O t f 0 I D
N NN p0 v f f ( ~ D ~ N
~t ~N N ~
~

. ..
O p c0 ? c0" f0OfO Of ~ Oi N O a p M N
t h ~

OfM ~ M D _ O Om O O M ~ ~ O O
a0i D r h l ~ O O f tN_hi0N a D M D M u 7 c0h O O ~ D O~ t 0 i N M M ~ 0 M _ hO O O t 0 D f 0 N N M
fDD N t ~ ( N i ~

N O MO O N N ~ f0 N O~M
O ~ O h ~<DWO M ~ O O O 0 f0T
O N h v O a ~ t n OD0 O~Q~h~ m h N ap O f i0O
h 0 N ' E
N

i0e 0 Of NM V0 0 h D f O N M V W
h O if a O

O W Of O OO OO O O O
O O O

N N N M MM MM M M M ~ (h f~ P1P7 N M M f f~

N a0 a0 00 Y7 (O a0 N N u7 y f1 cO O a0 O ~ M

N N tD ~ aD N r O N cD 01 tD
M O ap a0 N ~ f0 r ~ r v(7 ~ ~D
N V V < Y
f0 _ f0 a0 ~ fD ~O N r O ~D ~
oO O ~ t0 ~G f0 ~D t0 t0 r _ u7 fD
~D tD O
u'1 N

M O CD ~ r ~ r a0 M t 01 N N N N
r r 01 O ED N O V N N N
M V r V
UI a0 V t0 fD
Of M t0 t0 N _ t0 10 O N _ tD O r N M
f0 ~ _ N O _ O M fD aD N Of O ~fJ O O M cD O ~ N
O O u7 a~ t0 aD r O O~
N
M

N M U7 ~l'1aD W ? r M O N N M O O aD
m e- M O f V u f0 iD M f0 00 n 0 _ of c ao o ~n _ 0 0 ~.i o~ ~c ~c o so r ~ v ~c ai a~ r o ' NNNrOdD ~D NM O N _ ~O NaDNN ODV~1~7 r~ V
r N O M _ ~ N M h VtO ~f t0 N O Vt0 N f0 (D
CO f0 (O (O N
fD r tD u7 ~D
GO

~ a0 Of ~ M ~ a r M 07 c0 N N t0 N
N Of M ~ ~ D N N N N N
' N ~ t0 N ~ M
0 ~ f0 O N M
fD

N tD u N _ f _ Of O N V M a0 (D N
! r ~D N N O CO r ? CO M
aD M N O N N N M N N CD
O Ql ~ aD r ~
f0 N M N ~U nf1 f0 u7 V N ? N M O M O ~O a0 <O r O M t0 t0 M
M Of o ~o M ci ~c ~c <c ~c o cc a> o~ o~ c n so ~ o o ao r r ri o ~ M a M ao o ~c v r so se _ O N O N N ~ N m_ N ~D O) ?
N N M M O ~Cl ~D Of N_ t0 V fD ~ ~T t0 W O r f0 f0 !D ~ u7 ~p m at <O ~ O O tD
O r t0 h fD W fD ~ a0 _ OD ap N 47 00 N N ~ N
N 4D O N O N f7D O O C N
r ~ N ) N ~
N N
r op f0 _ ~O V ~O M N r aD _ t0 cp N a0 ~D tD N ~ Of _ CO ~O

G N O r N M N O a CO O V W O N u7 N
t0 M < M u7 N O o0 N N N
t ~- ~7 O O
N M
~

_ a0 N _ O Y O a0 M O (O O
? O7 M f0 a0 Of a0 M O ~ M 01 ~f7 tD V a0 O tD M ~f N r O W O
t0 O Of O a0 01 t0 r a0 N O f0 O~ M
~ O r t0 N
O h O
O

Y ~ O O O aD M Y Of N N 10 ~ V N
N V tp r fD O V V ~O W t0 N ? V N M r ~(7 r t0 a0 ~

_ W a0 07 O O~ ~D t0 N ~ ~ N ~
~D O (O ~ aO r Of O V t0 ~ N N
N a0 tD ~ tD O r N fD ~
~ f0 N ~ ~ ~ t0 ~ t0 ~ N 10 ~ N ~ N
~ N ~ ~ N
~ N
N e-~l7 V O N N N f0 01 a0 N r f0 N t0 f0 ~1 r M Of N N N N r N N N
~f) N O N N M t0 N N
~f M

r N ~ ~D Q) a0 t< N r N O) r OD
N U1 O M M t0 N r CO u7 O r N ~ O
O r O OD O 01 O O M N OD M N
O M a0 O ~ CD aD N O
M if M
O M Gf M

1O 00 O QO O tD N 01 ~ a0 00 O tD ~
N ~ tp CO N N O ~C1 Of t0 O
r ~ W O) f0 N O~ M CD
aD ~
' aD M O O O 07 O M M r M r m N 01 N
O N O V O O O Of 10 O r O Of r r f0 fD r M O~ t0 U
0 f0 N N 47 117O V aD N ~ V 1 O) ~ O Of ~ ~ N M t0 ~ t0 f0 ~ ~D

M tD 00 ~ O O W ~ G1 N f0 N ~
t ED t0 fD (D ~O a0 t0 ~ ~
~D Q~ N N f0 ~O M 00 ~ O
tD ~ M aD t0 u7 N

~f7 N 1n N ~ N M l0 N tD N N N M N N
N N M N N N N N N N ~ a0 M N N N '- N M
~ M
h 1_11L_1J l_11p ~ u_1 l l t U C
L L L
.

_ _ _ _ w t fn fn N d ~ ~ N !n ~

U U U c ~

m c o Z
~ 7 ~ ~

v ~n n 7 (D N O

O O OI
cD O a0 O C

O O O .-O O O O c0 u. ~ ~ E

d a a a o a c c c c ~ .

d ~ .

o n o o o ~ ~

a a a a c N

c c c c S
~~ = ' ~
' 'a~ ar ar ~ a~
E N c 0 o o E o 0 0 U d a Q d d H
d N c c ~ c a c ~
O

'm "m 'm ~ '~o a w E

~ U

U U U H
m nN

y o in co w ~ m of - - ~ - m O
a ~

_ ~ _ , '' ~ ~

n o ~ rc ' E o M r m .. U
y .N

m co = ~ M ~ v H
m ~

N r O O r GI m OD N ~ N r D j r H H a ~ Q Q ~ N : ~
N C C t ~

C ' G U U N d co ' ~ E E
' A
' . m ~i m a a o ~
- ~i m m gin E f m a Q a E E a Z 7 in 7 m N N

~ m ~ , a a> a~ a o ' c ~ ~n o o -~
o a~

r o g r m ~ E ~ c E ~ ' o o E ~ a o c o o E a, a o ~ ,n o , N
E E p n V m M ~ ~ _ _ a o ' O v _ ~ ~ ~ o o 0 a c c ~

; Q Q v 'a~ ~ ~ ~ a ~ c 'd E _ . . _ ' .

of ~ t _ o~ o~ ' ~ ' c ' ~m n n ~ a o o a> c c c c a~ c c ~ c c c n c a E

n ~ ~ ~ ~ > o m m oo m a0 ao m o m 2~ m o ~ r ~ m o H ~

C7 o C~ C7 C~ C~ C~ C~ C7 0 C~ C7 ~ ~ o L = 'E c a E ~ ~ c E E E Q ~ E '- E
E E ~ o o E o E Z c R
~ ~ ' ~ ~ ~ ~
v ? ' ' 'y1 '(/IN 41 N N H t N ~ C V! f%1 ~ T T N b U
~

cY c~H C~_ cY Ct ct cn~ cd-y ccm c ~ ~ ~

ao ~ ~? ~: ? .' r? ~ n o g? ?' r .r c ~ ~ 'n ' o c ~ 3 ' ~

O h O O O O O O N O Q O O
1A O ~1 r ~ ~p ~
~ . ' a m a a a a a a ~ n. r a a a ~ o o o o o , a a t =

~ d ~ d m d o d o E d D ~
a"o ~ o o o E o d ' o m v .r m c ~ I - a Z a Z Z Q Q Q Q Z rn y ~ Z
o~ '~ Z Z Z Z D Z o~
N t O ~

M ~ M M ? ~ Y ~ O
~ O f0 ~ f0 f0 t0 t0 O tD N t0 ( N N N N
N N N N N N

~

M ~ ~ M M ~ ~ V ~ 1n c0 t0 f0 tD t0 tD ~D tD O tD 10 N ~ ~ .N..~ N N_ N ~ .N..
v W r M f0 r N ? 01 O N ~ ~ ~

u7 (D M (O ~ ~ l0 O r n r ~

c' O ~ N 10 0 c0 M
~ ( ~ m u~ o o r ~ r v r ~ c0 Of ~ aD aD m Of aD Of m ' O r ~ O N N N N N N

M M M M M N M M M M M
M

m Of o7 O ~O O O N Q1 ~I7 ~ M Of ~O
~

O~ N O O ~ 1~ O Of V O~ ~ f0 O
1~

O a0 ~ O CD f0 O N M _ f0 O~ M 1~
h M cDM O) f0 O Of O t< et ap ~D 1D (D O ~ O N f0 h O M t0 ~(7 CO ~ N N m N tf w7 1~ f0 M t0 N

1' V M N N ~t ~t'fN N O f0 h a0 V h V M ~ I7 ? a0 C1 O l0 O t0 N O~ ( O 1~ O M 01 O M N
M t~ Of Y N (O a0 <D M ~ O aD
N N M . f0 O M aO O CO f0 ~ M 01 c0 V '~t tD h !f V
f0 N dD 07 N r O t0 01O (D _ M <O N O
N N <O M aD f0 V w7 N M N f0 N t0 V
O ~O O~ O O

_ V t 0 Y N M U7 O Y N ~ N
N N r '- N t0 ~ t0 O f0 f0 ~ 01 t a0 ~ P ~ ~ ~ t0 O~ 1~ a0 V ~ Q~ t0 M O O f0 aD M
M
u7 v N N N M N N N N aD ED (O 1 ~ O N
1~ M f~ ~ 1l) N M N fD h N GD r tO 0D N f0 Of M O
~fl 00 N

m O N f0 tD A (O h ~O N N OD - N O f0 f0 O) 117 t0 ~ t0 O N O V f0 O 1_~
O M ~ a0 N O 47 M D u7 1 7 M t0 a ~ t~ ~f u N ~ N N < < N t0 ~ ~D _ _ m N o_0 N N V O 1 N t0 . e0 Of _ V 1~ <O t0 a0 fD tD N tD t0 O
1~ ~7 CO f0 1~ N M 1!f O N aD (O N 0O O a0 O 1~ ~l M N O
N O N u7 O~ t0 O f0< N h r O O O N f0 ~I7 O
N

N N M M ~O (O 01 ~ CD? ~O Of t0 t0 f0 y0 M 1A 01 f0 V M v!fr N t0 (O
t h M (D ~D M w7 O A 0D ~O
h fD a0 O O a0 a0 f~

p M M O M N < M N N M M Of V N N O N
f N (ON O) 47 r N N Y H7 N aD O) ~ O aD ~ GO
aD
N N N elf vt f0 N O~ M M CO N

M C_O t0 V 1~ 01 N W . O V <O O f~ 47 (O N h N nf7 f0 N f~ N N O O O
tD M t0 N ~ V N W N f~ if N N M 00 P N
O V N ? V N N Y1 M

O~ O) N fO . f0 . N . . M Of . N . c0 O Of t0 f0 N 1D fD t0 1~ c0 t0u7 . . N M ~O t0 V O f0 U7. 07 01 0D O K7 Of N ~
O N a0 O V N N u7N N ~f7 O M O f~ 07 tD N N f~ O O f 0 c0 N M
O
M
M

OD . - u7 - . Of N N O aD u7 r - N_ a0 . aD
a0 - t0 O M O f0 M . r (p N N N f0 O
t~ O~ M ~O P ~fJ O) o f~ 1~ N M ~!f - ~D
at N aD 1~ 1~ f~ D N O f~ O a O O a0 a0c D t0 ~ O h h t aD

N ~O M O t0 aD aD M _ _ _ I~ _ aD Of V 47 M h O) ~n_ N ~ M ~ f0 aD N O O) N ~ M c0 ~O (O f~ M
N N O) O~ O f0 ~LfM N ~O O) tp O ~
07 tp i~ O M O O O <O f0 N O P
M N ~n r U1 t0 tD t0 ~O

N 'C N O N N ~O N N M M t0 N N N N ~O tp N N EO
CO N N ~ ~O O N ~O ~O N 10 ~ ~ N t0 r V N
~ ~O tp ~ O M t0 r N O . . .
. . . tD tDN oD . Of . -. ~O . N O~ N O N 01 O) W a0 -. r N O N N aD M f0 a0 N V
fD N ~f7 N N N ~O N u7 M
N Of N N V M N ~O
O

O . N . - fD . . O . N 1~ V o0 M OD O . O
aD f~ N O O O OffD . . (p N M 4'ff0 .
M r op M Of Of aD Of 47O O 0D . (p CD t~ r r M M M r ~Lf i(7 O N V N O) r n O 1~ Of a~ t0 1~ ~ n O f0 a0 O O V M
1~
r op aD 07 r O O r a0 aD u7u7 V N N N r N O a0 r ~G
a0 ~p O ~ a0 a0 f~ u7r a0 (p W O M O) t0 N
N O t0 t~ N (p 1~ c7 M a f0 u7 aD
O O M r O O N if h tf7f~ D O f0 O ~ M h N O
O f0 u7 O W h O O I~ M O O ~O
u7 N M N O
O
~!f Q) V M ~ O N V Of ~ N ~ ~f _ ~ N O) O) V t0 N O t0 V M N < ~ ~ ~ et ~ u7 ~
0 N a0 O~ Of fD N N r cp tp a0 ~ t0 u7 O O tD O aD
f0 ~D t0 r M O N ~
M u7 N fD
O) aD f0 O) ~O tD ( N D r (O (O (O ~O tD N r tD t0 r f0 M N M ~O0 N N N M N fD N N N
f r t t N N 47 N N N
r N N N N N N N N N N r N N M r 1f! N M N M
M

IJ JJ

LL _ lL L L _ N L
L_L l l L_L L

In "

g g 3 g g g L g n r N

7 7 ~ 7 N ~ n O M

r o .-'_' o a ~- a c c y o n o v a c ~ c y . .

m c a~ or o c ' _ N ~ N C

c n c N
.

.m - m o c o ~ o , U N. U m a~
J

.

N , c - ~' E
m N f n _ m O A ~ N
~

yj p 0 ~ V G7 Q7 M 0 . O

y D ~ M ~ V
N T

N ~ ~ ~ r N
L U .

J ~ V c . l . ~ C
.. ~ ~
y C ~

Q U n m~ mE m?~ o,flm' ~

a N a m a Z a Q a m m t _. ' O N ~ O ~ ~. ~ N
N O

M v ~ O fD C N M ~ O
C O y m O E E m E

= N vZ
U

~ m ~7 o c cc u ~ ~ y ~

Q ~ ~ C c ~ N V C
~ N C

N O)I .0l . r 01 . Ol .01 O) .

O d O ~p O

a m Q >' m m m m ~ m m m ~ 'o ~
~

(~ C~ ~ U' C7 U' 7 C7 0 C o n C

~ D ~ o n _ '~L Q

Eca~7 E~c E'~E~ Eo E~ Ec E
w ' N N ~ ' N
~ ~
~

H N c N L jA N N N
c nU c ~ ~ Y n c c c c Y
m 2 c Y o o pp _ O N N 10 y " Q d r O N z O O O ~O O N ~p O O O O
N ~ C
C

a o Q a d d co d ~ o a a a o o ~ o~ 'm a~ d o ~ o ~ o E d d d o ~ v o ~
~

i c 0 m m m ' m ., o ~ m o o o o o o o ~ ~ o Q
~
' zwN z z za za= z z za rn~

~

u ~o ~e 7 o m ~o m o m o N N N N N N N N N

M N Is f M N h O
O

u7 O O O 0 ~O t0 0 D
c f c t0 ~D t0 D 0 10 t0 p O
N N t f N_ N f < N
N N N N

n M ~ M h 0 ~

W ! ~ a 0 ~ ~

N f' 1 ~ O N ?
7 1 ( N ~f1 W N ~ V' O W V
M r n I M eo o 7 o n u s 1' a0 01 O N M ~ O
~

M e'N~ M~1~ f'M~ ~ M M
f ~ _ o O

M f aD N O) ~ tD O O V
~ O h O
O t~

t0 a00 O ~ ~ ~ ~ Of u7 ~D
t0 _ r n ~ N
Opf u 'J

_ N N O (~O f0 ~
h t0 47 O ~ f0 ~ O O aD ~ N
N
t0 P

N N N Of t0 ~ V) O N N N
N OD N ~ N N N N
N 10 ~ N N

N M N tp9 f0 ~ 1~N f0 I~ (D Of N
Of ED f~0 f0 N CD
N CO

M a0 N O7 ~ ~ ~O) V N O O W
M c0 t0 t0 N t0 M O
m M ~ M O7 N
O u7 1~ u7 c0 _ N N N~ N N ~ ~ ?
Q~ 07 O tD ~ V <
h ~ < tD t0 W N V a0 Y1 t0 t0 V O M t0 t0 tD

a0 t0 M f0 o0 aD OfN -O NNN NNNN
t0 N a0 N
NNOOM

N hO~NO c0 00 ~O OD O

<

N N N O~ (D N 10 u7t0 V c0 O W a0 O
Oi t0 a0 V h O ~f N N O OD t0 OaD M O O O O
' N ~ tD ~ ~ fDcD 10 ~ f~ f0 fD
M ~O
O~ ~ 1l) h 1~
f0 10 u M 07 u7 O N N ~t V N N ~ ~ ~
! M 1n (O N ~f V ~
u'7 V N 10 V' ~O t0 V m O M f0 tD
~ f0 (O
~D

tD tD t0 f0 ~l7O) f~tD N V N N N N N

1~ O aD N
t0 N N 1~
O M

N O fD N 0 N

~ D O m 1~N ~O f ~ M a0 07 N
1~ ~ Of a~ M 01 ~7 f ~l7 1~ M O a0 ~ fD
a O W t(7 O M h ~ OCO OD O 01 _ OD m M CD 01 N (D h ~ tO O 10 M ~ N
O t0 O N
f0 m fD N G) M f0 t0 Of10 ~O _ N ~ ~ ~
t0 O t0 O f0 ~ N ~~ ~ (D f~0 N N h N fD (~O
~ M
~
~

~O tp f N N NN N p f0 N N N
t0 D O f0 f O f0 a0 N N N N
N D N
N 4'! N N f0 N N t0 4'!

OW ~ N ~O 07 a0 O nff O~ O a0O~ 01 O tD aD r 'f ~ t0 ~ N M ~O r V h aD 1' 01 ~D
f0 O N Qi O O V GO t0 Oa0N 1~O a~ N O 00 a0 M c0 t0 47 10 10 ~ c0 f0 a0 u~7 a0 O Oa~ O M O) Q~7t~0t0 O O)W~ 1~ O O) V~ ~7 ~O O ~ O a0 O ~ M ~ O f0 ~ O) ~O ~ f~ ~ ~
~ N V' ~
~ ~ ~
O ~ ~
~ ~
~

t ~~i 0f00~ ~~f ~ t t0 tOt Ot t 0 0 0 O O OtOt Of cOt O Ot O~tOfO~ ( Ot O

N N N N M N ~ N N N
N N
N

~

W l l!J
JJ

_ _ _ C C
LL Lt.LL

N fn f4 N

5 ~
N

V O O
z z z z ~ 2 ~ c ~

H rn x o~ 7 o o~ o c o o o E o a a a ' a c _ _ _ ~-O C C N G
C n ~0 N N N f0 C

O Y

O ~ O O O
' ' d Q ~

C C C C C
T N N d ~y m E

o a o o n v ' r n y a a c~
c ~ .

c c c c E a d d _ ~0 ~
R V

C ~ C . C
O > .. O
C ~G

U n U U uJ U
~ ~ ~

c o C ~ x , _ - ~ _ - _ . ' ~ N d c , ~n ~ a Q ~
~

0 o E E N ' ~ ' o -'.
E z of a '~ o o m w r v E ,~ ~ ~ a _ o v m M m C 7 O _ U, fN~f ~G M ~ C

O~N ' ~ N '-NE~ G >
a p Q ~ . '~ ~' , r ma a _.O Eiv a ~
a p v, n ~ . a p ~ ui - G -~n ~c ,-_ a m E C1 X E a 7 U . _ v m o ~

d a vi m o ~ n. d y Y a N
~ v E

r E N t0 N O ' H U M N
Z' ~ ~ C

O _ c~ OW' U ~ ~ c 0 a ~ ~
' d ~ o ~ E t x ~.~
m 11 d ~ y o w a ~ c ~ ~ g B N r~ ~ o- r~ v ~ Q ~
o '0l O Ol v ~ O Ol 0) ~ O C
W N v ~ ~
V

V C W
C ~ O i N V M y Y 'C
~ ' O

C C d C ~o C C C A m c>
z ,a ~a ~ A ' m 7 ~ M
E ' m ~, ~ ao ~

,a r m m ~ m m m ~ ~ m > m O ~ p ~ ~ m p m E M

W C~ O C~ C~ ~ ~ ~ V C ~ ~
111 O~ N (/) OI
C ' ~ =

a ~ m 'jn N N O O N N N d C N N y M y~ N ~ ~ U Z ~
H N ~

nz ~Y c'? c~o~ cd co~cncOW~ c~y a .

,.d. O ..d.. .-O. r Y Ø. O r O
U N P7 ~ f~ O ~ V!
t T U f0 U 01 . ~ ~
~

O O 01 O O ~ O O O ~ O >
u7 N (p of ~ t~ O
~ Y

d a ~ d. a ,'l,a a a M ~ d a o ~ E o ~ o ~ m ~ o, a ~ Y ~

o~ ~ o d y o d d d o c d d o "~' N a ~ ~ w Q ~n .~ E ~, a ovj om o' o~~ ovc o'~o~' NZ o~~ omZ
~

~ a ~= ' '~ t zwe zQ ~
- n ' a ~~

zwz za z z z z m c z ~

(V ~ f0 00 ONtf f0 a0O N V f0 n r r. n aoaoco ao eoo~ o~ w o~

~n ~o ~o ~o ~n~n~c m ~ucc m ~c m N

N N N N NNN N N N N N

M N n 01 M ~ r 07 P1 u) n o aoao rn a~ o~

co r n r~ raco ao m <o m m m cc m o msom m N_ v N N_vN_ v N ~

N ~ 0 N N ~ ~ M

o ~ M MaO c ~O~ 1~ M M

~ a0 p N tD O) !D 01 N N 10 10 1 N
1~ ~

a0 t0 ? OCO t0 fDN _ ~ ~ M N M O O ~1N N

1 t O O aDi0O O O O
1~ ~

a0 Of a0 a0 a0a0aD a0 N Of a0 a~ a0 ' M M M t~07O~~ V' ~ Y O r a0 M M M M ~MM M M M

N 0 m ~ 0 aD O _ O . op M ~O _ aD o0 M c W . m N O ~f7 f tD N ~7 cD O t0 N _ ~ tp . f0 ~ .
M h . <O N f0 _ N aD _ 10 V l~
W '? 'C ~ CO P f0 e- ~ f~ ? ~ O ~
? M K) - tD f0 P N
fp t0 t0 O V
aD N ~O u7 47 tD ~p tp _ . e . M t0 . . . _ ~ N
I~ C a0 ~ _ 01 ~ 10 O N V CD N V O N Of V CO N O N ~ N
V C~ t1~ W M M N N ~
N

_ O t0 O t0 N u7 t0 V ~O V V
N f0 M f0 W M f0 O N f0 O 01 V W Cf ~f7 N ~ N 01 O M fD
N M tD N ~ a IA f~ ~ ~7 ~l7 ~ tp D N N M N f0 O 0 t0 10 M t0 ~fl f ~
N M O M N V O M t0 N M
W

_ ~ ~ f N 1 . m O t0 M O tD A . Of t0 h h Of 0 M M <O
. t0 t0 . 1~ W f0 M f0 P N
f~ ~O
f0 h ~

t0 N V O V u7 fD N ~O N O Of ~ M . .
f~ N V <O N V tD f0 eD . f0 Of t0 O O t0 h N t0 W N ~ O c0 N Qf f0 f~ O O f~ ~ O t<
N M ~
~O

O~ h N M ~O
O~ N N ~O fD N O O_7 n0 ~ N N M N ~O
~ f~ O N M O M M N a 07 aD N ~O N ~D D ~ N N
tp t0 N ~O O N aD ~ aD h N

_ t0 10 _ N (O
1~ oD 1n N h N aD O ~ N O
O O M O N Of N N O O M f~ O
1~ O M a0 V O~ V t0 h ~

_ a0 N Of h M M t0 ~ O
N O . 07 O IA N ~ fD tD M
N h N M Q) '- u7 O M 00 a0 aD ap ~ ap Of O fp m tD O 4D N CD M t0 O f0 O M N O
N M ~ V N 0D N M ~ N O u7 '- M M f0 N P '- N M a0 M N 01 ~
07 tp ~ tp <O N ~ ~ V ~O N 1(7 ~ 0D ~ 00 N
Of ~ DD
N ~
O

_ O O 1 tD O_ t0 cD N N V N N ~ N V ~ ~O O N N V
t0 h Of t0 aD O 1~
(D V O a f0 N
0 01 ~ V ap O 0D
N N N V N
V

_ t0 ~O ~O ~O u7 f0 Of cD O~
4O t V N N N N 10 O a0 O tD
. ~D M f~ O 0 M O O N Q) N (D
N Of Of N V N f~ O N V 1~ O ~
O M M O M ~ O 1~
~ O1 N

~O ~f7 O M N fD ~ 1~ V N N N M tD O a0 u7 a0 O aD 1D ~
O) <O
N

O7 N Y7 O a0 h N e< I~ _N f~ O O N h ~ f0 1~
N O O~ N O 1~ ~O O ODO t0 t0 a0 O M A
t0 ~ V O O f0 f0 a0 Oi O~f0 h O
W l0 Of N ~ O V O O ~ 1~ N f~ f0 N t0 O~ 1 ~O et ~ M f0 ~ 07 N
~ O I~ N t0 aD ~O O O~ Of t0 O N N t0 N t0 V ~O (O f0 N ~O O
M ~O tD V
~O CD

_ N N O
M N N ? O V N M N ~ V Mt0 V at ~O N t0 ~O
V ~ N M ~D fD~O N N V V N N st tp O f0 f0 V tD (O ~ N M ~ N N O~
t0 fD tD M f0 N
tD N

t0 N O N N ~D N N N N N N(O N N N H7 4'i M t0 ~f7 f~ N Of V N M aG Vj N Qi u'i N

N
N

07 t0 f0 N _ V V . CD N Vf 07 N m _ 01 N tD MN t0 N r f0 f0 fp O~ O aD O 1~ O aD N 10 a0 P 7 a0 f0 f~ O M M p ~ tD W O
elf ~ O f ~
t0 aD f0 O u7 (O f0 O O)t0 O (O N off f~ N P
~O ~ m t~ O f0 h M ~ aD O N
W a0 t0 O
m O aD a0 (O

M

r o~ a~ o~ n n y mn o~ coa~ oW o r o n o 0 n iri o ~a u~ r ~n v ~n w ~o m 0 ~c o co ao ~c N ~D ~ V ~f W 00 fD '? ~t0 ~ V N Q N O O_f N ?
~ f0 V V (D tDu7 V t0 ~ Of N N ~ ~ t0 (p f0 N ~ u7 t0 f0 tD N 10 V
W t0 M O t0 M tD t0 O ~O 1~ 1D N (O
~ ~ ~ I~ f~
(O

10 N M N N N N ~J N NM N N N N N N N CO N N
N 1A N M fO N N !D M N N N N N
M CO N
N N
N

W l l t U
L 1J 1.l J

LL _ _ _ _ G
lL lL LL LL

a l m U U U

U

> j 7 7 7 a o ~

yo aY

c ' ' m ,r - c ' ~
E
E

c c o y o c o :c d H O

O
c d O
.A

O Z
m U m ~

- . o _ r o WZ

O N O

N M N n O
O

4] n N 7 1n ~ ~ d m C

N _ _ ~ y) 'N ~ Q d O Q O D .
O n d N
QI ~ U

O ~ , O ~ M O~

-C N C
2 ~ 9 r O
' v E o v E o c o z o n _ _ ~
N

N R ~ N N Q C _ 01 v O) Of v lL

Y Y Y Y ~j Y W
G p fp ~ l9 c0 ~ l0 n f0 d d M

_ ~

C~ C~ C7 C~ N C7 o n o O 0 _ DY
~~

E E E E ~ N E
3 t ~N ~ N .N ~ ~N - ~N
Q ("j c a~ c c d c a c m m ~

_ O T O O T O O . O
f0 -a o n.~ a o _ aN
aa, ~ N

t C
m 'e O d d t0 d O
O ~ O ~ O d ~ O ~ d O

Q O ~
~c L

oi N

aD O N <t0 a0 O

cc r r ~ nn n n N N N NN N N

1~ Of M1n 1~ Of ~O t0 n nr r r N_ N_ N_ N_N_ N_ N_ m (O r t01 u7 f0 ~

~f M N aD_ V c0 M

M fp~ O O

N O f 'O~O~ M N

_ r O m O aD 0 aO ' O
a D

O NM ~- N

M M f'~~f'O~ M

o; r~ _ a0 O M O N Of CO Of - . N O O u'f 7n !D M
01 O t0 .

07 t0 ~ 01 O ~ O7 O m u7 V W O i0 ~ V1 ~ M
a0 <O tD t0 0 ~ a0 r N 1(7 O ~ . t N fD
1n ~ O M N N ? M 0 N t0 W N t N Of N
t0 M N fD CD

p t0 N V ~O C
N fD 70 N N N Y r r N r a0 O ~ t1~ V fD v0 Of r t0 a0 r N O a0 t0 N O f0 ~ . N O ~ ~ N M O a0 ~O
M e0 r r ~ N N 10 N M

. O CO N ~ . W O f0 . M . t0 .
O M . t0 O 1n O M . ~ 10 f0 70 N f0 O p O N O r V a0 O a0 V ~O t0 t0 O O M
O) ~O m 70 (D W
O t0 M 0 O
t0 ~ r M

O 1 N tO 7!7 (D M
O N 70 u7 M _ . O N ~
N M N N W N e- ~ a0 N t0 r V M tt e- t0 a0 t0 . N ~ a0 . M N ~ M
f0 . _ ~ t0 _ ~ t0 N fp M

r 70 a0 N r Of M M M fD r M
N Qf CD V O N 10 N M O r N O aD O u7 t0 ~T M O V
~ ? r N O ~t7 aD t0 t0 W M N 1 00 of M
~O

N 07 M O N 70 O) O O O 07 O
r f0 7n t0 t0 ~ 70 O
Of tD O ~D ~f O
If7 N t~0 OMf 70 N ~ p N (O N ~ ~ f0 O ~ ~ ~ ~ fV t0 ~ 07 u0'7 ~ ~ tD
~

~ N 4~ N ~ r N W ~ t0 N N N f0 N M N N V N M M N
~D N N
N

O) f0 f0 01 (O r t0 OD 47 07 aD N N u7 f0 N ~ t0 tD M
N s! CO ~ Of aD N N
~ r ~ V N O ~O 70 t0 t0 ~ N W O of a0 N N - O a0 O . r- N O N M
_ 70 ~ t0 fD c0 _ N a0 . aD 10 r aD tD M ~D a0 f0 M
O M r a0 r 70 r a0 aD M
M 00 O t0 a0 01 Yl O r O O Y 01 01 O f0 M V

N aD 07 O V N O CD V t0 (O aD
t0 W ? 0 7t7 t0 f0 ~

O O M O N ~ O r f0 ~
O t0 f0 N ~ ~ ~ ~ t N c0 777 f0 t0 M t0 ~ ~ ~ N N (D t0 ~
N N N N ~ CO n M Y7 N N ~ N M I0 f7 ~ N N ap ~ M

r N N N N Of t0 <O N h N a0 N Of ~ ~ 01 ~ V N aD CO N ~
r ~O V t0 N Y M
~ N

O) _ . _ ED OD N . r N N _ ap _ 00 1n r W N h . t0 M _ (O CD N ~D r M of l0 r r O 7n 00 M M
fD N _ CD N CO OD CO O ~
M W r r M r OD r ~ ~ M M O
r M
M M

a0 O 10 10 O N f0 ~ O N ~ ~ CO N l0 O
O cD r a0 M f0 a0 N a0 Of O r O
N cD c0 a0 (D ~ O O Y N
O Q7 a0 W M 07 aD M M ~O M
O O r N 07 O f0 O N f0 O O t O r M
O O
O O
f0 _ _ ? _ ~ t0 M 01 M M oD V V u'!
_ W tp _ O ~ Of e0 ~ aD V < ~ c0 at 7n V ? N t0 m Of !O V
V u7 ~ tD f0 7I7 tG f0 O
a0 <O r d0 70 W ~ O f0 f0 f0 ~ a0 - h N O
t0 a0 t0 aD

~~ N N N N tp ~ 7C7 N N f0 N N
N N CD ~ r N t0 N N
N ~ N ~ M N N N N 1t~ f0 N N N In N

l_L ul t 1J.

l_L t _ L L
L

_ _ ' g g O N

N 7 T 7 d J O

N (p O N M
C

M O _ t ~ d O

O O O _ O ' ~ O

~

E

a a ,~ a ~ a a ~ .

c c n c n c c ~m o E E a7 E E E
a ' 0 0 ._ o ~ o 7 m o a a a ~ a d a v'E
o c c c a c c ' C N m ' ~ y N y ~ y ~
N U

o o c o ~ aFd. c f n a' am aC7 na o N N E N N N
a O E O C

C C C C C
~. . a o . > O
. , .
r m m a m ~a C c5 m Q

U U N U ~ U U
~ a ~

c N n C -.

7 U _ _ C N
.C O N N O U
~

'C M ~ f0 K7 O D M n O " _ M N ~ ~ u7 O r n E
N

O
~

M_ U ~ N ~ N ~ ~ y0 d C C ~ N L
y C

o _a~ m a m a7 m ,a_7 u'7 m tn U c ._ > ?~ a .

_ j ~ ~ E a m a m j a ~
N ~i m m E N a N a N ~ a n n O ~ N ~
7p 47 ~ N M O r- O ~ N ~
' C d O
.

aOD O O a ~ Q V ~ ? ~1 01 N N f0 ~ A

s o a ~s ~
>

z .

a 0 ~ i ~ C ~ U~ ? O
D N C r C

_ d _ _ U
O~ y ~W 01 O Ø. _ 01 01 Cl OD ~ Of O y .ØtV
~

Y Y Y Y Y ~ Y ~ Y Y Y
O Of ~ ~ O

g ~c~S ~ m mn ma m~
~

e _ o ~
o m ma m m m, m~
~ ~
~

C7 U C C U o C7 o C 7 C~ C~
._ U a7 E E E E _ E ~ E E E
a E d E ~ 'o ~ o ~

N H . N 10 N N _ N N fn N N ~0 N ~J
'-c o c c c c Y c Y c c c .0 o ~ m . ;~ Y _n . N .0 ~ . d . .
~

1 ti Q 7 N ~D N p c G) a) ~ m r so 0 t0 0 7n o 0 o o 0 o o d E a a a a ~ a s ~ r a ~~,, ~ '~ a a L
m o7 u7 N

> ~

>; i > >u >m >m >o~ >m >nd Z ~ N Z 2 a a 2 a t d r c ~

Z Z Z Z Z
c N V t0 ~ O N ~ t 0 CO D N

N N N N N M M
n ~ i~ n r r r r r r r N N N N N N N N N N N

M N r O M ~ r W

r r r r r r ~ n M

N V v v ~ N N N v N N

N ~ ~ 0 O O N

01 O V ~ N M 0 ~ ~

r d M M
f 0 r M O a0 7 0 r O O

7 _ G O m r r r 70 7 a0 M
07 m M m m 0 W O O m aD
a M M M M M M c9 M M M M

_ V N O h m M h O M M f0 M M t0 7 C aj 07 t0 a0 . O u) t0 N u7 h h f0 f0 aD m aD N
_. W 0D
O Of Of O
h O O r- c0 O O O Y V M

~ ~ ? sf ~ V a0 O u'7 V 1f1 h t0 fD 00 t0 a0 O f0 cO a0 f0 M
h p - M h t0 ~ N O O) h ~ h ~ t0 _ N O ~
h W t(7 N Uf n0 N O oD tf~ ar h M M Of N M ~ N N N N aD ~ ~ Of ~t tD W a0 ~D N V ~f tD O ~O Uf ~ N O t0 h N
OD O N CD f0 aD M

h N t0 N f0 t0 M N ~O N M O N O O v t~ ~ N N M ~ O
~p O O nf7 h O ~ Q1 op tD j N h N ~ N N M
N N h N N ap t u') fO O h M M N V of a0 t0 l0 M N M Y M N if) N (O O O O aD h 00 M N N e< aD M
~

? ~ aD t0 aD O <O O M M O h N tD O ~O IA
N f0 tD N O ~ a0 ~p Of h f0 fD f0 u7 h t0 N ~O
M tD tp O Yf ~ M N N O (O 0 N h W ~l t0 N (D ~ N N O N a N t0 u a ~ .Q ~ 0 ~

f 7 elf u7 t0 h O 1f1 h N N
7 O m N O fD 1!f M h f0 f0 t0 (O M u) N u7 h O fO Q CO
u7 O O V O

~ f0 00 ~ a0 t0 N O Y ~ M N aD N
h ~f O~ h ~ M t0 ~ N aD N N N N t1~ ~f tD V 00 V
O N u7 N
~O aD N f0 lD tD t0 tp N O ~O
t0 N ~!) O

. O N (O
M h ID O~ N N O Oi N N a0 u7 N ap M a0 Of ~ N W
O N N fD ~ u7 h Of ~ N t0 u'7 N O N 10 ~ Wf O
N

f0 N t0 O! Of tD ~ ap O M O N N M M t0 a0 M
~ N tD ~ M N ~
N M o7 O O O M Of N M Y1 ~ fD 07 U

7 t0 N M M M u') (p M O O
N M M O N 1n ED 0D N N 07 h t0 N tp r ~ a0 t0 O M h fU N ~ V N N O M u7 M t0 M N O ~ ~
YI a<

~ ~ M M O t0 M N h N O O 01 <O tD 1D O O f0 W Of ~ ~D N r M CD fp h M N
' V f0 V tD O O 07 N h tp O ~O O f0 1f7 u N N V N N c0 N h '? V O N
f f0 N O ~f aD N < < O t0 N 10 W h ~ < N t0 fO
O tp N ~ <D N ~ f0 ~f) aD cO f0 ~ M tp f0 fD t0 u7 l0 N O N
a0 V h O~ CD

N cp N N M tD
N N O7 N N N O h N N h N O N a0 Oi t0 f0 f0 O
N M M u'7 M ~ O ~O O u7 h aD t0 i eh Qi aD N N
N O
-N ~ O
f0 t0 N N t0 . . h CO M N tD M O N N a0 O M
O f0 N t0 fD ~ 1n N aD

0 a0 G~ aD N N M N O Oi N M a N M aO N O N h O 47 O tD p f0 0D O Of IA Qi 0 c0 t0 h N O f~ N h ~ 1I j ~O t0 O c0 u'7 m ~p Of t0 O M (p t~
N O (D ~ 1f1 O M
~ ~

N M O t0 M M 10 fp O M tn Of M O M f0 ~ Of M
O) u7 1n f0 <O h ~ O t0 h f0 f0 t0 h O M
M aD tp O (O ~ ~
M N t0 M
~O ~-N

~ ~ ~ M ~ O N O N ~ ~ t0 N N
N ~ ~ N O ~ M e- N f0 ~L7 ~ N ~ N M ~
' ~ ? M N
~ ~

u N h N f0 f0 ( W
J 10 O 10 N N N Of N N O N h N V D t0 (O N N OJ ~ In N N V N (O fD N N f0 ~O
h O N O 1f7 N h N N N N N
N h h c0 O h 1A M a0 N 10 a0 0 07 m n n V u7 m fD O7 0D f0 CD ~ aND O> O
h O O M OD M M h C 47 N Of n ~ r n ~ o Of N a0 O
aD ~f a0 O O h a0 V aD N O a0 10 O aO O O t0 f ap Of (O N Of h aD N ~ a0 t0 ~ M M fD M N ~ Of O
? Of h M 07 O U1 tD of O t(7 Of a0 t0 O a7 O O
' i!f u7 O ~D 4 N M 01 O h M h Of h M M
f O Q~ e< O i17 7 f0 h O~ O O O fO u7 O O O~
IDN~t~Ot ~p h W of O
0~ ~ ~ ~ ~
~~O ~ O O
~ M ~
~ ~
1 ~
0 ~
~ ~
N

DC t tD N~~( N~( 7h DO ( pfD DfDtO~Off~
tOf 7f O ~f O D p~
aD hf f t a0f DM
O
N In N N N N M CO N N N
N N M M

1n N N N N N 00 N N N N N N N N N
N M N O N N N N N N N M
N M

N

C
O

W m W

_ l C
c N E .d s ~

U o N a c Z

0 7 a N ~

O M N
O p C

a a a ~

c c ' c m m .m E

E
0 o E d c v v .~ c c c c d c d ~a~ ~
. o o o a m a o a >, Q E

a~
C ~ C
lO

.l0 N
.

Y C a a o o ~ c ~ E

U ~ '. ' U

v E

H

..

a o I y ' '~

v _ o~
N

m N

Q E

C ~ Q 7 C
N N .N ' O

O N d a ~ ~' m M o A m E H a a, c H

d o Q ~ o_ H " n N

~ ~ ~

~x ~~, a (V
C ~

~ ~ m O Y H
v d n ~ ~ ~, ~ a . . ' ci o~ is H

C Y Z Y Y
C

m ' ~ m m ~ m c c ~

, -N

~ I
E a E I

a E E E a ~ ~

C t N O N H C
O

C_ G d C' d . ~ . =
. .

: O O O ~ N
~ C d M .

O O O N ~ N O O
L

d W d a ~ N
a a d M ~ ~ M 7 d N
O >
N

O O O ~ C E
a ~ ~

Z Z Z Z 'cr u E Z 'or a f'~T,~ M a D O N

h ~ r N N N N

M

h ~ ~ ~ V

N N

O ~ ~ O N

N O O O

N N ~ O ( O

~, , M

c O

o D

h M ~ c~~ 07 M
~

o 0 o' ao ui ui ai ~ c 7 . v ao ~ <c _ o ~

to ao to r o~ N ao ao r o to co a~ a~ o Ici O O r o0 0 ~ ao ui 'C M O O~ V O 10 O r V In r O ~ M M M t0 (D N M O M O 10 O M O t0 ~ tD t0 ~O
t0 ~

O O a0 . N
07 u7 t0 a r N N Y
N If7 N O~ fD
OD M t0 N t0 a0 M f0 O~
t0 ~ r aD M O M 10 M t0 N V O
1I7 O M aD O f0 ~ r N
~ O N M 01 t0 fD f0 m 10 G1 tD

r ~ N A M O N N N fD
O N V N ~ O N
t<) N t0 N M Of ~ N N et r a D r Oi ~O f0 r a0 ~ N N t0 _ N _ 00 01 O r W aD
N Y1 ~ N M N N t0 a0 V N N N O
V N ~ N N f0 N N O aD r N O tD N 10 10 u7 r t0 01 M aO cD
O ~ N lD 0D N t0 O O O h t0 ~ ~ r ~ t0 at N M N V h h N Of M 10 i0 M V N ~ ~ O O M
O N M V N f0 V

ID u'! Of O~ N r O> O Qf t0 V tD N tD O O t0 t0 N _ _ O f0 10 10 ~ t0 tD t0 It7 N
O 7 u7 N N ~O V V N N
0 a0 10 O V
~ O O O
O

r ~ m O N .
t0 1 tD N N . 0D tD ~D (O O
~ r _ ~ fp Of M r aD V N
tO 0D 00 CO ~ t0 ~ t0 tn V
~ N t0 117 N r W 0 t0 N

_ _ . f~ N 01 ~ N Of r N . N N N O N O
4D r r r O M ~ N N M Y r W O O O O 10 01 M Y O~ O O Q~ O N M
~ M
~
O
~

f0 p N N u7 N O
O r f0 . M f0 V Of aO 10 Of r O r l0 r ~O c0 (D N N N V t0 ~ N N N ~ O7 M r r- M N O tp N c0 t0 u7 V7 M ~ 47 t0 ~ U7 Of O u7 N N N M O V u7 ~ N t0 N N if N M O~ Il7 N N M t0 M M M M LO V r N 10 t0 N
M _ _ N _ _ 01 10 O . f0 . r Ql M f0 f0 10 (O
O _ . M . _ tD _ f0 ID 10 10 _ N
HI r r r N M f0 tD r 10 M N 'C Y t0 of (O M N ? ~ ~ N
4D t0 N lD r M Of 10 M ? OD N V t0 f0 ~f N
u'! M Op In t0 f0 fD iD (p i0 (p 10 ~ c0 Y1 M a0 ~ f0 M 10 00 Of N O~
OD
(O N f0 -_ _ _ _ _ u7 N _ M N aD N N N M
O . N M N N Q
CD . ~
. N
r !D G~ N N O N N N O O M N
r 07 O N N u7 M
~

10 CO 10 a0 N N t0 O r O aD t0 r- O . . ~
r O W O t0 Of 07 u7 aD O~
O t0 aD t0 ~ O 07 N M 1n r aD r aD M W l0 t0 ~ N t0 O f0 tD
01 O aD 07 ~t t ~

_ < _ f0 1n ~ O u'1 t0 10 ~ N ~ (O O O r f0 ~ (O 07 Of N ~ f~0 a0 V u07 V
V t0 M ~ r W L
M
0 r N

O ~ N f0 N N
W 1O 47 O O 1 ~ ~ N ~ ~ ~ N
Q) 10 M O M ~ ~ 10 ~ ~ N
~ ~ 7 ~ N r N f ~ 47 Y7 N ~ f0 M ~ ~ ~ M N r ~ N If7 N 47 N M ~ 00 N

N N r 10 t0 N u7 aD N N M v1 O N N N N N N ~
N Of O N Y7 Of H7 O W N h N N N O N N f~
N ~

N O r 4D N N 10 1W O t0 f0 - - ~ - O N
t0 O r N m O aD O M
~O - a0 O 10 a0 M O V ~O
10 u7 N W aD aD Of Of Of Of Of h - OD r r (O ~ r M O

r ~ N ~ _ ~D O Y N t0 ~ O O O O) aD ~ ap t0 O (O N M
W N t0 10 N ~ r O M a0 O M 10 a0 O fD
aD O

O r 01 c r iD O) tD 10 M
t0 M O O N M M Y7 O O O f0 N O fD (D ~7 O
fD 10 O O r u'1 t0 O r t0 r fD ~ t~0 _ ~ ~ Y07 ~ ~ Q~
f~0 O ~ f0 1D ~ <n O1 ~ f0 10 M (~O ~ ~ a0 u7 t~0 ~ r 47 tD O O t0 ~ M N f~0 t0 tD

N N N N7 ~ M N N N N N N M 00 10 N N M N N N N
N fD N N N N tD M 10 N ~ N N N '- N N 47 N N

_N

O O
~

U
O

N
N

~

N c ~ I
c o to g m U t a Z ' c Z F
~-U ~ E ~G 7 Q

p N

O N

V
O O

O O

1y LL.

a ~ a c n c . , ~

E E
~

o o c y v c a c .d U~ .?
N

O O
Ip n~ n~

. .

fp V (p N

uJ

~

U U
w c X 'e N

N V lL O

O ' O U

y a O N O C O
O

_ m ? ~ J
U

D v ~ Ur ~
A O) f0 U

Q

op t p r m V
O J

a p _ W ~

~ ~
~ N N

l0 r O
CD ~ _ 7 O. ~L

~ = ~ ' _ ~

01 01 07 p ~ O
, Of c d Y Y
O

!C f N !V W O f0 N d O

m I 0 m Y m ~ f~
N n O

C7 U' ~ - ~ ~ ~
~ n m t E E m E ~ E
' ~ E v n _ _ _ fl) a _ .N op H1 a .H
N N

C 7 C O C ~ C
c c A
~p N d d ~j .N N ~
~ C

O~ O O10 O'~Q. '0Q
C

a~ a a~ a~.,~ a o d j ~ j o ~ ~ lUtl y o t c o'~ o o~ o-~ o :

z z z a z o> a z .__ o~

~

v v W n u r r r r r r N N N N N N

M ~ r O c~

~f V Y < 47 r r r r r r N_ N N_ N_ N_ N_ r ( O N O N

_ ~ O 01 O N
4'f ~

~ O D M O ( o O

O O W W O O

IN M V M tD r r r r r r r M M M M M M

N f0 tD O
(O O f0 O ~ r ~O
O ~f O

~t t0 a0 O~ r u7 ID N
r ~O O
~

~ ~ M N O ~ t0 t0 O _ r r O O
N r t0 N O aD O
O O f0 W ~O
Ip O

c0 aD N O O) M N N O O~ M O~ cD O
O O O O~ 07 fD M fD 01 r O O C~ O u7 O Q) y0 t0 O N V 10 ~O ~f7 O_ ~ M ? O 00 N
M 1n M r ~l7 O N t0 N
1 fD 01 t0 aD (O
r ~f7 N

t0 t0 tD r O tD N N CV N N O N V
M c0 t0 N O V 1l7 Q) M
O) f0 O ~f N
V ~ N N ~O
N N

N N N N Q! u7 ~ O O f0 f0 tD
(O . f0 O Of 1(f f0 M r N Q N m r r ~ ? o0 f0 O~ 01 N t0 N M N N N ~O f0 N r r O
O t0 f0 Q7 f0 t0 O ~f Ol N _ f0 a0 O tD f0 aD O 1n O
Of M (O Of aD _ N O N O r Ip O O O
O
N

O pp (D N aD r O O N N (O ~ ~ r M
t0 !D aD (D M a0 ~ if V O O
r f0 ~ V
N t0 M a0 tt 1p W N N h 10 _ fD tD _ ~ ~ t0 (O V O ~ O fD tD ~O tD f0 fD M M N f0 r fD f0 O u7 r tD tD 10 r t0 r N

N N 0 N N N O V N N N N O N ~O
N t0 N V O '? N N f0 M
N N M M

~ O 0 ~ O _ ~O O ~O ~O O t0 r fD t0 f0 aD O7 N 1A 0D
N W t0 N N O a0 M
E V V OD
D ~ 'C
N N
V

00 N r N N _ (D tD a0 N Of 47 tD M
00 tD W N ? _ (D . N f0 Q) aD (O V
u7 (D

O Q ~ N r 07 t0 NN N ~ ~O O) O N ~ O
07 M ~O N O N M ~ N r M ~
N N O N t0 M O ~
t0 N Q) O N ~ pp ap O47 M N _ r O O M ID
pp (D pp M ~ O O M
' M
O
r r 4D 01 N O J aD fDaD Q7 O M N t0 O ? ~
O ~p aD f_0 itM ~D a0 ~ f0 O r O
r M u vt r M
N M tD O O
~O ~ oD
? t0 N ~p O <D N O> t0~ O~ O Of N O 01 O t0 N M O n!7 O tD O tD N O r ~ a0 r r u7 M
r N ~ ~ ~ N N N 4D N~ ~ O N N M V t0 N
u7 ~- V N ~ N M N h N f0 aD ~ CD f0 M O

~ N N N Of O (ON N N M N r N N W
r Of ~ V fD ~ N M O ~t r M f0 ~ N M N M
~O

O N O O O N u) G1u) 117OD r N O u7 O
OD O N 1p Ma0 a0 O M fp O) aD O o0 O N ~O e0 O V
M i0 M N N M r N a0 O aD V
O

O O aD O O ~O aD M ~OOD O (O N 01~t O r O CO
f0 M N 0D r (O N N f0 07 ~7 aD O aO ~ N a0 r r a0 r N O O ~1 t r M M OV O) Q) M N r M W ~ t0 vT 4'1 D lp V1 r Q1 O c O O fD 47 O 01 p O fD O V
O

_ V7V _ N M ? V ~ fD _ ~ N M ?
N Q ~O < f0 V c0 N Y (Ou7 Q) (D M
t0 t0 V ~ (D r aD ~ t0 ~ tD O f0 0 t0 M

N (O t0 f0t0 r N Of ODf0 tD M fD N ID N N M CO
Q1 M N N tD O cD r-f0 N O ~ N N N
c0 M 1n 7 t M
N N N N N f0 N N
N M ~ N M N M
M N

l!J W ~JIL L!J W

lL lL LLl1 LL lLC
~

tn t/7 tn(A fn N d g 5 gg ~ g a ' . p c 7 > >> > > o~

1I~ T
o E

m a ~-c a ~~

z E

~
o ._.

v y C N
'y f0 O w n C

N N
C_ T

C
O

U Q

o ?
a - ~

, , o Q' N Q N 7 o z m n o n o i Pj i O .-.
N Q C ~ U O M
(p N N
d C

~

M ~ O1 m ~ r C
~ t 7 M Of N N U O
U u!

E a E

~
c a _ N , u1 N

~ O M d O N n 9 ~
O

O ~~ r X ~ r _ M r O
a0r !
C O O
O
d . N r~ N ~ ~ M
r C d n!!~

a O tOOa o~ N ~ D D E
o 'nr M M ~
d --_ U
> m ~ ~ N N v f ~ Q - n a>Q
a r -C N ~ T - Q
'~ N '~'~ O) ~ p O O O
"' f0 Y O Y Y Y Y Y Y Y wj C
E d pp ~ Q C C
C L O d C
p C p C C C V O N ~p O n O f0 lO C O r O
(Of0 Y . C
= N f0 O
H

(9 C7(7 C~ U~ C7 C7U ~ n ~ N ~ N Z g c o U

, E'~EE E~m EK E=",E~E~
E~

~N 1/l N N D f0 N ~ (/~
C

c a c c c c c c c u, ' rn a ~ . I ~
E a~ ~
' 'y 'd'y ~y N d ..N..-O. ? V1 ~ N E N
~p O

' O r O O O O O O O tD
d M o0 ~ N p~
=

ar a ay a"' a m H

C O C N
~~ O
C

y O y p d N d G1d p A G) ~
~ N

> > > ~ ~
N ~ ~ ~ C
O m z a z z z z Z z z a> o m a ~Of a v Q
N ~ v iD aDO N ~ f000 O N V t0 ,p r r r r r r r r r rr r r r r N N N N N NN N N N N

O r Of M Or Of M ~

,n ,n cp r r r r r r r r rr r r r n N ~ N ~ W .v ~ ~ .N_.N

V N f0 tD ODu7 aD 07 a0N

r v ~ r o~a> ao v u~uo ~ n ~ n o~ ~ ~ co . i n .~

' v ~~ M ~ n n ~ r ao n c ~
C

m coao ao o~ ao ao m a~

c0 O O N M~ ~l ~O r O

r r ao ao ao aoao m ao m co M M M M M MM M M M M

N m aD ID tD OD h I f) aD f0 O O f0 O ~
ID

~ Q7 ~ ~ O 0WU07M aOD NMODU7Y
~ 0 70)0O

INaDCOV Olnp V ? _ O 0 V I~ tD a D a0 m tO t0 ~ N f0 D t0 ~ c U7 ? aD In m W

N M ( O O V N O V h h O M ~ N 1~ ~ 1~
00 M O N O I~ aD N 07 W O O) M ~f O ? f0 aD 10 c0 O V 10 aD

M N . 07 ~ V a0 t0 W!7 N N u7 M
aD f0 117 N 0 N N V 07 M h N O N h M O M N V < ~ tD O N u7 1~ a0 In O
N u7 u) u7 M N
f _ M N of Il7 D ID 10 ID N N N t0 N M O ~ ~1 ID
N N N Q) M V c0 a0 Y f~ N ~
? t N O f0 CD O 1n aD

<r 1n M O N N 1~ 1~ (D V h ~ 01 a0 ~ h N ~
M t0 ~_ ~ 10 O 07 10 N O M ~ O
N p7 u7 aD N O aD ~ 07 N O
f~ f~ 'C 10 ~
O N

G1 O f0 Iff ID aD t0 N M 07 07 a0 N t0 ~ r7 t0 1~ 1~ t0 P 1~ N

V N M N M V N O

Of N N 1~ Ql tp tD N O D aJ u7 N t0 If7 ID
f0 M M 1~ 70 N N I(7 _ t0 aD t0 ID G7 O C t0 ~ O O t0 t0 I
ID

tD N O) N 10 M h h N M M t0 ~! 117 If7 N O aD N O IC1 OD M N ~ aD O Of M I~
t0 M a0 N V fD ~D N
N M u7 ~
O M O (D
IA

N O ~ ~ ~ ~ m ~ M N N ~ V M O (D a0 t0 N aD 1~ c0 M OD N
f0 ~ O h ID 07 7 h O P CD u7 O N
I~ M O N N O of O N c0 O

O 01 N N tD u7 N _ N Ip r N GO N O N N N N t0 N ~ ~ IO 117 O mf1 N V N ~ M N

~ O O 10 f0 O t0 u7 h . t a0 .
N t0 t0 D 1O 1 fD a ~ N IA O7 V N N f0 OD
IA O N M fp O 1A f0 117 _ N ~ h ? N u7 ~ f0 ID tD
(O ~ O ~ f) f0 ~ N I t~
O I V 1f7 1~ 10 O f 0 N tD 10 O f0 N

O N ID t0 _ _ m aD t0 N ~ N P l0 N 0 ~1 O O aD O 117 M O
1~ N M N ~ 1~ 0 M N N O N I~ ~ N 0 O M aD of 1 ? N ID O M N Q7 a0 O 10 _ _ N ~t V N tD ~ M M
aD Of t 0 a0 t0 . < ~ O) M M O O M O ~O OD
f0 I~ 10 10 M fp O o0 O M M M
Q) aD O O V M O O f0 O
O a0 1(f O

_ 0 M I~ 1n M N Q1 V M ID '? V 10 M O
f~ M aD 01 N V h ID u7 ~ f0 a0 V ~ a0 0 N M st 07 ~ 1 M O c0 O O O ~ O tD O
N 117 N ' h t0 tmn u7 s< O O
t t N 01 t0 O 1 10 01 O 10 f0 N M f0 f0 N ~
O tD ILf N O In t0 u7 h ~ N N M ~ f0 f0 0 00 N t0 O f~ u P 10 f0 N a0 t N N N O N N7 N f0 N N
~ ~ N ~ N 117 N f0 ~ N M
( f0 10 tD M t0 fD M N N
N ~ Of N 0 K7 M Of M N t~ 07 N h 117 N t0 u') N 01 N Cf N M 0 N N h O) O t0 117 a0 N V 1 N O f M ~
CD

r N p7 (p N N 117 N N ? a0 O N N M O N Q 1 M 07m ~ . ~ N . O a~ ~ N of O Q7 M M f0 ~ N O
~ 1~ O M aD QI 1f) 00 fD
1l) O a0 N O O f0 D P f t 1 O a0 N 07 OD C

47 a_D t f) O a0 aD ~ _ D c0O
_ V N h M 07 aD _ ~
10 10 N f~ IA D 10 aD O ~ O (D Y7 ~ M I c N 1~ aD M aD t0 I
~ 1n 1 10 M 07 u7 O ID ( f~ M V O D N V O u7 M _ V ?
O O If7 tp h N ~ Of h M M 07 M ~
~ h ~ M O t ~ 0 10 N M M V ~f ID ~f D tn tD ~ M C tD ~ fD ~ ~
N V
V

N M ~ O 10 _ 01 N ~ N O O f0 O N t0 IDtDf0 f0 ~f M 0 M ~ Q I tD f0 In N M !D fD f~ N N N
f N 07 fD h tD fD
~ O7 W fD l0 N (O M 00 N
ID M t0 (O N ' M

(D N N N U7 N N 10 N 7 N N M 117 M ~ N
N N M N N 47 N M N ~ M N N N N f0 11 a0 N N N

W ~ W

_ _ g g g g U U U

a 7 7 7 a7 o c o o o a7 ~
a7 d o a m -- a u7 c C .

C Ol L R

' E
~

o ~
In a a an D~ 7 c a c c ' _ c m a7 t ~

O ~
V U

d G C d N

N
N C C
O

C C
~ O ~
C N C ~

l0 U
C

C w N p7 ~

U U
Q J

U N o m c ci w E

J i N
~

C O O
~ O = M f~

CD N

D R Q ~
W

v UJ 7 a N w o (n fn ~ ~ o a a O O N ~ t0 n ~
J

c0 = O ~ N N
= ..
N

I

'o-o= ~~ Z ~ 7 ~
ara O Y N Y7(nHY Y..~.
C

C

O m d m O U

C7 O ~ N U U d Ie ~

E
. ~ cn a ~N E U N N
Q.
H

~ Y c = S ~
~ Z
~
~

. 'y m O o J o ~ ...
u!
o ~

ao'o aM a~r~ a E

N O N O d ~ u1 Iv~7 ~
N

m ~ ~ Z
~ ~

Z ~ Z Z
07a m m ~ ~ W

N N N

N O M a00O 000 o r a m n 1-r n N v N v v N

Ic o ~ ~ n ' n o ~ M ~ ~

a a 7 o N N ~ O IOC)1 p ~ _ O ~ W
O O

N
~

M M M M M M

cc c r: Iri a6 v f ~

_ n ~ ,Wn ,~ ao o o In r v O O O M N
a0 O r u 7 ~ m ~ f0 01 a0 ~O
~ V f0 m V V
(D f0 O O
O

N N CD N O f0 (D _ ( O O 1~ f0 a M C N M N N
D OD D (O 0 ~ ~ n [~ ~

~ _ _ ~ t aD ? ED M
_ N N N ~ (D M f_~
i~ ~ M '- f0 t0 V M
tp Q~ . O~

M O 01 f0 u7 M h N Iv t0 Q7 N N h N ~ O
~ Of O) at ~ 1~ Ip ~ tD O
M

M N O ~ N ? M OD N N N V (O ~ ? N
N a0 ~ (O OD aD M aD
O O

~ O
M O~ O tD iD O c0 IA t0 a0 aD O t0 m ~
N 0D ~ M Of u7 t0 ~ tp t0 M
1~ Of N N N O (O ~
f0 If7 I N O N N
m l0 M O 47 1~ f~ (p f0 N c0 O N N
fD N aD . A N V aD O M
O

_ Of < N V N p O~ N ~ aD ~ Ia7 Q~ V I~ C
1~ c0 M V a0 V N N N 01 0 M O CD
u7 tD O t0 ID a0 fD O N t0 aD M tD t0 O cD f0 _ N _~ O 10 IA t0 f0 IA O W Of O N N M
N O ~ a0 M 00 ~ t<) 1~ M st N O ~ O M
1n N N N N O f0 f0 O h ? M <r cD Of V r 1~ M
~ tp f0 Q

N M N tD ~ O) M If7 M
(O W OO O) t0 M M N u7 1~ N ~ f0 ID O
OD Q) M OD O N 07 a0 1~ f~ t0 ~
f0 10 P t0 10 (O
ID N O
O

M
N N O N N t~ M M 0D ~ N N tD ~ N N O N N
a0 N et ~ M ~ M N N of Of ~
t0 M O O O t0 O fD t0 t0 O 1~ Ip N O O
f0 1~ 1~ 10 f0 ~

07 CO M 10 f0 N N f N ~ U) N7 1A ~ V N c0 10 a0 O) N N M ~ N 1~ CD N N N f0 ~ IA t0 ~p M
O) N 07 10 M
t0 If1 10 4D aD

p~ N cD t0 a0 cD O 07 O GO N N fv N O N O W O t0 r_- N N O m N M I~ M N M a0 Q) OO OO N 01 O IA OD
N N W IA In 4'7 N f~

a0 10 c0 O N c0 f~ 00 O . ID N O N a0 1~ M OD OD Of N M '- N 10 ID O
h O O N O CD O V CO
O t0 O7 O

h M O ~ N M 1~ h 1~
N M O O O ~ (p 1~ a0 In O f~ M 1~ O h O
N p M N M V fD a0 ~ f~ P M
N Yf f0 (D N

f0 N W O O O 10 M tn O N 07 tp O O Of t0 N
op O c0 fO O ~ t~ aD In O V'fO t0 f0 tD I(7 ~ In O

N N V 1f7 N M M W _ N N N u) ~ fp fp tp N
If7 ~ N N D ~ r- ~ ~ ar m ~ O N
1!7 ~ 01 ID fp ) f0 ID f0 M c0 f0 ID

c0 ID c0 tD O _ M _ m N N N N ~ ~ N N N ~ 10 N N N N
N N 1~ M N 10 N 00 N N M N N
N N 10 1~ N ID ~
N V

Of N 1~ 1~ N O 00 1~ OND OND N 10 ~ h N N P M O O aD O1 O t~ n CO M OD 100 CO O a0 1~ ~ ~ M
N O

~D N O O ID Ic7 N Ip N ~- O 10 ~ O ~ V
O ~ t0 N u7 M O~ 1~ m cD N M ID O~ aD N
N O) N M O c0 h O~ '- O
h M O) O 01 O c0 c0 c) M O f~ ID 1~ 1~
tD O O OD O 1~ h t0 O t0 N Ip ~ O ~ fD O
~ O

N O f t (O m ID _ INti(O U u7 0 f0 10 f1 t0 t0 (O O Q) tO tD f0 f~D l0 (O t0 I ( f0 t~0 O u07 f~0 n O N tp f0 00 N fD N N M N N N N In N N N N (O N f0 (O
N In N N M N N N N N N ~ N N N tD
In N In N

u_1 I!J l_L L L

L_L L_L _ _ I l L L

_ _ g ~ 5 g g n o ao o~ o o n o d_ d_ a_ C N C C

C

E v v C ~ C C
C

. .N .d N A

.. O 4 . T C
O O) d ~ d N
t0 v O
c o ' E c c , c ,~ ~~
v U (n U U
> 1~1J

J C
~

J Q

2 0 ~ U c In r~

a ~ F-_ a, --yv - ~ G
w ~
-o t E = ~ c w Q O O M m ~ C

117 C ~
f0 ~ ~ N

E t ,~ m n d N N ~ _ ?

. d d O O J W C I~ O
O f7 10 N E

p .
p O C ~ O f0 In =
N

U N

r' ? U U aD N In N
Z O

N u7 T ~ N M ~ 1 E O
d N O _ _ N O

y y L y y y y y a d C C d r N N H

N A m N 10 CI m L 01 m o C ~
O

C9 C9 a ~ C9 m m OD
C7 (9 41 .
N = p ~
V 'n N

( tp C N O N In N N N
~ ~ O T
~

c ,y c a c c c c c ~ N v E t p ~ ~ ~

= E ~ o a? d ~ _ ~
i. In ' Ie ~ 2 o ~ o ~ o o o o o L ao M In a a a ~ a a c a a a ~ ~ o o o < rn - d Y

O ~ O ~ O O U ~ ~ ~
~ ~ E J

Z tL Z a N U
N

Z Z Z Z Z
of Q t a c ~

W Of O ~ O

O

N N N N N O O O
_ N N N N

M f7 I v p~ M l n I ' I
' n n ~ N 0 0 , c a N N N

O ~ Of N M M

p O n ~ M O

_ O
(O M M M

~ N
~ N D
I

_ ~

~ 7 ~
Q

ID n p O
o O

O O O t V
V ?
' m ~ . m m N O n0 M O V

N . h tp m O O . O . . 07 '- n O n n N O M N . O O
~ m ~ n m m m M m N O ~ V m ~O 0) m_ ~ O n .- f0 ~ u7 M
V ~ m O . Y N m tD m N m ~ m m 07 N O n m tD . _ m m ~n m O V N O M N ~ ~ N V fp 10 V N N N
N vt N n 10 M N ~ Q
'- m tD N M . . n . m M m m . .
. . M m n u7 m N . (p m M IA N V N O) m n m D1 N M N N r- 01 n ~ fp ~ M M 10 m M ~f ~ ~ N

M M O u') p N O m m O N O m M O fD
a~ . ao m V' .- n o W ri o o n m M c~ co . o o m ~ o~ ~0 0o ui ~ M o m n N m O V N n ~ ~ < ~ O ~ O m W p 1!7 m N N M ~ N m tD ? M f0 (p . N 07 m . N m m m m O) O) m m m m O
O . . a0 . m O m m ~7 tD 00 ~ V m N N N N at 'C N N M N O
N m M N ~ N N ~ V 7 ~ ~

m ~ (D . O) - . O . . _ fp ~p _ m N t0 M m _ m m N N
N M N N O M m ~ f0 N N N N n ~ fO In m m N m M N O N N N

tD M O ? _ m t0 O7 N M
V ~ M O m ~
n ~ m O O n ~ Gf O O N m N m O r M n tD Y7 Qf N (D m O m O t0 f0 n V ~ fD
m N O n N N eyfl ~ m O O ~ m m V
m N N N M N ~ V ? M m ~n . o~ . m m m . o~ rn o o ~ o m n m n . cc . m co m so m ~n M m t0 ~ O (O N N N fD ~ ~7 ~ < Q~ N ~
01 N Q~ N ~D ~ N N N ~ ~ _ (p . N ~ M N M m f0 f0 m ~
m O O Q~ N . . (O . m fD
. n . O

h m N M O m n m m M N N N N N M N N
N ~ O n m t(7 V m ~ N N
O

n ~ . n m ~- O M V . . N N M
O N m N '- V Oi W m m N Of r t0 O M m O W O fD m ~D M (O
V u') n n M ~ ~ ~
n O (O ~ O
n ~ M O ~ O N M < M a< m O O u7 t0 00 ~ m O m N m m 07 of m M n ~f V M tD tD
O O~ O> N ~f ~ O n n ~O m m O tD M N 07 m M m u7 t0 m ~D ~ ~
N ~ ~ <D W n N

O N Q V V N N N ~ N V O < V ? m N N ~
V M N ~ N N ~ M N N V ~f ~

m . tD fD m . O . . M m cO t0 f0 t0 . tp m . . cD N . M . . t0 m t0 n0 ~ N N (D n m m ~ N N N N N N M m N
N M < N u7 O M m O IA N N N
M

N _ . N m r- W _ t!7 . O ~f1 . N
V _ n (p n N . m u7 O~ n O n M m ~
m m o0 r N ~ ~ O M - ~ m N O~ n O O O m n M ~ m r m v- O r- O m ~ m ~ m m O O 10 m m O ~ O
O n M m tD m (D 1I7 O n ~O N M m M
N

V M u7 u7 07 O) ~ ~? 07 ? 01 W n n m fD M f0 m N n V (~O O O O O) m ~ 01 u7 t0 ~ t0 O7 ~O tD u7 M ~ 07 t0 M M ~ m O t~0 fD t~0 t~0 (O ~0 m m ~ m ~ (O (D m O O cm') ~ ~ ~
~

( f N N N N N M m N N ~ N N N N N N N N t0 N M m N N ~ M N m M M N N N N N
N

p W

N y N

C ~ C E

m U ~ n U E

m O

O m O M
O O

O O

l1. LL

a a c c E E

a a c ~ c a> o 'a>

O O C

O a~,a na 4' c o c , ' e m - m a o C7 0 U u1 U U

c N

O ~
D

d M D_ to t' ~ - . a v 0 O m a~ ~

M Sri u~ ~ Z
X m U
nM

N o _ o MLY _ N M m w~
d _~ o p m ~

u v YOU
'a 3 ~ a~
~

U Q a mo Y c aa E

v ~ ~ c Q ~

~ U Q W Q a W
Z

~ ~ _ ~ Q W W
~w ~ m H r _ o.s m _' g ~

O ' _ h O ? N O l1J
O O N O
O. ~
N ~~

E G C
O ~> d m Q _ N
N

O V N a N N I H
d V U p d O

01 O d Oi N 'O! 01 M
O! n Q' Z
~ a Q
'p . L Y N Y Q Y V
Y d Y U Y W v O O Z
L

t U ~ p Q ~
' o m C m j m m m ~
O O U lL
N N C M
m N 7 y 7 N
~ a ~

C7 E ~ C C7 N C7 C~ Of ~ j a ~
c E~ ~ EE Ec E
QO

N'o~ a~ ~ ~ O
o C ~ C C a N C ~ C C d N C =

~ ~

~ N d a ~ a~ ~ ~d , ~ c~ 7 N ar o X a c ~ Q
7 ~-.

' ' ' n ' a 'o n a a-MV~w .M a .; n do y oQ "

N a o 0 o a U
H E H H
o ~

O N

Z Z ~ Z m ~ Z 7 Z -~ d U a Z 'Of a a Q a = d O N Q t0 ap O

N
m m m m a0 m N N N N N N

Of M u7 n Of O
m m m m m m N N N N N N

n n 'o n a a o M m ~ o o M m u7 N W < N

t0 W t a O O O O O

V ~f ~ V O
?

N 0D N aD c0 ~
O
N N

00 aD a0 f~ ~ Of < a D O c0 O

N _ M I~ M O CO CD N ~f N N
aD (p O N O h h aD M ~ OD V
f~ O O M 01 N

_ N N M t0 (O tp u'1 07 O 07 1n f0 N Q u7 a0 f~ t0 aD 10 N N M O N I~ O N
1n f0 1~ f0 fD O h ?

N N fD N ~ N t0 N N M N ~ U1 O1 O N V V <Ot0 N ~ f0 Y ~
OD t0 1~ c0 O~ 1~ f0 fD O c0 cO M

07 O h cD t0 01 N N N ~ t0 M ~ P N f~ O ~ N fD
O < N N W 1~ N ~ N N
aD
~

O f0 N 1~ O
O O 1!7 t~ p ~ ~ N OND 0D N f~
W f~ O O M ~ N ~ fop N M N
N N
N

O O f0 f0 < GO t0oD GO N fD
m ~_ f0 N f~ h op M M N O
f~ O) 01 O t0 N fD M aOD ~ O
f~ O N f~
OD

N V t0 (O < ~ N N ~ M M O u) (p Q7 V I(1 N aD N ? N O
N t0 N V I~ N N M O~ Of ? cD
h 1D f~ ~T M twl7 O f~ c0 1~ ap Of t~

N N fD M !O 0D N N N M N N f~ N (D
f N CD fD fp V7 1~ N N
IA (D
O !D N (O N
~ O

O W f7 f0 O In f0 f~ a0 N 47 N 1(7N
O ~ M ~ ID N (O N fO (D
N O '? ~ ~ O O fO N N N

_ N ? tDf~ C~ N O M 00 t0 O N O aD Q) In N u7 Of OI 0D tn M
tD N O V M N N ~ ~ N
O 0D !D
N O
N

a0 N O aD _ N W ~ N _ ~ _ (D
h N (O <D M tD ~l7 O
P M N M W 1A ap n N M ~- Q) O
O ~ O N N O fD aD ~
'?

N M aD M ~ f0 00N V M 1~ OD f0 CD
u7 <O 0D tn fDO O ~ tl~ st M t0 '? cD N t0 O f0 h an N W f0 Qf f0 N f~ t0 f0 f~ W f0 t0 M (p t0 ~O a0 lD

N N ~f N N a0 stO N N N f0 ~ N p N M ? N ~ at N ? N cD N
tf N

~ Of 1n O lD N 10 47 07 In Op N
N O N h N ~ N N 1~ N Q1 f~~7 M N 1~ M

O~ aD h M Of _ tD N 1~aD N ~O~ONDO ~ N eN-O7NQ71~ON Of ~

O N f0 ~f7_ O t0 V 0D t h I~ 1~_ t0D r f0 1~ M ~f V h 00 a O O t0 aD 0 N In N N
~ O O M V O ~ O I~ M ~ O O (O
Q7 D) et O ~ (p M
O

N V N ?_ ~ tD O N M ~ O Y1 Q~ f0 ~OO~ M ~O (O'? ~ t0 ? '?
M N (O M N t0 N Of Of c0 N O f0 f0 O N (O f0 O (D N tD
M (D f0 ~ (O O
OD

N tp NN N h N N ~ 1f7 N N N N N
N N M N ~ N N N N N N t0 M N

~

p _ W

N ~ L
L

U _ _ U~ U

~e ~r o ~ o O N
O

p O

O O

a a c Q c c ~ ' ' ~ d m m o o E
m m .
a ' d v o c ~ c c d 0 0 o n'o a m r n '"

c E c n c a~

c_ C C ~C C
V

U ~ U Q U
~

O N N C

Q W ~1 ~ N O
N ._..

C

Z O 't O ~ ~
"

m 1(~ N
d m ~

p ~ = ~ a~
E

N O t0M

U

= z E E w N Q

N fn ~

Q ~ N N n N d Z W m c0 M ~

W Z O C D F- U
Q D

O 1~ 1r N I~
'~w ~ tn N
N

M c c ., M Q ~ O C7 A _ 'O C
Z 111 ~D) N

Y Y l0 ~ m ~ N ~ m a ~ w ~ U
U
~

M ~ Z ~ Z C7C9 N
~ ~ ~

'~ ~ E E ~a N

. U
.

U Q ~

~ H d c d ' = c ~

~ "i d n ~ ~ a~'d m ~ Z a~ Q o o ~ r- o a o 'Z o 0 ' a a ' a~0~n w Ho a d ao -C
~ v Y ap M c c a N > > ~?
~ > ~ E v E c . r cn Z 'o~ Z N m v Z Z n v ~ ~ c, a p~

N N r ' ~D ODD ~ O
N CN N N
N

n O

N NN m N v.~ N.N

Gi~ O D
a t D

O0 ~ p 1 c c0 ~( ~OM

n <
O a 01 ~ ~f r' N~f f'r ~ ~~ V ~V
V ~r ~

1A O N O) oD n N O t0 a0 n N aD

O~ ~ u7 (O 1n . O t0 (p tp tp r O! . O ~ _ ~
N . (D 07 M

M O O O V O W t Q t0 O n n O O ~ O N VI V 11~
M n ~7 11~ a0 00 oD f0 O f0 fD tD t0 c0 tD ~(7 a0 a0 n tD
t0 N cD ~f _ aD O Y'l O a0 a0 O

O n m n ~7 N O N N N ~ O ~ O O O~ n u7 ~ V7 Of Of O O O n t0 N c0 07 M M t0 N

N c0 O c0 - W 7 ~ N N M n W 07 f0 N N f0 (O ~t o0 Of ~ N 47 N O a0 ap a0 ap N N Of N f0 a0 M 00 t0 u7 N f0 00 M u7 ~ 07 07 c0 OD fD 1n M n N n O
n m tD r-N M ~ M N tD aD N N ~- N a0 _ ~ t0 tD a0 ~ _ N N M N O M M n ~O N
c0 at (D M a0 O n f0 (D O N c_0 n cD o0 ~O ~('1 M O aD
n t0 N N ~- O yf7 V V (O O t0 LO
n O M N t0 fD ? W n n n ~ 1n aD N (O
N M et f0 ~- CD ~ N aD

O a0 N . ~- n ~ n O n ~ ~ O . N N O . .
n f0 f0 tO f0 N N . n . O . r- t0 . of aD OD

_ ~D a0 M ~ Of O> t0 N aD ap f'~ N m h ~ V N N N n O N aD M t0 a0 aD ~ N
fD O O O '- Y N M ~l CO f0 O O aD f0 OD n n O m N ~ d0 N N N t(7 N
'- f0 0D (D (D

O W M 07 N 10 cD n ~ Q) O (D M O aD ~ n N OD M M O ~
O ~ ~ M r- M N f0 < O 1f7 n t0 a0 N N

f0 M ~ a0 N O fD aD o0 ~t O f0 a~ N N M M O t0 ~ < V
N ~

c0 ~ Of 07 O~ n O f0 N O O ~ a0 (O ~7 N O M O O u7 O M O u7 M f0 f0 u7 V M Of aD f0 f0 n O fD
~ M N N O O OD tf7 ~ ~ N f0 N N M h N ~ r- 1A 1A N ~ M N N ?
~ (D N N Op ~ N t0 _ C~ O . f0 V _ _ a0 . O (p f0 . c0 O . . (p O ~l7 M
a0 . . N N . _ (p ~ 10 ~ aD V ~1 ? N N f0 N f0 n t0 fD N N n N ~D
fD n ~ W l7 aD M V M a0 c0 N O ~

O~ O~ 07 Of f0 f0 ~Lf c0 O~ ~p aD O~ . ~ tp .
_ _ N tD ~ t0 . n c0 f0 O 1~ . O N M a0 _ ~ f0 aD N M n t0 O ~ M ~ N O n M O O) ~ N N n O r H7 n f0 f0 M O M n n O M OD M SCI M ~
N

op a0 aD tD _ _ ~p uW . a0 O _ f7 . fp ~ c0 N aD . a0 a0 (O N O _ n n ~ a0 aD O ~ M !D O aO a~ t0 '- a0 N N V fD
~- O O O O n . N N
O O
f0 O t0 O O aD n O O ~ a0 Of m ~fJ n a O '- .- O r- a0 _ P O N ~ _ _ O _ N N N O O 00 N (O O aD O aD ap In OD ~
~ M O N u7 n n ~ ~ ~t ~

00 N N O aD O <O O n ~ ~ Q) M cD _ aD t0 aD f0 aD ~ ? N aD fD N t0 n0 t0 n ~O
~ N N N V ~ N N ~ '- N N ~ ~O O tD ~ h tD ~ at ~ V '- ~ ~ N u7 N N fD (O N N
~ N aD u7 u7 1p 1n N ~
n ao ~ ?
o _ _ s cu n _ M . . ~ so . . co . N . (O of a0 ap ~ (p 07 M V ~O
. N 01 O ~ N K7 ~ ~ M N
N ~ 0D aD N N aD 4D ~ p N
N ~ aD O aD s< N V O a0 O~ Q) Of N ~ . ~p ~p ~ t0 N ~ G~ fD a0 01 N N t<
~p n O O O n M V ~ ~
O

M O Q) ap OO n M r N M n O O OD _ n n M M ? M O O n aD M M n N QI 01 a0 0p M
OD a0 0D O O ap f0 OD M 1n M N N_ n_ O n O M
(O t0 ~ a0 0D M O m 117 aD aD OD (p (p OD 117 n (O aD n M (D N Q1 f0 OO

O_nnMOOO_OnfDOO~O_O_fDnn ~ NOO_NN M O_OOG~nNMM~O_Q~u)MnOMnn N N M V N V7 W T O ~ ~ p M O tp N V M M (O M V Q
O O ~ M W
) f0 ~I N ? N ~

_ t0 f0 (O C~ _ _ a0 (D a0 OD ~ N N f0 O~ C~
aD N N Of (D c0 aD t0 M aD (O t0 O M O N (O
fD f0 N CD OD f0 O N

~ N N N N N ~ N N N N N N N N '- N M N N N N C7 ~ N
N N r- '- N tD N N N N fD 00 N f0 N N
~

a a N N

N Q N
~

U U
O W O

N [y_ N

N N

N g N
N

V ~0 ~j fC

/_ Z 2 E...C

N Q ~ N Q Y

M

n O

O

a c E

o c a '~

c o a' a o c a o ~

N
N

C_ 'j ~a C

O N
U U

E

o -M ~ O ~
C Q

J O N
a~ y y Z

~

~;, o E
~

W n O U ~ N
a M ~ r~ ~ ~ ~ E
c c U ~ o o~

ti C D ,~ V'- N
~ .

Q N r a 7 U d N J d N

c E E
E Y o ~ n Z o d w '~ w d a ? m i D N a O C lL N 01 .~ N 7 ~
N N a ~ n n ~p f- _n N N
N N

QE ~ NA O. MCINL E.L-.

O _ -_ _ -_ I O N O
~ O O N Q ~ O E

O d ~.jZ

C ~ C C C C W 1A
O N C d c o m n . m m m m r m o m 0 U n r C t1 m U
m O~ N X p O

~ f= ~n D E
I

E ~ c E E E E ~c Q ~ -~ U
n ~ Z
~

p ' N ~uN~N N ~
.. C

O lL
c o c c c c 'E r ~ N ~~ d d , p W t ~ ' ' ~
' ~
' ' n a; ~ ~ ~ ~n 0 o v o>

o~Y o~ o o o Y ~No ' ~ n - ~o = a o a a ~ ~ c ui Y
o n a' ~
N r _ ~ O _ O t0 ~ 01 C d O Q T
N O n -_ . N _ ~ (O ~ N Z H
O. O ~ ~
.. O ~
~
m fC

~ Q L ~ ~ ~ L ~
N ~

Z Z Z Z Z
or o~ W

N ~ (p CD O N

M M M M V
~ O ~ ~ O

N N N N N N

M u) n Of M M ~

a a 0 N a ~

D ~
n O N t0 1 f c v n co m c N N Of ~ Q1 <
M c 0 u7 n N n ~t n n n n v W m ao m m ~
o lyo n_ co c N N

~t ~ ~ V ~ V

O

ri pp pp 10 N !O O O f0 M N N

i17 c~j01 1~ t0 M O N O N O n O aD N
_ O (O

01 O V O n aD O W ill u7 l0 ~ M c0tp n G~ V ~ O O V O
N

t0 (O O (O _ cD n iD O (D t0 M u7 ap N 01 ~ N N W l0 O N V ~ V
~ ~ O O 01 M N ~ N O
N 01 O a n N N
O n fD N t0 h n O

aO ~ iD O~ 10 _ M iD ~ i0 M l0 O m N iD f0 N n N m N M N
N V N O M
n n ~ N Of N O n n M f0 O Q7 n O 01 ~f V7 t0 O n O f0 N ~f M N N
i0 N ~D N N N ~ Y7 W N N
aD O) f0 ~ N N N O ~
M N

f0 ~ O O f0 n N O O f0 O M O O i0 M O M
(D i0 N

O O n O ~ ~ N i0 n N n ~ 4D ~ V 07 f0O
n O~ N O N lD f0 Qi C ~ f0 N

~ ~ N Oi t0 N n a0 O t0 f0 O tD i0 (O
n tD (D N O n ' N N ?

CD C_C V N (D Ql fD _ N 10 N < n ?
N n IO aD N O M O) N N l0 n fD O iD
N V (D O fO W_ f0 t0 GO N ~ M N OD cD 00 N .
f0 CD M cD f0 lD N M N ~ f0 N N M ~ N ~ h n N n N O N
n O ~ tD O O N n (O fD U1 O
~ ~

i0 M 1(7 f0 (D ~ M M _ O Q~ _ 1n n N O OO fD uW O N O M V W f0 10 i0 O c0 m n W m M n f0 N O a0 Of Cfl (D
W V a0 t0 M M f0 !7 O
f0 O
( O

CO Q1 N O G1 V tp N N ~ N ill ~ _ _ O) N 01 ~ N N tD t0 N ~ N a0 N ~D ~ M

t0 cD 01 O ID ~ O O _ tD iD O tD tp fD47 N N t0 n IO ? N ~ N f0 f O O UW O N ~ N W N ~ aD
N h ~ M W O f0 aD n0 ? N N
O N f7D

a0 t0 N t0 M t0 _ n fD tD f0 t0 O
N N u7 lD Of N f0 n f0 ~ O N V N ~ N
aD N M Q) a0 O lp 07 ~ O
n O 10 O) O CO l0 N n N O
N n M M CO O

t0 f0 ~ n aD i0 t0 V N f0 47 N (D
i0 00 aD i0 O t0 N
M

_ Of Oi M fD Of QOn M M a0 O a0 N W a~ O t0O
n ap O O N O O O M O O l7 n ?
O n 10 (p aD M O O if') u7~ N M M m 01 ~ ~ W (O N _ W
~ O O) m 01 07 a0 01 N U7 'C ~0 (D

1n V O Oi O f0 i0N N Of M cD lD cD it7M O Ofi0 i0 c0 01 ~ c0 ~ N a0 c0 tD O O ~ O v0 V_V
M ~ N ? i0 N ~ N N ~ ~ O N ~? N ? fD N 0 t0 N V N N ~ N ~ W N M N ~ M O

N N

1A f0 tD fD c0 tDO O fD i0 f0 f0 O (O ~ f N
f0 N N N N Of N (O CD N l0 V O N . tD N N N N
N ~ n N N n Q) V h V c0 N N
N N ID

n N ~ t0 N W N . (p O M i0 a0 . 07 n . O ~ n O n O c0 ~ n iD M n aD O~ aD Q1 a0 (p N ? W M O N
~O aD ~D ill O O m n O Q~ n u7 n u7 M
N M ~ n a n cn _ o M ao ao o ~ ._-a~ la ao~ ao 0) c0 o ao to O ao ao co is m c n o n soN f0 O ao a~ to V n M O O to t O7 ~ O
M 07 W fD O ~ n V n M O O O n O ~t fD O O N f0 u7 ~ n O 1(7M V V O 1!7~ N M ~ 117 N M i0 _ ~f ? ~ _ V V
OD ~ V 01 f0 M O ~ M Y V
V ) ? N aD

i0 ~ O~ l0 i0 f0c0 N Of f0 _ cD tD c0 iD aDlp (O
in c0 n 07 t0 c0 M M tD N O) f0 lD f0 tp cD a0 u7 u7 c0 117 N N N N ~D N N N N N N N N N i0 N N N ~ N N
10 N N N N N N M 00 N N ~- N N N N
N (D V7 N W W l W l l_L lJJ

fC LL LL_ C lL _ N LL LL
l1 lL

o g g g g g ~ 5 a~ o. a o =

v N U U N U U

z 2 z z c _T z z L z z E 7 NN ~ 7 Y O 7 7 N 7 p O~ O
N O C O

p ~ O

O O
O

LL O l1.
a a ~ a c .

c c c o E

' m l' m 0 o v y o v c Y

C C C C
~47 'y f0 _ N
~N O N

0 0 o n o a na c~
a a _ a c o U ~ U tL U
N

- N j( N

y N f9 Z !Np ~ ~ ~ ~ ti! ' O j j .-. in a m a r- in m 2 o ~
O
~

3 N H ~ O O ( T l0 p f0 U ' ~ c ~ v ~ ~ v a n E ~

o> o, N a _ m . v inv ' -- y c O a c c ~ . a - N

~ c d o ai U in U ~ ~
. ~ c l N (Ou! ~ J m D ~ ~
~ r 7 E O

0 N 7 A a E ~ a o c ~ ~ a in U mm L n o. > m ~ n ~ , a_ a~ v --, N y o t E m ' m n to ' v ' ~ y ~ m O o m o J i0 M W M
, -J aD O~~ j i Li i ~ ~

O n r. O n c ao ma v o N CDE
N

o O N ~ N l1 N _ V ~ V N
~.

-_ a -_-_ _ a _ _ . i t _ _ _ U d .
E

rnt m _ J o m E

Y Y ~ Y Y ' o Y Y Y Y Y
~ N O Y ~ U L N ip N d C C C C d C C C C C C
- C N ~ f (' (n N N N
01 p O N N N L ' "

ip tp fpcp C i ) ~ CD C~
O d ' CO CO I17 C

CO m m m 10 ,~
p vi ~ o N

~ U V ~ U U O U ~ U U ~
o ~ a ~ o s m f E ~ E d E E E E E
- E E m d a ~
E ai ' a ' ' c 'N~ a ~ ~N ~N 'N ~N'N
~ ' ~tp V) - a ' O d ' 'N C

t/1 (/l 3 C , Cad ~ C N C
C C C (A ~N C ~ C~
~ O C ~

_d _ _ _ _ N _ _ 'NO
N , ~ C1 u) N N
N ~~

y n C p ~ ~ ~ ~ O ~ .
O ' N o n o o o _.
~ o to U
N
a~
o o d o o, o o U ~ 0 o M y 0, N. a ~ a a = ~ d a a a a a ,' o ~ v ~ ~ ~ td a ~

y d j d N e0 N _ N > N > >
0 d 07 t0 C~'7 N j.Z~
a > U N

i 0 ' oEo 'o" t o~ o o~o>o ' ~ ''~~ 1l ' o-~

o ~ o zw n - z'c~a z ~ zaz r0 z z'c z'c~~ z o z'm_. c lp o0 O N V 10 aD O N ~ (O c0 ? i0~ 47 N O c0 iD i0t0 10 a0 O m m O m ~O 00 O t0 a047 OD
N N N N N N N N N N N N N

M K1 n D1 M N n O M 1l1 n ? Y ? 'CK1 N uW l7 M tD (Oc0 f0 O O O ~ O m O ~ O O

.Nr ~ v v v v ~ N N .N~..N...Nr O ~ i O O

O l0 N a0 O M

n n t0 M ~ O tD O O O ~ n ' pp n N N n M t0 M O M u M
n O O i0N N N l0 M N f07 O

Of N lDM N M a0 n ~ ~ tD n co in in o .r n v o n n in 0O c0 07 N Of O) W a0 O a0 l0a~ N

(O n a0 ! O N M

N N N N N N N N M M M M

V ~ V V ~ Y V V V ~t N OD c0 N a0 N
O ~ 1~
O

t 1~ 07 N ~ ~ V (D CO aD
D 1~ 07 1f1 O) 01 CC O N O 47 t~ of ~f tD ~ O K1 ? 1~ O ~f I~ fD
f0 V

N ~ _ fD _ t0 M O h _ O O
V Q~ Of 1~ h aD ~ t0 - fD (O N
M ~ P O N N f0 O N (D M a0 aO
h ~ u7 h O M 1f) P (O OD ~ u7 ~ ~ ~ ~ N I~ O O O (O M f0 (O
p N V
O f0 O 10 1~ V a~ ~
p N N N M tO f0 O M

01 O f0 O f~ O Of - a0 (O f~ N O N aD N M Of M t0 O V N N
O O N O n t0 M t0 O c0 O u7 M

~O 1~ sf ~O ~t7 N t0 N ~ N M I(7 M N 1f) N 10 O ~l tO W O_ N < Q! p N N aD N N
M N (O 0 f0 (O (O M fp M ~
f~ t0 M

D t0 O 1~ fD M fD M f0 1~ 1~
Of t0 N N M N aD tD C1 O aD O
fD N 1~ c0 ~D O N O 1(7 t0 c0 Ci N O N O ~
c0 ~ N aD N 1~ h Vf ~ c p O

Q1 M O O 1I~ t~ N D) ap Gp 1n O - O O (O Q) O
O - h aD 1A O (D
Of V aD O~ V ~l aD f0 N N O N O ? ~ ~O ~D N
O O 1D u7 Of O tT nf) I~ O ~ m V O < W
a0 N O O O t0 a0 N N t(7 N M ~
~ 07 ~ O f0 1~ c0 N N t0 ~O m aD t0 f0 1~ a M N ~l7 tD N ~ V O N N
D ~ 01 t0 h ~ N M N u7 O N M O~ N ~ Of O M
O M ~f7 1~ aD M ~ M O O) Q~ O O
1~

_ M N V t0 ~ V t0 ~ N '- (O ~
N < V tD ~ - aD O oD (O a0 O f0 O t0 M N t0 O
at N O u7 1~ h t0 O u7 O t0 N M O
N M tD t0 m O Q1 O ~f7 O
0) t0 O t0 N ~n ) O
~ ~ h N

N M N N O W t0 N O N O _ _ 01 ~ N N c0 O _ O ~
tt N M N t0 M O N N a0 t0 N M !~ M M N

Of O O h <C W f700 01 ~ O M ~t7 O a0 N M p O
fp ~D
(p a0 N O O ~f7 N u7 ? f~ ~ f0 ~O O~ ~ oD ~t ~O V nc7 ? W ~ t0 M M ? tp'- V ~ h u7 '- (O t~ ~O N Gf O f~ M f0 f0 (D ~ N V c0 M (p t0 fD ~O h N ~ c0 t0 O W N N (D M O c0 tD . O
tD ~(7 M f0 '-_ _ ~ C_O N ~ N N ~ N O N ? O O OD aD N ~ f0 N N
N ~ N N N ~ N OD N a0 1~ W M 1~ e-O M M

1~ a0 ~I7 M O ~ f~ - p CD W N M aD f0 ~_ W f~
a0 aD O O O o0 O N O_ N N Of ap M N 00 M I~ Iv M M aD a0 Oi M ~
I O W N O N M M

N O M p p O_~ O~ N h O aD N N M M O O N ~ O O
~ O W ~O O O_f 00 N aD N W O f0 N M M W O c0 O N tD (O O N N O) W O tO O O N O
f0 aD (O O s< tD O fD N O 1t~ aD O O
cD M
O~

N ~ M N ~ N ~ ~ ~ (D ~ N N N N ~ 47 1l7 CO _ N ~ ~ 1f7 t0 ~ N < ~ N N W f7 ~ cD at ~
t0 M

tD O f0 c0 t0 !D fD
N N N N ~ N ~ ef aD N h N O N ~O p N ~ N N ~ N ~ ~ m N N W f7 Of N at u~ N N
OD N M Op M

O W Of N N M u7 (p f0 N
01 Q7 CO ~ OD V' 00Q1 aD - h I~ O
1 V O O O Q) aD 00 I~ CD O) ~ t0 1~ N M M t(7 M O i~ N 1 O N
M ~ M 1~ 1~ M a0 1(7 _ I~a0 aD _ CD O
aD h ~ N O M ~ (O O~N O Op OD Cp O h M
N OD O OD f0 O 01 O QI c0 fD f0 N 00 h N M ~- O M O at 1~ M CO
O O O h t a M
D u7 :
h _ D ~ _ aD Of N V M 1~ O et N M (p cp ~ f~ h O u7 ~ p7 u7 ~ (ON cp ~ fD
N tD O~ tD cO O Q V 7 t at ~
f0 f0 f0 aD O 1~ N ~ O ~ O O O O O O c0 117 t0 ~O ~ cD fp f0 ~D ~ N N M M ~f M 1l7 ~
~O e< O O OW 7 ~
tD N
) N W O f0 f0 N N N fD N fD N N N N f0 W t0 (p tD OD (O (p N N N ~ fD CD N In N oO tD f~ M f0 N N N N N N N N N N N N N N
~ N N N ~ N c9 N M
N

~

O W
W

_ _f0 N i a c 5 i ~ U

N

U U
~ V

m Z Z c 7 ~C U

O

m N
~

O

O
~

O O
~ lL
N

a a '-' c a~

R
O E ~
E
c O O d Y

a a o T

.-. X
O O O
C

a a 'm C U
' O C
't9 N N
a ~i ' c -c c N
U

O O d D
J

U O v~
a N

' ~

Q Z ~ f1 <
U NpH~ 1 ' ,~

OD 1n_ ' V N ~ N _ F'~

~ - G) ~ ~
N ~
~

v =w m' " E ~L
' ~a~

M I-- O f0 Z T U N N
~ C O

a o ~ o ~ I- M ~ v O ~ d N a r ~ a N v m - ~ 'd c O Gi uJ r ~
O

a N d ~ Q - O Q ~ a O
N O ."' O ~n I~J tD Of n O Z 't Y C
7 O ' U7 N

V ~ N C N O T (p N
~

a0 N O = O) 0 O M C
N ~
~
t O o o c~Vi r' o E Z ' ' ' Z o d w c y N
U

~01N ~C1 O! ~ ~ a V
7 N " 'p~

Y f~ Y Y ~L Y Y y Y D : Y Z
~ O O
~ N

, U
~

m N m C~ m ~ a E ~ ~
U N d a c ~ O f "

Um C7U' C~ _ C m (~N_c NU C 7m C M

_ Z f0 O ~N
O p ~ ~
- N Of L

N ~ N N N lC I n ~ ~ ~ N c ~

d 7 ~ N
= c c c N N
o N L c~ = m ~ A c _ _ p = E p o c ~ ~
~

o O o d > ~H J , E V ' i;, o M a ~ ~ c a o ~ r-a o o o op o 0 0 a~ a~~n . ~~ 0 ~o ' a a tNd rod > > ~ > H ~ 07 O~ N O
O ~ E C E
O N

h N d ~ p > m a N ' ' O
N

Z Z Z Z N W T U ~ Z a X o~ L ~ _ c' ~
~ Z

O

O O ~ O p m p N N N N N
N

01 _ M n Of 1 h O O m O ~
~ p N_N_ ~ N_ v M ~ N O M
~

N O O N D
ap O ~ M
~

O M M M N
N

n ~ ?
t ~

O O O O O
~

O t D h p ~ O
a O

< V ~ t e o_ ui ai co ao . M o ~

_ ~ w h ~ . N O O h (p co u~
O O aD O ~ O aD t0 ~ O N
~ n O O

O h M
~
~ N aD Q7 f0 t0 f0 h f0 N .
O V ~ Of f0 _ O~ M M ~ p N aD N O V V V O O O~ h N ~ h N
Qf < N M O (D M ~ O fD f0 (O O 10 W h ~ h h N
N N M
07 t0 O a D O O N
O
O N

_ u7 tp a0 N 0 00 ~
V (C
~D N N N Q1 <O t0 u7 tp ~O N a0 <
aD tn 10 N ~ M a0 _ h h t ~ OD N N V (O ? ~D M In M N fD 0 O
V (O c0 aD ~ M u7 f0 aD N aD (O c0 M f0 cD h h u7 a) ~ O O
V 1n Of u7 Iv N O ~ V t0 N t0 a0 V O7 ~ ~ ~D tD
h h N M N M ~ ~ M f0 ?

~ ~
t0 G~ O N O ID O ~(7 O h N f0 (D N u1 ~ N
tp f0 M 00 (O N
N O~

O~ N
O~ V oD aD ? N t0 aD W (7 et N h C1 V N fD
O O O N N a0 ~ N N
oD 00 N O cp . u7 f0 (O ~ tD Uf u7 h ~

N
t0 N aD aND Of V h h t0 M u7 N r- N ~ N N N N Q~
O Of c0 M 01 ? M O) N M

O N N M O u7 00 . N m t0 at Y CD l0 N N O
M N ~p 1f7 (!D ~ t(1 et 01 N N M O ~ h h ? h ~D V' M N W ~f ~
O ~

h M f0 M N O
cD M N ID ~ O~ .~ M ~ h f0 M N N M N N O ~ h f0 O (D 00 ~ N M (O
t0 N M ~ N ~ ~ ~

p N ~
f0 O O t0 u7 O h 10 h 10 < N ~ aD tD t0 O ~ ~ N
a_0 c0 t0 ' N
N V h N t0 CD V N f0 O
~ aD ~ ? ~f t0 fD h u) t0 f0 N N aD
N

_ P N N M t0 N
W O N O f0 M !D f0 f0 N (D In h . f0 N 1n f0 aD h 00 O~ 0) N m e< N O N N OD N O~
M N O N N N ~ h O 1n M aD r- ~ O M Q Q7 M h CO OD OD N t0 _ M
fD N N M M a0 f0 h O N OD (O O
~ h h a c0 O O f70 D M ~1 t0 u7 M a0 O h O V Of O c0 fD
O t0 t0 aD t0 O u7 ~O

_ O ~ a0 N O~ u7 ~ N N M O ? O ~p ~O (D (D 10 O) of M O O
O h V aD ? M ? V a0 ~ O O
f0 N N (D

_ O u7 V
C~ Of 01 tD 10 h tD O h h h u7 h D t0 h 07 O
h f0 N tp t0 f0 aD f0 V
N N N M N N '? N
V

_ V7 N M N m N
~ ? N t0 et V ~ ( N
y7 fp N N7 N V N N N
O (O f0 fp f0 c 0 fp t0 O M t0 N m N N N N
N N N N ~O Of ~p M M p u7 N V 10 N
~

n O a0 f0 M u7 N Of O O) V N K7 ~ N O OD OD f0 O N N
~ ~ - (y ~ M aD h c07 M O h ~

a0 N cD ~ ~ ~O O N 07 O~ ap O of (O O uW O 0 O)OfM a fD ~O N 07 h aD u7 M O aD 01 t0 0 1A O ap D
O (7 M h fD

_ (Oa0 O
W Q1 N O 1A aD t1~ IA (p ~p O ~ h Q1 N M (D M (D M
O O O (D O O O (D h O h u7 O O
(D ~ h tp ~ V V u7 < ~ Q) 4) 1A V O
tD (O V M
O
u7 N V ~ ~ ~ ~ M M
aD (O 10 t0 fD 47 (O <D ~ f0 h ~O c0 ~ O
fD t0 f0 f0 f0 10 m u7 t0 O aD N ~
(O

O O cp00 O
~ ~O M N (D M N u7 N N a0 N N N N N N N N N N N Qf OD
N N N N M ~- M N (O ~ N N t0 N
r- ~
N
N
N

Q Q

O lL liJ

U W

_ o a v n N

U
H V U

_ v ' m ~ Z Z

N

' n W

O M ~ M

O ~ 00 O ~ O

a a a c c ~. ....
c c . .

a o o a a c a a 'y c c c c . .

o ? a~ a>
~ 0 c ' m ,n o n n n ~ c E
.

o c c c x c E

i - ' a ' C O f0 N (p a U p O
c ~ E
a o c~ ~
' U U U
tO ~ m o ~! '~ ~ E
.

M
N ~ N c0 N 7 f0 H ~

E ~ ~ aho o ~

a~ ~

fC0 d ~ h m fn ~ ~ (O
~ U ~ T u~
U O
N v U ~ u V ~ w M c cp ~ N
y ~

h ~ M a Z

E ~ c m N a ~i o e Z w ~ ;~
~ m _ a ~ ~ ~ ~ d a a N E Z o ~ c :

10 N M H ' C d N ~ V N d 000 U ~
O Y 7 V (O
E m Cd ON _O CTO ~7 O

V E
O O M

~ _G7 Q o6 _ ~ h w N m O
7 C ~ ~ N

X O N ~ ~ M C N N lL
N Ol ~ E 7 O

m o <_~ .-y ~ Q M
NQ m ~ n C Ol ~ p ~ .7C.Y .1L ~ 1C Y
~ E ~ 7 ~

A c ._ r d . N C Q . c m m m ~ m ~
o ~ E ~' ~
'~ '~

n e m 7 L n V m m O ~ m a m ~ N f~ N C a~
N CD

~ ~ ~ H ~ ~
~

E d Q L ~ X D a E N N Q
U N ~ ' f0 c n v ,, ,n E E E ' o ~ _ _ ' o ~ d ~ c ~ ~ d N c U U E
~ ' Vf Q
' ~

~ ~ d N
U J a =

C~ C~N . C C C
d O C_y~ N
. ~
' p . Q: d a N N N N
t! ~ O Y 01 ~ c'~ C
. ~ E v 'o c .r N ~ '- ~ ~ o ~~ a o ai o v ~ ' d a n. ,,'.,d a ~ M h ~ m c'.i 'r ~ c c, ~ E m m a~ ~ -o ' N o c c Z > > > y a h o ~

N a E D a Z Z 2 ~~ Z z a 'ouEi ' v u Q vW Z
l $
, ~

m v ~ o a co a o o rnrn ~

N N N N N N N

N

m ~D O O ~ ~
O

C D O O f 0 c N

N

h ~ W O O ~ M O

~ O O N

W M h n ~

V t f V

O

O M a0 O
f0 fD . O . O cD _ O (O
O O O
. c0 07 O) Of (D f0 O t0 (O
CD 1~ N ~
O 0 ~ r fD O
O ~l ~
~

a 7 O N 1~ _- O f~ 4D
N O N O cD t CO a O DD (O
Q1 N n 1 O ~ t('1 ~
u'1 W N N QI M
O N

_ O 1~ _ V ~ _ O) tn O
a0 QO OD N N fD O t0 ~ t0 O ~ W ~D M O t0 00 t0 O) N (D N ~ ~ Q1 ~ O O tD N
t0 ~ N N O
1~
~f7 Of ~O 1~ N N N N M ~O ~ N ~O ?
V7 ~ Qf O V'I N I~ (D . 07 t0 (O (p N . N 0) f0 O M
f0 . _ u7 00 ~ OD
O (p ~
M .
1~

N M N 1~ O OD N N N N 07 N
N fO u7 N N OD N tp (D M 1~ M ~D 10 ~
aD CD O of . N O .
N O N M ~ h fD . M
. tD tp . O

N a0 N a 01 O OD ~ h 1~ O N O
M O f~ ~f V M N ~
V N P ~ f0 a0 O
M

O . _ aD N ~ N r- ~1 (O Of aD 4D M 07 - O_ O 1D O f0 tC
fD t0 f0 t0 - - M
O N W M M OD O (D ~T
f0 M 1v f0 N M 0) N
N OD O N N t0 1~ I~ 1f7 M N

O ~ O N M N Y M ~ h _ f0 f0 m V (O (O O ~ . . N . -~ f0 Q) O O M t0 t0 V
f0 N N O GD ~D s<
fD QI N f0 O 47 f~
fD O (O CO t0 O ~ h OO N a0 ? N V ~ N N (O M N aD M ~ ~
tD N tD t0 elf N N tt tn t0 N
In W N O t~ Q 07 . ~ N i~ O _ . O O
. _ . O ~ O O
t0 O~ A
~

N N N N h t0 O f~ N a0 u7 N u7 N
W N I~ ~ ~ tD O ~1 f7 N ~O M N V
~ O

1n . . O Q1 . N N ~O .
~O u7 M M ~ N N t0 O ~ (O
u7 cG (O t0 M aD h O N 1~ (D O~ a N Of Of O~ O aO 0 N N N
aD W N M tD O~ M
1~ N
M

O (O QO N ~ c0 op _ 07 O h O O ~D N (p N o7 u7 ~ W
M

Q) 07 f0 O OD O f~ t01~ N M ~ _ f0N
N O V I~ (D M M f0M N N t0 M t_~ ~ N
'C Q1 f0 O O ~O Y h O_ M f0 h O N ~ M V M CD V
(O V7 N N M 00 f~
OD M ~ O ?
V O 1~

~O ~l7 f0 ~ h f0 N 1n_ tD O f0 O O ~ f0 t0 M f0 O N W fD h t0 1f1 ~(7 O CO O fp 10 CD
f0 (~

N M N fp ~ (O N ~ N N N N N N ~f'1V N
~ M M tD N N (O< < V N ~ tpV
M N N M N l0 f0 ~
00 ~ f0 (O f0 f0 (O
(O tD
M

f~ f0 f0 M N N N N ~O I~ P N h N N O
N ~ O O (O N N ~O N N
M t0 u7 N ~ M O
O N ~ ~D

aD N N O f~ O N N O) at W M aD O (DM O h N . N 00 - ~ 1~
f N 1~ f0 v!7 O) f0 M ~ a0 N 00 N OD O ~ O m O
00 OD Q) 1~ a~ O) I~
V Ql 0) O N M
M h f0 O M
(D

~ t0 ~ a0 vl7'- a0 O N ~ a0 ~ ~- N ~ O N
t0 O M m n ~n~ aD ~ O (D O cD ~nO
r~ (D a0 (D N N u7 M N aD
rn M aD 10 n M m M a0 r m n a n o n n M
a~ o n o M o~ M o~
o o ~ o o c o n o m _ _ _ _ _ 1~ f0 M ~ ~ ~ M N ~ M ~ N M M N V ~ _ ? t0 M N u7 ~ 1f1 V ? ~
10 O) tt (O ~fl M

fD 10 01 t0 f0O N (DfD N 07 O N c0 (DO
f0 O N N N N O) N N 07 t0 t0 cD N fp f0 ~ t0 O t0 ~O N t0 OD
N M OD N tD In N M OD
(D N N f~ N N N N t0 M N N N N N N N N
N N N M N ~
~ N 00 N

lJJW L_IJ W W ~ l J L

LL lL LL LL Ii _ _ LL LL

g g g g 5 g g a U U U a ~ U ~ U ~ ~ U ~ U

z z z c z ,~ z , c z ~ z 2 > > 7 ~, ~C 7 ~ ~ Y 7 0) 7 N
d ...

O

O N .-M

~ O

O O O
T N

li LL lL
d a a a = o _ _ _.
m C C N C
O

.E ~E .

v E

0 0 o m - ~ d E

c C N O
C C

_ _ _ a~ d ' ' m E

O O w O

n c_ o. a ' ~ U
d o N N N N
~ jp c E c L c ' ' o ' m o m o m o. E
'~-C ~ C C C
N O

U U U Q U
a N ].

J_ r cO ? O n Q ~ lL O N
E

O O 0~ ~ 2 ~ ~ C N
m O

(D O O ' N N Of O j > ~ (a O a c C
N t0 D
V N

N N O N M - O
C7 d d O ~ G) _ ~ N N O .
7 .
Q

~
o ~ Q ~ ~ o o' U
V a o N

ao E n I o~ Q o a? o N m m a E ~ U ~ Y ~ E
H m y ~ L _a~
_o n N 2 O O Z N M ~ d t 0 ~ is V c0 ~ Q n' n 01 N L V
N C

O N = t 0 ~ y~ t ~ d O
M M = 'N

' U a n o _ a~ N 2 ~ N ~ X
~ a~ p -m Q -o ~a ' o~ 'aro~ ~ M~ o~ ~ ~ ' or ' or a m Z a v o ' L

~ M
C

C C C C C C C ~. C C
jn O a J > m J ~ Q N
m m ea -. [1J N co A o m c m r m m E ~ a U X M m o m m m m = m m m m .~ ~ t ~ a m U ~ ' m ~

C7 C~ C~ C7 C9 C7 C~ ~ U - C ~
o c - ao o n V
>' m ' D
E ~ E m E E o ~ E H
~ ~- o d d a E E E ~ E
~ ~ U n , ~ ~

N N f/lN N N N 7 (/l tA
N (n O a a ~
~ W ~ ~

C'~ C= C Cd CQ GAL C_~~ C C
- ~ ~ d G1 d d d N N N r _ _ ~ N 9 Z N ~ ~ N
Q G7 <L
~
H

O O O O O N ~ O (p O C O
O O O y ~

d d d d d a c d p d .c a p N ~ ~ N t0 y ~ N
~ lL

C ~ ~ ~ O) '~ ~ N A O N
M M aD Q' U ~
U

oU 'oQo~ o~=~ 'oat~ 'o o'~? 'o~E o u o a E ' %

Z Z Z Z Z Z U Z ~or Z ~N Z
.r 'o> p> m v m > (n OD O N ~ O c0O N V O E~ O N itO
~ ( ~

0 m _ _ N ~

O W 0 W Of 01 OfO O Of Q O ) N N

r O M O h O M O r O M 7 0 0 0 O 0 ~ ~ N N

a 0 0 Q 0 O 07W O) O 7 ~ 1 0 N. f f f ~ .N.. N ~ N. ~ ~ C O
a ~ ~ N.. r N.. .Nr r Of 0 O W ~ (Ot0 0 O O O N M opn c e t O 1~ O) O)07 O 0 N O O
f 00 D 07 D V cDaD N O~~ O~ c0 O
~ O N O

O D I~ N O ~ h O tDO O ~ ? M 1 a n O ~ M O O N 1~O t0 O 0 tD C
t a0 ~ 1~ O ~ P M O D M M ~ I~O
( o a 1 n r n ~ n o o n ~ u~ o i.0 m o u c o ~ i m o 0 0~ o~ ~ 0 m a m o m o ao O O N M ~ O 0 1~0 Of O
t a N M

~t W t7 ~ ~ O W t7W ~n ~O 0 t 0 u 4 u t 0 t ? i f ~ V V ~ V ~ ~ V V ~ V

cc . c u7 O) 1n N r W . h CO
~

_ N . m . ~ M . 1n O . Op O) ~f ~ OD
h CO O f0 Q1 h V' N . CD _ aD
r 10 a0 r h O 47 01 N O t0 O C7 a0 M N
M

Of M M Cf ~ N c0 O t0 t0 ~ N O h r h a0 N
~ O N ~ O ~O O OD
O M CO V fD CD N N O c0 N M ~fl ~ O V N ~
(O 00 O ~ Q) N M M O O
M Yf ~ tD O aD O M O tD m 10 aD 10 a0 u7 N W

aD ~ Of tD a0 V f0 h O~ M h N N h vp Q1 t0 ~ N ~ O N Qr V
h ~ Of M M aD O a0 ~l7 M O M a0 h tD r (p f0 N N M t0 - ~ M O ~f r M O N f0 . et 1n _ N h t0 N f0 . N N N r fD 1n 0D r N r N

N _ O O ? O Of O aD O _ O - O ~D tD OD h . M
O _ u) u7 t0 OI ~ N aD . O CO a0 . N n0 N ~ N W QO . 1n ~ n0 tn r N N V ~ W
O h M (O t0 N u7 N a0 ~ W r r ~ N
N r O r N
~p . N . r tD . . (O ~ t0 O~ t0 h N O) . . ~ t0 N O
r . ~ . O tp . . a0 c0 a0 (O aD _ ap fp OD N N h ~ N M N ~ aD < (D ~ N h a0 Y N Q~ M 47 O N Qf u7 r a0 In M V
V O ~l7 M (O ~ ~ t0 h u7 0 O

W r O . t0 h aD _ N . ~O . N r r . N N t0 O ~D ~O O (O . tD . N _ M r 01 M O N N r OD a0 0 ~ O V N O N h t0 r O ED DD M N M O N h N O r M O O r (p r O ~f a0 M < O _ ~ N O V r r O r M . M Ql . it) M _ fp t0 (O . O~ aG h a0 p) Of ~ 00 r ~
. r h O f0 ~ N Q1 M O O O OD O t0 07 h M O O M m M
h ~(f O) (D ~ r a0 ~ O 00 r (p fD M OD t0 N 07 O ~ u7 r N h N N N h O Of ~f h t0 r K7 N O ? r f0 op tD M fD M N O N N V N aD r N a0 ~p N . . ~ tD tD O t0 ~D t0 . t0 _ O O M h O . f0 . f0 O . u7 fD . c0 . ? M aD . O . . .~ er N N O (O ? 10 (O N N h N Op et ~ (D M V
O O) M ~I (D ? N M r h N CO V M ?
N M

_ N O M tD . . aD (p pi . p~ N (D . . t0 N
r tp . (O t0 tp _ aD a0 tD . tp aD
op r ~ r t0 ~ CD r M N V r r M N OD M h M ap N G1 a0 N t0 N h N N N N r . O < M r h r M r O r N
O r . tD Qi r u7 ~D O N
. O a0 r N N o0 aD r . N u') .
r h N . ~p t0 c0 . M
N

m M a0 h OD O r W r hf0 h O O O M O N h e0 O M O
f0 O (O r fl0 0D O M O O M O h h M h 1n M

a0 M N O f0 CO N V M V ~ m M O N V f0 07 OD M CO
Q~ V M 00 tD Of0 10 a0 fD ~ M ~p O f0 h O O O O V f0 O a~ aD O m M ~O O M
h - t0 (D 1~ aD fD t0 r O c0 ~ M ~ ~
W O t0 M O

N N N O ~ N r N ~p 47~1 N r N r N V' ~ N N V N V
V N N ~ ~O K7 N r N r r ~ Op l0 M fD V

N _ . fD t0 N f0 . (ptp . tD _ tp O . cp tp . (O
t0 . . tp _ t0 . NN CO V Of . a0 . c0 . _ N N
N a0 N N N _ O r ~ (p (D
N h M N N u7 ~ Op ~ N N t0 CO N N
aD N V CD r 1n N N W
M N N

p~ u) _ . . ~ M . . pr O~ W pf N . . M . . N _ t0 N . ~ N a0 tp _ h ~p _ tp . a0 r h t0 .

Of D7 O 01 W 01 O NM O M ~t M f9 1~ r ~ r ap OD
h aD h O O h M raD h r M M r M h M 1n N M
O O M ap M c0 r O Q~ M r O ~
f0 oO (O O aD u7 ~ tp c0 t0 ap N c0 M a0 aO r O
r a0 tD h N r of r o0 a0 r M h pp a0 ~ h O~ W O V N at offc0 h Y O M Q7 ~ M O N O M t0 N O h f0 r O O O O O O O r ~f7 O O O
~D O
f0 ~

~ N f0 V Ip _ ~~ N _ _ M ~
< O ID ~ V ~O 00 c0(D N _ _ CO
(O N u7 (O ~ (D r W p _ Q~
f0 t0 r M ~ tD N a0 Qf M ? ? ~ ~ V ~ V tC
f0 u7 (O (O '~ u7 GO M 00 00 CO pf cD cD O tD
00 tD aD fD 00 t0 a0 h c0 N N M N N N N 1A NN N r N r N N N t0 N N N N
N N M N O N r N N r r N r N r aO N ~O
M r W ~ w W

LL N lL LL
f0 (n (A N

T
E

m U U N
~

Z Z2 v Z

7 Ol ~N N

M

O

O N

C

_ N

C O

n E ' o a~

' E

c m 'y U

O N

Q 'C
a N C

C_ O
U

O
C

_ U ~

M

h N
M _ r O ~ ~ ' ~ Q
~ ~ a , O

c0 N Q' U C l N O CJ
~
m h h O O Q y N h V
N ~ V L
m ~C E ~ N n O p O
c 0 m N
O H F-7. O O C

Q IL lL ~ C h 7 a0 ~ Q N
M ' m ~

U Q Q ~ , ~ " i ~ p a ~ U
f p t D c 2 ao ~ n a~
il o - ~
C - a rn a ~
Z Z m d ~ ~ Z o a H ~ in ~ Q y Y y : M O ' y _ p E Of Y E
~

U O E M N. W p < m ~ d C V1 h N N N
~, O ~
V' a p ~ O C1 o 2 ~ t W n c cc c U

~ C7 "' V (~ O ~ Q a0 N N ' a0 O

41 N a C
111 j m ~ ~ N - Q m ~ m r ~ w ~ ~
d pi ap p~ p~ m N W y p p p 'e ~ a ... Y ~e ~c ~e ~e ~e O M c a ~ M c ~ c E L
c c c y c v C
~ m m T

~n m n a m m m ~ I m ui D o d ' d ~ (7 Q ~
~~ O
r ~ Q C
"' E v a E H E ~ E E E m E_ ~ E-Q v Z ~? c ' d c ~ ' ~

p7 O ' Z N H N N y N O N N
- o ~

c d o ~ o c Y S ~ c E o, a c E
of ~' c l t ' -.

p Q ~ ~ E ~ V p _ ~ !a ~ O M 4:
V ~ tn J

O O r O ~ 0 0 O O O t O h ~ O
~ p y O

d . M d d a a n. a, a v ~ m a C ~ ~
l0 'C

M . o C
N G1 N O d N d V1 d ~ h y ~
J ap p O~ m O ~
V m N E N ~ m ~ ~ ~ ~ ~ Y7 C 7 C ~
N U

Z N UJ i. Z Q Z Z Z ~ Z 'or m 2 N
a ~ v c~ W
e~'o~ a~

aD O N~ (p c0 O N

N M MM M M Y V
O1 O 1 OfO O1 O p1 W

N N NN N N N N

h p ~ '-(~7 u7 I Q1 O NE WO OMf O

N ~ N ~v N v ~ N

N N hc0 N ~ N N

W W NN (p h_ QO
~

p'~ N tD (D

N N M O N

m ~ ~

~ ~ n 0 ~h O O O

t 0 t Y V
D

~f ~ VV ~

01 V ~ N ~ N N O

Q1 ~ M . (p O _ O O O 01 07 N O fO . O~ ~ O~ M N O .-t0 u7 t0 (D N V t0 <O
tD . fD O

01 OD ~ N N M M ' N ~- n V V ~ N
a0 ~T ? t0 Q ~ ~ O O O
c0 ~ . cp . u7 tp ? . ~ u7 cD
t0 . t0 _ cp t0 ~O t0 n tD
. f0 n ~

fD n M n N N O ? VI N ~ V f0 N W
aD of ~ N W f N ? N N M N n f0 fD O~ !D (p ~? O (O M . (O
N M O . 10 f0 t0 . 00 . . N
c0 N . . t0 (O

N O O 00 (O O) N O Q) N M ~ N N
N O f0 aD N N Q1 ~ O fD
~ ~ N n N

~t N N at ~ ~ t0 _ N (p ~ . ~ f0 _ f0 . t(7 n _ . O . tD Qf ~ M t N c0 V c0 ~ n O _ tD Of O O O
. t0 O N ~ n f0 M (O ~0 f0 fD u7 fD ~ ~ .

N u'! n N N M O (O f0 ~f N O u7 t< O N
~ a0 N M 4'1 ~ 'I ~ ~ ~ M
~ 00 N

_ . Cf N ~p ~ N . O 07 t0 O O
n ~ _ tD u) fp ~D c0 (D . t0 ~f7 ~p . f0 Gf V' tD ~
O t0 N V M Q < N aD ap ~f V
n aD N Q N N N a0 N
N

~O ~ '? O . aD O t0 ~ ~ O t0 fD _ fD
tD ~ ~ . t0 t0 _ N . . N tD
O . f0 n G1 ~ 01 N ~ N M N M 1 N N 0D N N
f0 CD N W N N ~ N 0D n WO a0 ~ O (O n . N M
Of n V ~ . _ O . M et . . M
. . Q) op n!7 ~ M
M tt O t0 tD t0 Q) ~ fD CO O c0 aD Q~ N a0 OW n aO r ~ N t0 ap O N Q1 M f0 O aD
O7 n f0 ~O t0 O
O t0 N ~ c0 f0 O N N O O N ~
aD aD N f0 M 1!~ ~ f P < <D
N p a0 . t0 N N 1n M O O N _ Of O ~ f0 07 N tO N f0 t ID tt ~ O f0 t0 N
n(7 ? N V . ~
N ~ h < M M of (D (D N ~T u7 N ~ ~ N V aD N aD t0 W N ~ _ . (O 1n t0 Op 1n t0 (p (D
(p . f0 f0 tD _ N . n(7 . fD
. (p . CD

_ O a0 O n n M N M N t0 O N N N N N
K7 N C7 N N N M N ~ ~ O ~t ~
M '- 0) _ M
OD ~ t0 ~ (p . _ u7 O . f0 . n M ~ 00 . N

M n M O) O W 10 ~ O N t0 O n o0 f0 n N
~ n M M O n r p M ~ M fD ~
O

00 N M f0 tff ~ ~ O O aD ~ fD O O W O aD
O t0 f0 O ~ M N t0 c0 c0 oD a0 et ~-N O (D 01 a ~ t0 N 01 ~ 10 O) O t0 c0 ~ 01 O N
n O f0 M n O
a (O O t0 (O
~ a0 _ _ t0 N V ~ ~ _ ~
a0 N N M N if V V t0 ~ M V ~l7 V t0 ~ Cl ~ 10 . tD Q N N ~- t0 . f0 ~ t0 ~ (O t0 . fD i0 f0 t0 O tD CO t0 00 .
_ V N f0 tn M M N N N O t0 N N N N N
N N N ~O N N t0 ~ N ~ M O
N N

W N N M . N . n N . _ N ~ _ . aD -M a0 a~ t0 O o0 '- v- op t0 n O~ t0 O ~ O aD oD r ~p GO ~ N t0 M ~ . a0 r op (p aD (p aD M ~f tD ~ '- CD n O O ~ '- O O 01 ~O
N fD (D ~ M nf7 (D f0 01 (O ~
O M aD f0 '- a0 n W O M M 00 ~ ~O N QW (O N M O O O n N O (D
n n f0 f7 fD n n (D 01 M W
f0 ~ ~ O

M M ? < ~ f0 V V '? M ~ N ~ ~ u7 ~ V ~f V V V ~t ~ V V '? t0 M (D
a0 O Of fp M fD Q f0 (O f0 t0 f0 f0 fD O O tp tD ~O t0 t0 f0 t0 t0 c0 f0 f0 f0 ~ t0 O a0 N ~ N N 47 N M N N N (O N N N N N N N
N N N N N N N N N N N M fD N
N ~

W_ W W_ L_L _ C L_L
L_l.

d ~

g g g n = a Z

N ~ Of 7 fp O - n N

a o ~ v U

O ~ O O O

LL N ~ LL lL

a_o a~ ac aEc c n. c n c c E ' ' ~ ~

E ~ E E E ' v ' o E o ~ o o ~ o v ~ c y v v ~ m -CN C~ C G~
y 7 d N d Q _ a N N O
d o d o o o a -''.

aE a~ nY nc ~ E ~ ~ o, c ~

'm 'm 'm E
'm y ~ o ~
_ C U C C C

U Z U ~ U U ii U
ii v N
U

.n w O
Y

U ' ~ M

CO Z_ _C

O) O z -' O O
~

_ ~ d ~ ~2 N
j _ O

O ~ O . J

u. O
a U m a ~ a Z
" E a c j W H
o H

~

m Z 0a ~

(~7 .a Q~ ~' ~
N

_ .O O ~ ~ ~
_ CD

Y Y Q Y O ~G O
~.j Fv ~C
d V f0 y O

C9 C9 (9 n ~ ~
N N o n . ~
~

~o E ~ E a E a a E E ~
~

N ~N O ~N d ~N C Ul N

C C C n C C
~ C N

_ ~N N ttJ ~ N
~ N ~ d d N

n O ). O O~ Z O N O O
O Z
O
O
=

d d U d ~ lL d ~ d pMp p tL
G fD

d d ~ a~ ' F- a~ '~ a~
u W
m ~

N N V d N

O O O O O
~ ~ ~
O U
~

Z Z N Z D) d Z a Z or o~ d t0 aD O N V f0 ? ~ ~ 10 1~ N
07 Q1 O Of W 01 Of N N N N N N N

M u'i n O fn u) ~ u7 O 01 O~ O O~ Of O) N_ N_ N_ N_ N_ N_ N_ t0 O W ~ Uf Of N

O a0 M N n t0 t0 O) O m N

(D O CO ? st u7 C7 O n ~f n n n m m n n n n n u~ is n n ao o~ ao m ao ao N M W (f t0 n a0 n n n n n n n w v ~ v < v v m _ ~ _ pp ap O h O N
~ O N

W- V < O N O O ~O ~O ~ OD
O O u7 t0 aD h h h <
O t0 M
op N t0 N O

ap ~1 t0 t tD O aD aD fD O) fD t0 _ N ~
~O M O _ h fD N O fD
h h 07 1n N OD N m O) h < h O ~ M

h O N ~ h N N h O M ~ f0 t0 W l7 M a0 N h O~ (O f0 _ N t0 _ a0 c0 ~ V O~ GO V u7 M t0 h M
N
O

N tD f0 O c0 h N N N N V ? O N O ~ M N _ O h O h h O M c0 h ? ~ M
t0 M N N N V V ~ M t0 ~ O

N tD O ? f0 O_~ f0 fD M N (O N t0 M O O _ O) N O m O
O M < O (O O N 0 N
?
~

(p ~ 47 M ~ O) n!7 t0 N N ~ ~f 47 ~O N O f N V N O ~ N N OD N N O M 00 O N ~O h M

m N ~O ~O t0 aD h O) _ O t0 O (D O aD N N
h t0 ~ O) M N f0 ? 01 h fD
Of aD N ~D N N ~ t0 O N u) ~D M
aD N M N ~

CO _ u7 (O h f0 N a0 O~ O aD 1n t0 O _ Qf V
O t0 N h aD ~ O M h O
O
(D

h M y~ h Qi Oj a_0 h O nl1 (D O _ h ~f1 ~ O t0 'V 10 N h O N h ~O t0 u7 h h N N V ~ ~ In h CO (O M tD M
N M M < N f0 f0 ~ f N u7 OD
V7 ~ aD V

N 01 ~ tD O N O (D N t0 tD O M ~n O ~O ? O) N N aD
f0 M fD u7 ~ ~ ~D aD O fD M ~ h u7 t0 O
V O f0 fD 01 ) N M ? DC (D '-N
N
N

N N N N IC1 V 01 _ O h N ~ O
O M ~ V N Q O N N N Q M f0 M
~ M M h V t0 a_0 (D V h <D t0 _ O N N N f0 N W N u7 O1 O) fD 't N < ~ O N M
O) N CD N M CO V N O O N t(7 V N N OD

O
' Of N cD O N O O h h O O~ N O f0 fD fD (O 7 (O _ (p ~f ~f7 N N N O ~
O pp tn ~ h 10 ~ O O V V7 f0 ? O h u ~D fD
f0 M f0 N M N n0 h Vf M N O N N
0) h O

CO h (D _ h h h ~ ~f CD f0 ~ (D f0 N fD (7D
OD fp ~ N CO h O O 10 O
a0 O fD (O t0 O O f0 O ~O N
~ N M
O h a0 O h M

h M h H1 O h h ~ h O _ f0 M N
u7 N N t0 Yf V ~D (D
M O tD h W ~O N h O h it h O~ O~ Q) V V
t0 t0 ~ V O N
~ c0 ~O aD
N O N O O O N c0 O

N _ O Ol M M O M O
N W O) M (D ~O ~7 ~D N 01 01 O O ~ M O h O O M M h tD ~O O O N Of OO V N O
M M > N
M f0 N f0 'C
N O

) ~O M M GO m N t0 O N N ~ N N h N tD O~ _ t0 N N V M N V O 01 N ~O tD ~ Y 10 ~C1 M (O ~ ~D O

_ ~D 10 N N N f0 M (O N
c0 . (O f0 N M V N CD N M
V N N N M N ~1 ~O d0 N N N M ~f CD V
V N N N 00 ~ OD

1n O N _ h O M t!7 N f0 ~ t0 DD O~ 01 aD Of 01 O aD 01 117 h ~O ~D a0 ~ O f0 a0 h h Of M N O O a0 aD 10 O O O
O O N t0 M O V aD O) h f0 N O ~
Q~ ~

N c0 O O t0 f0 aD fO 00 f0 O O Of O O if) OD O c0 QO N h fD h O ED t0 t O h M a0 O Of N a0 M
O) 10 h M
a0 ~ O
N M N t0 O h t0 a_0 h O) h O h O_ O) h O) O 1n t0 IA ~ M p u'7 tD O ~7 m O h O h O h_ O h O ~ OD ~ tD tD
h (O N f0 ~ 10 ? 47 07 M
~ V ? ~ tD ~ M < O7 M M V O O ID tD
N h f0 N ~ Q M M

_ a0 1n N tn tp (D (D (O N N N
f N tD O t fD fD fD h f0 (D e- O N N N M
M h ~O O N tD M f0 47 00 N

O N N tD N N N r- M N M N N N m N N
N M N N t0 N N N N fD N 00 N

~

W W

g a Z z 2 z z d ~ ~ 7 N 7 N
d O O
N

O O N
O

O O O
O O

a a a _ c c c .

.m m E
c v a c c c c ~ v '~ 'd m c ~ c E o 'o n n n v N
E

C C C C
Y . C
.

. L C
.d C C U
LL

U U W Y
W

Z

O h C
_ 7 N _ C

U ~

N d E

~ J
~ U O r O O m N ~ O) C
O

O O O N ~ O
I ~
,-. n 'N U v_ N_ ~ o _ o ~~..

' h IL M _ LL
LL N C Q
f9 N

Q E Q Q , d o _ d ~ L O
N

_ O N ~ n d (O

C N h Ol 1(7 l9 ? t0 N ~ ~ 4'7 N C ~
N

d N _ ~ _ M _ N O 0) C ~ ~ ~ ~ = Q
~ ~

O ?~ Q 4 _ ~y N O O ~

~ E C 9 N
~ 7 y Y tD y 7 C C C O C ~ C
C O M d ~
E C

N 'd N E A O O 'j O ~
1 ? d N

C~ M C f0 m y~ CD m m c0 m O m O 10 d N

~

(~ ~ ~ N (~ ~ (~ C7 C~ U ~ fn '~ ~ 0 N ~
~

O
E E -- E E E ~ E ~ E
w E ~ ~ a~ ~
~

~ 't/7 ~N 'N '10 (A N
C7 % N ~ V! O
~

Ul _ C C C a O ~ n d O = ~ ~ C C
~ I

C C Q 'y V y J O
m d ' 7 ' ~y a N
~ d y N .C ~ N y 'a Z N
~ y O V C O h O O O O O
O h a a d o a ~ a ~ ~ ~ ~ ~
E ._ O O O d O O O
~ ~ O a ~
O L N

' a ~ ~ Z Y Z ~ Z
~ Z Z t N 'or f0 Z Z 01 Of f v m~ ~ N V t0 aD O

Of Q1 O~ O) Of Of N N N N N N
N

_ M M h O
t0 tD tD (D O

O O) O O) O O 0 .N.. ~ ~ ~ ~ N

O

O N
O ~C7 M W

~ ~

m ~ O

O ~ O
~ O

h V ~ Y V

MQ07N u07 t00M
fDN

_ t0 I~ p a0 V a f~
W ~ N O D V 10 ~t N ~O f0 aD
fD

Vf !O

_ _ O
f~ ? N O aD N N O p ~ Q O e< O QI
~t ~p M N O
N ~ M

O t0 (O ~ gy ~ N o 0 n ~ O

W N O N M (~ ( ~ tp O N f p a0 t f0 p 0 Oi ~

u7 f~ ~ M M M N O N N N
(D N M N fD f0 LO ~
f0 l0 ap O O I~ O
~ N f0 07 V f0 O
O cD

N Q~ N N N N 00 h V ~ N
N aD 10 O ~ P c0 ? O ~ aD
N
fD

tD f0 _ N f0 1~ t0 N
~ O 10 a0 t0 N N CO

(D ilf N ~ M N p 1n I O OD N M
~ p ~ V
~
~

_ fD N N O_ N a0 ~_ O tD ~O (D M (O N M
O f0 O O OD M f~
O (O O 07 of t0 0D f0 N
N

'C _ M O aD a0 h M
O Q1 u7 V t0 ? ? M 01 N f~ ~ tD M O) O h O (O M tD N ~ ID
f0 Of V7 O fp O N u) p N W O N M N M N N 0D aD N
N O M M V ~t 10 N
~O (O f0 N

(O (O O) f~ 07 fD tD O_ N O ~D M N h N OD aD
47 O N a0 N 00 In O M M N N
1~ V
V ~f V

t0 Of N N N M (O u'1 W p 01 fD (O M cp O ~ Of V f0 07 ~ OD O OO N O
aD f0 ~ a0 D1 f~ OD
N N fs N O
N
N
N

a0 aD aD N t0 ,(7 O N aD
a0 V ~ ~D h 0O M f0 c0 ~ c0 1~
OD C~ m O O 07 1~ a0 t0 N M ,L7 t0 a0 M O Of N 1~

N (O N ~ M M N aD er ~ N
e- ~ O ID O O f0 N V N
~ O 47 (O ~ 07 ~ ~D
N O N M f 47 N
h W u7 O
f0 1~ t0 1 W
W
O
~O

N N ~ ~ N ~ N N N y(7 ~ N
OD ~ M ~ N N N M N
N ~ ~
~

~ N N f~ N P V'f f~ f0 N I~
V ~ N N N Ip N f~ Oi M N
N N fD
N

f~ f0 N O f~ ~ O ~ N Qf 1n n O O c0 fD O aD n O
~O Q! n M 00 O u7 ~ M M O
~O 1~ p CO n ? 10 P r ? ?
M

N fD aD tD ~ N N ~ O 1~ O aD
tD O O t0 a0 t0 l~ N N
oD N (D t0 O
~O

c_0 O f0 O t0 M a_0 O~ ~ O t~
O W u7 O N u7 O O u') a_0 N
O fD O V M N ~ I~
07 O 1~ u7 f~ V f0 ~l) u7 < W
V ~ f0 ,f7 'P
~O
V

~D c0 c0 Of _ f0 N
CO f0 t0 t0 tD t0 c0 f0 f0 tD tD f0 M aD M
(O fp tD

,l! N N N N N N ,fl (D N N N
N N (O N M ~- N V'1 fD
'- N N N M V7 N

C

C (n (n y (/~ (n C

g m ~ m U U o C T O Z Z C

Y N ~ n 7 ~ O

01 M y n ~

O ~ f0 O p f0 O

LL lL LL
O t a v a_ a a C Z

N C C C C
E .E .E .m .E
c ~

p O

a v ~, a D a c ' c c - c G c a~ .y '- ._ 'a .-y ~
a ~
n o ~ o ~ o n n d n n n 7.
o .

c c c o c E

m ~ m ~ 'm ~ m c c m c E c ~e H

U U U E U
U ~

J >

ma ~ w z ~
~ ~ o _ O _ ~
a O M L
Q IJ N
O Z

( V
HO V

H a aza , ,n a o c ~ N ,n o U r m N O W = 1~ N
~ C
t m a E Q ~ ~ Q
N ~

~_ d d a N

f0 ~O p t0 O C , r~ "a~-, ,.

~ N ~ O Z r V ( D ~
N
O
C

< ~ 4 z aig c c cr' c~OCZ c $ ~ E

m m m ~ _ m m ~ ~ ~ m ~ ~ ' N ~ w E

~. 0 ~
, ~
.
~

a~ 7 C7 9 r ~ C9 C~
C m C O 0 ?~
C .

E~ E m E~~ad E'n E
' o:- E~ a ' ' y) N H N UJ (~ ' H
C d 1/l N

CY C_ C_ C NvOO
Xm ~~

M ~ ~ ~ M n O
- f' 0 111 (n . _.
O O O M O O ~ .. .
~f7 vc7 = ~ Q O O
. O
C

d d d N . n Q a a M N Q ~ U Y 7 J ~
N

y ~ C d ~ = d y o M -y U O m X n c 'y >

o-'~o'~ oNa~N o3 zQ zaw z'm$ ' z zm~c,zE
maaa O N

O O O O O m N N O N N
N

N N

N r ~ > M
~ 0 O 7 O O Q ~ 0 0 l 1 N .N.. ~ ~ N

~O ~ 0 N
t N
N

N ~ t O ~ N
N O M
~

O p7 ~ p ~ n M N O
~

O a D 0 f ~ ~ O

V

_ of c rn O

r O O
O V
r N fD O (D O

P N M M
-N O~ O ~t O r ~ N N
V u t~ m t0 (O ~ fD h f0 7 a0 N tD

~If h Of N O aD f0 N ~ r_ O O N O O M t0 N O
f0 O
~

N N tD V'! 1 N O ~ aD fD ~
f0 ? N f0 O IO M N <O O OD
aD OD O t0 f~ ~
O I~
<
N

OD N ~O ~ W t0 Wf1 n O W DD ~1 M
M h O t0 O
O N N V M N ~ V t0 N M V M O) ~O < V t0 ?
O O Q~ 10 ~ f0 f0 ? 1~ Cf t0 N ~
t0 O u) aD ? K7 a0 a0 a0 ~ ~f c0 fD N
a0 t0 ~ N M ~c7 N ~ ~ f0 1~ N N t0 O ~ ?
00 c0 (O
f0 fD
~

t~ N ~ f0 M O f0 fD N N N N ~ ~
N tD fD (D N N N
O ~7 V r ~O M N 1~ 10 N
N ~

N O 4D f0 N tD ~ ~ ~
1~ V N N f0 t0 f0 aO ~fl t0 O N 10 O N
t0 1 M f0 1~ ~
nL7 O M h 0D N N O ~
~C1 O aD O M 117 N

M 00 ~ ~O
V O M O W 01 ~ t0 ~ tD O o ~ 00 V f M ui co o M
o a~ v yn o o o v cc co c u~ ~ ~ _ _ ~ <
r m v ~o o ~ M M ~
r cc rn cc o m co Sri t0 ~ V
s < O
N O N O n!7 ~ 4D N
O ~ N M fD N

~ . N h f0 f0 O ~D 07 a0 f0 t0 O~ f0 O cD 1 t0 f0 ~ ? Q~ ~ f0 N
~D f0 t0 u7 N N
N N
N

_ ? N N O O ~
(p fp p et N N O V N N
f0 ? ~ ~O N N
~
O

N N fD O !O fD fD O ~O 01 !D N N N 01 N f~
(D t0 (O O N ~ ~ N
~ N OO N !D Y N N P O O h M
f0 M N N ~ O N

o ~ o r co . oo ~o M w o r~ cc M 0 co r o~ i ao oo v ~o co r o o M M ni i u~ ~c r m c M o~ ~ ui o m r c~i ~c N o> n M c <n v . in o o ao ao M r a o so -cn v v oo N o co v ~
v u ~
v n v ~o so o M o u~ o w rn o cc y n o n n co _ ~e M o ~o o co r r o N ~o ~ o ~o o cm ca ~o .r m o~ rn ~o n0 N N ~ ~ N ~ N V N
M N V N M ~O ~f N M N f0 01 N
~ N N N N N N
V

f0 f0 M (D (O ~ fD
(D ~O tD a0 (D
N t0 . N 1~ t0 N N f0 N ~ N N
10 ~ 07 N H1 N N N f0 M N ~
N M N O N O ~ N
N

0 ~ t~ O CO
O ? M M . t0 N a ~ O N O O aD aD OOf a0 aD
~ N Of aD ~f7 ~ M M
M

_ 1 0D t0 m a0 h a0n17 O
c0 O O aD V a0 ~ a0 O O a0 ~ n P O O M Of 1W 1 ~ I~ N
~ t0 N h h h N a0 ~O fD

aD a0 N O N O a~ r o> o~ o v a~ nu n c e u~ um o NV ao M
o v o o u~ uo u~ ~o ~n o ~
~ oD
o n c r M ~ a _ V N ~O V ~ V M Nt0 (O Q7 _ o0 V u7 cD c0 u7 f0 1l7 _ t0 (D (D
N ~ Wf7 ~ Q1 O fD t0 ~t (O
f0 ~ < c0 a0 t0 N O c0 (O O t0 t0 (D N M N N N N NN N N
(O M M M t0 1~ f0 t0 (D N u7 N N (O N n0 f0 N N N M ~ ~
N N M M M N tD N n0 N
N
M
N

p p ~p W
~

L U LL LLLL N
-L

w N
~~ "

cn c E ' g g ' ~ gg w O

O N
N N v ' U c Z c c Z y ~ 7 ;e o o~ 77 N N O
M

K7 ~ (D C

M M O '~ O

O O

LL LL LL

a a d_v a _ _ C_ 10/1 C
C C

_ _ l0 (O
N f0 O

C E
Y O

O O O a w v v v c c 'a c c _ . .N ~ N
d O

d O 'a p C

O O d U
a d d~
y~ x C O C
N

(C
(~ C

C ~ C Y T
~

U U U u1 U
Y Y U

N

J Z J y --a~
n n i .E
p r Q _v M
r N .N
.

lL O r, _ lL C N
O Q1 N m 9 ~
W fn O

(D N C ~ ~p ~ f0 ~O N N
(9 M N ' m o o O ~ N d E Z
n r U t J ~ o ~ ~ O N
~ ~
O

Q ~ ~ O
I Q .~ M O
Q O m d r E
m .Q

a E ~ c ~ j j m . _. N
-O

-' ~ N d U . ' E N .r N N N
a ' Y of a0 M ~n o 7 O E Z ~ M ~ LL Q O) V O
E J ~ H J ~ N
C C

n ~ ~ ~ ~ ~ O

a0 N w = N

~ l~ M a N = N N M
C 1. O Y = 'd C
~

N t0 / N W
.~ .-O O ~G Y Y Y ~ Y Y Y Y Y
> O L N E ~ C Q T
.: E .:

N
C C C C O ~ C C C C
J d O. ~ J Y >, C
=: -: ~

m a~ m m m m O G1 m m m m a n L V N ~ n n E
r N ~ E

C7 0 ~ ~ ~ ~ U U U
~ o o E E o a ~ H

,, L

E E E ~~ E E E E
~ d y ~ ~ m ~ ~
~ ~ w 'H 'N N ~H ~N _ N N ~f/1 ~N
O C a L Q U0 Of Y a c c N O O S c S c c Y a c a~ ~n '~
~ ~~'cp ~

c ~G1 _ _ _ r y _ N ~G1 N N H
Z p O Z
O ~

Z ~ O N O O O O
O ~ J tD 'C n .-T.
O O ~ m Z C
p M

p O a~ a a'~~~E-pa~Q d~ a a ~ N '~ e~
~Q

aa a ~ > ~ a ~ ,, y0 > ~O jN jaND jN> j > >Zp ~N~ C~07m ~ U
E

O O O' O O (n O O ~ O
~-CDm ~2 ~2 ~=d V O
T
~

~ Z a Z N N Z Z Z Z
a Z Lu ul ~o~ E o~ E
to ~ ~N N a Z Q Z .
o~
~

aD O N Q t0 a0 ON ~ (O

O ~ ~ ~ ~ ~ ~ OO O O

O
N N MM M M

N N N N N

1~ Of M ~ t~ 01 M u'1 O ~ ~ X 0 ~ f OOf0 0 0 . ~~
..

O N 1~ N aO OD O fDh <O f0 N N M a0 00Of Y O

N N M ~ O O ~~ _ N
u7 fD

y nlf ?

r ' ' o ~ Wi o c r ~ n o ov 0 0 ao 0 o m a a~ o a ~ ~

M
o rn ~ ~ W

,u ~
o v v v v v n a; o;
N W M O
~ ~

O O ~ r O ap N O
N O

Q1 f0 _ N r O N < ? fD f ~ aD N O ~ ~ N ~ ~O

N ~ O N N a OD ~ r N Q~ N

O N
P a0 O t0 N W _ h N N
GI N O M
~ O t N O M 01 N ~
t tD

V . s M M M O O r r r f0 N f0 f0 M a0 OD f0 O O
N ~ M V N ~ a0 f fp Q
u7 u7 fD D ~ V fD
M M
c0 ?

f0 ~ t0 W <D fn M 07 . _ r GO ~ . tD
tD

N V N N N N V O a0 N
f0 ~ N ~ N N O ~
f0 fO r N n ~ f 47 fD 1f7 O O o O V . V OD O O O 0D c0 r N Gi N Q1 r ~ ~ N N M r N
~ O O O N u7 N r ~
O tp t0 r 0D u7 ~
O V O a0 M
op 00 op ~
p _ . N N V M OD (D
fn N f a0 r M 0D (O
M N O O O aD r- t0 M 0D O~ O fl) N
- fn V r u7 N O M
fn O
f0 ~f t0 W ~ N _ tp N f0 O u7 O W C1 O
r aD V W ~ f0 aD .
f c :
o n ~
o r fn fc fc v c o f co M fo _ a 7 f n ~ o r ao o a~
fo o r fry f r fo mn M fo N O f0 N ID M ~ 0D M 0 M a0 _ V
~ f0 0D f0 N cp CD y N f0 V N O
M N f0 ~ M
Of f0 f M N Of fD f0 O O7 cp Oi O O a0 (O
D O tD N u7 (p tp O~ N
N V fn 01 u7 N N N fD O fD
N M st Q O N _ M ~ N
? ~ Of t0 O N W ~f n ~

fn t0 _ _ (O r W fl f0 tD r 0 r O O N

O N ~ Ln Q1 f0 O N N a 7 f0 1~ ff7 Q7 r N N r M O t! N N A If7 N

(O f(7 ~ t0 f0 CO C
N

_ _ N N N f0 aD fn aD O
W aD 07 10 c0 op f0 CD
r O o a0 r 0D
fn D r N O a O o0 O M f0 O 07 O O 01 r O r O M

_ ? O~
f0 O _ O~ O O M aD ID O
~f N ~ ~ V 07 0~ (O aD V O
u7 W O N V
M N

u7 01 f0 N fp t0 t0 M M M 07 a0 M r f0 f0 O t0 a0 fn N O O f0 fn Of f0 f O fD f0 f0 M ~ f0 N N N N N M M M ~p r- ~ 0D N
N N fn V N ~ if Of W N t< M N ~
V N M M ~
f0 t f0 f0 O

N N n ~ ~ N M ~ N N N N N t0 f0 ~ N
~ r N M N N N ~ N
N N M M a0 N

_ ~ N N u7 r t0 47 ~

M c0 r u7 Of O a0 at O1M 07 Of O~ f0 V M O
O 01 O r (O Of N f!7 (7i r r O c0 N N N
O
M

1 O N _ M f7)f0 u7 f(7 1n O ~D f0 (D fn V aD N ~ N N O 10 O t0 t0 O
M aD f0 r ~ N r u7 a0 QI
M 01 r r M M C9 O fD
In f0 tD O IfJ 1n M (OO N N N f0 at O f0 01 M~aDCO NN~M fDU7~fmf0if~~ ~ f0 10 f0 r o0 M W
V u7 N O 07 t0 ~ ~ 1A f0 fD
Of !D ff7 f0 f ~ ~ O ~ ~
u7 ~ r ~
~ t0 ~ ~ ~
~
~
~

t c ( NtDrc t N 0 M t0 f0c00 0f D 0 D( N u7 f0 N f0 N 47 N N N 0 t f O
M N In N N N M N N N O 0r M
t0 N ( u'1 N a0 N
O N N N N
N N aD
N
M
N

W <L

d ' S g N

Z C T

Y Ol L Y ~ 7 O O C O O O
C
O
.

o o ,, o E
o u t ~ ~ .--. i o a a_ a a a_ a a E

C C N C C _ N w N R A f0 . C
.

c E E v C

O O Y O p 't se a a c a a a ' c c_ c_ c c c ~
~ _u> ~ 'a~

d d ~ fu -y c~
c 0 o n o c o o N
n O. d U n. fp G G ~
~ ~ U

c c c o c Y
n o ~

.m .'m .m a .' c ~ 2' .
tN

m _ m m o o ~ 0 2 p o O
c ~

U U 1L U cn U U ~
Q UJ

N ~ J ~ (D

_ 7 ca _ m ~

O U d Q 7 lL
o r ~ o n N O

< m fp U
o u7 ~ m Z > c fn f~ O C Y

U ~ ~ ~ c ~ J
c m m m ~u; u1 Q
d =

Z a ~ fn n a -. n 7 ~

a a a . , ~ o u~

v fh ' H ao a v o U ~' n v o ~ Y w Q ~ ~ ~
o o ~ o o , = a ~ ~ ' E f d ~ o Q M
.~ Q Q U '-' fu f = a u n y c -c I
~

O _ _ _ ~ _ O O
~

d V O fn .'C

C N C C C C J C
n ~ O
~ ~

m E m m m ~ -. ~ o n ~
ao fn Q ~ Q ' o g =:

>. o ~~ ~ ~N
u c~ ~ c~ ~ co o ~ ~r H
c~ ~ ' l I Q Q N
E v E 'm E H ' o a~ d E
a . ~ ~ o ~ h ~ Z E_ E
a C O7 C N N N d N n N
n C Y N d lL 7 U
~ C C

_ _ _ d N N fn d ~ N ' O 4j ~ l9 d ~ N O
~ ~N ~

V ~ O O O O Z O fm V O
r J a d d d d d ~ a o ~
to Z

N M Op ~ a U ~ a Q ONQ ~Y j a ~ ' ~

Z Z Z Z Z Z m Z 'c~ d Z
a c> o~ of U

aD O N V D aO O N V t 0 ( N N N N
'O 0 0 M M 0 O 0 ~ c P M 7 ' M c 7 c 7 7 f ~
c O O M ~ r O M
r '0 M E O

f M M M M ~ M

N Of O
0' 0 O r0 N u 7 W f7 V r 0 N
t N r f O N M ~ p O M N
a 0 0 ( N N 1 0 f p f a D

O p M

r f D M ~ M
O t 7 M
~
r m ~ o rn o r O a a O
G ~ r V ~ f 0 u 07 ~ u 0 N ) 7 O 7 u 4 c_ N In u7 < 1~ N
f0 u7 IA nj a~D O u7 ~t OD (O O) V u) O p N f~ ?
M ?

~

(O tf N N f~ 0D
t0 10 N f0 OD N
OO

t~D 001 O ~ N N O) r a .-p fnD f0 ~O at '? N 00 D (~j O O N ap _ (O
~ ~ ) O O f~1 O
~ N a0 u'1 n ~
~ ~ aD

~ ~ e~ N
aD aD W_ M O O u) f") h N
N c'~7O f0 tD
O O N 7 ~ t0 _ 7 _ 01 fD O
N fD N 1l1 u) f0 a~ O (O O Cf N ED 1f7 f~7 N ~O n <O N
~ N N N Of ~ f0 n N tn p1 ~ N N O EO N tD ~ O
n f N ~ ~ D

_ N N N V 00 Q7 f~ N f~
N W ? N (D N C7 f~ N
f0 f0 N ~ f~ V
N f0 N f0 1A t<
N

~ O c O V p 01 f~ N ~ O t0 O V V V N O O W N ~ O O aD N
O ~ ~7 (O Of ~

_ O7O O V t0 _ ? N ~ n O tD t0 M ~O ~ c~ <O P ? ~
W 1~ < <O ~O V th aD
N u7 c7 N c7 N
V 47 h u7 O

N h ~ h O O O cD _ O (O Q7O
M f~ ~ IA N V ~ N tD O th 1n cp M
N ~f N M N f0 O

O V N O) N h InN C7aD
N N t0 cD 01 (D u7 GD
~ u7 ~f GD
~O fh rf h f0 f0 tp ~D
p N N N N N M ~ O N ap NO
N ~ O r ~ ~ N N O
~ N c0 M

_ O ~ V
7 N ~ O
tD p a0 f0 u7 O O a0 (O c~ a 0 1~ O N OD 1A M O a0 t0 t0 O W ODh ~fN
M m O ~ (O V f0 ~ 1A O (O
1l) h (O u7 a0 f~

N f~ O p t0 N 1ff ? 1~ O Ih (~ ~ Q7 f"1f'7_ N t0 h N O O n ~ O 10 00 O fD 1~ O7 u7 (~ O
~ f~ t0 F7 OD
c'~ W

f~
~D N O M c~ ~D C'f N c0 ~ a0 V ~ V ~ W f0a0 V 01 V 1D Q (O (D 01 t0 st c7 u'1 N N ~ W M N 10 W V
~ M h 1l7 f~

COO t0 V f0 O t0 (D Of0 ~ N t0 N ~ In N '? 47 O h M O N N O
N Ip P7 N C~ aD O_ fD (O 1n N N N
N O
~

N N 1p ~ pp cD 1N O ~ _ h N KJ N t0 et' N GO f ~
01 ~D N O 0 M fv ~ N ~ ~ N N ~ ~ N ~ NN
N ~ N N t0 t0 N
O ~ ~ N

O, O fD n N n O O c0 O O c~7 c7 tO1f7 N V M Q7 O 1~ Pf ' O < p tD f~
('~
O

Nc~
V < u N O O7 t !D h W cD n f~
1 fD O f0 aD tD O O O ~D t0 Of O O
N 1~ t0 t0 a0 c0 O O h 1~ N 01 O O t fh O O O 1f7 c0 O7 O

_ ~ ~ ~ _ ~ u) O O t~
N ~ t0 u7 01 O O c O t0 h f0 ? f0 h 1 t0 t0 ~
t~ O h ~
~ ~ tD
V <
N

V _ P7N ~fV
N 1(f 1p u1 fD fD t01D t0 tD ch CO V C!u7 of P ~D M Imn OD ~ c0 f0 c0 aD
4'7 t0 cD aD N f0 c0 ~

N f~ N N OO N N N N N (D N c'1 '- ~ N fD NN
f~ N f~ '- N N N N N N
N ~ N N N

W W lLl1J lJJL1J

_ g ' g g g~

U

c U U
z Z

j ~ ~ E Z ?, zZ

7 N ~ 7 >

M M
(D O

O
O
~' _ O

a E a o m ....
c_ E v ' N

c ~

_ N
N (~ ~
C

N
O

M ._.

N t d c Y o1 c .

.N N c O

m C
U

_ U
Z

' r _ _ 1o D r~ a o ' ui s, ~

o a ~ m U
a a ~ ~ n ~ c_7 a m ~ o ~ C~ n N c n ~ W ~
m N
ao i. X v ~ '~ ~ ~ ao Q F- r A
Y o1 (O 1p ~ t C ~ ~ <l7 C N ? M O
Z N p ~
~ tn 05 U~~~Q o m ~ Va1 ~y 1 o~~ a ~1 N
M~

Q 'y 'E '? n ~ Q a m m u. p c y Z '~ '- =
c o 01 a1 m U
o ~ J Q y a Q
y ~ .

m y ~ _. o a N Q

,v_ . E o1 E Y , ~.
D O M Z d E n N C : E y X ~ f7 Op tD ~ (O _ O p O ~
p N E

OQ ~~ yy ~ ~ _ ~ c07= c0~ Z
~~ N d~ V

(J rr OD E M ~ ( O C
N N p 7 C n ' f0 Q C M V ~ ~ C7 _ ~ N N m ~ C.
' _ Q V ~
~

'0l G 'p1'p1I Of O 'p1 ~ .~
U ' N O

C ~ N Y y M Y a Y _ Y G
~ ' Y Z Y N M
O O = ~ O
~ ~

O a O O A ~ ~ ~ i0 ~ C C J
7 !0 J p : C
fC9 C C: Z N
(0~1 E w_ (D f'~ p N1 D m m f~ m V U ~ N N
M N a a C 10 01 N r O D

C7 O C~ C~C7 C~ U, C7 C7 U' C~
D N co O
E ~ O F-N O T L O C I
E Er EoIZE oo Eo N Emw E r o E ' E
Of V
V

N _ m _ _ N H ' ~ ~ N Z
a N ~ ~ N N ~ N N ~
' H f0 Z
d D ~ N 1~ C C a T N C C
~ 2 ( y C C L C ~ ~
C E (L n = ~ O
O Z f0 ~' ~

N ~ ~ D C
O y C1 . ~ f0 N
.- N ' N

~ N ~ O O O ~ O _ ~
fD M m ~ W O m nff N
t~9 Z 1 N

p O O O
a1 N dNIL~oO a a a"~ a O C7 TO V
H C O arnc N O O
N N d h u7 Of 111 J ' Q O y . . N.
~ J ~ N O O7 Z ~

' o v H m m > > > > c ~ - >
> ~ o E ~ E o ~.
~ ~ g o m z'o1d z~'~www = a " zQ ' N
~ = E

z z rn z z z z z aa o1 o, 'o1 Q

O O N ~ 0 D ~ ~ O
f a , p ~ N
O 0 0 O ~

O
M M f ~ ~ c ~ c ' ~ 9 ~ l'7~
'1 ~ f C
f n O c W f7 01 f ~7~
N N f ~7'7 h 4 f f ~

V.
O ~ O O O O O O O
O

OO
.

N . r Mh M u 7 N~ D D o 0 ~ ~
c'f f M c 0 ~O
r ~

p p N ~ ~ D O
c Nn a o n n n ~
~

a o h c c o o 1 a o ~ n o1 a 0 u7 O W r O a0 (p Of O tD h N h tD
1n M N CO (O N 01 V a0 r N N f0 c r M N < ? ~T ~O O a0 r N M <O ~ ~ ~
N h O ~
O
(O

N O ~ N (O O tD O~ (O _ W f1 0_O tn 1n CD 1O ~O t0 4) N < N f0 t0 c0 u) V t0 Of V Q) O Qf O N ~ N V N
M M O O O M O tD
f0 1l7 M f0 tf7 O Of M
M N ~ O7 ~
OD
N

_ at N (O N p O_ N (O r ~D In M ~ a0 h ~f1 M M N N W f (D M
O r aD M O M t0 ~O O O D (O N V N 01 1n M
N N r h M V N N 1A (O
O

N 10 M ~f r N CD M N ~O ~ N _ ~ N ~ ~ M
~ f0 00 r N O (D ~ aD N (O
M

O t0 07 O f0 r O O7 O) t0 M O) N r (p t0 f0 O O fD N O V O N r M O f0 M
t0 O

h O N ~O t0 N N N O et N M ~ ~t CO N (O N CD
N 1f7 C~ c0 t0 t0 r fD N V c0 f0 M (O
u7 aD t0 s<
c0 M . (D N u7 07 f0 M O IO O c0 N ~7 h N
V7 t0 N tp M ~ O ~D fD h f0 ~l7 r N Q) N Cl N O O N h ~ ~O N N V N ~ h OD t0 4'7 V N 10 Q r M M ~ N ~f V O 1!7 o~ co o r h mo ~ ~n o co a~ M so '- - cc co m ~o ~o c'b ~c ._ . r ~ M
M M ~ h N N l7 N O~ N Qf _. O M of fp h N aD N O N aD O O N f0 ~f7 N N vff r i!7 O '- O N
W

CD V N N Q m h V f0 O N f0 00 O . tn ~ M N W f0 a0 V Q! 1n N N M OD M

-l0 r _ (O U7 ~O ~ 00 O N Q) ~- M (D W O_0 CD M N O fD ~f r M t0 aD f0 f0 M a0 M u7 fD ~ ~ r u7 N N M O ~ N f0 < M
N ~ V aD O N V ? 00 (O V a0 f0 N N M 00 N CO V < O M 47 CD
N
M

_ t0 O t0 O ~O a0 W t0 h ~ V O) f0 N O l0 M N
IA t0 h O ~ h tD (D Y
O ~

N t0 (D tD r ~ r r ? N a0 et _ f0 1n 1n V N u7 ~ N (O (O t0 < tD N f ? ~ ~ r M
r N N V M
M

t0 t0 W ~O f0 Of N f0 _ N fD aD tD a0 N O (O
u7 O W EO f0 M tD (O N t0 fD N N
N r c0 ~O O aD N ~ ~ M t0 N ~ N a0 m Ip r M N r r 1n t0 N ap O N N W ~ M
W N N
N
r a0 N O _ aO OD M 1n f0 u'7 O N M cp O u) ~O
N u) O tD N
r CO f0 N O r h ~ h M h h M OD O 1n O ~ QI M ~l7 O r O O ~ M O N 0D ~ f0 LO f0 h M O Q) of u7 ~f ~ O O N M O ~ ~ ~ h OD
u7 N M M OD O N t(7 f0 OD ? Q7 tD (O M V O
t0 t0 c0 ~O N f0 Of N Qf 07 tD at M f0 f0 t0 c0 ~O Of O ~
u7 tD W O O O~ it7 ~
N O
r f0 ~ t0 ~ 07 f0 O
~O N N N N N M N N V N (D 7 O r c0 M u7 u7 N V N N ~ N N f0 ~ cD t0 t0 N f0 f0 ~ m f0 ~ N V ~f M N N ~O
~ ~ V N N st ~ M M 47 ~O
t0 tD

fD f0 c0 tD O f0 (O OD 117 ~ N N f0 OJ N ~ ~p ~O (O In N N N
r N 07 N N '- N N M N N N N N N N r ~
07 fp r O N ~O N

OD M r aD W t0 ap ap M 4'f fD _ r N ~ . .
~ 47 _ u7 ~ 1A tp 01 f0 CD

N O ~ N O~ a0 N N fO Y M aD O O N ~ a0 O ~
O~ N r (D O t0 r O M ~ O) aD O r M c0 t0 M M 00 (O N O N M t0 t0 N (D OO ~
(O N N N r i0 f0 (O N N a0 (O O O O
~ 0D N ~O 00 10 IA O (O
h f0 CO M fID :
OD O
GD
(D
N

_ a r m v a~ M o> a v a~ rn u~ _ _ o M ~c o M r r o o so o w o~ <c a o~ ~n c o ~ v o c o 0 o ~ rn n so o r u~

f0 aD _ N Of _ ~f tD V V _ c0 _ ~ ~ f0 '? ~ V V f0 tD V _ ~f V O~ N ~ '? O_~ 1f~ V V M fD ~t a0 N W ~D O ~ ~t tD ~ f0 t0 00 <
f'1 h ~ fD t0 h O t0 ~O ~ ~ O t0 ~D O~ h ~
t0 a0 O ~O fD f0 t0 f0 t0 u7 u7 cD O

M 1n h f0 N N N M f0 N t!1 N M N N N t K7 m N N t0 N N N N N M M N N W N M N N
N ~ N N ~ In f0 N N

W_ W

_ C

d N

O

Z Z C

O) 7 7 Y

O

O

LL N

a m c c _ 3 ~

m o E c O Y

a o C N

'-y Q

O C
' a m H E

c o ' m a ~i O D J

U a C7 N C

i O

C a E

U

O

U a ~ < aho N

~

~aa a Q ~

J -- yr ~ .r n V O
a O

H C W O c n r Z N
~

r v o a_~ _ N ~f (V N

U ~ . O ~ c .

x o~ or E o~ v o, Z

C O _ Y
Y O

C

m m c m 2 m ~ ~
~

U ~ C7 .~ C 7 3 C7 c C7 c_ .

E ~ E Y E ~ E
E

'N O N ' ' N c ~ N ' O
~ ~
O ' c QU c ~ c ~ c ~ N
Q ~ c a 'd v, a~ Z m - d ' d ~
~

O O O C O N O C O J
Q N
=

a a a a L a 0p N 7 C7 a c_ O O r p .

N ~ j j ~ j j ~ ~ 10 lL V
n _ ~ a ~
~

Z Of Z Z Z Z ?
In i (~
C

N ~ ~ ~ 0 c 0 O O O O O O
M M M M M M

M O r O

O O O

O O O

M ~ v ~ M

p O 7 t D N

o N N OMf O t 0 r '7 _ 01 p ~ ~ ~ W

tD r ~ O f O

m a;
01 O M f0 N - . O) O _ f0 M

~O Of Q t~ 1~ O M of p V O c0 N . . u7 . h ? ~D . N ~ . t0 1~ u'7 .
O

N ~ O V aD 1~ O h u7 N (D (D
M M N P ~ N 0D N CD O

~ t0 N M OD (D ~f7 ~ et 1A O
aD N N O t0 ~ N O
- N M W V O f0 e- W c0 M a0 O O O N O t0 O aD V c0 N M u7 ? tp M 1n N M tt N
c~ n N V ? M
ao ~ M eo O N V o ao se o 0 N ~ M (D Iwt _ M o r c ~ ~ N M s p V N N
w cc ~c v N V
N f0 P N o0 M V N ~f . O tD . N O . pp t0 _ V O . .
1~ if _ _ (p . (O N f0 10 W GO fD tt N f0 0D O ~D aD
p CD r V N P N W D p N
M

O f0 (D p e- e- O~ ~O _ O N . p O
? N N h . . .
aD

O) N N M r M p M u7 M 1~ Of N O O M M e< O ~- M M ~
~ ~ M M OD f0 p ? ~ O DD O
10 10 0D M tl~ N W
~ 47 fl h a0 tD (O W o0 O p cD tD O O O t0 N N (O f0 t0 O <O t0 O M
O M (O N a0 N N O M ? N N DO 1~ N
N N (O ' a0 r-. o n . n . ao . so . _ ~n .
o ~ f~ Of ao c ao ~n o O ~ ~ Of b . o 10 N f~
N p M ~ p N f0 ~ tD ~
~ N f0 ~ M u7 O 1p (O 01 OD . N . N . h . . p _ O ~f7 _ op GO M ~ a0 N N fD

N f~ N O N t0 h (O O CO ~O ~D M
. f0 1L7 t0 p p ? '- M ~
M u7 aD u7 N O O M
a0 N - ~ O O c0 - N ~O
a0 a0 - -N a0 V ~ I~ t~ M O M V ~ M Q) ap O O
O~ cp of O N N f0 OD O
fD CO M O

M f0 O N V O a0 ~ M ~f u) ~
p O C~ N O O h ~O tD 00 ~ ~O
f0 h p f0 O p ~t p (O t0 O
u7 t0 t0 f0 tD N a0 1~ O

N ~O V N !O 1f7 ~ N tD N nf7 N ~
N OD N N N p ~f N sf u7 ? ~ f0 ~

_ (p f0 . f0 . OD . N . _ (p .
. N N N N . tD . tD
(D ~ OD '- aD u7 N t0 ~
V N f~ N 10 Of 1n OD N N
~ In N QI N
N

N ~O I~ N O (O _ N ~ h N M O) p . ~ f0 I~ X17 aD O f0 aD O LO h ~ W 1fJ ap M
aD 1l7 CO ~ CO M M ~ p O
M f0 m f0 e- M
~ f~ M
O

aD ~ O O ~ ~- O aD t0 N ~ sf ~ a0 CD p t0 ~ ~ a0 f0 M (D O
aD OD O) c0 f~ o0 ~c M o a> n M o cc o o M n M M o ? o ~ 0 0 o ao o~ o M m 0 a~ n m n N M Y 0 M W N M 10 ~ p ~ M N ~ f0 ~
~ '- p t0 ~ ~f h M r- N f ~

tD OI fD u'7 Of (D ~ ~O W p 07 ap t0 (O M O ~ a0 f0 O t0 t0 aD ~ aD tD M 00 t0 N

N N N N fD N N N N N N N f0 N ~
~ M N ~ M ~ N N t0 N N
N N M '-O

_ W_ O

l l U
L L

_ _ g .

U v U N
2 c ' z z C

m m a a c c ' N
. (O N .f0 C_ O

O '' ~ N ~
C

C = C
. ~N

d N .d O

o U_ o n d O.
N U

.

C C O
C

. m w .m m .

C U C
O C Y
O

U N U
to c d c o ,n m ' Z M N of co o~ ?
H y Z ~ a~

~ X p N _ O
y N = ~ N ~ ~ ~ U

d d "
Z
o E

c m c w U ' N a~
U ~ a : c i c~
Q c ~n n E E ~ E u ~ E ~ ~ m c D ~ w ~
D

~ > a o u E o~ ~ ~ g E hi ~ O

N d ~ ~ O
C Ct d ~.,~
U

h ~ d N . ?
N ~ ~ O7 ,t O aD t O I~ O M
N 0 y H Z

00 p ~ 7 _ O C (n O
O E t1 I 2' N N p O E
fD E L N
U

"-Ct =N - = . ~
o ~~ -'H o" E
o ~
~
Q

p J U p~ p p~ C O~ U 0!
3 E N d O O O E E m N
~

~ p E C C C C C
~ O v ~' O
~

m a1 m m L tD m m u1 N O d E 7 m ~~oa E ~

~ U f0 E w J ~ 3 E E ~ ~ p E
~ c~ ~ E W J ~
v N a N N ' N N ~N Q ~N
v m ~ d E N N

~ f0 C C C ~ V ,L.. C
aD h C Y 'C C Z ~
0 M pp C Z

~ ~ . ~ .
.
O ~

~ m ~ O
~ N

O ~ .~ ~ O O O
t0 f0 d ~ c 0 ~
d d l 111 ~ J y "
~ ~

~ ~ k a 1 ~.
a ,~ U1 N U

oJOOJD >a~ > >. > >
>~z o > z E
' m ~-- n _ - H a tn ~ o o - ~
~ 0 E

o N p N 0 0 o N p 0 Z Z tn ae 0 o Z U 1L ~ Z o. Z U IL Z
IL t!J T U a ~ ~ n M t0 D M
t M

M M M M

O O O
v < O N t 0 f0 a0 N O p OD 1 h c p y 0 p 7 N
M O

f < c ~
~ s O

~ ~ n N O> W Of p ~ p IN M V ~

M M M M

u7 m u W n u ~ u~ ~f u') O h u'7 h tG c'O~ t00 N nj O tr0 O _ 1~ ~ N M (O t0 h N 0D f0 10 N u7 O ~ 0 O Of OD ~t 00 A I~ V at .p ~p O u N t!1 V O O OD 7 ~
N

~ N f0 N M fD _ fp u7 ? _ ~ O O Ql '? ~t W M Q7 ~ 1~
O M N M CO ? O O N N N M N
O M h ~ tff OD
M

07 V V M M O O7 N O f0 (O O N M O (D O N
V OD O N ID GD
V CD
OO

~O O N Of f0 M c0 O7 10 N N 07 G~ M ~ tD O h c0 O h 47 1~ N , (p t0 ~(j N CO 10 h u7 vf7 t0 ? N N ~ N U'i V 1~ f_0 V7 OD N 10 N Iff N u7 V _ (O ~? O M
V M fD N Q
(O

O O N (O O N f0 ~ N f~ 01 t0 (D 10 (D
f0 f0 (p 1f1 N ~O f~ O
CO N

01 tD t0 O f0 T N - f0 c0 N ~ Of ~ N ~
Q~ V Y N O M f0 N N V V O tD N N
M ~ a0 ~

a0 Q) N I~ ~ f0 t0 tD ~7 1~ O _ O N ~ N aD V < O l7 N O a0 1~
N O 'C aD O f0 n!7 O O N W ~ M r N
N 1~ O ~ M In ~O

~O a0 N t0 u7 aD O f0 f0 N O ? _ a0 ~ tD
_ (p N h N N tD M ~
1n W

O f~ W M Y7 M t0 O 4'1 N N N t~ 01 f~ N O N
O O ~ O~ M M O vt ? N N O
M fD
M

t0 N M (O M ~ Q~ Of V _ ~ I N 01 N et KI t0 tD N ~ M tp a0 i0 O
a0 V

O N M O M M 1~ M aD 07 tO 0D t~ ~ O N M
f0 M O aD O 1~ t0 ~ (O N aD fD 10 O h ~
M N M N M ~ OO CO a0 N O (D 00 O ~O tD N
N N M M f0 N t0 e< ~ O ~ N
(O N
O N

Q1 O O ~O 07 1~ O~ I~ fD O (O tD (O
M c0 c0 o0 fp a0 O

f0 00 N Of N f0 ~ M N N V V V P W N ~ ~t cC
01 f_~ M fD t!7 f0 M N N ~ N 00 (O N
aD N 1f) f0 (O ~ M ~O
Q1 W ap 10 10 OO f0 ~ 1~
u7 N 1~ fO M
N

O O N N O N h ~ M N N O N N N Of M V O N N O
O O M CD 1f7 (p N N M N O < N
~f V M
f0 a0 00 N N tD O f0 _ f0 u7 O M t0 aD ~ ~ _ N f0 ~D 1A h a0 ~ aD O O M
f0 M t0 1~ 1~ OD M 41 et O W 1~ N a0 O_ Q) W N (Da0 O O O_ 01 ~ O V7 Of O) f0 iD tn h c0 M Of aO
t_0 ~ aD f0 O Q1 M Of Of a0 N N '? t0 I~ O f0 OD f0 V < fD < O~ u7 t0 ~ 'C ~ O V W (7 a0 f0 f0 ? V

N N M O tn u7 O m tD ~ ~ m h N O aD O f0 tD f0M tD
Y7 M a0 t0 1~ fp t0 (O O tD O t~
O u7 fD
tD

N N M (O M (O N ~O ~ M ~ ~ ~ M m(7 N ~ ~ ~M N
~ M M '- N 00 N ~ N N N N f0 V' M N

O M O _ c0 O f0 t0 f0 M <O O01 ? 1~ N 10 OD M CD N N N N N N fv CO M f0 N N(O
N 07 t0 O O of N M W f7 N h tD N t0 a0 O O

Q) 07 N N M N f0 N - 10 N t~ O a0 OD
~ 1~ O7 V O GO fD N O
O
O

Of 01 01 ap f0 O7 O aD CD N O ~ M (O N N 1nO M
O CO N 1~ M h O (O O O M M f0 a0 O M - OOD
O a0 O t0 ~ f~ N O O M
OD OD 10 O N ? t0 00 EO CO M u7 (O n0 ~ a0 ~ M O aD M r-O 1~ a0 a0 OW CO
a0 1~ t~ N M M O O O M et M O~ O~ O _ Q1 WN N
~ O_ h 1~ 1~ 1~ u7 O N O~ M O
N N ~ M M 1f) 00 O tD O
1n ~ Gf cD N M N ~ O 1~
M

_ _ _ Y _ ~ V (D ~ ~~ OD
N cD Of O~ ~O 1f7 (O V ~f ~t aD Y (O V fD ?
~O N N GO 10 M N f0 ~ aD f0 fD cD
~ C~ f0 c0 ~D ~ N 10 ~D U7 M ap c0 ~ f0 00 f0 a0 O 00 M
N

N N N N N N ~O N N N N N N N O ~ N M N NN N
N N 47 '- (D aD M ~ ~ N N M f0 N
N N M ~
e- N

~<J

L t UJLL

_ _ <l ~ A C d (/~ NVI

O ~ '~

5 ~ ~ g 5g a v U o , U UU

~ ~ ~

C 7 d U C C 7 O

M

O
O

a c E

c .

~
c o ',~

a E

N
O

C
a '~
O

C

O
O
v U
m c C N C J O
O

C

O o c7 n ~ ~
d h Ol Z N d U LaL 7 ~E d f0 In O N m n f0 n ' 7 O) C Q N tD O f~ V
~ ~ n C

- f0 O E ~ ~ N
~ ?

U N ~N 'V M Z N J V O vf1 l0 E p M
a0 p N O
O

. a ~~~a' a a a a~ ~a a ~ ' : ~

r . . . ~ . . ~- ai ,~ a N j ~ 0 N ~ z ~ o~
C d c n ~ N m N
~

H ~ j ~ m in E u .

n ._ u. ~i m ~ v o co ' v d E ; Q Q 7 a _ ~ _ ~ N I O

Q) O n L E Cj ~ ~ ~ ~ N O 01 t Y O 7 F- p ~C Y yj Y Y Y Y
~ ~ 7 n ~G1 O =: O

'~ r m ~ m c m ~ E w N ~ m m a ~ m ~
m o ~ m ~
r U' U' U' E U' U' C7 U' ~ O U' ~ ' U
o ~ E I ~m ~ op c ~
I~p E ~ ~ rn c E
E U Z ~

~

m E E E E E
v n ~ ~ ~ ~ ~ ~
~ ~ ~ ~ ~
O = O
~

N a N N N N N N
O N ~ a V j N
fn ~ p N ~ C

N C C O d C C C C C O
C Of . 01 d ~ C ' r N

O " ~ O 01 N d O ~ G7 N 7 ~ N N ~ d = N Z ~

O IA V ~ y p O O ~ ~ O O O O O N
M O N E ~
(' ~ Z O

ap aO f0 ~ M f0 f~ M O V1 7 d d d a ~ d d n.
' Q d ~a o Q

o c ~ n ~ n c m o 2 E
c ~ N a~ d ~ m a~
d c p a O ~ O H M ~
Z a N E ~ ~n Q~ " ~ O ~ O O
o ~~ O
o Q c . p ~y O ~ O
QV _ L ~ =m ~ ~

Z ~. y ~ N N Z Z Z Z Z Z Z .r of or n o> o> a fn m - N o O O O

O O O O OO
M M M M M M M MM

I~ Q1 M ) ~ O M
u 1 n n O O O O O OO

M M M C v ~ M M

N ~ ? ~ O

? n aW
~ D

n ~ ~ 0 n ~ 0~
an t C rn n 7 ~

n <~

rn a ~ ~ a ~ o m ~o r'o o ag a" o~

O~ O N
M

aO
O

_ ( N m f0 O
p ~ M ~l1 h N
Q1 ~ M N N t0 M O u7 ? V aD aD N V f0 O CD O
M Y W (7 W O

N OD O t~f ~ (D a0 u7 fp p a0 N h a0 a t0 . N tD O fp O tD h O D aD M
u7 N O M t0 N N O~
M 1~ N O ? 1~ CD O Of ? y L7 N ~ ~ a0 O O ~
N 1~ D1 1(7 N 07 O N O N M 1~
N

N N N ~ t0 (O ~O tD O f0 t0V tD t0 O N f0 c0 a7 O fD ? 1~ c0 0~ N N
N o0 N O O a0 O (O n!7 f0 W u7 N t~tD 1n N M fD N h N N p 1f1 CO ~ W N t0tW nc7 M a D ~ O ~ M D N
1 ~f M N y!7 1AN M ~ ~p M (D

_ _ ~O M tD ~O N c0 t0 ID h tDV P tD M M N aD (D
OD O O u7. O ~ N
~O M O ~ p O
O f0 U7 (O M N O N N N N O 117 N 07 N 1n N fD ~ f0 V N N M N t0 (D V V N M O
aD G~ ~f7 O tD l~ (O f0 N7 p N O O
~

t0 tn cpOf aD h _ Cf N N O u7 t0 I aD ~D I . Of a0 N M O
~ N 4'f O ~ O a a0 V7 7 i N V
N ?

_ N ~ ~ c p M t0 c0 t0 u7 10 O O tD N Iw- pp N V N
N f0 p t0 t0 f0 O fD tD f0 O V O
u7 O~ ~

~ O t0 f~
f0 a~ ~t 07 N M O n17 N N a u7 N M O~ 07 O N l~ O O~ N a O t0 f~ M N M at N
h O N O ~f7 M M
N P

~ (D 01 tD M 1n N _ N op .p N s< M I~
~O EO fD u7 (p fD M O N . (p c0 N 07 ~ O N
O7 O n() W M
fD fD O f0 tn N

O O ap O O O O_ fD 07 O
N M ~t M O ~ N N t0 00 I~fD N M n O 1 V 07 N M N N O W h N O N f0 ~ N
aO ~ N N N cD ap O

_ ~O O O t0 O W f0 f0O O~ W aD fD N
t0 10 ~ M c0 O aD
tt~ O

N ~f N V ~ ~O 01 Of N N V' ~O(O ~ V ~ 1~ ~ M ~
N N N t~ a0 M ~ N of ~DI Of ~ t0 07 ~ ~ M O ~
D

N f ap N M _ p N (D .
O O O N ~ iD f0 (O aD tp f0 aD
O N CD N In N N t0 O
O O

W 47 N 00 N apN N N O O 00 p N
~O O M f0 N ~ N M Of < N N M M
(O M N O

~ N O ID N f0 1A 1fJ OD N O M
M N M M P 1~ OD(O p OD
t~ O M a0 1~ f' (O h t0O) a0 O h M N O
c a0 ~ O 07 OD fD t0 O f~ M M 1A h O

? _ ~ M O f0 00f0 O O '- N M N fO
O N V M O ~ ~ ap O tD 1!f (O f0 M p p ~ ~ O M N
N t0 O~ O~ M
h f0 O O O

C7 01 M off O O N Of M O
t0 N N N ~ ? 00 (D O I~ t0u) O O h t0 fD
a0 N O <O f0 O Of t0 N op N ? Q7 ( ~ M M ~t u7 N N ! V7 ? . f0 O ~O cp p ~ of00 M M ~ N N ~
Of O7 N (O lD N t0 10 O ~ N O c0 fD
In N O O (p N O fD t0cD tD ~t7 f0 N N 1~
O N N N c0 !D ~
N M N t(7 N N
N IA ~ ~
N

N f~ 07 a0 aD t0 1~ O ~ ~ N
a ~O O OD . Cf t0 Ofh N a0 M '-O 01 (O a0 O tf~ u7 O a0u7 1~ p I~ Of 1(7 f~ ~ 10 ~ tf N h ~O M O
I~ W O

_ 00 N O O t0 P ? _ 11~N O O a0 t0 O f0 M t0 t0 1~ CO O apM M 1ff ~ M
N f~ aD Of O O t0 O~
O aD O N N u7 V7 f~ C~
Q~ 1~

tD N N a_D O O p M O O
~ O N t0 f~0 (D N N ? ? N O aD O_ h O f~
IOC) (~O f0 1(7 ~ ? ~ tD f~ fD M Y7 ~ Wt ~ ~ ~ u7 1n u7 '? tp ~ V M OD M

O t0 N N fD tOt0 f0 t0 ~O Of tD
N fD N ~O N N 10 (O f0 (O f0ID (O ~D f0 f0 U1 N ~ N M O N tp f0 N t0 M 1n M
N N N N N N N N N M N N N
N N n!7 ~ N N M O aD
N OD

W l U N
1l J

LL _ _ (O
~y ~

(n N N ~ N

U U U D, in ~ L n d E > j ~ ' O ~ O N
O

et p p Q C

u ~ E
.

a a a o o c c L
a .m ~ >. c o .~ rn E o m E

' o ~ a~
d v :.
~

C_C- CN C~

m . .
E c o o c oa~

o a a r n o E
c N
E c m ~ o .~n c .m .m E
c ~ c E c c o U
~

n U C7 U C7 Z y o ri ~ 0 0 _ O ~
O

.n M liJ N
r (O 1n J
O h N
' N Q N mQ C C C
C Q C ~ ~
a m m G1 (n N m N m N
N

a a m O
m ~ m m H a L ~ N a a ~ N

N O O
O

c'cEinE zm m ~E ~E

2 > N m o ~ o LU x p = ~ o x ; c a c v .c M c m r ' o~ --0 0 ~ oo o c c $ ~

O c ~ c a c a c m r U m m ~,.~ c~ ~
m m$ m a o m ~ U U

~ ~ o o U

E E t a E ~ E
U E z a~ .
E
M
~
.

' Y ~ Y c c_ d c Y Y
a A ~
~

_ _ a~ d ~ ~ ~o 0 _ pc o u, v ~

O _ O O t0 O aD
O O M N
O ~
r n. a o~ a a ~ ' a N a ~ ~ -~ , > > m > > n ' > o d o m v . m tn ~n o o a ~ r ~ o o m a Z o o Z ~ ~

.r ... Z Z Z Q Z a a o~ N
C~

t0 O ~ 0 O
f O O O O _ O O

_ M M M M M M M

N n n O O 0 O O_O O

v v M v v ~ D 1 ~ ~ N O
C O r ~

O O p O

M O n n ~ M
M M

N M N N

~ W O p h p O D m O O1 f0 O O N M

N h 1 ~
O 7 h 0 o o o ~ o ~ o o ~
n a o a O ~ 00 N N 00 Q M
~ O 1f7 ~ O
A

< v!7 ID ~ ~ V aO N O 1f~ N
fD ID ~ 10 ~ O~ N
O f 0 t0 Of ~

ID h . M aD M
(D ~ IG V C N ~ N I~ O V a N ~ f0 O N 1~ tD Of V 0 It7 P r ~

_ _ _ O N u7 CO fD N ~ . a0 t0 M tp O O
O V aD t0 N 1l7 ~ ~ M

117 IC1 M O ~ N M O 117 ~ O) O aD N tD O cD N t~ M N O W f1 t0 ~ O N N M N Ilf ID f0 ~D
M 1~ V N t N N IA N 10 O O O
O 00 fD
N ~

0D M O O tD t0 1 07 f0 O 117 Of t0 t0 f0 O) 10 M ' O M O Of O
O O O N a0 N N
0 < ID ~O C1 f0 tD

N O ~ 10 111 V ~ 1~ N f~ M Q~ N O u'1 ID N ~ M N ~ N 11 N
0 u7 O 1 O O M .
O ID O N t0 (O t0 P O
If7 m O M tD 1~ ( N O Of a0 Q7 O aD N ?
M f N O ? N M M N M M
N Y t0 M N M ~ O N
Y N a0 ~ N ~

N t _ f N N 1!f CD h 1l7 aD
~ N O ap O N N M it 1~
O N O O N Y ~ 1~ N M N V W f1 N M
O Q1 N N N h t~ O M
( N t~ O

(p N t!) O N O N V M t0 N IA M N f0 f0 O f0 f0 f0 N 10 a0 t0Oi N
N ~! ~ O a~ O
' 07 h t0 ~ a W t~ N 1~ O ~ N t0 O f~ M n_ tD aD ID O aD O f~ a0 ID N N ~ O
1 m c0 Q1 N M 1 ~ 0 fD O N ~ er O 01 N N N O V t0 ~
OD N M M ~ V ID ~ N ~
f0 ~ N
f0 M

_ ~ O M (O f0 t0 0 O O O (D VO
N 10 ~ t~ t f O
M 1~ 01 10 N IA N
t t0 N In 07 N
G~

M V '? N N N N fD 01 ID t0 10 OO O - O
~ h M V M ~ N O~ O ~O
f0 M ~ f0 m ~ OI N O

t0 O t0 N op W O ~ a~ N N N N~ ~ O ~ N
f0 N 10 a0 O N f0 N ~ O N In ~ N
O N Of V N N ~ h N N

O
N W (7 u7 1n O OD N O N ID M ~ V
fD M _ l~ aD f0 W W W aD
~ O t D fD 10 u7 V

4D 10 O tml7 1~ A 1~ M M c_0 O O~ 10_ V O Q7 fD (O O_ M tD ~ O tD t0 V O
O ~ a0 tD N t0 t0 I c0 O V <
t0 t0 M I I N ~ M M - V
V ~ V 10 O~
? <O ~
a0 M

M W Of f0 cp D N O G~ _ f0 ~ hH7 IA f0 f0 f~ 47 10 01 M ~ M M tD ~ ?h O f0 h ~ f f0 1~ f~ ' tD t0 f f0 M M N O V
N N

M N V M M N N N f0 N ? N ~ 1u cco cc co 0 Y N ~f ~ V M N cc ~ n ~ V CO M
~ ~ < o so ~ ~o to ~
o In to if 1 ~ O N fD N N N N N~ O N f0 c N N N M ~ 01 N N fD O
o~ N N u7 N
N N N OD ~D D N 117 N O M N (O

M . tD N f0 ~ D Q7 01 N 117 Of 0D O _ M I~ O ~(7 Vf N N V tD a0 O I~Ou7 O
~ I O f O a0 O 1~ aD a0 W f7 O O ~ O N O a O 1~ O
N ~ 0 O O u7 M N h O
h a0 _ M N _ 1A O _ f0 _ If7 O O N f0 O OD OD O O W O 0 OO N N_ 00 10 tD 1~ M (O f~ M aD N N 07 ~1 10 M fD O
u7 ~
O O

N G1 O O h 1~ M f~ 1~ M N f_0 !'Vl O 1 1f7 N O O m O O O Y ~ 7 f1 V 1~ f0 ? < V a0 IA t0 1~ I~ ~ ~ 00N
V Of f0 ~ M tD N N M V O~ V 1~
u7 f0 ~ N f0 M f0 OD O (O ~
~ ~ t0 f0 f0 ~? In N
?

(D f0 f0 In M O N N O t0 f0 f0 N 1f~ (O fD N
ID tD M ID In ID f0 M M tD N NNN N N M
fD tD ID N N N N P N
N N N u7 N GO t0 N M OD O
N N M N IA M D N N
N N CD
t N N
N M

W N

W W_ WL_LI

lr_ lL L C ~ u'~C
l N

Q

O

L

of > >7v 0 ~ O
O

V
O

O O p O
CJ

" a a m a a v a~
~

~

N d ~ ~ ~ C
T O O Of p ~p y v o a a c c a ~ c ~ .~
= ~d t N

0 M o ~ o al o U

a N ~

N A ~ H N Q

c o c c c '1u U
" c 'm ~

m .
w ~ U Q

U ~ U U J
N
w a~

N
L

N 7 H = ~ Q U
f0 C Z
N

r d N , ~ lL
E O O

O d In a Q O U
M O N
'~ a cv ~ ~ ,~ N z ~ c O a a y ~ y o d o r '~ U _ U U7 ~ E U ~ E ~
~ E o~
~ o ' Wi 7 o yn Z
a ~ Q I ~ E

~ ~ ao ,n Q

~

c o Z ~ a ~ U
~E d E
o o _ ~
N ' ~' '>' o m ~n (~ O ~ D Z
O C ~ N

h Ip CI If7 fD C
jA OD G) f0 U

T ~ tf = ~ ~ C m E N E

N U M_ Q M ~

O Z J
~

G ~

m r m m ~ ~ m ~ m Z cn ~ ~ > D
M ~ m ~
v E
o t Cf p o C~ ~ uJ V
~
~

n C7 p C7 C~
p 0 Z ~ Q
'i O a p ' E E E oHm 2 " ~ E
.

E .cv y o0 c .
_ ~ ~ ~N _ Na_z ' a ~
~t/l U
N

y1 O_ N .-. ~ - d ELI
O N I
N ~ L ~ ~
C C

G C ~ C Q E :-. C N (' O
. n J lJJ ~
' D
E ~
E a =

r? v - Wn ? In ? in : r O W
' O N (~ ~
~N a0 ~ ~
L N
~

p M O O O O
l ~ a ' n. v a a c c ~ Q ~ U u pp o ~
c a Q a _ ~ > ~
'~

_ > M U > ~ C Z H _ = W
~ d > m ~

_ 'o m w o a N a z 'o v N

z z z .. z l v m > z .

O~ N ~f0a0 N O O N

~ N NNN

M M M M . M M MMM

O M47r O N_NNN

v r ~ ~ M v.M..M

O W f0 O O ~ CD~I~

N cD c~'f alD t0 ID10M

N N O O OCOf0 N ~ V p O NOf0 p N t0 a0 N (DM~h c0M1f~

m ~ ~ ~ O OOm O O

O NM

~ N 1~1OIf710 N _ ~ O
.

N O m m u7 1~ u7 W m 1A P . O W P1 u7 01 r m N h ~-O at M M N m m V r- N m O ?
~ f~ fD m t0 . u7 m m N N O Of N - O
m O . . (D ~ (O u7 it7 O
O

h V N ~ m O O~ _ O m_ ~7 07 N
~n N O O M N Q1 K1 tD . h N m i_~ ~ M m (O
t0 ~ f0 O M h f0 m Of N e- M fp O OI m M ~ mfW m N N N 1~ N ~- f0 m 1 M ~f7 P
N O ~1 ~

~ M f0 u7 _ N M N _ m O
r 1n 1p V N m N t0 M O M m M
O m ~ m . 01 m ~ O
N m m W . _ O 1~ . t0 m V . . . M
~f C7 _ N 1~ N V ~ 1~ N ~O O~ ~
m O ~ O m m N P '? M m at O N V M

m O tD Q~ . N N t0 07 . m O m u7 N . N m N ~ ~ O m tD N t0 ~ ~ N ~ m m . O N
~ tt - O m N m N O Hf W C1 N
off 07 01 h N V
P N M ~

. m . (p u7 ~ O ~ ~ ~ m N . (D
t0 t0 N . m m t0 N ~ m _ m fp m N O N . O M h m h N N M N M vfl ~ 1~ m m N
~- f~ O N O M Q1 O O O 1~ ~

W m Y M V M O N O O N m O
M m tn Cf t(1 ~ fD m ~ N M Of m Of 1A 1A O O M O h 01 ~ O ~1 O
f0 O) f0 m m M '- O O O
m 1~ 117 u7 u7 m O O 117 N N N N N N N N M ~f M ~
O m N m h t0 N A M 1n ~ ~ N m u7 Q

O 1f1 1C1 . O _ ~ . m O . m m f~ t0 m . m O N . ~1 M . O . 01 O ~7 O Of O M 1i~ N
- V N ~ ~ h N m m N N V V f0 V V ~ N N N N m m I~ V

M
N

m f0 _ m O m (D M N . m m . . m t0 .
f0 m . m fO . (p m M 1~ m 1n . . .
.

~ N N N O N 1~ m_ m u7 N N s< m N N
N N N ~ 1~ t0 h h - N I~ M M M
h O N O N N O
m N t0 M m N O m .
t0 O M (D m N O~
m O O M O P M O M M ~ N O~ m t1'7 W
~- ~ O m O f~ O h m O .- f0 I~ N O m O
O N

m M m M N ? O M M N m _ t0 O O 01 O O~ ~ m 01 m m ? O m 07 ~
f0 < m ~ N W 1~
m N O f0 N O m ~ ~7 M m O
m m I~ O - O Of N ~- O m m t0 h m N
~ m t0 'C ~ ~ ~ N m N N _ ~ M M N h V N
~ N ~ m N Q7 N N N m '- if ?
m m m m N N N 07 t0 N m m N N m m 0 _ . ~ . _ .
N N ~ N . IA I~ . N _ m m N N N N t0 ~f N N H7 . t N
N m N 1A . cD N
Cf O (O N N N
f~ N 1~ N O
N

. Q! N h N ~ . _ p1 . N . V7 _ tp . m . m . f~
O . h .
1~

m ~ m m O m N OD u7 nf7m O7 O O O N
m M M ~ 00 N m u) 07 m 1~ O M m f~
m M O O 1~ M f~ V c0 M C~ O ~ ~ ~ m N m ~ V u7 f0 m ~- N M m N m M
O t0 O < O
h m V
m ~ tn O~ I~ M m M 1~ u7 f~ N 07 Vf W O1 O fD m 01 ~ 1~ O~ ~ ~ O O O 1~ M
m Vf O u) m O t0 m V' V sf N M M V N V m ~ ? V
N V ~ ~ V' V O 01 m ~ st V O m V N '?
G~
t0 ~

m f0 m f0 N Q7 m W tf7 f0 N f0 h m m m m m m m m r- 47 f0 f0 N m '- t0 m N
N N N N M m ~ m l0 M
N N N N N N N N N N M N N N
N N N m N N '- N
M N f0 N
N
~L7 ~

O W_ W_ W_ L U L L l L L l. L

_ _ _ _ U U

g ~~ = g g g o Z ~ a Z a Z Z

S ~ 7 7 ? 7 7 N

~ N _ ~

O ~ O
O

O ~ O
0 o a o o L o d a a _ ~-c m c c ~

. .
a~ E

E E
n E

O O ~ O T
~

a a T a N

c_= cx c E

C7 ~ ~ _ N N .,~..

o o ~ o N
U

a n~ n~
' d C C y.=-,. C_ C
C N ~
~

N f0 _N ~7 nC 7 T

Q -_ o E c a ~ o UN a UH
U~~

Z a. m N

~ _ m a , C c 7 r7 (O

I Q' J N U o ai o E

Q Z
n d N U n N ~ ' '~

n ~ ~ ~ m a m ~ ai ~ ~

t0 O N m _ v ' "~ U Z U o~ n ,c ~ m - c o L1J = a ~ Ii r ~ d c~ ~
Z ~ c t c a ~n na ~ H ~ '? 'N a H ~
d r ~
~

a a N E C7 o v p v m ~ r o Z ~ _ ::.7 ~
a _ , L

Z MC LL n m N( d W Q ~ -~ '- L r ~ ~

ow U ~ or ~ ~ a? ~
a N
Z U o rN-_ 0 0 mOxw mT my mo m mU mo I r U' U' ~ U' U' , U' C7 o U' O

J p ~ ~ f _ a I
N

E ~ p ~ E E E E ~ E E a . ~ a ~ Z
. ~o .

UI ~ ~ N 'L N N tA N N
N C ~
N

c c c~o ca~~cY cy cd pI0 7 _ _ .r ~ :~ '~ ~ 07 '~ Z 't O f0 C) f~7 O C
= O IV

~ J O O m O O O m O O M
O) (D C
= =

_ a N d N.. d aoo a d r d d V- ~ O ~ ~ O

c _ N
Q N O
C

> ~ j O j 0 j j j m T
Y J O j m c 'Q
~ a V V
O

O O O O O O
a Q O ' a y C
' Z

Z , Z Z Z Z Z o~ a h- w o~ a ~

N ~ M

M ( ' f M ~ V
~ ~

M M M M M M M M M

N M m M C c M M
'7 7 M M M M M M M M M

O ? i ~

m p t0 m m t ( p p M ~ O! m mD M O
c ~ ~ N

Of O ) N N
~ ~ ~ ~ 0 m O

a D a 7 C O ' m O

~ ~ M I(7 10 . 07 ~ N OD M

07 e- u7 (p 00 n0 N . 10 tp O~ N tD
fp O~ Of . M

m ~ h f~ tD f~ ~ ~ O 01 1~ ~D tp V N
f0 h ~ O~ a0 f~ M O V O a CO G~ ~ ~t f0 ? a0 N t0 aD O Of V f0 1~ M u'1 u7 O t0 Y7 M
Y Of V

OW n f0 ~D O t0 N O t_0 N O O t0 t0 V _ (O O tD a0 CD O aD tD fD 1f7 N CO ~ u7 M N OD Of 01 fD ~ M DO M Y7 P N O N N m O O O M Of V '? Of O 1~
M V N V N f~

_ ~f h f0 ~D (D tD M f0 M 0D
OD ~ O aD N N f0 . t0 ~ N ? Y7 V O M N

O fD 07 h N N ~D M tD 00 N N N N O7~ N Q~ f_O
N ~ M 00 O M O O W ~ N ~f7 N W O V O~
N N ~ . m o7 N t0 c0 _ M t0 O f0 O~ ~ M N u7 h M ~ M
M N h V N ~
~ O> et ~

ap . . O ~ c0 N Q) . O ~ f~ O Oi cDM _ _ f~
a0 _ cD _ aD fD ~n . I~ ~ aD ? ~O tD ~ c0 O~ m of C~ s< V _ t0 f0 O (~ O
a0 a0 V ? ~ N aD N N Of O ~ n17 ~ O ~ aD
f0 N Q) V ~O N ap o0 N N t0 Of O1 V ~ t0 (O . N O . O O O1 M t0O M N _ tD f0 t0 f~ . _ M O O t0 t0 u7 M . h tD t0 N

1~ O V t0 V N N N 00 ~ < ~ ~ V ~ N c0 a0 00 a0 V 1~ N M at 1~ M 1~ N Y N ? M m ~O
O CD (D N t0 . O ~O t0 tD ~ N t0 tD f0 . 0O aD N f0 10 tD (O tD t~ M h ~O . V

M h V n0 N ~ 01 a0 M N M N N N N h O M M O
N O ~ O M t0 W ~ t~ O N V N O O e<
h a0 t0 O p !O N '- . IA tD ~ M . a0 _ . 1n O M M N
. O O ~ aD (O ~ O N N . M u7 O 00 47 tD
O N Q) O~ O> M M C~ m O ~ O tD _ OD v-M a0 fD aO O u7 t0 O N ~ 01 Qf O M
t0 t0 tD O h 1~ V 1~

N N O O aD V ~D M N O aD O O O tD f7~ N N o0 N V ~ ~ p t0 N a0 c0 uW < N t0 ~ ~ f0 W M

a0 . . O O O c0 O . O c0 O tn O fD ~D(O . . N
I~ _ tp _ aD t0 O c0 . t0 h t0 N tD . O u7 r- f~ 1~ ~ O N . et tn ~ u7 N M
V P N O ~ N N O ~1 ~ ~ N ~ N N N 47 47 N c0 ~ N ~ W O
M sf u7 a0 _ O~ N t0 (O a0 . aD (O f0 f~ f0 . ~O N _ _ t0 f0 . h . _ . N ~ t0 . f0 tD(O h OD 1ff 1~ Of 00 N N ~ Of N N CD t0 N 4D c0 N N
~ N f~ O M e~ t~ u7 1n N N N N W O O) M e- CO N N ~
N t0 ~7 a0 t0 ~ . tn . 1n N . ~ _ _ M . N O (O r- O
(p O OD M t0 N ~ r- OD - a0(O CD . m c0 1~ M t~ O N N h r O7 . _ 10 M ~O O t0 O N M aD ~ r tD ' Of 07 M u) !O vff M tD M t0 ~ M t aD
O M f0 O t0 aD N

_ ~ V O at Of O t0 _ V _ M ?
_ m O ~ ~ ~ ~ N M O ~D aD
_ ~D O O (O O 01 O O ~ M ~
N M O m aD 07 O O h (O t0 tD O 01 t0 N Q) O) O) O O h O O tD N t~ N ~
<O ~ ~ 00 ~ ~ tD f0 N N N V V) ~ N _ _ ~ ~ V u'1 M N M N N
N ~ N N N t0 ~O ~ ~ N ~ 01N CO N N
(p ~ t0 a0 c0 N f0 i0 N c0 ~ V
f0 f t0 (O (p D O 0 tp _ . _ p f0 f . . _ _ . . . . N N t0 _ ~ 47 f0 ~O N N N ~- . c t N M t0 O N P
N t0 Of O1 10 ~O 10 N N N N N cD M
N O ~ (O N N ~ N
O O ~

01 N . _ t0 N (O f~ N . u7 . . 10 . ~ 00 Of Q! M
~O O . . O op of r- OfOD M _ r-M Of aD h aD r O a0 tD Of a0 O~ ~-. . N
V t0 1~ t0 O aD ~ a0 ~ O O a~ N Of Of V
O ~ M aD O M O t~
~7 N O~
M

aD t0 ~ O O ~ t0 ~ ~ O ~ ID O '- ~ W c0 QO a0 N
t0 t0 CD W O Q) c0 N f~ '- OD aD N ~ N ~ ~O
1~ M r- O O 1~ cb h M h N O N N
1~ O V o0 O 1~ O) M O '- ~f7 W <O M Of 1~ I~ a0 O N O ~O O O N ~ ~ O O
O O f~ ~ O a O

_ W M O aD ~f V ? ~ ~ t0 N _ N M V Y7 ~O < V ? O tD ~O ~ V ~ aD a0 N u'7 O~ N tD N f0 M ~f ~f7 tD

a0 N 07 fD t0 t0 tD 01 t0 c0 f0 (D O u7 N N t0 (O fD ~ Of O O tf7 t0 ID 1D t0 N u7 ~n t0 N tD M aD fD u'7 N f0cD tp W c0 ~ N N N N N N N W N N 117 M N M N N W
N N N M N N N M r- N N N h W N M
N N M N N n0 aD

L L LL

d I _ _ 1_L C
O _L L_L

f0 (n (A (n d g ~ 5 r' n n ~ 0 0 o Z Z Z T
U

n > > > O

O i , , M E o 0 0 r o M o~ ao U
O L O O
C

LL L a a a ~. a d C C N C C C
~ Q
.

E ~ ~ E E E
a ~o ~ E 7 ,o ~ ~

c c N c c D N = ~N
a ~N f' N N N
' 0 0 o o o c U X

nv X n n n ~ y N C O N a N N
D Ol d C C C C C
'N G) C 'f0 (fl C ~G
' 'f0 W

(p C t C C
U d w ~

U 2 n U U U
iv N

Z _ ~ ~ V
~

Ct ~ t ~ ~
a 7 .m a D d ~ v> o ~
~ v a 2 c r r _, m o ~ o> ~
c j 0 V ~ NE ( pp O O

0~ N '-' _ C
n W m Y y n ? M m o m ' o~ U v) ~ ~ o o~
U o~ U M .r ~

: ~ ~ ~~ m~ ~
o D c ~m a> E ~ c ~ d ao ~ a n N a o a o ~ nN w ~ -' r ~ ~

~ h j _ ~ ~ n ~ ~ ~
~

E ~n o_~ ~ N O m N
O O - X O p M y m O ao v ao ' Z Q a ~ m E n . C7 W ~ ~ o 0 a ~

d M U O N ~ a N ~ N C
F- ~ C

~ D w- ~p~ ~ ~ O O~ O! m N Cr C ~

Y ~ ~C ~ y Y N A JC Y Y Y U
C C C Q V C C
a C C
C O
~

N t E = ~ C

m O m ~ V m a O m m m m 7 ~ N r ~

C7 O U~ o o C7 O ~ U~ C7 (~ (~ o ~ p ~
U

~ E n E=r E~ E E E n Ed d ' ~N ~ 'N N ~ ~ N .~ d ~N ~N ~N 'N GI
a >' ~
Z

c a~ c ~E U c . v c c c N E m ~

: c a~ .' 'H ~ d E ? 'a~ 'd 'm 'a~
~ - o ~ ~ y>
v) o M ~n o m o o 0 o o ~
N t M 0 r =

am~in a~NN d~U a~ a~ ani c c .

o p N o ~ t~n c a d o o o o ~
d o N m u.
~

Z Z ' % 'rn Q a a d v o, IL d Z Z Z Z Z ~
c Q
>

m O N ? tpN~ O N

? ~ O ~ t0h ~O tD

M M M M M M M M

r O M i0r 07 O W ~ O O c0 t_~ M_ M_ M_ M_M M_ M

N Of O f O oO N

O M Q O M
O O c0 1~

t O ~ M M ~ u9 t~
O

_ _ N O 1n OD
N M M iD O N O

p ~ ~ ~

1 01 m O 40 Of O D

n ~ ~ ~ n n o ao uw n u ~ um o o n m m r ~
W

O N O a M M p r r aD
D N ? O1 p O h r C tD
r O~ . N M
M

M (D ~ Of c_0 G_O o0 N N <O N t0 O ~ O t0 G~ f0 r M r ~ r 10 00 tD N CD CO M V (D a0 ~
V aD

~p~O r V VO O O Ot0<N t0N N ?~ NNM _ r0 ONO'C
a ' a Or MMN

O f0 tD _ _ O p ~ O
f0 _ O t!7 ~ M O p 10 t0 O _ O N c0 N
_ M O O1 N r N N M M M t0 C7 N if O~ M
u) aD ~O 'C
a ' u7 O 7 M N O aD N M h O O N O r N O
N OW 0 K7 N V t0 a0 h N ~D N aD Q7 01 u M
O !f N N N V ? WO i0 m N N ~ c0 ~

Of t0 ~O O f0 M O W t0 O O O O ~D ~O
O) N N (O O r N N ~D f0 t0 M (D r M O N ~D
r N aD CD M Q) M ~ N N V aO (O N ~O O
O f0 N O N 41 V ~
N O O
h N r G~ N O a0 O t0 t0 M f0 O O O~ O M O
O r O N ~t O r O ~ ~_ N ~ N
N O r N < O O O f ~ M N Q O aD ~l N N M t M a0 < N
s D ~7 O N
~ O) N a M

I N _ ~ O a0 M t0 V N N c0 ~ ~t W _ aD aD (O a0 aD
N ~D _ N O O
f0 Y aD N N O ~ aD 10 N D 00 . r Ip M O

aD f0 D M O < O ~ O nf1 N O f0 M O _ N O r r r O M ~ ~
N r r a ~ V ~ O ~
f0 0 M N

OD ? _ 0 f0 M O r O M fD
M r f0 f O 07 fD r r O
CD N N M r ~ r a0 N 07 O N O
~f N f CO
w7 N M O7 (O fD ~f1 1l7 Ip m O M p M
N t M O N f0 N M N fD N f0 nfl N N M N O M ~ M In ID N CD N h M M aD N t0 ~ tD u'1 V ~1 O
tD aO ~D ~l7 Qf ~O
~ aD
fD
tD

Of N Of M N f0 M t0 r ~ 'p N N aD
O~ N t0 N Q1 a0 O M V D ~ ~ N (O V N N N
r O ~ r N M t0 M M of ~ r' (D IA ~
N O (O (D M N
N ? .
~ N
O

ID O GO m m M 1n u7 tD Ol N . N N CO O CD
tD C N r N '_- - N M M N f0 O (D
fO M ~ N O7 N V ~ (O r 07 00 fD M 01 O N n!7 N r O O ~ M ' N
~

ap r f0 f0 ~7 N f0 N 1(7 _ N O O f0 iD f0 ~D t0 N r ~_- W ~.D aD 00 OD 10 M
W N N r M EO M 07 O ~ M M
!1 D 01 O O u'1 GD M O Y7 O N r (O
D M O t M GD
O N M V 0 r r ~O

N t0 t1 _ N M O vl7 t0 O ~ V M t0 OD 10 _ a0 a0 N M f0 01 01 ~ ~ 01 f0 ~ O
N O ~ ~ t0 a0 ~ c0 O
a0 t0 ~ ~ M O fD O f0 M

M O M _ N Q~ O O N N N N
N tp N ~O (D O 01 tD M tD f0 N tp O
t0 r M f0 M ~C1 f0 O DD O N ~ N
M 10 47 f0 N
' ~
N N

M 7 M N t0 N u7 O N ~ ~ ~ ~ _ N a0 ~ N N ~ ~ ~
u ~

f0 ~ O) Y7 01 Q1 N O t0 D ? N V N N N N r N
N CD V N tA r O ~f N 47 ~ N N 'V off N ~ W t O M
N O -M r O O f0 47 '? M r D N r (O r r ~ e u7 f0 u7 tD IA a O r ~ a0 t0 V f0 r N M
0 Of O N O O a0 O V r N V r t(7 t CO r O r CO ~ N a 01 ~(7 aD
r aD t0 r N
a0 Of aD ~O OD t _ M O W < O aD
N c ~ a0 aD V t0 ~ O N 0 O aD Q~ t0 t0 N
N O a0 ~f t0 ~f7 V O a0 t0 10 t0 0 a0 ~O ~ r ~D u') M
u7 O
tD
n0 N O r _ 01 M O O O N r M r r O~ N r r N W et O t_D f_0 N t0 u7 O f u1 t0 ~ O 07 ~ 01 (D O 01 Y7 O n(7 O N M ~
~ V Y N N V t0 (D ~ 00 0 M ~f7 V V C) Q V
V ~ 07 (O t0 00 f0 V O M ~O if ~ ~O m f '? c0 ~ QJ O t0 f0 O~ r O
~D f0 ~O

(O O O N N O tn N c0 ~7 n 01 f0 N N N (O N
(D u7 r f0 ~ O N u7 u7 r (O ~O N N N 10 N
f0 ID r ~ ~D N N N f0 N N ch f0 N N f0 M ~O N tn M N N aD M
N m N N M u'7 IA M N N N
N aD N

C1 Ct 0 I O W t1J LLJ

_ f0 G7 lL LL LL

' ~ ' g g g a ~ ~ N

U U U

r Z Z Z

n 7 c n 7 ~ 7 N O

O O

O O
O O

O

a d a d N

C f0 C C

'~ C ' N l0 ~

E E
M
O
J

O a v a 9 c ' c m y a~
o 0 0 0 o n ac a;a N
m ~ r c n c o ~

'(O d (0 N

c C o O
O
L

U N U Q U
~

a m O

C t0 n N ~

~'m r'~ ~ ~ o 'a E M N

v E m v v o~ ~n m v ~ v o v m N ~ = r N ~(7 N r U . V D ~ pp o N v c m E o ,a p ~ H
~ ~ ~ > c p -o - a u m m m u E Ex o ~ m . . 'aa Er a E Q Q
~ oo N N N Ol O _ ' r d aD u7 L N O ~ O M (D
C M ~ ~ r ' 01 ~O ~

OD u7 0D E H O
J O p M ..r ~

~ = a N n M C
D C
~

~ ~ C N r N O N
n C ~ N O
' 77 f' OT ~~ ~~ ~ ~ f - -_V_ _E
7L l_y ~ ~
~ ~

W C1 '~ '~ O 01 r Ol O~ O1 O~ O
> p y p d Y L Y Y 9 ~ C Y
C c c o m c E

c n c c >, n a~ c c :

m m N m N CD C~ f~ m N
N U ~ ~
d V ~ ~ ~ O
C J
~

E d E E o E ~ E E E E E
~ ~ c ~
~ ~ m ~

~N ~N ~N G1 ~N N Hl N N
O ~ "O~A ~
~

c n c c m c Y
v c c c c U
d '~ o ~
' >, ~

.y '~ 'Y 'd o d d d d c ~ o c ' n --M E a o o 0 ~~ 0 0 o ~ 0 o m o a a ~ a a v 0 a ~ ~, a o y a ' o E
L

a a _ r, o d p d O O > > >
C

C > E
> > lL ~ > m ~ O O O
J A
O

~ a Z N L Z N
Z N
~ Z
' Z a Z Z Q N Z v . ~
Q

O
~ n n r tD f0 r M M M M M M M M

~ ~ M ~ r n r r p O r M ~ M c_'~i_o N ~ N f0 tD M
CO M

~

N ~ N ~ r p aD

M O

n N r m m m oo~

0 0 0 ~

m m m of ~n ~tf u~

N r p Qf N O O . M tD _ - M

N cp O O r p M tD M _ tA N
~f O~ sf p N
' t0 p f0 ~ r u fD O~ 00 ~ ~ ~T fD
O 1 M ? M ~c tp . t0 10 o v o aD m ~ u~ ~ N V u7 o~ co ao ~o ~o r cu r V O 00 c_c M N ? N cc r un (O O N O ~f ~
M r r ~
N

~ N ? er N u7 N r M t0 ~ f0 ~ y7 e< et O fD (p 7 f0 N

_ h M f0 N N N
f0 (O CO ~D O) O N N N N
O ~7 In N O N
r N

N ~l7 W - O N N p N ~ ~ O
N 47 s< M
N ~

M t0 a0 u7 ~O Qf N O f0 00 p O O ~-Of O~ (p ~O ~O r cD
M r N V 00 ~O ~ W aD
a0 CO N N < C~ (D
f0 O 10 fD a0 ~ ~
07 N N tD M
~O W (O N

r V !D t t0 aD O fD
N CD r N Of fD r N O N t0 47 ~ r M Y r N ~ ~ ~p N N ~
O 10 N ~t ~ ~ e<

_ ~D O t0 ~O N ~O . c0 fD
tD t0 t0 O~ t0 aD f0 ~D
C~ f0 Of M O O u7 N N N p raD P7 N r N N
N O O N O N a0 N N N
r ~ N ~

Y7 M h M ? O N ~_ tDO M 07 fD O
p t0 c O Of O et O~u7 07 fD r 01 O
N O t0 a0 ~O M U7 t0 if N Qf cD O ~ ~ t0 M r h N N

~ N N _ N V O f0 00 MtD N ~ ~ ~ ap ~O N O~ N V M fD ~ O M N
f0 N N Q~

~D r tD M t0 W tD Uf lD~ tD 1D c0 f0 O
r ~O ~ r t0 f0 N !D
v c0 h u7 M

N fD t M h N V of p NN of N N N ~f7 ~f I ~ O V N ~ ~ ~ V V
~ ~ sf ~f N p t0 Of (p (O lD fD N ~O t0 l0 r N O tD tD aD a0V (O M N tD (O
~ N ~ fD N t0 ? ~ N N
~D 00 r r N N a~ N N
r N r O N N N N
N N N

Q1 f0 N N O7 O u7N . O ~ N
tD N 10 r p O M O ~ M o W ra0 ~ M (O _ c0 N
aD O a0 O 0 Of N O r- p Of a0 N M r tD f0 N 00 V ~f CD M Of O ~? _ VM M M ~ ~ O tD
~ O_1 0D O O O f0 ~ tDM c0O M N M
O O N < M (D t0 O
r Q~ ~ N O M O~ tD O
tD ~ N r fD
(O ~

t0 fD t0 M ~ M
N N N V tD M V R N NM ~ N N tD f0 (p N ~ f0 ? N N ~ ~ ~ W N M et N ~ ID t N ~ V N ~ ~
p p W fD LO O (DtD p f0 N Its fD N tD tD ~O aDt0 N f0 cD p tD tp ~O N N V N N N N O r ~D
N N t0 N M N r N N N N N N
N N N N
~ u7 N 10 tp r N O a0 N O GD
. a0 ~ ap N
N

01 OD O 10 OD 00 a0 ~N D1O CIfJet O 00 r M p r OD r r CO (D p 0 (D V M
~ W tf p N M O f0 M
M

oD M 10 v? V a0 O u7 fpO W ~ _M (O 07 O r N (D N N t0 ap tn M pa0 N O M(OaD f0 Q~ m V M M ? t0 M t0 O N ~ u7 a0 O O O r V O r t0 o0 V a< O
N O N 01 ~ r t0 O) f0 W O ~ O

O

M V 1f7 V N ~ ~ V M C ~ f0 M _ _ M
O) IO ~ if 01 f0 < O~ Q)~ c0Y7 ~ ? 10 1A t0 t0 ~ (O 1A V V
O~ O tD c0 ~ ~ tD tD t0 V
tD f0 h t0 O
(O t0 N W O~ t0 fD ~O
N N (O N N fD N N N N NN N t0 NN O~ c0 t0 N
N N N N N N M N N t0 N (C a0 1!7 M N a0 N N N N
~ N N
N ~
N
~

a a~

D D D O O D _ ' w lL l L L L W
L L L L

_ LL _ _ _ _ LL
t lL l1 l l _ (l~ _ _ (~ IQ
~ ~

I

1f! O N

O f0 > >

j Z ~T ~

> N ~ Q
U

m r '~ o '~ a, M o ~ o d 'E

o o o o ~ ~

N

a~ a a~ a c c cc c ' c E ~ ~
~

of n O O O O
N a N

a a a a y o ~
c C C C C
C N ~
N

.a~ .m .d .d m a d o o o 0 0 ~ 0 0 n c. n a $
~ E ~ 'm a~

N N N (/l E O E E
~

R ~ f0 !fl C U ~ a ~

~ o E

~

U U U U
v U N
E

A

m m c c ~

N

(O O C
N

r O

p Q7 p d ~ ' r p p C V N

N p V NN lAj p a D

_ O O E O O

U U N ( O o V N
o a D J O IL C ~ N lL

g E ~ Q a 'n Q ~ Q
~ c ~

N OD ~ M n N
N N

' Q N
t ? . aD tD
m O - !n m U N

r m o ~ U
E in E

ao c ~ ~, Q ao ~ ? ? o a Qa c ~

~ ' Q= t u n ' ~
' or o c~ o ~ m a o Y Y ~ Y Y Y Y Y Y
M N p N ~
C N N d N C N C C C C C C
~ M op m M
~p ~ p N
~

m C ~ N m m O r m O E N ~p C
N

UO U 3 U ~ ( 'O L ~N
O

I ~ = ~ I~ UQ U
~

d ~ O a a t0 (/l l0 ~
Z

~ N V1 N N M E
~ ~ ~ L
O
H

G d E ~ ~ ~ ~ ~ ~ O
W 01 ~ Of N C V

O) N O Z V r C V d f0 ~

o o ' o o o 0 o o v c .- o~ o m > 0 E

i~ acr,o da a;,.' duo a~i dc a~3 m N d ~ ~ d ~ d _ N Y
~ ~ N ~ N
N G1 ~ ~

N
~ ~ ~ v C ~ Y
C ~

O O O O O O O _~t ~ ~ V ? ~ ~ ~ ~
to U
Z
o r Z Z Z Z Z Z U Z
b : rn oi o> o~
r 7 O N V (O 0 O N~ t0D ON ~f 0 a 0 a a t p O O O 0 W pO O~p OO O O O
o M M M M M M MM M M ~M M M

41 M u'1 r p M ~l7r Q7~ M u'1 r m r a o co o c o oo> a w a~0 0 0 0 a ~ ~

_ v _~ _ _ v' M v M_ M MM_ O O M N 11 7 ODr p 7 Nfpr N M
p N f0M (O 0 N Nn M OY 0 r 1 t N c c0 ~ t r ~ OD p 0 ON Of O a D
D a a Q1 r N _ M O ~ M_ N 1 pM D N
r D O) r Mr O t nf N O N
M a 0 p f 0 N
t0 ~

a r W pp p OO O ~ N
~n r e r v r rn o>o r on 0 0 0 ~ r ~~

a~ aom o~ o n rm aoo ao~ o p a o a a a a O N M ~ O < Or t07 O N M
. O

OO O O O

f 00 0 0 t 0 tf t N f0 N m I~ O) O N
O V CD ~O N N N O 0 V ~

a0 _ 0 M
N N M ~ t0 Of a0 00 O t O 01 aD aO N O~ O 1~ h Of O G1 _ (O N
f0 ~ t0 ~l7 N M m f0 V n tD f0 ~O fD _ (O tD N
~ ~f ~ ? V ~ _ ~O 0 ~O
u7 Imn V < O~ N O~ ~ M O N 1~ t Q ~D c0 1~
(O f0 u7 f0 a0 t0 V
~ N

(D I~ 10 (O fD ~ G 1 cD t0 N N n0 10 1~ u7 V t0 aD O
h aD N O 10 N N (p fD N N
N f0 ?

N ~ ~ M N M O ~ f0 N V O _ 0 ~ ~ 47 N h N N N -~D
f f~ M Qf Q) t0 N ~ ~ O O f O_ op O M ~ h Q1 ~D < N W ~ of W M
Of h O N OWO W M M aD H
O M O~ ~

0 a0 V

f O t0 A Q~ N t0 1~ fD c0 (O - 00 t f0 tD O t0 N f0 O) (D

~

~ O ~ M O O OD N O_ ~t ? N N _ m N tD 10 h N f~ ~ h < Of ~ r u7 (D CD N
(D ~O O
~O Y CD O OD

t0 N N _ CO D O
N N 01 N _ N

CD Y Of 1~ M Of M 1~ IO ~
t0 h O ~O O Of f N 'C _ M h V f~ (O W N M O V fD ~ f0 O ~ M
Q ED W N t0 f0 (D O
O) N f0 N 01 u7 f0 O t~ M
M O O M u7 10 1~ O

r (p O ~ a0 aD O N ~ M M M N N
O t0 ~ tD a0 O o ? tp M ~0 O N N ~ N Q O) M N
V
N

o~ cc o> _ ~o (7 n 0 n ~0 0 0 r o o O ? m O N 1n N (O N 00 ~o ~ f70 N M N f0 1~ ~t ~ ~ N

D fD 0 (D 47 O O) N M O OD c0 V7 0 m N W f0 N f0 1~ a0 f0 ~
(O N N
f 1 f ~

N N 01 N O M t0 a0 V N N ~ Of 1 0 Q) N h O O N M M N
N N ~O N f~ tD aD W N

f O CO W t0 f7 CD a0 1~ O N O V 1~ O O
0 ~ M N N
1~ f~ O t0 ~
M ~ N O O W aD O
ef ~O aD ~ V Q
V I~ I~ V

Of N O _ ~ Of O
~ aD O _ O~
t t0 M _ u7 O O (O N N ~ f~ t0 V W ~f7 t~ t0 ~ a0 M

n0 N 01 N N N O) ~D !O ~1 N 1~ O
fp O f0 O ~ ~ t0 M f~ aD CD 10 N
1f7 N t0 < n0 f0 N ~ ~ N N N N ~O f0 ~O ~If Y
~ ~ t0 N N M N ~ '- < ~
'C

~D m ~ M t0 N _ (O tD
f0 ~ f0 M (O t0 t0 N N f0 N f~ ~ h O O ~O M V N N 0 N
M Of N ~O f~ I~ O O N N N
N N e N
f 0 __ n M . 0 O 01 0 O ? o r o~ ao r v u~ cc 0 N M O O
M O) h m c M
~O r 10 O O O O O N O a0 ~J
W O) h O N M M M

O O aD a0 O ~ N a0 O fD V O tD ~O O~ 0 00 u7 m f0 O O ? ~O aD V t0 O o~ a0 n M M wn M v v o f n ~
o wo o~ n so o _ ~ 0 V V
a~ o m r o a~ v co ~
o o so o_ ~f co o r v u~ v ~ f c a 0 N f0 f0 f0 V ~ ? 07 f0 t0 ~ f0 t~0 N V ~ _ t0 0 fD (O
(~O t0 (O V f f0 f0 ~ Q7 ~ N (D N N M N t0 M (D f0 ~ N ~D ~O N N f~ aD N ~ 1 (O f0 f0 N N N N N nfW O N n0 M 1n N M N M N N N
N N N N N N M off N W fl N
N N N N N

O
O O

~

U l lL LL LL
L

_ N

~~ ~' g x g _ c U Z ~ Z Z

(/1 N ~ 7 O d n O

O O

O O
O

O

a a c .m .m E
.m o o E

v c v c c ~~
c m ' -' c ~ E

n a o v N
C y =
~i c E

~j U
E W

c c~ m U E

_ ~ C ~ ~ d C . ~ L ~ d m ~

r c E
i Q p _ ~) y C
N ~
O~U

m , C
M '~ f M oyn U

O E N m C M 01 N J
N N

01 ~ d m Y i U ~ ~ 'n aD
~ U

n d N M C lL

j ~ N (n Q E y ~ ~
J

> N m C ~ G N
N

~ E O. A
O ~ ~

O (O O N aD aD
~

. v v = ~ ~ ~ ~' ~ ~ z ~-m g d N ~ c cn 0 ao m o N
~
w ~, o. a N r ~ N ' - cn o >, -, ._ a 'o y , y, o c, o~ ~
E ~ j Z

y Y Y ~ ~ C C ~ N
Q) aD Z c ~ fn O
W
c~

" c c m m m .' o ~ ' m a0 c U
O Q

M ~ ~ U m m m ~ O

(~ v C7 C7 = C7 ~ ~ ~
o C7 o " N~
O N

f ~ E o E E~ , ~ Eye NU
~

a N fn H -~N ~Vl N ~ U U
~U1 T t ~

~ ~ W H .
c c c c r c ~ ...
d ~ Y ~ ~ C
E c ~

v~, v~, vN y~ ~ ~ ~~n3 ~ E

O O O O M ~ ~ ~ ~
I~ ~ ~ ~
C N

d ~ d a ~ d d d p 1M V N C ~ C
~ 01 N

N
o n o v ~ ~ ~'' ~ o ' ' 'H 'm ~ E E

> E
,r~ E o 0 v 0 ' V a Z N
~ '~ n v Z Z Z Z a Z Z c ~af oi a ~

O N V t0 W O N ~ t0 N N M N M ~ c'N~f'N~ f'N~

t C C
~7 D D

pj M ~O A _ O N N N

N N _ N N N N N N
N M

v .M '. .M-.v ~ ~ r .

01 . N O N
M

N O O O 1~
r O p~ y~ N O O M

N O W N t0 f~
N n ~ ~O N ~ ?

N N _ ~ O O V
O O O W O ~ O O

O O O ~_ N M

p O O O ~O tp f0 tD f0 O O

O

o ;

a0 . (p _ t0 O r O . r r M O u) f0 ~7 N O
r N . 1W
M

O~ CO r N O r _ rD a0 N . ~ m (O O~ . . N M _ O
'- tp t0 . aD ~p O off O7 '- V aD ~I7 10 N O aD u7 ~O V f0 'C Qf a0 ? O
Of tD O1 ~l7 O N r r f0 V r 1n ~ a0 ~D
~

fD . O ~ . (O (p (p 10 ~ O . (D (O N O ~ N ~ f0 f0 10 tD 10 ~ . u7 . (p 47 N r fO r u7 . (p M a0 ~ t0 O N M C
r 0D ~O N V M O of M 07 ~ (O N D D O N O 07 N O 1n V ? 01 O) M a0 01 of O
~ u'1 u7 N

N O ~D M O ~D (D t0 t0 M 'C u'1 cD _ _ t0 t0 t0 e- ~D aD t0 N ~f Of < M . N tD
V 10 ~ aD 10 N Q1 N Q7 W ~ N N O t0 r r N r M (D Ql ~O
ap IA r N <O nf1 O r ~f7 f0 N '- ~- t0 t0 CO f0 N t0 nf7 M M U7 N V - O N ? ~ ~D M O N N f0 a0 O N N N h M N
M 1A N ~ M r N M N ~ - fp M M
M

. f0 r . t0 N . _ O _ ~ c0 . m 07 . t0 . r N . O O O ~ . . r fD . _ _ M ~ 1A 01 W O 01 'p f0 N O N N O 00 r N '- r N u7 OO N 01 cp N W U7 < tf f0 O M
~ O f0 N 47 00 (O
V ~

O . O t0 O) . _ O7 Of N r ~ r (O (p . O~ N ~n r (D ~n tD O . c0 M aD tD u7 r aD M O N N
~ u7 _ t0 N 01 0D O '-O N ~7 Of o0 c0 m O~ aD 07 N ~ N O ~ Q~ fD
N r M N ~ ~ ~ r M r- N of ~f ~
O ? N N N

t0 N t0 aO O ~ t0 aD ~ tD . aD . O~ aD ~ t0 O
. f0 _ _ (D t0 t0 f0 _ r 10 tD r M ~ Q (D
M t0 O u7 a0 . O r M Q7 tD
r GD N r ~O D N r O O 10 m D) O 10 M N r m M O M ~ N N M N
r O '- r r M ~ r f V

N . ~O _ _ O f0 N M l0 ~t O N M N ~ m N N N M (D (O O M r ~ N f0 N M ~ (O N f0 (O V f0 tD ~ M N Q) ~l1 ~ ~ M ~1 4D ~ N N O M M r O O ~ O O (O 10 1f7 ~ ~ M r h O M h r N M N f0 N N V t0 N N N M f0 0D V N N N M f0 CD (O M O) N Q M N M f0 M Op f0 M
~ N CO

_ O~ _ . t0 N . _ ~ . O ~ _ ~ fD . O _ Ip . O O r f0 . _ m r Q1 _ t0 N ~ N ~O V r ~ N f0 fp O N N V a0 ?
N a0 ~O tD a0 ~7 N tD ~D O 07 N t0 < M tp M N V M ~- ~ tD
~ N ~

p~ - <D CO N _ O C~ N ~ N C! t0 . Q! r N N (O
- f0 ~ . cD . (p N O ~f N . f0 10 u7 (O N
N t0 _ r M W OD O ~1 N N 00 O r ao O Q! N N 00 O r M ~ M ~ a0 M O 47 CO CD
~ r M ~O N N N M N O
M N 00 ~ M V

cO 1n . t0 ~ O a0 CO ~ cD _ ~ O CD V ~ . M .
1n t0 M . _ N (D _ r r t0 . tD r aD fD
_ N _ ~ N

r N O M O M V tn r r M O ~ V aD O r r M M ap O N a~ r N N O ~ W n W u7 ~_ O1 M a0 ~ O_ N V O ~D W ~ N N M tp W f0 ~ M N N
O fp M C 01 fD N M M O ~
N N f0 ~ N f0 f0 (O ~ ~ 07 iD 1f1 M V

_ O O~ _ M N u~ O O O
O t0 aD r ~ N N W O u'! N O ~O u) O N M aD
N f0 O f0 t0 O M M ~ f0 N N fD
O M N t ~ M t0 N N ~l1 f ~O N ~ N ~O M M ~ (O V M ~-~f7 U7 M N h N N M

_ V N t . . tD _ (D
N N . tD 0 N tp _ N t0 ~ (O . f0 N . t0 _ fD
(D a0 N
(O _ . . . _ N (O N N r N Q7 . f0 N ~ N fD N aD N V N N N N u7 s<
N O N ~- ~l N K7 In N W N f0 N N ~ M
r N ~ N M

p> O _ O 1A . ~ O N N . OD . O a0 ~ N N . N
. f0 . . . . t0 _ N f0 r M . N . ~ r N ~
O N a0 aD O) OD aD O O t0 CD CD OD
Of O) N O O Of O r ~ r O ~ N M O N r N W (D
Q! r ~ f0 a0 M W a0 M M
M M DO N

a0 aO ~ aD fD a0 t0 a0 ~ r- O r (D t0 t0 ~ .- O a0 ~ f0 N O fp ~ a0 t0 N u7 tD '- ~ N ~ O aD
O N N a0 ~ a0 c0 N
M

r r W O r m m sf r M M W O O f0 W(f Q~ M M O M ~ f0 O O r_ r tD O O aD O V 10 M r_ O a_D p N N ~ Vf a_D ~ (O N M M ~ t0 ~Cl t0 tD ~ M M IA
Q1 10 N f0 ~ Of Y7 ~ ? ~D (D f0 ~
~ ~ '? M
~ V ~
~t N N <O N ~Cl (O N N Q~ 01 t0 M ~ ~ ~ tD
f0 r- fD fD (D (O ~ (O N r 00 t0 Q1 N C1 O (O
f0 O (O f0 N f0 r t0 O CD
(D (D

N N N N N M N N 47 N N N N M N M M tn N N N N
N N f0 N N N N N u7 N ~ O N N t0 N t0 ~t'1 N N ~ ~O
N

W W O W_ LL LL U L
L

X (/~ O w _ (/) a n o.

o y m ~c d U U a ~ U

E ~

7 L 7 d N

_ C
' M Of O
O

~ _ O p f_D O _ O O O O

a a a a ._ c c c c c m .
' E E
n o Q

v Z
~

v v v fn ~

c ~ c c c .- ~- d ~
a ~

y y y y x > ' m o o o o f w d G d ~ d d 2 C

C Y c d C C O
~N

O
T .eo d .m U

O S

U d U Q U U

r r c ~

N Q O7 J cC

~p V U v t m H p ~ Y

O 'L U lL T F- a0 O

"' m v N
~ Q r-~ E J
m r N N Q _~ N O u1 H N Q
M =_ U
U

N y) L1J
n a N

j~ a . Z' d ai Z

~ ~
~

~ N N I C t G7 O u1 w E

'o W o o~ ~ . :
o a ~ E

o ao E o o ~ N C J c , ~ N U ~
N

O L ~~ O ~ ' .N
' M ON w d . 0 o Of n ~. ~~Eo U= vc n c ~

u Y
, ~

~ .O~ O ~ V ~ ~01 O

O u1 E Z O
Y Y ~ Y m M y Y Y Y Y
~ U

c N c n c ~ o~ E ~ ~ c c c ,r, c p a N
Z

m n C m n m ~ M V N y m m m p m ~ ~ M
~' c~ 0 d C7 0 c~ ~ O rn E y p U p o U
r- o ~
;

_ ~ o ~ ~

E ~ m E ~ E W J t E E E a E
' , D V O v ~ ~ ' N , x ~
m N N N Q f/1 N N ~ N
~ a N

c ~, E c Y c Q W U o c c c m c aZ Y

. . . . ~ . .
J

o n = o ~ o a N p o o o ~ o p p o ch ~ v a o d ao d t1J ~ U N n. a a ~' o d o o ~ IL

c N Q UJ J O ~ ~ ~ M ~ ~
pp . f0 ~ In a H

> v o ' m > ~ Z ~- m E > > > u~ E >
v m M
p 'c Q N w w 'o z 'rn r 'o o a a z z z z z z . u ~ ~
~ x aD D N ~ f0 ~D O

N M M M M

N N N N N N N
M M M M M M M

r W M O 1~ O

N N M M M M M

N N N N N N N
M_ M_ M_ M_ M_ M_ M_ 07 O N O O off M O ~ t0 00 ~f7 cc a ao r ao u~ ~e ~

a0 _ O N V V

N N O) r N
N M O N M M

0 ~ 0 ~ ~ h O~ a a a m n cc r ao o~ o N
t0 ~O ~O f0 10 t0 ~O

.~

_ t0 Of ? ~ ~ N aD O~ V (~j O
O O O O

V ~ n f0 O1 1~ M OpD O N N fD I~ W
~ 000 N N
~

f 01 e0 tD N t0 CO N N O t0 4'f 0 O r O O O N f0 1~ N
N ~ N O V N 1 t O M Of O ~ N M O ~
~ 00 N N O O _ ~ 7 N tD O O ~ V 1l~ N OD 07 M
~ N ? ~ O O tp (O
N ~ M V

N Qf ~O p O _ N N M O t0 Of c0 N
fD O~ f O) 1~ N a0 aD N f~ O P f0 O
N OD (O 01 N N O

N N ~ a0 N U7 N M f0 N O N t0 O
~ ~ ~ ~ QO cD 't f0 O u'! N N t0 N ~ N M fD O
_ N f~ u7 h 01 O f~ Of O c0 O
f0 OD N M N N 0p M N 10 O 1~ N l0 N ~1 OD O
N OD ~t ~ Is N M OD !D O) N O M f0 07 O N W f0 O~ m f0 f0 tp O N n0 t0 M . 1~
~O OD Y7 O t0 10 N M _ N (O N
M ? ~T V OD In O N N N M O O 00 O N V ~
N N M N 1~ t0 tD V N fp ~ 1n N

00 f0 fD ~O O O~ aD _O (O (D 00 4'1 ~O M tD N
u~ a0 Qi Of . 1~ N V h W N
N t~ aD f~ O P ~ h ~ 1~ N M O aD M O
~f7 O M Of O M O N O O 1~ Of t0 O ?

_ O ~ _ (O N V M f0 O ~ O
f0 f0 M t0 t0 00 N N t0 o~ t0 N ~O
47 Q~ Q~ t0 O
O f~ tD O~ i O aD O
f0 O 1~ N 00 ~
u7 O M

_ N N c0 O~ u7 O O t~
N ~ m ~ ~ N f t0 aD t0 t0 if7 LO
~ O_~ _ O u7 h ~ N N N h Q 10 N N N M 10 t0 N ? O N V N f0 M OD

N O1 V N N u7 N t~ M fD (p 47 O7 1~ ap N
W_ N p N N N f0 N f0 c0 < ~ h M 10 1~ O f0 N ~ N of ~

N O O N tD _ V7 1~ ~ ~ N O O) f0 u7 O N f0 Of W . N (O N (D O N
N u'1 O aD ~ m N aD ~f ~ O O ~ a0 Of M N
f0 f M P N N N O, 01 O N M
D

V aD In _ _ O 00 aD aD 10 ~ N ? O M ~f N
M fD ~O M ~O N I~ V7 1~ ID O O
1~ 1~ aD ~ O 1~ O~ M < Q) M M O M ~ a0 M 01 (O N O tD O O N W O t0 P
Im0 '? Of <
u7 N N O M ~ M CO N ~O M f0 O~ ~ f~ (~ ~ ~p ( t0 O M st O t~ ~ Cf 10 s< ~O ~O ~ O
~ OD M M ~
M N Q~ M t0 1~ N N QW
M 1~ M ~p ~ (D '- t0 tD f0 (D

N (O O ~O O tp 10 t0 N ~ O N N N N ~ N M N O 1 ~ M P O V
~ O a0 N N N N N h u'1 (O f0 N N f0 N n ~ ~ ~p M M N t0 N f~ N (O 0p ~ f~ ~ ~ at n nj pj N
N (O of ~ N t0 N h M A N 47 0D O N N
N 0D O n pp N

Of Of _ 07 . _ aD _ N ~O . O QI O N N O N
O O O f~ a~ t0 (O f0 10 f0 M ODCO
M W M N M O N N CD 0D N O) O Op CO u7 N
1~ M O ~ M f~ O M M ~t f0 1~ N M 1~

a0 a0 O CO V u7 cD fD O O V ~0 W N N fD O t0 ODa0 O~01 N O a0 1~ aD f0 ~ a0 f0 of cD V t0 Q1 O~ M
O 1~ Of O
h O O t~ t h D
tO

_ ~ O~ O M n0 V 1~ 1~ M M M ~ t0 NN
? N 'C V 1W 1~ V O_ O 01 O 1~ O W ~ u) V
t0O N ~ fD (O N N M M h V' fD
CO V f0 ~t M ~f ~t Q
~t O f0 ~ ~ ~ ~ (O V

N cp ID CO t0 cD N ~ _ ~c0 N t0 tD O 1~ N O N N N C~ O) tO O
N m ~ N N ~D f0 N 1~ N t0 r- N N N
N N (O
N

~ i0 N N N 1 NN
(D N N N N N (D f0 ~J7 N N N N ~ N 10 N

Q p p p L_JJW _ W

LL(L

a N

c n o d g U

U U o ~ U

> j a j ~ Zn Y ~G1 N

N

(O
O

O

C
.

O

E

O

a C_ d C

O '~

n E

N O

c a '~c r c ~

oa U tn a~ ui _ - O Q
V M

C pp C1 Z ~

O r m Q f'~
tn V

~ M ?

j ' a O 0 " D
so m E
<
~

Z o c ~ c U
T

~ v ~
~=

li ~ 11 O m d _ O
N O lL ~7 V) -! ~ a d ~ ~ N cG Q
N Q C

' ~o, ~N,,E oo rm ~
~

N N d r U ; ~ O O eC O
~

U N N = ' ~ c'o o ' E m ci ui g M m a c ti E
o M o E
~ W

~ ~ ~ ,r Q (O ~
~ O Q
~

O7 N O~ J O r - - O
C U O ~ t .O1 N N Z ~
m C N C C C Q Y < d Y
> fD O ~ v o c ~ p ~
E o m o m ~o ~a m > o m m C~ a C C~I-M 7~ ~ Q
7' o o C U ~
c Q

o~ ~ tn o p ~ c ~ a>

E E W J E ~ E ~ o . o u~ m ' E
N m (O
~ d N
~

N C N N Q N _ N M ~a 5a a c~WDp~ c c N Y ~~
ca7 ~ C ~ .Ø _ _ N
_ C1 J d f0 O O
V E

7 O ~ ~ (l1 O O p ~ = 0 Z M ~ U
o aow w~~D aM ao,Q a a o O
z o E o~~ o~ >o ~~p >
l-N E p o z ~ z z N a ' 'o ~ W T m a U

, . z z z o> r N V fD pp Q N

N N N N N
N

M M M t9 M NN
M MM

M ~ ~ M0 ~ 1 N N N N N O

M r c0O t 0 0 a 0 Of MW
c ~
O

~ M

I ~~
V V

M ( OO

~ f h ~
O W I ~O

O O O ~ Om N M W O
N

~O0 c 0 0 ( p N
f f O

f 0O
~

M O

N ~ O 0 r a n n O a D E

t0 N Of r N f0 N M N
O M O ' ~ ~ V 1 V 4 1n O ! ap - ~ O
t0 NN Ot~Ot~Df~D a OON r ~ M
~ ~N
~ N
M

(D N N t O ~D u N 0 10 M 7a N N 0) '? N
N of _ N D
N a D 07 u7 ~

N O N M Of _ t0~ O N ~O CO at r N ~ tp ~ p ~ O r f0 N r N

_ O_ O fD LO fD t0 a0 r N ~ Ot h u7 r aD f0 N N (O V 47 tp N X17 ~ ~ (D N l0 ~ a0 ~ N
Y V CD

f0 (D u7 fD 07 f0 N r fD O
O M OD 1n et O N M f0 N CO O ~ N
N N f0 M 07 N 47 O CO O
N ~ t0 00 M
~ O N
of In of N

(O c0 O r M ~D . N
O O M N N N f0 M r N u7 N CD
f0 N t0 fs W f7 e7 p N
M N O~ r !D O f ~ N p N
O

O r M . O t0 t0 N W ? _ tDr N r r O 07 r O O ? M N u7 f0 ~(7 M O N fD ~ V
W u'f p) t0 O r 01 CD r M r Op t0 M r r (p cD r N ~D N O) O Of M V N V N N N u7 aD
~ O M O u7 V t0 N N a0 N ~ ~O ~
~

_ ~c o~ r o ~o ~o <c u~ ~ r o o r M ao a~ cc N v N so ~
N M V r ~t o h N Oi c0 Y h ? Of a0 ~ ~ ap N N ~D tp N
N V 1n N ~f7 tD 'p t0 ~ N

f0 t0 N O~ . f0 O N fD ED r c0~ GD N N N tD ~ r O O) ap N ~L7 N N t0 N ~ OD 00 N
N ~ N O N M nf7 M
N
N

u0 01 (D ~f7 Of O N ~ aO
M N M 01 O r N N r N M M 0) ap O o0 N 0) r O O a0 O O
r O a0 O N O
O ~p t0 f 00 O

M M O tp offM _ ~ O ~ t0 pp M of O
QiM ~ O N t0 N f0 ~f op fD ~O r a0 Of~ O~ a0 N O ( r QI r LO Y7 ~
(p m N
t0 ~O O
O
fD

O M O O <O O r N N N ~ ~ ~ N N (O N r u7 h c0 N ~ ~ ~ ~ ~ N N M N N O ~ ~
N ~ ~ N N f0 W ~
N <

N ~ N N N N N W (i > ~ tD N N N
N N N N N ~ O N M
~ N N V N
aD

r O (D O) aJ 1n . tD
~ aDO a0 r a0 r . O aD N r ?
~ f0 ~ t0 tD t(7 c0 N O t0 ~O N ~ r 07 M fO r O
M '- aD M
ap r t0 r O M _ O a0 0D O ~ pph (O a0 pp ~p ~p O
4'fM M a0 O N tD pp (D O cD O~ O
fOM m W t0 M
t0 O

fD ~ O r r n!7O r M _ V M CO M N tD u7 N N < O O of O) O) O
f0 V '? ~ ~ O N <O r f0 r Of~ ~ st O Of N V tD t0 1n t0off < N M W ~t V 'Q 00 O ~ u7 V M
O~
~

~O t0 t0 fp (O V) N t~ _ ~D u) tA 10 N N a0 t0 l0 c0 N O a0 t0 fD ~D
N In N t0 ~D O M
N N

~ N N N f0 N N N N N N M M N N
N N N ~ N N N tf7 W
N N N
N

~

W_ I_JJ W W

LLLL LL- LL 1~

N ~ ~ N

U U

U

2 Z Z Z 2 Z Z c Z

N ~ 7 7 N ~ ~ Y 7 M O
C

_ O O

O
E

~

a a~

-(O N
f0 N

E E
c 0 o y a a c c ~

a~ 'a~
m o o o n n O. d d U

C C
C O

A

C r G) C
Y

U U
t~ W

N

- ' a ~

(0O W W N !9 OD O

O O O ~ V
E ~

c co N 'n v o v E
~ i r ~ ' N v Q

c ~ ~ ' !
n c7 ~

a ti ~ o -E m a E a a d Q E r m o ~

a_ d N a ~ a N V
N U ~ 1 ~ N 7 ' O ' (C _ O _ O O

r ~ ~ ~ r Y u~ ~ eo E L

o , ao ~ n' o ' o ~ ' _ ~ c 0 ~ Q

N O 7 u ' N y N (O
'f O

N Q O. m N ~ T
O!

Cl p1 (' 'p1 C ~ ~ 'N ~~ O
O a d ~ ~ ~
C

.
M O p N O O O
N

f0 m . m m a p C7 -' ' ~ ~ m ~ C7 U' m C~ n . E o ~ Q o E Q E v E E E
E a c 'N ~N ~ o ~ M c ~
N N

~ V N N '~ N O
c c E c c ~. c o c n Y . a ~ c . . co d N

m d a~ .~ . ~ ; $ .a? o o r a~ ~
~ ~a ' O O O O _ O O
~O N O
7 ~

O.. d v d p d N V
~ d O G a r Y 3 m aro y ~ r . -y v ~ y a~
o ~
'a O f0 a , c > N
o > > Y
V

z O O O p z z Q z r ~ ~ z U ' ' ' z z c~ ~
o, E

aD O N V f0 f0 O

m e o ~ n co r r < c r N N N N N N N N N N
N

M M M M M M M M M M
M

i ' ~ r ~

s c c c ~ n c ~

N N N N N N N N N N
N

M O M ~ .Mrr v ~~ v M

r ~ N M r O r0 N O O D _ O
a O ~ t 0 O 0 0 N G D
( a f ~

M Ofp _ ~ O O r r Of M O
r ~ M
O r r c 0 r O) N ~

m O

O O O O ) O 0 O

N ~ r ~

N M M f ~ ~ M M ~ M f ~
f' ~D 0 D t D D O D D ( O ~ O
t f f ~ t ~ f0 a0 Of N
t0 ' O

O ~ O a0 ~t O a0 N P O M aD ID
1~ N M ~1 07 O N O N V
u7 V ~ O aD tD 10 00 u7 1~ O t0 O7 N O
O O O O r O ~ M M ~ N ID O) N
M N ~

N V' t0 N t0 IO f0 t0 t0 O P O N It7 O
u7 a0 M f0 N t0 ? t0 Ip O ~
W N

M ~ N 00 ~ N M C O In V' N M ~ CW _ O O fp N O W O ~ if m V 'f 0 N f' 10 ~O ~ V a0 a ~D ~ f~
t0 V f0 M tD O~ a0 _ Of N N 10 O Q~ Of V V ~ _ M N N t 1~ In M u7 G1 D N 1~
< f~ In W O O
O7 f0 f0 O N P O N Y O N 10 N _ f0 47 a0 f0 U1 N f0 V N (O N
1A O N N (O 47 N M Q1 N
~ N V

(p O tD O M O N h f0 M Q1 O aD N ~ W M 00 . (O N
M

c0 N It7 CD ~7 (D N aD f0 N 10 tD ~ 10 tD 10 Of IA ~ Ic7 h f0 OD V N N
M ? aO N f0 1n N

OD 1A f0 ~ (D N tp N W 1~ aD N N M
O f0 Wl7 tD W O In f0 f0 t0 Q1 M
' t0 t(7 N DO
~f1 ~ ~ CO N
't N M

N O N uW f) N aD O aD f0 ~ tD M M N
1~ N M aD N N O M t0 tD t0 O c 1l7 tD
~ O

~

Ip cp (O f0 . M M N N m M V d0 t~
Imf7 O 1~ O OI M N N 1~ a0 ID M
0 1f7 O~ O ~ tD 1~ u7 ~
n Of OW O N N O M 1!1 M . t0 M O ~
O t a0 ~ ~ M ~t ~ N
t0 fD O O Q~ N V
O IO f0 01 ~ h M ~ I~ O Of fD O aD O> W C~ Of 07 u7 In O V 1 O t0 h M N 1~ M OI N a_0 O N f0 1~ 10 ' _ ~ N N ~t N O f0 C ~ N ? 10 M M Vl h N N7 N ID Q7 f0 N 10 M M N N N M f0 M N
O h O W
i~
tD
~

f0 ~ O O . ~O f0 IA t0 ~ ~ 47 u'7 N a~
N t0 . 1~ 'C tD f0 Iff Il7 P N f0 IA 10 N O CO ~ V N M
c0 O~ N N N f0 f0 a0 u7 N M . N ~ t0 1~ N ~1 1~ N M f0 f0 (D 0D f0 c0 ~7 a0 (D 117 . O O (D O I~ t0 ~_ ~O f0 O M M M CD t0 O ~O
~ h N N N f0 M
M N N
N N

_ O 1~ N ~0 . tf V1 O 10 M 00 IA N ~O 1~ a0 Mf~ N O (D
O aD O M N O OD 00 M m 10 Of M Cf ~
1~ I O V M O aD M 1~ h . (D N I~ ~ M O tD O Y) M
N V
O O ~ f~ M
O

f ~ In aD OD M O ~ OIOf M O
Of M O u) 1~ aD t0 M o0 ~ (O
01 M ~ O 01 a0 V M f0 t0 ~ O
117 f0 N N Gf M
fD M
O

m fD O O f0 O V7 Of Q7 1~ fD~D N V
ID M In a0 ~C O In N 1~ ~ N ~ f0 N
O a0 I~ a0 fD if M
fD In f0 u7 N N In IA N N u7 N ~ V QO f0 IC
N N M fD N 10 ~ ~f V V t0 aG ~ ~
N f0 t0 0 t0 (O

t0 tD t0 cD aD M c N N N~ t1 N N
In Of O O ~ 10 N N t0 N 4D ~

a0 O
N

47 m IA N N ~ Of 1~ N O N N N 00 O 1_~ M M O) M 0D f~ In 1~ I!7? t0 01 h a0 M N N M ) O M O (O Of OD a0 1~
N O M ) O IA 00 CD 1~ M
A 4D Q) O) M O M
O O
CD
Q

u7 N ~ O O_ ~ _ _ O In a0aD O ID O
N Q) O 1 N 00 f0 t0 t0 f~ 1~ O
N N N Q In Y7 07 < O M t0 aD
P ~ In a0 a0 M OD O O WL7 1~ u7 M Q7 1~ t0t~ M M O
V O In 01 O t0 O 1~ IA O O O
In ~l O O tD In In ) 1f1 f~ W 7 a0 < 117 fO (O c0 N t0 M Y < VN M ~ M (D
f0 !O ~ 10 ? IA < ~ IDIn f0 O K7 ~ W ~O N V iD OI a0 Y7 N M (O M t0 f0 N Q~
f0 t0 N t0 f0 tD fD
00 op 10 M M
N t0 t0 O t0 t0 N N M N N N N NN N N N N
ID N In M 1L7 N If7 N N N N M N 10 Y7 N ~ r- N M
1n t0 In N N
N In M M M
N

LL LL LLlL LL V' U U U UU U U

~

Z Z ~ Z >j > j 7 ~ N

M O

M O

O
O O

a a c c m d E o ~

~
N

C CI
~

_ ~~
' U

o N f0 N

C E C
C

'~ O f0 IC

G
U

C J O
C

U
N

c ~

N
C

r N r U ~

j~ d c M

E ~

V
O

O N

O O c Q

U v v U
U t o a o n m O ~ N .d d d N
M U O

r E

d ~ N
H

I j 0 O O
N
I
U

N_ _N = C _ n ~O7 N O O
f0 C C
T

C
~ m d' CD
d c m ~

.m .N N

E L
C l0 C

C L _ _ d d . ~
w l0 O O

O V O L !D
' C
O

a~ a a alc C o A

H a y ~ D N ~ j n ~ ~' Z a d Z E Z ' Z
N

~

Of07 Of N N

N N N ~~ M M

M M M M M

pj M Il7 h Of M h N N N N NN N N
N

~ ~ .M.. v MM

~

(D 10 (D N W N O
O

10 N ~ IA aDtp V N
MN a0 N M O O N

~ ~ ~ Oc ~ ~
~' ~

a 1 ~ a a ~

~ O M 1~ N M Q- (O a~ t (O O f 0 _ N M O N N O M
N O N f0 Q) t~ fD 1 D P

(O Q) m u7 a0 t0 f0 (O O tp N OD aD < f~ D aD V
M M V O N m 7 O O G
O nf7 M f0 O (D

01 u7 (D . tD f~ f~ t0 ~f1 a0 N O O cD _ 00 N t0 c0 O t0 N M fD
O st N ~1 h O

Qf N M f~ Q7 N ~ ~ ~ r O1 ? N CO M O O ~O 01 V M O M
O V N N O O ~ N N t0 (D GO V
OD (O O~ aD C~

OO ~f M O O O f0 f0 f0 c0 I t0 M M O ~D Qf O
aD V 07 M O O ~ 1~ tD h M a0 ~
f~ cp m O O a0 t0 f0 N N ~O ? 10 N O ~ N a0 W ~ M 10 t~ M M O a N N N '? < O W ~ Q1 M D1 ~O _ N N N N ?
~ fD M a0 N N (O M N N O ~ O) N
~ O N (D ~ V
~1 N N N

N - ~O ID O V1 tD Q1 CD O N O M t0 OD f) a0 O N
00 f0 N (D O N f~ O f0 N f0 ~ 01 N 01 tn N N ~ V N QO ~O M N fD M N V N M
N 1~ ? O M ~ h N GO Q~ N ? W

V N tD f0 . O N f0 n(7 t0 aD N Of ? (O fD M W CO tD
~f f0 aD ap ? tD
V

(D N ~ M O V ~ I~ O C_D N ~ V Q) N Q7 f0 O ~D ~f1 117 N N ~ ~ ~ N N N 1n aD fD N
V V ~O O N ~ V 01 c0 N O
n o0 O t0 N ~D N ~l7 ~O
Of U7 f0 ~O N
O

_ f~ - N 1~ M O~
a0 N O ~ O O O O ~_ M N M 0D 1~ h M 01 N
N M M O h CC O N N N f~ N u'1 O ~f7 M
O EO M e< aD O O N ~f N

7 N m M t0 O f0 CD V M O (D tD N 'p ~f fD Y M V ~ O M u7 t0 aD h t0 In In '? 1~ M V
K V t0 N O t0 D O <O O) O) O O M O N
a O h ~D m O tn O
fD

_ (D N N Q) ~O N ~ N ~O N
D h t ~ M N 01 V ~l1 W O O> t0 ~ O ~ t0 (_O M ~ f0 N ~O
a0 O ~f7 O O (O ~ O f0 O
) 4'f 'P N ~ N tp (D f0 N N Y7 M N W ~O C
~ ~

_ O O O O) f~ . M 10 ~ O
N M a0 N (O N ~
N t0 M O f0 t~ < M M ?

M 07 V !D N N V < O ~ ~ 01 ~ OWf) N N ~ aD O N M ~D
N GO l0 Of r- N N off N tn W Q1 fD M N O 4D
V ~ M O

O~ N N . O O t0 (O ~D t0 aD 07 N tD ~O . Q1 QO OO O
N O aD tp N t0 07 0D a0 V C7 1~
~O O Op 0p 00 ~ fp ~ N N M O N N 1~ M ~l1 N M
N O 1~ ~J < N O M M N aD O O

W aD O cD a~ t0 1~ t~ M a~ ~ a0 O N tD ~O GO N . (O
M a0 ~ O~ ~O a0 ~
~ O O O 1~ n!7 h M M N
~ V O O
1~

~ O N 1~ M t(7 N f_~ _ N M M N V
O ~ M O I~ V 1~ f0 O N O O aD fD u7 N
M fD fD O O ~ N ~7 N ~
O P c Y7 N M ~ N aO
7 c O
N f0 _ (O _ 01 N O Of f0 a0 N M M V ~ O~ 01 ~D o0 a0 ~ N W (O M O O M fD O
~ Q_~ N fD aD < V t0 ~O ~ N t a0 p~ p~ t0 f0 u7 O 1~ t0 O
M O f0 fD aO M N

I N ~~ NNNNO~~N~~N NO_N NNNON~~ N
NNNNNN~N~~~NN~MmNN~O~

N N N h N N N aD N N N O (NO ~7 a0 ? ~O f0 f~ f10 N 1~ O
1~ N M ~ ~t7 O ? t0 N h N N OD N N N f0 '?
O h N
N

- M N f0 - N u7 ~O aD - Q~ N N - ~O O O N N 47 O
O~ N N O M 1~ O O W

_ ~ QO h M 1~ O W M aD OD
t0 O CO 00 In ~ O N aD 4'1 M OD O7 a O) C1 1~ h N 1~ O m aD M M ~f N O a O a0 P
O O O O (O 0D
~ ?
' ~O m N N m N O ~t aD ? f0 00 _ a~ OD 47 N 1~ N t!7 00 00 O a0 _ f0 O M M O
' _ N O N 1~
_ O
1 Q1 ~
a0 00 a0 fp O
C1 u h ~

Y ~f O V 1~ M M Q7 1 M M u7 t0 7 OD In t0 V f0 ? O O N O O N O f0 M M QI of f0 O) O O I N N
~ P C7 f N V
1n N

_ _ at N M M V Y7 N aD O O M
V N M M h V aD V ~ V t0 ~l1 ? O~ V V f0 f0 f0 O_W fl ~O ~ cD V ~ t0 tD N Q7 Of f0 t0 N
fp N 01 Q! tD t0 f0 O tD CO f0 t0 ~ ~D N
t0 N (D M fD ~f7 GO 00 f0 N
f0 f0 N N N N f0 ~f7 N ~f7 N N N N N N N N N N N N N N M
N ~ N N M N M ~ ~ N N ~ N N N N N N N (D
N
N

UJ

C

N (n N N

C O
.

d L U O U

a ~ v T Z

In N _ 7 Ol Q7 h <
O

_ O
O

O O

a c c c o v c c . .

d a~ .~

0 o a o. a o c N N
O

c c E

c m ~o o v U U
a a c~

~ v _ N

a o 00 N m n N

C

U d U a a m M a E E H j E

d a~ o ?' c a~ ~n m E
'a~

O N

O 7 n ~ j d ~

a~0 N M ~ N O M p~
p~
~

.o c .o~ o 'o, .o~ H
a ai -E

~ , Y r Y d Y ~C
y O
V

d C C N O

m C m N7 v CD (4 ~~ C1 d C7 U~
U

D

' E E
o E E Q a N . .
' .N '~' N N T N N fp c m O C L N C F-C C
d ~
L

O 'y 'd N d U O

o o cnn v m a a a a .r ~ $
o d ~ O , E O O
O O O O
L N

> M > > J > >
J >
U

Z Z Q Z Z Q
Q ~
~

O N g O

O
Q~ ~ M

N M M M

M M M M M M

M 47 n O

N M M M M
N

M ~ v p1 M N M

N

~ N 00 ~ (~O
~O

Q a N
f N
M

<O
M

f0 V O
nLf n P

O m O O O) O N M

f0 f0 ~O fD fD

m_ O

01 A O N _ m m (O r m N r m O (p O Of r ~

Of O M r W N m m r r O O Of m m M ~
M M m (D m N ~ . In r OW 1n (p m ~O m . ~ _ 07 O U7 O N
N N m 10 N . m 1f7 O7 . N
f0 m r K7 IA r r m M m r M O N Y ~O V u7 ~
O M ? O N M W < O M N V M V
N
N

N m r ~ m N M O ~ m m O O m m iD f0 ~D
N Om Q_) m N m 10 r N t0 m fp NMO~m NMOQlrON MV _ ONNNNNNV)~4'fN~N
r~h N M m N 01 N M N ? ~ N N f0 m ~O ~f7 <
M m f0 N
M
M

O M m . m Q1 tD tD m m N 01 m r O_ N ~l m W ~ 10 N O_ 01 m O M C~ u7 Of M ~ ~ m N m N N ~ m tp f0 m m m r m O O fD m M m N ? M N m ~
V

01 N N m Q7 N _ r m m (p N7 O 1A O m r m ~ m r 47 fD (O V
f0 O m_ m_ t0 O~ O m_ n17 r M ~ ~ V at ~t N 07 N fO w_ f r ~ O O M N M ~t r f0 M N N ~ m t op m N O u7 m tD N m t0 m O ~
N O m f N

. p 0 rM~ M r0 rNMOMONON?~ OOr m m NO N ONNNNNNm07Y7N10N

_ M m N ~ M V M W _ W V' N M ~
N M of Q1 O_ Q) N r V O t!7 O
~ O N O~ m M m m 10 O O m m m m N Of O M (O m ~f7 t0 V m O

? N
N N 'C N O N N N N ~ N N O~
f0 N r OD N h m N N m m m W ~ O O O m tp N
V ~ ~f M N m m N _ O N (O O 10 m O~ ~f1 O m r N m r m t0 m t0 N V N m W O m iD ~? (D N sf ? W V ~ ~
N ~O <O ? r N O m r N N V m N M N
N

m N M N M m O N O u7 (O t0 (O i0 m m m m ~ m Of m . m O W (O m m N m u'f M N O) m ~ t0 r m N N N N N N
m M N r N r ~- O C1 Of Q7 ~ N M N
M
N

m V m O m m t0 O m m fD m ~ O_ M m V' N M m N . O m N O O N
O~ M O O r M ~ O O u7 m O) m m O N N O O O~ O O r O O u'7 ~ M ~ O
r tp O

m M V M t!7 _ O _ ~ tp N fD N M ~ O~ N m O O O m m r of of m 01 u7 r N ~ ~ ~ m O~

N W V m t0 h N m 07 m M '- 07 h O ~ O tD
m N N O m Q) N N f0 ~O ~ m ~ m O t0 M N N N N N m ~l7 M N (D N ~ N N M N r m ~ ~ W n V M
N ~ ~1 N f0 N ~f ~
m N N
N
N

N m m m N 10 m m t0 m m r ~ ~ N r u') m ~ m nff r ~ M m f0 r O~ N m N ~ O) N m M N N N N N N
m m M O m M h N h N
N

O N - N N f0 O N N V M 10 m ~ m ~ O m m N m m ~n m m m M o~ m m o v c'~ ao ao ao n ~ ao m M o ao r m of M imn ~o r c~i m ~
v v ai M ~

~ O m N m m ~- ~ M ~f m m O O O O m m r m M f0 m m m m m O ~ M m t0 V M O) M ~ r M M sr M m Wfl O) O u7 O
~ ~ O ~ O ~ O O ? r O f0 Of t0 N N m O u7 t D
O

m M ~ M M _ _ ~ ~ V O ? 47 ~f m i0 O 10 m N M M m V m O
~l7 117 et 01 M ~ ) m ~
N Q1 O N N 07 O) ~
N M m O
Ip t0 m Q7 m m N _ ~ N N N N N r m m t0 tD t0 47 M N ~L7 N N N t0 r 1n m m tD
N ~O lp N N N N m N N N N N N N
~ 1f7 N N M N ~ N
m m N

w a m m ti c ~ ~ ti a N N

o ~ ~ N

U ~ U U

~ U

j, Z ~ Z Z Z

N ~ a 7 >

m W C
~

r N
~

O~ O~

O
O

N l1 LL d ~ d y ~

_ _ c C J
~ .
.

N N U
~

- C
. .
.

E Z

a a E .

c c o c o .-y 'a~ o o a o o a .c Z

~ ~ N

C ~ O
' O

N f4 H
. c O

~

m O
O

U U ~
~
~

J

~ Q

(D N O H U
d W

m y m I W
o M

O a O

~ J mi V

?. ~ ~ f f Em a ' Ec Nm =O

a~ E a L a~ d =
tn -IsN ~O d' On ~~ 111 d' a~o'~= aroE ~?' VU

f7 N - d M N
E

01 L O) ~ 01 O Of j V
N J
~

Y y y a y y fn M

C

c c c ", c c y U
~ ,~ J
.

N N l0 l9 N L_ C ~C l0 ~ O
d Y

C~ Z 7 C7 ~ 3 ~ C~ 7 O ~
C d O ~
E C
C

E~ E ~ E~~ d E~~ E
E_a_m Z

N N H N N H _ ~ !n ~
C) C CN G _ Cd ~ NC C'~

_ d _ Y ~ N G7 N d' ~N N a N ~
O
O

0 0 0 N 0 o a ~ o 0 ~
a a~

a,' ao a'r n. a' a'o r,~ d o N

~ ~ ~ o~ Y
, ~
o~ c ~ m d ~ ~ v m o ~

O O O O ~ O O O N
- d ' O

Z r Z Z Z N V Z Z
~ or t c~ N
C U

O N ? 0 m O
t M M M M M

M M M M M M

M 7 i s f u O

M M M M M M

v M v ~ M

~ 0 ~ O

f N I ( ~
~ 0 m m r r c .~

co a ~ r r a NO M

m r m m m m O

u 7 N ~ ~

m o ~ a m . tD aD _ (O N ~-.

O V N h O ~ (O CO O . O O W
V 07 O h h h t0 O) ~ O f0 M ~ aD Of O M
h O tA C1 e- Q) 07 N O) ~ V V V o7 ~D f0 h M
a0 h t0 M

O V O O CD c0 OD N t0 . N tD M t0 ~ O h h (O
c0 t0 t0 ~ M O CO ap h h a0 In ~ f0 ~1 N ~ N N ~ V IW
W M O_ N O Of K7 fl O) O V M
N ~ '? M N ap N N (O 0 . O l0 N (D . aD (O f0 t0 ~ h t0 N M f0 ~O

G O ~ N N M M V1 h M a O ? V V aD CO fD ~ D 1f7 N O ~ N N O
~ ~7 O t0 O~ f0 c0 N 10 _ N ~ _ _ N fD M ~ ap N N M M V aD O O W O Q) O O ~t 'Y
t0 f0 ~ fD N 01 h ~
M N M (O CW p (p h (p 1c7 M Of O
h M h ~ tD N M h h f0 fD
OD fD

M a0 ~O ~ CO ~ 10 N (7D N ~ _ N t0 M N O ~t ~ h < f0 c0 M ~ ~ t< t0 OD OD
O N O f0 N h N N M N
N O
c0 O~ h N u7 cp ~D Q1 O tD t0 h <O ~O
N ~O W ~D OD fD tD M O u7 f0 Of Of M h Of O 07 O 1n O~ N N ~ N N V ? n0 f0 N M N N h N M ~t f0 O V ~ OD
~

O N 00 10 OD V 4'f M Of t0 _ .
O> M Of t0 aD t0 V c0 t0 f0 M h M t0 O N O Y M N h O N M ~ O m (O Qi N ~ N N N h O aD O N h O of M M f0 N u'f M ~f ~A _ N 07 V M N a0 00 O M (O M aD ~ 00 tA h M 01 N (O M
~

N 01 tp M O h N tD t0 O aD M N N Of o0 O O M t0 (O W O a0 O N O m h O N N O t0 h tp h N O N ~O N N M uW f0 O O h c0 t0 ~O
~ N N M N ~ f N nf7 M M Q~ ~ O~ N M
~D ~D N O 0 ~
t0 O
tD M h M
u7 f O~ h tp h h h f0 c0 N 1~ O ~ W O ( aD tp h ~ ~ M a_0 m c0 fp tD M Of ~f u7 ~ t0 01 P W N fp N ? N V V ~ N N
N M O fD N ~D N N t0 N N aD ~f ~ u7 ~ aD
tD O N c aD h Of W N O ~O O

. O t aD a0 a0 a0 tn O 01 t0 a0 _ <D
t0 h N O N V h Y h M N O 0 O ( tff N M M a0 N ~O Y N N N
M ~ N W oD N V

O (O N CO aD N 00 OD O h t0 O h f0 N . N u7 ~
t0 t0 N O M W
~

O M M N O M tO a_0 h h t V n7 a0 O ~ O N h aD O t_0 O_ Of u'1 O h O O O t0 Of t0 O fD
~ O f0 M h O ~ O aD O 0D ~ fD
a0 M M O M O N N M ~ tD 10 10 07 e< (p M M OD
f0 10 f0 at Q) u7 ~ ~
N

h m O~ u) W O t0 N N O~ t0 M 07 t0 O O f_D ~D ~D
h f0 h N aD t0 (O t0 10 N t0 O (D 10 t0 O (D
N N N of W u7 N N N N M N h N N O N N N N ~ N M N ~f ~f ?
N a0 ~ - f V O~ N a ~ N M

~ o N f0 . t0 tD _ N M aT
t tD (D f0 h t0 fD f0 (O ~ M c0 N tO N N N N f0 f0 OD !p O N N N N a0 N N N N
CO N 07 (O fD Of h O M ~l 1 N V M ~ N N M N l9 N

N O M tp O7 YJ aD O N M tfJ _ O (D 1C) u7 t0 (O ~ . 00 N
ao ao m ~ V N '- a0 O h Q) h ~ 00 O
o co h h M t0 N 01 OD a0 M 10 O O ~t V7 CD t0 ~ h M h h O O a0 f0 O O 07 O aD
OD N O N O M t0 OD M a0 a0 a0 (O 1n Of h f0 f0 f0 ~ CO t0 c0 h M N u7 In (O
O
t0 M

V M O !~ O O of W h M M M tD V O O) O Y7 10 f0 O h ~ h O O O ~ t0 M N h OW D UI W fW
M h ~ a0 of lD t0 N M M ~ O u) '? 01 N O_~ O~ O_) tD V < V ~O V u7 Y ~t V ~t ~ M N O N Of Gf O < <O ~ t0 tD V' V
Of tD (O aD h ap M 1D O R
u7 f0 N f0 tD ~f7 f0 f0 t0 tD
M ~D f0 t0 n(7 M 1n tG t0 fD

N N (O N ~ N 47 M N N N Ip N M N N N N N N N
10 N N ~O N aD ~ N N M N M N M M N N N
N c9 cD

O O

W w N

N

Z Z

c 7 :~e co ~ r h ~ a~

o M
o ~

o a .,~ a c : c ~

~o .
- c .

E

v v E

c c o c ~y o c ' -y o .c z o c $ o a.m ~ ~ o d o ' ~

A m v ~ ~

U U

m m ui O ~ N O

V!
M
~

"' m N N

c Z V d ~
c . ~ V D m N

f0 d l0 N O ~ N

O

fn N M O W

7 = O O

D

V N M
C

h . 00 O . _ O) .r ~C ~ Y lNL Y d ~C O
c n h c a c c m mo~ m~ m '? m~

~ ~ ~ ~ t C~ ~

It E ~ E o E - =

c h ' d~

c m c c N c t c Y
' ~
~
' c N

O O O O O O O O
Z

aoui do a.~

d ~ 'c d ~ d o d o ~

J m z " 'o a Q
~ a rn z z z ~

N ~ f 0 M M M

M u 7 W

M

M M M M

r h O O
h <

M

I
~

O
f 0 1 t00 f 00 0 t0 t D

r o0 ~ r N

. c0 N r- ~D O _ ap r aD et aD h O r O r . (O
~ U7 .

~ u7 t0 ? Qf O1 10 f0 V a0 a0 Of V
M V M V O ~ M O ~O
N r r 10 N O . _ u7 1p O t0 O
. a0 . 10 O f0 ~O

O Q ~ '? aD O ~7 ~ N O) N V r V O N
~ N aD ~ ~ r O iD cD M tp O t0 f0 O O t0 . ~- . fD
fD fD ~ ~ pp N . O 01 10 _ O~ ~

N N N N M (O O N r tD r M fD O '-N t0 N 1 N O M ~ r N ) fD
aD ~ t0 f tD M N ~f _ O c0 ~ _ a0 O u7 N r- W W OD N O V ~ O N (O M
O ~ ~ f0 fD O O t0 n!7 N f0 Of t0 f0 ~ in N O r N O t0 . N O 10 m ~t N f0 _ 00 M . N ~ ~ N fD _ ~ N OD M ~O Yl N N tD
~ O ?

. ~n ~p . ~ . . o <o ~o r r N so o_ r ~o . n . i . . Of V r o co aD V ~ Of < tp U7 N 1 N ~f ~
N Of Q~ O N N M M C
~ ~ M O N
O~
r N

tD . i0 f0 N t0 _ tD . cO f0 ~ N _ N
N <O ~ (O N . r ~ N ~ (O
00 .

a0 N N N < O op N O N Of M O CO M aD
N N ~ r O O N O - N ~ M N O _ (p ~ ~ 1A . 1n _ 1n at O
f0 e- O M N O . M ~
f0 . W
O

M Q7 M f0 07 M O v0 tD h O t0 r M O) O N
O ~ u7 t0 O t0 f0 t0 i aD
a0 M ~ O

M O W f0 N N N M '- 00 (O ~ ~ N M M N 1L7 M
N ~ O_7 N V N ~ f0 . M o~ CD ~
o~ rn u~ ~ rn u~ so i a~ N W
r so r . c _ ~n _ c o ~ .
r N ? V ~ W r 01 N ~ ~ O N N V ~ CO N r N
N N O O f0 M u7 ? CD
tD f0 ~ ~ N h (p r c0 (O t0 N
r r t t0 N
O~

_ _ _ . . ~ . N
. O a0 . _ O O Of r tD N N ~ r . a0 N r N N V M N N ~O N N N
r O M of W

N . _ ~ ap ~ N . _ ~p O _ O O N ~O ~
a0 t0 pf op ~ O . cD

~ r N O r M ID O a0 ~ aD ~O O ~ a~ r O O
aD O r O O (O O O ~ ~ r t0 aD O
~ O O O N M r- f- O ~ ? ~ ~ ~ O f0 <O M f0 e- 07 ? ~ M r M N 10 fD
QW
fl M Of i0 N Gf M O~ O ? cD M ~ M N t0 1 tD r r r O '- t0 a0 u7 t0 r ~
a~ r u7 ~O

M ~t ~t N N GD M V ~p s< N ? M f0 M N N <
V V M 01 e- N N ~ M f . M of ~f fD
O (O (O 01 fp f0 . (p O N V
fD f0 t0 _ _ M M f0 . _ M f0 _ f0 N N N N t (O N N N N r r N N M N f0 ~ N
N aD < N ~ aD 00 M N N r N N N N

r N ~7 . . tD ~ ~ N . _ ap u7 a0 tp O . op f0 . O ~ a0 0O O) Of . cp f0 fD f0 O Of f0 00 Of N N r f0 f0 O aD 07 r t0 N M r Q~ aD M u7 O u'l ~- O

a0 O ~ 1 ~ O~ u') O W 7 ~? ~ a0 u~ t0 (D O
~ tD M a0 r '- tD O O N oD
aD f a0 ~ 7 aD t0 M ~O

? Q) O Qi M N 07 r O ~ O M t0 N Q) O Of ~ r ( O_ f0 O r O_ ~O t0 f O t0 ~
~ v!7 r fD ~ O N
~ t~0 ~ r t~ f~ t~0 t p t ~ O 00 ~ ~ ~
M N ~
O M

( p W fD D O ( f0 f tD t0 ~D ( N N N N N tD f0 !O f f0 N f0 '- N ~D N N N N
N N N N ~ N M N tD N M N
N N N N M (O N N
N N N
N
N

W_ C
L

D ~ _ V-O N ~ N

0 C ~ (O N

c N n g g d c U U E
' c y , c Z Z c n L Y > > Y a r t N
C

O _ O C

~ ~ p (d O O O O. O E

l1 L L LL O l1.
p a a a c a a C C _ C (O _ C C C N

c E c E c m o Y

a a a a a y a c ~

C C C O C N C
~ C N ~ N
' oa o a o n o a o c - a v o_ ~ t o_ O

rn c c Q c c ~

. ~ Z '~ > ,t U ~ U i U d U u ~ J

a~

N
C n ~ N

r . ~ C D
~ x w Ia Q M C v m ~ O
~ ~ C E j ~ Q

Z p O N W t0 [L a Q Z '_' L

M M O~ O Ea~H JO
~ O ' V ~ m O I~ u7 ~ O C J <
o Q Z in Q to Q
O a C
m M
d ~ U ~ Y ~
~ .c a>

t~ a p m Q ~ a v O r v o V a Z m - >, ~ u.l r c 'a ' a a v o~ d d Q a N ~
~m N w ~E
a Ii a Z

o d t M ~ E ~ n c ~ ~ Z m ll rn ~ ~

~p 2 D o c o '~ ~ ~ W N Y ~
U '~ ~ n a~ a ~ ' o a _ o Y no Wo ~ Z ~
U ~ o N c ~ ~ c j M ~ ~ r w in . N ~ 4.
a 'vi X ~ U : . a~ 'c> ' I O o~
.w 3 3 cQ.i . c ~
o l Y Y O N Y Y Y O T O
c ~ o c n O ~ E c Y c c o c a m d ' c ~
~

_ c .~ ~ Y
~ ~ ~

f ~ M U m ~ m m > ~ m [ > U N IL
y w N

c~ H C 7 ~ ~ c~ o C7 C7 ,~ C7 ~ ~
o m E ~ Z C
~ ~ ~

'o v U ~ ~' ~' Y E c E
E E C9 E c Z n E r E

_ c O Z Q O ' . U U N
E O M O

N N N N H y O N N
a H E ~ ao a LL
~

c ' c a c Y c a> -U I
N .

'O-'N _ ~N ~ .O. UNNVf -0N= r~V1 JIL OrN O
~

O d OMd~ ON ~~ t ~ O
C p ~ J
U ~
NZO

y o y rn d o C ~ p ~
Z V y o O m ~ c o ~ Z d ' N ~ m m O J O U c ~ O p O~~ o O W
o t0 l Q __N N p ~
1l Q ~~ ~

Z Z Z Z U Z d .~ Z Z
N o~ ~ D IL LiJ oi N N
Z a~ C

O N V I O aD O N

M ~ M fM~ ~ M

M M M M M M M M

O M t n r O M

M M M M M ~ M

v ~ M ~ ~ ' ~ . Mr v M

v ~ ~ ~ O n M

f) t D t0 ap O M a D
O

~c c o co i n r ao c N ~ N O N N ~ p 7 N M N O N t0 M N

O W ~ m 01 m arD 00 a 0 O O 0 ~ r ~ r t D l 0 i f 0 0 ( D ( 0 D ( N 1~ CO _ O

~ ~ fD < V n ~ A Q7 ao u7 O tD Of cD 01 fD a0 N M N o0 ~ ID
u7 u7 O T tD t0 a0 M u7 O N ~t aD N OD aD f0 N _ Y
t0 cD N c0 ~f7 M a_0 M
O f0 h 1~ f0 f0 ~ c0 ~ V O m ID N M ? 10 M t0 ~ a0 tp 1f1 a0 V N ~ ~ OD 1~ O (D Op M ~ V M f0 O M
~ ? N V ? ? N O < f0 O t~ N
1~ O t0 . t0 tD N N c0 N 10 M aD 1l) N W
tD f~ M f0 tD ID O aD V V 07 f0 V
nCf O ~O N N N N M ? N O~ N ~ Ol ~ M Of c0 ~
M t0 N N N 10 M aD O ID f0 aD fO Is ~ V <p ~ ~t M . 01 Op t0 N (O V f0 N 00 N N t0 et ~ V aD 01 h N ~ N n!7 Of t0 I~ aD a0 N M (O ~D N Q7 O aD _ N
O7 t0 O tD V fD ~f7 10 W c0 t0 u'7 O~ G~

O N O O O aD (D O f~ M N N (O O W ~- O) N
~ N N f0 N ~t < f0 aD u7 M V ~
M V ~

~D 0) 1~ (O N 1~ O~ ID O t0 O OD t0 . W _ c0 OD . 47 u7 p f0 N K7 (D u7 a0 u7 <
W N ~ t0 CD ? N u~ ~ 1~ O aD
~ O 1~ ~ M OD M 1~ CD
~ N N M O
N ? N
~

C'J f0 O ~t O N (O N O (O (O t0 t0 aD O
f0 tD (D aD 10 aD f0 I!f 0 ( M
M f O

~ O N t0 N N N Of 1~ a_D o_D M 07 N M O M f~ Of N O t0 N N ~ a0 O N O_ O O_ O ~L7 OI 1D O N ~t 01 10 N cn t0 aD Q N 1~
M O~ t0 O aD V ~ N W O~ N i a0 t0 O M
f~ (D fD ~ 1~ ~O c0 aD M O aD 10 O a0 ) ~
N c0 N M N O u7 aD N
f0 ~ O O
M

_ _ M ~
CO 10 O ~ (O CD N N M V M _ N M O
N M at) a0 N ~ M O M O V N ~ M N N
~ ~ 00 N ~ OO
OD

t!7 O) 01 1~ 1~ Q~ cD O c0 O !D aD t0 f0 f0 tO O t0 O t0 cD if if _ V (O N N '- a0 ~(f N V N ~f M ~ V ~ V ~ N N OI N N N C~ ~ u7 M N ~ Q (p ~ ~ V ~ N O W a0 QI M
CO (O (O f0 t0 O aD I~ ~ Q) ~O . 10 f0 M N
cD ~O (O t0 f0 t0 aD N i7D tD t0 N

~ O N N N N N M f0 N of f~ N N M N M O O a0 N
OD ap N N N h ~ O N M ~ M M V N
M ~- O Q1 ~
M

u7 N N O aD (D N N O_ OI a0 v0 00 f0 O~ N m O u') M M N a0 N aD QI a0 tD N M l~
aD O tD O Y7 M cD C~ ap f0 aD aD f0 Q~
f~ h O aD M O h M O t0 1~ O~
O Of Of O 07 O O a~
O h O

V O O c0 t0 M f0 V O < aD O O t0 N M
1~ V tD M f0 fp Of u7 M ~ t0 O a0 O O tD t0 N c0 vCl O u7 t0 O ~ M t0 M aD ~ a0 u7 N
h ~ (O h t0 ~ 1~ t0 aO O c0 a0 0 ~ f0 tD ~D
c0 f 07 O
N ~ ~ ~ ~ ~ f0 N M M N M N ~ N ~ N ~ O O u7 N M ~ ~ V aD N ~ W M ~ ~ N ~
V ~ N ~l7 N
~ O h M

O f0 O (O l0 M IO OI O Of OD ID m 10 f0 cD (D f0 t0 ~

N t0 N N N N N N f0 N N V '- 1~ N ~ N t0 N
M Of M N N N f0 N f~ N aD Q1 ~f 01 1~ N
N M N ~ 10 N M
~

O~ O N N ap O c0 N QI . M N c0 f~ Q7 aD 01 ~ OI ~t N u7 t0 ~ a0I~ aD aD N N Q~
f0 O V ~ O) tD a0 ID Of Of a0 aD M t0 n0 O) M u7 O~ h - M f0 M M M aD ?
cD 1~ h h M aD O
O

OD CD O O W f0 M N N N u) O _ ? 00 O
0O O h (O M M ap 10 M O ~ aO a0 O m aD O
t0 (D OD 4D aD OD f~
M CO

~ 1~ Q~ QW 1 1~ M a_0 N N 01M of O_ O O 1~ h 01 tD tD u7 G~ (O M 07 O Of V O V O_ O O_ M c0 t0 ~ ~D cD O O_ N u7 V N st ~f ? < ~ M V I~ h M W u7 N N
< ID tD ~ ~ V fD tD V ~ M ~
t0 N tD t0 t0 cp V ~ ~ ? t0 t0 f0 M N ~ f0 Of O) ID M

O t0 t0 10 (OOf ~ N fD
N N N N N N N N !D c0 1n ID N a0 f0 c0 OD O~ tD N
M M N N N N 10 c0 ~ Q) aD aD a0 t0 M
f0 u7 N M 00 (p N
N (O M N N N ~- N N ~- N N
M N N N ~ ~ N M
N
OD

tJJ UJ L_JJLL W LIJ

lL LL LL11 O 1L 11 N

m ~ g g g gX g 5 c U U

c c Z Z Z Z ~ ~

~C Y > > 7 7 U >

O ) C

. O
M ~ m C_ N

O D p N

a r a ~

~. c C T C N
. .

E o~ m d U _ O O
C
~

~ f0 ~ n <p c v E c o ~

N N O
~

o d o n n in U

C O C C E

f0 ..~.. ~ .fp A fO N

c o o L

U d a U U V

a~

c a ~ W n - '~

~ o . c o a I a ~ an ~ - Z

U D _ 00 'c~ a t ;~ N o E
O ~

Of ~ ~ (D M ~ M O O
v O
M
O

Q O m O N M i ~ O O
N

m M O Q O N D H O d Q ~
y CO N N
~ ~
V c ~

o U n o = ~ m v c m ~ ~ ' ?~m c .
' a v ~ ~ E ~ - ' Ii -a ' g o~ m a a m Q N of ~ ~ ~ a a o D N a N

n < ' c E ~o ~n cc...._ ao 1.
W (D (p U ~ o N O d o . ~ (D ~ M

N Z N E N E
O D ' ~
O

'J N a0 ? ~ < ~ ~
t O to O O
D E C = ~ Z
Y

O O (O N (O 'rN D
h C U ~
O

O N ~ M O M (p ~ O tn M N V M ~O N N O
N N d C L C

p O . ~ _ . _ ; . . O . .
. . .
.

C1 Ol O! O O) O O) x Ol ~
f0 d n p Ol Y O a 7 Y Y ~ Y Y Y O Y Y
n N O C O

C C ~ C C L C C C D C C
O ~ N M n l9 N n N (C (O c0 (9 (C

O m m ~ m m m ~ m m m y ? .-, c U o C~ d ~' ~ C~ C~ o C7 C~C7 Q U C7 ~ r r o D ~

_ E r E E c E E E ~j E E
!~ ~ o o ~ ~

.H L E O . H N O N H N ' ~ N .N
a .

C N 'N II C C O C C C C X , C
L ~ Y .. Y
C
y d n u1 ~ d C7 d N N ~N O ~C N d N ~ ~p C f7 O O C V O O ~ O O O O E O O
fD 07 C N

_ a d E a a n. U N d a d N ~ fn N p v O 007 ' C C C

O LL V O p O LL m ? yC-..>
m O

C d O c O O O y O 2 a U Q a a ~ v a al Z z 2 Z Z E Z a z t0 c 0 O N ~ t0 CO O N ?

M ~ ~ M ~ M M ~ M M

n 07 M K7 I~ W M

W t ~ ~ 47 W O O c0 M ~ v v .Mr v v N O O r O n O

f D a p 0 N ~
O ~ a _ o D D a D 0 t h ~ N
t a 0 ?

aOD a N0 r ~ ~ 0 N O et c00 f O c D 0 O 0 m Of O f O M
a a M ~ f t~ 1 0 ~ 00 O O N
t 1 A r n n N n n ~ m 10 t 0 0 1 0 0 0 c0 f 0 c0 ~D
t 1 t N < Of f0 O O M

(p O O ~D a0 N m N W

aD G~ r ~ a0 01 t0 ~ fD O N ~t0 a0 N
(p O N < O n n r n M u700 O ~O p O O c0 V M ~ O V M ? O
< M (O m 01 O
V
n O O O r t0 f0 N t0 (O O O f0 Y7~ m N ~O tD
M n f0 N f0 (O O t0 ~!7 ~O

(D V ~ V1 D V O O) N ~ ~O _ ~_ fD N
? N ~O M M N aO Q N CO N V M
W a V C N
D a O O (D

O tD l0 t0 _ ~O t0 N m fD_ 4D N
f0 ? M _ (O (O O O Q) 10 f0 tD Q < M
~ O
N

n0 N N N _ ~ N N V aD NN < O p ? N r N r f0 ~D _ fp N N ~- N N M at O
N ~O M O O - f0 O t0 M O
N t_0 V ~ r u7 fD r M M u7 r N
N r n n O M 07 Of f0 O Of ~ t0 O O~f0 N ~D O 01 O) O O tO r f0 ~ tD tD fD O 47 (O O~ aD

N O O f0 V N N fD t ~O p V NN (O < V O fD
n!7 In M OD f0 N M 00 ~O N 00 N O ~
~ M ~f W O O r Q1 OI M t0 fD O r f0 fDM (O t0 _ M
W f0 M tD cD ~O VtD ~ N c0 N
N ? ~O O O1 O K Y N p M n O) M
~t 10 OD ~ r M N ~ ? N V 'V' r ~
~ N N ~ V 0 N O N
t0 ~
M N

M t0 f0 t0 o~ a~ a0 t0 t0 . t t0. N a0 u~
f0 ~l7 ~ ~O t0 t0 fD r NO N aD
O N N N N M i0 N O O O N
M O) N r O O N aD N N N ~ N
O O M M N N r (p tD N K7 r O ~O 0D O W M In p O O
07 N C N M f0 O fD fD o0 N ~ V7 ~ O O M O Or V fD f0 M O O
N a0 M a0 M f0 V O ~ ~f7 O aD O O~ r M n aD
V

t0 O O ~n N (D f0 ~ ~D M ~ (ON N N ~ _ ~
fp tD M 4D N ~f !O f0 O M V t0 M f0 ~O O O
r ~O O) O r N M cD u) O O tD rN a0 (p O 01 (p r r fD r N CO f0 O~ ~N tD N t0 O
M Wfl ? V N 4'f M ~f1 N . O O
~ M ~1 ? n N N V ~ ~ tf N CD 01 N
K7 ~ ~ V N N ~ O
N V
<
M

t0 t0 t0 V (O lD ~D ~O aD (O t0(D M t0 _ fD ~O N 10 (D f0 f0 Of t0 (O
~O (O

fD N N N c0 O n Cf N N tD N(D 10 f0 07 a0 N N V N N n IO ~ m N N O N N N
u7 N '- O r M N
N
N

a0 , , t0 f0 tn O O f0 . O m N N t0 O t0 O
N ~7 ~ M t0c0 M N aD O) O7 Ot r f0 Y7 t0 O) t0 V N O a0 ~(1 r r N O V u~ r-O N fD Q7 O O r a0 aD
tD

~O O Q~ (D <Df0 ~ O ~ O O O ~ ~O O ~D n O V
fD t0 M V m Oi V M M O aD t0 ~t r V u7 ~l N N
f0 O Of N ~ ~fN t0 t0 O O (O O Om m O O _ f0 n n O t0 ~?Y f0 f0 f0 f0 ~C Vr t0 W V7 O
f0 ~ ~ ~t ~O N N f0 N M ~O Q7 V ? M ~ V N 'C N ~ ~O N fD V f0 N
N p N V N u7 V r N
~ N t0 (O M
?
N
?
~

1!f f0 (O f0tD ~O f0 t0 t0 f0 fDu'Y tD M f0 (O
c0 ~O t0 t0 t0 _ f0 (D cD
t0 M N N N N N 07 00 t0 ~ N N N n NM N GO N M N fD
N Of N N 1n N n N N N N r f70N N
N O M ~ N N

O r_ O) N r . t(7 a0 _ M N
O O u) t0 M . (p . - M O tD Qf ~M r OW o7 t0a0 O O~ O tp O O r N ~ t0 O~ aD ~ O O
01 aD r M of aD o0 O
N O O) M r r _ (O~ Op 00 _ u7 Of0 O f0 (D O _ O O (D l0 (O N (D N O ~0 O M V OD O N
r M a0 Q) M M OD ~O aD M
f0 Q) N W 01 u7N r M ~O aD O> O 01 Ofn(7 O~ M r N M
r M ~ ~D O O a0 O O f0 O M ~ f0 n O
? r tD O O O (D f0 u') M V < V ~ ~ V N M V V WO ~ t0 ~~ ~ ~f V ~ V ~ M
tD V V Q) u7 ~ 10 t0~f fD c0 ~ fDN
~ V N 0 f0 t0 O c0 O r ~ V
0 n t0 a0 f0 f0 O f0 W
f0 aD aD fD fD
O tD
t0 fD

tD t0 f0 f0O N O t0 f M NN N f0 N N N N N
t0 M t0 N t ~Cl N N N N M 00 (O N
t0 N N '- N ~- ~ N N
(O fD N N N N
N N N N N N N N
N M N N N N

~

W W WW

_ N

g g 3g g O

N L

Z Z C Z Z ZZ ~ Z

7 7 Y 7 7 ~7 U 7 N 1n o0 N

O N O O

O

O O O

[L LL LL

a a a a c c c c . .

. .

E E E E

a v o ~ v c C C N C C
~

.d c .d c .c> .d E
' o E o y o 0 d m O_ d N ~ N ~ C
C

C
C ~ C .
. . .
G

N ~ A C f0 _ L c0 c c a m a 0 U C~

y w N C

p _. N

N r C7 r C N Z
' V ' v ~

o ~ " .
' d U ~ ~ ~ N
~

_ N M
r E

r ~n ~

' v CJ M c ~ ~ Z
d N (h M N

M ~ N m N LL m ~ O O G
~

o c a 2 a a ~ Q Q o~ O
j o a ~ , ~ vi o _d :~c a N n ~ O M O (D OD
v O

O O C N O Q ~ ~
U

N J
~n o i. v o o ~

m M = p ~ v Ii J

fp N ~ ~ N .-. O r O N a fV
f ('7 . ~ 1 N G Q ~ ,a p L
) ~ ~

O N O ~ e- p O! O O I
N

O C C ~

C CM~tn GO n O. C0 Nt00 N
r 1 ' (1~ In T' tGO m N fDr m~ ' mU ( C m O V C7 ~ C7 C~ O C7 C7 O N C7 r U

I Z fn N D O N C N
Ea E E o '- E E~ E E
E N
~a p N ~ ~ _ o _ N

N C C N y~ = t9 (/fN ,r IA
E a d ~-y ~ c m D G " S c Y c _c c c ~ or ~ a~ o a ~ ~

_ ' ~ v ~ ~ n ~' m o~ d d c_ d ~' r a~ E ~ .n ~ 'o o _ O ~ O o0 O O ~ O O O
p O n C C
=

Q ~ d N d d 0 O d O t1 d r d p ~ N
T p O y C1 G d . O ~ d 4 d a y ~ ~
p C 41 1 O t0 O N C N
> , a > C7 Z > m > > m > > ,~
~ ", O
o O C O O O O O O y ,_ ' a~V a ' Q A
' Z Z Z 2 Z Z Zc Z
o~a c~ a rn fD aDO N 'C ~Da0 O N ~ f0 w w r n n rn ao ao aoao M M M M M MM M M M M
M M M M M MM M M M M

1C) n O M 4'Jn Ql M ~O

co ~c~c n n nn r co aoao M M M M M MM M M M M

~ M v v ~~ ~. ~ ~ .Mr M O)N O O NO t0 M OWf1 O aD O ~~ ~ N O n N ? r ~T ?O M N r n M N N

M f M N n NN ~ Of O O
D aD M N O
O

~ ~ ~ ~ ~ ~~ ~ W

~ O 0 n m ~

a a a a m Of f0 t0t0 ~O ~O t0t0 t0 ID f0t0 r N n O a0 r a0 QJ O aO

07 O (D Oi _ tD N a0 <D r 07 f0 O u'f 07 O~ a~ V V 1f) M t0 (D
? N a0 V
N t0 aD N O t0 t0 _ O 10 O t0 (O c0 t0 O
tD a0 '? h O

r 0D p N V N W 10 O) N ~ N (O V N p V N 1D M f0 N O N ~O 1n V Q) ~

N ~ p _ <O Of W O ~ a0 O N _ O r ~ f0 f0 O
r a0 M O N O c0 N O ~O
N M cD t0 r O~ W a0 M N N
M N !D p O f0 < V r r r aD
aT D N
O r N M N O t0 c0 a0 _ ~O _ ~
~ M ~ N u7 O f0 O M O
N ~ aD

O~ O O r a0 O . r t0 Of 07 O M O~ O fp fD t0 aD fD r c0 O ~O O7 t0 (p N O ~

m N O7 ~f1 O p OD N N ~ Q1 CO N U7 N
p Ip N N ~ ao OD <O N (O co M aD
N N N M ~ co _ a~ ~o _ u~ ao so c~
a~ a~ o ~c r ~a o ~

_ ~ Of V N _ _ f N W
p N ~ N N N O V O _ V
V ? tp N m N N N O M N
w W N f0 - - ~O r ap r O p _ CO N tp ~ u7 OI r h aD O ~O O r N N r (D
r aD M N O W ~ O M N N
tD N f0 M ~ r at ~O V M N
~ N O
V ~ u7 _ W N a0 u7 O M u7 aD O ~
_ O n!7 r D1 ~t O
N h N st OD O aD O~ M O
V N t 0 O
N M O~ ~ M M O 00 ~
o0 f0 O ~ t0 O

_ _ cD rVf a0 N t a0 Of (D
N M N V M aD 10 ( N r_ N M u7 aD N N N t0 N 'C O f0 ~ t0 N '? N M O f0 O N
N '- OD

Of (O M O c0 r ~ Of(O r r a0 t0 (p t0 N OD Op r t0 r t0 _ N ap ap u7 M_ tr N a0 f0 N N N V V v- V Qf ~ (Oh N Y r ~ t0 ? at N mff O CO N ap f0 N
07 in O aD f0 O ~D Of O f0 O 01 off N tD

p N O N f0 ~ Qi O c0 u7O N01 r c0 N N t0 O
N (O O aD h Ip N ~D 07 O~ V N N
aD t0 ~ N

m N t0 ~f . ~ ap ~ Mof a0 O n0 O c0 ap _ O r nC7 m t0 c0 t0~ Or _ m r N N
r a N i0 r W r N r - M r r r r Of M (O s<
D O~ O N ~ p st O
M O t Y7 O

_ tD N W f0 ~_ _ tD N
_ ~ t ~r N st O tD Of ~O
_ O ~O O r a0 ap N
_ 07 N f0 ~ Of m a0 t0 N M O V ~ O
f0 O O 1n r N N N <O O O O 01 N
N M M t0 y('1 N t0 NC~ ~~O t0 O_ 1n c0 r ~ ~D M a0 O N N N O~ r tD fD
W N f0 c0 f0 u7 M N N ~O ~fl '? N
00 N N M tD M OD ~t (O N

f0 t0 tD M O (O u7 (D
(D N a0 ~O N Is V7 N f0V Nf0 N f0 f0 N N CO '- M N N O N ~ O N N elf M N
N M M ~ N tp N O
O

a0 N i0 - N pf r O 0DN O O) _ (O p 0D f0 m (D
N O

N O a0 a~ p V O~ N O < No0 NO V N '- 07 O Oi p O (D r M p M ~ aDr r f0Of 07r r ~ U7 O t0a0 a0 M a0 O t0 ~ tD r t0 t0 ~ O O ~f r 00 f0 ~ tD f0 O
V t0 O t0 m cD t0 r u7 W
r tD t0 p O N M O~ O O cD r f007 p OM O~ O O 07 O~ M ~ r V O fp Of O r O O 07 Of h N r O
h r O
r _ V N Y ~ fp t0M V_ ~ ~ ~ N
fD V M ~ O O ~ Cf t0 M ) M M W fl ~ ~
'Q Q N O N V N O O
7 V t0 N

_ f0 N tD_ u7QI t0_ ~O f0c0 _ f0 07 ~O N N N (D M M(O NN Of t0 f0 N N f0 N
iD f0 f0 f0 N t0 N t0 t0 tD N t0 O cC M N fD N N

N N N M ~ N N N N N tn N
M N
N

p d W W W_ ~_ N

N l1. C lL lL LL lL

E ~ 'd cnQ in in in V
a a v U~ UU U U

~

E a 7c ~~ 7 ~

c~ m co o~ p rn _ Y O
O p O

LL

a o d c r~ c 'm 'm ~

_ O

O J

~ N ~
N

C H C_ _ N

o c'~ o U

N ~' N
O

C O .. C
' O~
' C (V
c0 d W

O Z j C

U ~ H O
U
m = o t C Y J
Q ~ ~ N i V ' C '- U
' ~

, M ~ ,N o N E c a F
' ' c-a o ~

-d v N ~ rn N ~ a n '.' ~_~ m ' m n N M o a , 2 m M E

m a~ ~ _~r r N p r H
O ~ ,~ o _~ ~ O

Y M_ N_ N n_0 p 3m0 N r O
N ~ N
O

. LL d M lL ~ 11 r m ~ ~ N

d a a ~ m U

G) 7 _d _d h-' ~

M d m O N ~ M ~ O N Z
~

N

O t0~ m n M a F- ~ CND~
a O ~ E

N ~O M r N O
d ~ p a N
d ~

Q 1 flQ 11 M j V _V
st U
~ U

r- o, o,_ y, ~o _ _. - rn vi'or ' o ~ ~ Z >, m ~ E c ' ' Y N a Y Y Y Y Y Y N ~ ~ M Y Y Y Y
C N ' j _d O N C C ~ m ~ ~ 7 C ' O
C C C C ~ d C C C
N O 'Q O ].

N p d N f0 f0(C a, (O (C T UJ p l0 f0N N
r ~ O_7 N T O

m O C7 m m C~m a0 m m Q N N d r N N 7 C

C7 p C7 C~ C7C7 ~ C7 C7 d ~ Z ~ C7 C7C7 C7 ~ ~ = o O o ~ o , N N

~ E E E >~ d c, o c9 m U '~' n. o o N~d ' y~~N'~T'E='~ ? N NNDMV(n ~ C y Q ~

C C CL C C C' N N N N
y ~ C j~C~ 'N ~
~y _d _ _~~ _ C C C~C CN
C ~ O ' Q ' ' ~ N U O ~ d O d ~ 'y~ C E N N d N
O) t0 O d ~ ~ Y
O ' O Z ~

O M N O O O O M O O C O O O O O
' r p7 ~ C p O_ N c = L '7 Z

01 ~D M O O O ~ ~ N fD O
d a a Q. N d Q.a Q.
O 10 U ~ ~ r M
W

a ~ N Y

> ~ > > > > 7 > h ~ E E > > > >
p O U ~ O C 3 ' m (~
~
~
O

O ~ ~ O O O O O O N V O O O O a -~
Q X ~ N ~ Q

Z a r Z Z Z Z o~ Z Z m U ,t Z Z Z Z
a~ ofm = a c ~. ~
d m O N
~ p ~O OO O N

a0 O W M O M~ ~~ O p ~ Y
M M M 1 of M

M M M M M MM MM M ~ M M

a0 a p O) O)O) ~0 OO O O O
f M M M M M MM

.M..M.. M M ~ .M..
~

aD ~ D M h M c0N O ~ r a p ~ p N nO VO n OO I f p O
f 00 Of < O O ~f On O D N O O
O N ~ ~ Oh tO t 0 N O O
~ N r N r O r r ~0 ~r t n 0 r r s a f v v r ~ r rr cor > c r r rn w o o o ao~ ~o ~ ~ o w o0 a a a a n a ? N 0 r ~ 01O N M N
c a ~

p 01 f W p 01O OO O O O
O

~c ~ n o c o ~cr rr r r r r ~ c s t0 n N M N N r O C 4D t0 f0 D O In N f0 O O) M O 0D OD ~ M aD _ O tp O
f0 ~1 M r ? M N m N O ~ u7 ~ ~ c0 10 cD O u7 . O) r O
~ V ~_ N ~O t0 ~ O 10 tD
(O f0 N M M Of r N r ~l n0 V
~ N M W sr ~ M nCl t0 M ~ V
N V ~f r O ~O ~ M M W ~ ~ N O t0 n0 N t0 f0 ~
N N t0 aD (O V M N M f0 tD
~O

07 N ~ tp Qf p O f0 (D ~D N M O N N N
M ~ O N N ~O 10 M ~ t0 N N aD
V a0 ~

_ _ r N ~ _ t0 ap ~(7_ N
f0 N N N ? N p N W et ~Or r N
< 47 t!7 V M t0 O N r O
01 fD M t0 f0 ~ O p c0 47 a0 r p Of O

N N u7 N t0 O) M M tD _ _ N O O O~
~ tD N N ~O V M M N N N M V
f0 N t0 ~ M

r t0 u'7 r N O _ (O f0 N O O O aD O) O QO
W u') r N r- ~O t0 ~ O t0 O
V N M O 0D V N a N r O ~ t0 (O
a r fD M O O N M V < ~O N
O N sf ~O
~ N

_ ~f- (O O _ N fD r t0~O t0 N
u'! O ~O (O O N f0 N t0 t0 f0 _ OD O

N p N O) M V V < M O aD a0 r N N M
O K1 M O r O r M N N M f0N N N
~ y!7 O M ~ tp M tD. _ t0 r a0 O) M r aD ~ ~ r M ~!f DD ~
O p aD r of (O ~D f0 Of Of Of Q) N M N r O t0 10 O
u7 M ~O O O aD O W 01 O V O
M f0 r f0 O V'J

N N O ~7 N N fD M N V M QI ~ W O Of fD
OD 00 N f0 '- fD aD M tD f0O) O
N ~ M ~

_ p O_ O M CD N (O (D O> OD N m 10 t0 r (O ti 0D N M N t0 N N tD ~
n ap ~ M ~ r ~ f0 ~ N fD a0 a0 Q7 N N N ~ ? V V N
Y N Q < ~
N D t0 ~O

p O 00 01 N m . r N f0 t0 if t0(O t N
aD tD 00 O N M V N CO r t 00 O ~ N _ N N p ~ 10N N N
~- ~ ) r r ~O ? O O N N ~(7 a0 Of OD V Q O

aD ~p _ O tD O> N O ~f7 O~
u7 a0 t0 M t0 . O r 00 r aD M M

V M O r M C aD O M O a0 ~7 r 47 O M
M h O O p ~ f0 07 N 01 r r ~ O M t0 r t0 M
~ r _ _ ~ M V a0 ~ ~ O t0 M
N M (D N M O O p tD r ~ M O~M f0 O
O) Y t0 aD m fp M M 10O1 Of O) N Of u) t0 07 M O ~ O t0 t0 r c0 N
r fD N W O) r p t0 f0 ~O O) t0 M O
t0 N

N N ~ _ CO N N M of N N '? ~f N
V V N N N N N N M V f0 N V ~ ~ O
N M N a0 ~ ~
N

(O f0 O 4D ~O Of t0 tD10 ~D tD
f0 1D M ~D f0 tD
t0 (D iD p N CO f0 N N ~ N N ~ r N N N
N N N O 10 Of CO N M O N N N N
f0 M ~ O M N N
M

p N r r N N ~ (D r r u7 01 O r M co 0o N N n coN o ai r . ai of m ac ai u~ oo ao .- mn o c~i N a~ao of ~n r of u~ r n ao a~ c ai o o 0 of M
M

ap O OD N O 00 t0 O u7~ ~ O) a0 ODO O N
~ t0 aO r n0 m : ~ OO N (p O
% - a0 N M M N
LO ~ N

o in o ao co c _ ~or _ r r u~ o> ao o so ~ 0 0 o m o~ c a~ o o o r ~p a~
u~ nn ~ ~o rn ao cp o rn M

M O ~O M M ~O O_~ V ~ N O V st N N ~ ~ V
~ c0 cp it M (D< vt M N u7~f ~
V tD O) O) f0 u7 t0 00 N ? ? V
aD G7 f0 r Cf (O O f0 fD (D c0cD f0 (O
(O fD M t0 i0 fD ~D (D
fD u7 t0 ~7 f0 ~G
f0 c0 O

~ N N u7 N N N N N tD ~O N N N N N N
N N ~O W N N M N f0 N N ~ N N N N
N N N M O N N
f0 0 0 C)p C1 0 W W W ~ t lU
lJ

_ LL
lL

!n (n~ ~ ~ ~

p d U

U = U U o ~ U

Z ~ Z 2 ~ c Z Z m , > > IA Y >
N

a0 '- C M

~

N ~O ~O
C

_ O ~N O
O N

a '- a ~ a c ~ c o, c . .

o 0 o c o a a a a a C T C C
C N

_ C

O O ~ O
y=

n ' a ~ o.
o c ~

C d C ~ C
N

.IC c0 .f0 C .O
v O

c E c ~_- c d ~
0 0 o c r o U ~ U N o U
ao c E

a N

~U
E
~

' n _ o o~ " a ao r , N
f0 ~ N

O ~

N G1 f0 (~ (p D
N

O A (O Z x ~ a N a C

tD N LL p~ ~ ~ 01 M O tD
d E N

~ xo~, ti a o~ '~'o pc _ H a L a W .I ~ '~ oho aoo a~ t = v O

~L >~ O N x 7 :~ ~ N 7 d L U O. d m C V
' d >, a~ - . _ :
a ~ o v E
~ =' ar ci o ~ r i N
E p Y C ~ C C t0 C C d C
r T t0 V
N f0 ~

N O O ~ ~ ~ O (O
- ~ m D m w IYI C O O
C7 ~ O N C7 0l C~ C7 C7 .. C7 ~' U
. N 0 o o m l l E d E _ E
i. . E .o E ~ O
d ~ ~ ~
'~

~N Z H C ~N ~N ~ N N N
O C N m ~

c N N N c c d c c Y c c ~ j ~ i~ E
~

, m m m d d ~ a~
d - a: ? ~ ~ a~p ~ ~

o o o~ ~ ~ , o so o o N o ~ o E 0 M
~

a ~ a~ d a a ,t a a o, a a; r a: N

~ A N
N O

> > ~ ~ L E > > ~ o > > >
N ~ ~ ~ m m ~ ~ ' O V

N p O O O O
O ~ W Q a ~

za zWE E zW~ z z z z oW a;~

O p N N N N ~

r N M
M M M ~ M ~ ~ M

M

M f1 r O M ~7 r O
n _ N N N N N M

M ~ M ~ ~ v ~ v ~ r 0 O ~ M

C m r N O 4 ~ p 7 0 'f O O
N M

O N ? M O ~ N
~

O N_ N r 0 V Q
O ~

m O) O N Q) p ODQ1 fD
D

r O OfO ~ N M ~ tn t0 O O ~ n n ~ r r r r c co _ o ,-: ,.

~ ~
N ~ V

W Of (O tp aD V t0 O O t0 10 . f0 ~O

O N o0 ? 'Q OD O N ~D M (O N ? CD O in t0 tD ~ h 07 N ~ t0 Y O V O V M

O 1~ tD t0 t0 c0 N O M t~ t0 N O Of ~D P O u7 ~O O
t0 N ~ <p M t0 h V N
(O ~l7 Y7 ~ c0 f~ M Of a0 1() ~ N ~ O ? M O
? V N N N I~ O ? O O N off O l0 N O M O O
O ~O t0 t0 M O N

N . ~ _ tD (O tD N ? u7 N aD u7 7 N C~ N V t0 c0 ~ V M ~ N ~ N I~ W a0 h a0 Q! N N a0 '? t0 fD t0 (O M M t0 N t0 M O N O ~ M O N h t0 1~ U1 1~ O ~n if O O h V ~ N a0 07 N tD N V W tD M N ~ fD V N N f0 N N
(O ~p N (O M cD M N M f0 OD

M f0 N CO ~ <O O f0 00 O 'P O aD 1~ 07 O O ID a0 M
f0 V M 10 N f0 . t0 M M
M N ~O f0 M (O 1~ OD f0 N
N (D a0 < M e aD 01 f0 T N N O (O m 07 N Q) ~ fD
01 O P 1~ t0 N O f0 V N V N (D ~ M
Q) O t0 a0 ~ u7 W O N Q) CO N
O N ~ N a0 h 1~ t0 a N c0 ~O D

N Of V ~ ? ~ N _ _ c0 N O a0 O fD O N a0 N Of ~ N O O ~ O~ ~ N 1~ Oi O
O tD f0 O~ A aD h M ~ N O~ h N <
~ a0 01 t0 ? 0O ~O h ~O ~O
t~ cD ~ 0 . . ~ V t u7 ~D N
Kf ~ N N N N M O) M n0 1~ N N O~ N N N C~ O Of M
tD M ~ M ~ f0 ~ O Of ~ P u7 ~O M a0 N O
O M

N ~ V aD N 00 fD h M ~ ~ ID V f0 00 N M M M 00 M
N t0 CO N O 1~ 10 O

a0 ~O O) h N O ~l7 tD Of (O (D ~ 1~ aD N m O ~O O
V t0 Of t0 O tD f~ 1~ O M t0 O u7 f0 ~ h tD
O fp a0 ~ ~f7 Of N O Q~ f0 a0 M t0 N N N t0 N M O ~ (O V N N N N
N N M off h M ~- ~O ~ N tD Y M f0 N
c:~ o~ in M _ o o so o a~ r. r co o n M o n so ~o ao ~o co ~c ~o ao o M N ? V h if _ O f~ ~ a~ V Qf GD ~
V V ~ N N N ~O CD t!7 N N f0 N V aD N GD
~ ~ O M f0 of ~ 7 N O M M N

Of ~O f0 f0 _ O~ N f0 f0 (O Of t0 N
f0 t0 f0 tD f~ a0 t(7 M M f~ t0 . tD f0 N O N N N N ~O c0 O f0 N O OD N N N 1~ ) ~7 O N N ED M u7 O V O N N M O T N ~ O
N O 1~ V M

~_ 1 a_D
f0 . 1A aD . (O ? N t0 N N . 4D O D1 ~- M O 1~
O) N f~ U7 f0 N t0 fD t0 a0 f0 OD

Of Of cD N P c0 f~ a0 W a I~ M t0 O O h a0 O M
O~ a0 ~O ? O O~ O O Of O~ M c0 ~O a0 O O ~!7 O
M M ~ 1~

47 <O O O CO _ N M O f0 EO N O N M
OD tD N M fD N (D OD O f0 ~ a0 ? M m t0 01 W ~ u7 fD iD 10 p M
M N ~

N u7 O M tD cC ~ t0 W f0 u7 N W m O h O N O tD 07 R7 ~O t0 O fp 1~ c0 M n0 ~D ~f7 f0 t0 t0 M
O tp ~O 0D N N ~ ~ ~ ~ l0 N
M ~ ~ M ~ fD f0 ~O M N ~O N h N ~ N ~ N N
~ ~ ~ O ~ ~ N M M M N N N aD
N ~ ~ N

N m N N N _ t0 O t0 O 0D n(7 O N N N ~ N W t0 h N N ~ N N N N 1~ M Of ~ 1~ V N t0 ~t Of s~
M at 1l7 st 47 N
N

N In . N O O ~ N M M u7 f~ a0 u7 1~ O M 10 IW
O) ED f~ O r- N ~ r . h f0 I~ ~
f~ M M O O1 M O f0 00 ~ O n0 N IA ~- ~p OO t~
O OD D) O M M O M O (D u7 O) 1~ O
N (O M M
O 1~ M M
M

t0 O a0 W m fv 00 N M O ~D ~ N N O O OD '- m O ~f ~
M M M 1~ f~ a0 M a0 N OD OD fD CO
O OO CD CO

u7 M Of O~ O c0 O M M M M ~D aD M 07 N cD h O I_~ O~
O O_ ~O tD ~O N u7 M O_ ~O t0 O aD u7 O_ O O_ f0 ~O V M M ~ ~ ~ a0 t0 O O O_ M ~ V N V f~ fD fD ~ V if if ~ 00 N If1 01 'C ~ 1f1 a0 O m O) O N at O
O f0 fD t0 ~ ~
a0 t0 10 f0 f0 <
N
tD
tD
M
fp N

fD t0 M M M aD tD O N ID O t0 N N N N N N N t0 c0 (D t0 ~f7 aD oD W
~ N N N M ~- (D N N f0 OD O tD 1~ aD aD
N N N O M M ~ t0 f0 N N N N N (D ~
N N N ~O '- N N ~ N ~ e-a0 ~

N N N N

g g g g g N

z z z z z C

> > 7 7 n cD

O

O

a c E

v c .

.' C

o ~~

nE

N
O

C
L

O

C
O
j U
H

J O

a a~ U o w L ~

a , o M w r Z m E a~ p N
~

M
r' in O a Q
d ~
H

U ~ a o '" ' U
V

. c~ o.

E S T E N B

m L_ a> N ' E N ~
7 O ' ~' O Z ~ _ O

Q N A d t0 O n Q ~ J V , V = M
_O

( ~ ~ NO OpD
0=

r C
=

N C ~ m Q N ~ ~ G) i R
. O

.O ~ . p .O O . O
N

O O M v Y Y
h N ~ O

d r = ~ n ~ ~
N

N 0 10 ~ !O
l C~ ~ O O O C7 U
C N

~ ~ O I Y r L N

'N a ' N ~ N ~ ' N M ' N T ' (p ' C ~ C N C N ~ C (~ C t C
' ' ' ' ~
' y a~ C~ d N y n o m w u, o o, Y ~

O N O W C O O O OD
z d Q) d M d ~

p ~ ~ d C y ~ y j N _ f Ct O V ~
' O O N ~ x O p J O
r d ' m z z o~ z z s z a z a o~ E a ~

~ M ~ p f ~

M

M M M

M 1f 1 M
~

M M ~ . p N ~ M

N f 0 O ~ l M N

O M

N O M o p n ~ ~

OD f 0 ' p O

n N n n n h N

1~ h Of O O ~ c'7. fp 01 N V O In aD (O fD . t~ '-Q1 O f~ O

Of aD M u7 V O tD ~t N O O) ~O ~ V 1'f Op ~ Iv . (D f0 . c0 1f7 Q) h . . In M K1 W tp .
f0 f~ c~7 ~l7 O N N N N O < ~ N
u7 r- ~ ~ it V O
N ('~ (D ~ O i0 O (O f0 (O iD
f0 f0 . P7 G~ ~ (~ O fD N N a0 01 N N a0 I~ N N 07 M C) V r N ~ O t0 N

_ N f0 aD (p f0 ~D N O N P7 f10 h tD ~ 1~
N V C 1 10 ~ a0 47 t0 Of O f~ 10 f0 h t0 0 N (O
O

1~ . t0 . . '? C'7 O O f0 . t ~f1~f f0 N ~ N f'7 t0 h Y V O ~ aD ~
N N V N N O DD

O W ~O N 1~ 4D O ~O t0 O) O tD O
C~ u7 ~D V ~ O ~D O
O) O N OD 01 ~ ~ N N N V ~ N 7 ~ EO O O t-) ~ V V O lh V

~ t0 . aD . O f'~ . N t0 f0 _ Of - - f0 f0 f0 . ~ N ON
N ~ 07 f~ ~l7 f~ ~ f7 f0 f0 t0 V O O ~- N N a7 N N
N ~ N ~f N

aO ~ c'f tD O O . 01 ic1 fD ~O
M ~ off N (O M Y1 O f0Of O) N N Of M m O O tp M t0 07 ~ C~ P1 tD eh a0 N
I~

~ O ~ N ~ t0 V t7 O aD ~fa0 ~ ~ cp tD
~ PJ
N M

. ~o o~ o> o> cno t m o mn ~c N~
mn N N ~ ~f ~D
D W ~D ~ ~"~ '~t ~ 10 N N N N V N fD 0 cD f0 0D V t0 V ~f ~
~
~

fD h N CO f0 07 c C7N
c7 1 N fD
(D (O O N N N
N V1 O ED ~ a0 N O aD N f0 N ? O ~ O N N

. N N ~ 1~ O - - 01 i!7h - . N CO
N 00 O . . . fD

f~ a0 O t~ 10 10 0D M N O1 O (D
O N 10 tD (O f'7 tf)O f0 tD
f0 N V') aD u7 fW D ~ O ~f aD V O O t0 V
f'7 ~ E~ ~ tD OD 1n t0 ? I~ t0O
t0 t0 t0 O 1'7 ~D ~l1'Q
m tD tD ~D ~f7 1~ O tp u7 O~
t0 M N f~ h f0 t0 f0 ~I7 N N l'~ N ~ N _ N s< V N~7 ~ N h CD N ~ ~ ~ ~ < N
~ N

. tp . fD . . t0 tD a0 . c0 tD _c0 N GO a~ f~ 01 O N t0 t0 t0 00N
~O N f0 V CO O N ~ . f0 .
N N fD N N
N N 1~
N a0 ~ O
O
O
O

OW l7 O f'~ ~ N 00 OO u'7 W O V fD f0 a0 Of ~O
CO O N
01 (~ f0 O O
N O a0 ~7 a0 f0 a0 1~ N ~ N M N
r- ~ f~ I~ f0 O ~
t0 f0 V O f~ ~l7 M V f0 07 Q~ 1n O) V01 ~ W ch 1~ tD (D O f0 tD N O7 'C
1~ 1~ ~ tD tp Off0 ? O) N tD ? '? a0 ~ (O ~ ~
~ ~ f'W O p tD sf ? tD
~O ~ N c'~7 O O f0 f0 ?
~ tD O t~ 1~ f~ (O u) tD ~D
~ c0 t0 t0 ~ t0 h N N N f~ t0 N N X17 N t~f N N NN
N t0 OD CD aD N N N N N ('7 W W W_W_ _ _ LLLL
LL (L

N (/~O NN

O

E

7 ~ L

(O r7 O) N

O O
O O

O O
LL LL

d_.d_ C C

N N
N

n O O
~

N

C C
=
~

d N
N

o o V

a n ;fl ' ' a ~ a c ~ c ' m m ~

C C Y
U

O O C
C

~N ~a a m r~

Y

ch o M N
~

O C~ ~ O

N I 00 O 4]

a H

~ a a a N

N N N ~p C p _ ~
Q) N O f0 C
N
N

(p ~ O N M

c n m ~ ~y E

N f'7 a (O

O C 01 D) r t a Y Y Y

C C C C C
~p O

~
O

m N m m C m (~ ~ U' C7 N U
~ ~ ~
~

E'-'' E m E~o ~ E ~

I/J ~ ~f9N N t~l N
Ca C~ CO C

_ d N N d ~ N
d O

O t0 O O = O
C if 4. ax a d c rn Q

N c o ~' . o ' > > > >
~i 'n m - ' o o v Z a H 2 Z a Z
N 'pf m v < u ~

~ M M ~~

C f ~ 7 to n O rM

V ? ~' 47tC1 M M_ M M~_ (p 117N

aD O Of ~c0 op Nc7 pp M ~!D
O

W m O O~

N

N N N N

A r n rA

~ ED N N aD r _ r aD
O ~ m N _ tD
tD

O 07 N N f0 0D r u7 r aD <
O 01 a0 O ~ ~ m aD O 01 r aD N fD Of 'C r M

m aD t0 W f0 N fD W t0 C t0 n!7O W f0 f0 t0 O

t0 r Of N V V M 07 ~ O r ~ W(7 ~ Of N M M N
r r O> M O ~ < Of Of ~
(O

_ fD V M M M O
N 07 aD ~ N t0 of u7 N
N N 117 M f0 n7 t0 ~l7 c0 f0 tD O Of N
t0 tD t0 O N M
N W O tn M t0 f0 Of M

_ N N N V
N N N m ~ O 47 M O M O N N r r M (D O
n0 f N O
N N ~ N M M M Of o~ ~ (D M r O u7 tD
N f0 M O N M
' i ~

u ~ p Q f0 u7 1 tD tD r_ r OD W M t0 M ~_O ~ M fD O V f0 N N M
t0 _ a0 K1 r N r N V N ~ CD cD Q1 aD
M f0 V Y V O N

N M O r t0 r 10 ~l1 M t0 t0 t0 O N t0 N O ~O
O O r r r Q1 N t0 N
t _ V a0 ~f1_ s Q7 W OD M M ~O Of DD aD ~f c0 V OD DD ?
'? N r V M N r N (D ~O O f0 f0 N (O
r 01 tD
O f0 (O

N aD ? N 07 M ~ . ~O 1D f0 t0 N M O M ~ N
t0 O m m tD N O r N
4'f N N Of O N M N ~ a0 < r K7 u7 N

a_0 r O C_O M N V Qf r ~ (D M O M r O
N N M N N Y o0 O) O) r 4D M M CO _ ~f7tD ?
fp N 10 O ~ W O (O
f0 N M fp O r a0 N t0 O O M 1f7 ~ O O GO
f0 N t0 O 10 f0 f0 N N t0 (O

47 N V h N O N N O <O a0 < N O _ Y N t0 r N V M N7 V < M N V N N O OD
OD M N
t tD

O O) t0 M t0 O r t0 t0 O t0 cD O~ O tD M (O u7 <O fD tD tD u7 D
f0 V
~

is t0 fD p f0 47 V CD N ~ < N ~ O N N M M
r 47 N N t0 N N ~O O N ~O W N (O
~ O M t0 ~ t0 t0 t0 r _ O (O N O V ~D
f0 ~ N _ t0 O~ aD N N N a0 r cp M
M N ~ ED GD N CO tD ~ O N N N f0 N ~O aD N
~ r N M 0D M f0 if O 07 N N

(D (O 01 O M (D f0 _ N N m M 01 O O fD
M < 01 CD _ O
N V
M

f0 t0 O r r M O M ~ aD
Q~ O M M fD O Of M O 0D N Of ~ O f0 r O) r O O t0 O N (D
O N

_ O M ~ M of Q1 _ ~ O V O~ t0 t0 ~ M M O ~ O ~ O aD f0 tD 01 G) Of f0 tO tD
N r ~ ~ ~f M N c0 Q~ r O
O u7 ~D aD f0 (O r N at O

a0 ~n t0 Q1 W 01 tp O O t0 O ~ N N N N V
l0 M O N ~ a0 Of ~
N W t0 N ~ Y V Of N O t0 N ~ tD ~f7 ~f N N M N
- M N N N

~ ~D tD N ~D fD
t0 t0 tp t0 ~O M M tD
tD

Ql ~f7 O N O N N N N ~ N N N N N N u7 N
N fD N M O ~ O O m M V N t0 N N
~f7N N
N

r O~ N a0 O O r ~O r r ~ ~7 ~_ ~ N ? r O
r tD a 00 ~7 r M
a0 aD O) ~O O O aD ~7 M
aD M O) N
O O

_ O _ tG N N O Of O O a0 N O ~ ~0 V ~ r a0 ~ 01 M O ~ N OD
r O N M M fD Q) ~ t CO N O N O r 4D < m ~D (O
N O~ aD aD O M N fD

07 M t0 M u'7 07 M V a0 W t0 O r O) r O t0 N O r M M O~ O off f0 O ? t0 O fD
r O O f0 O

_ ~ M <D r u7 p _ M < aD 1l> st ~ Of N M '? ~ r of fD O ~ ~ ~ tD Of ~ f0 f0 O N V ~D ~1 ~ g '? M t0 N f0 f0 tD (O a0 aD u7 O f0 cD ~O c0 (D IG

O t0 N O~ O t0 fD tD M r <D f0 N N N N (D N N
f0 cD OG N ~flN N
(O 10 N N t0 N t0 N M 00 N N N N N
N N N N N ~ '- M (O N (O N

W

N

t0 U L

Z Z Z

b N

c~
E

o a c .

C
U

'~
N

E
o o 'c ._ c o .~
c o..
N
O
O

d T
~:

N
p c t a ' ~
a am vaa a E

' z r r M m o h o ~ c r U _ ' a j N

O ~ .~ ~ K7 O M O

O

O (O O

7 = r O ~p ~ M N 'r ~i7 N ~> C

aD cD c N ' ~
' ~

y, o~ o~ = c~
a r. o~

n c c c.
m m m m m a7 C
C9 3 ~ ~ ~ o E c E c E E E ~ E
z' ~' ~ .
.

~N N N N
~ t%1 c J c C C Y C
a0 O. ~ 7 'N ~ ~~ ~ m ~
~ ~ V

~ O O O r O
aM .. a N
aL o n ' E

_ -M N N _ d ~ O N O N

o ti o o o o a X Q ~
Z Z Z Z
r Z Q ,-, p u7 c n v M M M '~ M

M ( ~

i ' o M

,y u < c ~ ~ ~ M C~~

C
~

w n ~

n ~ ' n o r c a o o N N _ _ ~ N
M

01 01 O m Of a0 m O O N M V

N N M M M M M
r r r r r r a;
v ~

o ~ v m i v ao o~ Wri o o f0 fD ~ r o ~ r (O
N O

p~ t0 N i0 . . u7 O701 ~ ~ V N
a0 O N O M ~ < N O r Of OD V O t< r O) aO O M O M

OO O ~D ~O O N M _ tp N O (O 00 V7 (D N 00 O N tDO N r N
aD O N tD
r O1 ~
N

r W N ~ M r ~ O O 10 ~ u'! . 47 t0 t0 O a0 O O cD (D f0 N
N V CO CD t0 V r N ~ r ~
~ f0 N

0D _ fDO (D ~ r r M
O o0 Q~ (D N r ~ O p N f0 W ~ u7 tD nf1 M
O O in N
?
t0 _ r V N N _ (D O N c0 _ f0 N . Of M . O) N N O 01 ~ ~
'- ~ ~ ~O fD
O r m m r M tD

OO N ~!7 ~D fD N ? ? O ~ O r N
'- N r V M r M N M
M O N M a O~ N (D . OD 1n O~cp f0O (O _ f0 aO ~D r aD N N r M O N r O O O
~fl O N N r M M O
V M O 0D O O (O r M a D N ~ N ~O

_ _ _ ~ O W ~f ~ a0'~t N O O7 M t0 _ N M O N 0 Q1 u1 ~O V
cO a0 tD a0 O M (D
st O O
Q) O M aD O fD O (O ~DaD ~ O t0 47 01W f ~
r O O a0 f0 O M O O ? N N V N
f0 N ~ N f0 N ~ ~ fD
~ ~ ~O O 47 N ~
~ V

M O ~O tD r O D c0~D r tp~O t0 N t0 ? O ~O ~ 10 oD Q7 O tD
t0 O CO

r- N 47 N N r N O O O N r < ~ N N ~f ~
O C7 '- O N tD N ~ N N h OO N N O

f0 N r ~D ~f7 M fD N tD t0 N _ V Of N O N . N N M ~faD N N cD 07 D r <O
O M N iD c0 o0 c0G~ a0 u7 O N Q~ ~
W ap p1 u7 O a0 O a0 O t0~ O M _ O a0 a0 N N M t0 O O ~ (D O N O
O tD ~
M O M
r O

M N r O M Q1 Q) O M Of 0 r M tD N st ? _ ~f O f0 tO O O t ~ fDr M ~ aD
cD ~ O O7 00 O O M O (Or tD
00 ? ~ ~1 V M
O ~ <
~ (G

O t0 O ~O O N t0 O~O) D O 07 Of O t0 ~D Q) iD
fD G1 '~f r t0 O f t0(D ~ N N N O O
aD r cD t0 O ~
f0 M
N N

N 10 N V N ~ N 4D N V N W_N V (p ~
~O ~ O N N ~f70 N N ~
N O_) f0 fD

f0 f0 0O f0 . t0f N N O N N aD N ~ ~
N N ~O N N N O N r O N N N O O (O O N N
01 1n V

_ a0 M ~ ~ N ~ ~ a0 O O ~ M O
at O t0 O O N
O

_ _ COOD O ~tN t0 r 07 ~Dr ? aD
f0 O f0 tt O ~ M 00O 0 aDN O aD u7st O r r O r N M M M c O O O N
M ~ N M f0 N
0 r O N O <
a0 00 aD N O r ~O a c~a~ a~ ~oM o~ o r u~r ~ ao f0 N r a0 W N o o~M co 0 0~
v M o m o r v ao o r v o o m o M o ~ 10 m r N V

f N t0 _ M ~ 0 < V V W N VN N f0 ~ ~ O t0 h < V ~O ~ f 7 t0V ~ tpN tp~ t0 O
~ O 0 O CO O~t0 t0~f (D off O M O tDu N O tD
O
t0 _ t0 t N N M N (D N N N Nt0 ~ O N
D N t0 N M (D N M (O
c0 O fD M tp (O ~ N N
f0 f0 M M (O
N t0 N M N
N N N M ~-0 ~ 0 0 ~ ~0 111 I L L U l_L lLL_1Jp L

_ _ _ _ N ~ N

5 5 g 3 g g5 U ~ U U ~ U U U UU

Z C Z Z caZ Z Z ZZ ea Y ~ 7 7 7 7 >

cO ~ M O
O (D ~ ~D O

M O

>' O O O

a a a _ _ _ C C C . C C C
. N . Q
.

c0 .E . E E E E
d o m o 0 o ~ 0 0 a a a a 0, a o c a c c c c a' a~ .
.

.d N .d. d N d O O O
y 'a d d d d C_ a U

N N N N
O Q C

c c c 5 E . o N 0 . . .

.m m o m m m m L o U UJ a > j U U r U
U Q U

~j u .

c a ~ O

a m v N ~ ~ U
o .' lL
c r ~a m ~ Q
E n o>o y=-o~ o , a~ o N d v> w co U

o, o ~ N o ~ 4 a N
c C7 Q ~ ~

E . E a a E _. =
Q w v a ~ a m , N v o x o v E N ' Z F- o ' ~ N Z

a m ~N o~ ~ ~ " m a E

v ~ ~ ~ Q
'~~
o ~i a o N E _ a E ~ r _ Q ~ U N N ? ~ - x ~
- - : ~ ~ ~

C .OfN C1~ . N f0 O~
.D) ~0 Z

y ~ Y ~ ~y Y Y Y Y Y Y Y Y ~' ~ L ~ ~ 7 r C
U O C .: C
C C =
=: C~

C ~O C ~ C C C p~ O J N N
m O O m N N O 10 N r C U ep ~..~ Q
O
N

m o m o n m m m m m m m . ~ o >' ?
U

O M U a O ~ U O O ~ U O O
o ~ ~ m m E ~ Z

E~ Ed~' E E EoE~''Ea E~Z E~w E_m ' ' ' d ~ ' ' O Z
.

'(/l N H C C7 ~N~N f/1Vl (/l U/l N N y N O R a a O

cdN c c~ cUco,a~c~'~ EaZ c_n~.c_E
~ ~

~p~ 7 G1 y~ _ N GId N N d N tp r N ~ ~ ~ M N H
Y ~ d -V O ~ ~ O O O O O O O O L
O ~ O~ Q) N f0 7 N N Z ~
~

a 10 O N OO d M 1f1 D 'o a a a,oa~.,a,na aooQ a, a o d a, y H ,Y

m n m N ~ ' _ M 0 ~ 0 D u1 0 y ~ ~p j SOD ~1 jN> jM > O
ja ja N p O d ~_ n r 7 V O V ~ n O

O ~ O O O O O O o o o ' V O ~' X ' ._ m ~o Z ~
' ' ' ' Z Z Z Z Z Z Z Z Z
or ~ oi ~ n a~ o~ o~ r c U ~

O N Y ~D ~O O N V (Dm ON

M ~ ~ '~ M p ~ ~ ~ M~ '~~

P f' c f' P f 1 ~ 7 ~ 7 Qi M ~ r O M ~ r Of M

r r r r r o 0 0 0 oas a~

V V ? ~ ~ ~ Q V

M ~ ~ ~ ~ M W .

< n O O ~ ~ O ~~ M

c' f' ~ ~

ap ~ c0 n O _ W ~ O O M
t 10a0 OD N O GO ~O~ Of0 O fN0 cDtD N W aD c0N OfN N

M r M h O r O N NM

~ 0 N

OD 07 aDa0 COOf CD a C~ Of ~ 0 r ~ ~

c' M t ~ Y ~ V
n ~

n r r r r r r r r rr r f0 1~ O V 1f! N O
~

f0 O . O 1n (O O t0 ~ _ M _ O

A . h O (O t0 1~ h t0 N O O
~O a0 1~ fD O O N t0 a0 ~O 1~
Yf P f~ t0 aD O ~
~O ~ Qf V u7 V t0 V
M (O

M M f0 (O ~ f0 V N O M . O N t0 O M f~ (D (D 00 n0 O c0 tD fD ~1 ~ ~ aD < N V N O) C_D O ~ c0 O I~ (O ~ N V 00 W O ~ ~7 N
N O f0 V f~ M
N ? tD f0 Of ~ M O~ I~ a0 (O f0 of N

OD Q! ~f7 1 f0 N aD f0 M (O M O M M
N ~ N N N N N ~ N t0 N O
~ M (O N

_ M f0 _ O . In 1n M N ~f M M Q1 M (O f~ . O . M . . N . N N ~
(O N Of O h Q~ O cD CO O~
~ O 00 ~t7 f0 N . u9 c0 (O OD f0 aD

V7 N f0 (D aD ? V aD ~ N O f0 N N ~
f0 '~t ~Cl (D OD aD O) N ~
'? h M

1~ O . N t0 O (O O~ . 1~ . . _ fD
tD O O 10 tD ~ N t0 t0 h Q) ~ ) tn ~(f O ~ N
V CO ~t N ? N O Q) Q) fD O
N N W ~t N f~ V 1~ '?
V V ~-N 10 _ O fD _ tD . 00 ~ tD H1 a0 tD . ~ (O . ~ (O t0 tD .
. tD tD ~ N N

a0 N Of N O N 1~ 1~ N ~7 M O N 0D
N ~ N 01 N M N N O N CD M (O
t0 N ~ O N N f0 M n0 O 1~
h fD O _ O . N V N O
N f0 O N . N ~ M M tD ~
Of ~ - 1~ O N O O 00 N fi M O
N I~

M ~ a0 p ' N N M ~ N (O e<
Of N t0 M y N N N tp u7 M < M ~f ~ ? N
~ fD t0 st ~- m c0 ~

Of N f0 _ M cD ~n _ O . M . O O (O
O t0 (p 1~ . u7 ~ _ Of C~ t0 u~ O

N 10 '? f0 V N ~ N ? h 1~ (D ~ (D
Yf ~O N V (O Q 1~ 47 (O N
CO O t0 M ~t 0D tD
< . O . f0 . W O N t0 f0 N
_ (O ~n f0 1~ ~
f0 c0 t0 u7 (O

00 N O) N (D N 1 O 01 aD O) m 47 N OD t0 N M N f~ N 1~ N OD
~ 1~ N M n0 N <O
N aD _ OD . m OD CO ~ N tD ~ V' h (O . . cD . OD ~O
. ? CD 00 tD

~ N m M 1~ ~ N 07 M 1~ 1~ M N O N O
P f~ N aD a0 O O f0 I~
1~ 1~ aD V u7 ~

N ~ c0 01 N t0 tD O ~t N N M N W f f V
O t0 M ~ t0 (O N 01 N ~ ~ sr (O
Q~ N M N N O M ~ < V
u7 N f~ O m cD ~ O aD t~ t0 a O ~f7 1~ (O (O st O t0 u7 O
O fD
t0 ~

_ N V N ? t0 ~ N N N N V N ~ N f0 u7 ~ tD C~ ? V < N ~ ~ aD N Of ~f f0 V _ O . tD . N
~t . t0 u7 f0 (O . _ N
tD ~ . f0 ~
f0 t0 t0 tG (O
tD

M N N N n17 M N N N 10 O f0 t! I~
N V O N N N N N N f0 N ~ 00 Y7 N O N N N
N M

O . t~ . . O _ ~ O aO . iI7 O
O f0 ~ O h _ N aD aD f0 . c0 . tD QI
N ? O O N ~ ~ ~ aD O aD
O O M I~ 1~ M aD O N 01 O) f0 f0 f0 07 1~ O N r s< M O

00 O i~ ~- V OD OD O I~ OD (O GO N O 07 OO
~ M O c0 c0 O 01 t0 '- ID N f0 O
N ~ K7 V t0 M f0 00 Of tD
10 P O O~ t0 ~ 07 ~ ~ 1~ M O O N
~p ~D t0 t0 O O O cD O h O~
O fml7 fD u7 f~ h u7 M

V f0 N _ O ~ ~ ~ t0 ~ ID N 117 1t7 N ?
~t ~ M c0 ~ if V V < O) ~f'7 ? ~
u7 M 0 N V < N N f0 ~ M C N ~ cD M tD t0 ~O t~ OD N O

f0 N M N f c0 f0 c0 f0 (O N N N
(D OD D t0 M (D N 1A N t0 N M N
(O N ~ f0 t0 (O N N N N '- (O
N '- M N f0 N
N N (O N N M
N N N N N
N N

a _a~

' O

U
a N N l C
L

_ _ f0 O f0 U L

c I A m C

N N C_ L O C

ai ~ a o.
o E N N 'I

a V

Q ~ 7 d o ~ n v ui o aW ~ co 00 m m n rn _ O O
N

O O O O O
i C N O

O O O O O a p a a a r a d n c _ _ _ _ ....
y C C C C C C
'H T

N

E E'a, E E E E T
c ~ d _ 0 0 o o 0 o o m ~
' a a a a a a N
n n >, c c c c c o c =
o a~ a ~ ~

a (' ~ ~

o o o 0 0 0 o U
~ o ~ 0 a n a n n N a d ~ ~

c ~ d N C C O
O

C G C C C A W
fQ f0 R f0 N ~
' ~ C d ~ U
c c c c c ~, c m o~ ~ Q
E

U U U U U Q U n~
O ~ ~ ~
a M

M c ~

_ C (/~ n 1/f J J t C
U ~ , - .-~

N m U Q Z n ' d co o v ~ ~ ' V O s n m v o ~ o w ~ w ~ ~ n v ~

~c ~ N ~ ~ ~ m O

p V N F- _ ? N O u1 C ~ .

N ~ U ~ ~ o ~ rn D N U
~u Q a o U ~ ~ m :

_ v 2 2 v o Q ~ ~ r a E
c Q ~J ~ . E
v r , ~ a , = ~
a y C7 d _ , O
~ U ~

N m 1 D ~ M L... N (p N
N N
t ~
>

cn m Z N h (O N
~ W a a ~
W m c n Z r~ M U
a~ n (n m u1 v c v ~ .
~

N ~ N I cV ~ r ? ~ C
C

C N

~

- - 01d N OI V Ol 07H O1..
Of.r .

Y ~L Y Y Y Y JL = a Y Y V JL
~ ~ N ~ (' O
~ O O

C C C C C C id C lL U C C O C n O ~ N a r f0 C N f0 (E N
IC f N l9 ~
l0 ' m C O m l0 m ~ ~ ~ m m ~ m y ~p p m E m m ~
N !~ ~
m ~ J
~f7 ~

C7 C7 C7 9 C7 C7 0. C7 ao C7 c~ ~ ' C~
p < 0 ice., x o~
m o ~
c E E E E E E ~ E E
I ~ N ' w ~

Z n a a o E ~ z m ~ w ~ ~ ~ ~ . ~ ~ ~ ~

N N N N N N E N a - N N 7 ~ N C
~ ~ T 7 ~. C C Z N Cd C~N
LN C C C~
C a r ~ C _ _ p d H W d ~~ p N N ~ ~ N Z V
~ ~ d t0 N
~

O O V O O O O F- O O O Q O
N O D ~ 00 N
a0 ~C C a ~ O
f d n. _ d d a ; d ~ ~ O. d f0 ~
Y p a p ~ E
Y ~ ~ N D
U

d ~ d d d d a a~ d o a ~
~ c o c ~ a H
~ 'm a 'N Y

" > > > , c , > > U c~ >
, L m > > Y > I 7 > ~ N t a 77 O

~f ~ L - _ M
p ~ ~ ~ ~ z Z Z Z Z Z Q Z Z z Cl O a a O Z 7 Of Y Q

c0 m O N ~ ~D aD O N

M ~ M M 0 M M (~ M M C

u7 t' Qf M u7 h O M

O O p O O O O O
~ ~ ~ ~ ~ M ~ M

f f _ _~1 C _ M_ t _ M_ _~ ~ c _'7 _~7 a a~ Of (O l7 M ~ N a0 a0 M n 0 gy N
O

(' M f ~ ( O 1~ O h Y p O tD N ~ N M C~ 1~ t0 M
O M 1 M V N O V O) M
M

0 ~ M O ~ m ~ W

a ~ 0 o 0 a D

aD Cf O N M W (7 c0 h V ~ W l7 h 47 u7 U7 ~ t0 h h n h h h n h n h ~

ap ~ O O V O N

(O tn h W V f0 O ~ _ O O_ fD < N
I~ t0 M V '? (O ~

a0 ~ N ~ O 'Q (D V 1~ U7 aD h ~
M f0 V O f0 O) fO
? N f0 (D DD ~O
h N
~ ~

t~ O O O (O . ~O O a0 Qf N < N N
M t0 Ir O f0 f0 1 N ? N
M O O ~O N ~ N O 01 tD
01 N M ~ ~f ? ~
M

M O _ . V !D ~O Q7 Q_~ ~ t0 m N _ a0 01 N f0 1~ aD M C c0 f0 h h N O V M f~ a0 N f M O ~ N 07 O) N
t0 O7 O N O (D N N M a0 _ N _ _ O 1~ N (O ~ N O N _ N O a0 K7 N
N K7 O ~ N W DO ~f GD M V O) M
N N ~O

tp ~ tD W N O O~ c0 a1 N a0 Q1 N u7 c0 O !D
O o0 N c0 O~ 1~ O O M cD t0 O O

N N h N N O V ~O ~ ~ ~ N 00 N N sr u7 e- N N (O ~ (D h ~ N N O 1 tD N f0 t0 D f~ ? N
tD (O ~ O f0 ID O
t0 N cD ~ O
OD

N u7 t0 i!7 Of (O N N N O < N N O N ~l7 N N
a0 a0 ~D CO h u7 1~ M f~ f0 N N O
O N Of N ~ M
N O ? N ~ V
O M ~

O M O N tD tD O O1 . (O ID ~O p ~D . (D CD
M O (O t0 _ O
N N ~

M N M t0 Of N Cf N ~f7 N ~ Of O h Of V N O <
O f0 M N <O tD O N 1~ <O I
N f0 O O O a ~ O Y7 N h N

M '? . ~f t0 N tD ~ aD O O~ (D t0 0 N ~ V I~ aD O f~ (D f~ 1~ O M t0 I Q1 O Of N
~ O
O
~

Of t0 t0 u7 aD N 1~ t0 07 ~O O N V O ~O a0 O ~O < aD O c0 ~ O M (D tO N O M N
N N O N at ~ O h ~
if) N (O M O N ? t0 N M t0 W
N ~ M ~ h t0 t0 (O N O~ M fD 1~ f0 ~D n M In N f0 O i0 O
tD fD f0 (D 1~ tD t0 u) M

p O C ~ DD V N N N N 117 M N N N 47 N ~f N Q1 O O ~ ~t N t0 ~ N h N N O
V P (D M M c0 c0 t0 f0 O

O P t0 1~ _ O f0 N 10 . V O N ? N I~
O V tD O (O M a0 01 O ~ O
O N ~I7 f0 . 01 N OD
O N (O QO O N fD
N O O N 1~ V
~O M
~

Q7 07 N N 10 ~O (O 1f~ N M 1f) m 4'1 . W (O
~f t0 O N 1~ O
aD tD aD 07 fD
fp I~ M 01 h u'f Of M h O 1~ O N O M Cf N O M N ~ t~ Q1 tD 1~ O f0 O W V O O 1~ aD O O M I~
f0 O O (O f0 c0 V f0 00 M M O ~ ~ OW 7 c0 N
10 u7 t0 O ~ ~
O
O

N f0 O t0 ~ O V t0 ~ ~ c0 Q~ ~O O t0 ~7 O O
~O V fD N M ~f cD 01 ~D N t0 O N
~ O W Of (D t~ t0 O
h u7 t0 ~O t0 cD ~O

O M ~D (O V ~ N N N N N ~ N N ~ N V N N N
N M O I ~ M s< ~ N N Of N V Q
N M N a0 N ~ N N

<O t0 f0 t0 ~D (O _ ~O tp O OD (D f0 fD
a0 In N V N ~f N N aD N O u7 (O aD Of N N N N
M u7 N h N N N N 1C) t0 h M t0 I~ N O fD 'P
M 1~
N
O

O N ~ N 1~ M ~O _~ N Of m N O M o0 p t~ O 0O
~f7 O~ O ~ W a0 M t0 01 O 1~ m Of a0 N f0 f0 ~ O
~ . O oD
O~ V O~
a0 O
1~
aD

p a0 t~ OfO tD O n0 4D aD aD O O f0 m a~ O 47D O t0 N (O ~O N M
o0 M N O O N f0 tD aD
OD O p 1~ ~ N M N N 117 tp ~f1 01 1~ M O O PO 07 O 1~ M h t_~ o_0 I~ Y 1~ O~ O O
O ~ O ~O t0 t0 M M O O) aD M O Q~ ~O
a O C) N h ' ~O O) 01 V N ? W N ~
N 01 W O 1~ 07 (O ~ M
u7 (O N '?
~ t0 N

N M 1n u7 ~_ Of N O (O N ~D f0 N tD f0 f0 (D ~ ~ u7 ED ~ fD ~D t0 fD (O ~f7 N Of t0 a0 (O tn u7 f0 M
M f0 M ? V ~f 1f7 N
~n t0 (D c0 tD
u7 t0 10 fD f0 O

N N N M NO N N N N N N t0 Y7 N ~ N N N N N N
N M M N ~O N N (O N N N N M N CD
N M M
N M N

UJ WL W W
L

__ g g5 g g d ~

U UU U N '~ U

Z

7 7> > ~ U 7 O .
a c~ o c o ~ E

_ r o a ~ O ~ _ (D
:~
C

O N O V O .fl -rn ~ u._ E

a a ~ a ~ ao _ c _ C U C C C E
Z of N
~

f0 N
X l0 C N

E d E . ::
~ m E

m o U

v E ~ v v ~ c c' c c a ~

m p U O C O c0 ~ O

d N ~ O.
~ O

C X U
. C
O

C C C ~ C
N N

C
c ~c c E c ~-~ ~
'-U C7 U = U ii E a N r ~ ' = d ~ N Z N o~ , c y O C O V=
m V o ~
o ' m m o 7 d a Z n o E ~~ w o Q Qn ~ < pr = c c U d ~ p ~ n U cco a Y
c U m U a y - E cn E

E ~ a O N d t ' y G) U (O
~ e ' o n -o a ao ao o ~ , < V m c n v c o y ~ o o N O a N O O
W

a0 C O N U c0 O c O
f0 D O
a0 7 a0 M

In Q l'7 V N

'a o~ ~ I 'c~ o~ o~
~c~ c U c U n C T (/~ N _ ' O

C 'N C N C ~ C C C
O.

m U ~ ~ CO m N m CO v N

C V 7 ' C~ c~ C7 C7 C7 C
E

E E ~ ~ E p E o E a E E d 9 jn O V 'N 'N 'N ~ 'N N
= j ~(d C O. C C n C_ C_ C_ C m ~ d ~ N fn t ~

'N _ 41 N I N ~ N d p p O N O O O O ~ O ~L7 O ~ O d ~ N (L m N d n d h _ d ~ l1 C
N O.
N
Vl . Z rn c N m M ~ N O M N N ~ d d y N N d 41 > . >
m > > Q > N > ~
'd > ~ ~ ~

Z a ~ Z or Z Ca Z a Z v Z o.
U N

N V t0 a0 O

N N N N N

u u.~ u u ~n "

M MM M M M M ~
~

O hO N N

N N N
N~ O N ~ ~ O

M ~. .M.. ~ .M.. v M

Nt ~ ~ M Onf Q!
D

h h_ O Mh ~ 0 r O

N ~N 0 V
f O N W M
N N

10 OfM ~ ~ O ~ O
m O 07 a0 N M

n~ ~ r n h ~p N N 0 O O Q1 O tD aD
o c N O ( O O 0 O) O ~O O ~O M
7 f c ' p o0 ~ O
r p N M N M N ~O a C O
~ 0 N p (D '? M ~O r r ~7 (O O N
0 tD 00 tD M O~ fD t0 _ r O N ~O t0 t0 _ O t0 O f n h M f0 N (D ) N N N M ~ ~ ~ ~
N < ~ ( N N
~O N O
N
O

~ ~O N t0 fD In 0 ~ Q ~_ _ _ 1 f0 10 t N 10 O r 01 ~O M ~O
iD t0 t0 N ~ O
If) O ' f0 u M N a0 u7 O N r N 7 ~O
~f7 N ~O N N M ~ N M O W ~ N V O
N O) N N tD >
(O V

so ao so m w r~ o~ o o ao o m o o v ~o _ v ao ~n so r 0 ? N
N
N

~O Ip O N tD O ~ ~ O t0 W 10 tn N aD
N M t(7 1IJ (D ~ M 1 ~ ( ) ~ M t0 tD f0 N
f0 ~O u7 m fD
O

r O_D 10 m O> O V O M N m N N r O
Of t0 N ~ N a0 V N r r O
M V ? N
V N

O ~D O~ ~O _ c0 ~O 01 p N t0 Q) ~ f0 tD c0 tD t0 ~D a u7 tD N
N N O! N V O
Ql O
O
O

r N 1(7 ~ N N h O r aD 01 N f0 r ~ tD
N N M ~O ~O O ~O
c0 N f0 O ? O O N 07 N
f0 N (D Of O ~O (~O O~ tOD O~ M O O tD u7 ~D W O
a00 t0 O r N M u1 r O t0 fD (D
r ~ a ~O
r cp OD N f0 < O ~O M _ M
~ ~O ? f0 N M M O ~ N V N u7 N
st M O V N
O t0 f0 N
N

r f0 V1 r t0 01 M O Of Of t0 (O (O ( 47 p 01 r ~ O 4D 0 N 07 '? N CO N ?
N t0 01 ~O r N N M r N 01 ~ N V 1 CD N
V ~ N r ~O
cD

~ N ~O ~O O N r ao ~O _ M t0 N ~(7 ~O O M ? M M r r M

N OD N O N N O ~O O O) N N ~ ~ r_ ~D N
N N O N r tD
~ ~ N ~ M ~O <O N N f0 f0 m tD N

01 tD O) M N a0 o0 1p O r a 0 N M ~O W M O N O
Of O~ O O O Qi O ~O O
cD r M
(O

r Of M (O ~ O O N ~ V t O V 'V ~O ~ 01 ~
M O ~ ~ M t0 r t0 ? W
t0 N
O

r O O) r 1D ~J tD N O) 0 f0 O W f0 O !O _ ~O Q) ~O r (O f0 ~ ~ m ~O ~D
fD r f N N t0 M ~ N p M
N
N

CD n0 N ? N ~ V N N ~ N f0 ~? N fD N t0 t0 < Q N V N
V (O M

M f0 tD f0 iD f0 N Q1 10 N ~ O O (O N
f0 f0 N ? a0 r M CD M N V
f0 N m N N N
V N

fD N V N r V p r p N M 1f) ~ tp r M N 10 V n u7 _ N N O W
~ 0 p aD O ~ a0 W ~ (O
If7 r O N M O r ~
V O
r t0 M r a0M 0D O ~ a0 O Of V' a0 O ? O 00 ~ Y
O N fDa0 t0 u7 M Of <O ~ O1 N Q) (D 01 'f 01 ~ Y f0 i (p O~ aD ~ O ~D M
M O M ~ n7 aD

u o ch~nc o> a~ r r r ii ao r m n ~ ~c <c r o r r cn u~ v r_ ~_o o so ~o m o <c 0 r O N N M ~ f0 a0 Of 0 a0 V ~ N V N
Of (O N M~ 'Q a0 ~ M N u7 N 07 t0 N O r ~l7 '~f ~ 01t0V ~ ~ tD M V ~ ~ O fD O fD N M
M tD N ~? N tD tD
N f0 (D u7 tD
t0 cD tp f0 M ~O u7 tp 4'f N NN N Y7 N N t0 N O N N N n0 fD aD fD
N N N N t0 N V1 N n0 N c0 O N M

( N

d Q QQ
O

W LL W J

C
~

'd W W d H E

o ~n ~n~nE ~ _-w ' g 53 - ~

U UU E ~ ~ Z

T Z ZZ O N

> >> U

If1 Q7 N C

p7 N d O u1 O O O
O O O O d ~

d a a a ~

c c c ia S
~ c E
' > m , ' o o o o o o ~ o U

~ a a a U

C v c o C
'N C C C N L
C1 a' C U

d O 41 a O
~=

O O C O h p d d O d O. O
C ~ d ( ( Q
E N N
' O C C O C
N ' (p ' ' G
.

'~a ' ' a m m ' n Q U 't ~
~ Q a c I c~

U H U ~ U U d U
O ~
v ~

~ Q

c U Z U
' M = U
N

N Z Q In ~ ~ 7 LL
A

a0 d ~ d Z O ~ O (O M ~ I-m O

e- o N ~ O
a ,-, _ z i d m a ~ ~ ~ i o r E O p ~ Q a m ~ w _ V
' Z ~
~

~ ' ~ o ~ N o~ Q
O ~ ~

~a Q f-D N? 'rmm~ 7 ~~

J _ ~
~ Z
~

Q r ~ O) N .~ S
d ~ ~ m ~

v ~ W Z Q m ~ N
Z _ - d ~

C~ o~ ~ O - H' ~ ' c ~. ~ o Y Y
E O

Y ~C ~G ~ ~ Y C7 C C
C~ ~ ~ r H
~ ~

mo ~U~ mOZ ~ m as ~~
Z m~

m m m <o U __ ~ 00 a H C~
~ Y m ~ m o ~ ~ ~ .~ N
~ Q

C7 C9 C7 M w C7 "~ ~ O ~' C9 ' M ~, Q Q y o a Z C7 N

Ego .

.

N C C d Z C N ~ C C. "~' C
C~ '0 ~ > > 01 0 N
~ ~ Z Y

C

N d d N 111 ~ J Ø. .. 7 C N ..
r ~ J N . 01 ~ O W C~ U ~ .
C~ ~n ~
t0 ~
~ Z
N

O M O ~ Z H O O V _ a o0 N O O = U
p a ~ a a J J ~ ~ ' Z Z

f d d O C p O N ~ ~ O O~ H
~ . 'f d N O
O

W > > r_ ~ m is j >
O > QI > ~ O
O~

z z z 'o> z 'o~ z z a a c z 'o~ a OU a a 'o~ 'o~
~ ~ o a a E

N ~ t0m O N ~ ~ m M MM ~

p ~l7y0 W l7 ~ ~f7 M
M M MM M M M M

M ~r O M ~ r M M MM M

W uW nu~u~ ~n u~ u~

M ~ M

t0 t0CD~ O N M
r ~ O m N ~ Map0l M M t0 N
'~

m ~!7~c0_ M M
~ N

O r NM ~ ~ ~
u~ r or a~ ao oao0 N M I~
o~ o 1 c r n n ~ r c r r rr r O

tO O N O a0 O O N tD ~D w7 ~ h r N ~O
a0 m O O M _ aD r u) M

N N 10 N O ? M OO ~ V a0 N l0 (D
N M ~f) CO O
~ ~

f0 N N ~O N O ~f r t0 r ~D O
- O N ~ N c0 N N f0 O
O O M (D ~ t0 ~ < r r ~ N r O N
O N

01 M N fD V f0 O ~
fD Y r c0 V f0 t0 aD c0 ~ t0 ~ p N c0 tD V o0 r aD t0 ~7 N
~ N N
N N

O O f0 h h (O N r c0 O t0 N (D O
O N ~O u7 ~ O V O W O t0 r O t0 O N
p N 1~ V
0 ~ N N O

M tD !D O 10 N fD r ~ _ r O O
In GW - M f0 ~ f O M a0 O N O c0 (O O r '- r ~ M

0 N o0 ~ N N O O ~ O
~ N V O f0 M O N M ~D N a0 O f0 O ~t7 OD O) M N M
t0 O

_ - N O ~ O t0 N tp O
_ O ~ ~ N fp r N M c0 M 10 r tD N O
~ r fD - <

D N W O ~ N O N M c0 aD _ <O D (O f0 u7 W O N ~n O O ~O t0 aO f0 O a V O 1f7 r D a O 1n 1~
M 00 f0 N h ~ f0 t0 Q~ t0 t0 GO OD t0 O~ cD tD
a0 _ O u7 O N h W ~ aD N
_ r <O O ~ O N N
. O) r m M M ~ M fD N u7 O M N N f D V

_ u7 _ tD tD a0 t0 O
07 M M of t0 W N c0 ~ O_7 O N OfK7 h ~O aD V tD N u~ I~ M V t0 t0 O) OW O O 1~ O7 (D O O t~7 t0 h f0 O M O t0 h tD t0 (O N

t0 N N V f0 aD (O N fD M O) N ~O MO (O
N r ('~ ~O M ED O N O) OD M
N > N M o f0 ~
N

co 0 0 ~ _. o _ 0 o ~o cco h ~ N N N O N 10 O r r ~O r- 10 Qcu 00 t0 M ~ f0 N ~ cD N OD (D N N
O V ~ ~ <
(O ?

r N ~ N ~ ~D t0 M _ N f0 c0 ~Gf0 f0 fD N f0 a0 O N tD f0 f0 M t0 N O t0 1A aD O 10 N ~O N 4D N OD N N 07 NN N
N r M N ~ N ~ O W 01 01 h ~ O N N
~O Of 1n O N N N
aD ~O cD t0 f0 O) N t0 M N oD f0 . M OD . O f0a0 00 D M Of V M O aD O) t0 07 M Of a0 c0 O cD 07 ~ N r M h h O O
a _ M < fD M O ? f0 r OO t0 M (D N (D m O O < ~ N 01 01 O i0 O~M
<O M 10 N Of O Q~ O (D M 07 0 W O O f0 f0 h ~f1 f0 ~O (D c0 Yl 1~
~D <O N O N O c0 t0 Of 1n O M

_ N nt7 N O N M (O VM V
u7 N M t0 DD u7 ~ N M N V u7 ~
N ~f N M WO N f0 N ~

t0 _ t0 t0 f0 fD tD _ fD _ ~O M tDO f0 f0 fD tD

N r OD ~O ~ V N N 4'f N t0 N r M NN N
h N O h N Q O N O r N N N N
M 10 ~ N

r O N M 10 f0 O r h fD N ~ (O N -~ O O f0 f0 . ~ tD r ~OO) r 00 n0 O a0 W CD r r ~ OD r r O) m r N M N O O O h O M r N M
r r O
aD

< aD N O f0 ~O t0 V ~D O m (O aD O OW O t0 N r 00 M M O~ Vf O N M O ~O~ h ' O h a0 f0 ~ l0 O N O
? h r ~l7 7 O ~O r h 01 O) O M O O ~ ~ ~~ V ~?
r r M a0 I_~ O O ~ o0 O O ? f0 f0~f f0 N O O u 07 O) M 47 ID ~ ~
N N M V' OW W V OW W In W 10 c0 f0 f7 t0 ? M N O M fD
) (D t0 fD

~f7 N W t0 O f0 ~O N _ O t0 O N NN N N
fD M CO t0 M N (D t0 OD (O tD N N
t0 N N N tO N N N (O 10 M N N
N N M ~ N a0 N ic7 N N ~ N
~ N M N N N

M

W U_J lIJ W W

(~ ~ ~ ~ C

g ~ 5 g g g ' U
Z Z Z ' Z

c > > > 7 S

n a c .

m E

a c n c N
~U

C

td N
C

O
n U
Q

J -O
Q ~ Z N I

O _ N Z
~

r E n ~ to v o ~ r X
~

~ o u~ uI ~ Q ~-. ~ v c~ U
o 2 O ~ ~ o n H
N
y in O O _ in M m ~ d E N
~

> C d O N C .Ø.
. co a~ m a~
U

c m m ~

a H a = ~ ? oy a a a m o ~
E

a a i = y O C 'O n $
H m U N .

p U (p O U O n a (O N M
O ~ M O

O a ~ d Z ~ M d O N ~
E W O) E

O 2 . O~ O G1 a'o2UU ~ ~d~~" o'o= a ~i E

C N p O ~ lL V r N
d ? I N C Z
~ O

~ . p CC7 Y -a ~ : . .
~ : .o .

.c~ d ? Y ao , ~ o~ or o~ c> m c _ a E

y p y Y D ~ Y E F- y y y ~ Z H 0 .
O O
O tn c o~
~

Q c c ~l V UJ n H
N

O m m m M ~' (~ C~ C7 r C~ = C7 C7 (~
O Z '.' O ~
r Z c x N _ E ~ u~ E ._ m E E
~ ~ c o E ~' ~ H ~ o Y ~N N a ~ ~N ~ ~N ~N ~N
~ O O
~

d d ~ ~ a 'a i~ 'a Z ~
c U a o m d Q v O ~ '~ ~ ~ W Wl7 ' F- H

d N N d a' a, N D N d f' a M x a ~ r- d O
N y M
U

N

co n oQ '' oNVa Q ~~ gi 'N' o d o . n - Z Z Z Z

Z ~. N Z Z 01 Q .r ~
.- .~ ci ~

y f) O (O <D ID

47 1n N I~ 1~ 1WO

M M M M M MM M

O ~ ~ ~ ~ M

N fDf f0 y n ~n m cf um vn o v M ~ v .Mr~v o ~o v ao n nn u~

M ~ ~ N u~ o~ ro 0 _ O M ~

M h f~ h~ r 1A M 7 VQ~
M N

~ ap O OO r h ' ~ ~
~

O
O O aD aaD OD
D f D

r ~ n n m on o r r a~ o of v r ai cv ili rn ~ ~ ~
ao ~ i0 O V m < < 1f1 m O) '? ?

(p O r m m m N O V N N m _ (O W ill O Y N
N O r u7 m m N V V ~ N V _ m N O
fD m m m O O ~ M ~ N m ~

O M t0 ~ ~ N m M r N N N N N M N O ~ O N
m V ilf O m N

O m V r M W m M N N ~ N m O
N fD N O) ~ O 07 N m m O) iC7 O) m N r 01 m O M
m m M m r V N m m ~f N N O ill O ~ M ~
m N m V N Y

O r f0 m r O N fD u7 W M m m t0 N m ~ N ill ~f t0 r N r iCl N ~f N i0 m O ~ ~ r O N N N m Q N
N m ~

u7 f0 m ~ ~ i0 _ O t0 m Qf m N N r N t0 N lD W t0 O f0 N N N N m M N (O N tD
N t0 N K7 fD ill ~ W N
N

~ M m (O M O W m M O O
~rmr ~r~mmMU~ f0 (O mNm O~ OOm MOOMrMVl7 t0 O O if) O M N N M ~ O W if V m N N V m m M M t0 ~ to ~f oo ~n m ai in r ~n rn o r m <o ai M m _ m ? ~ N N
m io m o is N r r ~ N ~ < V' < N N V O N V
V N < r M vt u7 _ N tD O m O lp O O
~ N l0 m m m m _ m t0 O O
_ m W N N N N r- _ M N N ~m h N O) N '- il'1 01 m f0 N N N
l0 N r N
O O

u7 _ IfJ i0 M ~ V V 01 N N l0 ~N 07 m N M m r ~ '? O_ m N m r V ~ M m 01 V r m sf O M m Of ~ r ~

O O 01 m f0 m ~ M O O m O m M_ ?
Q~ V M ~ tD fD N Q1 m rN O
O) O u7 O O r N O r M m i0 m m m O1 O~ O ~ O m M N if) O
N r N V i!7 ~ ~ ~ N N ~ N m ~ V MM N
M ~t N V N ? ~ m N ~C ~ ill f0 t0 t0 m m m f0 f0 ~1 m tD MO m m m i0 nNNNN~~N M m mm NNN
NN NNN NN
N
NNNN~N

O ~f7 ~ 1L7 m m m m V' mm O
N r M r r tD m O
_ O) N 47 W O if) 10 01 r N V m O

m o o rn o m ~ o m cc o m m mm m m a~ m M a~ n v M m o M

0 M O t0 C) t0 r M W O) tD ~N W
r ill m O ~ r ~ O) f O) ~ O i h r O
O G fD
~

~p e~ l0 a~ ~~ O
~ iNm~(~OtDOMil7 ~~f~0 ~~f~O~f~Omf ~~f~Of~Om~(~00(~OVO'ff~ON

M N N N N N N t0 N N N N N N NN M
N N M N N N N M (O N N N
N
N

W O~

W L_L _ w__ _ U U

U ZZ

7 > > 77 O

i_0 O

O

a c E

v c nc c E

'~ o C

O =

U a ~

'~ ~ m d Z N

(O
E O
M d ~ U o U t l r ~t b c is U ~ o r ' N ao~'~ ~a ~ ~
a ~ a E w a a ~ V N
r v m a ~ E
~' a, N p W y o~
N- n a~ 9 Q

v ,n E o ~ E cp oo c a Z ~=

in p m o ~
~ a~ m m m 'E

lL m ~ O
r Q N O

~ C d M m N
~ O ~

_ N
'o, 'm o 'c~ o~ ~ ~o~
~ a m ~

Y E ~l ~G N U
(O
O

C n ~ ~

~ f0 m "- f0 ~' l0 j T m N

m m c~ coo c~gw E E ~ E E ~ E
y m r_, a Q ~

'jA _ ~N ~N Q Ul U y~ d = Z
a ~

c c Y ~ ~ ~
W 1l d l ' ~
' ' 'd -~ r d 0 d H ~ , o~
~ ~

0~ vg= o ao~ a~.a n_NUy dli N

N ~ y O
Z Q >' O ~

0 O O m O O ~ O
O ~ !n ~ 41 m a z~~ z um z z zQa o ~

O N ~ i0a0 O

m r r r rr m m m M

ri iri~ of ~

m r r rr r ~

ip N i0 hillN

M_ M_M_ M O O V OfOf O
N ~ ~

V ?
r M N
O O

ip N ~ m N
i0 r O O m m Om m M t0 r a0O) O

r n h ~ n~ n rn rn o ~ ~ o m Wri ' o ~

f o v ~ h ~ ui . . o ao a o> N rn N n o M co o> o ~ v r ~ ~c o m of < c m cc o M f v m v v o M M M r~ o o o~ m ~ ~ N _ 7 m M . f0 u7 ~n O tp f0 O t0 fD m m f0 ~f7 (O f0 t0 O h t0 ~f7 N . N m O~ u N N ? V V ~ N N O h ~ M N 1~ ~ N V t(7 V ~- V ~
< ~ M 1~ O O O 1~ N P 1_~ M t0 A
M c0 f0 c0 h 1~ ~O
u7 N ~ Q O l0 m t0 4'1 CO . tD f0 f0 (O f~ N N O O) O f0 O N N
~O ~O 01 m N OD O h O N OD O O O ~7 1~
u7 N N N N O O 1~ O f0 m N ( V
N N M ~
O

C~ O M O a0 O N N O W - W N N N ? ~ V O_~ O
fD V ~ N tD Q m N ?
O t0 O
m O ~

m 10 O m m N N O M O ~ ? O) O) m O N ~f O M f0 M I~ N N m Y W
m N O~ tD O M 1 u7 t0 N ~
~1 0 N 1~ N ?
M

(p ~ s< O O M O ~ ~ 0 7 N N O~ f0 47 u7 et 07 (D ~O fD O W N fD fD c0 tD
n N 1~
0 h 1~ 1~ CO

c N _ f m 1A ~t Q V ~
1~ f0 f0 Of O t0 W 07 N m N m ~1 N t0 O) ? (O N
1 Q7 1~ ~1 M O ~O N ~D
N N '? ~ ~ '? N ~ (O 1~ f0 N
N ~ ~ h u'1 ~

tD t0 m 10 m N N
~D f0 tD tD . N u7 t0 f0 m N ~ M N N ~ M u7 N 01 01 N N N N m O M 1 1~ Q1 M 117 f0 N N N ~ M 1~ O M O M N 117 ~f7 h O ~ O m ~D t0 f0 m < m ~ O m . ~ O _ N M <D O
1~ N N 0) r O fD ~ N ~7 M M M t0 N Ql O) m tD 01 1~
M N fp M if Oi ~ ~ 1~ O u7 O 01 1n N N O CD M O (O M ~l1 (D O m m O
!D

m V ~ N M m O OD ~ N < N V Of N N N ~ O ~ O_) M O
lD m N O (O M N m O fp a N o r ~n o r~ m is so o~
~ n o a~ o ~n ~ o o ~c ~o u~ o _ . 0 ~f N 1l7 V ~
o_ . o m N N ~ ~ V O) n N co ~ ~
~c cc ~c 07 10 N O M f0 tn ~ V V V ~ N m W 1 ~ N N ~

~ ~ h O ) N ~D . a0 t0 ~D
tD m cD t0 m <O 1~ 01 m O> . t0 u7 m f0 ~O
tD f0 m (O O O N 1~ Q) m N N
N N
N

N f~ M N N N N O _ 7 m m N m ~ N N N ~ 47 O) M N N N O m O M ~ f0 O h ~D O 0 m N N
f0 f~

O O ~ m Q1 N M N t0 01 m O f~
f0 M fD t~ t0 W m N O N ~l7 m V ~ M ~ t0 O fD f~
CO r ~ M 1~ f0 N 1 M 1~ V O
t 1~ O M N m h O
m m m ~ O O M ~fl _ _ _ M O
M (O m f~ tp ~ N V 'Q O O ~ N M ~ O N m m m ~ h N 01 N t0 N t0 m V m ~O f0 M
~O N t0 O 1~ O e< O O~ f0 N ~ N O~
f~ O M O ~ N Q~ tD O O ~O
O t0 (O O t0 O~ O (D N N N t0 V W O _ V ~
u7 ~D O ~ ~O m N N M N < ~ N N M '? ~ V
N ~ K7 V V ~ ~ N N N N ~ ~ O m 'Y
tf < ? V c0 t0 cD
m m tD t0 f0 t0 f0 f~ fD O ~O N t0 _ N N
f0 ~O t0 f0 ~O N . f0 _ (D u7 m N N
M N N N N N N N ~fY N O f~ N f0 N r N 01 N ~ N
N N N m ~O 1~ N M N ~ N O M M
e N

N ~ p~ r p~ ~ cD . N m N O ~O N
N O O N N m m O O m O 01 N y~ N O M Of O m M m ~ ~ N f~ 1~ t0 M O O ~ ~t N O) 1~ O 1~ N Q1 I~ O < m ~ m m m f0 1~ N O M Q) m O m <O N f~ V m m ~ O O r M m m f0 m m 1~ m O M O f0 N V m V O N
m ~
~O

1~ it1 m u7 O <O f~ _ O M < 1~ O ~O ?
Y7 O t~ 1~ t0 ~ I~ f~ O O N O M O ~ O) ~D W 1 t0 Q~ O N h V M ~ u'1 p 0) V ~
V t0 V V ~ ~ 'C f0 N N h ? u7 ~ t0 m V ~ ~
~ Y V Y ~ N V On t0 N ? ~ ~f t0 t0 N N M N N N N N N f0 N f00 N N N N N N M M N N
N N N N N M N N N N M fD N N
M N ~ N N N
m N

O

W tU W

C lL N L L LL.C
.

4' fN I t n ~ O

v v o v a ;. z j o , Q >

1n N

~ ~ ~ A

O O

O
a~ a a a c .r C O~
:

c C C c C
A E

E E E m E c E:~

_ o v v a ~ ~

m c Z

c c c c c d ' eo 0 o o ~ 0 0 o E n no n nL ~

~

C O C C N >
V ' ' ' .~ C ~ O O ~ ._.
O _ C C V C 'O
!C

U U U d C7 C~

N
C

d _ n _~ N
r v N N r O m Z
. W

N O V = Q N
d .

N N

Q E

a ' ' , a ?' o j U

o 0 o I
w _ ~ 0 ' ~
=

a V C 1~ ~ C t N

. L
E

N ~ L
O .d N '~ O
o o n N ~ L D

C V C c O (0 C l0 ~
O lL
Z

T

y (~ (~ <
Z

E m E E ~ v E n '~
~ ~ . o O

~'~ E '~ c a ' r m c c o o c~
~ N

m d o n.
o O

d a~ Wi o a~ o >
r N m U

a > > m a o ~ o o ti m > m Q

o ~ o o - c Q ' Z a Z
o~
~

Z ~ Z Z
~ o~ d O N

m M M M

O
M ~

O
~ M

cV
M_ O h O ~ m O h a0 m N O r O
r ~ y O

1~ VM1 _ !~ O t0 w m o m r m r ,~ ,~ n r r ? M 00 V N

O Of X10 r ~O O O N ~ _ . ~ f0 .

Of t0 Of cD V aO cD c0 u') N a N
o~ .t o> of ai a of m ri O r M r r o o~ ri M <o v a6 v ao .- M a>
M ~ ao so op u7 c0 a0 N a0 t0 _ r . c0 O ~D ~n u7 tD
c0 . . u7 . r fD O u') r . <O f h . O O r p7 ~ tp N O N W V V V
r r r N N O N f0 N ID M r N V V
O O O N O O aD

N fD N N N r aD t0 O ~O a0 . ~ . . f0 t0 O) t0 f0 aD M . m tD fD M aD _ ~p fD
O) - u7 O) N O N M M 1f7 f0 O N N N N fD O 01 1n N
~ fD r O ~ f0 OD M lD N N QO M e- N N
r N V R fD V C1 O t0 Of N r O M t0 ~
N O 10 M r N ~ O~ p N V ~
N t0 _ f0 . O O M f0 ~ f0 O O (O . M Of . r N
N O . M . (O (O r V O M M fD
u7 a0 N r ~O f0 M N N N a0 t0 V N aD M O M
aD ~ Q~ tD 01 ~ N M 07 a0 cD aD
N N h . M ~ N O <D 1O u) aD O
Of _ O . v- c0 M tD ~ ~ t0 W O
fD V u7 r V
. .

Of r Of t0 aD V r a0 _ O Of N r M M a0 N tp _ c0 M t0 t0 O M N O N < ~ ~ < ~ ~
t0 00 N O W f) . ~f7 ~f V
O O . ~p . r ~ r ~ . . tp aD . (p fp a0 tp f0 (O _ aD tD cp r 0D r GO O r M r N 1n N O ~ W ~ t0 Q1 N N
O ~ ~ O M nff N M M N N 10 ~ N N
'- O of c0 t(7 _ (p O t . O c0 . _ N O N ~ N t aO Q~ p aD
O) f0 W N f0 aD
V r t0 ? r-N r N M f0 O O O c0t0 (O r r c0 ~ ( O~ ~ t0 .- r ~ O M ~ f0 t0~ O r ~D Of M M u7 ap V ~f7 tD O) - N (O ~ M O M O M M
N N N M N W (O ~t N M a0 (O t0 OD
f0 N r M M N O ~
t0 . O . O . ~ t0 ~ OtD . t0 O t0 . 07 . N O . tn . ~D ?N m . O f0 t0 (D O u7 ~

r tD O~ aD t0 10 N r ~f O~ N ~f ? N f0 ~
uW t0 O r- ~t ~ ~t ~ ~t ~1 !1 N
M

Of . r . r _ ~- . t0. t0 ~ . cD t0 . r tD
t0 t0 M ~O r M Nr ~ f0 t0 t0 00 (O t0 . . O ~ N c0 01 O O O O aD r N N N 07 M N N M N N
r N N r M N 10 N N ~ N N N
r O

aD ~ ~f N t0 M ~ N _O ~ . ~n c0 _ O aD
tD . cp . t0 r t0O ~ ~ O '- M t0 O aD t0 N fD ~- O O O tD
r Of O N u'! V O ~ a0 O N O t!7 ~n O
O O a0 O ~ aD ~n O~ ~ r tD

N V O ? t0 M W f0 u7U7 r _ 01 aD O N ? 00 r 1n(D ~ a0 aD V ~- O N ~ ~
N M N O ~ G~ O O) t0 ~ t0 (D
N t0 f0 fD M M f0 U1 (D V f0 (D OD 01 ~- 00 ~ f0 N r- O r M ~O O O O O N r W f7 r f0 N t0 N N 1A N M ~ N W ~N f0 ~ V N ~ < r ~ ~ V ~
N N V N In N 1f1 f0 f0 N ~ ~ ? <
N N M N (D
fD 10 O (O ~ (D t0 t tD 0 tD N . ~ N. f0 !p . . ( O r . N ~ 1n .
M . M r 0 t . O t ~f O7 OD f0 t Qf N r N ~ N N r W N f0 ~ N N

O N O O7 N _ ~ . .~ OD '- O . . r _ N ~ . t0 _ fD O ~O M t0 O O O O r M O fD
N r ~- OD U7 ~ O OD ~ ~
O CD O) O CO r ~L7 O N
N Q7 OD r O N M O ~
O In O
f0 aD ~ aD a0 '- N O 01~ t0 aD t O ~ O O a0 ~-? W a0 C cD N N ccv N O M M O ~ Ip t0 t0 r t0 a0 00 O ~ ~ r rn ao m ~ o r M r r M r ~ ~ aD u~ o ~c o r o m r r v o~ o v o o ao o o~
u~ o ~ r a a o .-v N Q) _ ~ t~ _ _ N u7 _ t0 1~ tp0 (~O i~ O
M N N O f~D r 0 ~ OD fp0 ~ ~ f0 n OD N O tD f~0 (~O (D f r ~

N N f ( N N N N N N a0 N N~ M (D ( ~ M N N N N '- N u7 p f0 t0 M aD N V'J N N M N N N ~ N N N
N N N N N N N

O

W

O

_d N

N

o a , r a N N

op N ~ U U

a f0 V O ~ O 'T

h O N d O N ~ N
N

~ C M ~ M
~

O m m _ ~ ~
r ~' u o ' a . ~ a a a ,n m v v C7 N

~ ~ O
~ ~ a _ ~ te' ~ J

N N '_-' O m a~D o0 - _ O

c 'w m ~ o, a a~ a . z Y Y a Y Y Y Y
j C~
~

C C ~n C C C N
d C (n N ~

(0 f0 O N cO f6 ~ r N
N r (n N ~

' ~ r d C~ C7 C~ C7 d C~ N
N U
N

' _ _ r' .
. U

E ' E ~ E m E m - ~ E U E ~
. . ~ . .
. . N N
N

N . N d N N Y fn N
n ~

c c cY ca c c '- ~ .

N d ~ d O d _ ~ ~ N O
E ~

O W O
n h a _ a'~ a' a'"V a' a' = =

c c d a d ~ d a~ d m ~ 'd o ~ ~
'd ~

0o m ~ ~ o a ~

z z z zw z z Q v~ '-v~a o~ a~ o~ o~0 0 0 _ O f 0 M (pM N O

r ~N N
N N r ~r 0 r M _ OO O
N N N aDt0 1~ f0 N N M OO r O
c rm r u~

o~ o~ m m~ ao a~

r a 0 Of O~ N M

Qf W O~ OO O O
r r r aom ao ao O N O O t0 Of O 1~ O a0 u7 ~t1 -'- N a0 O M ~O < ~O
M O ? O
M fD V
W

117 ~ ~O N t0 D O) f0 V' D ~_ 1~ st O 4D !D t0 f0 ~ O O ~ Of f0 tD
N N 1~ cD O
f0 ~

O tD _ t0 M O N cD 01 N V N ? ~ V V N at M
N 1~ ~ O aD of ? V ~t N
Of N M N
O N f~ N

u7 N M f0 N ~D 'P N t0 fD fD f0 (D . a0 i ap O aD f~ tD aD ~O (D t0 M O
N N N N ~ N
N O f0 t O M O O ~ ~7 ~O f0 N N N N ~D V
p V f0 N u7 t0 M N
t0 M u7 ~ aD ~
N ~ aD O O

N N N N 1~ t0 ~ . Om0 O aD
N ~ N n0 O O O~ G~ Q Of I~ ~O
f~ ~ V u7 N ~ ~O O~ '? M
<D 07 Qi O

~ M c0 ~ t0 M V7 _ ~ O h W c0 O ~ O
Of t0 N Of a0 M a0 N N M M < N
1 f0 ~ D f0 f0 a0 O ~ ~O
tD f0 _ N O M f0 tD C~ tD O 10 h h ~ N Q m O O aD 1f7 M U7 CD t0 N O
t0 CD tp 1~ m N t <
07 O tD V I~ ~ N 10 tD ~ Y
W ~ aD ~ Vl ~ ~ ~

a0 4'1 CO ~ M t0 f0 M fD f0 t0 N
t0 M ~ i0 Y7 f0 tD O
~ 0 N

~

h N M M O _ fD ~O N M N N 7 N f u'1 Of N N Y N 07 O N N N N N f N f0 W N
CD ~
M

N ~O M CO O V M (D c0 O . . (O
N O '? N t0 N 07 ~ < t0 M fD V
u7 ~ M W O f0 1~ O 00 N ~ (O
1~ O ~f7 t0 00 I~ f0 N
(D I~ OD

N M N O ~ 1~ ~ V V ~ O) ~D f0 O N V N
M N W fD M ~ m N M M t0 N a0 N M CO M i o a~ ~o or cw e o M <c rmn u~ ~a r o c_o ~ N < ~o ~c ~o ~o so w v V
V t0 (D u~ m W(7 N
? O N so M V
M ? N N ? ~ if ~
V V V ~t < V
V

f~ ~ u7 ~ t0 O (O t0 t0 (O tp t0 l0 N
aD 01 tD N tD tp ~D t0 t0 t0 N
V M f0 (D t0 O f0 N
~O
t0 N

O N aD N aD fD N O N N N N N N N ~ N CO
1~ ~O N N ~ O N N N N N f0 O
N ~ N N N
~

ao ~c ao o ao o~ ' ~ _ co r . ~c O W cc rn O 01 M a0 N O) 1~ M
1~ 07 M a0 N N7 f0 t0 > M h f0 a0 1~
O (O t0 01 M N h N M
W 01 ~

N O M O ~ (O ~ '- ~O O GO tD n0 O M
07 (O O a0 t0 V t0 t0 O~ M u7 V O
C7 O tD fD tD u7 M aD t0 (O
~D two O O t0 c0 m O u7 1~ 1~ N O 1~
M !O M ~O 1~ t~ c0 c0 c0 M
~O u'f t0 V W

N Q) N ~l7 N fD N a0 f0 V ~ V V V V V N
c0 a0 V V M N ~ ~ ~ ~ ~ N M
vf7 M M ~ V ? V
N V
N ~
<

tD ~O ~ ~ ~D u7 u7 ~O t0 ~O fD ~O
tD t0 O tD tD ~D t0 ~D c0 ~D
~O M N N t0 O ~O !D u7 N
N 1~ Q7 V M N N N N N N N N
N N N N N N N N
N

N N < et ~ N
10 fD N O 1~ 00 -N N O
1p t0 N
N
N

_ M CD W ~ a0 OD 47 ~ O fD (O aD fD W
1~ a0 P ~D O G) 1~ C7 CD N ~7 O M h N ~ N a0 1~ M M f0 ? r f0 01 tD
D O V O aD N O (7D O O O O aD O
t0 V7 OD a0 t0 a0 OI M a0 O
N t0 n0 M (O M

( M O M V ~ O ~ ~ O1 t!7 M ? 01 M
~ 01 M O 07 Q) O ? f0 t0 t0 (O O O O
O O ~ O ~ ~O t0 f0 ~ h f0 N

(O 'V M IfJ M r 10 V ~ ~ V V ? V ~t ~ M
Q) M 1(7 M t0 ~ V ? ? ~ < 'V ~t m u7 (D ~ ~ N N N N ~
V ~ ~ N
N

1N N N N N (O N N N (O N N
N N N N N M N N N N N N
N t(7 N N N
N

W W_ W_ _ t0 (n N

N ~ N

N

V N

2 z z z c M

N

O
O

O

d_ C

E

a c n ;a N d c a C y O C
UQ

m C7 Z

_ ~ > d O_ r -M y a m _ ~

1n Y N 10 N ~ a' a H

~, ~ ~ M O.
~

H H c Q
H c c m '~ ui Z '~ c N tn n ~
tn IL lL N N Q C tp W N f4 LIJ ~ ~ ~
N

Z Z d o_ a E
2 ' a N m N 7 2 ~ ~ r E D
O O O a E
~

N U a N p U U N o~ E n re o ai ci ~ r r o N n u~
~ E
d O I t c J

n ~ m ~ o .r w Q
' ' = a N
~

o d w ~ o ~ ~ r O
N ~n G) ' t f'7 d < ? - py C y C ' y p C r_ ~ ~ p .~ ~ r ~ lL
Y

Y ~ y y y n Y Y ' Q Y
E E O
~

C O C C C C C r m C y~
E E ~ d ~o ~ co m m m U

m c m m CO - N Z m C
.. m M m m ~ -.~ p CD
CO N
N N

y O ~ C9 r O c9 ~ Z c7 ~e d ~ E E o E E v w E ' ~ E ~ ~
E a ~ U
U O

. ~ ~

C y C C L C C C d 10 d Y C N Q ~
1~ C N

~ d ~ _ _ ~ ~ V a O " a r E ~ O D ~
O ~

M C o a ~ o ~ O ~ :~
o ~ N o o a~UU d~.,a o a Nx~ a m M a o d ~
p O O _ _ _ _ O
O ~ O _ ~ M p W
O O
~

d V V O O -~ 2 ~
m fD ~ O O H
! '~ ~

O n O O Q n O Z
2 ' Q ' 2 p Z N Z Z Z Z Z m UJ o~ p~ ~ d u1 m v O N ~ fD O N N N

(O ~O f0 tD O _ ~O ~O ~D
~O

M M M M M M M M M

M ~O f W M
r W ~ ~

_ _ _ _ f0 <O ~O (D tD tD 10 M v v M v M

M 10 N N ~ aD tD N

o r so M co N M t~ O h ~ M N

_ m Q

1~ M M V ? N O O N
O t0 M O

n M ~ O m " O n O O I a ~ Q1 a O D D ..

N O Of O ~ N

~ ~ ~ ~ ~ m m ~

ai oo ao r of ~
O M

. ~ 1n M V O f N
O O ~ O N N ~ ( V
N

r ~O N ~ n t0 (D ~ ~ O ~ 01 O O W ~ V
m M o O M O
~

< ~o ~o ao v v c w o ~c N N a0 et ~ N tt M N ~ r N r ao O a~
M N M aD N 07 N .p O ? r N N N
Q O N 1A O O r ? O ~f7 t0 m N M V M fD O t0 _ (D ~ N N
f0 O M oD N t tD N ~O t0 O N K7 N t0 N tD f0 O O 0D O O r O N M N Qf M N (O 0D
r V O V ~ O M N O O N N c0 O M CD O O
p N tt V 'p N
O M

O
~D tD ~ M N t0 M ~ O Of f0 N O ~ O ~ ~ N O
aD f0 t0 O ~ (O f0 ~ h O M ~ N

~O N N N M fD t V N O~ c0 07 N ~f O (D
07 00 t0 N tp N N at fD N O N N O Of 1L7 N W < O N N N
O

_ o~ N N . co ~ o m u ~c o~ ~o ~n r _. r r r r ~ r o ~ o ~ O r t< Q aD N C N t Q ~ N O O O O M ~ QI

_ ~ _ OD N O N N
N O t0 tD l0 O N ~O N t0 p M O N N ~ W O
l0 Qf M N a0 N O M O OD ~D
O t0 Of N N 07 f0 V a0 a_0 h IO N W N M r N O O N W M CO r M r h a N N t0 tD M O O N N N O N O r C r r N r ~
~f <

. aD N M O_ O yO ap ~ ? 01 _ M ~ 00 O f0 N f ~ ap 1p (D CI N ~ f0 N O t0 t0 f W r C O 07 r O O N
D O M f0 ap of N
f0 aD ~ 1A OD N

_ N O O
M N O OI f0 N N V N N ~ N O N t0 N N V O N
t0 N N ~fJ ~ of (O OD fD u7 N W f7 O) Q~ 117 r ~ ~ ~ ~ N O
r ~f7 N

N M f0 f0 O f0 N fp N f _ N N ~ V s~ (O r t0 N V N (O N (p tp e< ap 1f7 N M O N t0 N r uW ~f7 a0 r N N
~ O r D) N ~f t OD N M N e/
N

u7 t0 f0 (O Of a0 O O cD O~ fD N tD f ~I7 O OD
f0 tD 1fJ f0 N N ~f7 a0 (O N s tD Q! 1f1 W N tD
O O N N N N (D
r CD N t0 M N r aD r M O m CD
O1 t0 f0 O aD N O O O N M N r N M t0 I
cD OD N r a0 . 47 M a0 M
4p ap m a0 t0 00 O
M f0 N ~O a0 N m r O a_D N Of M O u7 O_ m O M O M r r O O
Of O O O O t0 O O ~ ~_ r O cD O r O
~ t0 O t0 W ~O O ~ W ~ t0 aD a f0 M V l7 f0 t0 O a0 D
t0 < _ V t0 N ~ t0 f0 ~l7 Of Of O~ N O f0 t0 aD O~ aD M u7 O O N ~ c0 O M Y7 t0 (O r u'1 O (D ~f O O aD
t0 M N a0 V
f r 01 (O
t0 r f0 N M ~ ~ ~ ~ ~ ~ f0 N N ~ ~ N N N (D Qf N N N
N M ~ N N OD M M ~ ~ ~ N N N O
~ N ~f7 O 00 N N N M N h Cp j y N N N r A
N f0 V N N tn ~ 1A N N N 01 V
~j In Of r N . f0 r N N M r (D m O t0 N M 1f~ t N 1 O N r fD O Op O N N
W N OD

N C_D (D r aD ~ 00 aD O M 00 _ N f0 01 CO
~- M r M r ~ a< r O O r M aD CD N ~O
O a0 f0 M OD M M r N O O aD t0 OO O N 00 ap c0 O r M
ap M 07 (O r M M 00 a OD O a0 (O c0 00 N
aD M Of O O ~ O M M W r O 07 (O r m t0 aD a0 t0 O O fD f0 O off O~ O O O f0 r t0 tD O ~ M r r M M
O O ~f7 N O
r h M ~ u7 u7 ~f V M M O~ N ~ N 'P M Of (D N M ~f 07 V N f0 V < a0 tD c0 ~ ~
~D O~ f0 t ~ f0 Of Of ~ tD ~O 07 ~O c0 c0 t0 t0 r M t0 N t0 O a N t0 a0 f0 0 ~ M ~ N Of h N N N N N N N N N u7 N ~ N O M N O ~O
N r- N N t0 N M N N N ~ N N (D a0 ~
N ~- ~ N M N N ( fD N ~
N

D

U lL

N v E

U ~

U p N
U

Z N c Of 7 in ~ L ~

r O M

O

O O O

a a c c a c E

v v d ~

c a c .-c y c ' o o - o m n.E c a ~o a m c E c n ~~ x z = c o p ~e U ~ U Q

M N O

x N ~ Q y ~ > O
N

w c ~ U ~ v o o E
~j E

. ~ U

N iW () W lL E ~ O J CJ
N Q w N ~ O r m tA N

n '~ Y ~ O ~ r ~ .T 2 ~ m E

r O tn U ~ U m u1 N

a i U ~ a O a N h o ~ r ~ E
~
O

a ~ _ d c n J ~ c n J N
N

C N p. (n l1J

r ~ N

V Z U N d Z
' w M
n c ~ r w U co ~ ~ c O
> H

. ~ 'm r V 2 ~ c ~ ~ v ~ t Q fn m IL J
? a m ~ w n .

Q a '01 9 - y ~ ~ r n. ~ N ch Cl C' '01 .01 O ~ Z
lL W

O

M m ~ ~ N
r ~

m O CO Q fO O ~C V N C
D V m CO O CD I
J W

N ~ C D N , f~
~gw c~~~ c~ ~ ~ ~ o ~o ~a .

Z

E ~ E ~ = E E v E o ~ ~ o~~ ~
~ y ~
Q E a ~ ~ ~ Q , ~ ~ N

c ~ c a c c a c s ~ 5i c d ~ . w ~ ~ 4 ~ d ~
~ l ? ~c c ~ ~ m a~ ~ a~ n ~ ar a y ,~
t- x E
~ d Q

o M a o . o o N o 0 o a o ' g a z =

a a a ~ a ' .~ H a ~
L r o o a ~ o y o ' d c d a a c M d Z ~ Y ~ a c:~ 'c O y w o ~ E > n > ~ ~ ~ > c til > > > ~
~ E E E
c z -o r Q r. J "
a z ~

~ a z z a ~ z ~ v z a o~ 'o~ c.
a z M M M

M O

M M M M ~ M

.

~ D 0 t 0 ~ M
t r v N r M O a D 1C J
n r v o r w O ~ m r t a o , O
N

M O
m r ao 0 o m ~ o r M v u ~ s r ~ a , i m 1~ I~ N . ? tA aD M 0D
-O _ O aD e 07 _ p . f0 p N fD O f0 Of . . tD ~
O M O p O
M ~ 00 M 1~ ~

a0 N O . 1~ t0 ~
. N . W . f0 a0 ~ ~ . fD
N M m 1~ O 01 M V V I~ O ? f0 O
~ Of ~ 1~ ~ ~D N 1~ O Q~ c_0 N ~ p fp (D ~ N N f0 10 1A
iD ~D N OD N (p 1~ (D
N M f0 O N N N M N M f0 p W P h M M O W O 1~
N

N M N ~ f0 ~O N W f1 M N fD
M 0D N = 07 f0 M 0D

_ a~ . co ao . _ o . M . M
0 0 - o o ao .- M _ _ 4D ~ N t0 N V tD
tO N a0 N ~ M Y N M ~ ~
M O7 p ~
O

O~ . N _ N M ~ _ O O 07 ~O
(D ~ ~p a~ t0 . . c0 V
op O ~ 00 O 117 (D
p ~ aD N ~ tD N N K7 O N
N 1~ ~ O ~ ~ O
fD M N
t0 W f0 M

00 N ~ Of N N ~ . ~ .
. . (O . M N N O ~ 00 h 00 O7 1~
M
p ~

n Q 1~ N f0 CO
N (D ~ V' M

a0 01 N N

p 00N M Of fD ~ Q~ ~ N t0 10 N N
Q~I~O f0 ~ O cD I~ sfN O s< 1~ M
N ~ O ~ N tD N 47 N M N N ~ < M V Of ~O N a0 ~ N f~ N

~ p_ O . _ tD tn Q) f0. M _ !D ~ N
~fMfD _ u7 f0 10 N fD O N ~ h N
. V W N In N
1n N N N N ~ ~ 1n N CO t0 D n O 1n O

c0(O1~ . ~ M . N O ~ .
N N. . t0 M t N f~
~ N ~ O O t0 M CD
O p O c0 M O O N 0D N
t0 M f~
M a0 N tG O Of . _ N ~ t0 . (O
1~aDf0 f0 . N a0 OfV cG ~ c0 ~'l ~ Of 1f1 O
Cf N Q1 h < t0 ~ O~ 01 Of V
~L7 h O ~ t0 t0 of r- Of O~ O

O t0m V ~D O h O ~ f0 p c0 O cD
) ~N ~O t0 M (O? O V ~O p O O N f0 N ~O N O N ~
D O~ O~ c0 I~ 1~ u7 O ~ ~ fD f~
u7 Q 1~O t ~ ~ N W 10 M ~ h N
~ ~ ~ N
~ ~ N C~
47 N M f0 N N N ~
M

N N~ aD fD O N N O O
(O '- P M N f~ (O O N 00 N O N p Q1 t0 N M
N

O W N M V7 O W OD M ~l7 if)hIn !O h a0 f~ ~ N f0 N a0 07 Q~ aD M ? ~ Q~ O m y0 aD M M 1~ fD a0 N O N ~ ~
O M

O Oa0 00 ~ ~ aD O N ? N O O M 00 U7 M CO f0 O) M V N t0 fD O
N 0D aD O

O~O1~ I~ M M V 07 M f~ of O M (O I~
~ M O ~O tD ~ V O t0 07 ~ Y
O O O ~T 1~ ~ N ID ~ fD
M M 01 47 ~ ? N ~ (O ~
V ?
V V

t0~_ f0 t0 O N N N f0 ~ 1~ (O
(O_ t0 tD N t0 I~ u7 N N ~O (D (O
N N 07 p ~ OD ~ f0 a0 N NN N N N fD N N (GN N ~O N (O N
~ N N ~ N N OO N N N M
N N N

_N

C1 ~ CIO

W l1J tll O

u. LL LLN

N

g y g g N

N

Z Z Z f-> > > Q

n O

O

O

d_ C
C

O
O

~V

C
C

d O

a n o N
p C
O

~
C

c E

U
E

n ''' N

C . ' ni .~ ~ U

E c c.N~ ov '-m ~ m Q G O ~ N
~

GI O U M

a ~ Q a ti Q

E N E Q
o a~ o .Q a~

O

M N O
~

v = o G G

a .v~ ~ 'ow 'oi c o Y d Y Y Y N
IC d c ~ c c c M
E ~

V V n m 07m t C

C7 L U ~ U~ ~ N
W =

o E E m a o E

E , 'N~
'N T ~N T 'N N
>

c c crc ~E
t '~

_ _ ~ .~ ~ O
O ~ O M
N

O O O O O aD =
~ (~

d a d O
N N

C
N O d N d (O .N
~ O

J p p p ~ O
O J

Z a Z Z Z 'o~ a a a O N~ t0 t0 O N ?

? Ye< ~ V ~ ~7 M
t0t0f0 tD f0 ~D(D tD

M MM M M M M M

01rM O n Of M

~ ~~ ~ ~ ~ ~D c0 D lM_ M_ M_ M_M_ M
M_0 M_ N OM O W f7N N

tne-N M N N _ V Nu'7 M O (D N
p ~ N N O M n ~ ~ r ~

?N f0 ~ f O O A D

~ aGf a0 a a O ' e0 D D D

M ~ K7(p n N NN N N N N N

O ~~

O O N t0 O n O
~ N

_ a0 O C CO O (p f0 M
aD _ O
O

_ _ N W M h n N
Of O~ N O M O N ~f7 O
~O c0 a0 (O C~
tD N N n t0 f0 N 10 fD u7 _ M Q) n V n IA
O O N M ~ N O !D O N V n 01O aD CD 'p O m 1() N f0 N f0 f0 V
CD V N ~ Y N u7 O (O 1n O u7 ~ N t0 ~ M 1n a0 ~
i i n t0 a0 N ~ N N O ~ t0 c0 O N N n t0 O n 0 N
N M O M N ~(f O N
~D t0 h op ~ ~ N tO N
N N t0 N V N V N CO aD N f0 N ~ ~

N M ~ h M tD O M O N _ fD (p 10 (O
N Of M u7 t _ a0~ aD N N O
aD a0 N M N
0 V ~ N V N aD ~ n Of N
c0 N
O O N N N fD O n t0 (O aD
s t cD ~ O) Of y~ M
1f) O N CD 0D 1n N 10 m ~ tp ~p O
~ N ~ N O M 1n M O Q) O O aD
n M N M 47 n CD . . M CO f0 ~(7 n M c0CO OD <O fD
n 10 N f0 N t0 N n O M M N ~- ~ ~t 10 n N
N a0 W W O (p Cp ~

_ n n O O O M
N N tn M M O M M t0 t0 t0 O a0 ~ N
fD ~f ~ N N tD V7 M
O n V (O

a0 N N O 01 ~ ~ a0 M n O Q1N N ~ (p Of ~ n n ~ M t0 n f0 n O ~ n 07 Gi ~

N O N N M N N N
t N N N O ~t aD u7 ~p p ~O N tO
e< M M N ~ N tD
t0 tp ~ n O

f0 n t0 10 1A u7 1nM h N n N ~ n n N (O of N Y OfV n u7 W N
N N O M W et N V V n M N M h ~D N h tD ~
N

_ t0O O N u7 O1 O f0 N fD . CO fD
N m O~ o N O~ 01 a~
0 f ~O n O
0 cO cO fp n O N ~l7 oO N
n O o0 N O N

~ 00 ? V O ~ tO O N aD fD V c0 aD c0 c n u7 Of 01fD N n n p a0 n O M n O W M O u) a0 n n M ( M (p O 1A Oi aD n ? D O O t(7 O

_ O
(D N N n M O n7 O M O_f M i O_ a0 ~ op ~ O tp ~p M N aD O N N M 01 tD
N M t0 O O) f0 O M f0 O f0W t0 M ~f7 f0 M u7 f0 N 'C O N N O n f0 O
M (D

N N O f0 N ~ N ~ O N n ~ ~ N N N a0 M
~ N N M M ~ N ~ 1AN N M N O
47 t0 c0 ~f fD N Yf N (O N t0 cG N t0 et ~ ap N ~ ap aD h N f0 n N
tC N O N O~ f~ N

_ _ N
~0 N N M 1!7 _ u) tp n O 00~ O7 N 07 Of c0 N M o0 a0 OD V aD M Of CO(p O f0 ~ M
N O M n f0 O t0 O t(7 O) OD N n O n _ M a0 N
~O fG O O N O O 01 t0 t0 O ~c'7 a0 of O O
a0 i0 O '- ~ Of tD O t0 ~ n 1n n 'C ~
~

01 O M M u7 a_D O ~f7 O_ ~ ~ n M V O M f0 O n M O_ O n u7 n ~ O W f7 O~ n tD M M ? u7 ~ Y7 'C Gl ap ' of n V' ~

N ? f0 N M (O M ?
t V O tD f0 ? tp (O N ~ OI O~ t0 f0 fO t0 cD(O f0 N N
M <O ~ (O OD O 1n f0 N ~ON N Gf N Of t0 N N M u7 N c0 N M N N N N ~ N N M N N N O N N U7 47 N ~ N f0 1l) N N N N M M M N
t!7 N
(O

p W_ N

C y g s a c E

a.

c n N d C N
'~y N

C O
O C

U t1J

,.j p u7 L n A a N N
~ E U Q

a o c co 0 V >. z a Of Y
L p ~

N _N 7.p _ N V1 O Q a O n : C
~n ~ U Z
d n a~

c ~ o_ ~ a u a~

d 7 Y ~ o ~
ui ~j ~ c p n a v ,M a ~ ~ ~
M a Z co ~

U M v U
i ,a - w 'm .
- ui a Q a>

_ o' a _ Y ai .o~ a ~ o . C '7 x of U
C < U
(9 C M a m O m d 7 T ~ C
V

C~ f . m C~
v ~

E z N ~ c E

'!n Z E c, n . p iii ~ a .
~ ~ H ti' d c m ~
'- Q

y- y aL ct >.Z
~ ~

o r~ m a ~ M a p N :' ~ Y ~
a c, a -~' o c ' y ~, ~ ~ .m v ad a m a ~n Q
~
U Z ~

41 .p Z Of Z U N Z d ~
U d O N

M

M ~ M

O M

O M O
M

M M M

_ _ n N M M

~ O 0 t O

n ~ N _ ~

O ~ ~,~ N

O

O

m Of O O aD Qf N m u) V aD (p N

01 O ~ p (p N O ~ h 1~ (D O
O ~ ~ cc M
a> of co v v v < to r M v o 00 00 0 to to ao o W n _ n ~o M
m oo Ir7 r to o>

1~ N ~ N N O nl1 N fD N _ f~ M
fO ~ f0 N N IO 1~ 1n OD M Ifj N N V n t0 f0 M fD O O N aD (O W
00 N (7 N M t0 N aD u7 N 0D O 1~ O ~ O O O O
f~ O~ M M 10 ? N O c0 ~ O_ 07 fW
N c0 ~ (O 7 N O O f0 aD tD N M ~ ~
1A tO N

~ N (O
117 O M a0 N O N off O W h f0 1~ O f0 N cD ID ~f f0 o~ f0 Of N Ofc0 ~ N t0 ~ N (p O M ~ 07 Of p ~ of t0 N r- M
O O N

_ 1~N fD O ID N
01 O) (O O 10 t0 f0 N V7 N fD QI N u') !D
t0 t0 O a0 O O _ O < 1~ N V ~ N N 1~ M a N N ~ O D
00 N ~ f0 N
t ~
~

u7 N M Q~ O N 1~ O f0 _ D f0 N t0 O N O 1~ ( m M f0 M
f~ aD M
V tD N t0 1~ N M N O N oD ~ u7 Iv _ M u7 1f1 f0 ID M
_ 1~ OD 47 N
N 10 OD f0 O V
~ M a0 N

_ OfO p (p M I~ O O
N M Of t~ u7 O ~ f0 O 10 O 1 O
1~ O 1~ ID M N t0 N M N O V G_f ~ tD aDN u7 N a0 ~ W N
N O~ N of a0 N tDM t0 N ~f 1~
Q1 O f0 10 O t0 (O 10 tD a0 ID N
O u7 _ ? N N O ? O N N ~
1~ N N et N N ~ N O N ~ N fD
CO ~ N N M ~

_ IDN O~ f0 _ N
W In f0 t0 t0 aD aD N M
~- h m N O N Of fO N N f~ N aD CO N t0 1~ 07 aO
N ~ ~ ~ OD 1A O N M
~ M

t0 N tD O 117 ~ t _ t0 O tD N O fD
r M N ~ c~ M W o O_ 1~
r ao awc a~ M ~ M n n rn v o v co ao o Ire to of M to so M 0 0>

N ID O ~t M aD aD O~ O M s< ? a0 O I~ M
N ID ~ In V f0 V oD
M

N M If7 OI c0 M O O O O~ tD O O OI f0 ~ 01 f0 O M (p 1!7 O O 10 h O IA N
a0 f0 N M M V N ? N ~ N 47 ~ N N N IA N N N
M N vt f0 W N N N f0 e<
~-O~ fp O 10 a0 c0 (D tp 10 _ M tD
_ (D N a0 In u7 a0 N a0 tD
~ N P N u'1 ID N ~ N N O N7 N ~ M 47 N t~ N O N CO ~ 1~ t0 N
~ O
N

Of N V _ _ Ip N m O 07 N p N N M f~
~ ID ? . 1~

01 O a0 W O M r- t0 O Of a0 01 O a0 ~ M u7 f~ O t0 t~ aD O M O M P tD N O of O t0 M
t0 OD IA O et Q7 EO fD u7ap (O a0 O M M Ql N
f0 N yf It) 00 f0 C7O M m N M N (D f0 h N M 1l7 Q N O fD N M O In 1~ M OO
I~ O O P 1~ u7 t h 1~ h O V O u7 O In (D O N aD
1~ 1~
O
M

_ V N M N 47 M of _ N ~ M tt f0 V N ~ ~ N < O I(7 M 117 ~
p1 47 N N ? ~ M V

N t0 m t0 N ID f0 ID t0N _ N f0 07 O t0 (D
f0 ID 117 ~ f0 I~ N f0 Of 01 tD M f0 N 00 f0 N M N fD N f0 t0 N N N N 47 N N N N N N N N N N aD N u7 N N f0 t0 N aD N N N N N
aD '-N

W_ W W

_ _ N

g ~ g g a ~

' ' N ' f~ M ~ aD

O C IA ~ O 10 f0 o E o o ~ o '~ ~ c u .
a a a .~

_ ~ _ C N C C C C
O

m c 'IC'lo ~ 'm n Y d O
a G C a T a ~

C d C C X C
. . .
~

N O ~ N C N
o n o 'o 'e o m c a as $ ~ a u ~

_ N C

C C C ~ N
O

C N .I9.10 7 .f0 ~ U 7.

, C C ~ ~ C
C Y O

o ~ o o a E o :_ U W U~ U7~ U

c -d Z C7 to ~ > w o ~ z a ~ o o ~, z ~ ~ G
a a ~ O Q , a~ ~ c%>
co ~

a ~ ~ In m ~ m E

V o w O

U H- N
m ~

o a ~wa c . to ~ E Q
U a m n v ' wwN~ aN -' a ~ to o~ 0 ' v a ogZ o I:,Lcn ~

j o ~ i N

U~y t ~ _~ O
n d O_ !L' D ' N ~ Q
_ O O C

~ d r ~o> 0> o~
j u~ 2 'm 'c~~ c _ ~ ~ ~~ M
c a ~

~

' c ~ a v o o tu Qa o m U

~ ~ ~ N ~
z O
~ d N E E a ~ E E-a ~ Z ~ r .

C N N Q ~- H
C ~ 10 ~ lL
C

_ _ C_ G_ C_ C_ ~ d O_ M C ~ ~ O ~ ~ ~ N d p H !n N t N ~
1 O d O O O X O O O
00 ~ N y O t0 ~ cp d a d a a d ~ 1,, ~n N
~

~ f' C
' m J
U

' ~ v E o '- o 0 1 o o o o n ? Q I a o '" ' ' ~ Z ' ' of o1 o1 U H N o~ rn F- O. =
u!

c0O N V t 0 0 O N
a t0 O p M c'c~ M M M M ~ M
~ 7 W M N r W

~ f0 p 0 f 0 0 0 0 t f t c f v v M ~ v v ~

? O CO O ~ Of 0 0 f) 1 c 0 I

O ~

f~1~ f N M ~ ?
? N o 0 U

7 ~ D f D
a M ~ f M N

p f ' V M O

G1 a0~ D ~ - Of O D p I C a a O m O O

~o o r~

n (O ~ a0 O M

O M c0 CD t0 1 a0 O Of O ~
M Q1 O < (O N O O
1~ M M ? Of ) M N

M V O N N O ~ ? O _ M
a0 a0 ~ 0 01 ~1 ~f7 h ~D fD M
N

W fD 1(7 aD N o0 D V N
fD O O N N 4D
O O O O O f0 V ~ 1~ O ? O u7 r N N M O tD tO OI O ~ a0 O
f0 Y7 a0 fD Of N O V
aD
(O O

_ M U) ~ N ~ N ~ O
~ f~ N N M N ~ ~ ~O ~O
fD r r V N N
f~

N N O M Of f0 1~ c0 tp ~ O O
00 CO IC) t0 fD aD tD V N V ~1 V a0 M N N V' N N ~O N
Of M Of N N O

M ~O M O tD V f0 M N t0 _ N Of (O M I~ 1~ O O Qf M M s< N N O 1~ t0 CO M O
O O M cD h O N
O

M M N N t0 O N O O t0 W M ~
t0 1~ N N a0 u7 M ~ O N
O O
O O
~

O n u7 aD f~ O O O O O M N N
O M N M
~ O
O
~

N N O aD ~ O ~O ~C1 ~ f0 O ~ O
~ t0 O ~ D N N
t0 O ~l7 ( M f0 O N M 47 N N ~ ~ N N N N N ~
N ~ ~D N N N N ~ N
i N

t Vf r M O O7 aD QO QO ~
N N O ~ O aD ~ N M
p M ~ M N O
cD a0 ~ t N aD fD
~ V

if M a0 M N N N ~ CO ~ Q) O _ t0 ~O a0 ~J 00 I~ M O 07 t0 O ~ N a0 V
O O t0 O

M M O f~ V ~1 N ~t O O V M ~ ~ t ~l tD M 1 N N ~ M a0 1~ of O (O ~
f0 N ~t M M ~ O O N
M V c0 1~ c0 O

_ ap !D O M t t0 W O Qf cD fD u7 O 01 ~ O ~ M ~ tD o0 ~ lD N N N 07 M (D O u') N N r N tD N
W f~ M N N M
V tD
N u7 N N (O ~O N ~ V 1 N f0 . (D
V N aD ID ~ t0 Of < (D t0 O OD ~f7 O M

N t0 ~C'1 N N N 00 N I~ u7 117W ~
N f~ ~1 CO N N M M N M
N <O V ~O M CD O
r 10 N N

1~ r u7 N _- O O M O O N 1~ V N
~ 1 cD t~ _- a0 N l1 U1 t0 ~I O N
M M a0 a~ aO O 01 if7 W a0 a0 M Q) ~ O M M M a0 y I~ f0 ~ ~ O O CD M O ~ N N O aD a0 N N r ~ a0 W Of N Of h N 01 m ~D O M a0 N f0 O> 01 t0 I~ M O ~
(O t0 ~O M f0 1~ N ~ DO O (O M
~ (D f0 47 O t0 O ~f1 f~

I ~ ~ V I~ ~ N M _ ~ M
0) O P M ~ ? N a0 f0 ~ V
_ '? ~f < W N
N f~ WO
V V < ~

u7 f0 cD ~O O) t0 (O <O N O~ ~D O O
t0 f0 aD fD ~O N ~ M aD t0 fD
t0 t0 fD (O t0 f0 t0 ~l7 t0 (O N N N N N N tD N N N N f0 N
N N r N N N N N M r N N
N N N ~f7 N f0 N

a _N

D O D D ' ~

lL l1l lit o Lil o o -LL LL LL U lL U N C

v w N N y N N a a ~1 5 g ~ ~~ g y N G
~

N N O U I
z z z z ~ o Q in a c m m o m o~ in 'm N o E o o w O O O O O O

O O O O O O

lL lL lL LL lL lL

a a d a a a G

c c c c c c c 0 0 o o 0 0 Z

a a a a a a ~ N

c c F_ c c c c ~_ ~

p) N O d d G1 N
X O N

0 0 0 'o o 0 o t 0 U

a na a o.a. a y Q n d c N 01 N y Ul N N N
O y p O
C C C
E

C C C Y C_ y C
fp ~ N - _O f0 l0 N
f0 -a X
~

O = O (~ O O O O
N (~ = G

U a U tL U U U U
I W a n1 E

N J Q ' ~ ~' r ' O

_ -v U ' N r U ' ~ N L O) M
O

H W - n F- U r - T

=W H N N- m ' ~ U

~ W u n J o d tn ~ Z N 'n U ~
~ y Q N C .n ao tn r O O w ~ m ._ .
a r Z D ~ a O ~ ~ Z a d w v a ~ rn N ~ ~ v a '~ci~ ~E vd m -~

. , Z E , m n c ~. oo ~
O

N ~ u~ = U a~ _ ~ ~ o o I U o N o m Q o 'r' N =
U =

N m Z , ao o U ~ a c N
a N
N

M d ~ - OD y ~ f~ n V N
Z p N ~ ~ r O C
O ~
M

N ~ y Q E r 01 '01 N f7 Of ~ '~ : C
O '~ - O
N Q
N

d V - r _ y y y In ~ ~ Y y ~ N
L
p C Y Y Q y I~ C m C C
C C ~ U ' O C n Q
]- ~' C O
~ O ~ ~p C U~
y m m so ~o w m C m m m a~ O E w ~ ~a m m m D . p ~ n O m d C~ (17 CO 4 C O C7 t C~
M o U u1 y p o o O
O ~ p ~
U ~- a~ U C7 M
-(~ ~ C7 U a c ~ 0 y N U O ~ o H E a~

y o~ rn Z ~ N a p, m Z E - ~ E E E E E
E E ._ Q a Z ~ c o " ~
- ' a . a w E H a ~ N ~N H W
w d ,~, w W

N C N O C H U C C C C C
O ~ ~ ~ U~ N Y C
~ y ~
~

G1 d ~ ~ d n M N N N N N
~ ~ E ~ ~ ~ ~p N
Q' U U

p a O O O d O O N O O O O O
aD M 0 N (O ~
d y ~

a~o a,~o n.<',, a~t a~ a,.o,a~ a~~, mQ,...
C

d ~ r ~ ~ ~ N O

07 N V O j O O j j j j j O (~ O ~ O
N ~

o d N -~ Q y ~ o o O
N ' ~ c Q ' Q
~ Z

Z o~ Z Z Z ~. Z Z Z Z
or vi v T tL rn o~ ._.
M U A

0 ~

W
a ap Q) Of O~ Of O O

O O M ~ ~ 0 0 ~ n I C f f f C ~ ~ ~ s M r 0 W 0 o m a a Of W ~ 7 O
p D 0 0 ~ ~ M M V

M M ~ ~ M _ N M N 1~ O ~ O O7 ~ ~ ~ Q M

N

a-0 N aOD anD

N ~ ~ V r p n h t C1 ' 0 W a0 O c0 m a0 c0 ~D W

N M ~ u7 t0 1~ a0 Of O

m m O

a;

r~ co Sri ao ui ri ao iri ~ ~ 0 0 ui rn N v ~o . rn ~p vi ai ~ ao r ao Sri r M
m of v rn ao o ao o> of ai n N o M in N a~ of o ao c ~ ao M v ~ M . .
a0 ~ c0 N u7 aD nf7 N ~ ~O O tD N ~D O h N aD O N
~O aD ~ M _ 1~ Of M ~ t0 f~ N O ~ O u7 of ~D O~ a0 V u7 ~ ~O
O N O OI Of f0 O ~t V O M O

N ~1 M c0 1n N V ~ t0 (O f0 O ~O O ~O e0 ~ _ M
1fJ u7 O fD t0 N CO QO M
f0 V

_ O) N (D ~f ~ N ~ t0 O 01 N f_0 u7 CO
N N O N M t0 N N N f~ O N N O) c0 O CD r- M
c0 f0 W 1 t0 N N c0 M V O a0 M ~ O
f0 O O M V u7 N 1~
N V N K7 M ~ aD
N a0 N t~
M N

tD M fD In 1~ N I~ t0 O off (O 01 h M N 1~ I~
V 1~ N a0 O N

tD N 10 N ~ ~ ~D O ~7 W O N M N t0 N O aD N N
V' of O~ f0 M 1~ f0 N CD W m 1~ <O V M O
t0 N t0 u7 sr 07 <D ~O 1~ O~ O . O tD O
Of N O O ? ~7 Of N (O N N M 1~ aD
t0 t0 M 1~
O

01 O~ CD O N 1~ Q M V 4'f ~ ~ Of Of N ~ a0 c0 tD ~f N 1~ ~ f0 N N Q ~ t0 M M ~ ~ ~l1 c0 V f0 V t0 (O V N 1~ ~D ~ t0 ~ aD ~f t0 cD N t0 ~ f0 M Y tD ~D aD a0 0) _ 1~ O V aD u7 N aD f~ f~ O N O aD t0 h O M O O h N N M V 1_~ N N ~ <_ O O tD N N
a0 O M t~ O O <O t0 M ~D N N N ~ ~ M O
N N M f0 N
N V D> O 00 N

N M O 1n N ~ N M M EO 07 N V' O N M OD f0 M M
~ t0 Y1 O1 N O N P DO 01 Cp fD M O
N

N ~ N M N f0 < N u7 M M N i0 M (O N < O N c0 M ~
~ N V KI N M 10 1n tD t0 N V ~ if O N
n o M ca so ~c ~o ~o wn o o r v in o> re tD (D V I~ v o~ cc m ~1 ~7 tp ~f1 o o V aD N A N ~D f~ W N O V M ~ ~ V a0 t0 N N N
V M ~ it I~ N V ~ N V h s<

t0 N N O M N (O Q) f~ tO t0 t0 f~ c0 I~ f0 f0 _ f0 I~ ~ f0 f0 ~ t0 c0 1O N 1~
_ N O OD EO (D ~ 1~ O N O N M N M O 07 N V N O Q) O f~ O M N N M N N N 1~ X17 M N N
cD Q~ N u7 fD o0 N t0 N _ f0 tD V ~7 _ ap 4W O
f0 W ap N O (p 00 M O
M

M aD O 1~ a0 ~ t0 ~f ? Q~ N r t N N
O) ~ M M O ~ O O aD O N O W f0 M O O a0 ~ f0 O ~ ~O I~

_ _ _ ~O ap t0 ~ M M a0 f0 O N (O O fD M _ ~ M
~D O) ~ V tD V (O CO (O O ? O o0 P ~
t0 I~ tD O_7 N ~ t0 Of ~ O N t0 f0 O f~ M
0 N O CO <D
~

O 07 07 m u7 N M M 07 ~ ~O N ~ CO N N
O a0 O t V N h ~ N ~ ~
M N N N V Uf N a0 N ~ ~ t0 1 N N M M of t0 if ~ ~ N N ~ '?

f0 c0 N ~ tD fD t0 tD f0 O fD 1n c0 t0 ~O
t0 ~O

N O N O N ap N Wl7 N 1~ N M N N ~t 01 N V t0 O
~ U7 O O M N N n0 O N N N ~ N O M N N
h 01 N CO M tD f~ N _ a~ 10 O) O Q) ~(7 e< tt f0 I~ N _ tD _ O f~ Of N ~ O

N O~ aD N h h 1~ O N aD aD O~ N _ O Q7 W f~ N M M fD M M ~l7 t0 ~ M Of O O I~ O aD
~ f0 1~ ? N O M

f0 N a0 N aD ~O 'C O O O O O~ ~O OD OD ~ (O ~ t0 N OD N O M O aD a0 fD fD ~ a0 t0 N 1~ M V
ao n c:~ M cc o a~ fn ~n u~ f0 00 o~ O
o M o 0 0 a~ o mn o co o r o i. ,~ u~ o o> n o ao n ~0 0 o m o~ r~ v v n N M ~ u7 V ~ Of Of < M ~ ~O ~ N N V O) V W(f 01 N
~ Q1 ~l7 ~ ~ ~ V (D ~O t0 e< M V
0 a~ t~ aD N N tD '- t0 N
D tD f0 ~D t0 M ~O ~ t0 ~ t0 M O
~

f0 N O O fD c N '- N N N N N ~ N
O ~O f0 a0 ~D tD fD 0 N N M M N N N
fD f0 a0 f0 N N N (O N c0 (D N N N ~ f N N N u7 N N N N N
N N '- 00 N N N

V

N

c0 W ~ O

[y N
N

N ~J n (n ~o ~
a~

d N

U U ~

U U Z f-> > C C ~ Q

Y

M

O

a c E

v c c E
~

~ r c a -o d U x '-o d _ >

O n . N n f~ N ~ O ~ p ~ Of N N C
O ~

O

d O N
M W (O
M O~ ~' O

ap ~ M C O
n (~ ~O, N g c ~ ~ Um ~''-c ' d V ~ : ~ ~
a ' u~ 'o.

O E ~ E N N
N .

Uf L N ~

~

O ( N hN ~E
D N9d 7 _ N
~
O

Q O N ~0 V x O~ ' N
~ n J N

47 O ~ O) M
a > j, C

~~ N ~>wE ~~ ~r ~ ~ ' ~or n or o~ o Y v~ a o E o C L C _ C C
" C N H

~ C f0 C f0 c0 f0 lO ~ O
c0 r' O

CO p ID ~ m m N O ~' m m v t U C7 E C7 C7 D a o C7 C9 c o ~ c ~ d N ~ f- _ N N Q A O. N N
N N ~ y mQ c~ c~'cvUo cm c c v _ d r ~ O N r _ O ~ O 0 C~ O

07 ( .. 0 .. O O
) . . n O
N N C d y~

O O O O a~? a~
~ a ax a a~ a~ ~' ,~~ ~

N r _ d _ N O
N ~ O C7 > O O O V d > j ~ ~ O J O
M

O ~ O N L O O
V X a O a " a z z z z z z o~ m a Y o E

fp aD O N ?

O O O
~

M M M M M

M N n O M

O O O O
M M

M_ _ _ M M_ O 1~ N Q!

n N O ~ a V
D

M N o~ _ _ V

N M N M N
N O N N M

~ ~

O pp bf 1 O

M ~ t0 A
~

H 47 10 10 t0 0p W m aD OD

ao cc ai o ci a0 ~ O 07 O~ N N aD t0 N u7 O r fD . u7 O a ? ~ (O N V ~ 117 _ ? 10 r M r N

cD r O t0 _ t0 (D (O N ~l1 .
O ~ N u7 O) O) N c0 nf7 r a0 f0 p O N N r O O '~ ~O ~1 Of u7 t0 00 N
M

O N . ~ (O N V N (D 01 U7 fD 07 00 O ~ M O (O O

O W O) ~f M fp a OD O O f0 N f0 M ~l7 r r 0 f0 M r t(7 N

aD O f0 t0 Q cD _ r O O_f N N V V M
aD N f0 < u7 ~D c0 ~t 4D
N O N V ~D r tD O7 n0 c0 O 10 O of M

M M ~O M N _ ~ ~D ~O -~ N ~ n0 N u7 r M N ~f7 M N < N ~ O N V
N M ~ f0 O O t0 ~ O fD f0 t0 r ~ ~1 ~ r t0 O aD t0 07 O

r N N N Y N N N N r M O ~ N < O
N ? r O N N N r Q1 O N
O tp r N ~O 10 f0 N tn t0 f0 O

O r r O r r r ~O r O Of N u7 N V7 07 ~ N Oi ? ~ O r O u7 O r f0 O O M ~ M t aD N 01 Q
r 1W _ a0 N O O N _ f0 N O M t0 ~f M aD a0 fD V ~ Of N Of ~ O M O t0 O~ O aD
0 O ~O O tD W N c0 N
M M r Of V

f0 ~D O O O (O t M ~O ~C7 M N Of N
r M tO t_0 a0 W ~(7 N M N '~T ~
N r M f CD
N nff 10 GO
f0 O) N
N N

O M tD tD ~ f0 tD Of fD aD _ u7 fD N
(O N r ? t0 ~O 1D f0 V O

~ M N N a0 _ N _ ~ M t0 V O ~
W V ~ N N < N _ N 47 N N N N
N N N
N

N O~ tD O~ Q~ a0 N o0 f0 N l0 M r O t0 07 O fD N a0 ~
a0 N r O CO N ~ 4D D M O N 47 N N M O N r N ~ O ~ N N N a M

O . op N W f7 O~ O _ M M M t0 t0 t0 . f aD aD c0 O ~O t0 M O O O N (O N ~ O r M O ~ < t0 Of O t0 ~c1 W fD ~ a0 M O G1 t0 M
~ W ~ ~ < (D M N r 01 Q N ~ u7 M fD tD t0 1f~
V t0 M tD a0 aD N

M N <D fD ~ r f0 ~ 10 W O v0 ~l7 N
t0 ~O a0 10 t0 f0 M r ~O O~ EO ~ M
O f0 O O O
M
N

N ~ N N N ~ N N N N M M ~ ~ ~ N
~ ~ ~ N N ~ N O ~ ~ M O ~ N
~7 ~ ~

(O N ~ V tD N O O N Y f0 O N N t0 N N O M f0 N O t0 V r t0 ~ N
- N N

Q) N ~ r ~D . O O O r f0 N M X17 fD N f0 r . N N r r O O r a_0 N N O) O M M r (D O ~D 01 ?
O O t0 r O M QO M aD CD r 07 O
N M M N (O W (D O M
a0 D1 f0 ~O HO N CD (D OD O O

N OD M ~ N

r ap O a0 M O Of fp r r ~' O O V n0 r N O
f0 t0 O O ~O O ~f M M M O N O
r a0 ~f f0 O
O
~D

N n0 V M ~ tD V N N r O_) ~ M M u7 ~f ~O Y O ~ ~? ~f aD O1 ~ O c0 tD
< ~ f0 N < ~ ~ O~ OW O ~
~ a0 N ~O a0 t0 t0 t0 c0 ~O N f0 (O Q) _ N N N f0 ~ N N N fD N N
N t0 N M (O M N ~- N N f0 N N N N ~
r 00 t0 N N N
N tD
N N N M
N N ~ ~1 N

W W

O ~y LL

d E
g N N U ~ m U

c Z ~, c Z

Y 7 t0 Y

N

O tD 47 C

O O
Q

a a as a _ C C C_ C N

_ _ C
O

O O
Y c a a a a c c ',a c c u~ c c 'y 'm E
. .

.a> .m m d a~
o o o O O L O O
'd p, a n a c a n ~ v U

O N
C d C

C C O ~ y O A l0 fQ
' N C C C
N ~ Y aD
C
O

_ U

U U U U ~
~ uJ

j J

.

r U S N ~ F- ~ n O

~ ~S
' ao ~ N J OC: Z v , o r ~ ~ Z ~ p O Q y om in Y m ~ .
U

w ~ ~ r a a E ~ O a X
~

n ~ ~ ~
Q ~ >- E n 2 E N :_ : ~ m d ~ a Q 'o. ~ d mU ' d o 0 m ~ d v w eo r N ~ . a~ M Z r E 0 E O ~ E o t i~EuN7cMC~ 1--U~m ~o,mW c= ~o.
'm _ O ~ m _ c1 O L
O

S_ O Y ~ N N 7 f0 u7 Y _ ~ f~ ~ ~ N C~
C N N

rn ? GI ' 'w Q ~ ~o~ ~ ~o~
:: N o~ o U ~o~ ;~ ~.
'oi Q a y Y Y Y Y O. Y Y Y Y N Y d 1 ~ 'a J D ~ c c c L ~.

c c c c o c c c ~ ~ O
f0 a ~ O ~ N a N M f0 V -~ N (C w C f0 N ~0 Y

m m m c J C~ m m r m m tD ~ m m 'y N ,G
h C9 C7 C7 C7 ~ U U ~ U O U t C7 M 0~ E ~ o o u~7 x M
E E E E E E E E ~ E o E_ ~ ~ ~ ~ ~ o ~
c _ ~ ~

'V) 'V)'H 'W C 'N 'N N N a 'U) .r N
N a O N d W

~o c c~ v c c0 cE ca cL c c Y c ~

_ _ N _ N ~N,~d N r d r M N ~ N ~ tn N m Y
d Z

O O O O C O O O O N 4 ~O O~
O N G M ~ M Z a ~y Y N

a' ao a'xaa d~ ao a~? a~u~ do a-' E Z c y a~ d d d d d m y rn -y co -y o c ' r F- t a y_ c c c c ~ c c c o N o Q o ~ c ~ ~ ~ o ~ =

Q m ' 8 ' E 'o z Z

z z z z a z z z > a ....
c~ o~ z H
c U

iD a0 O N V t0 QO O N

N N N N N M M
r cr9 fryM M ~ f y N r Of M u7 r O) M

N N N N N M M

r~ r r r r r r r M ~ ~ ~ .M..

~ M ~ N O

f O ~ N

M ~ M M W O ~D aD QO
n r O t0 O

a0 r O ~O N t ? < ~O r N O N ~O r r 0 r N ~ ~ n n ~ n 0 O O O O ~ ~ O a0 0 N ~ ~ 0 r N ( 10 t tD D f t 0 0 ( 0 0 O O O m O ~ O a0 O O

OD N OD CO ~ O . N
1A tA
t0 (O O O7 N O u7 M W f7 O'1O M
N r O c0 ~ N r M aD W n ~ ~D f0 ~ ~ M 07 O V V O
~
V

N c0 . O O~ V f0 O f0 ~O fD r t0 G~ tC f0 O
fD t0 aD N O ? f10 N of V N e< N QO ?
47 r N (O r (D CO N N ~f V
O O N O ~f r t0 O tp M N (O N tO (O
.

_ N O O OD N r- 1A N r Of N
M ~t f0 ~ tD ~ M N V N N
f0 N f0 O

M r N O u'1 47 f0 . O . ~1 ? N M N f0 00 O fp CD

O7 Y7 r aD 10 O aD ~ 07 ~- Uf cD OD
fp M r (D O ~ r V aO Y7 N LO 1A t0 N 4'f r ~ ~ r N O st c0 tf1 N O

a0 ~
~t ~

M tD O O) ~O O r O ~ Y'1 (D N Of O O N o0 u7 t0 O~
~O fD
~D

O M r f0 N r N Q) ~t N N V N 01 M
~t O N fD ~f fD e- t0 N f0 07 f0 ~ O O (O cD N a0 r 07 ~D (p M ~

. N O a N N Of N N N N
01 O O u1 D N r O M ~ N N
M r M m t0 aD

cD O O~ O _ r h O Of N
N ~O N t0 _ u7 M Of N 4D ~ t(7 a0 r O O O t0 off t0 f0 M a0 M M
N O 00 t0 u7 a0 tD O
N a0 O
u7 sr N ~ N ~ O N ~ 00 O~ (O O V r et ~ cp N O fD M aD 00 M ~ ~ tp 47 t0 V
V

N fD . Of tD tD N ~ O 10 01 cD O r tD 00 t0 . N Q ~ O tD N r h N N N ~ Of Of N V tO tD f0 OD 1p V r ~ N M f0 ~ M O s< V

t0 N

fO O (O tD (D c0 f0 tD O t0 r aD M u7 t0 fD ca N a0 r N a0 N f0 O EO ~ N N r N N N N O N N
N O r N ~- f0 N
M ~

O O OD . V In . O N N
N N OD a0 10 ~f1 O O O O O N O t0 ~ of N Of 01 0D a0 t0 f0 t0 O~ O> O M r fO ~T O
r M O O

aD u7 ~l7 O ~ M o0 O Q~ W ~ O ~ O aD
~ t0 Q~ t0 (O t0 ~n u~ M V ~ 0 r co ao f0 M am so o~ a~ We ~e ~o a0 ~o ~a ~o rv I: ~m ~n u~ uo o r ~p o N N ~ N ~ ~D N ~ t~Dt0 ~ f0 N N o N aD ~ ~ ~ M f~0 t~0 ~ N ~
~ M ~
O

m tp N t0 t! N ~ ~ N N N N M N t0 f0 N
01 ? tn N QI ED N N N ~ N N
N N N N
~- fp ~

N r ~D N t0 oD ap r t0 a0 aD tD O O O a0 t0 N aD r O~ ap V O a f0 r c0 O O~
r N M t0 D r f0 ~ M cp O r t0 O r M M
o0 M

c0 aO fD O _ O O O O t0 ~ (O
fD c0 10 (O f0 M aD M a0 O M
fp M fD aD M t0 W O
M aD

V M (O O M O r ~ u7 ,f7 V O O N r O aD O m O O f0 fD fD O t0 N r t0 f0 O O O
~D r O

M Of ~ if M O V V < ~ _ t0 _ ?
V Q W ? V 0 V V V u~ _ Q
a> r r ~f rn co o V Q V ~ o m o ~f o 0 0 ~o 0 V ~
~o 0 0 o o o 0 co ~o 0 o o N N ~ N N ~ N N N ~ N N
N N N N N ~ N
N ~

l_1J LIJ IIJ l W LL

c LL LL LL _ LL l1 lL

~aW n t~ cN tn (O

d o N ~ d t~ fn In N

a g g ~ 5 g 5 5 _ Z Z o Z Z Z' Z

C or 7 7 d 7 7 ~ 7 O M

O O

O O

<i a a c c c d o o y 0 n c c a~

o o ~

a E

c c m a~

. p .cV
d .. ..
U .
.
C

U U m ~

N

C N 7 d d , d , 2 r _ r _ _a~ ~ -a o~ N t a> 3 n _ 00 N Q O N r, N

F.. N 01 (D ~ N ~ d N
V
cn c' E ui a~ a~ ~ o o a~
tn := a r N ~ l1 Y _ C r 07 O
~ Q N d O

U of a c U m N c N U
m ~d ' Z .
H

L ~ E O
N O i v E ~ $ ~ N E o Q o. u n ~ .. n a in ~
m a~ o y E a> " o v a of c ~n ~ a ' uivEy,~ , a,c coc oo ao ca o N O j ~ 'y (C N O f1 E C V E W C
O

_ M n!7_ M
r ~ O O O N
O N ~

U7 N O O) a0 M
N CJ n G) N N

~ - ~ d ~ In t0 O~
~ n ~ ..~. d ~Of ~ =_C NE ~C N_II M_O
. .

C1 J C7 ' 07 N p~ p) C~ p1 E N N ~ ~ C

= "' C C 7 C ~C Y Y
C ~ ~ Q C
~ U

~ ~ _ ~ ~ N
, d E

CD W N m m N m OD V m N p N ~ m ~ ~ o E U U a~ U c U' U' w ' 7 n S
'a rn E to ~ ~ E ' E . E c c> d E ~ ~ E ' E
' n- ~
~ o m ' N a N N fn ~ y~ N _ O E ~ d ~ VJ
O.

c Z ~ ri c c Z' c c c c ~ ~ 4 Y ~ 'c of . ~ . ' ' ~
' O O O O O O O
~ N Q r N M tC ~

UiY,- a~~ a d a~ a n. N ~
~

M p, >
~

o o o o o o u.
D t) c ~ > m a o n m o N z~o'~wN z za z z Y z o ~ a z ~m a c ~

M ~ ? ~

~ C ~ ~ ~ ~ u M r r r C r r f y y f M ~ M f 7 M y P y f V ? ~t V ~ N

~ ~ ~ 0 O

W t N c h O

W V

r ~ M O N
r ~ M M ~ M

O O ~ n r t 0 ~ a0 O O , n s QO
W a 0 O m Of I 1 0 D

: n ~ ~ c r ~

I ~

0 0 ~ ~ o o m ao of ~ ao o ui o Sri ao 0 0 0 so o M ~c ~i ~n a~
r o N o a~ o o r . r ~
N
~

c~n~m~M~ ~ c n ~~v~c c c t0 aO f0 N ~ N O r O M t0 N N a0 O N N N
O <O O

_ M M (D
~t M N . Y7 fD OD Y1 r O O) c0 O
'? ~ N t0 0 01 r D

c O M O N 01 O O r N r r <O r 1D
~O a O N CD O ? ~ ~ O N
N ~ N M OO f0 f0 Of 01 ~ tD fD ~D O r O
fD t0 ~(7 ~f1 M ~f O N
~ < N

nLJ p e< N N N V r t0 M fD r N ~ M
N ~ t0 ~ . fD Of N
N ~ CD l0 D N N aDN M O
~ N N V N N O) f0 f0 M
~f N f (O 0D

_ a0 N ~D O
_ O
N M O t0 r ~ t0 t0 t0 ) ~ t0 ~ ~O r IO

(O M N O V' < ~ tD O OfO a0 ~O N N <D M a0 00 ccr ao so n o~
h so cn ~u r mn so v rn ~ '?
o~ ~ m ~ ~ ~D r t0 N aD V < N N N ~ (D
M M N M V t0 V M

~ N ~D t0 (O N fD t0 N N N (O ~O
a0 t0 M
M N ~O N N N ~ N N
(O O N < N ~ N

a0 aNp M V1 O V O n r nff ~ O
O r ~ ~ ~ N N t0 a r ao M o r u~ ~ ao cu o ~ o co ~e o ao u~ ~ io m (Dao O W
~ O N O M r O ~ (O 01 O fD
~

M O O ~ ~ ~ Q
f V ~
~ M N ~ V t0 N N V
Q) M N ~ ~ ~

cD rn fD f0 M _ f0 1D tDt0 _ aD tD (O N N f0 N N
N N N N N M OD N N N OD
O N u7 N N

Q~ O~ O O~ C> O O f~~lN (OO~ a0 OD
O~ OW O O 1 to M ~f (O N ~ f0 (O h cD O O N 00 t0 O f0O O O
f0 O r N M aD f0 fD f0 a0 M

t(7 N 07 O Q) G> O O r ~ O~ ~
M r r N t0 t0 O ~ u) r 10 fD

~ ~ t0 ? O 't ~ O ~ V V ~ ~ V
~f ~ tp~ t0 ?
(O O 10 ~ ~ O a0 t0 t0 ~D r tD
t0 O M (O ~ a0 t0 t0 ~D t0 N N M N N N ~ ~ N N N N N N N
tD M N N ~ N N N CO N

W W W_ _ _ O

d 7 s M~ N

N
O

C
O.

~
d a a o c c_ a ' ' ' c d a 'm ~ C
C C C

.d t' ~
U

O C O

C
n N a 'm C
C O
N Y
. ' N - f0 C

U Q
U
~

r O N

n n IC O
U N m ~ c Z
~

M N ~ ~ C N
j ' ~

' _ ~o m Z
E c _ ~ U

7 10 ! (n N

N ~ a ~ IL
~ v Q

M

~.v., ~ '_ r v a~
a~~ ~
' tn ~ ~ _ O
O N ~
a Q y f7M M ~
d a ~ ~

C7 d r .O701 01 d L

Y Q Y Y Y Y Y
nj ~ ~ C (yJ
H

c c c c c c op v ~5 a~ F

C~ m m V N
c C7 3 U~ C7d C~ C~
M ~ C7 . N
N Z

. c .

E EcE E E
d W

'nc m N o a 'N m ~ E d~

d ~ _ _ __ N G) C7 d G7 C ~
~ E (C N
~

p N O O O O O
< ' _V C Z
= N

a a a a a ~ N d o N
~ Q

c o ~ M
.

o a, o > > >
> > > o w O
U - a c o o < 0 o 0 a o 0 ~ Z Z _ Q o t a Z
' i 'a U

Z Z Z t ow M M M M M M

if) r O M N

~ O tD f0 r r r r r r v v ~ v r c0 M a0O O r _ p aD O~~ V a0 O N_Q N f_0 M O
M O N ~1 N

_ O t0 '?

O O O~O O W

c0 01 O N M

m m ~

~; ~ ~ ~ _ m O u) aOD
M

M r ~ O ~D N n O aD t0 ~ _ tD

O ? ~ O V t0 ~ < u7 ~O C~ < ~ M M ~P
O M M ~f a0 ~ O c0 _ f0 N ( O N t0 07 N tD O t0 u7 f0 tD r t0 M ~ N aD O~
N f0 O t0 l N
t0 N

~ aD O~ ~ N V 4O Q1 ? N ~ N O M N N u7 O '?
M O 01 O M N ~ ~ ~ M O
~ N (O r O

CO t0 ~C tp ~ ~ f0 (O N r O N M _ O O N
(O u7 'P Of f0 t0 W CD O O ~ 10 ~ O ~
M ~O W
N

r M N N O N r 1A N N N O O N N CD O O p pp M M (O aD f0 ~
m ~ r OD r M M ~O 10 N M M ? CD O ~ ~O ~ O O M O N
N 07 t0 ~ O t0 10 Of t0 W m ~ ~O ~ M
r M O C1 M t0 ~ O O~ M
N

N N r O V N ~f ~O aD f0 M V Q~ ~ ~ ~ ~ cD
t0 V V u') V N u7 M M ~ O
~ Q~ N ~O
t0 Yf N O t0 O r O t0 M ? M a0 t0 ~ _ t0 r O t0 a0 fD iD N C N N r N
M ~ N u1 ~O N M N N V D N O r < Q' N N

t0 N CD ~ N V 00 a0 ~ N ~ f0 N _ N M O _ ~ ~D (O M tD
f0 '- m OD
tD f0 M

_ ~O M M r ~ ~ 1 O
Op N N 4D M t0 O r ~ N
V O N 0 O) O M N 1n N O ~ N N N O O ~ aD
V M O ~ M
(p O

_ O V M O r N O M
_ a0 (O a0 t0 a0 N aD M N ~D 07 O ~ M ~
(O O O O r O O
M M N O o0 O ~D
W cD M aD t ' _ V tp N U7 ? < N CD
_ N tO N N W N
1 ~ 01 O V r aD O~ tD ~O ~ N N
~O M Of u O 10 M N O N O 0D 1 O ~f a0 t0 ? r 'Q ~ V' N ~ V

t0 Q1 07 a0 O 47 t0 f0 t0 t0 O t0 aD ( O t0 O ~O
N r t0 ~ ~O ~O aD t0 O ~O ? N N N
V N t0 N N V N fD O ~ ~ W M
N O N
10 ) N 'C

u7 N r '? ~ ~ N N t0 _ N ~ _ fD N aD
c0 f0 t0 ~ t0 ~ M ~ . fD O N O c0 V ~O r N

p O N ~ N N O N O N N O M D1 O a o O r 0 ~
CO r ~7 O M N N D t0 M O r ~D
fD N M 00 f O W M u7 N t0 O ~ O N O M M t0 n c0 _ O M D O
~ ~ ~ ~O M t (O OD r O r c0 r M 01 O a M
Q) Q1 N ~ O r N f0 f0 D r <
f0 M O) ' P a V M O

_ ~ N M V _ _ M N f0 ~D V tD N aD O_ c0 V r O O r Y7 ~ t0 f0 ~ ~O Q1 t0 O_ O
O) aD if M M ~ ~O r N O t0 N W O
~ N r t0 O f0 f0 (O t h N ~

t0 f0 t Ol7 u7 (O O r r c0 N N N N N 1 N ~
t0 M u7 t0 f0 M c0 V ~ N M N N
O ~ ~ ~
N V ~f n0 N CO N V ~

_ ~ ~ ED f N tD V V V t0 N 1 CD V sr t0 cD 0 0 t0 t0 M t0 U7 tD t0 ~O t0 tD
O ~ ~O

a0 t _ ~ O7 ~ N N N M f0 N 47 N 10 OD N r ~ 1 r' D N
N r N f0 ~ 1f) N N N N N N r N a0 N
~ N O) N
O f N
~O O O ~O
O

r ~ ~0 O r Of N N 00 0 Of M O
O 01 N a0 M oD r M O fD ~7 ~ N O) t r O r ~D m aD c0 N
O 10 a0 r O1 a0 O a0 CO O r M M O O M ~ CD aD ~ r O (O 0 O
( N 07 M O~ r 07 (D
a0 N O O O O~ ~ O fD aD m O~ r t r O a O~
u) O~ N aD 1 M aD O~ GO QO O f0 f O In r Y N fD M M O u'7 O t0 t M M h > O ~O c0 r f0 i0 t0 a r O
O) t0 ~O O O t0 O f0 ~

_ < N _ M ~ ~ ? 01 i f0 ~ M M ~D _~ V
~ ~ M V V u7 ~ 00 ~ V '? ~ N N V f f0 V
~ (D ~ ~ tD N t0 f0 O~ Of N D ~O
0 t0 tD c0 10 ~ aD N ~ ~ ~ 1~1 0 tD f0 t0 M N tD
a ~D O 7 t0 t0 fD ~D 10 t0 N N N N N N N N N
tD tD tD 1 N N N t0 N M N
N f0 N N N N N N N N N N N N N N N
M N N ~ M N ~ N N

V

_N

D ~U

~ U _J

L ~ N
L

_ (n U7 N N

~

U - z Z j Q r , c ' v E

0 0 o v a a a c_ C C_ C E

_ O
(O

r O O O Z

a C
C C C N

y 'y y N
' O O O "' ~' O

' n c a n ~
E

1A f0 N N C
' c c E c m . .

c v c Z

U U U n ~ U c c U

o -Q -' U

U Z r m ao , N C

J N v O

v O ~ ~p ~ ~ r N -a a U d a ~ E ~ c r Q

a n Qm ma m c v ~ =

o _ a m Q ~ ~ U y ~p " ~ N
~ fO

~ ~ o ao H ~n U o V (l7 ~ IlJ M O 7 07 N E

a0 Q C Z ~ M p ~ O
N
' ~n to ~ a a m E v x o U
M O , N c ~

I N d M C Y .N
N ~ ~
-Q a o' O _ ' o ~ ~' ' c ~' _ C _ C N ~ ~ d Y ~ C
j n C C C C
n O N m CD C~ p C~ C~ m if 0 ~ ~

M ~ ~ ~ O ~ ~ 7 ~
~

C~ M ~ I N O
N y E E E Z E E o E
~ v ~

Vl _ N Vl - ~ Ul H
~ i9 O N
a 'n n Z d N c c Y
c ~
p a o c c c _ y ~E d,~ d~ d- _ '' me '.v ' E

M O O O O N O O O tD
K7 ~ O

af~0= Q~A d~ ay a~x a' v a0 N

N o j O Q: j j j ~ ~ j L j N ~ ~ m Y

v o 0 o o 0 o c ~ d ~ a Z O~ d Z Z Z Z Z 0~ Z
rn Q rn N
N ~

tD aD O
r r m r ~ ~ r r M f' ~ f~ f M ~ 7 '7 y n r a~
~ ~ r r r a r r r r r r r M ~ v ~ M v v _ 0 O N p M o r O

O
n O N N N

O V c' ~

M n N r r O

O t ?
O o0 D Of ~ a7 ~ a0 a0 y 0 tp r ~ a00 00f W O ~ ~ m O

O

CO O ~ V O tD N
p O N O

O f~ O tD N O M 0 ~ 7 N ~

C . O M f~ O M V' OD OD ~ f Q) Of M C7 Of P O o0 V h f0 O iO 0 ~
M aD in O 07 W tp a0 O
O ~t ~ M ~ (O
aD ip t0 c0 O u7 Of ~ lp t0 !O H7 N f~ O f0 f0 i0 O O iD _ t~ fD N W <n O N
IA N N M Of N ~ N N O V OD 'p M O N
~ ap O ~ ~ tf7 O aD fD aD a0 Q7 O t ~ 1~
O

M D O M t0 N Of f~ O 1~ a0 N O O f0 t0 fD N _ tD 07 a0 N f0 f0 lD N M f0 Of ill N N h 1~ O
N

O O _ N A O aD N ~ M O N M 00 N
1~ ~ N f0 f0 N m O f0 a0 N l0 O aD lO f~ _ tp tD O N
O M O f0 u'1 t0 O 07 O O
aD OD
lD

O N V i0 r- N f0 N f V 1A O N ~ aD Q! f~ N
p O O N fD N O O M 00 10 'Q Q) M
i0 i0 t0 f0 iD ~f t0 t0 07 IL7 f0 O
O (O M u7 O tO Of V O Of N
u7 lD lD

Y CO N W 1~ V N ~ N N ~ Of V ~ 01 C ?
N st ~ V O M O V O V V n0 V O N N
t0 O i0 u7 O7 N !D 07 O t0 M h lp t0 07 t aD f0 _ O
N 7l7 CD u')Of OD lD N V N 0 fD N a0 t0 iD
t~ N N N a0 f0 M aD N N N 1~ M
N h N N G7 07 N CD O
M

N O _ aD a0 O _ aD t0 N N N M N
~f 07 O N N O7 t~ l0 O t 1~ M O t0 1~ t0 M aD N N O O Of 01 D t0 f0 Of t~ N aD ~ N
O N M (O
o~

a0 N V _ N M u) a0 ? O V O aD N N Uf O
iff M N l0 N at cp O O O M ? N W
O 1~ u7 N t0 O ~ tp f0 Y
i0 (O i0 O N O i0 f0 tp 07 cD tp tD t0 O t0 N i(7 fp O

~ N N V a0 N N N V N 07 ~? lp y(7 Y c0 Of vt ~ u7 O N M V ~ of N O < N ip Q7 N f0 f0 f0 N lD c0 p O a0 O
t0 t0 f c tD Of oD 10 N aD O O N N t0 N O N N t0 f0 N fD t0 O N N N M V N M N O N N O N
N N O N 07 N f~
el 00 N
1~ O

1~ h O I~ N O l0 ~f u7 O _ aD N t0 _ _ N 1~ c0 M O i0 Of _ O if) aD O) aD O N u7 aD 1~ M a0 a0 M M N M O ~ O M V O O 1p O Q7 O
M ~ O Qf O f~

t0 M aG V V < QO l0 h O ~t O O N ~ 7A O
f0 O ap c0 M O7 1~ M (D m Q_) I~ Of O (D I~ M (O O ~ M ~ O N O
O 117 fD fD N O O tD 01 t0 07 f0 N O tp O 00 t0 O ill M N
f0 t0 N ~ O N N M N if) N V N < h N f0 ~
CD CO f0 V Q h fD of ~ Y u7 ? N V N
l0 tD O 07 ip i0 M < f0 N N
a0 t0 iD N 0 l0 f0 f0 l0 M

N N e~ icy_ N in N cD t N
~ N N N f0 N t0 N N N N M tD (D 10 4'7 O i0 M r- N N O N OD N
~ N fD ~

N O N I~ f~ O N N t0 (O G O CO aD Y7 1~ 1~07 (D l0 O
O l0 O O O 01 aD N M ~t 00 O O 0D
N O 07 a0 P (O N 00 N f0 OD 00 a0 O M M 1~ h _ f~ M
aD O O aD f0 N 07 oD aD O N O O u'1 aD V N a0 M f0 V O O) N M a0 cD ill N f0 O lD
01 M t0 CO

lD M 07 h ~ N M ill O 4'f a O N 1~ M N (O
07 c0 V lC P cD l0 f0 D I~ f0 M ~ O
O M P t0 O f0 f~ O
O

M V i!7 N V 'C M ~ ~ ? ~ _ N M M O V
V ~ ? Y if _ ~ ~ V m f t0 W l0 ~ N l0 l0 O7 f0 ~ < V ~ aD ~
~ c0 tD N a0 tD O l0 f0 V N Q1 f0 t0 tD 00 tD f0 Ip O (D
N t0 ~ O
t0 a0 N N N N N N N N N ~ N N ~ N N N N N N _ N
N N N N f0 N N N ~ N N N N N N N
N N ~ 117 N

W_ UJ W

lL C l1 (O N (O

~ ~ ~ o U ~ ~ U t ~ ~ U
~

N ~ 7 U L O1 O

N ill n 07 C

O M N O

p ~ fD Of O

_ O O O
O
d u.
E

c a a a, c c "

c r o c o ~

v v v N

C C C

d f0 d G7 O d O O
C f' aU n d $'m $
E

c c c o ' ~ c .:'_ . 'm ~ .m .m .m v o Q

m o a o o E

U U v7 U U
N. ~ Q

r J

Q ~ O

N ~ O d m O O

M ~ ~ Z

~ O

C a N O O 1~
U ~ J ~

c m a m Q O 7 o ?' o in am EN a Q Q

v7 -. u ~ ~

_ y O '~ "
' ~ L 7 l0 v E rn m O ~

O i ll (A _ O
GD N
C

O = Q 7 O D
N .-. y N
E

O O

u7 G7 N V
C ~ d _ V
41 00 ~ ~ ~ 07 01 V O

O O O
_ _ C C ~ C C ~ C C
N J pi O

R N V (0 !O ~ N (O
p m . Q m m m m m o o, r C7 C 9 t C7 U' ~ C9 C) O ~ m N
~

_ H E E N E m H W

d , M , E7 U
n ' r c c Q c c c aC7 E ' . N . _ . N N G7 N
N d M N N . N C
Z
.

O M _ _ O O
O O O ~ ~C
fD
Z

a a a a ~ ~ o v Q

_ _ i m O ~ ~ N d G1 N L
~

m J 7= _ Z Q Z Z v7 Z Z
om~ a7 ~>

N V tD O 0 N ~ 0 O O

07 O m p f O f 0 p 7 O 7 M M M n n ~ n n ~ O

M M M M M M M

~ ~ n 7 t ~ O n O7 O

O n n n n n M v v M ~ M

~ N N O u')07 n r o t 7 N ~ ~ M

a0 a 0 a0 a D t 0 O 0 a M N M O M '7 ~ M
O ~ ~ u f r ~

~ t D l0f 0 f 0 ~ ~
m m O ~ O ~ m ~ M ~ 0 r 0 O7 O ~ 7 7 7 f 0 O 0 0 O O O O m m W m 7 m 0 a; ~ ~ a; _ h ~O O O O M a0 r O O W Of . M N O) O
. r ao _ _ ao r o ao M . . o so ao co o ~c . r ~ r oW ri co so t0 ~ N O V N 01 u7 O ~ V O h O aD _ r O M M aD ~ ~ ~ aD V M t0 W

O~ N t0 'P N N f0 . (p r M ~ . O fD V _ r f0 .
~ (O c0 N N . a0 1n . a0 aD f0 fD . ~O N
M a0 07 O 1D M ~ O N M r O N tp ? Y N ~ N
O O O N O O) N t aD N N ~ ~
O N ~ ~
O

_ O ~ t0 _ a~ ~O N ~ ~D M O V t0 N G~ ~ ? ~O Q1 07 fD
r a~ cD M O tD t0 ~

O t0 ~fY M M O M aD N t0 O O t0 N N N tp M u7 07 f0 00 <O t0 ~!7 a0 ~ M r M ~ 1A N
M of M fD M tp O_~ N ID N ~ r N N
N t0 r v- M V OD M M O O ap M r O O O 07 ~ ~O h c0 M V ~
O O N
O f0 O
M ~ ~

. . M f0 r a0 .
. . O M W
. . r O fD N t0 . . N ~ aD a0 N V V ~f . . V . N N M tD c0 ~ r ~ t0 N f0 N M ~ O N N ~f r cD
N ? tD r M ~p M M tD ~O N

. Qf r _ _ N ~ O f0 O O . r tp _ O 01 t0 . N f0 t0 ~D f0 ~- . M (p N N 0D _ r _ tp u7 ~
f0 M O O O m O N N O ~ V N N 1f7 O O
r O N M r at h M N < O) CO N N O
Y7 aD V O oD r t0 0 ~ ? a0 V ~f f0 tn tf W ~ 1!
tD ~O t0 tp r N ~ N t0 . . N . f 7 ~ ~
. . O N N .
fD _ O (p . aD M ~ t0 ~ . N N M O a~
~ O Q~ V O M O r O N tt~ O~ f0 aO N N a0 N N
r a0 O 01 M Of m 07 ~ O ~
r M
t0 off ~ O ? u7 M t0 O O . f0 Of ~ M . . p M O O V
~ ~ aD O~ f0 op O t0 c0 aD ~ f0 t0 . O _ V aO fD f0 ? 07 1C! O~ O~ O _ ~O Q) f0 07 O
M O r O N YJ O u7 m O) tD r of O ~ Of aD M aD u7 O
f0 O 0 ~
- ~l N f0 N M ? M aD ~f7 ~f N N
M r ~O
- O

_ M O DD ( _ Q) N N N V N
M M M r N t ~ <D (O
' ~ o~ r N . . N . . co ~ o~ . M . cp o> so c~ co ~c _ . oo u~ r co <c cn r r ~c ~ ~n O
so . _ N N ~ ~ . .
. ~ V .
N N t(7 a0 tn r aD N N tD M (O N V fD M N N 1(7 N N 1f7 r ~ (D Of f0 N er ~ N V
~ ~

~
r r a W l7 N N N O oD N 4D
D 0 f0 N N N N
7 C) N ~ a0 t0 off O N
M c0 N 01 aD ~ ~ O M f'~W N
f1 ~D O u7 O f0 CO aD N ~ ~ O at . M 10 N _ . . tp r O O
V 10 ~ (O ~ O . r ~ M M f0 c0 R7 ~f7 ~f7 . O
~O ~f r r a0 ~ M O O a0 M r Y . O a0 O) u7 t(7 In ~t O ~- ~ r u7 ~ t0 r ~f7 h M u7 O7 O tt aD r O M
aD
r ~

? c0 N N r M ~f V O ? ~ t0 4D r O of O O f0 t0 t0 N
V 01 a0 ~ 1C f0 aD ~ M ~ 01 N M fD r (O a0 ~ N N N M t0 m ~O V Of r O M ~ ~O
O O tD N t0 t0 O V 07 M O c0 M O 01 O ~ r e M tD t0 f0 O fD
f0 ~ f tD u7 N N M f0 N N 47 f0 N O M M 47 ~ V M M N r M 't N N ~O t0 M M ~ N CO N N V tD V
N u7 V ~
C~ N ~
r N t0 . _ <O O f0 tD . . c0 _ tp _ . N . 1p M
. . fD t0 t0 _ . N f _ fD N r N Of f0 . . N N N N M N M N N
~O O ~ r N ~O r d0 u7 N W a0 a0 N
V 00 Of O ~O N ~f f0 O ~ M N N
f0 tD O O . N N O . . N M a0 . ~ . M . ~ f0 C1 . N
N t0 . . cO r N Qf ~ _ .
r aD M m Of G~ ap a0 1 ap N N O r Of O r 00 O M ~ r r O ~ M N r M N M O M O r Of N CO N N t0 M
~D t0 aO a0 h ~ ~ tD O ~ N N V t0 aD u7 a0 f0 r ~ aD V t0 N O t0 00 ~ O N OD O O O ~ ~ M O
N f0 tp tp ~ O M
M
a0 ~

V t1 r r N M M ~ m Y7 M ~ O O ~ N Q) ~ O V 07 O V O t0 O Y O O (O aD O M r M ~ M r Of n17 f0 V
V t0 N N V M M V V ? GO fD u7 N (O f0 r r f0 O ~ 1n V f0 V t0 ?
~ N ~ V ~ ~ ~ V V ? V V ~
V V
~f ~
aD

_ t0 ~O ~O ~O O a0 O t0 ~O
fD N N N t0 07 O O ~D t0 O t(7 N t0 f0 O c0 fD ~D N
M t0 c0 N t0 t0 r N O O O O fD t0 tp N u7 N N N N N N N N t0 u7 M t0 N N N M r- N N
N ~ ~ N N N N ~ f0 f0 fO ~O N M N N N N
N N N N
fO
N
~

t_L LIJ

C LL LL

a ' 5 g a ~

u~ I U v U

~

v N

N ~ C'7 ~ A O
N C N

O~ O

a ' ~ a c Z c ~ c E '~ E .' o ~ 0 0 v C N C

_ .d W .N

O y O

nE nE

T
C C

O C .c0 d .A G .f0 o z E c v U O a U m E-Z

U~

O Q ~ H- N
d' c : ~ U u~

N t ~ Z N

M D r w ~ c a ~ ~ O
OQ ~

M ~ r ~ Q = ~ N

N W ~

M O ~ Z ~ O

Z ~

O ~ r M O
u7 lL 7 ~ Z S
N

~ ~' p t_nO _V M_ ~Z M_C
N

Ol ~ Of O j O N O) r O
~

Y a Y ~C Y ~ Y O
E U Q

.~ U

m ' m n m m C7a ~ a U~Z Oo c9 0 o _ C r Z
E z E E fn E < E
g ~

'N 'V1N r fn H
J a ~

c ~ c c ;~ c c Y
U d0 , ~

o z F- o o a o ~o o~ ' o ' a ui z a a d N a ~ ; o O O O y j M ~ O
O N

2 ~ ~ ' zav~ za z z z o~ a m O ~ p a0 O N
( O O
M ~ ~ ~ ~

M

M 7 r O
u O O O O O

M ~ M v M

M V M O N

~ I ? N
O f1 N ~ pp i O ~ M M

O u7 f p h O ~ N

a D a D

N M ~ ~O tO

007 ~ W ~ ~ W

00 N 00 1~ f0 pp op O 01 a0 O M O M N N (D

O N 01 N Of u) W N t0 t0 O 1~ 7 a0 O V t0 a0 O _ 1~ V
tD 7 M
u O
0 ~

Of N O f0 ~D 01 N aD ~ ? a0 N ~ f~ O w7 u O f~ tO O V t D c0 N ~ h O~ Of ~f O 1~ O O
f0 0 Cf W ~O
f P f0 N f0 f0 aD N c0 GO t < ~ ~ ~ ~ V ~
_ 00 CD N t0 t0 M N N O OD ?
W a0 O M N O f~ 4D P1 N O N V M ~ N O N
M ~O O O O) ~ N M h 0 f~
~ n t0 N tD r- aD _ (O 1 N N M N M _ M f0 (O QW 1 f0 ~ M f f O f0 N N N N D f O N M O f~ ~J M V N O O O V ~ N N N N
~ ~ O M N t ~ ~ M O N tO

N M ~ tD ~ _ M _ O N M N O V M V f0 < t0 N N ~D M aD tD <O
N M M 4D ~f t0 M a0 ~ N N M 1~ N N 00 f0 ~ 1~ ~ u7 ~O aD t0 O~ O it) f0 1n Of u7 f0 1~ t0 Of O~ t0 CO O N C_D V O Of O O O 00 ~7 (O N f0 f~ M V M M ?
(O N CD N ~ h N h ~ N O fD ~7 ~ tD f a0 ( N f0 N f0 to r a0 O~ O N M D
N

a0 N O M ~ O t0 O t0 O V . t0 ~ Of 01 O ~ tD
01 N fD 1 tn N O
f fD O f N 01 V V Q fD
e- ~ N

O 01 O M elf _ ~ ~ 0 (O f0 !O
O V a 7 0 ~ 1W I~
N O7 a 0 N O ~ ~ ~ N W f~ O M V
v ~fJ O 07 a tD M OD f~ tD M N
t0 _ _ N N ~ N N N N
_ . O M ap M N
O N ~ h CO 1n M O W 1n 1 u) COf ~ M 1~ ~7 f~ N M ~O V ~O ~ 07 N
O N O N d0 N O Of ml7 1~ tD ~ M f0 f0 N M ~D N N ? M O N ? M OD W fD (O f~ N _ N aD fp 1n ~f7 01 O_ ~l O '? 0D u7 N tD 1~ ~
N 4O N f0 W W a0 O t0 O ~f O C1 f0 O ~
W ~O 01 ~n N M ~O M O ~ M ~

u7 M O O ~O N N N N O ~ c0 N M Of M a0 O O N O O O t0 QO t0 t0 N O t0 ~ rn 1G V M ?
N ~o m cn o N O
) N
M

~ ~ ~ o_ o~ o co r _ o rn n N ~ ~o o> c~ <c o r m ~n . N
~ n N ~
' (O fD O N _ ~ O ~
O aD N M C O ~ 117 N 00 01 ~ f0 fD
~ ~ fD Of (O N ~ ~ N M ~ N fD t0 V f~ O
f0 O f0 ~O N t0 O O O CO

f0 O ~ N N N Q~ N N N N
W f0 N N O O O O O N ~ GO N O N ~ N N N N u7 O Of N f~ h f0 N 00 I~ ~O M t0 ~
~ N h O Q) M

t0 tn yc7 h o0 N O O h M u7 ~D a0 . a aD
aD c0 ~ O_ i~ I~ ~ aD ~D a0 0 . O I
~_ ~ ~ a0 O V ~ m 1~ 1~ O O r - r 1~ fD
O V O O 1~ M M 07 G~ aD u7 O 1 tD M ~ M
1~ N N M ~ f ~ ~

_ _ O ~D _ ~ 'Y r N < N V M p ~ O c0 N_ ~_ aO u7 N O t0 aD
N ~ M a0 O 01 O f0 M N ~ ~ ~l1 a0 M aD
VI M h N O Of f0 t0 O M O tp O I~ N Of ~ O 1~
~ ~O M t0 u7 M a0 tD t0 ~ O tD
O

_ N N tD N N N O M c0 ~ CD ~ Y N O V < N
O M 1~ ~O < N N V M N c0 V N ? V
V ~ ~ tD ~O
N tD aD fD
N N tD ~ a0 aD
V N t0 <O
<

O f0 N M O Uf fD ~ t0 ~ f0 t0 t0 t0 D N N N N
N W ~ O N f0 ~ 01 07 07 N N ~O ~ N t0 N O N
N tD ~ M ~7 N (D !~ N O V M N ~ N tD
(O N N
N
t 1~ O~ N ~ W O~ CO 01 O . u7 cL N N O ~_ .
t0 P N ? O W tD N ~ 01 a~
~ N 1~ O M a0 O) O N V h ~ M f0 r ~ '? ~ a0 Qf a0 a0 t0 h O~ N ~O M ~ tD O O ~D

~ Of a~ M a0 a0 00 N f0 N M 07 O a0 u7 0 O O h O
pp p) pp op fD ~ N ~? a7 tD N M 01 O fD V N M
c0 Of Of tD M
M ~D W ~ Of I~
1 t0 1~ ~ t0 h V' LO f0 I~ h M N ~ ~ 1~ f~ M ~ u7 M tf7 O t0 N O t0 tD O t0 tD tD O O P O 07 O I~ 1~ ~ ~ D
t0 M N V ~ ?
~
t N N M ~f ~D V N N V 1~ ~ ~t V ~ ~ ? O c0 ~ ~
Q) V V oO Y7 N t0 V tD ~
t0 u7 ~ f0 (O N N O O~ f0 f0 O t0 ~O f0 n f0 fD N
f0 ~ (D tD ~ u) f0 O CO u'1 t0 (O t0 t0 M N t u7 N G~ N N N f0 N l0 N (O N N N N N M N N N N
fD N N N a0 N N 1n N t0 ~ M N CO N N N ~ N N N
N N N N N N

W W

(n X

, N n "

g ~ o Z t >~ ~
t N

p N

0 O C_ 0 ~ N

d a o ~ a c n .

.m E c E c , o ,~ 9 'm a c c .
.

T O

O C
d d N f0 N
w ~ c E

m v c t o a U ~
U m N N N

O ~

(~ W
Z

U M

f fD O N
D

_ O N Z_ o O
O H

H
Q

Q ~ N

W
y N

co n ~
c~
.a o ~ m O

u N

. ~ o M Y I C

C C F-N ~ G r N
O

O N m m O
~ U

d O o Lt D.

m E E~ Eaw E ~ ~

~ _ N N
N
.

~ ~ o ~ ~ c Y
. 6i .

o~ E .~ d d ~ p ~ Z

O aD O N p N Q
Z ~ M

a E z ~ d d d~
o i > > > m > .- O
Z ' Z 'c> n Z ~ Z a o~ V

O_ N

O O

M M

n O

O O M M

M M_ ~t cD

M ? ~O

M
M ~

W

n ~ I~ p I

l ' ~ :

cc v ~ ai W i ~c in c v of o c ~

N O Of _ O c'~ h tD Of 1~ N c7 N m 47 07 ap O~ 01 tn ~ ~ tD f~ c0 c0 M
P 47 O 00 a0 a0 Yf 1~
O ? ~ V M
~

GO a0 a0 O f0 t0 O st O tD N O f~ N O
(O ~ CD fC a0 CO f0 c~ 1~ I~ f~ O N (p c0 N G1 O M O V tD Of a0 c0 N O M P 't O N m ~ ~t1 c0 N N N V aD _ Of Of O~ f~ a0 fp 1 f7 O N 47 f0 t0 ~l1 N t0 ~ N a0 V tD
h ~

O O V N N 40 10 VI O M O (D O) O r a~ c~
O u7 N N c0 ~O N N I~ fD f0 N
V O N N
u') N N V N N N r 1A OO N N V 4~ N 1(7 N N M (O
h r f0 N . tD N c'7 N
~

_ O t0 t0 aD O f0 fD (O CO O ~O N 47 O~
_ fD f0 40 O~ 1_~
47 f0 (O f0 ~ N Y ~ 40 N 1n 01 N f0 N 07 aD
N N N ? (O OD 117 N f'7 W 07 h '? V u7 aD ~O r V N N
f~7 V

O 10 a0 01 u7 ~ f0 47 (D O QI 47 N 47 O <O
O h f0 fD N 1A (p 1(7 f0 1f7 f0 f0 _ t0 07 V O N ~O O N Of O CO ? O < tp f0 W f~ N M ~ ? ~ N Qf N f'~ ~J
CO N ~ t0 at N N
CO N ~ a0 a0 f~ 10 N 10 7 V 47 ~O r f0 ~ 0D
~

N O ~ . P 1~ O N W N a0 tp oD _ N 4 N u7 tD O N
O O ~ a0 N t0 O C'1 N
h u7 D Of ~O aD V M N O N V
m O 01 O t0 G a D f~ a _ _ N N N f0 47 V
of a0 _ 40 P t"') O
t0 t0 N t0 O < aD N 07 N
oD h 47 M f0 47 f0 f0 N M N CO O ~ ~O N N W 01 ~ Of t) fD O c~ t0 O N u7 fm!) 1~ 10 M op O
P'7 I~ f0 O
O Uf O
' ~ N Of u7 N c~ 07 O u7 ~ ap N N OD tD C~ M O
a0 N ~O fD c'~ Ih t0 47 r O a0 t~ O_ ~ t~ r c a0 O Qi t0 P I~ O_ ~O ~l7 O C~ ~ ~
W O aD (D M M t0 O c7 M 01 N r nl7 ~ N h ~ N N a0 V oD U7 N O~ O
V 1~ N P7 f0 aD N V O Of a0 - (O
a0 c0 t~

V < f~7 N ~
V

1~ P 1~ f~ r <O 1(7 _ 00 m O ~D ~O N 47 M
aD <O f0 I~ f0 117 10 f0 (D

Y7 Of 10 O N N i~ t0 r r O Of t0 N G V N
CO 1n N f~ O N O C7 M N N fm0 D N N
r 10 f~ f~ CO
fh N

N f0 N V N Y O (D N 01 r 00 ~D O f0 _ N
C7 (O N f0 _- N aD a0 01 ~O D 1~ O 47 O O a0 O 1~ 1~ O a N Of a0 ~ O <O c'W CJ O ~ O) O P) O) O f~ a M a0 O) C~7 D 01 a O
f~ O ~

t0 N _ _ _ O fD M
t0 O7 _ N N ~(f c0 C1 M
OD 01 1~ O u) Of ~O fp c0 07 O) N
OD 07 1f~ ~ a0 N ~ N f~
M

tD C~ f0 t0 M fD O t0 ~ t0 N N f0 O O aD t 1 t0 O t0 1~ N t0 ~O ~ aD t0 h t~ f0 c0 W
O a K7 1~

Y7 c'~ N u7 c~ 47 N ~ N V _ N V M ~ e<
a0 Of ~ N N N h N N N N u7 r V t0 ~ ~ c0 fD V N V 47 ~
t0 ~O 10 ~ ~O ? W t0 10 ~O 10 c7 10 tD

h O do Of nl7 47 h 47 N N N
fm0 N 1D N N N OD N N
N r n 1n N U) N IA N V N ~ O N
N N !D N ~ ~O h N f~
N

N _ _ O 01 N M _ 1~ 47 1(7 1~ G7 N 47 1~
C7 CO 1~ O _ In O 0D f~
07 c0 c~ 01 O a ~ O c0 P u7 a0 D 10 ~ V O) ~ h O t0 t~ tD f~ aD h f~ I~ O N aD W
t0 N

a0 m _ N 4D a0 N N O u7 O
47 W a0 a0 N O N Of a0 aD t0 N c'7 aD O
H7 (D r O a0 f~ O aD t0 c~ !~

O c~ O h N P7 W W ~7 (O aD 1~ f') 0D N In t0 u7 c~ O f0 O 1~ O f0 f~ O fD tD Of P
f0 u7 O O f0 f0 f0 t0 t0 M ~t N V c7 V < u7 ~ W CO N fW O V if ~f V' ~ V ~ N V 07 tW ? if tD
? O I~ 10 ~O M O a0 f0 ~f f0 ~
N fD N Of t0 (D V
0 f0 LO (~ f~ t0 t0 tD t0 ~ ~O
t0 a0 O a0 N t0 07 <O t tf1 N N N ~ N N N N
t0 t0 ( N N N N CO N
~O fD r N N N N 47 N i0 N N N N
r N N N N ~O t0 r N N N
N N
N

L u_1 JJ

_ N

2 z C ~ N

07 m f0 m c ~ t i d a d_ a~

_ _ C
C N .

.f0 d .47 N c0 N

n v v v U
~

c c Z c ' 'a~ ~ 'a~ U a>

0 o U o ' a E n n NN N~ N

_ c C C c C , ' ' E

m m 4=

W

U O U N U

c N

o o n a c~ o aMO a~ n aNo c c ~ c ~ c U a0 Q ~ m Q m a n a a m 5 m m -p N ~N a N ~ N

n N ~ O t(1 c~ E O

' v N Y cc v E
N E

z z oZ

~ ~

; a ~ c c ~ c ~

Q _ ~ 0 _ . .
.
d N .O~ .Ø r 7 . ..
r Of .
.. 00 O O N O O O

c ~ E c a c' E c n c $
~

o m m ; o m ' m m .7 o U W ~ o C

E ~ ? .
' ~ ' 'N O 'N H ~ O N N

c ~ a c Y c d o c 'd a~ .' v .~ u~ E .d ~ cu m n O m V O h O ~ L O Of O 10 d C7 n.

m O N 41 41 d 0 = 0 y O 0 ~ d 0 m ~ u7 N

' a ' a Z a t V

Z Z Z Z
oo o~

N N

N N N M c M ~ O 0 0 M f" C f ') 7 ~7 C7 10 h Q7 m ~ W ~ m m ~ ~ 0 C ~ 0 ~ M tn f O O
O f~7 h ~ ~ 1~ M um'1 007 o~ o~ rn ao a n N f') Y ~f7 t0 O Of W W O O

N . O O V OD . N

a0 . f0 O~ 1p 07 f0 N h O) 1n t0 . aD

N a0 V h t0 Of t0 N fD M N ~ h M h OD
a0 O M CO M f0 f0 h O) W D N a0 ~7 M M O of V O ~O V
dD CC
f7 1~ O V a O) ~O Of _ M O
t0 t0 ~O a0 t0 t0 . O N ~ tp c0 h t0 t0 f0 h 10 < V

m M ~ ~ ~ h O h N M CD O a0 ~ V ? N N a0 ~ N Of V ~ N V V N

c0 M ~O Of N M ? O a0 u7 fD fp t0 O a0 O ~ u7 ~O ~O ~O ~D h _ O N ~t M O h Of ~ N O N N N h tp h fh O N t0 ~ f0 ~ N N N N N N
N N h O N N M O N N h f0 N7 0D f0 V ~D O
tp O N t0 h O t0 H7 O h tD tD M
~
h ~

O 10 h O h M u7 fD tD
aD O M t0 O t0 ~ N O
01 t0 O M ~D M
07 a0 tD _ N
~ t0 O
N ~ h ~f Of a0 N O a0 M O h W M tD (O V f0 t0 O O O O u7 u7 h O h O h ~O O
h ~

N Of O) (D t0 O N h a0 O h h M
N N a0 V h ~ Of N N a_D aD ~ M u7 ? V O
< <T N ~ V M N a0 ~ ~ N ~ ~ O ~
0 t0 00 t0 N
~ h O a0 N ~O t0 tD ~O M V O>
N

<O 1 . O at N
u'1 ~ M N N O
N N ~O ~- M CO O N M N M N N ~ ~ N N N N
N N CO ~ ~ N N ~ N N

c0 Of M a0 a0 t0 N N t0 M
h f0 Of 00 O tp ~ O O M Of t0 a0 Q1 01 t0 N
O h M M f0 O~ t0 t0 f0 N O N ~ M aD ~
V O <O O O M M W L7 u7 O O a0 O
~ 00 N
N N
t0 N

c0 ~ N N Yf M N h M N N N M ~C) M M W t0 h N
t0 a0 10 h tD 01 O O O t0 (O ~
O f0 1D t0 (D f0 (D O
O u7 h O~ N 1A V _ N ~D V
~t ~ aD tD N t0 N N M V s< M Vl M f0 ~ ~ a0 tD ~! V ~ ~ O N ~f ? ~ M
~ 117 N M
0 t0 f0 (O c0 fD cD t0 CD ~D N
f0 00 f0 ~
M

N ~O (O aD _ ~O N
N ! aD N N ?
N N ~ N f h N 0 O h N N a0 N N N N N M O N M
N ~ N N
N h N M a _ M N
O N M fD O 10 fD N (O off h _ _ a0 . N ~
O f0 CO O V aD 01 M M
V t0 M O O O N M W Of t0 Of Of ~ O) N M O O O a aD

a0 M O M _ M ~
u7 O tD a0 O f0 N Gr M (O (D O N M M 07 N
~ M O ~ c0 ~f7 Of ~ ~n O ~O ~ t0 O
h t0 t0 M t0 O W t0 t0 Of ~f7 u7 Of tD tp u) f0 U7 W L7 a0 t0 f0 O h t0 ~ N t0 N N ~ ~ ~ ~ N M N ~ N M M ~ ~ N ~ ~ ~
~ ~ ~ ~ ~ ~ N ~ ~ ~ O ~

N f0 V N ~ h V h N V Q1 ~f N N of N N h C1 N
N N N N N N N h a0 N N N N N ~O
N

O N . tp 01 01 _ N N t0 h O N
O O c0 Hf a0 h O O a0 N 07 ap M O a0 ~f7 O O M
O u') Of h elf M off O N ~ h ~ O) ~ M 0 N
M a0 0 h ~

thDahOm~~t0t0Or0~~vf7t ~MN~W f1 f0 ~O~~f00MVa00~00fO_~O~~vcl ( 0f 0f ~

fD N O~ ~ h ~ ~ ~ tD t0 t0 l7 tD f0 ~ ~ ~ N N t0 O~ N n ~D t0 a0 t0 N O
c0 ~ tD ~O tD t0 N N N N N N N N N N N ~7 N N N ~ N N N N (O N N
N N N N N N VJ CD N N N N N N N
(O

W l_JJ

' S 5 2 2 z z x d a d C
N

_ O
_ a .

> h or o c~
Q d h a N
V

j ~. M fn 1f1 r N '' = o o m w m E ~ a c ~ o o _ N Q Q v O N
m N _ Z

c U ai o - W i ~

m d Li a ' N t ' H op a m a E E Q
= o ~

~ N , d ~ ~
E ~
h o M v h eo Q7 ~ ~ O
a0 ~O ~ N _ M O V O N W N
D N
Of O = M h OD O
N Z
~

~ E

Q '? =M Q
U -- H
o V O) ~
g 7 ED

C N Y ~ C C
~ ~
N

d c 2 h ~ ~ N of ~ lil h ~
v ~ N N
~ = ~
' ~

C9 O_ C9 V g Q c ~ w E E ~m EZ~ ~
' ~ E c~
~ ~
' fl! fIl N Q

Y c Z c c W c ~

'y O~ 'y h ~ d ~ N N
r N h d ~ N

O O O O N O O
t ~ W
O

d G~D n. ~ y) n. d d ~ L O
ll~ f0 L
p N n ~ N
.

O ~ Z d CI 7 > > > >
~

N ~ o U Z c ~

Z a Z wi ~ Z ... Z Z
U ... o~
.-O O

M

M M M

M ~ M M

O O

v ~ N

m W ~

O N M OOf N O ~ N

pp M N

ChD Of ~ Of h h c > N

N
W O) Of O 01 DEMANDE OU BREVET VOLUMINEUX
LA PRESENTE PARTIE DE CETTE DEMANDE OU CE BREVET COMPREND
PLUS D'UN TOME.

NOTE : Pour les tomes additionels, veuillez contacter 1e Bureau canadien des brevets JUMBO APPLICATIONS/PATENTS
THIS SECTION OF THE APPLICATION/PATENT CONTAINS MORE THAN ONE
VOLUME

NOTE: For additional volumes, please contact the Canadian Patent Office NOM DU FICHIER / FILE NAME
US2000008621.TIF
NOTE POUR LE TOME / VOLUME NOTE:
CD 2000/192 available in Client Service Centre and images available via AppFiles (5502 Pages)

Claims (32)

What is claimed is:
1. An isolated nucleic acid molecule encoding a polypeptide comprising an amino acid sequence that is at least 85% identical to a polypeptide including an amino acid sequence selected from the group consisting of SEQ ID NO:2n, wherein n is any integer 1-3161, or the complement thereof.
2. The isolated nucleic acid molecule of claim 1, said molecule hybridizing under stringent conditions to a nucleic acid sequence complementary to a nucleic acid molecule comprising the sequence of nucleotides selected from the group consisting of SEQ ID NO:2n-wherein n is any integer 1-3161, or the complement thereof.
3. The isolated nucleic acid molecule of claim 1, said molecule encoding a polypeptide comprising the amino acid sequence selected from the group consisting of SEQ ID
NO: 2n, wherein n is any integer 1-3161, or an amino acid sequence comprising one or more conservative substitutions in the amino acid sequence selected from the group consisting of SEQ
ID NO: 2n.
4. The isolated nucleic acid molecule of claim 1, wherein said molecule encodes polypeptide comprising the amino acid sequence selected from the group consisting of SEQ ID
NO: 2n, wherein n is any integer 1-3161.
5. The isolated nucleic acid molecule of claim l, wherein said molecule comprise the sequence of nucleotides selected from the group consisting of SEQ ID NO:2n-1, wherein any integer 1-3161, or the complement thereof.
6. An oligonucleotide less than 100 nucleotides in length and comprising at least contiguous nucleotides selected from the group consisting of SEQ ID NO:2n-1, wherein n is a integer 1-3161, or the complement thereof.
7. A vector comprising the nucleic acid molecule of claim 1.
8. ~The vector of claim 7, wherein said vector is an expression vector.
9 ~A host cell comprising the isolated nucleic acid molecule of claim 1.
10. ~A substantially purified polypeptide comprising an amino acid sequence at least 80% identical to a polypeptide comprising the amino acid sequence selected from the group consisting of SEQ ID NO: 2n, wherein n is any integer 1-3161.
11. ~The polypeptide of claim 10, wherein said polypeptide comprises the amino acid sequence selected from the group consisting of SEQ ID NO: 2n, wherein n is any integer 1-3161.
12. ~An antibody that selectively binds to the polypeptide of claim 10.
13. ~A pharmaceutical composition comprising a therapeutically or prophylactically effective amount of a therapeutic selected from the group consisting of:
a) the nucleic acid of claim 1;
b) the polypeptide of claim 10; and c) the antibody of claim 12;
and a pharmaceutically acceptable carrier.
14. ~A kit comprising in one or more containers, a therapeutically or prophylactically effective amount of the pharmaceutical composition of claim 13.
15. ~A method of producing the polypeptide of claim 10, said method comprising culturing the host cell of claim 9 under conditions in which the nucleic acid molecule is expressed.
16. ~A method of detecting the presence of the polypeptide of claim 10 in a sample, comprising contacting the sample with a compound that selectively binds to said polypeptide under conditions allowing the formation of a complex between said polypeptide and said compound, and detecting said complex, if present, thereby identifying said polypeptide in said sample.
17. A method of detecting the presence of a nucleic acid molecule of claim 1 in a sample, the method comprising contacting the sample with a nucleic acid probe or primer that selectively binds to the nucleic acid molecule and determining whether the nucleic acid probe ~
primer bound to the nucleic acid molecule of claim 1 is present in the sample.
18. A method for modulating the activity of the polypeptide of claim 10, the method comprising contacting a cell sample comprising the polypeptide of claim 10 with a compound that binds to said polypeptide in an amount sufficient to modulate the activity of the polypeptide
19. The use of a therapeutic in the manufacture of a medicament for treating a syndrome associated with a ORFX-associated disorder, wherein said therapeutic is selected from the group consisting of:
a) the nucleic acid of claim 1;
b) the polypeptide of claim 10; and c) the antibody of claim 12.
20. A method for screening for a modulator of activity or of latency or predisposition to an ORFX-associated disorder, said method comprising:
a) contacting a test compound with the polypeptide of claim 10; and b) determining if said test compound binds to said polypeptide, wherein binding of said test compound to said polypeptide indicates the test compound is a modulator of activity or of latency or predisposition to an ORFX-associated disorder.
21. A method for screening for a modulator of activity or of latency or predisposition to an ORFX-associated disorder, said method comprising:
a) administering a test compound to a test subject at an increased risk ORFX-associated disorder, wherein said test subject recombinantly expresses a polypeptide encoded by the nucleotide of claim 1;

b) measuring expression the activity of said protein in said test subject;
c) measuring the activity of said protein in a control subject that recombinantly expresses said protein and is not at increased risk for an ORFX-associated disorder; and d) comparing expression of said protein in said test subject and said control subject, wherein a change in the activity of said protein in said test subject relative to said control subject indicates the test compound is a modulator or of latency of predispostition to an ORFX-associated disorder.
22. The method of claim 20, wherein said test animal is a recombinant test animal that expresses a test protein transgene or expresses said transgene under the control of a promoter at an increased level relative to a wild-type test animal, and wherein said promoter is not the native gene promoter of said transgene.
23. A method for determining the presence of or predisposition to a disease associated with altered levels of a polypeptide of claim 11 in a subject, the method comprising:
a) measuring the amount of the polypeptide in a sample from said subject; and b) comparing the amount of said polypeptide in step (a) to the amount of the polypeptide present in a control sample, wherein an alteration in the level of the polypeptide in step (a) as compared to the control sample indicates the presence of or predisposition to a disease in said subject.
24. The method of claim 23, wherein said subject is a human.
25. A method for determining the presence of or predisposition to a disease associated with altered levels the nucleic acid molecule of claim 1 in a subject, the method comprising:
a) measuring the amount of the nucleic acid in a sample from the mammalian subject; and b) comparing the amount of said nucleic acid in step (a) to the amount of the nucleic acid present in a control sample, wherein an alteration in the level of the nucleic acid in step (a) as compared to the coy sample indicates the presence of or predisposition to said disease in said subject.
26. The method of claim 25, wherein said subject is a human.
27. A method of treating or preventing a pathological condition associated with ai ORFX-associated disorder in a subject, the method comprising administering to said subject polypeptide of claim 10 in an amount sufficient to alleviate or prevent said pathological condition.
28. The method of claim 27, wherein said subject is a human.
29. A method of treating or preventing a pathological condition associated with at ORFX-associated disorder in a subject, the method comprising administering to said subject nucleic acid molecule of claim 1 in an amount sufficient to alleviate or prevent said pathology condition.
30. The method of claim 29, wherein said subject is a human.
31. A method of treating or preventing a pathological condition associated with an ORFX-associated disorder in a subject, the method comprising administering to said subject antibody of claim 12 in an amount sufficient to alleviate or prevent said pathological condition
32. The method of claim 31, wherein said subject is a human.
CA002383592A 1999-03-31 2000-03-31 2384891 acids including open reading frames encoding polypeptides; orfx Abandoned CA2383592A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US12760799P 1999-03-31 1999-03-31
US60/127,607 1999-03-31
US12763699P 1999-04-02 1999-04-02
US60/127,636 1999-04-02
US12772899P 1999-04-05 1999-04-05
US60/127,728 1999-04-05
US54076300A 2000-03-30 2000-03-30
US09/540,763 2000-03-30
PCT/US2000/008621 WO2000058473A2 (en) 1999-03-31 2000-03-31 Nucleic acids including open reading frames encoding polypeptides; 'orfx'

Publications (1)

Publication Number Publication Date
CA2383592A1 true CA2383592A1 (en) 2000-10-05

Family

ID=27494693

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002383592A Abandoned CA2383592A1 (en) 1999-03-31 2000-03-31 2384891 acids including open reading frames encoding polypeptides; orfx

Country Status (5)

Country Link
EP (1) EP1165784A2 (en)
JP (1) JP2004507202A (en)
AU (1) AU3774500A (en)
CA (1) CA2383592A1 (en)
WO (1) WO2000058473A2 (en)

Families Citing this family (260)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6372473B1 (en) * 1997-05-28 2002-04-16 Human Genome Sciences, Inc. Tissue plasminogen activator-like protease
US6482932B1 (en) * 1997-11-05 2002-11-19 Ribozyme Pharmaceuticals, Incorporated Nucleoside triphosphates and their incorporation into oligonucleotides
US6528640B1 (en) * 1997-11-05 2003-03-04 Ribozyme Pharmaceuticals, Incorporated Synthetic ribonucleic acids with RNAse activity
US6617438B1 (en) * 1997-11-05 2003-09-09 Sirna Therapeutics, Inc. Oligoribonucleotides with enzymatic activity
US6300096B1 (en) 1998-01-15 2001-10-09 Whitehead Institute For Biomedical Research Polynucleotides encoding fatty acid transport proteins
US7033772B1 (en) 1998-01-15 2006-04-25 Millennium Pharmaceuticals, Inc. Methods of identifying inhibitors of fatty acid transport proteins (FATP)
US6365365B1 (en) 1998-03-20 2002-04-02 The Regents Of The University Of California Method of determining whether an agent modulates glycosyl sulfotransferase-3
US6265192B1 (en) 1998-03-20 2001-07-24 The Regents Of The University Of California Glycosly sulfortransferase-3
US7105639B2 (en) 1998-05-15 2006-09-12 Genentech, Inc. Anti-PRO 4405 antibodies
WO2001066756A2 (en) * 2000-03-07 2001-09-13 Millenium Pharmaceuticals, Inc. 22105, a human thioredoxin family member and uses thereof
EP1593687A3 (en) * 1998-06-10 2006-10-18 Bayer Corporation Human genes differentially expressed in colon cancer
US20030003507A1 (en) 1999-06-02 2003-01-02 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US7258973B2 (en) * 1998-08-31 2007-08-21 Mayo Foundation For Medical Education & Research Method for detecting a differentially expressed sequence
US20030096391A1 (en) * 2000-12-22 2003-05-22 Millennium Pharmaceuticals, Inc. 17903, a novel human aminopeptidase and uses therefor
JP4315301B2 (en) * 1998-10-30 2009-08-19 独立行政法人科学技術振興機構 Human H37 protein and cDNA encoding this protein
US7867731B2 (en) 1998-11-04 2011-01-11 Novartis Vaccines And Diagnostics, Inc. HX2004-6 polypeptide expressed in cancerous cells
US6743602B1 (en) 1999-07-26 2004-06-01 Chiron Corporation Polynucleotides differentially expressed in adenocarcinomas, polypeptides encoded thereby, and methods of use thereof
WO2000039150A2 (en) * 1998-12-30 2000-07-06 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
DK1277833T3 (en) * 1999-02-12 2006-06-19 Genentech Inc Genes that propagate in tumors, as well as related materials and methods
ATE348108T1 (en) * 1999-03-08 2007-01-15 Genentech Inc METHOD FOR DETECTING TUMORS
US6881555B2 (en) 1999-03-19 2005-04-19 Aventis Pharmaceuticals Inc. AKT nucleic acids, polypeptides, and uses thereof
PT1144600E (en) * 1999-03-19 2008-10-10 Aventis Pharma Inc Akt-3 nucleic acids, polypeptides, and uses thereof
AU764092B2 (en) * 1999-03-23 2003-08-07 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1180151A2 (en) * 1999-05-28 2002-02-20 Sugen, Inc. Protein kinases
WO2000075320A2 (en) * 1999-06-07 2000-12-14 Lexicon Genetics Incorporated Human genes and proteins encoded thereby
JP2003529325A (en) * 1999-06-17 2003-10-07 インサイト・ゲノミックス・インコーポレイテッド Human transport protein
DE19928021A1 (en) * 1999-06-18 2000-12-21 Basf Ag New nucleic acid encoding testis-specific calpain-11, useful for identifying specific inhibitors for treatment of fertility disorders
AU5799500A (en) * 1999-06-29 2001-01-22 Mcgill University Human alpha 1,2-mannosidase
AU6113700A (en) * 1999-07-23 2001-02-13 Human Genome Sciences, Inc. 29 human secreted proteins
WO2001007614A1 (en) * 1999-07-26 2001-02-01 Chiron Corporation Polynucleotides differentially expressed in adenocarcinomas, polypeptides encoded thereby, and methods of use thereof
DE19936563A1 (en) * 1999-08-04 2001-02-08 Boehringer Ingelheim Int Tumor Associated Antigen
US6818750B2 (en) * 1999-09-01 2004-11-16 The Burnham Institute Card proteins involved in cell death regulation
KR100543857B1 (en) * 1999-09-01 2006-01-23 제넨테크, 인크. Promotion or Inhibition of Angiogenesis and Cardiovascularization
EP1127118A1 (en) * 1999-09-02 2001-08-29 Smithkline Beecham Plc Human gs protein regulator gene
AU7101700A (en) * 1999-09-02 2001-03-26 Lexicon Genetics Incorporated Human calcium dependent proteases and polynucleotides encoding the same
US20020049312A1 (en) * 2000-05-23 2002-04-25 Turner C. Alexander Noel human thrombospondin-like proteins and polynucleotides encoding the same
US20020045212A1 (en) * 2000-02-29 2002-04-18 Glucksmann Maria Alexandra Novel human GTPase activator proteins
US6329171B1 (en) 1999-09-30 2001-12-11 Millennium Pharmaceuticals, Inc. 23484, A novel human ubiquitin protease
US7329529B2 (en) 1999-09-03 2008-02-12 Millennium Pharmaceuticals, Inc. Ubiqutin proteases
AU6974900A (en) * 1999-09-07 2001-04-10 University Health Network A p53-induced protein with a death domain that can promote apoptosis
WO2001019860A2 (en) * 1999-09-15 2001-03-22 Incyte Genomics, Inc. Proteins associated with cell differentiation
WO2001019850A2 (en) * 1999-09-16 2001-03-22 Mcgill University Nrage nucleic acids and polypeptides and uses thereof
US7029895B2 (en) 1999-09-27 2006-04-18 Millennium Pharmaceuticals, Inc. 27411, a novel human PGP synthase
US6451994B1 (en) * 1999-09-27 2002-09-17 Millennium Pharmaceuticals, Inc. 23413, a novel human ubiquitin protease
GB9924060D0 (en) * 1999-10-11 1999-12-15 Chiron Spa VIP54 protein
US6420155B1 (en) * 1999-10-14 2002-07-16 Curagen Corporation Aortic carboxypeptidase-like protein and nucleic acids encoding same
US20020081625A1 (en) * 1999-10-14 2002-06-27 John Ford Member of the immunoglobulin superfamily and uses thereof
AU7934300A (en) * 1999-10-19 2001-04-30 Merck & Co., Inc. Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof
US20020081679A1 (en) * 1999-10-22 2002-06-27 Millennium Pharmaceuticals, Inc. NARC8 programmed cell-death-associated molecules and uses thereof
AU1230201A (en) * 1999-10-25 2001-05-08 Millennium Pharmaceuticals, Inc. 27875 a human adam-ts homolog
AU1449001A (en) * 1999-11-05 2001-06-06 Human Genome Sciences, Inc. 28 human secreted proteins
JP2004500054A (en) * 1999-11-10 2004-01-08 レキシコン・ジェネティクス・インコーポレーテッド Novel human ATPase protein and polynucleotide encoding the protein
US7005285B1 (en) 1999-11-15 2006-02-28 Pharmacia & Italia S.P.A. Human p21-activated kinase 5 polypeptide
CA2391908A1 (en) * 1999-11-17 2001-05-25 Curagen Corporation Novel polypeptides and nucleic acids encoding same
WO2001040468A2 (en) * 1999-12-01 2001-06-07 Millennium Pharmaceuticals, Inc. Molecules of the card-related protein family and uses thereof
US20030109428A1 (en) 1999-12-01 2003-06-12 John Bertin Novel molecules of the card-related protein family and uses thereof
CA2490909A1 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001042291A2 (en) * 1999-12-10 2001-06-14 Curagen Corporation Polynucleotides and polypeptides encoded thereby
US7115558B2 (en) * 1999-12-16 2006-10-03 Cytochroma Inc. P450RAI-2(P450 Cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof
AU1686701A (en) * 1999-12-21 2001-07-03 University Of Zurich Dispatched polypeptides
JP2003517838A (en) * 1999-12-23 2003-06-03 インサイト・ゲノミックス・インコーポレイテッド Human kinase
US7119165B2 (en) 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
AU784349C (en) * 2000-01-12 2006-09-28 Yale University Nogo receptor-mediated blockade of axonal growth
JP2003523741A (en) * 2000-02-01 2003-08-12 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド Bcl-2-like polynucleotides, polypeptides and antibodies
AU2001230560A1 (en) * 2000-02-01 2001-08-14 Taisho Pharmaceutical Co. Ltd. Novel gene tig104alpha and protein tig104alpha encoded thereby
WO2001059114A2 (en) * 2000-02-09 2001-08-16 The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services Tumor suppressor gene, p47ing3
US7078205B2 (en) 2000-02-17 2006-07-18 Millennium Pharmaceuticals, Inc. Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
SE0100472L (en) * 2000-02-18 2001-08-19 Hoffmann La Roche New metalloproteases having thrombospondome domains and nucleic acid compositions encoding these
DE10007468A1 (en) * 2000-02-18 2001-08-23 Basf Lynx Bioscience Ag New central nervous protein that modulates K · + · currents
GB0004196D0 (en) * 2000-02-19 2000-04-12 Smithkline Beecham Plc Novel compounds
AU2001243283A1 (en) * 2000-02-25 2001-09-03 Millennium Pharmaceuticals, Inc. 44576, a novel g-protein coupled receptor and uses therefor
US20010039331A1 (en) * 2000-03-31 2001-11-08 Hunter John J. 16836, a novel human phospholipase C family member and uses thereof
US20020042098A1 (en) * 2000-02-29 2002-04-11 Rachel Meyers 32253 transferase family members and uses therefor
WO2001064905A2 (en) * 2000-02-29 2001-09-07 Millennium Pharmaceuticals, Inc. 2504, 15977, and 14760, novel protein kinase family members and uses therefor
US6864078B2 (en) 2000-02-29 2005-03-08 Millennium Pharmaceuticals, Inc. 14790, novel protein kinase molecule and uses therefor
US20040033509A1 (en) 2000-07-18 2004-02-19 Millennium Pharmaceuticals, Inc. Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor
AU6802801A (en) * 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2003525057A (en) * 2000-03-02 2003-08-26 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド Serine / threonine phosphatase polynucleotides, polypeptides, and antibodies
EP1262487A4 (en) * 2000-03-02 2004-12-22 Chugai Pharmaceutical Co Ltd Dna encoding squalene epoxidase promoter
US20020055159A1 (en) * 2000-06-15 2002-05-09 Meyers Rachel A. 23680,a novel human aminotransferase and uses therefor
WO2001090322A2 (en) * 2000-05-19 2001-11-29 Millennium Pharmaceuticals, Inc. 32244, a novel human amp-binding enzyme and uses thereof
US7301016B2 (en) 2000-03-07 2007-11-27 Millennium Pharmaceuticals, Inc. Human transferase family members and uses thereof
WO2001068851A2 (en) * 2000-03-10 2001-09-20 Curagen Corporation Polypeptides and nucleic acids encoding same
AU4945001A (en) * 2000-03-22 2001-10-03 Curagen Corp Angiogenesis associated proteins, and nucleic acids encoding the same
JP2001335598A (en) * 2000-03-24 2001-12-04 Takeda Chem Ind Ltd New protein, method for producing the same and use thereof
BR0109524A (en) 2000-03-24 2004-01-20 Genetics Inst Isolated nucleic acid molecule, vector, host cell, method for producing a polypeptide, isolated polypeptide, antibody, method for detecting the presence of a polypeptide in a sample, kit, and methods for detecting the presence of a nucleic acid molecule in a sample to identify a compound and modulate the activity of a polypeptide
WO2001073043A2 (en) * 2000-03-24 2001-10-04 Millennium Pharmaceuticals, Inc. 32451, a human ubiquitin conjugating enzyme-like molecule and uses thereof
EP1402027A2 (en) * 2000-03-24 2004-03-31 Millennium Pharmaceuticals, Inc. Human methyltransferase family member, 25552, and uses thereof
WO2001073014A1 (en) * 2000-03-24 2001-10-04 Merck Patent Gmbh Human survivin interacting protein 1 (sip-1)
EP1138768A3 (en) * 2000-03-27 2002-08-07 Leadd B.V. Apoptin-associating protein AAP-5
EP1138765A1 (en) * 2000-03-27 2001-10-04 Leadd B.V. Apoptin-associating proteins AAP-5 and AAP-6
FR2806739B1 (en) * 2000-03-27 2005-02-18 Fond Jean Dausset Ceph GENES INVOLVED IN INFLAMMATORY BOWEL DISEASES AND THEIR USE
WO2001073022A1 (en) * 2000-03-29 2001-10-04 Kyowa Hakko Kogyo Co., Ltd. Proliferative glomerular nephritis-associated gene
US20030198953A1 (en) * 2000-03-30 2003-10-23 Spytek Kimberly A. Novel proteins and nucleic acids encoding same
WO2001072957A2 (en) * 2000-03-31 2001-10-04 Nobuyuki Itoh Fibroblast growth factor-like molecules and uses thereof
CA2405181A1 (en) 2000-04-07 2001-10-18 Merck Patent Gesellschaft Mit Beschraenkter Haftung Human pyruvate dehydrogenese phosphatase
WO2001079272A2 (en) * 2000-04-18 2001-10-25 Tularik Inc. Sitosterolemia susceptibility gene (ssg): compositions and methods of use
US20030119081A1 (en) * 2001-10-29 2003-06-26 Millennium Pharmaceuticals, Inc. 32235, a human aminotransferase family member and uses therefor
AU2001253804A1 (en) * 2000-04-26 2001-11-07 Pe Corporation (Ny) Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
US20020019348A1 (en) * 2000-08-02 2002-02-14 Applera Corporation Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
JP2004511208A (en) * 2000-04-28 2004-04-15 インサイト・ゲノミックス・インコーポレイテッド RNA metabolism protein
WO2001083744A2 (en) * 2000-05-02 2001-11-08 Merck Patent Gmbh Natrium-calcium exchanger protein
US6808876B1 (en) 2000-05-02 2004-10-26 Immusol, Inc. Cellular regulators of infectious agents and methods of use
US20020028465A1 (en) * 2000-05-03 2002-03-07 John Bertin Novel molecules of the NBS/LRR protein family and uses thereof
US7034135B2 (en) 2000-05-03 2006-04-25 Millennium Pharmaceuticals, Inc. Molecules of the NBS/LRR protein family and uses thereof
US20020132298A1 (en) * 2000-11-14 2002-09-19 Millennium Pharmaceuticals, Inc. 67118, 67067, and 62092, human proteins and methods of use thereof
JP2003532412A (en) * 2000-05-12 2003-11-05 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング Novel serine-threonine kinase-4
AU2001268060A1 (en) * 2000-05-15 2001-11-26 Curagen Corporation G-protein coupled receptor proteins and nucleic acids encoding same
GB2380197A (en) * 2000-05-26 2003-04-02 Aeomica Inc Myosin-like gene expressed in human heart and muscle
WO2001092524A2 (en) * 2000-05-26 2001-12-06 Aeomica, Inc. Myosin-like gene expressed in human heart and muscle
EP1158049A1 (en) * 2000-05-26 2001-11-28 Aeomica, INC. Myosin-like gene expressed in human heart and muscle
EP1659177A3 (en) * 2000-06-02 2006-05-31 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids ancoding the same
WO2001096575A1 (en) * 2000-06-14 2001-12-20 Sankyo Company, Limited Ceramide kinase and dna encoding the same
WO2001096561A1 (en) * 2000-06-16 2001-12-20 Merck Patent Gmbh Hunc-2, human member of unc-protein family
EP1176200A3 (en) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases or wound healing and their use in indentifying pharmacologically acitve substances
EP1295940A4 (en) * 2000-06-26 2005-01-12 Ajinomoto Kk Polypeptides, use thereof and process for producing the same
WO2002000691A2 (en) * 2000-06-27 2002-01-03 Curagen Corporation Polynucleotides and polypeptides encoded thereby
EP1320590A2 (en) * 2000-07-13 2003-06-25 Millennium Pharmaceuticals, Inc. 47885, a novel human ubiquitin-activating enzyme and uses therefor
EP1174502A1 (en) * 2000-07-18 2002-01-23 Schering Corporation Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
US6740751B2 (en) 2000-07-18 2004-05-25 Board Of Regents, The University Of Texas System Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
AU2001283062A1 (en) * 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
PT1309690E (en) * 2000-08-18 2006-10-31 Merck Patent Gmbh MFQ-111, A NEW PROTEIN OF THE HUMAN GTPASE TYPE
CA2420101A1 (en) * 2000-08-24 2002-02-28 Incyte Genomics, Inc. Kidney-specific protein
AU2001293778A1 (en) * 2000-08-28 2002-03-13 Lion Bioscience Ag Novel cofactors of the pregnane x receptor and methods of use
US7166428B2 (en) 2000-08-31 2007-01-23 Millennium Pharmaceuticals, Inc. 62112, a novel human dehydrogenase and uses thereof
AU2001290860A1 (en) * 2000-09-21 2002-04-02 The Regents Of The University Of California Spas-1 cancer antigen
EP1323732B9 (en) * 2000-09-22 2008-02-27 Kyowa Hakko Kogyo Co., Ltd. Beta-catenin nuclear localizing protein
WO2002024744A2 (en) * 2000-09-25 2002-03-28 Millennium Pharmaceuticals, Inc. 49938, a human phospholipid transporter and uses therefor
WO2002026955A2 (en) * 2000-09-29 2002-04-04 Lexicon Genetics Incorporated Human proteases and polynucleotides encoding the same
JP2004528006A (en) * 2000-09-29 2004-09-16 インサイト・ゲノミックス・インコーポレイテッド Secreted protein
US20020150916A1 (en) * 2000-10-05 2002-10-17 Rachel Meyers 43716, a novel human G-protein and uses thereof
NZ525422A (en) 2000-10-06 2006-09-29 Biogen Idec Inc Isolated polynucleotides comprising a nucleic acid which encodes a polypeptide which modulates axonal growth in CNS neurons
HUP0301356A3 (en) * 2000-10-12 2010-03-29 Ferring Bv Novel serine protease genes related to dppiv
WO2002033062A1 (en) * 2000-10-16 2002-04-25 Bayer Aktiengesellschaft REGULATION OF HUMAN ACYL-CoA DEHYDROGENASE
US20020119518A1 (en) * 2000-10-17 2002-08-29 Merkulov Gennady V. Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2001295778A1 (en) * 2000-10-20 2002-04-29 Inpharmatica Limited Novel cysteine proteases and uses thereof
FR2822165B1 (en) * 2000-10-24 2004-12-24 Aventis Pharma Sa NUCLEIC ACID REGULATING THE ABCA7 GENE, MOLECULES MODULATING ITS ACTIVITY AND THERAPEUTIC APPLICATIONS
JP2004512045A (en) * 2000-10-24 2004-04-22 アベンティス・ファーマ・ソシエテ・アノニム Nucleic acids that regulate the ABCA7 gene, molecules that modulate its activity, and therapeutic uses
AUPR107800A0 (en) * 2000-10-27 2000-11-23 University Of Sydney, The Peptide and nucleic acid molecule ii
MXPA03003745A (en) * 2000-10-30 2003-10-15 Bristol Myers Squibb Co Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme.
WO2002036781A2 (en) * 2000-10-31 2002-05-10 Bayer Aktiengesellschaft Regulation of human glutathione-s-transferase
US20030032776A1 (en) * 2000-11-02 2003-02-13 Feder John N. Polynucleotide encoding a novel human potassium channel beta-subunit, K+Mbeta1
AU2002227929A1 (en) * 2000-11-17 2002-05-27 Bayer Aktiengesellschaft Regulation of human nmda receptor
WO2002042457A1 (en) 2000-11-22 2002-05-30 Bristol-Myers Squibb Company Cloning and expression of human slap-2: a novel sh2/sh3 domain-containing human slap homologue having immune cell-specific expression
CA2324663A1 (en) * 2000-11-27 2002-05-27 The Hospital For Sick Children A novel adapter gene
WO2002044358A2 (en) * 2000-11-28 2002-06-06 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3
AU2001297765A1 (en) * 2000-12-05 2002-10-21 Incyte Genomics, Inc. Ligases
AU2002235748A1 (en) * 2000-12-05 2002-06-18 Bayer Aktiengesellschaft Regulation of human patched-like protein
WO2002046767A2 (en) * 2000-12-08 2002-06-13 Oxford Glycosciences (Uk) Ltd. Diagnosis and treatment of alzheimer's disease
EP1343899A2 (en) * 2000-12-14 2003-09-17 Bayer Aktiengesellschaft Regulation of human uridine kinase
EP1350847A4 (en) * 2001-01-09 2005-12-28 Inst Of Gene And Brain Science Human glioma antigen and process for preparing the same
US7122345B2 (en) 2001-01-09 2006-10-17 Curagen Corporation Nucleic acid encoding a NOVX13 polypeptide
US20030059924A1 (en) * 2001-01-10 2003-03-27 Helen Mancebo Cloning of a novel inhibitor of antigen-receptor signaling by a retroviral-based functional screen
US6605710B2 (en) * 2001-01-11 2003-08-12 Board Of Trustees Of Michigan State University Gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages
US20020119523A1 (en) * 2001-01-17 2002-08-29 Millennium Pharmaceuticals, Inc. 67073, a human phospholipid transporter family member and uses therefor
US7317085B2 (en) * 2001-01-22 2008-01-08 Shinae Kondoh Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby
WO2002063006A2 (en) * 2001-02-06 2002-08-15 Incyte Genomics, Inc. Receptors and membrane-associated proteins
JP2004529620A (en) * 2001-02-07 2004-09-30 ユニベルシテイト マーストリヒト Markers of unstable atherosclerotic plaque
WO2002064783A2 (en) * 2001-02-09 2002-08-22 Lion Bioscience Ag Novel cofactors of the estrogen receptor beta and methods of use
AU2002250911A1 (en) * 2001-02-12 2002-08-28 Bayer Aktiengesellschaft Isolated polynucleotides encoding putative tyrosine kinase
WO2002064777A2 (en) * 2001-02-14 2002-08-22 Axaron Bioscience Ag Proteins 7b6 and 11b4 and dna sequences encoding the same
GB0104440D0 (en) * 2001-02-22 2001-04-11 Oxford Biomedica Ltd Novel genes
EP1365801A4 (en) * 2001-03-08 2004-10-13 Nuvelo Inc Methods and materials relating to fibulin-like polypeptides and polynucleotides
EP1373526A4 (en) * 2001-03-08 2006-01-25 Curagen Corp Therapeutic polypeptides, nucleic acids encoding same, and methodes of use
WO2002074906A2 (en) * 2001-03-16 2002-09-26 Eli Lilly And Company Lp mammalian proteins; related reagents
AU2002258622A1 (en) * 2001-03-27 2002-10-08 Human Genome Sciences, Inc. Human secreted proteins
US6913904B2 (en) * 2001-03-27 2005-07-05 Applera Corporation Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
US20020168668A1 (en) * 2001-03-27 2002-11-14 Millennium Pharmaceuticals, Inc. 14691, a human glutamate receptor family member and uses therefor
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
JP2005507236A (en) * 2001-04-03 2005-03-17 キュラジェン コーポレイション Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding antigens, and methods of use
WO2002083919A2 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
CA2443123A1 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US6607895B2 (en) 2001-04-16 2003-08-19 Lexicon Genetics Incorporated Human adenylsuccinate synthetase and polynucleotides encoding the same
US7309760B2 (en) * 2001-04-17 2007-12-18 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
AU2002254615A1 (en) * 2001-04-17 2002-10-28 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
CA2443770A1 (en) * 2001-04-23 2002-10-31 Curagen Corporation Proteins and nucleic acids encoding same
CA2445532A1 (en) * 2001-04-27 2002-11-07 Sunnybrook & Women's College Health Sciences Centre Breast cancer-associated genes and uses thereof
AUPR470101A0 (en) 2001-05-02 2001-05-24 Murdoch Childrens Research Institute, The A molecular marker
US20030017159A1 (en) * 2001-05-02 2003-01-23 Jerome Ritz Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
CN100463967C (en) * 2001-05-29 2009-02-25 人体细胞组织有限公司 testicular carnitine transporter and its gene
US7157558B2 (en) 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors
AU2002327176A1 (en) * 2001-06-06 2002-12-16 Human Genome Sciences, Inc. 20 human secreted proteins
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
EG26529A (en) * 2001-06-11 2014-01-27 مونسانتو تكنولوجى ل ل سى Cotton event mon 15985 and compositions and methods for detection thereof
EP1407049A4 (en) * 2001-06-19 2005-03-23 David Gladstone Inst Histone deacetylase and methods of use thereof
JP2005505258A (en) * 2001-06-21 2005-02-24 イシス・イノベイション・リミテッド ANGE gene in atopy
AT410945B (en) * 2001-06-27 2003-08-25 Burkhard Dr Jansen Diagnosis of multiple sclerosis or tumors, by detecting absence of wild-type stem cell factor-apoptosis response gene, or the derived protein, also new nucleic acids
CA2451374A1 (en) * 2001-07-05 2003-01-16 Wyeth Aggrecanase molecules
JP4702819B2 (en) 2001-08-01 2011-06-15 生化学工業株式会社 Chondroitin synthase
GB2399087A (en) * 2001-08-02 2004-09-08 Aeomica Inc Human zinc finger containing gene MDZ7
WO2003102029A1 (en) * 2001-08-15 2003-12-11 Endocube Sas Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion
CA2461094A1 (en) 2001-09-25 2003-04-03 Sony Corporation P300 histone acetylase inhibitor
WO2003031627A1 (en) * 2001-09-28 2003-04-17 Hokkaido Technology Licensing Office Co., Ltd. Platelet-origin polypeptides having sphingosine kinase activity and sphingosine kinase genes encoding the same
DE10148037A1 (en) * 2001-09-28 2003-04-17 Aventis Behring Gmbh Use of the protease activating the blood coagulation factor VII for the prophylaxis and therapy of vaso-proliferative diseases
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
US20040253598A1 (en) * 2001-10-26 2004-12-16 Baughn Mariah R. Vesicle-associated proteins
JPWO2003037930A1 (en) * 2001-10-29 2005-02-17 財団法人かずさディー・エヌ・エー研究所 Novel human N-methyl-D-aspartate (NMDA) glutamate receptor polypeptide and gene encoding the same
GB2381526A (en) * 2001-11-03 2003-05-07 Sequenom Inc Detection of predisposition to osteoporosis
US7129063B2 (en) 2001-11-16 2006-10-31 Eisai Co., Ltd. Exocrine gland tight junction-constituting protein jeap family
ES2605445T3 (en) 2001-11-26 2017-03-14 Hivih Protein-protein interactions in the human immunodeficiency virus
AUPR913901A0 (en) * 2001-11-27 2001-12-20 Children's Medical Research Institute Muscle transcription factors
AU2002365894A1 (en) 2001-11-30 2003-06-17 Children's Hospital Medical Center Antibodies to magmas and uses thereof
ATE451387T1 (en) * 2001-12-18 2009-12-15 Endocube Sas NEW CELL DEATH-ASSOCIATED PROTEINS FROM THE THAP FAMILY AND PAR4-RELATED SIGNALING PATHWAYS INVOLVED IN THE CONTROL OF APOPTOSIS
US7858297B2 (en) 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
WO2003064654A1 (en) * 2002-02-01 2003-08-07 Bayer Healthcare Ag Human serine/threonine protein kinase
JP2003252801A (en) * 2002-02-27 2003-09-10 Japan Science & Technology Corp Method for using pituitary-specific gene
WO2003079884A2 (en) 2002-03-19 2003-10-02 Children's Medical Center Corporation Methods for diagnosis and prognosis of cancer
WO2003083049A2 (en) 2002-03-22 2003-10-09 Munin Corporation Cloning and characterization of g+c-rich promoter binding protein
US7473526B2 (en) * 2002-03-29 2009-01-06 Veridex, Llc Breast cancer prognostic portfolio
AU2003240572A1 (en) * 2002-05-30 2003-12-19 Avalon Pharmaceuticals, Inc. Cancer-linked gene as target for chemotherapy
AU2003260618A1 (en) * 2002-06-24 2004-01-06 Exonhit Therapeutics Sa Treatment of amyotrophic lateral sclerosis using pgc-1 activity-modulating compounds
GB0215406D0 (en) * 2002-07-03 2002-08-14 Inpharmatica Ltd Protein
US7115402B2 (en) 2002-07-09 2006-10-03 Bristol-Myers Squibb Company Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42
US7122358B2 (en) 2002-07-09 2006-10-17 Bristol-Myers Squibb Company Testis-specific tubulin tyrosine-ligase-like protein, BGS42
CN1671843B (en) 2002-07-25 2010-07-14 索尼株式会社 Factor participating in transcriptional regulation
WO2004012817A2 (en) * 2002-07-31 2004-02-12 Kylix B.V. Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
DE10309368A1 (en) * 2002-08-06 2004-02-26 Aventis Behring Gmbh Intellectual Property/Legal Pharmaceutical preparation with RNA as a cofactor of hemostasis
US7408048B2 (en) 2002-08-09 2008-08-05 Melbourne Health Mammalian grainyhead transcription factors
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
AU2003267097B2 (en) * 2002-09-11 2009-09-17 Genentech, Inc. Novel composition and methods for the treatment of psoriasis
GB2409680B (en) * 2002-10-02 2006-09-20 Us Gov Health & Human Serv Methods and medicaments for controlling proliferation of cells
AU2003291990A1 (en) * 2002-10-25 2004-05-13 Technische Universitaet Muenchen Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof
CA2505919A1 (en) * 2002-11-15 2004-06-03 The Board Of Trustees Of The University Of Arkansas Ca125 gene and its use for diagnostic and therapeutic interventions
DE10254601A1 (en) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
AU2003297696A1 (en) * 2002-12-05 2004-06-30 Diadexus, Inc. Compositions,splice variants and methods relating to breast specific genes and proteins
GB0228337D0 (en) * 2002-12-05 2003-01-08 Yorkshire Cancer Res Campaign Replication protein
EP1576005A2 (en) * 2002-12-27 2005-09-21 Applied Research Systems ARS Holding N.V. Notch-like polypeptides
US7326768B2 (en) 2003-02-05 2008-02-05 Juan Saus Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
PL1606409T3 (en) 2003-03-19 2011-02-28 Biogen Ma Inc Nogo receptor binding protein
EP2311468B1 (en) 2003-08-08 2014-01-15 Perseus Proteomics Inc. Gene overexpressed in cancer
US20060216292A1 (en) * 2003-09-05 2006-09-28 Cellzome Ag Treatment of neurodegenerative diseases
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
EP1734998A2 (en) 2004-04-14 2006-12-27 Genentech, Inc. Compositions and methods comprising an egfl7 antagonist for modulating vascular development
DE102004024617A1 (en) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
US20090239793A1 (en) * 2004-09-24 2009-09-24 Isabella Caniggia Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover
GB0426960D0 (en) 2004-12-08 2005-01-12 Ares Trading Sa TGR-3 like protein receptor
WO2006094813A2 (en) * 2005-03-10 2006-09-14 Nascacell Technologies Ag. Dimeric or multimeric microproteins
US7893032B2 (en) 2005-07-07 2011-02-22 Yale University NgR variants and compositions thereof for suppressing axonal growth inhibition
SI1904104T1 (en) 2005-07-08 2013-12-31 Biogen Idec Ma Inc. Sp35 antibodies and uses thereof
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
US7811787B2 (en) 2006-04-25 2010-10-12 Bristol-Myers Squibb Company Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3
US8128926B2 (en) 2007-01-09 2012-03-06 Biogen Idec Ma Inc. Sp35 antibodies and uses thereof
CA2729961C (en) 2008-07-09 2018-05-01 Biogen Idec Ma Inc. Li113, li62 variant co2, anti-lingo antibodies
DE102008045696A1 (en) 2008-09-04 2010-03-11 Drk Blutspendedienst West Ggmbh Granulocyte HNA-3a / b antigen
CA2746256C (en) * 2008-12-09 2020-03-24 Loren D. Walensky Methods and compositions for specific modulation of mcl-1
US8444983B2 (en) 2009-03-23 2013-05-21 Quark Pharmaceuticals, Inc. Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases
TWI428142B (en) 2009-05-08 2014-03-01 Genentech Inc Humanized anti-egfl7 antibodies and methods using same
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
MX2014013950A (en) 2012-05-14 2015-02-17 Biogen Idec Inc Lingo-2 antagonists for treatment of conditions involving motor neurons.
WO2013174404A1 (en) 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
CA2890438C (en) 2012-11-13 2022-10-18 Biontech Ag Agents for treatment of claudin expressing cancer diseases
WO2014127785A1 (en) 2013-02-20 2014-08-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
WO2014146672A1 (en) 2013-03-18 2014-09-25 Ganymed Pharmaceuticals Ag Therapy involving antibodies against claudin 18.2 for treatment of cancer
WO2015082525A1 (en) * 2013-12-03 2015-06-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Mafb mutants and uses thereof
CA2973266A1 (en) 2015-01-08 2016-07-14 Biogen Ma Inc. Lingo-1 antagonists and uses for treatment of demyelinating disorders
CN112190710B (en) * 2020-10-28 2021-07-30 江苏省人民医院(南京医科大学第一附属医院) Application of lipid-derived polypeptide in preparation of metastatic breast cancer targeted drug
WO2022212928A1 (en) * 2021-04-02 2022-10-06 The Regents Of The University Of California Modified viruses and viral particles, methods of making, and uses thereof

Also Published As

Publication number Publication date
WO2000058473A2 (en) 2000-10-05
JP2004507202A (en) 2004-03-11
EP1165784A2 (en) 2002-01-02
AU3774500A (en) 2000-10-16
WO2000058473A3 (en) 2001-01-25

Similar Documents

Publication Publication Date Title
CA2383592A1 (en) 2384891 acids including open reading frames encoding polypeptides; orfx
WO2001092523A2 (en) Human polynucleotides and polypeptides encoded thereby
AU766279B2 (en) Novel secreted proteins and polynucleotides encoding them
WO2001090366A2 (en) Human polynucleotides and polypeptides encoded thereby
US20020082206A1 (en) Novel polynucleotides from atherogenic cells and polypeptides encoded thereby
US6620615B1 (en) G-protein coupled receptor—encoding nucleic acids
US20030199103A1 (en) Novel amino acid sequences for human epidermal growth factor-like polypeptides
AU2005200105A1 (en) Novel Polynucleotides and Polypeptides Encoded Thereby
AU2001251247A1 (en) Wnt-7b-like polypeptides and nucleic acids encoding same
US7566536B2 (en) WNT-regulated cytokine-like polypeptide and nucleic acids encoding same
AU4216800A (en) Novel human proteins and polynucleotides encoding them
US20030017457A1 (en) Novel polynucleotides and polypeptides encoded thereby
AU6785700A (en) Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
US20040014173A1 (en) Novel polynucleotides, polypeptides encoded thereby and methods of use thereof
CA2375424A1 (en) Novel polynucleotides and polypeptides encoded thereby
WO2001036644A2 (en) Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
WO2001027277A2 (en) Proteins and polynucleotides encoded thereby
EP1469073A2 (en) Polynucleotides and membrane-bound polypeptides encoded thereby
JP2004527202A (en) Novel polynucleotides and polypeptides encoded thereby

Legal Events

Date Code Title Description
FZDE Dead